word,dsocial science,dengineering,dmedicine,d-lifescience
,0.192844677138,0.306864456079,0.396451425247,0.103839441536
Cognition,0.193598750976,0.302888368462,0.39968774395,0.0991412958626
Attention,0.173661360347,0.292329956585,0.421128798842,0.112879884226
Memory,0.191860465116,0.27519379845,0.414728682171,0.116279069767
Schizophrenia,0.210204081633,0.287755102041,0.412244897959,0.0897959183673
Social cognition,0.20351758794,0.276381909548,0.429648241206,0.0904522613065
Working memory,0.191977077364,0.355300859599,0.355300859599,0.0974212034384
Neuropsychology,0.155172413793,0.278735632184,0.416666666667,0.0775862068966
fMRI,0.191740412979,0.306784660767,0.412979351032,0.0884955752212
Aging,0.222950819672,0.27868852459,0.396721311475,0.101639344262
Alzheimer's disease,0.230215827338,0.255395683453,0.424460431655,0.089928057554
Emotion,0.186813186813,0.29304029304,0.432234432234,0.0879120879121
FMRI,0.205882352941,0.27731092437,0.403361344538,0.113445378151
Perception,0.122881355932,0.237288135593,0.279661016949,0.0889830508475
Executive function,0.206730769231,0.293269230769,0.418269230769,0.0817307692308
Dementia,0.184466019417,0.257281553398,0.446601941748,0.0922330097087
Parkinson's disease,0.219387755102,0.290816326531,0.40306122449,0.0867346938776
cognition,0.230769230769,0.328205128205,0.358974358974,0.0820512820513
Depression,0.188481675393,0.340314136126,0.403141361257,0.0628272251309
Spatial cognition,0.229885057471,0.298850574713,0.373563218391,0.0977011494253
Cognitive function,0.166666666667,0.32183908046,0.402298850575,0.103448275862
Vision,0.201219512195,0.365853658537,0.353658536585,0.0731707317073
EEG,0.179012345679,0.320987654321,0.401234567901,0.0987654320988
Autism,0.2,0.264516129032,0.425806451613,0.109677419355
Children,0.258064516129,0.290322580645,0.4,0.0516129032258
Prefrontal cortex,0.209459459459,0.283783783784,0.398648648649,0.108108108108
Language,0.20979020979,0.20979020979,0.328671328671,0.132867132867
Event-related potentials,0.181818181818,0.356643356643,0.377622377622,0.0699300699301
Cognitive control,0.232394366197,0.30985915493,0.394366197183,0.056338028169
Cognitive impairment,0.264705882353,0.286764705882,0.330882352941,0.110294117647
Embodied cognition,0.174242424242,0.25,0.44696969697,0.128787878788
Learning,0.160305343511,0.251908396947,0.465648854962,0.12213740458
ERP,0.178294573643,0.193798449612,0.53488372093,0.093023255814
Hippocampus,0.1875,0.3125,0.3515625,0.1328125
Mild cognitive impairment,0.196850393701,0.354330708661,0.354330708661,0.0944881889764
Eye movements,0.188976377953,0.291338582677,0.409448818898,0.110236220472
Visual attention,0.24,0.368,0.328,0.064
Visual perception,0.225806451613,0.225806451613,0.411290322581,0.137096774194
Visual search,0.131578947368,0.298245614035,0.5,0.0701754385965
Development,0.2,0.309090909091,0.4,0.0727272727273
Visual cognition,0.238532110092,0.330275229358,0.357798165138,0.0733944954128
Reaction time,0.198113207547,0.301886792453,0.396226415094,0.103773584906
Multiple sclerosis,0.153846153846,0.298076923077,0.432692307692,0.115384615385
Theory of mind,0.203883495146,0.300970873786,0.388349514563,0.106796116505
Executive functions,0.257425742574,0.257425742574,0.425742574257,0.0594059405941
Anxiety,0.19,0.29,0.42,0.1
Functional magnetic resonance imaging,0.212121212121,0.363636363636,0.343434343434,0.0808080808081
Stroke,0.103092783505,0.319587628866,0.453608247423,0.123711340206
Reading,0.223404255319,0.244680851064,0.414893617021,0.117021276596
Rehabilitation,0.139784946237,0.333333333333,0.430107526882,0.0967741935484
Elderly,0.266666666667,0.211111111111,0.444444444444,0.0666666666667
Amygdala,0.25,0.306818181818,0.363636363636,0.0795454545455
P300,0.204545454545,0.25,0.386363636364,0.159090909091
attention,0.176470588235,0.294117647059,0.411764705882,0.117647058824
Numerical cognition,0.164705882353,0.270588235294,0.447058823529,0.117647058824
Cognitive development,0.253012048193,0.349397590361,0.289156626506,0.10843373494
Neuropsychological tests,0.192771084337,0.265060240964,0.433734939759,0.10843373494
Selective attention,0.1875,0.3,0.45,0.0625
MRI,0.275,0.3125,0.3375,0.075
Human,0.230769230769,0.333333333333,0.358974358974,0.0769230769231
Quality of life,0.179487179487,0.179487179487,0.487179487179,0.141025641026
Face processing,0.155844155844,0.311688311688,0.441558441558,0.0909090909091
Inhibition,0.181818181818,0.324675324675,0.363636363636,0.12987012987
Neuroimaging,0.233766233766,0.298701298701,0.415584415584,0.0519480519481
memory,0.186666666667,0.213333333333,0.506666666667,0.0933333333333
Functional connectivity,0.2,0.266666666667,0.373333333333,0.16
Cognitive,0.27027027027,0.256756756757,0.378378378378,0.0945945945946
Episodic memory,0.256756756757,0.310810810811,0.351351351351,0.0810810810811
Epilepsy,0.208333333333,0.263888888889,0.375,0.152777777778
Object recognition,0.125,0.444444444444,0.333333333333,0.0972222222222
ERPs,0.147058823529,0.264705882353,0.455882352941,0.117647058824
Psychosis,0.176470588235,0.205882352941,0.485294117647,0.132352941176
Neurocognition,0.176470588235,0.25,0.470588235294,0.102941176471
Cognitive performance,0.194029850746,0.283582089552,0.402985074627,0.119402985075
Event-related potential,0.328358208955,0.268656716418,0.298507462687,0.089552238806
Face perception,0.179104477612,0.298507462687,0.328358208955,0.179104477612
Dopamine,0.272727272727,0.30303030303,0.333333333333,0.0909090909091
Cognitive functions,0.169230769231,0.353846153846,0.353846153846,0.123076923077
Bipolar disorder,0.215384615385,0.307692307692,0.369230769231,0.107692307692
Categorization,0.230769230769,0.292307692308,0.369230769231,0.107692307692
Magnetic resonance imaging,0.21875,0.203125,0.40625,0.140625
Traumatic brain injury,0.301587301587,0.349206349206,0.269841269841,0.0793650793651
Brain,0.290322580645,0.306451612903,0.306451612903,0.0806451612903
Intelligence,0.213114754098,0.245901639344,0.459016393443,0.0819672131148
Cerebellum,0.180327868852,0.344262295082,0.426229508197,0.0491803278689
Processing speed,0.25,0.25,0.45,0.05
Visual,0.216666666667,0.25,0.433333333333,0.1
Decision making,0.254237288136,0.220338983051,0.474576271186,0.0508474576271
Consciousness,0.254237288136,0.186440677966,0.406779661017,0.152542372881
Mood,0.224137931034,0.172413793103,0.534482758621,0.0689655172414
Gender,0.172413793103,0.327586206897,0.327586206897,0.172413793103
Face recognition,0.310344827586,0.327586206897,0.310344827586,0.051724137931
aging,0.181818181818,0.345454545455,0.436363636364,0.0363636363636
working memory,0.181818181818,0.4,0.345454545455,0.0727272727273
Sex differences,0.203703703704,0.277777777778,0.351851851852,0.166666666667
Mental rotation,0.222222222222,0.259259259259,0.444444444444,0.0740740740741
Individual differences,0.277777777778,0.203703703704,0.388888888889,0.12962962963
Neurosurgery and Psychiatry",0.0,0.0,0.0,0.0
Ageing,0.132075471698,0.490566037736,0.320754716981,0.0566037735849
Neuropsychological assessment,0.245283018868,0.22641509434,0.415094339623,0.0943396226415
Functional MRI,0.211538461538,0.326923076923,0.307692307692,0.153846153846
schizophrenia,0.192307692308,0.25,0.423076923077,0.134615384615
Alzheimer disease,0.21568627451,0.333333333333,0.372549019608,0.078431372549
Visual cortex,0.26,0.28,0.34,0.12
Magnetoencephalography,0.2,0.36,0.3,0.14
Faces,0.18,0.26,0.48,0.08
ADHD,0.16,0.36,0.34,0.14
Driving,0.16,0.32,0.38,0.14
Behavior,0.26,0.28,0.34,0.1
Navigation,0.163265306122,0.30612244898,0.34693877551,0.183673469388
Pain,0.285714285714,0.285714285714,0.326530612245,0.102040816327
Basal ganglia,0.354166666667,0.166666666667,0.4375,0.0416666666667
Metacognition,0.229166666667,0.25,0.395833333333,0.125
Affective and Behavioral Neuroscience",0.0,0.0,0.0,0.0
Assessment,0.0851063829787,0.404255319149,0.404255319149,0.106382978723
Priming,0.127659574468,0.382978723404,0.425531914894,0.063829787234
Auditory,0.282608695652,0.239130434783,0.369565217391,0.108695652174
social cognition,0.152173913043,0.304347826087,0.413043478261,0.130434782609
Eye tracking,0.173913043478,0.217391304348,0.478260869565,0.130434782609
Information processing,0.239130434783,0.304347826087,0.304347826087,0.130434782609
Action,0.217391304348,0.282608695652,0.369565217391,0.130434782609
Task switching,0.108695652174,0.326086956522,0.478260869565,0.0869565217391
Electroencephalography,0.222222222222,0.244444444444,0.444444444444,0.0888888888889
Spatial memory,0.0666666666667,0.377777777778,0.4,0.155555555556
Stress,0.111111111111,0.377777777778,0.466666666667,0.0444444444444
Reward,0.159090909091,0.340909090909,0.431818181818,0.0681818181818
dementia,0.279069767442,0.255813953488,0.302325581395,0.162790697674
Alcohol,0.186046511628,0.372093023256,0.302325581395,0.139534883721
Infancy,0.209302325581,0.232558139535,0.488372093023,0.0697674418605
Parietal cortex,0.238095238095,0.309523809524,0.309523809524,0.142857142857
Spatial attention,0.190476190476,0.238095238095,0.428571428571,0.142857142857
Cognitive aging,0.166666666667,0.357142857143,0.428571428571,0.047619047619
Saccades,0.214285714286,0.404761904762,0.333333333333,0.047619047619
Attentional bias,0.170731707317,0.365853658537,0.414634146341,0.0487804878049
Eye-tracking,0.15,0.25,0.55,0.05
N400,0.15,0.25,0.45,0.15
Visual memory,0.1,0.375,0.45,0.075
P3,0.075,0.35,0.3,0.25
Plasticity,0.153846153846,0.435897435897,0.333333333333,0.0769230769231
Cognitive decline,0.282051282051,0.307692307692,0.384615384615,0.025641025641
neuropsychology,0.179487179487,0.307692307692,0.358974358974,0.153846153846
Williams syndrome,0.230769230769,0.282051282051,0.358974358974,0.128205128205
Semantics,0.179487179487,0.333333333333,0.358974358974,0.128205128205
Face,0.102564102564,0.307692307692,0.461538461538,0.128205128205
Outcome,0.105263157895,0.5,0.315789473684,0.0789473684211
N170,0.0789473684211,0.342105263158,0.5,0.0789473684211
Hallucinations,0.236842105263,0.236842105263,0.421052631579,0.105263157895
Virtual reality,0.135135135135,0.432432432432,0.297297297297,0.135135135135
Monkey,0.189189189189,0.459459459459,0.27027027027,0.0810810810811
Motivation,0.305555555556,0.25,0.277777777778,0.166666666667
Biological motion,0.166666666667,0.416666666667,0.388888888889,0.0277777777778
emotion,0.222222222222,0.25,0.472222222222,0.0555555555556
Emotion recognition,0.194444444444,0.333333333333,0.388888888889,0.0833333333333
Executive functioning,0.228571428571,0.228571428571,0.457142857143,0.0571428571429
Impulsivity,0.285714285714,0.228571428571,0.371428571429,0.114285714286
Resting state,0.171428571429,0.371428571429,0.428571428571,0.0285714285714
Dyslexia,0.0571428571429,0.314285714286,0.542857142857,0.0857142857143
Arousal,0.228571428571,0.285714285714,0.342857142857,0.142857142857
MEG,0.342857142857,0.2,0.371428571429,0.0857142857143
Multisensory integration,0.176470588235,0.205882352941,0.5,0.117647058824
Mental imagery,0.264705882353,0.411764705882,0.294117647059,0.0294117647059
Facial expression,0.0882352941176,0.235294117647,0.5,0.176470588235
Cognitive deficits,0.0882352941176,0.235294117647,0.529411764706,0.147058823529
Emotion regulation,0.264705882353,0.323529411765,0.294117647059,0.0882352941176
Empathy,0.323529411765,0.264705882353,0.352941176471,0.0588235294118
Affect,0.205882352941,0.235294117647,0.558823529412,0.0
Psychophysics,0.147058823529,0.235294117647,0.529411764706,0.0882352941176
Visual working memory,0.272727272727,0.272727272727,0.363636363636,0.0909090909091
Motor control,0.181818181818,0.272727272727,0.484848484848,0.0606060606061
Expertise,0.242424242424,0.30303030303,0.393939393939,0.0606060606061
Mirror neurons,0.181818181818,0.363636363636,0.393939393939,0.0606060606061
Child,0.151515151515,0.333333333333,0.515151515152,0.0
Adolescence,0.0909090909091,0.30303030303,0.484848484848,0.121212121212
Awareness,0.242424242424,0.333333333333,0.333333333333,0.0909090909091
Familiarity,0.181818181818,0.242424242424,0.454545454545,0.121212121212
Transcranial magnetic stimulation,0.151515151515,0.212121212121,0.545454545455,0.0909090909091
Semantic memory,0.212121212121,0.454545454545,0.333333333333,0.0
Diffusion tensor imaging,0.212121212121,0.393939393939,0.272727272727,0.0606060606061
Temporal lobe epilepsy,0.09375,0.40625,0.46875,0.03125
Embodiment,0.125,0.34375,0.46875,0.0625
Cognitive dysfunction,0.15625,0.1875,0.53125,0.125
Balance,0.125,0.25,0.5625,0.0625
mild cognitive impairment,0.34375,0.25,0.28125,0.125
Short-term memory,0.193548387097,0.290322580645,0.483870967742,0.0322580645161
Older adults,0.0645161290323,0.354838709677,0.451612903226,0.129032258065
Cognition disorders,0.161290322581,0.161290322581,0.612903225806,0.0645161290323
Infant,0.225806451613,0.225806451613,0.387096774194,0.129032258065
Frontal lobe,0.322580645161,0.322580645161,0.322580645161,0.0322580645161
Rat,0.266666666667,0.266666666667,0.366666666667,0.1
Cognitive flexibility,0.133333333333,0.433333333333,0.333333333333,0.1
Perspective taking,0.166666666667,0.5,0.266666666667,0.0666666666667
Aphasia,0.2,0.2,0.566666666667,0.0333333333333
Infant cognition,0.333333333333,0.3,0.233333333333,0.133333333333
Laterality,0.166666666667,0.2,0.5,0.133333333333
Eye movement,0.2,0.266666666667,0.433333333333,0.1
Visual discrimination,0.2,0.4,0.266666666667,0.133333333333
Inhibitory control,0.275862068966,0.310344827586,0.241379310345,0.137931034483
Fatigue,0.172413793103,0.344827586207,0.310344827586,0.137931034483
Anterior cingulate cortex,0.206896551724,0.344827586207,0.344827586207,0.103448275862
Communication,0.137931034483,0.241379310345,0.51724137931,0.103448275862
Endophenotype,0.241379310345,0.241379310345,0.344827586207,0.172413793103
Child development,0.310344827586,0.172413793103,0.275862068966,0.241379310345
PET,0.206896551724,0.413793103448,0.344827586207,0.0
Recognition,0.241379310345,0.275862068966,0.379310344828,0.103448275862
Dual task,0.172413793103,0.344827586207,0.379310344828,0.103448275862
Cognitive load,0.172413793103,0.51724137931,0.310344827586,0.0
Cognitive functioning,0.206896551724,0.344827586207,0.379310344828,0.0689655172414
Acetylcholine,0.103448275862,0.448275862069,0.275862068966,0.172413793103
Recognition memory,0.172413793103,0.206896551724,0.448275862069,0.172413793103
Concussion,0.214285714286,0.392857142857,0.321428571429,0.0714285714286
Down syndrome,0.107142857143,0.321428571429,0.464285714286,0.107142857143
SYSNEURO,0.214285714286,0.357142857143,0.392857142857,0.0357142857143
Frontotemporal dementia,0.214285714286,0.214285714286,0.464285714286,0.0714285714286
Decision-making,0.285714285714,0.357142857143,0.357142857143,0.0
Lateralization,0.178571428571,0.321428571429,0.357142857143,0.142857142857
MCI,0.142857142857,0.357142857143,0.321428571429,0.178571428571
Serotonin,0.142857142857,0.285714285714,0.428571428571,0.142857142857
Distraction,0.214285714286,0.285714285714,0.428571428571,0.0714285714286
Visual processing,0.25,0.392857142857,0.321428571429,0.0357142857143
Emotions,0.0714285714286,0.178571428571,0.607142857143,0.142857142857
Nicotine,0.214285714286,0.285714285714,0.357142857143,0.142857142857
Adaptation,0.25,0.285714285714,0.392857142857,0.0714285714286
perception,0.222222222222,0.148148148148,0.481481481481,0.148148148148
depression,0.259259259259,0.296296296296,0.296296296296,0.148148148148
Meta-analysis,0.37037037037,0.333333333333,0.259259259259,0.037037037037
Context,0.111111111111,0.518518518519,0.333333333333,0.037037037037
Imagery,0.185185185185,0.333333333333,0.333333333333,0.148148148148
Adolescents,0.222222222222,0.407407407407,0.37037037037,0.0
Longitudinal,0.259259259259,0.444444444444,0.259259259259,0.037037037037
White matter,0.333333333333,0.222222222222,0.333333333333,0.111111111111
Divided attention,0.148148148148,0.333333333333,0.37037037037,0.148148148148
Parietal,0.222222222222,0.296296296296,0.407407407407,0.0740740740741
Multisensory,0.333333333333,0.148148148148,0.407407407407,0.111111111111
Caffeine,0.307692307692,0.346153846154,0.269230769231,0.0769230769231
Neglect,0.0769230769231,0.230769230769,0.423076923077,0.269230769231
Blindness,0.0769230769231,0.423076923077,0.384615384615,0.115384615385
Dementia with Lewy bodies,0.307692307692,0.307692307692,0.307692307692,0.0769230769231
Visual impairment,0.0769230769231,0.346153846154,0.423076923077,0.153846153846
Infants,0.384615384615,0.269230769231,0.269230769231,0.0769230769231
Music,0.230769230769,0.269230769231,0.423076923077,0.0769230769231
Gait,0.192307692308,0.230769230769,0.538461538462,0.0384615384615
Prediction,0.192307692308,0.307692307692,0.423076923077,0.0769230769231
Visual word recognition,0.153846153846,0.269230769231,0.538461538462,0.0384615384615
Mild traumatic brain injury,0.0769230769231,0.461538461538,0.269230769231,0.153846153846
Problem solving,0.192307692308,0.269230769231,0.461538461538,0.0769230769231
Interference,0.153846153846,0.153846153846,0.576923076923,0.115384615385
Temporal lobe,0.230769230769,0.5,0.230769230769,0.0384615384615
Education,0.192307692308,0.115384615385,0.423076923077,0.230769230769
Grounded cognition,0.153846153846,0.269230769231,0.461538461538,0.115384615385
Humans,0.12,0.2,0.44,0.24
Addiction,0.16,0.4,0.28,0.16
Self,0.12,0.44,0.36,0.08
Executive control,0.12,0.32,0.52,0.04
Motor,0.12,0.44,0.36,0.08
Genetics,0.36,0.2,0.44,0.0
Parkinson disease,0.2,0.24,0.44,0.12
Gender differences,0.28,0.28,0.4,0.04
Number,0.28,0.44,0.2,0.08
Functional magnetic resonance imaging (fMRI),0.166666666667,0.333333333333,0.375,0.125
Motor learning,0.208333333333,0.375,0.375,0.0416666666667
Disability,0.25,0.25,0.458333333333,0.0416666666667
Emotion perception,0.25,0.291666666667,0.375,0.0833333333333
PTSD,0.25,0.375,0.25,0.125
cognitive function,0.208333333333,0.291666666667,0.458333333333,0.0416666666667
cognitive impairment,0.166666666667,0.291666666667,0.458333333333,0.0833333333333
Reasoning,0.125,0.208333333333,0.541666666667,0.125
Dual-task,0.125,0.25,0.583333333333,0.0416666666667
Naming,0.291666666667,0.125,0.541666666667,0.0416666666667
Connectivity,0.333333333333,0.208333333333,0.208333333333,0.208333333333
Risk factors,0.125,0.25,0.541666666667,0.0833333333333
Voxel-based morphometry,0.166666666667,0.333333333333,0.375,0.125
Response inhibition,0.217391304348,0.304347826087,0.478260869565,0.0
Age,0.260869565217,0.260869565217,0.391304347826,0.0869565217391
Sustained attention,0.217391304348,0.173913043478,0.217391304348,0.391304347826
Default mode network,0.260869565217,0.260869565217,0.434782608696,0.0434782608696
Simulation,0.130434782609,0.347826086957,0.391304347826,0.130434782609
Perceptual learning,0.217391304348,0.260869565217,0.304347826087,0.173913043478
Comorbidity,0.0869565217391,0.173913043478,0.695652173913,0.0434782608696
Representation,0.173913043478,0.347826086957,0.434782608696,0.0434782608696
Cortisol,0.0869565217391,0.304347826087,0.434782608696,0.173913043478
Facial expressions,0.217391304348,0.0869565217391,0.521739130435,0.173913043478
Aged,0.217391304348,0.130434782609,0.478260869565,0.173913043478
Striatum,0.173913043478,0.347826086957,0.478260869565,0.0
Epidemiology,0.130434782609,0.217391304348,0.608695652174,0.0434782608696
Autism spectrum disorders,0.260869565217,0.260869565217,0.347826086957,0.130434782609
Independent component analysis,0.347826086957,0.260869565217,0.260869565217,0.130434782609
Insula,0.0869565217391,0.347826086957,0.565217391304,0.0
Motion,0.173913043478,0.260869565217,0.391304347826,0.173913043478
Reversal learning,0.173913043478,0.391304347826,0.391304347826,0.0434782608696
Implicit memory,0.173913043478,0.304347826087,0.478260869565,0.0434782608696
HIV,0.318181818182,0.272727272727,0.318181818182,0.0909090909091
Behaviour,0.181818181818,0.227272727273,0.363636363636,0.227272727273
Olfaction,0.272727272727,0.227272727273,0.409090909091,0.0909090909091
Cognitive training,0.136363636364,0.181818181818,0.454545454545,0.227272727273
Color,0.272727272727,0.136363636364,0.409090909091,0.181818181818
Visual acuity,0.272727272727,0.227272727273,0.363636363636,0.136363636364
CANTAB,0.318181818182,0.318181818182,0.227272727273,0.136363636364
Electrophysiology,0.227272727273,0.181818181818,0.5,0.0909090909091
Eye gaze,0.181818181818,0.181818181818,0.318181818182,0.318181818182
Cortex,0.272727272727,0.227272727273,0.318181818182,0.181818181818
DTI,0.318181818182,0.0909090909091,0.454545454545,0.136363636364
Medial temporal lobe,0.136363636364,0.363636363636,0.318181818182,0.181818181818
Oscillations,0.181818181818,0.363636363636,0.409090909091,0.0454545454545
Postural control,0.0909090909091,0.409090909091,0.409090909091,0.0909090909091
Antisaccade,0.136363636364,0.227272727273,0.545454545455,0.0909090909091
Amnesia,0.272727272727,0.272727272727,0.363636363636,0.0909090909091
Change detection,0.136363636364,0.227272727273,0.454545454545,0.181818181818
Joint attention,0.0909090909091,0.272727272727,0.363636363636,0.272727272727
Brain imaging,0.227272727273,0.363636363636,0.272727272727,0.136363636364
Social perception,0.227272727273,0.136363636364,0.590909090909,0.0454545454545
N2,0.136363636364,0.272727272727,0.363636363636,0.227272727273
Saccade,0.0909090909091,0.181818181818,0.409090909091,0.318181818182
Encoding,0.142857142857,0.238095238095,0.47619047619,0.142857142857
EEG/ERP,0.285714285714,0.285714285714,0.285714285714,0.142857142857
Language comprehension,0.285714285714,0.0952380952381,0.47619047619,0.142857142857
Sleep deprivation,0.0952380952381,0.285714285714,0.571428571429,0.047619047619
Delirium,0.142857142857,0.285714285714,0.380952380952,0.142857142857
Childhood,0.190476190476,0.428571428571,0.380952380952,0.0
Visual imagery,0.571428571429,0.190476190476,0.142857142857,0.0952380952381
Line bisection,0.380952380952,0.238095238095,0.0952380952381,0.285714285714
Synaesthesia,0.142857142857,0.428571428571,0.428571428571,0.0
Menopause,0.333333333333,0.238095238095,0.380952380952,0.047619047619
Visuospatial,0.333333333333,0.333333333333,0.238095238095,0.0952380952381
Verbal memory,0.142857142857,0.380952380952,0.47619047619,0.0
Spatial,0.285714285714,0.380952380952,0.142857142857,0.190476190476
Visual hallucinations,0.047619047619,0.238095238095,0.52380952381,0.190476190476
Anorexia nervosa,0.285714285714,0.285714285714,0.333333333333,0.0952380952381
Adolescent,0.238095238095,0.285714285714,0.333333333333,0.142857142857
Mentalizing,0.333333333333,0.380952380952,0.238095238095,0.047619047619
Gaze,0.190476190476,0.333333333333,0.333333333333,0.142857142857
Neuropsychological,0.285714285714,0.190476190476,0.47619047619,0.047619047619
Perceptual organization,0.190476190476,0.285714285714,0.47619047619,0.047619047619
Superior temporal sulcus,0.1,0.35,0.4,0.15
Cognitive bias,0.2,0.25,0.4,0.15
Automaticity,0.15,0.2,0.45,0.2
Planning,0.15,0.25,0.55,0.05
Alcoholism,0.15,0.3,0.45,0.1
Posture,0.15,0.25,0.6,0.0
Animal cognition,0.2,0.25,0.35,0.2
Sleep,0.25,0.15,0.55,0.05
Thalamus,0.2,0.4,0.35,0.05
Neuropsychological testing,0.2,0.4,0.35,0.05
Imitation,0.2,0.35,0.45,0.0
Dorsolateral prefrontal cortex,0.2,0.25,0.5,0.05
Cognitive rehabilitation,0.1,0.35,0.5,0.05
Epilepsy surgery,0.2,0.45,0.35,0.0
Autism spectrum disorder,0.4,0.2,0.3,0.1
Morris water maze,0.25,0.15,0.5,0.1
Estrogen,0.25,0.2,0.4,0.15
anxiety,0.2,0.4,0.25,0.15
Vigilance,0.15,0.2,0.45,0.2
Cognitive abilities,0.15,0.3,0.45,0.1
Neuropsychological test,0.05,0.35,0.45,0.1
Attentional blink,0.35,0.15,0.45,0.05
Longitudinal study,0.45,0.25,0.25,0.05
Event-related brain potentials,0.263157894737,0.473684210526,0.210526315789,0.0526315789474
Obsessive-compulsive disorder,0.105263157895,0.157894736842,0.526315789474,0.210526315789
Performance,0.315789473684,0.263157894737,0.421052631579,0.0
visual attention,0.105263157895,0.105263157895,0.368421052632,0.421052631579
Discrimination,0.315789473684,0.315789473684,0.263157894737,0.105263157895
Cognitive assessment,0.0,0.210526315789,0.736842105263,0.0526315789474
Cognitive disorders,0.210526315789,0.368421052632,0.315789473684,0.0526315789474
Concepts,0.105263157895,0.210526315789,0.578947368421,0.105263157895
Mental number line,0.157894736842,0.315789473684,0.473684210526,0.0526315789474
Bilingualism,0.263157894737,0.315789473684,0.368421052632,0.0526315789474
Cross-modal,0.210526315789,0.105263157895,0.526315789474,0.157894736842
Donepezil,0.157894736842,0.315789473684,0.421052631579,0.105263157895
Comparative cognition,0.0526315789474,0.526315789474,0.368421052632,0.0526315789474
Orientation,0.157894736842,0.421052631579,0.315789473684,0.105263157895
Numerosity,0.157894736842,0.157894736842,0.421052631579,0.263157894737
Implicit learning,0.105263157895,0.368421052632,0.421052631579,0.105263157895
Insight,0.0526315789474,0.421052631579,0.473684210526,0.0526315789474
Valence,0.157894736842,0.421052631579,0.263157894737,0.157894736842
Neurocognitive,0.210526315789,0.210526315789,0.421052631579,0.157894736842
Attentional control,0.105263157895,0.473684210526,0.315789473684,0.105263157895
executive function,0.222222222222,0.0555555555556,0.5,0.222222222222
Exercise,0.222222222222,0.277777777778,0.444444444444,0.0555555555556
Evolution,0.388888888889,0.333333333333,0.222222222222,0.0555555555556
Social interaction,0.166666666667,0.333333333333,0.444444444444,0.0555555555556
Intellectual disability,0.166666666667,0.222222222222,0.555555555556,0.0555555555556
Agency,0.166666666667,0.222222222222,0.333333333333,0.277777777778
Diagnosis,0.166666666667,0.388888888889,0.277777777778,0.166666666667
Obesity,0.0555555555556,0.388888888889,0.444444444444,0.111111111111
Parkinsonism,0.166666666667,0.277777777778,0.444444444444,0.111111111111
Perirhinal cortex,0.166666666667,0.388888888889,0.333333333333,0.111111111111
Cocaine,0.277777777778,0.444444444444,0.277777777778,0.0
Training,0.166666666667,0.333333333333,0.444444444444,0.0555555555556
Lexical decision,0.166666666667,0.333333333333,0.388888888889,0.111111111111
Time perception,0.222222222222,0.277777777778,0.333333333333,0.166666666667
Situated cognition,0.111111111111,0.222222222222,0.611111111111,0.0555555555556
Recollection,0.176470588235,0.352941176471,0.470588235294,0.0
children,0.235294117647,0.294117647059,0.294117647059,0.176470588235
Hypertension,0.176470588235,0.294117647059,0.352941176471,0.176470588235
Prefrontal,0.176470588235,0.294117647059,0.470588235294,0.0588235294118
Evaluation,0.235294117647,0.235294117647,0.529411764706,0.0
Intraparietal sulcus,0.0588235294118,0.411764705882,0.470588235294,0.0588235294118
Orbitofrontal cortex,0.235294117647,0.235294117647,0.470588235294,0.0588235294118
Culture,0.0588235294118,0.411764705882,0.176470588235,0.235294117647
Space,0.117647058824,0.470588235294,0.294117647059,0.117647058824
Associative learning,0.294117647059,0.352941176471,0.352941176471,0.0
Treatment,0.117647058824,0.294117647059,0.411764705882,0.176470588235
Normal volunteers,0.294117647059,0.411764705882,0.294117647059,0.0
Huntington's disease,0.235294117647,0.117647058824,0.529411764706,0.117647058824
Visual system,0.235294117647,0.352941176471,0.352941176471,0.0588235294118
Action observation,0.117647058824,0.411764705882,0.352941176471,0.117647058824
Neurodevelopment,0.411764705882,0.176470588235,0.294117647059,0.117647058824
Audition,0.235294117647,0.352941176471,0.411764705882,0.0
Motion perception,0.294117647059,0.176470588235,0.529411764706,0.0
Learning and memory,0.352941176471,0.117647058824,0.470588235294,0.0588235294118
Recall,0.352941176471,0.176470588235,0.235294117647,0.235294117647
Event-related potential (ERP),0.235294117647,0.235294117647,0.411764705882,0.117647058824
Long-term memory,0.294117647059,0.411764705882,0.176470588235,0.117647058824
spatial cognition,0.117647058824,0.235294117647,0.470588235294,0.176470588235
Binocular rivalry,0.176470588235,0.352941176471,0.352941176471,0.117647058824
Cognitive processing,0.294117647059,0.470588235294,0.176470588235,0.0588235294118
Cannabis,0.117647058824,0.235294117647,0.352941176471,0.294117647059
Emotional processing,0.117647058824,0.235294117647,0.470588235294,0.176470588235
Mirror neuron system,0.176470588235,0.176470588235,0.588235294118,0.0588235294118
Reliability,0.294117647059,0.176470588235,0.529411764706,0.0
Medial prefrontal cortex,0.235294117647,0.352941176471,0.352941176471,0.0
Negative symptoms,0.117647058824,0.117647058824,0.705882352941,0.0588235294118
Alertness,0.235294117647,0.235294117647,0.411764705882,0.117647058824
Cognitive outcome,0.176470588235,0.294117647059,0.470588235294,0.0588235294118
Falls,0.117647058824,0.294117647059,0.588235294118,0.0
Breast cancer,0.176470588235,0.411764705882,0.176470588235,0.235294117647
IQ,0.125,0.25,0.4375,0.1875
Motor imagery,0.25,0.1875,0.5625,0.0
Social anxiety,0.3125,0.375,0.1875,0.125
Pattern recognition,0.25,0.3125,0.375,0.0625
Parietal lobe,0.1875,0.4375,0.375,0.0
Primate,0.1875,0.3125,0.5,0.0
Fear,0.125,0.125,0.625,0.0625
TMS,0.125,0.1875,0.375,0.3125
Classification,0.0625,0.375,0.3125,0.25
Category learning,0.125,0.5625,0.25,0.0625
Delusions,0.125,0.3125,0.5,0.0625
Semantic,0.1875,0.25,0.4375,0.125
Evoked potentials,0.0625,0.375,0.5,0.0625
Sex,0.0625,0.25,0.5625,0.125
Stroop task,0.1875,0.4375,0.1875,0.1875
Creativity,0.25,0.3125,0.1875,0.0625
Cerebral palsy,0.25,0.375,0.3125,0.0625
Spatial ability,0.1875,0.125,0.5,0.1875
Art,0.25,0.25,0.375,0.125
Theory of Mind,0.3125,0.1875,0.375,0.125
Object permanence,0.25,0.25,0.4375,0.0625
multiple sclerosis,0.266666666667,0.266666666667,0.266666666667,0.2
Event related potentials,0.2,0.266666666667,0.4,0.133333333333
prefrontal cortex,0.0666666666667,0.533333333333,0.333333333333,0.0
learning,0.133333333333,0.333333333333,0.533333333333,0.0
Neurophysiology,0.0666666666667,0.333333333333,0.533333333333,0.0666666666667
Psychomotor performance,0.333333333333,0.2,0.466666666667,0.0
Dogs,0.2,0.4,0.266666666667,0.133333333333
Scene perception,0.133333333333,0.466666666667,0.4,0.0
False memory,0.133333333333,0.2,0.666666666667,0.0
Major depressive disorder,0.266666666667,0.2,0.4,0.133333333333
Spatial learning,0.2,0.2,0.6,0.0
Dog,0.266666666667,0.6,0.133333333333,0.0
Macaque,0.2,0.466666666667,0.266666666667,0.0666666666667
Imaging,0.266666666667,0.266666666667,0.4,0.0666666666667
Automobile driving,0.0666666666667,0.133333333333,0.733333333333,0.0666666666667
cognitive control,0.133333333333,0.533333333333,0.266666666667,0.0666666666667
Frontal,0.4,0.266666666667,0.333333333333,0.0
Movement,0.4,0.0666666666667,0.466666666667,0.0666666666667
Oculomotor,0.0666666666667,0.333333333333,0.333333333333,0.266666666667
Heart rate variability,0.333333333333,0.2,0.333333333333,0.133333333333
P3a,0.4,0.266666666667,0.333333333333,0.0
Trauma,0.2,0.4,0.4,0.0
Prospective memory,0.2,0.4,0.266666666667,0.133333333333
Frontal cortex,0.133333333333,0.266666666667,0.466666666667,0.133333333333
Phonology,0.2,0.266666666667,0.333333333333,0.2
visual perception,0.0,0.466666666667,0.4,0.133333333333
Autobiographical memory,0.0666666666667,0.2,0.6,0.133333333333
Computational modeling,0.0666666666667,0.333333333333,0.466666666667,0.133333333333
Hypoxia,0.133333333333,0.266666666667,0.4,0.2
Stroop,0.0666666666667,0.533333333333,0.333333333333,0.0666666666667
Glutamate,0.0666666666667,0.533333333333,0.333333333333,0.0666666666667
Visualization,0.0666666666667,0.6,0.2,0.133333333333
Brain and Behavior",0.0,0.0,0.0,0.0
Declarative memory,0.4,0.333333333333,0.266666666667,0.0
Distance effect,0.2,0.333333333333,0.333333333333,0.0666666666667
Personality,0.133333333333,0.466666666667,0.333333333333,0.0666666666667
N1,0.0,0.733333333333,0.133333333333,0.133333333333
vision,0.266666666667,0.266666666667,0.466666666667,0.0
Adults,0.214285714286,0.428571428571,0.285714285714,0.0714285714286
Physical activity,0.142857142857,0.285714285714,0.357142857143,0.214285714286
Dorsal stream,0.285714285714,0.428571428571,0.214285714286,0.0714285714286
Validity,0.0714285714286,0.428571428571,0.428571428571,0.0714285714286
Body schema,0.285714285714,0.285714285714,0.357142857143,0.0714285714286
Masked priming,0.214285714286,0.428571428571,0.357142857143,0.0
Event-related potentials (ERPs),0.0714285714286,0.428571428571,0.428571428571,0.0714285714286
Brain injury,0.142857142857,0.571428571429,0.214285714286,0.0714285714286
Safety,0.357142857143,0.142857142857,0.428571428571,0.0714285714286
Neurofeedback,0.142857142857,0.571428571429,0.285714285714,0.0
Theta,0.142857142857,0.357142857143,0.428571428571,0.0714285714286
Repetition priming,0.0,0.285714285714,0.571428571429,0.142857142857
quality of life,0.285714285714,0.214285714286,0.357142857143,0.142857142857
Scopolamine,0.285714285714,0.357142857143,0.285714285714,0.0714285714286
Magnetoencephalography (MEG),0.428571428571,0.142857142857,0.428571428571,0.0
Migraine,0.428571428571,0.214285714286,0.285714285714,0.0714285714286
Object perception,0.0,0.5,0.5,0.0
Modafinil,0.285714285714,0.214285714286,0.5,0.0
Attentional capture,0.142857142857,0.285714285714,0.5,0.0714285714286
Chronic pain,0.142857142857,0.357142857143,0.428571428571,0.0714285714286
Binding,0.285714285714,0.214285714286,0.357142857143,0.142857142857
Accidental falls,0.285714285714,0.142857142857,0.428571428571,0.142857142857
Corpus callosum,0.142857142857,0.0,0.714285714286,0.142857142857
Neural networks,0.214285714286,0.357142857143,0.428571428571,0.0
Number processing,0.285714285714,0.428571428571,0.285714285714,0.0
P3b,0.0714285714286,0.285714285714,0.642857142857,0.0
SPECT,0.285714285714,0.214285714286,0.357142857143,0.142857142857
Spatial working memory,0.285714285714,0.214285714286,0.428571428571,0.0714285714286
Spatial vision,0.0714285714286,0.714285714286,0.142857142857,0.0714285714286
Testosterone,0.142857142857,0.5,0.357142857143,0.0
Person perception,0.142857142857,0.214285714286,0.642857142857,0.0
mood,0.285714285714,0.357142857143,0.285714285714,0.0714285714286
Positron emission tomography,0.142857142857,0.428571428571,0.357142857143,0.0714285714286
Insomnia,0.214285714286,0.142857142857,0.571428571429,0.0714285714286
Older drivers,0.0714285714286,0.214285714286,0.357142857143,0.357142857143
elderly,0.214285714286,0.285714285714,0.428571428571,0.0714285714286
Premotor cortex,0.0714285714286,0.285714285714,0.571428571429,0.0714285714286
Psychology,0.0714285714286,0.142857142857,0.214285714286,0.214285714286
Electroencephalogram,0.142857142857,0.214285714286,0.642857142857,0.0
Craving,0.0714285714286,0.285714285714,0.571428571429,0.0714285714286
functional magnetic resonance imaging,0.142857142857,0.428571428571,0.214285714286,0.214285714286
P1,0.428571428571,0.357142857143,0.142857142857,0.0714285714286
Facial emotion,0.214285714286,0.0714285714286,0.5,0.214285714286
Methylphenidate,0.428571428571,0.142857142857,0.214285714286,0.214285714286
Semantic processing,0.214285714286,0.285714285714,0.357142857143,0.142857142857
Magnocellular,0.153846153846,0.307692307692,0.384615384615,0.153846153846
Arithmetic,0.230769230769,0.461538461538,0.307692307692,0.0
Chimpanzee,0.153846153846,0.384615384615,0.461538461538,0.0
Spatial frequency,0.230769230769,0.384615384615,0.307692307692,0.0769230769231
Developmental dyslexia,0.307692307692,0.461538461538,0.153846153846,0.0769230769231
Central coherence,0.307692307692,0.153846153846,0.461538461538,0.0769230769231
Estradiol,0.307692307692,0.153846153846,0.384615384615,0.153846153846
Word recognition,0.230769230769,0.153846153846,0.538461538462,0.0769230769231
event-related potentials,0.307692307692,0.153846153846,0.384615384615,0.153846153846
Expectancy,0.230769230769,0.153846153846,0.384615384615,0.153846153846
Affordances,0.153846153846,0.307692307692,0.384615384615,0.153846153846
Control,0.0769230769231,0.153846153846,0.692307692308,0.0769230769231
Motor skills,0.230769230769,0.307692307692,0.384615384615,0.0769230769231
Spatial orientation,0.153846153846,0.307692307692,0.538461538462,0.0
Cognitive neuroscience,0.0769230769231,0.153846153846,0.769230769231,0.0
Dissociation,0.307692307692,0.230769230769,0.307692307692,0.153846153846
Alpha,0.153846153846,0.538461538462,0.307692307692,0.0
Mismatch negativity,0.153846153846,0.230769230769,0.615384615385,0.0
Habituation,0.153846153846,0.461538461538,0.230769230769,0.153846153846
Prism adaptation,0.230769230769,0.307692307692,0.307692307692,0.153846153846
Working memory capacity,0.230769230769,0.230769230769,0.461538461538,0.0769230769231
Attention-deficit/hyperactivity disorder,0.230769230769,0.307692307692,0.461538461538,0.0
Pigeons,0.307692307692,0.153846153846,0.384615384615,0.153846153846
Smoking,0.153846153846,0.384615384615,0.461538461538,0.0
Asperger syndrome,0.153846153846,0.384615384615,0.230769230769,0.230769230769
Activities of daily living,0.0769230769231,0.153846153846,0.692307692308,0.0769230769231
Transcranial direct current stimulation,0.384615384615,0.307692307692,0.230769230769,0.0769230769231
Reaching,0.153846153846,0.461538461538,0.384615384615,0.0
Facial emotion recognition,0.230769230769,0.230769230769,0.461538461538,0.0769230769231
Effective connectivity,0.153846153846,0.307692307692,0.461538461538,0.0769230769231
Time,0.230769230769,0.461538461538,0.230769230769,0.0769230769231
Symptoms,0.0769230769231,0.307692307692,0.461538461538,0.153846153846
hippocampus,0.153846153846,0.307692307692,0.538461538462,0.0
High-functioning autism,0.0769230769231,0.461538461538,0.230769230769,0.230769230769
Conceptual knowledge,0.230769230769,0.384615384615,0.230769230769,0.153846153846
Change blindness,0.307692307692,0.153846153846,0.230769230769,0.307692307692
Speech perception,0.230769230769,0.307692307692,0.230769230769,0.230769230769
Spatial neglect,0.230769230769,0.307692307692,0.307692307692,0.153846153846
Extinction,0.0769230769231,0.384615384615,0.384615384615,0.153846153846
Fluency,0.153846153846,0.230769230769,0.461538461538,0.153846153846
Synesthesia,0.307692307692,0.307692307692,0.307692307692,0.0769230769231
Lexical access,0.0769230769231,0.230769230769,0.615384615385,0.0769230769231
Right hemisphere,0.230769230769,0.153846153846,0.538461538462,0.0769230769231
Saccadic eye movements,0.0769230769231,0.307692307692,0.307692307692,0.307692307692
APOE,0.230769230769,0.384615384615,0.384615384615,0.0
Cerebral blood flow,0.0769230769231,0.307692307692,0.538461538462,0.0769230769231
Pseudoneglect,0.230769230769,0.384615384615,0.384615384615,0.0
Chemotherapy,0.153846153846,0.384615384615,0.384615384615,0.0769230769231
traumatic brain injury,0.153846153846,0.384615384615,0.307692307692,0.153846153846
Spatial navigation,0.230769230769,0.384615384615,0.307692307692,0.0769230769231
Prosopagnosia,0.153846153846,0.307692307692,0.384615384615,0.153846153846
Grasping,0.153846153846,0.153846153846,0.538461538462,0.153846153846
Pediatric,0.307692307692,0.307692307692,0.307692307692,0.0769230769231
Approximate number system,0.25,0.416666666667,0.333333333333,0.0
visual search,0.0833333333333,0.333333333333,0.5,0.0833333333333
Metaphor,0.166666666667,0.166666666667,0.583333333333,0.0833333333333
Nutrition,0.0833333333333,0.333333333333,0.416666666667,0.166666666667
Monkeys,0.0833333333333,0.25,0.666666666667,0.0
Asymmetry,0.25,0.25,0.5,0.0
Spatial representation,0.0833333333333,0.416666666667,0.333333333333,0.166666666667
psychosis,0.25,0.416666666667,0.25,0.0833333333333
Prosody,0.166666666667,0.166666666667,0.5,0.166666666667
Gaze direction,0.25,0.333333333333,0.333333333333,0.0833333333333
Feedback,0.166666666667,0.166666666667,0.416666666667,0.166666666667
Tool use,0.166666666667,0.5,0.333333333333,0.0
Cognitive remediation,0.25,0.5,0.25,0.0
Suppression,0.0833333333333,0.416666666667,0.333333333333,0.166666666667
Cognitive ability,0.25,0.0833333333333,0.5,0.166666666667
episodic memory,0.0833333333333,0.333333333333,0.5,0.0833333333333
Surgery,0.333333333333,0.416666666667,0.166666666667,0.0833333333333
Chinese,0.0,0.166666666667,0.583333333333,0.25
Body representation,0.0,0.25,0.416666666667,0.333333333333
NMDA receptor,0.25,0.333333333333,0.25,0.166666666667
Action perception,0.25,0.166666666667,0.5,0.0833333333333
Intervention,0.0833333333333,0.5,0.416666666667,0.0
Neurotoxicity,0.25,0.416666666667,0.333333333333,0.0
Language acquisition,0.166666666667,0.416666666667,0.416666666667,0.0
Neuroscience,0.333333333333,0.25,0.25,0.166666666667
Attention deficit hyperactivity disorder,0.25,0.333333333333,0.333333333333,0.0833333333333
Language development,0.416666666667,0.166666666667,0.416666666667,0.0
Fusiform gyrus,0.0,0.25,0.5,0.25
neuroimaging,0.166666666667,0.0,0.583333333333,0.25
Cerebrovascular disease,0.0833333333333,0.166666666667,0.5,0.166666666667
Predictive coding,0.333333333333,0.0833333333333,0.333333333333,0.25
Cognitive task,0.333333333333,0.166666666667,0.416666666667,0.0833333333333
Ecstasy,0.0833333333333,0.416666666667,0.416666666667,0.0
Central executive,0.333333333333,0.166666666667,0.5,0.0
Contrast sensitivity,0.416666666667,0.333333333333,0.25,0.0
Mice,0.333333333333,0.416666666667,0.0,0.25
Novelty,0.166666666667,0.25,0.5,0.0833333333333
stroke,0.333333333333,0.166666666667,0.416666666667,0.0833333333333
White matter hyperintensities,0.25,0.0833333333333,0.583333333333,0.0833333333333
Cortical thickness,0.166666666667,0.333333333333,0.5,0.0
Speech,0.0,0.333333333333,0.5,0.0833333333333
Apolipoprotein E,0.0833333333333,0.416666666667,0.416666666667,0.0833333333333
Self-awareness,0.5,0.166666666667,0.333333333333,0.0
Electroencephalography (EEG),0.25,0.0833333333333,0.416666666667,0.25
Neuropsychological functioning,0.0833333333333,0.25,0.5,0.0833333333333
BOLD,0.0,0.416666666667,0.416666666667,0.166666666667
eye tracking,0.0833333333333,0.666666666667,0.166666666667,0.0833333333333
Perceptual load,0.0,0.25,0.583333333333,0.166666666667
Subitizing,0.25,0.25,0.5,0.0
Strategy,0.0833333333333,0.166666666667,0.666666666667,0.0833333333333
Mental simulation,0.25,0.25,0.416666666667,0.0833333333333
Pointing,0.166666666667,0.333333333333,0.5,0.0
Mouse,0.166666666667,0.166666666667,0.666666666667,0.0
Visual perspective taking,0.166666666667,0.333333333333,0.416666666667,0.0833333333333
Picture naming,0.166666666667,0.333333333333,0.25,0.25
Threat,0.0,0.333333333333,0.5,0.166666666667
rehabilitation,0.25,0.166666666667,0.5,0.0833333333333
Cognitive map,0.333333333333,0.25,0.333333333333,0.0833333333333
Drawing,0.166666666667,0.25,0.5,0.0833333333333
Set-shifting,0.333333333333,0.416666666667,0.25,0.0
Visual illusions,0.0,0.333333333333,0.666666666667,0.0
Pigeon,0.0833333333333,0.333333333333,0.583333333333,0.0
Functional imaging,0.166666666667,0.333333333333,0.5,0.0
Blood pressure,0.272727272727,0.0,0.545454545455,0.181818181818
behavior,0.272727272727,0.545454545455,0.181818181818,0.0
Normative data,0.272727272727,0.181818181818,0.454545454545,0.0909090909091
Semantic priming,0.0909090909091,0.363636363636,0.454545454545,0.0909090909091
Visuomotor,0.181818181818,0.272727272727,0.363636363636,0.181818181818
Mania,0.272727272727,0.0,0.636363636364,0.0909090909091
cognitive functioning,0.181818181818,0.454545454545,0.363636363636,0.0
Hemispheric asymmetry,0.0,0.272727272727,0.727272727273,0.0
Visual function,0.0909090909091,0.363636363636,0.545454545455,0.0
Monitoring,0.0,0.272727272727,0.636363636364,0.0909090909091
Information visualization,0.272727272727,0.272727272727,0.363636363636,0.0909090909091
Older people,0.0,0.272727272727,0.636363636364,0.0909090909091
Structural equation modeling,0.181818181818,0.545454545455,0.181818181818,0.0909090909091
Reappraisal,0.181818181818,0.454545454545,0.181818181818,0.181818181818
theory of mind,0.0,0.454545454545,0.545454545455,0.0
Executive,0.272727272727,0.181818181818,0.363636363636,0.181818181818
Visual evoked potentials,0.181818181818,0.181818181818,0.545454545455,0.0909090909091
Sentence comprehension,0.363636363636,0.0909090909091,0.545454545455,0.0
Categorical perception,0.181818181818,0.454545454545,0.272727272727,0.0909090909091
TBI,0.272727272727,0.363636363636,0.363636363636,0.0
Follow-up,0.0,0.454545454545,0.545454545455,0.0
magnetic resonance imaging,0.272727272727,0.363636363636,0.363636363636,0.0
visual memory,0.0,0.545454545455,0.454545454545,0.0
Visuospatial attention,0.0909090909091,0.272727272727,0.363636363636,0.272727272727
Hemispheric specialization,0.0909090909091,0.454545454545,0.272727272727,0.181818181818
Body image,0.181818181818,0.363636363636,0.272727272727,0.181818181818
Cognitive enhancement,0.181818181818,0.454545454545,0.272727272727,0.0909090909091
Top-down control,0.363636363636,0.181818181818,0.454545454545,0.0
Part A",0.0,0.0,0.0,0.0
Timing,0.181818181818,0.0909090909091,0.636363636364,0.0909090909091
Biomarker,0.272727272727,0.272727272727,0.454545454545,0.0
Locomotion,0.181818181818,0.272727272727,0.454545454545,0.0909090909091
Women,0.0,0.545454545455,0.454545454545,0.0
Cognitive architecture,0.0909090909091,0.454545454545,0.454545454545,0.0
Social functioning,0.0909090909091,0.363636363636,0.272727272727,0.272727272727
Recovery,0.272727272727,0.272727272727,0.181818181818,0.272727272727
neuropsychological tests,0.181818181818,0.363636363636,0.454545454545,0.0
MDMA,0.272727272727,0.363636363636,0.363636363636,0.0
Neurocognitive functioning,0.0909090909091,0.454545454545,0.363636363636,0.0909090909091
Postmenopausal women,0.0909090909091,0.181818181818,0.636363636364,0.0
BDNF,0.181818181818,0.272727272727,0.363636363636,0.181818181818
Prevalence,0.181818181818,0.454545454545,0.363636363636,0.0
Compensation,0.181818181818,0.363636363636,0.363636363636,0.0909090909091
categorization,0.181818181818,0.363636363636,0.363636363636,0.0909090909091
Cognitive processes,0.0909090909091,0.272727272727,0.545454545455,0.0909090909091
Oddball,0.181818181818,0.272727272727,0.363636363636,0.181818181818
Oxytocin,0.181818181818,0.0909090909091,0.636363636364,0.0909090909091
Phenomenology,0.181818181818,0.181818181818,0.454545454545,0.181818181818
Animacy,0.272727272727,0.272727272727,0.454545454545,0.0
Pregnancy,0.181818181818,0.272727272727,0.181818181818,0.363636363636
Posterior parietal cortex,0.0909090909091,0.363636363636,0.363636363636,0.181818181818
Walking,0.181818181818,0.181818181818,0.363636363636,0.272727272727
Inferior frontal gyrus,0.272727272727,0.0909090909091,0.454545454545,0.181818181818
Analogy,0.272727272727,0.272727272727,0.363636363636,0.0909090909091
Inference,0.0909090909091,0.363636363636,0.363636363636,0.181818181818
Configural processing,0.181818181818,0.272727272727,0.454545454545,0.0909090909091
Generalization,0.272727272727,0.363636363636,0.272727272727,0.0909090909091
Set shifting,0.181818181818,0.272727272727,0.454545454545,0.0909090909091
Causality,0.0909090909091,0.363636363636,0.363636363636,0.181818181818
Auditory cortex,0.454545454545,0.0,0.454545454545,0.0909090909091
Remission,0.0,0.363636363636,0.545454545455,0.0909090909091
Temporal processing,0.272727272727,0.0909090909091,0.545454545455,0.0909090909091
Visual field,0.272727272727,0.0909090909091,0.454545454545,0.181818181818
Fragile X syndrome,0.181818181818,0.272727272727,0.545454545455,0.0
Temporo-parietal junction,0.181818181818,0.454545454545,0.181818181818,0.181818181818
Modularity,0.181818181818,0.272727272727,0.272727272727,0.272727272727
Counting,0.0,0.363636363636,0.636363636364,0.0
Emotion processing,0.363636363636,0.272727272727,0.272727272727,0.0909090909091
Biomarkers,0.272727272727,0.363636363636,0.272727272727,0.0909090909091
Deception,0.0909090909091,0.181818181818,0.727272727273,0.0
Crowding,0.0909090909091,0.363636363636,0.545454545455,0.0
Primary visual cortex,0.363636363636,0.0909090909091,0.545454545455,0.0
OCD,0.0,0.636363636364,0.0909090909091,0.272727272727
Mortality,0.0,0.272727272727,0.636363636364,0.0909090909091
Radiotherapy,0.181818181818,0.363636363636,0.454545454545,0.0
Attention capture,0.181818181818,0.545454545455,0.181818181818,0.0909090909091
Ventral stream,0.181818181818,0.454545454545,0.272727272727,0.0909090909091
Cognitive deficit,0.0909090909091,0.454545454545,0.363636363636,0.0909090909091
Schizotypy,0.454545454545,0.272727272727,0.272727272727,0.0
Psychopathology,0.181818181818,0.0909090909091,0.454545454545,0.272727272727
Similarity,0.181818181818,0.272727272727,0.454545454545,0.0909090909091
Wisconsin Card Sorting Test,0.3,0.4,0.1,0.2
Proprioception,0.1,0.3,0.2,0.4
Major depression,0.1,0.2,0.6,0.1
Search,0.3,0.1,0.3,0.3
Part B: Neuropsychiatric Genetics",0.0,0.0,0.0,0.0
Weak central coherence,0.2,0.3,0.4,0.1
individual differences,0.2,0.2,0.6,0.0
Reinforcement learning,0.2,0.2,0.5,0.1
concussion,0.1,0.2,0.7,0.0
VBM,0.2,0.4,0.2,0.2
Emotional faces,0.1,0.4,0.4,0.1
Video,0.2,0.1,0.4,0.3
Health-related quality of life,0.3,0.4,0.3,0.0
face processing,0.3,0.3,0.4,0.0
Experience,0.3,0.3,0.2,0.2
Phonological processing,0.2,0.2,0.5,0.1
Deaf,0.6,0.1,0.3,0.0
Crossmodal,0.6,0.0,0.3,0.1
consciousness,0.1,0.3,0.3,0.3
Body sway,0.1,0.2,0.4,0.3
Heart rate,0.0,0.6,0.4,0.0
Subliminal priming,0.0,0.4,0.3,0.3
Outcomes,0.3,0.1,0.4,0.2
Melatonin,0.1,0.2,0.5,0.2
Default network,0.0,0.2,0.7,0.1
Source monitoring,0.1,0.4,0.5,0.0
Alzheimer,0.1,0.3,0.4,0.1
Motor cortex,0.3,0.3,0.2,0.2
Visual hallucination,0.3,0.2,0.4,0.1
nicotine,0.1,0.5,0.3,0.1
smoking,0.2,0.3,0.4,0.1
Event-related fMRI,0.1,0.4,0.1,0.4
Expectation,0.3,0.4,0.1,0.2
embodied cognition,0.1,0.1,0.4,0.4
Perspective-taking,0.1,0.3,0.5,0.1
Mild cognitive impairment (MCI),0.3,0.2,0.5,0.0
Screening,0.1,0.5,0.1,0.3
Synchronization,0.0,0.3,0.5,0.2
Antipsychotics,0.2,0.4,0.3,0.1
Cognitive profile,0.0,0.3,0.6,0.1
Conflict,0.2,0.3,0.4,0.1
Enumeration,0.3,0.2,0.4,0.1
Self-recognition,0.3,0.4,0.3,0.0
Learning disabilities,0.5,0.2,0.3,0.0
Lewy body disease,0.1,0.7,0.2,0.0
Cognitive reserve,0.3,0.1,0.4,0.2
Visuospatial memory,0.1,0.2,0.7,0.0
Saliency,0.2,0.8,0.0,0.0
Posterior cortical atrophy,0.3,0.3,0.3,0.1
Motor cognition,0.2,0.5,0.3,0.0
MK-801,0.3,0.1,0.3,0.3
Disgust,0.0,0.2,0.6,0.1
Path integration,0.1,0.8,0.0,0.1
Precuneus,0.0,0.4,0.3,0.2
Benzodiazepines,0.2,0.4,0.3,0.1
Audiovisual,0.5,0.1,0.3,0.1
Tactile,0.3,0.1,0.5,0.1
Menstrual cycle,0.1,0.3,0.5,0.1
Posttraumatic stress disorder,0.5,0.4,0.0,0.1
Memantine,0.5,0.3,0.2,0.0
Integration,0.0,0.2,0.7,0.1
Substance abuse,0.2,0.5,0.1,0.2
Object processing,0.2,0.4,0.0,0.4
Primate cognition,0.1,0.3,0.5,0.1
Matching-to-sample,0.0,0.6,0.4,0.0
Mental fatigue,0.0,0.3,0.6,0.1
Occlusion,0.2,0.2,0.5,0.1
Speed of processing,0.1,0.3,0.5,0.1
Unconscious,0.3,0.2,0.4,0.1
Fusiform face area,0.1,0.5,0.4,0.0
Prodrome,0.4,0.3,0.1,0.2
Pupillometry,0.0,0.1,0.7,0.2
Self-regulation,0.2,0.4,0.3,0.1
Prematurity,0.3,0.3,0.1,0.3
Fibromyalgia,0.1,0.2,0.5,0.2
Food,0.1,0.3,0.6,0.0
Cancer,0.3,0.2,0.4,0.1
Auditory perception,0.1,0.3,0.5,0.1
Fixation,0.2,0.2,0.6,0.0
Bias,0.2,0.3,0.4,0.1
Complexity,0.222222222222,0.333333333333,0.333333333333,0.111111111111
Touch,0.333333333333,0.444444444444,0.222222222222,0.0
comparative cognition,0.222222222222,0.666666666667,0.0,0.111111111111
Geometry,0.222222222222,0.444444444444,0.333333333333,0.0
Repetition suppression,0.0,0.333333333333,0.333333333333,0.333333333333
Computational model,0.222222222222,0.222222222222,0.333333333333,0.222222222222
Frontal eye field,0.333333333333,0.333333333333,0.222222222222,0.111111111111
Detection,0.111111111111,0.444444444444,0.444444444444,0.0
Cognitive style,0.111111111111,0.444444444444,0.333333333333,0.111111111111
Active vision,0.444444444444,0.222222222222,0.333333333333,0.0
Blindsight,0.111111111111,0.333333333333,0.333333333333,0.222222222222
Hearing,0.333333333333,0.333333333333,0.222222222222,0.111111111111
Cognitive set,0.111111111111,0.555555555556,0.333333333333,0.0
Brain plasticity,0.222222222222,0.555555555556,0.111111111111,0.111111111111
Object-based attention,0.111111111111,0.444444444444,0.222222222222,0.222222222222
Beta,0.222222222222,0.333333333333,0.444444444444,0.0
Anticipation,0.111111111111,0.333333333333,0.444444444444,0.111111111111
Primary progressive aphasia,0.222222222222,0.222222222222,0.333333333333,0.222222222222
Feature binding,0.111111111111,0.333333333333,0.555555555556,0.0
Cerebral cortex,0.333333333333,0.222222222222,0.333333333333,0.111111111111
Infant development,0.222222222222,0.111111111111,0.555555555556,0.111111111111
Object representation,0.111111111111,0.333333333333,0.444444444444,0.111111111111
Preterm,0.333333333333,0.222222222222,0.111111111111,0.333333333333
Cognition and Neuroscience",0.0,0.0,0.0,0.0
Rumination,0.222222222222,0.555555555556,0.222222222222,0.0
Neuroplasticity,0.111111111111,0.333333333333,0.333333333333,0.222222222222
Chimpanzees,0.333333333333,0.555555555556,0.0,0.111111111111
Neurodegeneration,0.222222222222,0.333333333333,0.444444444444,0.0
Euthymia,0.222222222222,0.333333333333,0.222222222222,0.222222222222
Unipolar depression,0.333333333333,0.222222222222,0.444444444444,0.0
Pupil dilation,0.111111111111,0.444444444444,0.444444444444,0.0
Visual short-term memory,0.222222222222,0.222222222222,0.444444444444,0.111111111111
Implicit cognition,0.222222222222,0.333333333333,0.444444444444,0.0
Number sense,0.0,0.111111111111,0.444444444444,0.444444444444
ImPACT,0.444444444444,0.333333333333,0.111111111111,0.111111111111
Hepatic encephalopathy,0.111111111111,0.444444444444,0.444444444444,0.0
Neuropsychiatry,0.222222222222,0.333333333333,0.444444444444,0.0
Vascular dementia,0.111111111111,0.444444444444,0.444444444444,0.0
SNARC effect,0.111111111111,0.222222222222,0.333333333333,0.333333333333
Body,0.111111111111,0.222222222222,0.666666666667,0.0
Placebo,0.0,0.333333333333,0.666666666667,0.0
Preschool children,0.444444444444,0.222222222222,0.222222222222,0.111111111111
Pictures,0.333333333333,0.111111111111,0.444444444444,0.111111111111
Synchrony,0.0,0.555555555556,0.222222222222,0.222222222222
Atrophy,0.111111111111,0.111111111111,0.555555555556,0.222222222222
Cluster analysis,0.111111111111,0.222222222222,0.333333333333,0.333333333333
Dual-task interference,0.333333333333,0.0,0.555555555556,0.111111111111
Hemispatial neglect,0.111111111111,0.333333333333,0.555555555556,0.0
Action recognition,0.222222222222,0.444444444444,0.111111111111,0.222222222222
Homocysteine,0.333333333333,0.0,0.555555555556,0.111111111111
Perceptual grouping,0.0,0.333333333333,0.555555555556,0.111111111111
Electromyography,0.222222222222,0.444444444444,0.333333333333,0.0
P600,0.333333333333,0.111111111111,0.444444444444,0.111111111111
ICA,0.111111111111,0.222222222222,0.666666666667,0.0
Lesion,0.444444444444,0.222222222222,0.333333333333,0.0
Phonological awareness,0.0,0.333333333333,0.444444444444,0.222222222222
Functional neuroimaging,0.222222222222,0.333333333333,0.444444444444,0.0
Confidence,0.0,0.333333333333,0.666666666667,0.0
Visuospatial working memory,0.333333333333,0.444444444444,0.222222222222,0.0
executive functions,0.333333333333,0.333333333333,0.333333333333,0.0
LPP,0.222222222222,0.333333333333,0.444444444444,0.0
Interaction,0.222222222222,0.222222222222,0.555555555556,0.0
Transfer,0.222222222222,0.222222222222,0.555555555556,0.0
Operant conditioning,0.333333333333,0.222222222222,0.444444444444,0.0
Primates,0.222222222222,0.333333333333,0.333333333333,0.111111111111
Functional outcome,0.111111111111,0.666666666667,0.0,0.222222222222
Stroop test,0.222222222222,0.222222222222,0.444444444444,0.111111111111
MMSE,0.111111111111,0.333333333333,0.333333333333,0.222222222222
Judgment,0.111111111111,0.333333333333,0.333333333333,0.222222222222
Backward masking,0.333333333333,0.222222222222,0.111111111111,0.333333333333
Cingulate cortex,0.0,0.111111111111,0.666666666667,0.222222222222
Gaze following,0.222222222222,0.333333333333,0.444444444444,0.0
imaging,0.111111111111,0.444444444444,0.444444444444,0.0
Mental representation,0.111111111111,0.666666666667,0.111111111111,0.111111111111
Brain development,0.0,0.222222222222,0.777777777778,0.0
Acute,0.222222222222,0.333333333333,0.444444444444,0.0
GABA,0.222222222222,0.444444444444,0.333333333333,0.0
Brain tumor,0.0,0.111111111111,0.888888888889,0.0
RBANS,0.111111111111,0.222222222222,0.555555555556,0.111111111111
metacognition,0.444444444444,0.0,0.444444444444,0.111111111111
Asperger's syndrome,0.222222222222,0.222222222222,0.444444444444,0.111111111111
Hearing loss,0.111111111111,0.222222222222,0.666666666667,0.0
Signal detection theory,0.333333333333,0.444444444444,0.111111111111,0.111111111111
Amnestic mild cognitive impairment,0.333333333333,0.333333333333,0.333333333333,0.0
Implicit,0.222222222222,0.111111111111,0.666666666667,0.0
V1,0.111111111111,0.111111111111,0.333333333333,0.444444444444
disability,0.333333333333,0.222222222222,0.444444444444,0.0
Function,0.222222222222,0.333333333333,0.333333333333,0.111111111111
Hydrocephalus,0.111111111111,0.111111111111,0.444444444444,0.333333333333
Gestures,0.333333333333,0.222222222222,0.444444444444,0.0
Sensorimotor,0.333333333333,0.222222222222,0.333333333333,0.111111111111
Handwriting,0.0,0.333333333333,0.555555555556,0.111111111111
Preschool,0.222222222222,0.0,0.777777777778,0.0
Action understanding,0.0,0.333333333333,0.666666666667,0.0
Low vision,0.222222222222,0.222222222222,0.444444444444,0.111111111111
Verbal fluency,0.111111111111,0.111111111111,0.555555555556,0.222222222222
Distributed cognition,0.222222222222,0.333333333333,0.333333333333,0.111111111111
Top-down,0.0,0.111111111111,0.555555555556,0.333333333333
Social neuroscience,0.222222222222,0.111111111111,0.555555555556,0.111111111111
Reinforcement,0.444444444444,0.222222222222,0.111111111111,0.222222222222
STS,0.222222222222,0.333333333333,0.333333333333,0.111111111111
Subliminal,0.25,0.375,0.375,0.0
Magnetic resonance spectroscopy,0.375,0.25,0.25,0.125
Vascular cognitive impairment,0.125,0.0,0.75,0.125
Reading comprehension,0.25,0.25,0.5,0.0
Comprehension,0.375,0.0,0.5,0.125
Resting-state,0.25,0.0,0.5,0.25
cognitive performance,0.25,0.375,0.25,0.125
Health and Aging",0.0,0.0,0.0,0.0
Action selection,0.375,0.25,0.375,0.0
Sign language,0.5,0.0,0.375,0.125
Mobility,0.0,0.625,0.375,0.0
Visual experience,0.0,0.375,0.625,0.0
neuropsychological assessment,0.125,0.125,0.75,0.0
Gesture,0.375,0.125,0.5,0.0
cognitive,0.25,0.0,0.5,0.25
Attractiveness,0.25,0.25,0.375,0.125
Autistic disorder,0.25,0.125,0.5,0.125
Methamphetamine,0.375,0.25,0.375,0.0
Anterior cingulate,0.25,0.125,0.5,0.125
Malingering,0.125,0.125,0.5,0.25
Specific language impairment,0.25,0.375,0.375,0.0
Relatives,0.375,0.125,0.25,0.25
Visual event-related potentials,0.125,0.25,0.625,0.0
gender,0.375,0.375,0.25,0.0
Healthy volunteers,0.5,0.0,0.5,0.0
Rhesus monkey,0.25,0.375,0.125,0.25
Psychophysiology,0.25,0.25,0.375,0.125
Explicit memory,0.375,0.125,0.5,0.0
Cardiovascular disease,0.375,0.0,0.625,0.0
eye-tracking,0.25,0.0,0.625,0.125
eye movements,0.125,0.25,0.625,0.0
Occipital lobe,0.5,0.5,0.0,0.0
CNV,0.0,0.25,0.625,0.125
Response time,0.25,0.125,0.375,0.25
Brain injuries,0.25,0.25,0.5,0.0
Perseveration,0.25,0.375,0.25,0.125
Treatment outcome,0.25,0.375,0.375,0.0
Shape,0.125,0.25,0.5,0.125
Gamma,0.25,0.375,0.375,0.0
Motor system,0.125,0.5,0.25,0.125
Ketamine,0.25,0.375,0.125,0.25
First-episode schizophrenia,0.25,0.375,0.375,0.0
Language processing,0.125,0.5,0.25,0.125
International Journal of Paediatrics",0.0,0.0,0.0,0.0
Allocentric,0.25,0.5,0.125,0.125
Design,0.25,0.25,0.25,0.25
Spectral analysis,0.125,0.25,0.625,0.0
Motor preparation,0.0,0.625,0.375,0.0
Human cognition,0.125,0.5,0.375,0.0
face perception,0.5,0.125,0.375,0.0
Virtual environment,0.125,0.25,0.375,0.25
Visual recognition,0.625,0.0,0.25,0.125
Semantic dementia,0.5,0.25,0.25,0.0
diagnosis,0.25,0.25,0.125,0.375
Seizures,0.0,0.375,0.375,0.25
Anomia,0.25,0.25,0.5,0.0
Case study,0.125,0.625,0.25,0.0
Coherence,0.0,0.375,0.375,0.25
Apraxia,0.125,0.25,0.625,0.0
Flanker task,0.375,0.25,0.25,0.125
Local processing,0.125,0.25,0.375,0.125
Anhedonia,0.375,0.5,0.125,0.0
Visual illusion,0.375,0.375,0.125,0.125
Holistic processing,0.25,0.375,0.125,0.25
Social,0.5,0.25,0.25,0.0
Memory disorders,0.375,0.5,0.0,0.125
Modality,0.125,0.625,0.25,0.0
visual cognition,0.125,0.375,0.5,0.0
Factor analysis,0.0,0.375,0.25,0.25
Imagination,0.0,0.375,0.625,0.0
Simulator,0.0,0.125,0.375,0.5
Motor planning,0.25,0.25,0.375,0.125
Variability,0.25,0.625,0.125,0.0
Audiovisual integration,0.125,0.375,0.5,0.0
Competition,0.125,0.375,0.5,0.0
Neural plasticity,0.125,0.25,0.5,0.125
Inattentional blindness,0.125,0.125,0.625,0.125
Discrimination learning,0.25,0.25,0.375,0.125
Optic flow,0.25,0.5,0.0,0.25
Signal detection,0.25,0.25,0.5,0.0
Limbic system,0.375,0.375,0.25,0.0
Reference frames,0.25,0.25,0.5,0.0
Smooth pursuit,0.25,0.125,0.5,0.125
Task-switching,0.25,0.5,0.25,0.0
Episodic,0.375,0.125,0.5,0.0
Hormone therapy,0.375,0.125,0.5,0.0
language,0.25,0.25,0.5,0.0
Intention,0.5,0.0,0.375,0.125
Number comparison,0.125,0.25,0.375,0.25
Natural scenes,0.125,0.125,0.625,0.125
Headache,0.125,0.125,0.625,0.125
Hypnosis,0.125,0.5,0.125,0.25
Graph theory,0.125,0.5,0.25,0.125
Multivariate pattern analysis,0.25,0.25,0.375,0.125
Review,0.0,0.5,0.5,0.0
Cholesterol,0.25,0.125,0.625,0.0
Visual analytics,0.0,0.25,0.625,0.125
Masking,0.0,0.5,0.375,0.125
Rats,0.125,0.375,0.25,0.25
Visual evoked potential,0.25,0.125,0.5,0.125
Human factors,0.25,0.25,0.375,0.125
LORETA,0.125,0.125,0.75,0.0
Gamma oscillations,0.5,0.0,0.5,0.0
Visual fields,0.125,0.125,0.75,0.0
Autonomic nervous system,0.375,0.0,0.5,0.125
Electroconvulsive therapy,0.25,0.375,0.375,0.0
Object identification,0.375,0.25,0.25,0.125
Cohort studies,0.0,0.5,0.5,0.0
Aggression,0.0,0.25,0.625,0.125
Transitive inference,0.125,0.25,0.5,0.125
TVA,0.125,0.25,0.5,0.125
Egocentric,0.25,0.375,0.25,0.125
Animal model,0.125,0.625,0.25,0.0
Frontal lobes,0.5,0.375,0.125,0.0
Executive dysfunction,0.125,0.25,0.25,0.375
genetics,0.0,0.25,0.625,0.125
Handedness,0.125,0.375,0.5,0.0
Brain activation,0.25,0.375,0.375,0.0
Age-related macular degeneration,0.125,0.25,0.625,0.0
Prognosis,0.25,0.25,0.5,0.0
Analgesia,0.0,0.25,0.625,0.125
education,0.125,0.375,0.375,0.125
Heterogeneity,0.125,0.375,0.25,0.25
Brain mapping,0.125,0.375,0.375,0.125
Simon effect,0.125,0.5,0.375,0.0
Cerebrovascular disorders,0.125,0.375,0.25,0.25
Multistable perception,0.375,0.0,0.625,0.0
Visual cues,0.25,0.25,0.5,0.0
Information processing speed,0.125,0.625,0.125,0.125
Visual categorization,0.125,0.625,0.25,0.0
Synaptic plasticity,0.0,0.25,0.625,0.125
Somatosensory,0.25,0.25,0.5,0.0
Antisaccades,0.375,0.25,0.375,0.0
Topiramate,0.125,0.125,0.75,0.0
Eating disorders,0.25,0.125,0.5,0.125
cognitive development,0.125,0.375,0.375,0.125
Exploration,0.375,0.375,0.25,0.0
Face memory,0.375,0.375,0.25,0.0
TDCS,0.25,0.125,0.625,0.0
Cooperation,0.0,0.0,1.0,0.0
reaction time,0.285714285714,0.428571428571,0.285714285714,0.0
Charles Bonnet syndrome,0.285714285714,0.285714285714,0.428571428571,0.0
Mood disorders,0.142857142857,0.428571428571,0.428571428571,0.0
Discourse,0.142857142857,0.285714285714,0.571428571429,0.0
Entorhinal cortex,0.0,0.285714285714,0.428571428571,0.285714285714
Skin conductance,0.0,0.285714285714,0.714285714286,0.0
Cerebrovascular accident,0.285714285714,0.0,0.571428571429,0.0
Soccer,0.428571428571,0.0,0.571428571429,0.0
Cognitive therapy,0.142857142857,0.142857142857,0.571428571429,0.142857142857
Machine learning,0.428571428571,0.571428571429,0.0,0.0
Human performance,0.0,0.142857142857,0.571428571429,0.285714285714
Neuropathology,0.0,0.714285714286,0.285714285714,0.0
Young adult,0.285714285714,0.142857142857,0.428571428571,0.142857142857
Affordance,0.285714285714,0.428571428571,0.142857142857,0.142857142857
Response preparation,0.142857142857,0.428571428571,0.285714285714,0.142857142857
Oscillation,0.0,0.285714285714,0.571428571429,0.142857142857
Neuropsychological evaluation,0.142857142857,0.285714285714,0.571428571429,0.0
Modeling,0.285714285714,0.285714285714,0.142857142857,0.285714285714
Word production,0.285714285714,0.285714285714,0.285714285714,0.142857142857
Risperidone,0.142857142857,0.142857142857,0.571428571429,0.142857142857
Geriatrics,0.142857142857,0.428571428571,0.428571428571,0.0
Late positive potential,0.142857142857,0.285714285714,0.571428571429,0.0
Numerical processing,0.142857142857,0.428571428571,0.142857142857,0.285714285714
Normal aging,0.142857142857,0.571428571429,0.142857142857,0.142857142857
AD,0.285714285714,0.428571428571,0.285714285714,0.0
Brain damage,0.285714285714,0.142857142857,0.428571428571,0.142857142857
Switching,0.285714285714,0.285714285714,0.428571428571,0.0
Mathematical cognition,0.142857142857,0.285714285714,0.571428571429,0.0
Lewy bodies,0.142857142857,0.428571428571,0.428571428571,0.0
Magnitude,0.142857142857,0.428571428571,0.285714285714,0.142857142857
Task difficulty,0.142857142857,0.142857142857,0.428571428571,0.285714285714
functional connectivity,0.142857142857,0.714285714286,0.142857142857,0.0
Sentence processing,0.285714285714,0.428571428571,0.285714285714,0.0
Preparation,0.142857142857,0.142857142857,0.714285714286,0.0
Action simulation,0.142857142857,0.428571428571,0.0,0.428571428571
Psychopharmacology,0.0,0.142857142857,0.571428571429,0.285714285714
Age differences,0.428571428571,0.142857142857,0.428571428571,0.0
Landmarks,0.142857142857,0.571428571429,0.142857142857,0.142857142857
Vulnerability,0.285714285714,0.285714285714,0.428571428571,0.0
Touchscreen,0.285714285714,0.285714285714,0.428571428571,0.0
Eyetracking,0.571428571429,0.285714285714,0.142857142857,0.0
Psychomotor speed,0.142857142857,0.142857142857,0.428571428571,0.285714285714
Preterm infants,0.285714285714,0.285714285714,0.428571428571,0.0
Default mode,0.0,0.285714285714,0.714285714286,0.0
cognitive decline,0.428571428571,0.142857142857,0.428571428571,0.0
Nucleus accumbens,0.285714285714,0.285714285714,0.428571428571,0.0
Sensorimotor transformation,0.142857142857,0.571428571429,0.285714285714,0.0
cerebrospinal fluid,0.428571428571,0.285714285714,0.142857142857,0.142857142857
Paranoia,0.142857142857,0.142857142857,0.714285714286,0.0
Lutein,0.142857142857,0.428571428571,0.428571428571,0.0
Visual information,0.142857142857,0.142857142857,0.285714285714,0.428571428571
Object,0.142857142857,0.428571428571,0.285714285714,0.142857142857
Temporal,0.428571428571,0.0,0.428571428571,0.142857142857
neurocognition,0.142857142857,0.142857142857,0.571428571429,0.142857142857
Sensory substitution,0.142857142857,0.428571428571,0.428571428571,0.0
Neural network,0.142857142857,0.142857142857,0.714285714286,0.0
Exploratory eye movements,0.0,0.428571428571,0.428571428571,0.142857142857
Visual feedback,0.285714285714,0.428571428571,0.285714285714,0.0
Lead,0.0,0.571428571429,0.428571428571,0.0
LRP,0.142857142857,0.142857142857,0.714285714286,0.0
Virtual environments,0.142857142857,0.285714285714,0.428571428571,0.142857142857
Cholinergic system,0.285714285714,0.0,0.714285714286,0.0
Music cognition,0.428571428571,0.428571428571,0.142857142857,0.0
Haptics,0.142857142857,0.285714285714,0.428571428571,0.142857142857
DLPFC,0.285714285714,0.142857142857,0.142857142857,0.428571428571
Error detection,0.571428571429,0.142857142857,0.285714285714,0.0
Visuospatial function,0.142857142857,0.285714285714,0.428571428571,0.142857142857
Tractography,0.428571428571,0.142857142857,0.285714285714,0.142857142857
Sensitivity,0.428571428571,0.142857142857,0.428571428571,0.0
Resting-state fMRI,0.142857142857,0.428571428571,0.428571428571,0.0
Spelling,0.285714285714,0.142857142857,0.571428571429,0.0
fatigue,0.142857142857,0.428571428571,0.285714285714,0.142857142857
Visual awareness,0.142857142857,0.285714285714,0.285714285714,0.285714285714
Syntax,0.285714285714,0.285714285714,0.142857142857,0.285714285714
Decoding,0.0,0.428571428571,0.285714285714,0.285714285714
Object naming,0.142857142857,0.428571428571,0.428571428571,0.0
Procedural learning,0.285714285714,0.285714285714,0.428571428571,0.0
Mirror neuron,0.0,0.285714285714,0.571428571429,0.142857142857
Age of acquisition,0.142857142857,0.428571428571,0.428571428571,0.0
Affective,0.285714285714,0.0,0.285714285714,0.428571428571
Anterior insula,0.285714285714,0.285714285714,0.428571428571,0.0
Cognitive screening,0.285714285714,0.428571428571,0.0,0.285714285714
Personality traits,0.0,0.571428571429,0.428571428571,0.0
Brain atrophy,0.0,0.0,0.571428571429,0.428571428571
Aesthetics,0.285714285714,0.285714285714,0.428571428571,0.0
Developmental disorders,0.285714285714,0.142857142857,0.428571428571,0.142857142857
Video games,0.0,0.428571428571,0.428571428571,0.142857142857
Anemia,0.428571428571,0.428571428571,0.142857142857,0.0
Trait anxiety,0.142857142857,0.142857142857,0.571428571429,0.142857142857
Trail Making Test,0.428571428571,0.285714285714,0.285714285714,0.0
frontotemporal dementia,0.0,0.428571428571,0.142857142857,0.428571428571
Language impairment,0.428571428571,0.0,0.571428571429,0.0
Humor,0.285714285714,0.285714285714,0.142857142857,0.285714285714
Human brain,0.142857142857,0.285714285714,0.428571428571,0.142857142857
Leukoaraiosis,0.142857142857,0.285714285714,0.285714285714,0.285714285714
Cognitive reappraisal,0.142857142857,0.285714285714,0.428571428571,0.142857142857
Anesthesia,0.0,0.428571428571,0.571428571429,0.0
Visual motion,0.285714285714,0.0,0.714285714286,0.0
Impairment,0.285714285714,0.0,0.714285714286,0.0
Noradrenaline,0.571428571429,0.142857142857,0.142857142857,0.142857142857
reading,0.285714285714,0.571428571429,0.142857142857,0.0
Conceptual development,0.142857142857,0.714285714286,0.142857142857,0.0
Near-infrared spectroscopy,0.142857142857,0.285714285714,0.428571428571,0.142857142857
Gestalt,0.0,0.428571428571,0.428571428571,0.142857142857
Visuospatial processing,0.142857142857,0.285714285714,0.428571428571,0.142857142857
Startle,0.0,0.285714285714,0.428571428571,0.285714285714
Human-computer interaction,0.428571428571,0.142857142857,0.0,0.428571428571
Heritability,0.285714285714,0.285714285714,0.428571428571,0.0
ASD,0.285714285714,0.0,0.571428571429,0.142857142857
Language production,0.285714285714,0.142857142857,0.428571428571,0.142857142857
Interval timing,0.142857142857,0.0,0.714285714286,0.142857142857
Quantity,0.428571428571,0.428571428571,0.142857142857,0.0
Organophosphates,0.428571428571,0.0,0.571428571429,0.0
Grouping,0.285714285714,0.142857142857,0.428571428571,0.142857142857
Scene recognition,0.142857142857,0.428571428571,0.285714285714,0.142857142857
Inferotemporal cortex,0.285714285714,0.0,0.285714285714,0.428571428571
MMN,0.285714285714,0.142857142857,0.571428571429,0.0
Spatial processing,0.285714285714,0.428571428571,0.285714285714,0.0
Gamma band,0.0,0.285714285714,0.428571428571,0.285714285714
Social phobia,0.285714285714,0.285714285714,0.428571428571,0.0
Volumetry,0.0,0.142857142857,0.571428571429,0.285714285714
Brain connectivity,0.428571428571,0.0,0.571428571429,0.0
Multitasking,0.142857142857,0.285714285714,0.428571428571,0.142857142857
Word learning,0.0,0.428571428571,0.571428571429,0.0
Preference,0.0,0.285714285714,0.714285714286,0.0
Deafness,0.571428571429,0.428571428571,0.0,0.0
ACC,0.142857142857,0.428571428571,0.428571428571,0.0
oxytocin,0.0,0.285714285714,0.571428571429,0.142857142857
Volition,0.571428571429,0.285714285714,0.142857142857,0.0
NMDA,0.428571428571,0.142857142857,0.428571428571,0.0
Cochlear implant,0.285714285714,0.285714285714,0.285714285714,0.142857142857
Object individuation,0.285714285714,0.0,0.714285714286,0.0
visual,0.142857142857,0.428571428571,0.142857142857,0.285714285714
Cognitive science,0.285714285714,0.142857142857,0.571428571429,0.0
Efficiency,0.142857142857,0.571428571429,0.285714285714,0.0
Non-human primate,0.0,0.571428571429,0.285714285714,0.142857142857
Haptic,0.0,0.571428571429,0.428571428571,0.0
Inversion,0.285714285714,0.0,0.571428571429,0.142857142857
Mental retardation,0.285714285714,0.142857142857,0.285714285714,0.285714285714
Metamemory,0.142857142857,0.428571428571,0.428571428571,0.0
Coordination,0.285714285714,0.285714285714,0.285714285714,0.142857142857
RSVP,0.285714285714,0.428571428571,0.142857142857,0.142857142857
White matter lesions,0.142857142857,0.142857142857,0.428571428571,0.285714285714
Neural regeneration,0.142857142857,0.142857142857,0.571428571429,0.142857142857
Amblyopia,0.0,0.285714285714,0.285714285714,0.428571428571
empathy,0.142857142857,0.428571428571,0.428571428571,0.0
Accuracy,0.428571428571,0.0,0.428571428571,0.142857142857
Brain MRI,0.0,0.285714285714,0.428571428571,0.142857142857
development,0.285714285714,0.0,0.571428571429,0.142857142857
Nonhuman primates,0.142857142857,0.571428571429,0.285714285714,0.0
Salience,0.0,0.428571428571,0.428571428571,0.142857142857
COMT,0.142857142857,0.285714285714,0.571428571429,0.0
Numbers,0.142857142857,0.571428571429,0.285714285714,0.0
Pharmacokinetics,0.142857142857,0.571428571429,0.142857142857,0.142857142857
Consolidation,0.142857142857,0.285714285714,0.285714285714,0.285714285714
Error processing,0.142857142857,0.285714285714,0.571428571429,0.0
Frailty,0.142857142857,0.0,0.714285714286,0.142857142857
Ambiguous figures,0.285714285714,0.142857142857,0.571428571429,0.0
Sensory,0.142857142857,0.285714285714,0.428571428571,0.0
Alcohol dependence,0.285714285714,0.571428571429,0.142857142857,0.0
Eyes,0.142857142857,0.428571428571,0.285714285714,0.142857142857
ERN,0.285714285714,0.285714285714,0.428571428571,0.0
Biased competition,0.142857142857,0.571428571429,0.285714285714,0.0
Neuropsychological outcome,0.142857142857,0.571428571429,0.285714285714,0.0
Estimation,0.285714285714,0.428571428571,0.285714285714,0.0
Rubber hand illusion,0.285714285714,0.285714285714,0.285714285714,0.142857142857
Disorganization,0.285714285714,0.571428571429,0.142857142857,0.0
Visuo-spatial,0.142857142857,0.285714285714,0.428571428571,0.142857142857
Broca's area,0.142857142857,0.285714285714,0.571428571429,0.0
Location,0.428571428571,0.285714285714,0.142857142857,0.142857142857
cognitive assessment,0.285714285714,0.0,0.428571428571,0.285714285714
Tau,0.0,0.0,1.0,0.0
Uncertainty,0.142857142857,0.285714285714,0.571428571429,0.0
Computerized testing,0.0,0.333333333333,0.5,0.166666666667
Preferential looking,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Concept learning,0.166666666667,0.166666666667,0.5,0.166666666667
ACT-R,0.166666666667,0.166666666667,0.5,0.166666666667
Sensory integration,0.333333333333,0.0,0.666666666667,0.0
neurodevelopment,0.5,0.166666666667,0.166666666667,0.166666666667
Animals,0.0,0.666666666667,0.166666666667,0.166666666667
Cognitive biases,0.333333333333,0.333333333333,0.333333333333,0.0
intelligence,0.166666666667,0.5,0.166666666667,0.166666666667
Self-face,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Depressive symptoms,0.166666666667,0.166666666667,0.5,0.166666666667
Orthography,0.0,0.166666666667,0.5,0.333333333333
Zeaxanthin,0.166666666667,0.5,0.333333333333,0.0
Gray matter volume,0.166666666667,0.333333333333,0.5,0.0
Maintenance,0.166666666667,0.333333333333,0.5,0.0
Visuo-spatial cognition,0.333333333333,0.0,0.666666666667,0.0
Lexical retrieval,0.333333333333,0.333333333333,0.333333333333,0.0
Illusion,0.0,0.5,0.333333333333,0.166666666667
facial expression,0.166666666667,0.166666666667,0.666666666667,0.0
Pathological gambling,0.166666666667,0.0,0.666666666667,0.166666666667
Validation,0.166666666667,0.166666666667,0.666666666667,0.0
Dependence,0.0,0.0,0.833333333333,0.166666666667
Oddball paradigm,0.333333333333,0.333333333333,0.333333333333,0.0
Eye-movements,0.333333333333,0.333333333333,0.166666666667,0.166666666667
Rivastigmine,0.333333333333,0.166666666667,0.5,0.0
Bimanual coordination,0.166666666667,0.166666666667,0.166666666667,0.333333333333
Conflict adaptation,0.166666666667,0.666666666667,0.166666666667,0.0
diffusion tensor imaging,0.0,0.833333333333,0.166666666667,0.0
Feature integration,0.0,0.666666666667,0.333333333333,0.0
Inhibition of return,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Morphology,0.5,0.166666666667,0.333333333333,0.0
Gaze-following,0.333333333333,0.0,0.5,0.166666666667
Horse,0.5,0.166666666667,0.166666666667,0.166666666667
Bottom-up,0.333333333333,0.166666666667,0.333333333333,0.166666666667
Psychometrics,0.166666666667,0.166666666667,0.333333333333,0.333333333333
Autistic spectrum disorder,0.5,0.5,0.0,0.0
Usability,0.0,0.333333333333,0.333333333333,0.333333333333
Verbs,0.666666666667,0.166666666667,0.166666666667,0.0
Blind,0.5,0.166666666667,0.333333333333,0.0
Turner syndrome,0.0,0.5,0.5,0.0
visual processing,0.0,0.5,0.333333333333,0.166666666667
Associative memory,0.0,0.333333333333,0.666666666667,0.0
Ventromedial prefrontal cortex,0.0,0.333333333333,0.666666666667,0.0
Mood induction,0.166666666667,0.5,0.333333333333,0.0
emotion regulation,0.333333333333,0.166666666667,0.5,0.0
Cholinergic,0.166666666667,0.5,0.333333333333,0.0
Time-frequency analysis,0.5,0.166666666667,0.166666666667,0.166666666667
N200,0.166666666667,0.166666666667,0.333333333333,0.333333333333
Evolutionary psychology,0.333333333333,0.0,0.666666666667,0.0
Mercury,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Rhythm,0.166666666667,0.166666666667,0.666666666667,0.0
Facilitation,0.333333333333,0.333333333333,0.333333333333,0.0
Identity,0.166666666667,0.166666666667,0.333333333333,0.333333333333
tDCS,0.0,0.5,0.5,0.0
Sedation,0.0,0.666666666667,0.166666666667,0.166666666667
Oncology,0.333333333333,0.5,0.166666666667,0.0
Fractional anisotropy,0.166666666667,0.166666666667,0.666666666667,0.0
Clustering,0.166666666667,0.0,0.666666666667,0.166666666667
Anatomy,0.166666666667,0.0,0.666666666667,0.166666666667
Visual mismatch negativity,0.166666666667,0.166666666667,0.5,0.166666666667
Motor simulation,0.166666666667,0.166666666667,0.333333333333,0.333333333333
First episode psychosis,0.166666666667,0.333333333333,0.5,0.0
Spatial relations,0.0,0.0,0.833333333333,0.166666666667
Stimulus-response compatibility,0.333333333333,0.333333333333,0.166666666667,0.166666666667
Pragmatics,0.5,0.166666666667,0.333333333333,0.0
Endophenotypes,0.333333333333,0.333333333333,0.166666666667,0.166666666667
IAT,0.166666666667,0.5,0.166666666667,0.166666666667
Identification,0.166666666667,0.5,0.333333333333,0.0
Social attention,0.333333333333,0.333333333333,0.166666666667,0.166666666667
Neurofibromatosis type 1,0.166666666667,0.166666666667,0.333333333333,0.333333333333
dopamine,0.0,0.666666666667,0.166666666667,0.166666666667
Spatial updating,0.0,0.666666666667,0.0,0.333333333333
autism,0.0,0.333333333333,0.666666666667,0.0
Perceptual simulation,0.166666666667,0.166666666667,0.666666666667,0.0
Atypical antipsychotics,0.333333333333,0.5,0.166666666667,0.0
Peripheral vision,0.166666666667,0.166666666667,0.333333333333,0.333333333333
Levetiracetam,0.166666666667,0.333333333333,0.166666666667,0.333333333333
Number line,0.166666666667,0.5,0.333333333333,0.0
numerical cognition,0.166666666667,0.333333333333,0.166666666667,0.333333333333
Youth,0.166666666667,0.166666666667,0.166666666667,0.5
Seizure,0.166666666667,0.166666666667,0.5,0.166666666667
Obsessive compulsive disorder,0.333333333333,0.5,0.166666666667,0.0
Induction,0.166666666667,0.166666666667,0.666666666667,0.0
Temporal cortex,0.166666666667,0.333333333333,0.5,0.0
Attachment,0.333333333333,0.166666666667,0.333333333333,0.166666666667
Collaboration,0.0,0.166666666667,0.833333333333,0.0
Space representation,0.333333333333,0.166666666667,0.333333333333,0.166666666667
Neuroticism,0.0,0.5,0.5,0.0
Dynamical systems,0.166666666667,0.166666666667,0.666666666667,0.0
Go/NoGo,0.666666666667,0.0,0.166666666667,0.166666666667
Coherent motion,0.333333333333,0.5,0.0,0.166666666667
Neuropsychological function,0.0,0.333333333333,0.666666666667,0.0
activities of daily living,0.166666666667,0.333333333333,0.5,0.0
Genetic,0.0,0.666666666667,0.166666666667,0.166666666667
Visual masking,0.166666666667,0.166666666667,0.666666666667,0.0
Cues,0.166666666667,0.5,0.333333333333,0.0
functional MRI,0.166666666667,0.5,0.333333333333,0.0
Psychotic symptoms,0.333333333333,0.0,0.5,0.166666666667
depressive symptoms,0.333333333333,0.5,0.166666666667,0.0
Aftereffects,0.0,0.5,0.333333333333,0.166666666667
Reference frame,0.333333333333,0.5,0.166666666667,0.0
Objects,0.0,0.333333333333,0.5,0.166666666667
Intentionality,0.0,0.333333333333,0.666666666667,0.0
Positive affect,0.166666666667,0.166666666667,0.5,0.166666666667
Opioid,0.0,0.666666666667,0.166666666667,0.166666666667
Action control,0.666666666667,0.166666666667,0.166666666667,0.0
Knowledge,0.166666666667,0.166666666667,0.5,0.166666666667
Joint action,0.0,0.333333333333,0.666666666667,0.0
Montreal Cognitive Assessment,0.0,0.5,0.166666666667,0.166666666667
22q11.2 deletion syndrome,0.166666666667,0.166666666667,0.666666666667,0.0
Deactivation,0.333333333333,0.333333333333,0.333333333333,0.0
Functional status,0.5,0.333333333333,0.166666666667,0.0
Emotional expression,0.0,0.333333333333,0.666666666667,0.0
Late effects,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Cognitive effects,0.333333333333,0.5,0.166666666667,0.0
Visual scanning,0.166666666667,0.666666666667,0.166666666667,0.0
Core knowledge,0.166666666667,0.166666666667,0.166666666667,0.5
Retrieval,0.333333333333,0.166666666667,0.333333333333,0.166666666667
Asperger's disorder,0.666666666667,0.333333333333,0.0,0.0
Statistical learning,0.333333333333,0.5,0.166666666667,0.0
Antipsychotic,0.333333333333,0.333333333333,0.333333333333,0.0
Reading development,0.166666666667,0.166666666667,0.666666666667,0.0
Dynamic causal modeling,0.166666666667,0.0,0.833333333333,0.0
Mathematics,0.5,0.333333333333,0.0,0.166666666667
Brain networks,0.333333333333,0.0,0.5,0.166666666667
MCCB,0.0,0.5,0.333333333333,0.166666666667
Ethanol,0.333333333333,0.166666666667,0.5,0.0
Bayesian inference,0.0,0.833333333333,0.166666666667,0.0
Mecamylamine,0.166666666667,0.5,0.166666666667,0.166666666667
Social behavior,0.166666666667,0.166666666667,0.166666666667,0.5
Visual exploration,0.166666666667,0.333333333333,0.5,0.0
cognitive aging,0.5,0.333333333333,0.166666666667,0.0
Interpretation,0.166666666667,0.333333333333,0.5,0.0
Behavioral flexibility,0.5,0.333333333333,0.0,0.166666666667
Analogical reasoning,0.5,0.166666666667,0.166666666667,0.166666666667
Categorisation,0.5,0.166666666667,0.166666666667,0.166666666667
ECoG,0.333333333333,0.0,0.5,0.166666666667
Food reward,0.333333333333,0.5,0.166666666667,0.0
Predictors,0.0,0.833333333333,0.166666666667,0.0
Psychotic disorders,0.0,0.333333333333,0.5,0.166666666667
Brain-computer interface,0.166666666667,0.666666666667,0.166666666667,0.0
Pupillary response,0.333333333333,0.333333333333,0.333333333333,0.0
Spatial language,0.333333333333,0.333333333333,0.166666666667,0.166666666667
Capacity,0.0,0.166666666667,0.666666666667,0.166666666667
High risk,0.0,0.166666666667,0.5,0.333333333333
mental rotation,0.166666666667,0.666666666667,0.166666666667,0.0
Oddball task,0.0,0.5,0.333333333333,0.166666666667
Craniopharyngioma,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Cognitive modeling,0.333333333333,0.333333333333,0.333333333333,0.0
Brain function,0.333333333333,0.166666666667,0.5,0.0
Artificial intelligence,0.166666666667,0.333333333333,0.5,0.0
Systemic lupus erythematosus,0.166666666667,0.5,0.166666666667,0.166666666667
pain,0.166666666667,0.5,0.0,0.333333333333
Occipital cortex,0.166666666667,0.5,0.166666666667,0.166666666667
Mental arithmetic,0.333333333333,0.0,0.5,0.0
affect,0.166666666667,0.666666666667,0.166666666667,0.0
Covert attention,0.0,0.166666666667,0.5,0.333333333333
Mental processes,0.166666666667,0.666666666667,0.0,0.166666666667
Central nervous system,0.166666666667,0.333333333333,0.5,0.0
Water maze,0.166666666667,0.666666666667,0.166666666667,0.0
Brain tumors,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Illusory contours,0.0,0.5,0.333333333333,0.166666666667
Fish,0.333333333333,0.333333333333,0.166666666667,0.166666666667
Response selection,0.333333333333,0.333333333333,0.166666666667,0.166666666667
Withdrawal,0.166666666667,0.166666666667,0.5,0.166666666667
Breakfast,0.333333333333,0.333333333333,0.333333333333,0.0
Motor function,0.0,0.166666666667,0.833333333333,0.0
breast cancer,0.166666666667,0.333333333333,0.5,0.0
Preterm birth,0.166666666667,0.333333333333,0.5,0.0
Visual word form area,0.0,0.166666666667,0.5,0.333333333333
Source memory,0.166666666667,0.0,0.833333333333,0.0
PCA,0.166666666667,0.166666666667,0.333333333333,0.333333333333
Verbal working memory,0.333333333333,0.166666666667,0.5,0.0
Head injury,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Williams Syndrome,0.0,0.666666666667,0.166666666667,0.166666666667
Fronto-parietal network,0.0,0.0,0.5,0.5
Object discrimination,0.333333333333,0.166666666667,0.5,0.0
face recognition,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Ownership,0.166666666667,0.5,0.333333333333,0.0
Cytokines,0.166666666667,0.166666666667,0.5,0.166666666667
Longitudinal studies,0.0,0.5,0.333333333333,0.166666666667
Borderline personality disorder,0.0,0.333333333333,0.666666666667,0.0
VEP,0.166666666667,0.333333333333,0.5,0.0
Post-traumatic stress disorder,0.0,0.5,0.333333333333,0.166666666667
Cueing,0.333333333333,0.333333333333,0.0,0.333333333333
Parahippocampal place area,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Multiple object tracking,0.166666666667,0.166666666667,0.666666666667,0.0
Acetylcholinesterase inhibitor,0.166666666667,0.5,0.333333333333,0.0
Multimodal,0.0,0.333333333333,0.333333333333,0.333333333333
Sensory processing,0.166666666667,0.666666666667,0.166666666667,0.0
Facial affect,0.166666666667,0.333333333333,0.5,0.0
Vascular risk factors,0.333333333333,0.166666666667,0.333333333333,0.166666666667
Fluid intelligence,0.166666666667,0.666666666667,0.166666666667,0.0
Alcohol abuse,0.166666666667,0.333333333333,0.5,0.0
Side effects,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Clinical trial,0.333333333333,0.166666666667,0.5,0.0
serotonin,0.333333333333,0.5,0.0,0.166666666667
alcohol,0.666666666667,0.166666666667,0.166666666667,0.0
PFC,0.0,0.666666666667,0.333333333333,0.0
Norms,0.0,0.5,0.166666666667,0.333333333333
Tamoxifen,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Naltrexone,0.333333333333,0.333333333333,0.166666666667,0.166666666667
Motor development,0.5,0.166666666667,0.333333333333,0.0
neuropsychological testing,0.5,0.166666666667,0.333333333333,0.0
False belief,0.0,0.5,0.333333333333,0.166666666667
Benzodiazepine,0.0,0.5,0.5,0.0
older adults,0.333333333333,0.333333333333,0.166666666667,0.166666666667
Limbic,0.0,0.166666666667,0.666666666667,0.166666666667
migraine,0.166666666667,0.333333333333,0.5,0.0
Dravet syndrome,0.0,0.333333333333,0.5,0.166666666667
Event perception,0.333333333333,0.0,0.5,0.166666666667
Spatial cueing,0.166666666667,0.333333333333,0.5,0.0
Entrainment,0.5,0.166666666667,0.166666666667,0.166666666667
Postural balance,0.166666666667,0.166666666667,0.666666666667,0.0
Anger,0.166666666667,0.166666666667,0.666666666667,0.0
Environmental enrichment,0.0,0.333333333333,0.5,0.166666666667
Premotor,0.333333333333,0.333333333333,0.333333333333,0.0
Vocabulary,0.666666666667,0.0,0.333333333333,0.0
Human navigation,0.0,0.333333333333,0.666666666667,0.0
Rheumatoid arthritis,0.0,0.166666666667,0.5,0.333333333333
Confirmatory factor analysis,0.166666666667,0.333333333333,0.166666666667,0.333333333333
Conflict processing,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Specificity,0.166666666667,0.333333333333,0.5,0.0
Fear conditioning,0.333333333333,0.333333333333,0.333333333333,0.0
Memory retrieval,0.166666666667,0.333333333333,0.333333333333,0.166666666667
neuropsychological test,0.333333333333,0.166666666667,0.5,0.0
spatial memory,0.0,0.5,0.333333333333,0.166666666667
Mexico,0.166666666667,0.333333333333,0.333333333333,0.166666666667
Caudate nucleus,0.166666666667,0.5,0.333333333333,0.0
Hormones,0.333333333333,0.333333333333,0.333333333333,0.0
Hemodialysis,0.333333333333,0.166666666667,0.5,0.0
Negative priming,0.0,0.166666666667,0.666666666667,0.166666666667
N2pc,0.166666666667,0.166666666667,0.666666666667,0.0
Diabetes mellitus,0.333333333333,0.333333333333,0.333333333333,0.0
brain,0.166666666667,0.333333333333,0.333333333333,0.166666666667
UFOV,0.333333333333,0.166666666667,0.5,0.0
Corticobasal degeneration,0.5,0.0,0.5,0.0
Visual mental imagery,0.0,0.166666666667,0.666666666667,0.166666666667
priming,0.166666666667,0.333333333333,0.5,0.0
Neurocognitive testing,0.0,0.166666666667,0.833333333333,0.0
Neurocognitive function,0.0,0.5,0.333333333333,0.166666666667
Facial expression recognition,0.166666666667,0.166666666667,0.666666666667,0.0
Linguistic relativity,0.333333333333,0.333333333333,0.333333333333,0.0
Adverse effects,0.5,0.166666666667,0.166666666667,0.166666666667
Twins,0.333333333333,0.333333333333,0.333333333333,0.0
Dreaming,0.0,0.333333333333,0.666666666667,0.0
distraction,0.166666666667,0.5,0.333333333333,0.0
Driving simulation,0.166666666667,0.5,0.166666666667,0.166666666667
Anxiety disorders,0.5,0.333333333333,0.166666666667,0.0
Movement disorders,0.0,0.5,0.333333333333,0.166666666667
Effort,0.0,0.333333333333,0.5,0.166666666667
History,0.166666666667,0.333333333333,0.5,0.0
Flexibility,0.166666666667,0.0,0.666666666667,0.166666666667
Auditory distraction,0.166666666667,0.5,0.333333333333,0.0
Hip fracture,0.166666666667,0.666666666667,0.166666666667,0.0
MT,0.5,0.166666666667,0.166666666667,0.166666666667
Type 1 diabetes,0.166666666667,0.333333333333,0.5,0.0
Pharmacodynamics,0.0,0.666666666667,0.166666666667,0.166666666667
Cigarette smoking,0.166666666667,0.166666666667,0.666666666667,0.0
Self-report,0.166666666667,0.666666666667,0.166666666667,0.0
Event-related,0.166666666667,0.5,0.166666666667,0.166666666667
Tea,0.6,0.4,0.0,0.0
Calculation,0.2,0.0,0.8,0.0
Bird,0.4,0.0,0.6,0.0
Voluntary control,0.2,0.0,0.4,0.4
Hunger,0.4,0.2,0.2,0.2
Visual representation,0.4,0.2,0.4,0.0
Motion processing,0.4,0.4,0.2,0.0
Rhesus macaque,0.2,0.2,0.4,0.2
Dynamics,0.2,0.4,0.4,0.0
Hippocampal sclerosis,0.2,0.4,0.4,0.0
Subcortical,0.0,0.2,0.4,0.4
Hearing aids,0.0,0.2,0.6,0.2
Attribution,0.4,0.0,0.6,0.0
Adherence,0.2,0.4,0.2,0.2
Polymorphism,0.2,0.4,0.4,0.0
Motor resonance,0.0,0.4,0.2,0.4
Gravity,0.0,0.2,0.6,0.2
Neuromyelitis optica,0.0,0.2,0.8,0.0
white matter,0.2,0.2,0.6,0.0
Perceptual priming,0.0,0.4,0.2,0.4
Driving simulator,0.0,0.4,0.6,0.0
cognitive training,0.4,0.2,0.2,0.2
Cardiopulmonary bypass,0.2,0.6,0.2,0.0
Reaction times,0.4,0.4,0.2,0.0
infancy,0.4,0.2,0.2,0.2
"Alzheimer's disease,0.0,0.0,0.0,0.0
glutamate,0.0,0.0,0.8,0.2
Essential tremor,0.2,0.2,0.6,0.0
Questionnaire,0.0,0.2,0.6,0.2
Common coding,0.2,0.0,0.6,0.2
amygdala,0.0,0.4,0.6,0.0
Task complexity,0.0,0.0,1.0,0.0
Target detection,0.6,0.4,0.0,0.0
visual hallucinations,0.4,0.0,0.2,0.4
delirium,0.6,0.4,0.0,0.0
Qualitative research,0.2,0.4,0.4,0.0
Old age,0.2,0.2,0.6,0.0
Developmental,0.6,0.4,0.0,0.0
Continuous performance test,0.4,0.0,0.4,0.2
Circadian rhythms,0.0,0.6,0.4,0.0
Visual agnosia,0.4,0.4,0.2,0.0
basal ganglia,0.2,0.4,0.4,0.0
visual working memory,0.4,0.0,0.6,0.0
Gaze control,0.2,0.4,0.4,0.0
A?,0.2,0.8,0.0,0.0
Multisensory perception,0.0,0.4,0.4,0.2
Perspective,0.0,0.2,0.6,0.2
Wayfinding,0.0,0.6,0.4,0.0
IAPS,0.0,0.4,0.6,0.0
emotions,0.8,0.2,0.0,0.0
Schizotypal personality disorder,0.2,0.4,0.4,0.0
Animal models,0.0,0.4,0.6,0.0
Go/no-go,0.2,0.4,0.2,0.2
Neocognitron,0.0,0.6,0.2,0.2
HPA axis,0.0,0.6,0.4,0.0
Antidepressant,0.2,0.2,0.6,0.0
Resting state networks,0.4,0.2,0.2,0.2
Psychiatric disorders,0.2,0.2,0.6,0.0
Attention allocation,0.0,0.4,0.4,0.2
Visual pattern recognition,0.2,0.2,0.4,0.2
Conduct disorder,0.2,0.4,0.4,0.0
insula,0.0,0.6,0.2,0.2
Source localization,0.2,0.0,0.6,0.2
Progesterone,0.4,0.0,0.4,0.2
Category specificity,0.0,0.4,0.4,0.2
Prevention,0.6,0.0,0.0,0.2
Neurobehavioral manifestations,0.0,0.6,0.2,0.2
Feature-based attention,0.0,0.6,0.4,0.0
Peripersonal space,0.4,0.6,0.0,0.0
Adult,0.0,0.4,0.2,0.4
Fixations,0.0,0.4,0.2,0.4
rTMS,0.2,0.4,0.4,0.0
Neuropsychological profile,0.2,0.0,0.4,0.4
Unconscious perception,0.2,0.2,0.6,0.0
Post-error slowing,0.4,0.2,0.4,0.0
Visuo-spatial attention,0.2,0.6,0.2,0.0
default mode network,0.2,0.2,0.6,0.0
Correlation,0.2,0.4,0.4,0.0
Risk,0.4,0.0,0.2,0.4
Neuropsychological impairment,0.2,0.0,0.6,0.0
Pediatrics,0.0,0.6,0.2,0.2
Task set,0.2,0.2,0.4,0.2
Inflammation,0.4,0.0,0.4,0.2
Hemisphere,0.4,0.0,0.4,0.2
navigation,0.2,0.0,0.6,0.2
Picture superiority effect,0.2,0.0,0.8,0.0
Superior colliculus,0.4,0.4,0.2,0.0
Magnitude comparison,0.2,0.0,0.6,0.2
Error,0.4,0.4,0.2,0.0
reward,0.2,0.2,0.6,0.0
mTBI,0.2,0.0,0.8,0.0
Information theory,0.0,0.2,0.4,0.4
Multiple system atrophy,0.2,0.2,0.6,0.0
Disconnection,0.0,0.4,0.6,0.0
clinical trial,0.2,0.0,0.4,0.4
Cognitive impairments,0.2,0.6,0.2,0.0
Event-related brain potential,0.2,0.2,0.4,0.2
Comparison,0.2,0.4,0.4,0.0
3D,0.2,0.4,0.2,0.2
Trustworthiness,0.4,0.0,0.4,0.2
Circadian rhythm,0.4,0.0,0.4,0.2
Gene expression,0.2,0.2,0.4,0.2
Response conflict,0.0,0.4,0.6,0.0
Semantic interference,0.2,0.4,0.2,0.2
Near-infrared spectroscopy (NIRS),0.4,0.4,0.0,0.2
Meaning,0.0,0.2,0.8,0.0
Educational status,0.0,0.4,0.6,0.0
Hemianopia,0.2,0.6,0.0,0.2
Driving ability,0.0,0.4,0.6,0.0
Cognitive evolution,0.4,0.2,0.4,0.0
Affective stimuli,0.0,0.6,0.2,0.2
cognitive deficits,0.0,0.4,0.4,0.2
Impression formation,0.2,0.0,0.8,0.0
Visual art,0.0,0.6,0.4,0.0
Population-based sample,0.4,0.2,0.0,0.4
Evoked potential,0.0,0.2,0.4,0.4
Cognitive testing,0.2,0.2,0.4,0.2
Words,0.2,0.4,0.4,0.0
Accessibility,0.6,0.0,0.2,0.2
Intellectual disabilities,0.2,0.6,0.0,0.2
Symbols,0.4,0.0,0.6,0.0
Marijuana,0.0,0.0,0.6,0.4
Tryptophan,0.2,0.2,0.6,0.0
electroencephalography,0.4,0.2,0.4,0.0
Developmental coordination disorder,0.2,0.2,0.4,0.2
processing speed,0.2,0.4,0.4,0.0
Illiteracy,0.2,0.0,0.4,0.4
Down's syndrome,0.2,0.4,0.4,0.0
First episode,0.0,0.0,1.0,0.0
Target,0.0,0.4,0.4,0.2
Inspection time,0.4,0.2,0.4,0.0
Opioids,0.0,0.6,0.4,0.0
Spatial learning and memory,0.2,0.2,0.6,0.0
Depth perception,0.4,0.0,0.4,0.2
Long-term effects,0.8,0.0,0.0,0.2
Event cognition,0.4,0.4,0.2,0.0
Distractibility,0.2,0.2,0.6,0.0
Docosahexaenoic acid,0.0,0.2,0.8,0.0
Acute tryptophan depletion,0.2,0.6,0.2,0.0
Noise,0.4,0.0,0.4,0.2
Attention network test,0.0,0.4,0.4,0.2
Tracking,0.4,0.2,0.4,0.0
Polychlorinated biphenyls,0.2,0.4,0.4,0.0
Hearing disorders,0.0,0.2,0.8,0.0
Young adults,0.4,0.2,0.2,0.2
Contour integration,0.2,0.2,0.2,0.4
Psychiatry and Neurosurgery",0.0,0.0,0.0,0.0
Path analysis,0.2,0.4,0.2,0.2
Necker cube,0.2,0.2,0.6,0.0
Event-Related Potentials,0.2,0.0,0.6,0.2
Everyday functioning,0.0,0.2,0.6,0.2
Schizoaffective disorder,0.2,0.2,0.6,0.0
MVPA,0.8,0.0,0.2,0.0
Retina,0.2,0.4,0.4,0.0
Amphetamine,0.2,0.4,0.2,0.2
vascular cognitive impairment,0.0,0.6,0.2,0.2
visual impairment,0.2,0.2,0.6,0.0
Overweight,0.2,0.2,0.4,0.2
THC,0.2,0.2,0.6,0.0
Speech production,0.0,0.2,0.6,0.2
Visual representations,0.4,0.0,0.6,0.0
Visual discrimination learning,0.0,0.6,0.4,0.0
Early visual processing,0.2,0.2,0.2,0.4
Skin conductance response,0.0,0.4,0.4,0.2
SSVEP,0.6,0.2,0.2,0.0
Number cognition,0.0,0.0,0.8,0.2
Visual development,0.2,0.2,0.6,0.0
amyloid,0.8,0.2,0.0,0.0
Worry,0.2,0.4,0.4,0.0
Expression,0.0,0.4,0.4,0.2
chronic pain,0.0,0.4,0.4,0.2
Parahippocampal gyrus,0.2,0.6,0.2,0.0
Oxidative stress,0.2,0.4,0.4,0.0
Vestibular,0.0,0.4,0.4,0.2
Hearing impairment,0.2,0.2,0.6,0.0
selective attention,0.6,0.2,0.2,0.0
Temperament,0.0,0.2,0.8,0.0
Facial recognition,0.6,0.0,0.4,0.0
Repetitive transcranial magnetic stimulation,0.0,0.2,0.6,0.2
Social skills,0.2,0.4,0.4,0.0
Auditory imagery,0.2,0.2,0.6,0.0
Frames of reference,0.2,0.2,0.4,0.2
connectivity,0.2,0.6,0.2,0.0
Processing efficiency,0.2,0.4,0.2,0.2
spatial attention,0.0,0.6,0.4,0.0
Vitamin B12,0.2,0.4,0.4,0.0
Metabolism,0.2,0.0,0.8,0.0
Error monitoring,0.2,0.2,0.6,0.0
Glucose,0.0,0.6,0.4,0.0
Oculomotor control,0.2,0.0,0.8,0.0
Rapid serial visual presentation,0.6,0.2,0.2,0.0
object recognition,0.0,0.6,0.2,0.2
Error-related negativity,0.0,0.2,0.6,0.2
Creative cognition,0.0,0.0,1.0,0.0
Magnetic resonance imaging (MRI),0.2,0.2,0.6,0.0
Myelin,0.2,0.2,0.6,0.0
Race,0.2,0.0,0.8,0.0
Performance monitoring,0.4,0.2,0.4,0.0
Growth,0.2,0.2,0.6,0.0
Non-motor symptoms,0.2,0.2,0.6,0.0
Comparative psychology,0.2,0.0,0.6,0.2
Multivariate analysis,0.2,0.4,0.2,0.2
Motor coordination,0.2,0.2,0.6,0.0
Cholinesterase inhibitor,0.4,0.0,0.6,0.0
Semantic richness,0.0,0.4,0.6,0.0
dyslexia,0.0,0.8,0.2,0.0
Localization,0.4,0.2,0.2,0.2
Neurodegenerative,0.0,0.2,0.8,0.0
Global,0.4,0.0,0.4,0.2
qEEG,0.2,0.6,0.2,0.0
Set,0.2,0.8,0.0,0.0
Perceptual processing,0.2,0.0,0.8,0.0
Glucocorticoids,0.4,0.4,0.0,0.2
Deep brain stimulation,0.2,0.0,0.6,0.2
Brain oscillations,0.6,0.0,0.4,0.0
Avoidance,0.2,0.2,0.4,0.2
Physical performance,0.4,0.0,0.2,0.4
facial expressions,0.0,0.6,0.4,0.0
Motor speed,0.6,0.2,0.2,0.0
Alpha oscillations,0.2,0.6,0.2,0.0
Topographical disorientation,0.2,0.4,0.4,0.0
dissociation,0.2,0.2,0.6,0.0
gender differences,0.2,0.4,0.4,0.0
action,0.2,0.2,0.6,0.0
striatum,0.0,0.2,0.8,0.0
Olanzapine,0.6,0.2,0.2,0.0
Word processing,0.4,0.2,0.4,0.0
Alexithymia,0.2,0.4,0.4,0.0
Population coding,0.0,0.4,0.6,0.0
Hazard perception,0.0,0.2,0.4,0.4
Participation,0.2,0.2,0.4,0.2
Positive symptoms,0.0,0.4,0.6,0.0
Eye contact,0.2,0.2,0.6,0.0
Lewy body dementia,0.2,0.4,0.2,0.2
Latency,0.0,0.6,0.4,0.0
Conditioning,0.6,0.2,0.2,0.0
Landmark,0.0,0.0,1.0,0.0
Alzheimer's disease (AD),0.2,0.4,0.4,0.0
Event-related potentials (ERP),0.2,0.4,0.2,0.2
Sense of body,0.0,0.4,0.2,0.4
Granger causality,0.0,0.6,0.2,0.2
Psycholinguistics,0.0,0.2,0.6,0.2
Anosognosia,0.4,0.0,0.6,0.0
Cirrhosis,0.2,0.4,0.4,0.0
Visual-spatial,0.2,0.0,0.6,0.2
Tourette syndrome,0.2,0.4,0.4,0.0
Rules,0.2,0.2,0.4,0.2
modafinil,0.2,0.6,0.2,0.0
Environment,0.4,0.2,0.2,0.2
Circadian,0.2,0.2,0.6,0.0
Artifacts,0.0,0.4,0.6,0.0
SNARC,0.0,0.4,0.6,0.0
negative symptoms,0.0,0.2,0.8,0.0
Athletes,0.2,0.6,0.2,0.0
Visual performance,0.0,0.4,0.6,0.0
Chronic fatigue syndrome,0.4,0.0,0.6,0.0
Therapy,0.0,0.6,0.2,0.2
Self-esteem,0.2,0.2,0.4,0.2
Arm movement,0.2,0.2,0.6,0.0
Innateness,0.2,0.0,0.6,0.2
Well-being,0.4,0.2,0.4,0.0
Multimedia,0.0,0.2,0.6,0.2
Neuroregeneration,0.2,0.2,0.6,0.0
Cross-cultural,0.0,0.2,0.6,0.2
Affective disorders,0.0,0.4,0.6,0.0
Cognitive efficiency,0.2,0.2,0.6,0.0
Visual reasoning,0.2,0.4,0.4,0.0
Magnocellular pathway,0.2,0.4,0.2,0.2
Divided visual field,0.2,0.2,0.6,0.0
dementia with Lewy bodies,0.6,0.0,0.4,0.0
Foraging,0.2,0.2,0.6,0.0
Neuroinflammation,0.0,0.4,0.6,0.0
awareness,0.0,0.6,0.4,0.0
oncology,0.6,0.2,0.2,0.0
Apathy,0.0,0.2,0.6,0.2
Sturge-Weber syndrome,0.0,0.4,0.6,0.0
Frontal lobe epilepsy,0.0,0.2,0.4,0.4
Posterior cingulate,0.2,0.4,0.2,0.2
Cognitive tests,0.2,0.4,0.4,0.0
cognitive neuroscience,0.2,0.0,0.8,0.0
Nonhuman primate,0.2,0.0,0.6,0.2
Attentional resources,0.0,0.2,0.6,0.2
Hyperactivity,0.4,0.0,0.6,0.0
Dual-tasking,0.2,0.6,0.2,0.0
Animal welfare,0.2,0.2,0.6,0.0
Appetite,0.0,0.6,0.2,0.2
embodiment,0.2,0.6,0.2,0.0
Number representation,0.0,1.0,0.0,0.0
Attention bias,0.2,0.4,0.4,0.0
Stimulants,0.2,0.6,0.0,0.2
Brain stimulation,0.0,0.4,0.6,0.0
Stroop effect,0.2,0.0,0.8,0.0
aphasia,0.2,0.2,0.4,0.2
Quetiapine,0.0,0.6,0.0,0.4
Encephalopathy,0.2,0.0,0.6,0.2
Dorsal visual system,0.2,0.8,0.0,0.0
brain injury,0.0,0.2,0.8,0.0
Orientation selectivity,0.2,0.2,0.4,0.2
Model,0.2,0.0,0.6,0.2
ERK,0.0,0.4,0.2,0.4
Visual perspective,0.2,0.0,0.8,0.0
Mental workload,0.2,0.4,0.4,0.0
cognitive functions,0.2,0.4,0.2,0.2
Representational momentum,0.4,0.0,0.4,0.2
Hemineglect,0.6,0.0,0.4,0.0
Colour,0.2,0.2,0.4,0.2
Multidimensional scaling,0.4,0.2,0.4,0.0
Inattention,0.2,0.0,0.6,0.2
Inferior parietal lobule,0.2,0.0,0.6,0.2
Spontaneous activity,0.0,0.0,0.8,0.2
Interoception,0.2,0.4,0.4,0.0
FNIRS,0.4,0.4,0.2,0.0
Androgens,0.2,0.4,0.4,0.0
Haptic perception,0.2,0.2,0.4,0.2
Brain-derived neurotrophic factor,0.0,0.4,0.4,0.2
Corticosterone,0.4,0.4,0.2,0.0
Resource allocation,0.0,0.2,0.6,0.2
attentional blink,0.4,0.2,0.4,0.0
symptoms,0.0,0.2,0.8,0.0
Concept,0.2,0.4,0.4,0.0
Methylmercury,0.2,0.2,0.6,0.0
parietal cortex,0.4,0.4,0.0,0.2
Glioma,0.2,0.4,0.4,0.0
Mental model,0.2,0.6,0.2,0.0
Estrogens,0.4,0.2,0.4,0.0
Ventral visual system,0.2,0.8,0.0,0.0
Visuomotor integration,0.2,0.0,0.6,0.2
Nonlinear dynamics,0.2,0.2,0.6,0.0
Cross-modal perception,0.2,0.4,0.4,0.0
Implicit processing,0.2,0.4,0.2,0.2
arousal,1.0,0.0,0.0,0.0
VWFA,0.2,0.4,0.4,0.0
Cross-modal priming,0.0,0.4,0.6,0.0
Encephalitis,0.2,0.2,0.6,0.0
Lithium,0.0,0.5,0.5,0.0
Mediation,0.5,0.0,0.5,0.0
Accommodation,0.5,0.25,0.25,0.0
Psychological refractory period,0.25,0.5,0.25,0.0
Drug,0.25,0.25,0.0,0.5
Situation awareness,0.25,0.0,0.5,0.25
Neuropathic pain,0.5,0.0,0.5,0.0
Parkinson,0.0,1.0,0.0,0.0
Emotion identification,0.25,0.25,0.25,0.25
Thinking,0.5,0.0,0.5,0.0
Progressive supranuclear palsy,0.25,0.25,0.5,0.0
Local,0.5,0.0,0.25,0.25
Electrodermal activity,0.25,0.0,0.75,0.0
Cognitive strategies,0.0,0.25,0.75,0.0
Folate,0.25,0.25,0.25,0.25
Double dissociation,0.5,0.5,0.0,0.0
Posterior superior temporal sulcus,0.0,0.5,0.5,0.0
Play,0.25,0.0,0.75,0.0
Movement preparation,0.25,0.5,0.25,0.0
Sport,0.25,0.0,0.75,0.0
Architecture,0.0,0.25,0.75,0.0
Conflict monitoring,0.5,0.5,0.0,0.0
Beauty,0.0,0.25,0.75,0.0
Verbal,0.25,0.25,0.5,0.0
Visuospatial abilities,0.25,0.25,0.5,0.0
Musicians,0.5,0.25,0.25,0.0
Media,0.5,0.0,0.0,0.5
Errorless learning,0.0,0.5,0.5,0.0
N250,0.25,0.5,0.25,0.0
Cholinesterase inhibitors,0.25,0.5,0.25,0.0
NF1,0.25,0.25,0.5,0.0
rat,0.0,0.75,0.25,0.0
Lamotrigine,0.0,0.5,0.5,0.0
driving,0.0,0.5,0.25,0.25
Physical reasoning,0.0,0.5,0.5,0.0
The elderly,0.0,0.5,0.5,0.0
Early posterior negativity,0.25,0.75,0.0,0.0
Holistic,0.0,0.25,0.75,0.0
adolescent,0.0,0.0,1.0,0.0
Sleep disorders,0.0,0.0,0.75,0.25
Cognitive evaluation,0.25,0.0,0.5,0.25
Huntington disease,0.25,0.25,0.5,0.0
Functional brain imaging,0.5,0.25,0.25,0.0
Sex hormones,0.5,0.25,0.25,0.0
Propofol,0.25,0.25,0.5,0.0
Novelty detection,0.0,0.75,0.25,0.0
aged,0.25,0.0,0.75,0.0
Liver cirrhosis,0.0,0.75,0.25,0.0
Developmental prosopagnosia,0.25,0.25,0.5,0.0
Methadone,0.0,0.25,0.75,0.0
ketamine,0.0,0.25,0.25,0.5
Unconsciousness,0.0,0.5,0.5,0.0
Follow-up studies,0.0,0.5,0.25,0.25
perceptual organization,0.25,0.0,0.5,0.25
Measurement,0.0,0.5,0.25,0.25
automaticity,0.25,0.75,0.0,0.0
Numeracy,0.5,0.5,0.0,0.0
Structural alignment,0.25,0.25,0.5,0.0
Cognitive load theory,0.0,0.0,0.75,0.25
Free will,0.5,0.5,0.0,0.0
Number discrimination,0.0,0.25,0.5,0.25
Mirror,0.25,0.5,0.0,0.25
Mental time travel,0.0,0.25,0.5,0.25
Risk factor,0.0,0.25,0.25,0.5
Self-control,0.0,0.25,0.75,0.0
Early psychosis,0.25,0.25,0.5,0.0
Cognitive tasks,0.0,0.25,0.5,0.25
Attitudes,0.0,0.5,0.25,0.25
Action monitoring,0.0,0.5,0.5,0.0
Columba livia,0.25,0.5,0.25,0.0
Semantic association,0.0,0.0,0.75,0.25
Hypoglycaemia,0.25,0.25,0.5,0.0
Pattern separation,0.25,0.5,0.25,0.0
Cingulum,0.0,0.75,0.25,0.0
Networks,0.0,0.5,0.5,0.0
Auditory system,0.25,0.25,0.5,0.0
Visual cognitive function,0.0,0.75,0.25,0.0
Motor processes,0.0,0.25,0.5,0.25
WISC-IV,0.0,0.5,0.25,0.25
Preschoolers,0.0,0.0,0.75,0.25
Cognitive evoked potentials,0.25,0.25,0.25,0.25
familiarity,0.25,0.5,0.25,0.0
Network dynamics,0.0,0.25,0.5,0.25
mild traumatic brain injury,0.0,0.0,1.0,0.0
Neurodegenerative disease,0.25,0.5,0.0,0.25
Health status,0.25,0.0,0.75,0.0
WAIS-IV,0.0,0.25,0.5,0.25
Alpha rhythm,0.0,0.5,0.5,0.0
Grants-supported paper,0.25,0.25,0.5,0.0
Gaze perception,0.0,0.25,0.5,0.25
emotion recognition,0.0,0.25,0.75,0.0
Clonidine,0.75,0.25,0.0,0.0
Respiration,0.5,0.25,0.25,0.0
Executive Functions,0.25,0.5,0.25,0.0
Retinotopy,0.25,0.5,0.25,0.0
Constructivism,0.0,0.5,0.5,0.0
Reward learning,0.25,0.25,0.25,0.25
Psychotherapy,0.0,0.5,0.5,0.0
Tests,0.25,0.0,0.75,0.0
Landmark task,0.0,0.25,0.5,0.25
Face adaptation,0.25,0.5,0.25,0.0
Emotionality,0.0,0.25,0.5,0.25
Acetylcholinesterase inhibitors,0.0,0.5,0.25,0.25
Temporal pole,0.0,0.5,0.25,0.25
Contingent negative variation,0.25,0.25,0.25,0.25
Hierarchy,0.0,0.75,0.25,0.0
Buprenorphine,0.25,0.25,0.5,0.0
Startle reflex,0.0,0.25,0.75,0.0
age,0.0,0.25,0.75,0.0
Africa,0.25,0.25,0.25,0.25
Pan troglodytes,0.0,0.25,0.5,0.25
Survivors,0.5,0.0,0.5,0.0
contrast sensitivity,0.25,0.5,0.25,0.0
Motor inhibition,0.25,0.25,0.5,0.0
Single-unit recording,0.5,0.0,0.25,0.25
obesity,0.25,0.5,0.25,0.0
Art perception,0.0,0.0,1.0,0.0
Social class,0.25,0.0,0.75,0.0
Recursion,0.0,0.5,0.5,0.0
word recognition,0.25,0.5,0.25,0.0
Useful field of view,0.25,0.25,0.5,0.0
Subthalamic nucleus,0.5,0.0,0.5,0.0
Gain control,0.25,0.5,0.25,0.0
Sleep apnea,0.25,0.0,0.5,0.0
POMS,0.25,0.0,0.5,0.25
VAS,0.0,0.0,1.0,0.0
WCST,0.5,0.5,0.0,0.0
Brain mechanisms,0.25,0.25,0.5,0.0
Lateral occipital complex,0.25,0.0,0.5,0.25
Heart failure,0.25,0.25,0.5,0.0
Occupational therapy,0.0,0.25,0.75,0.0
Methodology,0.0,0.25,0.5,0.25
Oldest-old,0.25,0.0,0.75,0.0
Hemispheres,0.0,0.0,1.0,0.0
Visual-world paradigm,0.25,0.25,0.5,0.0
concepts,0.5,0.0,0.5,0.0
Psychostimulants,0.0,0.0,0.75,0.0
Alzheimers disease,0.25,0.0,0.75,0.0
Musical training,0.25,0.5,0.25,0.0
Postural sway,0.0,0.25,0.5,0.25
Agnosia,0.25,0.25,0.0,0.5
Cognitive demand,0.25,0.25,0.25,0.25
longitudinal,0.25,0.25,0.5,0.0
Motor performance,0.5,0.25,0.25,0.0
Sleepiness,0.75,0.0,0.0,0.25
Focus of attention,0.25,0.25,0.5,0.0
Appraisal,0.25,0.0,0.5,0.25
Sense of agency,0.0,0.5,0.25,0.25
Memory deficits,0.5,0.0,0.25,0.25
Prospective study,0.0,0.5,0.5,0.0
Fluctuations,0.0,0.25,0.5,0.25
Hypnotizability,0.25,0.25,0.25,0.25
Magnitude representation,0.25,0.25,0.5,0.0
Visual neglect,0.25,0.25,0.25,0.25
Parvocellular,0.0,0.5,0.25,0.25
Febrile seizure,0.25,0.25,0.25,0.25
Non-human primates,0.25,0.5,0.25,0.0
Top-down processing,0.0,0.0,0.75,0.25
Mapping,0.0,0.25,0.5,0.25
Anxiolytic,0.25,0.25,0.5,0.0
Cognitive models,0.25,0.0,0.5,0.25
assessment,0.0,0.0,0.75,0.25
Normal development,0.0,0.0,1.0,0.0
Auditory information,0.0,0.25,0.25,0.5
Executive attention,0.0,0.25,0.5,0.25
Flanker,0.0,0.5,0.5,0.0
Dysbindin,0.5,0.25,0.25,0.0
Word frequency,0.25,0.25,0.5,0.0
Obstructive sleep apnea,0.75,0.25,0.0,0.0
Perceptual disorders,0.25,0.0,0.5,0.25
Vision disorders,0.0,0.0,1.0,0.0
Chinese character,0.0,0.25,0.75,0.0
Cognitive representation,0.0,0.25,0.75,0.0
Simultanagnosia,0.0,0.5,0.5,0.0
Visual impairments,0.25,0.5,0.25,0.0
Goals,0.25,0.25,0.25,0.25
Cebus apella,0.25,0.5,0.25,0.0
Opiates,0.5,0.0,0.5,0.0
Neurovascular coupling,0.25,0.0,0.5,0.25
Domestic dogs,0.0,1.0,0.0,0.0
Beta-amyloid,0.25,0.0,0.75,0.0
encoding,0.25,0.5,0.25,0.0
Local field potentials,0.25,0.5,0.25,0.0
Coping,0.25,0.5,0.0,0.25
Sensorimotor integration,0.0,0.5,0.25,0.25
Stereopsis,0.25,0.0,0.25,0.5
Sensory perception,0.25,0.0,0.75,0.0
Conceptual,0.25,0.25,0.5,0.0
visual short-term memory,0.25,0.5,0.25,0.0
Pure alexia,0.25,0.0,0.75,0.0
Road safety,0.25,0.0,0.75,0.0
human,0.25,0.0,0.5,0.25
Chronic disease,0.25,0.5,0.25,0.0
Cognitive psychology,0.0,0.0,1.0,0.0
India,0.0,0.5,0.5,0.0
Maze,0.0,0.5,0.25,0.25
sleep,0.5,0.5,0.0,0.0
Macaca mulatta,0.0,0.25,0.5,0.25
speed of processing,0.0,1.0,0.0,0.0
Natural tasks,0.0,0.25,0.75,0.0
HUMDISEASE,0.25,0.5,0.25,0.0
Health and Medicine",0.0,0.0,0.0,0.0
Cue reactivity,0.25,0.5,0.25,0.0
Crossmodal integration,0.0,0.0,0.75,0.25
Cognitive change,0.0,0.5,0.5,0.0
Dynamic field theory,0.25,0.5,0.25,0.0
Neural compensation,0.0,0.25,0.5,0.25
Healthy aging,0.25,0.25,0.5,0.0
Prosaccades,0.25,0.25,0.5,0.0
Medial temporal atrophy,0.0,0.5,0.5,0.0
Association cortex,0.0,0.25,0.75,0.0
Antagonist,0.25,0.25,0.5,0.0
social perception,0.0,0.25,0.25,0.5
Top-down processes,0.25,0.0,0.5,0.25
Categories,0.25,0.5,0.0,0.25
Symptom dimensions,0.0,0.5,0.25,0.25
Creutzfeldt-Jakob disease,0.25,0.25,0.5,0.0
Bulimia nervosa,0.0,0.5,0.25,0.25
Guidelines,0.0,0.75,0.25,0.0
Gene,0.0,0.5,0.5,0.0
Simple reaction time,0.25,0.5,0.25,0.0
Alprazolam,0.0,0.25,0.25,0.5
Postoperative cognitive dysfunction,0.5,0.0,0.5,0.0
Listening,0.25,0.0,0.75,0.0
Bodies,0.0,0.0,0.75,0.25
Extended mind,0.0,0.25,0.5,0.25
Sequence learning,0.0,0.5,0.5,0.0
Ambiguity,0.25,0.25,0.5,0.0
PASAT,0.25,0.25,0.5,0.0
Emotional facial expressions,0.0,0.25,0.75,0.0
Healthy subjects,0.5,0.25,0.25,0.0
Action comprehension,0.0,0.25,0.25,0.5
First-episode,0.25,0.0,0.75,0.0
Weber's law,0.5,0.25,0.25,0.0
n-back task,0.5,0.0,0.0,0.5
Simon task,0.0,0.25,0.5,0.25
Response bias,0.25,0.25,0.5,0.0
Dentate gyrus,0.0,0.5,0.25,0.25
Single photon emission computed tomography,0.5,0.25,0.25,0.0
Nicotinic receptors,0.75,0.0,0.25,0.0
Locked-in syndrome,0.25,0.25,0.5,0.0
cognitive rehabilitation,0.25,0.0,0.5,0.25
gaze following,0.0,0.5,0.25,0.25
Pop-out,0.0,0.5,0.5,0.0
Cognitive intervention,0.0,0.0,0.75,0.25
Mindfulness,0.0,0.5,0.0,0.5
Tools,0.25,0.5,0.25,0.0
Work,0.0,0.75,0.25,0.0
Word,0.25,0.25,0.25,0.25
Acetylcholinesterase,0.0,0.25,0.75,0.0
Brain tumour,0.25,0.25,0.25,0.25
Statistical inference,0.0,0.5,0.0,0.5
SPM,1.0,0.0,0.0,0.0
intention,0.25,0.25,0.5,0.0
Writing,0.25,0.5,0.0,0.25
Mild Cognitive Impairment,0.0,0.25,0.75,0.0
Default-mode network,0.25,0.25,0.25,0.25
Physical cognition,0.0,0.0,1.0,0.0
Innovation,0.25,0.25,0.5,0.0
Affective priming,0.25,0.0,0.75,0.0
epidemiology,0.25,0.25,0.5,0.0
Light,0.5,0.25,0.25,0.0
FFA,0.5,0.5,0.0,0.0
Contralateral delay activity,0.25,0.0,0.75,0.0
frontal cortex,0.25,0.0,0.75,0.0
Voluntary action,0.25,0.75,0.0,0.0
Colour perception,0.5,0.0,0.5,0.0
Practice,0.25,0.0,0.25,0.5
Mindreading,0.25,0.25,0.5,0.0
anterior cingulate cortex,0.0,0.75,0.25,0.0
FDG-PET,0.5,0.25,0.25,0.0
Fixational eye movements,0.25,0.0,0.75,0.0
Events,0.25,0.5,0.25,0.0
Antiepileptic drugs,0.0,0.5,0.5,0.0
SEM,0.0,0.5,0.25,0.25
Strabismus,0.0,0.5,0.25,0.25
Haloperidol,0.5,0.25,0.25,0.0
Context processing,0.5,0.0,0.25,0.25
Glucose metabolism,0.5,0.0,0.5,0.0
Computational neuroscience,0.0,0.5,0.5,0.0
Lexical processing,0.0,0.5,0.5,0.0
Risk assessment,0.5,0.0,0.5,0.0
Representational neglect,0.25,0.0,0.5,0.25
Schizophrenic,0.0,0.5,0.5,0.0
Dance,0.25,0.25,0.5,0.0
Brainstem,0.5,0.25,0.25,0.0
Cross-modal integration,0.0,0.25,0.25,0.5
cerebellum,0.0,0.25,0.5,0.25
Visual extinction,0.0,0.5,0.5,0.0
Gray matter,0.25,0.0,0.5,0.25
Visual language,0.25,0.25,0.5,0.0
Reversal,0.25,0.0,0.5,0.0
Facial affect recognition,0.25,0.25,0.5,0.0
cerebrovascular disease,0.5,0.5,0.0,0.0
Color vision,0.25,0.5,0.25,0.0
Computer simulation,0.0,0.25,0.75,0.0
LPC,0.0,0.5,0.5,0.0
body image,0.0,0.25,0.75,0.0
Coma,0.0,0.75,0.0,0.25
Phenotype,0.25,0.0,0.75,0.0
Construct validity,0.0,0.25,0.75,0.0
Complex regional pain syndrome,0.0,0.5,0.5,0.0
SLORETA,0.0,0.5,0.25,0.25
Bipolar,0.25,0.0,0.75,0.0
Interpretation bias,0.25,0.25,0.25,0.25
Optic ataxia,0.25,0.5,0.25,0.0
Spina bifida,0.0,0.0,1.0,0.0
Incentive salience,0.25,0.25,0.5,0.0
Occipital,0.5,0.5,0.0,0.0
Alpha band,0.25,0.25,0.25,0.25
Arachidonic acid,0.0,0.25,0.75,0.0
Sensitivity and specificity,0.5,0.0,0.5,0.0
Norepinephrine,0.0,0.25,0.75,0.0
VEPs,0.25,0.25,0.5,0.0
Attitude,0.25,0.25,0.25,0.25
Toddlers,0.25,0.25,0.25,0.25
inhibition,0.5,0.5,0.0,0.0
Cortical development,0.0,0.5,0.5,0.0
Ethics,0.0,0.75,0.25,0.0
Gambling,0.0,0.25,0.5,0.25
Visual motion perception,0.25,0.25,0.5,0.0
Attention deficits,0.0,0.5,0.25,0.25
Callithrix jacchus,0.25,0.25,0.5,0.0
Kinematics,0.25,0.5,0.25,0.0
Bipolar II disorder,0.0,0.5,0.5,0.0
Brain concussion,0.0,0.0,1.0,0.0
Top-down modulation,0.0,0.75,0.25,0.0
Risk communication,0.25,0.0,0.75,0.0
PVSAT,0.0,0.5,0.5,0.0
Language and thought,0.25,0.25,0.5,0.0
Go/no-go task,0.5,0.0,0.25,0.25
Evoked response,0.5,0.0,0.25,0.25
meta-analysis,0.25,0.0,0.75,0.0
Cortical reorganization,0.25,0.25,0.5,0.0
Domain specificity,0.0,0.5,0.5,0.0
Neurocognitive functions,0.25,0.25,0.5,0.0
Relapse,0.0,0.5,0.5,0.0
Serial reaction time task,0.0,0.5,0.5,0.0
Contrast illusions,0.0,1.0,0.0,0.0
Microsaccades,0.0,0.25,0.75,0.0
Information,0.5,0.25,0.25,0.0
ASL,0.5,0.0,0.25,0.25
Odor,0.0,0.0,0.5,0.5
Narrative,0.25,0.5,0.25,0.0
Levodopa,0.0,0.75,0.25,0.0
Mirror system,0.0,0.25,0.5,0.25
MATRICS,0.25,0.5,0.25,0.0
Visuospatial functions,0.5,0.0,0.25,0.25
Experimental design,0.25,0.75,0.0,0.0
High altitude,0.0,0.25,0.5,0.25
Computational models,0.25,0.0,0.75,0.0
Caudate,0.25,0.25,0.5,0.0
Mentalization,0.0,0.25,0.75,0.0
Transcranial Doppler,0.0,0.0,1.0,0.0
Positron-emission tomography,0.25,0.5,0.25,0.0
Meta-cognition,0.0,0.25,0.75,0.0
Concussions,0.25,0.75,0.0,0.0
Comics,0.25,0.25,0.5,0.0
treatment,0.0,0.5,0.5,0.0
Interface design,0.0,0.25,0.75,0.0
Prepulse inhibition,0.0,0.75,0.25,0.0
Continuous flash suppression,0.25,0.0,0.75,0.0
Spatial behavior,0.0,0.5,0.25,0.25
Visual rating,0.25,0.25,0.5,0.0
Approach bias,0.0,0.5,0.5,0.0
Surprise,0.0,0.5,0.5,0.0
Canine,0.25,0.5,0.25,0.0
CREB,0.0,0.0,0.75,0.25
Dietary restraint,0.25,0.5,0.25,0.0
Ischemic stroke,0.0,0.25,0.5,0.25
Neurological,0.25,0.25,0.25,0.25
Cochlear implants,0.25,0.5,0.25,0.0
Motion sickness,0.0,0.0,0.75,0.25
Rett syndrome,0.25,0.25,0.5,0.0
Axonal injury,0.0,1.0,0.0,0.0
Parahippocampal cortex,0.0,0.5,0.5,0.0
Striate cortex,0.0,0.25,0.5,0.25
Recognition of facial expressions,0.0,0.25,0.75,0.0
Saccadic eye movement,0.0,0.0,0.75,0.25
Discriminant analysis,0.0,0.25,0.25,0.5
Type 2 diabetes,0.0,0.5,0.5,0.0
Macular pigment,0.0,0.75,0.25,0.0
Remediation,0.25,0.25,0.5,0.0
Eriksen flanker task,0.5,0.0,0.5,0.0
Clinically isolated syndrome,0.0,0.5,0.25,0.25
Health and Development",0.0,0.0,0.0,0.0
Glaucoma,0.25,0.0,0.75,0.0
cognitive ability,0.25,0.0,0.5,0.25
Brain polarization,0.0,0.75,0.25,0.0
Auditory processing,0.0,0.0,0.75,0.25
Mental health,0.25,0.25,0.5,0.0
MoCA,0.25,0.5,0.0,0.25
Cognitive complaints,0.25,0.25,0.5,0.0
Visual tracking,0.0,0.75,0.0,0.25
Randomized controlled trial,0.5,0.25,0.25,0.0
Shared attention,0.0,0.25,0.0,0.75
Tolerability,0.0,0.5,0.0,0.5
Hypersomnia,0.0,0.5,0.25,0.25
epilepsy,0.0,0.75,0.25,0.0
biomarkers,0.75,0.0,0.0,0.25
Freezing of gait,0.25,0.0,0.5,0.25
Neuroanatomy,0.25,0.0,0.75,0.0
Driving performance,0.0,0.5,0.25,0.25
Oculomotor capture,0.25,0.0,0.5,0.25
Functional,0.0,0.25,0.75,0.0
MRS,0.25,0.25,0.5,0.0
bipolar disorder,0.25,0.5,0.25,0.0
Fetal alcohol syndrome,0.25,0.25,0.5,0.0
Oldest old,0.25,0.25,0.5,0.0
Computer vision,0.25,0.25,0.5,0.0
Somatosensory cortex,0.0,0.25,0.75,0.0
Perceptual bias,0.25,0.75,0.0,0.0
Autonomic dysfunction,0.5,0.0,0.5,0.0
cognition disorders,0.25,0.5,0.25,0.0
Visual oddball task,0.25,0.0,0.75,0.0
Cingulate,0.5,0.25,0.25,0.0
Capuchin monkeys,0.0,0.75,0.25,0.0
motivation,0.25,0.25,0.5,0.0
white matter disease,0.0,0.75,0.25,0.0
Visual-spatial processing,0.25,0.5,0.25,0.0
Relational,0.25,0.5,0.25,0.0
anorexia nervosa,0.0,0.5,0.5,0.0
First-episode psychosis,0.0,0.25,0.75,0.0
Attention deficit hyperactivity disorder (ADHD),0.25,0.5,0.0,0.25
Visuomotor priming,0.0,0.0,0.75,0.25
Memory consolidation,0.25,0.25,0.25,0.25
Sensorimotor adaptation,0.25,0.25,0.5,0.0
representation,0.25,0.25,0.25,0.25
Face inversion effect,0.0,0.25,0.75,0.0
Amyloid,0.25,0.25,0.25,0.25
Time estimation,0.25,0.75,0.0,0.0
Audio-visual,0.25,0.0,0.5,0.25
Spinal cord injury,0.0,0.5,0.5,0.0
Minimally conscious state,0.5,0.25,0.25,0.0
Neurogenesis,0.25,0.75,0.0,0.0
Sex difference,0.5,0.25,0.25,0.0
Bipolar I disorder,0.0,0.5,0.5,0.0
Symmetry,0.5,0.0,0.5,0.0
EEG coherence,0.0,0.0,0.75,0.25
Outcome measures,0.0,0.75,0.25,0.0
Autonoetic consciousness,0.5,0.25,0.25,0.0
Transplantation,0.25,0.5,0.25,0.0
reversal learning,0.25,0.25,0.25,0.25
Dual-task performance,0.0,0.25,0.25,0.5
executive functioning,0.0,0.0,0.75,0.25
Dyscalculia,0.25,0.0,0.5,0.25
Semantic knowledge,0.0,1.0,0.0,0.0
Intentions,0.0,1.0,0.0,0.0
Body mass index,0.25,0.25,0.25,0.25
Invisible displacement,0.0,0.25,0.5,0.25
Visuo-spatial memory,0.25,0.25,0.5,0.0
Dual diagnosis,0.0,0.5,0.5,0.0
Congruency,0.0,0.25,0.75,0.0
virtual reality,0.0,0.0,0.75,0.25
Tremor,0.25,0.25,0.5,0.0
Animation,0.0,0.0,0.75,0.25
Art therapy,0.25,0.25,0.5,0.0
Delusion,0.0,0.25,0.5,0.25
Mindlessness,0.25,0.0,0.25,0.5
Visual association cortex,0.25,0.5,0.25,0.0
Construal level,0.5,0.0,0.5,0.0
Paediatric,0.25,0.25,0.0,0.25
Histamine,0.0,0.5,0.5,0.0
Avian cognition,0.0,0.75,0.0,0.25
Hypothalamic hamartoma,0.0,0.0,1.0,0.0
Efficacy,0.5,0.0,0.5,0.0
Long-term care,0.0,0.0,1.0,0.0
Differential diagnosis,0.0,0.25,0.75,0.0
motor skills,0.0,0.75,0.0,0.25
decision making,0.0,0.5,0.25,0.25
Hand posture,0.0,0.0,1.0,0.0
Microsaccade,0.25,0.0,0.5,0.25
N300,0.25,0.5,0.25,0.0
Abstract concepts,0.25,0.25,0.5,0.0
Morphometry,0.0,0.25,0.75,0.0
Body ownership,0.25,0.0,0.0,0.75
Attentional focus,0.25,0.25,0.5,0.0
saccades,0.25,0.0,0.75,0.0
Visuo-spatial working memory,0.0,0.0,1.0,0.0
tACS,0.25,0.25,0.25,0.25
Y-maze,0.25,0.5,0.0,0.25
Fitness to drive,0.25,0.0,0.5,0.25
Neural oscillations,0.25,0.25,0.5,0.0
Abstinence,0.75,0.0,0.25,0.0
Visuospatial perception,0.0,0.5,0.0,0.5
Interactivity,0.5,0.0,0.25,0.25
Binge drinking,0.25,0.0,0.5,0.25
Quantity judgments,0.0,0.75,0.25,0.0
Geriatric assessment,0.25,0.0,0.25,0.5
Reorientation,0.25,0.25,0.5,0.0
Chronic kidney disease,0.5,0.25,0.25,0.0
Myelination,0.0,0.0,1.0,0.0
Distractor processing,0.25,0.0,0.75,0.0
Event-related oscillations,0.25,0.25,0.5,0.0
Flicker paradigm,0.5,0.0,0.25,0.25
Affect recognition,0.25,0.5,0.25,0.0
semantic memory,0.5,0.25,0.0,0.25
Sensemaking,0.25,0.0,0.75,0.0
Serial learning,0.0,0.25,0.75,0.0
Self-consciousness,0.0,0.25,0.5,0.25
atrophy,0.5,0.0,0.5,0.0
Food cues,0.5,0.0,0.5,0.0
Temporal order judgment,0.25,0.0,0.5,0.25
Social learning,0.25,0.0,0.75,0.0
Emergence,0.25,0.5,0.25,0.0
Older adult,0.5,0.25,0.25,0.0
Friedreich ataxia,0.5,0.0,0.5,0.0
Apes,0.25,0.5,0.25,0.0
Intrusions,0.75,0.0,0.25,0.0
Diffuse axonal injury,0.25,0.25,0.5,0.0
Artificial grammar learning,0.0,0.75,0.0,0.25
cognitive processes,0.25,0.5,0.0,0.25
Psychometric,0.25,0.5,0.0,0.25
Pitch,0.0,0.5,0.25,0.25
Chronic schizophrenia,0.0,0.5,0.5,0.0
Moral cognition,0.25,0.0,0.75,0.0
Vserossi?skoe obshchestvo nevrologov [i] Vserossi?skoe obshchestvo psikhiatrov",0.0,0.0,0.0,0.0
comorbidity,0.0,0.5,0.25,0.25
design cognition,0.0,0.25,0.75,0.0
Attention deficit/hyperactivity disorder,0.0,0.5,0.5,0.0
Sensation,0.25,0.5,0.0,0.25
Cerebrospinal fluid,0.0,0.25,0.75,0.0
Brain lesion,0.25,0.25,0.0,0.5
Episodic retrieval,0.25,0.25,0.5,0.0
Tactile perception,0.0,0.25,0.25,0.5
psychometrics,0.25,0.25,0.5,0.0
Retention,0.25,0.5,0.25,0.0
Pedophilia,0.0,0.25,0.75,0.0
Diabetes,0.25,0.5,0.25,0.0
Social cognitive neuroscience,0.25,0.25,0.25,0.25
VSTM,0.0,0.0,0.666666666667,0.333333333333
Moral judgment,0.333333333333,0.333333333333,0.0,0.333333333333
Patient-centered care,0.333333333333,0.0,0.666666666667,0.0
Traffic engineering,0.666666666667,0.0,0.0,0.333333333333
MT+,0.333333333333,0.666666666667,0.0,0.0
Resting state functional connectivity,0.666666666667,0.333333333333,0.0,0.0
Bipolar disorders,0.0,0.333333333333,0.666666666667,0.0
Metarepresentation,0.333333333333,0.333333333333,0.333333333333,0.0
Visual-motor,0.0,0.0,1.0,0.0
Alpha rhythms,0.666666666667,0.333333333333,0.0,0.0
cognitive map,0.0,0.333333333333,0.666666666667,0.0
Reference values,0.0,0.333333333333,0.666666666667,0.0
Conscious perception,0.333333333333,0.333333333333,0.333333333333,0.0
Proton magnetic resonance spectroscopy,0.333333333333,0.333333333333,0.333333333333,0.0
Ginseng,0.333333333333,0.0,0.666666666667,0.0
women,0.0,0.333333333333,0.333333333333,0.333333333333
LAN,1.0,0.0,0.0,0.0
Tactile spatial acuity,0.0,0.333333333333,0.666666666667,0.0
Escitalopram,0.333333333333,0.0,0.333333333333,0.333333333333
Sexual orientation,0.0,0.333333333333,0.666666666667,0.0
scopolamine,0.666666666667,0.0,0.0,0.333333333333
Intrusive memories,0.0,0.333333333333,0.666666666667,0.0
REM sleep behavior disorder,0.0,0.333333333333,0.666666666667,0.0
functional magnetic resonance imaging (fMRI),0.0,1.0,0.0,0.0
Assistive technology,0.666666666667,0.333333333333,0.0,0.0
Self-referential processing,0.0,0.666666666667,0.333333333333,0.0
Grip force,0.0,0.0,1.0,0.0
Automatization,0.333333333333,0.0,0.666666666667,0.0
Depth,0.0,0.333333333333,0.333333333333,0.333333333333
Visual arrays,0.333333333333,0.333333333333,0.333333333333,0.0
headache,0.0,0.333333333333,0.666666666667,0.0
Precision,0.0,1.0,0.0,0.0
older drivers,0.0,0.0,0.666666666667,0.333333333333
Older persons,0.666666666667,0.0,0.333333333333,0.0
Dorsal visual stream,1.0,0.0,0.0,0.0
Perceived similarity,0.0,1.0,0.0,0.0
Facial emotions,0.333333333333,0.0,0.666666666667,0.0
Intrinsic connectivity networks,0.333333333333,0.0,0.333333333333,0.333333333333
color perception,0.0,0.333333333333,0.333333333333,0.333333333333
NMDA receptors,0.0,0.0,0.666666666667,0.333333333333
HIV infection,0.0,0.333333333333,0.666666666667,0.0
Cognitive bias modification,0.0,0.666666666667,0.333333333333,0.0
Primary insomnia,0.333333333333,0.0,0.333333333333,0.333333333333
Low Back Pain,0.0,0.333333333333,0.333333333333,0.333333333333
Vocational rehabilitation,0.0,0.666666666667,0.0,0.333333333333
Pig,0.0,0.333333333333,0.333333333333,0.333333333333
PiB,0.666666666667,0.0,0.0,0.333333333333
Speech recognition,0.333333333333,0.333333333333,0.333333333333,0.0
Quantity discrimination,0.0,0.666666666667,0.333333333333,0.0
visual system,0.333333333333,0.333333333333,0.0,0.333333333333
Emotional words,0.333333333333,0.0,0.666666666667,0.0
Holistic perception,0.0,0.333333333333,0.666666666667,0.0
Working-memory,0.0,0.0,0.333333333333,0.666666666667
Welfare,0.0,0.333333333333,0.666666666667,0.0
white matter hyperintensity,0.333333333333,0.0,0.666666666667,0.0
Pervasive developmental disorder,0.0,0.333333333333,0.333333333333,0.333333333333
Relational learning,0.333333333333,0.0,0.666666666667,0.0
Cognitive model,0.333333333333,0.333333333333,0.333333333333,0.0
IOR,0.333333333333,0.666666666667,0.0,0.0
Global/local processing,0.666666666667,0.0,0.333333333333,0.0
Motor adaptation,0.0,0.333333333333,0.666666666667,0.0
Early childhood,0.333333333333,0.0,0.666666666667,0.0
Cingulum bundle,0.0,0.333333333333,0.333333333333,0.333333333333
Hierarchical network,0.0,0.666666666667,0.333333333333,0.0
Fetal alcohol spectrum disorders,0.0,0.333333333333,0.333333333333,0.333333333333
neurocognitive function,0.0,0.0,1.0,0.0
Mild traumatic brain injuries,0.0,0.666666666667,0.333333333333,0.0
Painting,0.0,0.333333333333,0.666666666667,0.0
Oscillatory activity,0.0,0.0,0.666666666667,0.333333333333
cytokines,0.666666666667,0.0,0.333333333333,0.0
Trail making test,0.333333333333,0.333333333333,0.333333333333,0.0
Great apes,0.0,1.0,0.0,0.0
Cross-modal attention,0.333333333333,0.0,0.666666666667,0.0
Pupil diameter,0.0,0.666666666667,0.0,0.333333333333
Rating scales,0.0,0.333333333333,0.333333333333,0.333333333333
Prosaccade,0.0,0.0,0.666666666667,0.333333333333
linguistic relativity,0.666666666667,0.0,0.333333333333,0.0
Perception-action coupling,0.0,0.666666666667,0.333333333333,0.0
Cognitive engineering,0.0,0.333333333333,0.666666666667,0.0
Association,0.666666666667,0.333333333333,0.0,0.0
Spatial abilities,0.333333333333,0.0,0.666666666667,0.0
white matter hyperintensities,0.0,0.666666666667,0.333333333333,0.0
factor analysis,0.666666666667,0.333333333333,0.0,0.0
Visual landmarks,0.333333333333,0.333333333333,0.0,0.333333333333
Motor impairment,0.0,0.666666666667,0.333333333333,0.0
Macular degeneration,0.0,0.333333333333,0.666666666667,0.0
Unilateral spatial neglect,0.333333333333,0.666666666667,0.0,0.0
Substance use disorders,0.0,0.0,0.333333333333,0.666666666667
Phenylketonuria,0.0,0.0,1.0,0.0
Cognitive conflict,0.333333333333,0.333333333333,0.333333333333,0.0
Spectrum,0.0,0.666666666667,0.333333333333,0.0
oscillations,0.0,0.333333333333,0.666666666667,0.0
Gender difference,0.0,0.666666666667,0.0,0.333333333333
perceptual grouping,0.333333333333,0.0,0.333333333333,0.333333333333
Topological properties,0.333333333333,0.333333333333,0.333333333333,0.0
Siblings,0.333333333333,0.333333333333,0.333333333333,0.0
Recalibration,0.333333333333,0.333333333333,0.333333333333,0.0
Cognitive symptoms,0.333333333333,0.333333333333,0.333333333333,0.0
Concentration,0.0,1.0,0.0,0.0
Postmenopause,0.0,0.333333333333,0.666666666667,0.0
Transgenic mice,0.0,0.666666666667,0.0,0.333333333333
Corticospinal tract,0.0,1.0,0.0,0.0
Pedagogy,0.333333333333,0.333333333333,0.333333333333,0.0
Psychopathy,0.666666666667,0.0,0.333333333333,0.0
movement,0.333333333333,0.666666666667,0.0,0.0
Fine motor skills,0.0,0.333333333333,0.666666666667,0.0
Mismatch,0.333333333333,0.0,0.333333333333,0.333333333333
geriatric,0.333333333333,0.333333333333,0.333333333333,0.0
Posterior cingulate cortex,0.0,0.666666666667,0.333333333333,0.0
Choline,0.0,0.666666666667,0.333333333333,0.0
Area 7a,0.0,0.333333333333,0.666666666667,0.0
Novelty P3,0.0,0.333333333333,0.666666666667,0.0
Velo-cardio-facial syndrome,0.0,0.333333333333,0.666666666667,0.0
Non-smoker,0.0,0.666666666667,0.0,0.333333333333
Pupil size,0.0,0.333333333333,0.666666666667,0.0
AMPA receptor,0.0,0.333333333333,0.666666666667,0.0
Body-ownership,0.333333333333,0.666666666667,0.0,0.0
Cognitive speed,0.0,0.666666666667,0.333333333333,0.0
FRN,0.0,0.0,1.0,0.0
Locus coeruleus,0.0,0.333333333333,0.666666666667,0.0
mirror neuron system,0.0,0.666666666667,0.333333333333,0.0
multisensory integration,0.0,1.0,0.0,0.0
Learning disability,0.0,0.666666666667,0.0,0.333333333333
Physical therapy,0.0,0.666666666667,0.333333333333,0.0
neuroscience,0.0,0.333333333333,0.666666666667,0.0
Socioeconomic status,0.333333333333,0.333333333333,0.333333333333,0.0
person perception,0.333333333333,0.666666666667,0.0,0.0
blindness,0.0,0.666666666667,0.333333333333,0.0
Infant perception,0.0,0.0,0.333333333333,0.666666666667
Letter identification,0.0,1.0,0.0,0.0
Perception/action,0.333333333333,0.666666666667,0.0,0.0
CP,0.0,0.333333333333,0.0,0.666666666667
Functional brain networks,0.333333333333,0.0,0.333333333333,0.333333333333
Realism,0.0,0.333333333333,0.333333333333,0.333333333333
Early-onset,0.0,0.666666666667,0.333333333333,0.0
Cohort study,0.666666666667,0.333333333333,0.0,0.0
Irritable bowel syndrome,0.666666666667,0.333333333333,0.0,0.0
crowding,1.0,0.0,0.0,0.0
Orthostatic hypotension,0.0,0.0,0.666666666667,0.333333333333
Biofeedback,0.333333333333,0.0,0.666666666667,0.0
Enactivism,0.333333333333,0.0,0.666666666667,0.0
Satiety,0.333333333333,0.666666666667,0.0,0.0
Object location memory,0.333333333333,0.0,0.666666666667,0.0
Pain perception,0.666666666667,0.0,0.333333333333,0.0
Cognitive status,0.333333333333,0.333333333333,0.333333333333,0.0
mathematical cognition,0.0,0.0,1.0,0.0
Occipital face area,0.0,0.333333333333,0.666666666667,0.0
Manganese,0.0,1.0,0.0,0.0
Emotional state,0.0,0.333333333333,0.666666666667,0.0
short-term memory,0.0,0.0,0.666666666667,0.333333333333
Ants,0.333333333333,0.333333333333,0.333333333333,0.0
Finger counting,0.333333333333,0.333333333333,0.333333333333,0.0
Alexia,0.0,0.333333333333,0.0,0.666666666667
Temporal prediction,0.0,0.666666666667,0.333333333333,0.0
perspective taking,0.333333333333,0.333333333333,0.333333333333,0.0
Theory of visual attention,0.0,0.333333333333,0.666666666667,0.0
Subtraction,0.333333333333,0.0,0.333333333333,0.333333333333
Self-other,0.333333333333,0.0,0.666666666667,0.0
Gross anatomy education,0.0,0.0,1.0,0.0
Orientation perception,0.0,0.333333333333,0.333333333333,0.333333333333
Brain metastases,0.333333333333,0.0,0.333333333333,0.333333333333
Analog magnitudes,0.666666666667,0.333333333333,0.0,0.0
Middle-age,0.0,0.333333333333,0.666666666667,0.0
Mating,0.333333333333,0.333333333333,0.0,0.333333333333
Mini-Mental State Examination (MMSE),0.333333333333,0.0,0.666666666667,0.0
Probabilistic reasoning,0.333333333333,0.0,0.666666666667,0.0
Single-trial analysis,0.0,0.666666666667,0.0,0.333333333333
questionnaire,0.0,0.666666666667,0.333333333333,0.0
Temporoparietal junction,0.0,0.333333333333,0.333333333333,0.333333333333
Repetition effects,0.0,0.333333333333,0.0,0.666666666667
Dopamine transporter,0.333333333333,0.333333333333,0.333333333333,0.0
Relational memory,0.0,0.333333333333,0.333333333333,0.333333333333
visual analytics,0.0,0.333333333333,0.666666666667,0.0
Morality,0.333333333333,0.333333333333,0.0,0.333333333333
Sensory-motor integration,0.666666666667,0.0,0.0,0.333333333333
Autism spectrum conditions,0.0,0.333333333333,0.333333333333,0.333333333333
Esthetics,0.0,0.666666666667,0.0,0.333333333333
Resting-state networks,0.0,0.333333333333,0.666666666667,0.0
Standardization,0.333333333333,0.333333333333,0.0,0.333333333333
Time production,0.333333333333,0.0,0.333333333333,0.333333333333
Adjuvant chemotherapy,0.333333333333,0.0,0.333333333333,0.333333333333
Neural computation,0.333333333333,0.0,0.333333333333,0.333333333333
Prototype,0.333333333333,0.0,0.666666666667,0.0
Sleep disordered breathing,0.333333333333,0.0,0.666666666667,0.0
Functional recovery,0.333333333333,0.333333333333,0.0,0.333333333333
cognitive flexibility,0.0,0.333333333333,0.666666666667,0.0
Perceptual decision-making,0.0,0.0,0.666666666667,0.333333333333
Superior temporal gyrus,0.0,1.0,0.0,0.0
Spatial configuration,0.333333333333,0.0,0.333333333333,0.333333333333
Tobacco,0.0,0.0,0.333333333333,0.666666666667
Visual-spatial cognition,0.0,0.666666666667,0.333333333333,0.0
Emotion-cognition interaction,0.0,0.333333333333,0.0,0.666666666667
Connectionist modeling,0.0,0.333333333333,0.666666666667,0.0
Rhesus,0.0,0.333333333333,0.0,0.666666666667
Temporal dynamics,0.0,0.333333333333,0.333333333333,0.333333333333
Muscarinic,0.333333333333,0.333333333333,0.0,0.333333333333
central coherence,0.0,0.333333333333,0.666666666667,0.0
Eyewitness,0.666666666667,0.0,0.333333333333,0.0
Functional near-infrared spectroscopy,0.0,0.0,0.666666666667,0.333333333333
Extended cognition,0.0,0.333333333333,0.666666666667,0.0
adolescence,0.0,0.0,0.666666666667,0.333333333333
Visual recognition memory,0.0,1.0,0.0,0.0
Sexual preference,0.0,0.0,0.666666666667,0.333333333333
Automatic,0.333333333333,0.333333333333,0.333333333333,0.0
Visuo-spatial ability,0.666666666667,0.0,0.333333333333,0.0
cortical thickness,0.0,0.0,0.333333333333,0.666666666667
Proximity,0.0,0.333333333333,0.666666666667,0.0
Triggered reactions,0.333333333333,0.0,0.666666666667,0.0
Nerve regeneration,0.0,0.0,0.666666666667,0.333333333333
Efference copy,0.666666666667,0.0,0.0,0.333333333333
Causal learning,0.666666666667,0.0,0.333333333333,0.0
learning and memory,0.0,1.0,0.0,0.0
Posturography,0.0,0.666666666667,0.333333333333,0.0
Sadness,0.0,0.333333333333,0.666666666667,0.0
Affective processing,0.333333333333,0.333333333333,0.333333333333,0.0
Phonological loop,0.0,0.333333333333,0.333333333333,0.333333333333
Ecological approach,0.333333333333,0.0,0.333333333333,0.333333333333
African Americans,0.0,0.666666666667,0.333333333333,0.0
Advertising,0.0,0.333333333333,0.333333333333,0.333333333333
Valproate,0.333333333333,0.333333333333,0.333333333333,0.0
VLBW,0.0,0.0,0.666666666667,0.333333333333
Visual habituation,0.0,0.333333333333,0.666666666667,0.0
Anterior temporal lobe,0.666666666667,0.0,0.333333333333,0.0
Network,0.666666666667,0.0,0.333333333333,0.0
Reading speed,0.0,0.666666666667,0.333333333333,0.0
Neurophenomenology,0.333333333333,0.333333333333,0.333333333333,0.0
Recurrence quantification analysis,0.0,0.666666666667,0.333333333333,0.0
impulsivity,0.0,0.666666666667,0.333333333333,0.0
Cognitions,0.0,0.333333333333,0.666666666667,0.0
Neural synchrony,0.333333333333,0.333333333333,0.333333333333,0.0
semantic dementia,0.333333333333,0.333333333333,0.0,0.333333333333
Auditory modality,0.0,0.333333333333,0.666666666667,0.0
heart rate,0.666666666667,0.0,0.333333333333,0.0
Auditory event-related potentials,0.333333333333,0.333333333333,0.333333333333,0.0
Disability evaluation,0.0,0.666666666667,0.333333333333,0.0
Brain aging,0.0,0.333333333333,0.666666666667,0.0
Students,0.666666666667,0.0,0.333333333333,0.0
Cross-modal processing,0.0,0.0,1.0,0.0
Autoradiography,0.333333333333,0.333333333333,0.0,0.333333333333
RSA,0.0,0.666666666667,0.333333333333,0.0
Somatosensation,0.0,0.666666666667,0.333333333333,0.0
Abuse,0.0,0.333333333333,0.333333333333,0.333333333333
Stroke rehabilitation,0.0,0.0,1.0,0.0
Behavior and Evolution",0.0,0.0,0.0,0.0
Tract-based spatial statistics,0.333333333333,0.333333333333,0.333333333333,0.0
Functional decline,0.333333333333,0.333333333333,0.0,0.333333333333
Academic performance,0.0,0.666666666667,0.333333333333,0.0
Multivariate,0.0,0.333333333333,0.333333333333,0.333333333333
posterior cortical atrophy,0.666666666667,0.333333333333,0.0,0.0
Cortical excitability,0.333333333333,0.333333333333,0.333333333333,0.0
Semiotics,0.333333333333,0.0,0.666666666667,0.0
Linguistic processing,0.0,0.0,1.0,0.0
Evaluative priming,0.333333333333,0.666666666667,0.0,0.0
Species differences,0.666666666667,0.333333333333,0.0,0.0
validity,0.0,0.666666666667,0.0,0.333333333333
Self-face recognition,0.333333333333,0.333333333333,0.333333333333,0.0
Language evolution,0.0,0.666666666667,0.333333333333,0.0
Principal component analysis,0.0,0.0,1.0,0.0
Action priming,0.0,0.666666666667,0.333333333333,0.0
Brain volume,0.333333333333,0.0,0.666666666667,0.0
Cognitive recovery,0.333333333333,0.0,0.666666666667,0.0
Contextual cueing,0.0,0.333333333333,0.666666666667,0.0
Glycine,0.333333333333,0.333333333333,0.333333333333,0.0
Nonverbal communication,0.0,0.666666666667,0.333333333333,0.0
Hypnotic susceptibility,0.333333333333,0.0,0.666666666667,0.0
Conservation,0.0,0.666666666667,0.333333333333,0.0
Mental state attribution,0.333333333333,0.333333333333,0.333333333333,0.0
psychophysics,0.0,0.0,1.0,0.0
Apparent motion,0.333333333333,0.0,0.666666666667,0.0
occupational therapy,0.333333333333,0.0,0.666666666667,0.0
Theory-of-mind,0.333333333333,0.333333333333,0.333333333333,0.0
Perceptual categorization,0.666666666667,0.0,0.333333333333,0.0
Neurobehavioral assessment,0.0,0.666666666667,0.333333333333,0.0
Mind wandering,0.333333333333,0.333333333333,0.0,0.333333333333
Drug abuse,0.0,0.0,1.0,0.0
Depressive disorder,0.333333333333,0.333333333333,0.0,0.0
Sequencing,0.333333333333,0.666666666667,0.0,0.0
Lexical decision task,0.666666666667,0.333333333333,0.0,0.0
cerebral palsy,0.333333333333,0.333333333333,0.333333333333,0.0
classification,0.0,0.666666666667,0.333333333333,0.0
Human-robot interaction,0.0,0.333333333333,0.666666666667,0.0
Long-term potentiation,0.0,0.666666666667,0.0,0.333333333333
Anticholinergic drugs,0.333333333333,0.333333333333,0.0,0.333333333333
Cuing,0.0,0.0,0.666666666667,0.333333333333
Shaping,0.333333333333,0.666666666667,0.0,0.0
Focused attention,0.0,0.666666666667,0.333333333333,0.0
Depressive disorders,0.333333333333,0.333333333333,0.0,0.333333333333
Visual pathway,0.0,0.333333333333,0.666666666667,0.0
Androgen deprivation,0.0,0.333333333333,0.666666666667,0.0
dengineering receptor,0.333333333333,0.0,0.666666666667,0.0
Newborn,0.333333333333,0.333333333333,0.0,0.333333333333
cognitive dysfunction,0.0,0.666666666667,0.333333333333,0.0
Ultra-high risk,0.0,0.0,1.0,0.0
Autism Spectrum Disorder,0.0,1.0,0.0,0.0
Cat,0.0,0.333333333333,0.333333333333,0.333333333333
Prenatal exposure,0.0,1.0,0.0,0.0
Parahippocampus,0.666666666667,0.333333333333,0.0,0.0
ALE,0.0,1.0,0.0,0.0
corpus callosum,0.0,0.333333333333,0.333333333333,0.333333333333
Air pollution,0.0,0.333333333333,0.666666666667,0.0
Academic achievement,0.0,0.0,0.333333333333,0.666666666667
Sleep-disordered breathing,0.0,0.333333333333,0.0,0.666666666667
Morphine,0.333333333333,0.0,0.666666666667,0.0
Social information processing,0.333333333333,0.666666666667,0.0,0.0
Neurotrophins,0.0,0.0,1.0,0.0
Luminance,0.0,0.0,1.0,0.0
Phase synchronization,0.0,0.333333333333,0.666666666667,0.0
Exposure,0.333333333333,0.0,0.333333333333,0.333333333333
Socialisation,0.0,0.333333333333,0.333333333333,0.333333333333
Early diagnosis,0.0,0.0,1.0,0.0
Mental models,0.0,0.333333333333,0.666666666667,0.0
Eating,0.333333333333,0.0,0.666666666667,0.0
Family study,0.333333333333,0.0,0.666666666667,0.0
Steady-state probe topography (SSPT),0.333333333333,0.333333333333,0.333333333333,0.0
Gerontologicheskoe obshchestvo",0.0,0.0,0.0,0.0
Neuropsychiatric lupus,0.0,1.0,0.0,0.0
Cognitive reactivity,0.0,0.333333333333,0.666666666667,0.0
Testimony,0.333333333333,0.0,0.333333333333,0.333333333333
Solidity,0.666666666667,0.0,0.0,0.333333333333
Language/speech,0.333333333333,0.0,0.666666666667,0.0
Vegetative state,0.333333333333,0.666666666667,0.0,0.0
Ventrolateral prefrontal cortex,0.0,0.333333333333,0.666666666667,0.0
Breast neoplasms,1.0,0.0,0.0,0.0
Human vision,0.0,0.666666666667,0.0,0.333333333333
Apolipoprotein E gene,0.333333333333,0.333333333333,0.333333333333,0.0
Metabolic syndrome,0.0,0.333333333333,0.666666666667,0.0
Frame of reference,0.0,0.666666666667,0.0,0.333333333333
outcome,0.0,0.333333333333,0.666666666667,0.0
counting,0.0,0.666666666667,0.333333333333,0.0
pediatric,0.666666666667,0.0,0.333333333333,0.0
Gasoline,0.666666666667,0.0,0.0,0.333333333333
Prehension,0.333333333333,0.0,0.666666666667,0.0
Clinical trials,0.0,0.333333333333,0.666666666667,0.0
visual function,0.0,0.666666666667,0.0,0.333333333333
Neurobiology,0.0,0.333333333333,0.333333333333,0.333333333333
ADL,0.0,0.0,1.0,0.0
response inhibition,0.333333333333,0.333333333333,0.333333333333,0.0
unconscious cognition,0.333333333333,0.0,0.333333333333,0.333333333333
Numerical representation,0.333333333333,0.0,0.333333333333,0.333333333333
Alerting,0.0,0.666666666667,0.333333333333,0.0
Computer,0.333333333333,0.0,0.333333333333,0.333333333333
Visual communication,0.666666666667,0.0,0.333333333333,0.0
Hyperthermia,0.666666666667,0.0,0.333333333333,0.0
Expressive suppression,0.666666666667,0.333333333333,0.0,0.0
cognitive load,0.0,0.333333333333,0.666666666667,0.0
Spatial Working Memory,0.333333333333,0.666666666667,0.0,0.0
Japanese,0.0,0.333333333333,0.333333333333,0.333333333333
Action prediction,0.0,1.0,0.0,0.0
Remapping,0.333333333333,0.333333333333,0.0,0.333333333333
Reference,0.333333333333,0.333333333333,0.333333333333,0.0
Memory training,0.0,0.0,0.666666666667,0.333333333333
Forgetting,0.333333333333,0.333333333333,0.333333333333,0.0
Animal behavior,0.666666666667,0.0,0.333333333333,0.0
Selective partial GABA agonist,0.0,0.333333333333,0.333333333333,0.333333333333
Combined effects,0.0,0.333333333333,0.333333333333,0.333333333333
Endogenous attention,0.0,0.0,1.0,0.0
Semantic categories,0.333333333333,0.333333333333,0.333333333333,0.0
Visuomotor adaptation,0.0,0.666666666667,0.0,0.333333333333
Rationality,0.333333333333,0.0,0.666666666667,0.0
Emotion expression,0.0,0.0,1.0,0.0
Touch-screen,0.0,0.333333333333,0.333333333333,0.333333333333
Visual information processing,0.333333333333,0.0,0.666666666667,0.0
Representation of space,0.666666666667,0.0,0.333333333333,0.0
Birth weight,0.0,0.333333333333,0.333333333333,0.333333333333
Cardiovascular risk factors,0.333333333333,0.333333333333,0.333333333333,0.0
Individual recognition,0.0,0.666666666667,0.333333333333,0.0
Sensation/perception,0.666666666667,0.0,0.333333333333,0.0
Paired associates learning,0.0,0.666666666667,0.333333333333,0.0
Visual learning,0.666666666667,0.333333333333,0.0,0.0
Activity,0.0,0.333333333333,0.666666666667,0.0
Distance perception,0.0,0.333333333333,0.666666666667,0.0
Pramipexole,0.0,0.666666666667,0.333333333333,0.0
Property verification,0.0,0.0,1.0,0.0
Adaptive memory,0.0,0.333333333333,0.333333333333,0.333333333333
Face-processing,0.0,0.666666666667,0.333333333333,0.0
Eyewitness memory,0.0,0.666666666667,0.0,0.333333333333
Bivalent stimuli,0.333333333333,0.333333333333,0.333333333333,0.0
Hypersociability,0.0,0.0,0.666666666667,0.333333333333
Mimicry,0.333333333333,0.666666666667,0.0,0.0
Hypoglycemia,0.0,0.333333333333,0.666666666667,0.0
Doppler,0.333333333333,0.666666666667,0.0,0.0
Partial least squares,0.666666666667,0.0,0.333333333333,0.0
Lipoproteins,0.0,0.333333333333,0.666666666667,0.0
Psychosocial function,0.0,0.0,1.0,0.0
Metacontrast masking,0.0,0.666666666667,0.0,0.333333333333
Unconscious cognition,0.333333333333,0.333333333333,0.333333333333,0.0
Translation,0.0,0.666666666667,0.333333333333,0.0
dorsolateral prefrontal cortex,0.0,0.0,1.0,0.0
Parametric design,0.0,0.666666666667,0.333333333333,0.0
Preterm children,1.0,0.0,0.0,0.0
Constructional apraxia,0.333333333333,0.0,0.333333333333,0.333333333333
Face matching,0.0,0.0,0.666666666667,0.333333333333
Pervasive developmental disorders,0.0,0.0,1.0,0.0
Neurochemistry,0.0,0.333333333333,0.666666666667,0.0
Human locomotion,0.0,0.666666666667,0.333333333333,0.0
Sensory memory,0.333333333333,0.0,0.666666666667,0.0
Errors,0.0,0.0,0.333333333333,0.666666666667
Presbycusis,0.0,0.0,1.0,0.0
Shift work,0.0,0.0,1.0,0.0
Cognitive inhibition,0.0,0.333333333333,0.666666666667,0.0
Chemobrain,0.0,0.666666666667,0.0,0.333333333333
Child molestation,0.0,0.333333333333,0.666666666667,0.0
Multimorbidity,1.0,0.0,0.0,0.0
Object tracking,0.666666666667,0.0,0.0,0.333333333333
PRP,0.666666666667,0.0,0.333333333333,0.0
Feedback processing,0.0,0.666666666667,0.333333333333,0.0
Irony,0.0,0.333333333333,0.666666666667,0.0
Spanish,0.333333333333,0.333333333333,0.333333333333,0.0
delusions,0.333333333333,0.0,0.333333333333,0.333333333333
Population-based,0.0,0.333333333333,0.333333333333,0.333333333333
Childhood epilepsy,0.0,0.666666666667,0.333333333333,0.0
Autoantibodies,0.0,0.333333333333,0.666666666667,0.0
Concurrent validity,0.0,0.0,0.666666666667,0.333333333333
Dual tasking,0.0,0.333333333333,0.666666666667,0.0
novel object recognition,0.0,0.333333333333,0.666666666667,0.0
NMDA antagonist,0.333333333333,0.333333333333,0.333333333333,0.0
Lifespan,0.666666666667,0.333333333333,0.0,0.0
Neuropsychological performance,0.0,0.0,1.0,0.0
Texture,0.0,0.333333333333,0.666666666667,0.0
Neuroprotection,0.333333333333,0.666666666667,0.0,0.0
Sound symbolism,0.0,0.666666666667,0.333333333333,0.0
Anterior temporal lobectomy,0.0,0.666666666667,0.0,0.333333333333
Nonverbal behavior,0.0,0.333333333333,0.666666666667,0.0
Exclusion,0.333333333333,0.666666666667,0.0,0.0
estrogen,0.333333333333,0.333333333333,0.333333333333,0.0
Erps,0.333333333333,0.333333333333,0.333333333333,0.0
Global processing,0.333333333333,0.0,0.666666666667,0.0
Catechol-O-methyltransferase,0.0,0.333333333333,0.666666666667,0.0
Internet,0.666666666667,0.0,0.333333333333,0.0
conflict,0.666666666667,0.0,0.333333333333,0.0
Taste,0.0,0.333333333333,0.0,0.666666666667
Software,0.333333333333,0.333333333333,0.333333333333,0.0
Emotional prosody,0.0,0.666666666667,0.333333333333,0.0
Brain reserve,0.0,1.0,0.0,0.0
Interhemispheric transfer,0.333333333333,0.0,0.666666666667,0.0
Self-efficacy,0.333333333333,0.0,0.333333333333,0.333333333333
Emotional valence,0.333333333333,0.0,0.333333333333,0.333333333333
Visuoperception,0.0,0.333333333333,0.666666666667,0.0
Action representation,0.0,0.666666666667,0.0,0.333333333333
REM,0.0,0.0,1.0,0.0
Reading disabilities,0.666666666667,0.0,0.333333333333,0.0
Post-event processing,0.0,0.666666666667,0.333333333333,0.0
Mere exposure,0.0,0.0,1.0,0.0
Sensorimotor synchronization,0.0,0.0,1.0,0.0
Face naming,0.0,0.333333333333,0.666666666667,0.0
transcranial direct current stimulation,0.0,0.0,0.666666666667,0.333333333333
Orienting,0.0,0.333333333333,0.333333333333,0.333333333333
Numerosity perception,0.333333333333,0.666666666667,0.0,0.0
Fictive motion,0.0,0.333333333333,0.666666666667,0.0
Closed head injury,0.333333333333,0.666666666667,0.0,0.0
N100,0.0,0.333333333333,0.666666666667,0.0
top-down control,0.0,0.666666666667,0.333333333333,0.0
Prenatal Alcohol Exposure,0.0,0.333333333333,0.666666666667,0.0
Prolactin,0.0,0.333333333333,0.666666666667,0.0
item response theory,0.333333333333,0.333333333333,0.333333333333,0.0
Mirrors,0.333333333333,0.333333333333,0.333333333333,0.0
Dementia of Alzheimer's type,0.0,0.0,0.666666666667,0.333333333333
visualization,0.0,0.333333333333,0.666666666667,0.0
Orbitofrontal,0.333333333333,0.0,0.666666666667,0.0
Kinesthetic imagery,0.333333333333,0.333333333333,0.333333333333,0.0
picture naming,0.333333333333,0.0,0.666666666667,0.0
Outcomes research,0.0,0.333333333333,0.666666666667,0.0
Dwarf goat,0.0,0.333333333333,0.666666666667,0.0
RTMS,0.666666666667,0.0,0.333333333333,0.0
Reference memory,0.0,0.0,0.666666666667,0.333333333333
Lip-reading,0.666666666667,0.333333333333,0.0,0.0
Addition,0.333333333333,0.0,0.333333333333,0.333333333333
Attentional networks,0.0,0.333333333333,0.666666666667,0.0
Evidence accumulation,0.333333333333,0.333333333333,0.333333333333,0.0
Swarm cognition,0.0,0.0,0.666666666667,0.333333333333
face,0.333333333333,0.333333333333,0.333333333333,0.0
Forensic science,0.0,0.666666666667,0.333333333333,0.0
Diagnostic reasoning,0.0,0.333333333333,0.666666666667,0.0
Phonological,0.0,0.666666666667,0.333333333333,0.0
Maternal,0.0,0.0,0.666666666667,0.0
Capacity limits,0.333333333333,0.333333333333,0.0,0.333333333333
Social behaviour,0.333333333333,0.666666666667,0.0,0.0
outcomes,0.666666666667,0.333333333333,0.0,0.0
Cognitive maps,0.333333333333,0.666666666667,0.0,0.0
Multisensory interaction,0.0,0.666666666667,0.333333333333,0.0
Involuntary attention,0.333333333333,0.333333333333,0.333333333333,0.0
Multiple-object tracking,1.0,0.0,0.0,0.0
Visual-spatial attention,0.333333333333,0.333333333333,0.333333333333,0.0
Theta band,0.0,0.333333333333,0.666666666667,0.0
Congruity effect,0.333333333333,0.666666666667,0.0,0.0
Cholecystectomy,0.333333333333,0.333333333333,0.0,0.333333333333
sex differences,0.0,0.333333333333,0.333333333333,0.333333333333
Early development,0.333333333333,0.333333333333,0.333333333333,0.0
Clinical phenotype,0.0,0.666666666667,0.333333333333,0.0
Visuomotor mental rotation,0.0,0.333333333333,0.666666666667,0.0
Concreteness,0.333333333333,0.333333333333,0.333333333333,0.0
Electroencephalogram (EEG),0.333333333333,0.0,0.0,0.666666666667
Sensory modalities,0.0,0.333333333333,0.0,0.666666666667
?-amyloid,0.0,0.0,0.666666666667,0.333333333333
Neuroeconomics,0.333333333333,0.0,0.666666666667,0.0
Movement planning,0.333333333333,0.333333333333,0.333333333333,0.0
Asperger Syndrome,0.666666666667,0.333333333333,0.0,0.0
Functional networks,0.333333333333,0.333333333333,0.333333333333,0.0
Autism spectrum disorder (ASD),0.333333333333,0.0,0.666666666667,0.0
Speed-accuracy trade-off,0.0,0.0,0.666666666667,0.333333333333
Diffusion model,0.333333333333,0.0,0.666666666667,0.0
Systemizing,0.333333333333,0.666666666667,0.0,0.0
Rolandic epilepsy,0.333333333333,0.333333333333,0.0,0.333333333333
Weber fraction,0.0,0.333333333333,0.333333333333,0.333333333333
Associations,0.333333333333,0.333333333333,0.333333333333,0.0
Accommodations,0.0,0.333333333333,0.666666666667,0.0
verbal memory,0.0,0.333333333333,0.666666666667,0.0
Emotional pictures,0.0,0.0,0.666666666667,0.333333333333
Hippocampal volume,0.0,0.333333333333,0.666666666667,0.0
Subtypes,0.333333333333,0.666666666667,0.0,0.0
Extrastriate cortex,0.333333333333,0.0,0.333333333333,0.333333333333
Mental disorders,0.333333333333,0.0,0.333333333333,0.333333333333
Automatic processes,0.333333333333,0.0,0.666666666667,0.0
event-related brain potentials,0.0,0.333333333333,0.666666666667,0.0
cocaine,0.0,0.666666666667,0.333333333333,0.0
fNIRS,0.333333333333,0.333333333333,0.0,0.333333333333
Dendritic spines,0.333333333333,0.333333333333,0.0,0.333333333333
Driving cessation,0.0,0.0,1.0,0.0
Hemispheric laterality,0.0,0.0,1.0,0.0
Fear of spiders,0.666666666667,0.0,0.0,0.333333333333
Hemispheric lateralization,0.0,0.666666666667,0.333333333333,0.0
Pictorial representation,0.666666666667,0.333333333333,0.0,0.0
Attractor network,0.0,0.0,1.0,0.0
Honeybee,0.666666666667,0.333333333333,0.0,0.0
Hepatitis C virus,0.0,0.333333333333,0.333333333333,0.0
Ventral premotor cortex,0.0,0.666666666667,0.333333333333,0.0
CBT,0.333333333333,0.333333333333,0.333333333333,0.0
Causal reasoning,0.333333333333,0.0,0.666666666667,0.0
Practice effects,0.0,0.0,0.666666666667,0.333333333333
Evolutionary robotics,0.0,0.333333333333,0.666666666667,0.0
Load,0.0,0.0,1.0,0.0
Memory development,0.0,0.666666666667,0.333333333333,0.0
Biological and Chemical Sciences",0.0,0.0,0.0,0.0
Diffusion weighted imaging,0.333333333333,0.0,0.0,0.666666666667
ANS,0.666666666667,0.0,0.0,0.333333333333
alertness,0.0,0.666666666667,0.333333333333,0.0
Symbolic,0.0,0.333333333333,0.333333333333,0.333333333333
Value,0.0,0.666666666667,0.333333333333,0.0
Chunking,0.333333333333,0.0,0.666666666667,0.0
Late positive component,0.0,0.333333333333,0.666666666667,0.0
Amnestic,0.333333333333,0.666666666667,0.0,0.0
Oestrogen,0.666666666667,0.0,0.333333333333,0.0
autism spectrum disorder,0.333333333333,0.333333333333,0.333333333333,0.0
Memory impairment,0.333333333333,0.0,0.333333333333,0.333333333333
Place cells,0.0,0.0,0.666666666667,0.333333333333
Navon,0.333333333333,0.666666666667,0.0,0.0
Morphological processing,0.333333333333,0.333333333333,0.333333333333,0.0
Consistency,0.666666666667,0.0,0.333333333333,0.0
communication,0.333333333333,0.0,0.0,0.666666666667
Subarachnoid hemorrhage,0.333333333333,0.333333333333,0.333333333333,0.0
fibromyalgia,0.0,0.333333333333,0.333333333333,0.333333333333
Hot flashes,0.0,0.333333333333,0.666666666667,0.0
Diffusion-weighted imaging,0.333333333333,0.333333333333,0.333333333333,0.0
color,0.0,0.333333333333,0.333333333333,0.333333333333
Repetition,0.333333333333,0.666666666667,0.0,0.0
Continuous variables,0.333333333333,0.666666666667,0.0,0.0
Alcohol use,0.0,0.333333333333,0.333333333333,0.333333333333
Semantic fluency,0.0,0.333333333333,0.666666666667,0.0
Mate choice,0.666666666667,0.0,0.333333333333,0.0
Numerical competence,0.0,0.333333333333,0.0,0.666666666667
Bimodal,0.333333333333,0.333333333333,0.333333333333,0.0
Alzheimer's Disease,0.666666666667,0.333333333333,0.0,0.0
prefrontal,0.0,0.333333333333,0.666666666667,0.0
Action effects,0.333333333333,0.0,0.666666666667,0.0
Myo-inositol,0.333333333333,0.333333333333,0.333333333333,0.0
Cognition test,0.333333333333,0.666666666667,0.0,0.0
Cognitive factors,0.333333333333,0.333333333333,0.333333333333,0.0
Event-related brain potentials (ERPs),0.333333333333,0.0,0.333333333333,0.333333333333
Matching to sample,0.0,0.333333333333,0.666666666667,0.0
K-means clustering,0.333333333333,0.666666666667,0.0,0.0
analgesia,0.333333333333,0.333333333333,0.0,0.333333333333
Global-local processing,0.0,0.333333333333,0.333333333333,0.333333333333
MR spectroscopy,0.0,0.666666666667,0.333333333333,0.0
Vision impairment,0.0,0.0,0.666666666667,0.333333333333
Mental rotations,0.0,0.333333333333,0.333333333333,0.333333333333
Weight,0.0,0.333333333333,0.0,0.666666666667
Scale,0.0,0.0,0.666666666667,0.333333333333
tests,0.333333333333,0.0,0.333333333333,0.333333333333
Ecological validity,0.0,0.333333333333,0.666666666667,0.0
Sense of direction,0.0,0.333333333333,0.333333333333,0.333333333333
Cluster,0.0,0.333333333333,0.666666666667,0.0
Detection/discrimination,0.0,0.333333333333,0.666666666667,0.0
monkey,1.0,0.0,0.0,0.0
Hypoplastic left heart syndrome,0.333333333333,0.666666666667,0.0,0.0
Ventral striatum,0.0,0.0,1.0,0.0
Mental set,0.0,1.0,0.0,0.0
Status,0.666666666667,0.0,0.333333333333,0.0
Action video games,0.0,0.0,0.333333333333,0.666666666667
Pathophysiology,0.0,0.666666666667,0.333333333333,0.0
Mushroom body,0.0,0.0,1.0,0.0
neural networks,0.333333333333,0.333333333333,0.0,0.333333333333
Facial emotion processing,0.333333333333,0.666666666667,0.0,0.0
Event related potentials (ERPs),0.333333333333,0.333333333333,0.333333333333,0.0
Exemplars,0.333333333333,0.333333333333,0.333333333333,0.0
magnetoencephalography,0.333333333333,0.333333333333,0.333333333333,0.0
Subsequent memory,0.0,0.333333333333,0.666666666667,0.0
ApoE,0.333333333333,0.333333333333,0.333333333333,0.0
Pre-SMA,0.0,0.333333333333,0.666666666667,0.0
Sleep disturbance,0.0,0.333333333333,0.333333333333,0.333333333333
Mini-Mental State Examination,0.0,0.333333333333,0.333333333333,0.333333333333
Anorexia Nervosa,0.0,0.0,1.0,0.0
Future thinking,0.0,0.0,0.666666666667,0.333333333333
Theory of mind (ToM),0.333333333333,0.333333333333,0.333333333333,0.0
visual rating scale,0.666666666667,0.0,0.333333333333,0.0
Ordered sequences,0.0,0.333333333333,0.0,0.666666666667
Precursors,0.0,0.333333333333,0.666666666667,0.0
Pharmacotherapy,0.333333333333,0.333333333333,0.333333333333,0.0
declarative memory,0.333333333333,0.0,0.333333333333,0.333333333333
Employment,0.0,0.0,0.666666666667,0.333333333333
Emotion and cognition,0.0,0.666666666667,0.333333333333,0.0
Drug therapy,0.0,0.666666666667,0.0,0.333333333333
Sensory modality,0.333333333333,0.333333333333,0.333333333333,0.0
set-shifting,0.333333333333,0.333333333333,0.0,0.0
Antidepressants,0.333333333333,0.0,0.666666666667,0.0
Domestic chick,0.0,0.0,1.0,0.0
interference,0.666666666667,0.0,0.333333333333,0.0
Hallucination,0.0,0.0,0.666666666667,0.333333333333
Optical flow,0.333333333333,0.333333333333,0.333333333333,0.0
Nursing homes,0.333333333333,0.333333333333,0.0,0.333333333333
blood pressure,0.0,0.333333333333,0.666666666667,0.0
voxel-based morphometry,0.333333333333,0.0,0.666666666667,0.0
Affective computing,0.666666666667,0.333333333333,0.0,0.0
Reflexive attention,0.333333333333,0.0,0.666666666667,0.0
Cerebral visual impairment,0.0,0.333333333333,0.666666666667,0.0
Multi-tasking,0.666666666667,0.333333333333,0.0,0.0
Internal model,0.0,0.333333333333,0.666666666667,0.0
Polysomnography,0.0,0.333333333333,0.333333333333,0.333333333333
Geriatric,0.0,0.0,1.0,0.0
Duration,0.0,0.0,1.0,0.0
encephalopathy,0.333333333333,0.0,0.666666666667,0.0
Instructions,0.333333333333,0.0,0.333333333333,0.333333333333
Scanpaths,0.0,1.0,0.0,0.0
risperidone,0.333333333333,0.0,0.666666666667,0.0
ECT,0.333333333333,0.0,0.666666666667,0.0
Temporal lobe atrophy,0.333333333333,0.666666666667,0.0,0.0
Causal cognition,0.333333333333,0.333333333333,0.333333333333,0.0
cognitive disorders,0.0,0.0,0.666666666667,0.333333333333
Number magnitude,0.0,0.333333333333,0.666666666667,0.0
Temporal cognition,0.0,0.0,0.666666666667,0.333333333333
Neurobehavioural,0.666666666667,0.0,0.333333333333,0.0
Maltreatment,0.0,0.333333333333,0.333333333333,0.333333333333
Naive physics,0.333333333333,0.0,0.0,0.666666666667
Low back pain,0.0,0.666666666667,0.333333333333,0.0
White matter hyperintensity,0.0,0.0,0.666666666667,0.333333333333
Brain state,0.333333333333,0.0,0.666666666667,0.0
divided attention,0.0,0.333333333333,0.666666666667,0.0
Salience network,0.333333333333,0.333333333333,0.333333333333,0.0
Anorexia,0.666666666667,0.0,0.333333333333,0.0
Global perception,0.333333333333,0.333333333333,0.333333333333,0.0
Wilson's disease,0.0,0.333333333333,0.333333333333,0.333333333333
Continuous positive airway pressure,0.333333333333,0.0,0.333333333333,0.333333333333
Perception-action,0.0,0.333333333333,0.666666666667,0.0
Neurobehavioral function,0.666666666667,0.0,0.333333333333,0.0
Sensory gating,0.0,0.0,1.0,0.0
Visual deprivation,0.0,0.333333333333,0.666666666667,0.0
Auditory evoked potential,0.333333333333,0.0,0.333333333333,0.333333333333
sLORETA,0.0,0.333333333333,0.666666666667,0.0
Neuromodulation,0.333333333333,0.333333333333,0.0,0.333333333333
Cognitive styles,0.0,0.666666666667,0.333333333333,0.0
Rehearsal,0.0,0.0,0.666666666667,0.333333333333
pharmacokinetics,0.666666666667,0.0,0.0,0.333333333333
capuchin monkeys,0.333333333333,0.333333333333,0.333333333333,0.0
Spatial compatibility,0.0,0.666666666667,0.333333333333,0.0
Visual deficits,0.0,0.333333333333,0.333333333333,0.333333333333
Qualia,0.0,0.333333333333,0.333333333333,0.333333333333
Frail elderly,0.0,0.0,1.0,0.0
Misinformation,0.333333333333,0.333333333333,0.333333333333,0.0
Orientation tuning,0.333333333333,0.0,0.666666666667,0.0
Ultrasonography,0.0,0.666666666667,0.0,0.333333333333
Socioeconomic factors,0.0,0.333333333333,0.333333333333,0.333333333333
Augmented reality,0.333333333333,0.333333333333,0.333333333333,0.0
Psychomotor,0.0,0.333333333333,0.333333333333,0.333333333333
NMDA receptor antagonist,0.0,0.0,0.666666666667,0.333333333333
Event-related synchronization (ERS),0.333333333333,0.0,0.666666666667,0.0
Time course,0.0,0.333333333333,0.666666666667,0.0
magnocellular,0.666666666667,0.333333333333,0.0,0.0
Negative numbers,0.0,0.0,0.666666666667,0.333333333333
Ethnicity,0.0,0.0,1.0,0.0
Intractable epilepsy,0.0,0.666666666667,0.333333333333,0.0
error processing,0.333333333333,0.0,0.666666666667,0.0
PCP,0.333333333333,0.666666666667,0.0,0.0
Guaran,0.0,0.0,1.0,0.0
Mller-Lyer,0.0,0.666666666667,0.333333333333,0.0
Fairness,0.0,1.0,0.0,0.0
Auditory cognition,0.333333333333,0.0,0.333333333333,0.333333333333
Pupil,0.0,0.333333333333,0.666666666667,0.0
Neurosurgery,0.333333333333,0.333333333333,0.333333333333,0.0
Place,0.666666666667,0.0,0.333333333333,0.0
Continuous Performance Test,0.333333333333,0.333333333333,0.333333333333,0.0
Joubert syndrome,0.0,1.0,0.0,0.0
Perceptual memory,0.666666666667,0.333333333333,0.0,0.0
Parkinson's disease dementia,0.333333333333,0.666666666667,0.0,0.0
Psychological well-being,0.0,0.333333333333,0.666666666667,0.0
Dystrophin,0.333333333333,0.0,0.666666666667,0.0
Pattern-reversal VEPs,0.0,0.333333333333,0.333333333333,0.333333333333
AIDS,0.333333333333,0.0,0.666666666667,0.0
Multisensory stimulation,0.333333333333,0.0,0.333333333333,0.333333333333
Fetal alcohol spectrum disorder,0.333333333333,0.333333333333,0.333333333333,0.0
Punishment,0.333333333333,0.333333333333,0.0,0.333333333333
Serial order,0.333333333333,0.0,0.666666666667,0.0
Drugs,0.0,0.333333333333,0.333333333333,0.333333333333
Driver behavior,0.0,0.333333333333,0.333333333333,0.333333333333
Brain network,0.0,0.666666666667,0.333333333333,0.0
function,0.666666666667,0.0,0.333333333333,0.0
Salticidae,0.666666666667,0.0,0.0,0.333333333333
Case alternation,0.333333333333,0.333333333333,0.333333333333,0.0
Ataxia,0.333333333333,0.333333333333,0.333333333333,0.0
infant cognition,0.0,0.666666666667,0.333333333333,0.0
Modelling,0.0,0.333333333333,0.333333333333,0.333333333333
Visuospatial skills,0.0,0.0,1.0,0.0
Multimodal processing,0.0,0.333333333333,0.666666666667,0.0
Top-down attention,0.333333333333,0.0,0.666666666667,0.0
Choice,0.333333333333,0.333333333333,0.0,0.333333333333
Vocal communication,0.0,0.666666666667,0.0,0.333333333333
Cocaine dependence,0.0,0.666666666667,0.0,0.333333333333
CPT,0.0,0.333333333333,0.666666666667,0.0
Balance control,0.0,0.0,1.0,0.0
post-traumatic stress disorder,0.0,0.0,1.0,0.0
Spatial perception,0.333333333333,0.333333333333,0.333333333333,0.0
Demography,0.0,0.333333333333,0.666666666667,0.0
Threshold,0.0,0.333333333333,0.666666666667,0.0
Cerebral dominance,0.0,1.0,0.0,0.0
number,0.0,0.333333333333,0.666666666667,0.0
BMI,0.333333333333,0.666666666667,0.0,0.0
Picture,0.333333333333,0.333333333333,0.0,0.333333333333
geriatric assessment,0.0,0.666666666667,0.333333333333,0.0
Carbon dioxide,0.333333333333,0.666666666667,0.0,0.0
imagery,0.0,0.333333333333,0.333333333333,0.333333333333
psychomotor performance,0.0,0.666666666667,0.333333333333,0.0
Visuomotor control,0.0,0.333333333333,0.666666666667,0.0
Sequential learning,0.0,0.666666666667,0.333333333333,0.0
information visualization,0.0,0.333333333333,0.666666666667,0.0
Adaptive behaviour,0.0,1.0,0.0,0.0
Iron,0.0,0.666666666667,0.0,0.333333333333
Concept formation,0.333333333333,0.0,0.666666666667,0.0
Dysphoria,0.333333333333,0.333333333333,0.333333333333,0.0
Self-monitoring,0.0,0.0,0.666666666667,0.333333333333
Temporal order,0.0,0.333333333333,0.666666666667,0.0
Drug addiction,0.0,0.333333333333,0.333333333333,0.333333333333
Stimulant,0.0,0.333333333333,0.333333333333,0.333333333333
Immersive virtual reality,0.333333333333,0.333333333333,0.0,0.333333333333
Old/new effect,0.0,0.666666666667,0.333333333333,0.0
age differences,0.0,1.0,0.0,0.0
Curvature,0.0,0.333333333333,0.666666666667,0.0
Implicit Association Test,0.333333333333,0.333333333333,0.333333333333,0.0
Urinary incontinence,0.333333333333,0.0,0.666666666667,0.0
Arabic digits,0.333333333333,0.333333333333,0.333333333333,0.0
Place cell,0.333333333333,0.333333333333,0.333333333333,0.0
Impulsiveness,0.333333333333,0.333333333333,0.333333333333,0.0
Logic,0.0,0.333333333333,0.666666666667,0.0
Conceptual combination,0.0,0.666666666667,0.333333333333,0.0
tractography,0.333333333333,0.0,0.666666666667,0.0
Paired associate learning,0.0,0.666666666667,0.0,0.333333333333
Spatial bias,0.0,0.333333333333,0.333333333333,0.333333333333
Simulation theory,0.0,0.666666666667,0.333333333333,0.0
Perseverative cognition,0.0,0.666666666667,0.333333333333,0.0
Cardiovascular,0.0,0.0,1.0,0.0
Anxiety disorder,0.333333333333,0.0,0.666666666667,0.0
Boston Qualitative Scoring System,0.0,0.333333333333,0.333333333333,0.333333333333
Summation,0.0,0.333333333333,0.666666666667,0.0
Spatial cuing,0.333333333333,0.0,0.333333333333,0.333333333333
Bromazepam,0.0,0.333333333333,0.666666666667,0.0
Risk taking,0.666666666667,0.0,0.0,0.333333333333
Configural,0.333333333333,0.0,0.666666666667,0.0
thalamus,0.0,1.0,0.0,0.0
Information-seeking,0.333333333333,0.0,0.666666666667,0.0
Oxycodone,0.0,0.666666666667,0.333333333333,0.0
Short term memory,0.333333333333,0.666666666667,0.0,0.0
physical activity,0.0,0.333333333333,0.333333333333,0.333333333333
Iconicity,0.333333333333,0.0,0.666666666667,0.0
Numerical distance effect,0.333333333333,0.0,0.333333333333,0.333333333333
Preferences,0.0,0.0,0.666666666667,0.333333333333
Dental education,0.0,0.333333333333,0.666666666667,0.0
Slowing,0.333333333333,0.333333333333,0.333333333333,0.0
neuroprotection,0.333333333333,0.0,0.666666666667,0.0
Selection,0.333333333333,0.333333333333,0.0,0.333333333333
Picture-word interference,0.0,0.333333333333,0.666666666667,0.0
Other-race effect,0.666666666667,0.0,0.333333333333,0.0
?-Synuclein,0.333333333333,0.333333333333,0.333333333333,0.0
Transference,0.0,0.666666666667,0.333333333333,0.0
perspective-taking,0.0,0.666666666667,0.0,0.333333333333
Manipulation,0.333333333333,0.0,0.333333333333,0.333333333333
SF-36,0.0,0.333333333333,0.666666666667,0.0
Transactions of the ASME",0.0,0.0,0.0,0.0
Pupillary responses,0.0,0.333333333333,0.333333333333,0.333333333333
OFA,0.666666666667,0.333333333333,0.0,0.0
Fracture,0.0,0.0,0.333333333333,0.666666666667
Closed-head injury,0.0,0.333333333333,0.666666666667,0.0
Child neuropsychology,1.0,0.0,0.0,0.0
Dual-task paradigm,0.0,0.0,0.666666666667,0.0
Healthy adults,0.0,0.333333333333,0.666666666667,0.0
Task-induced deactivation,0.333333333333,0.333333333333,0.0,0.333333333333
Nonconceptual content,0.0,0.0,1.0,0.0
Trail making,0.333333333333,0.333333333333,0.333333333333,0.0
Erythropoietin,0.333333333333,0.333333333333,0.333333333333,0.0
Deficit syndrome,0.333333333333,0.333333333333,0.333333333333,0.0
Homeostasis,0.0,0.666666666667,0.333333333333,0.0
dual task,0.0,0.333333333333,0.333333333333,0.333333333333
Social robotics,0.666666666667,0.333333333333,0.0,0.0
Decision,0.333333333333,0.666666666667,0.0,0.0
Fmri,0.0,1.0,0.0,0.0
Fluid reasoning,0.333333333333,0.333333333333,0.333333333333,0.0
Neuroimage,0.0,0.333333333333,0.666666666667,0.0
Actigraphy,0.0,0.666666666667,0.333333333333,0.0
regulation,0.666666666667,0.0,0.333333333333,0.0
Mismatch negativity (MMN),0.333333333333,0.666666666667,0.0,0.0
Motion coherence,0.0,0.666666666667,0.333333333333,0.0
VPP,0.0,0.666666666667,0.333333333333,0.0
Subjective effects,0.0,0.0,0.666666666667,0.333333333333
Visualisation,0.0,0.666666666667,0.0,0.333333333333
Frontal eye fields,0.333333333333,0.0,0.666666666667,0.0
Sensorimotor plasticity,0.333333333333,0.333333333333,0.0,0.333333333333
Charles Bonnet,0.333333333333,0.333333333333,0.333333333333,0.0
Reading disability,0.666666666667,0.0,0.333333333333,0.0
Smooth pursuit eye movements,0.0,0.333333333333,0.0,0.666666666667
Food craving,0.0,0.333333333333,0.333333333333,0.333333333333
Demyelination,0.666666666667,0.0,0.0,0.333333333333
Neuropsychoanalysis,0.0,0.666666666667,0.333333333333,0.0
Abstraction,0.0,0.0,1.0,0.0
Very low birth weight,0.0,0.333333333333,0.666666666667,0.0
Myotonic dystrophy type 1,0.0,0.333333333333,0.333333333333,0.333333333333
Illusions,0.333333333333,0.333333333333,0.333333333333,0.0
Benign childhood epilepsy with centrotemporal spikes,0.333333333333,0.333333333333,0.0,0.333333333333
Robot navigation,0.333333333333,0.666666666667,0.0,0.0
Gibbons,0.0,0.333333333333,0.666666666667,0.0
Neuropsychological rehabilitation,0.333333333333,0.333333333333,0.333333333333,0.0
Comparative neuroscience,0.0,1.0,0.0,0.0
Pain measurement,0.333333333333,0.666666666667,0.0,0.0
Inner speech,0.0,0.0,0.666666666667,0.333333333333
semantic priming,0.666666666667,0.0,0.0,0.333333333333
Object recognition memory,0.0,0.0,0.666666666667,0.333333333333
High-risk,0.0,1.0,0.0,0.0
Nonsymbolic,0.0,0.333333333333,0.0,0.666666666667
resting-state,0.333333333333,0.666666666667,0.0,0.0
Arm movements,0.333333333333,0.0,0.666666666667,0.0
Galantamine,0.333333333333,0.0,0.666666666667,0.0
Frontotemporal lobar degeneration,0.0,0.0,1.0,0.0
Motor intention,0.0,0.333333333333,0.666666666667,0.0
Neurodegenerative disorders,0.0,0.666666666667,0.0,0.333333333333
Acquired brain injury,0.0,0.0,0.333333333333,0.666666666667
Manual pointing,0.0,0.666666666667,0.333333333333,0.0
Coordination dynamics,0.333333333333,0.333333333333,0.333333333333,0.0
Cognitive demands,0.333333333333,0.666666666667,0.0,0.0
Source analysis,0.333333333333,0.333333333333,0.0,0.333333333333
Self-motion,0.0,0.0,1.0,0.0
Goal,0.0,0.666666666667,0.333333333333,0.0
APOE genotype,0.333333333333,0.333333333333,0.333333333333,0.0
Object cognition,0.0,0.333333333333,0.666666666667,0.0
N-back,0.333333333333,0.0,0.666666666667,0.0
Negative compatibility effect,0.0,0.333333333333,0.666666666667,0.0
Chinese characters,0.333333333333,0.333333333333,0.333333333333,0.0
Preclinical Alzheimer's disease,0.0,1.0,0.0,0.0
hallucinations,0.0,1.0,0.0,0.0
Complex span,0.333333333333,0.0,0.333333333333,0.333333333333
Way-finding,0.0,0.333333333333,0.666666666667,0.0
Learning difficulties,0.0,0.666666666667,0.333333333333,0.0
Fragile X,0.333333333333,0.333333333333,0.333333333333,0.0
Scene gist,0.666666666667,0.333333333333,0.0,0.0
Visual adaptation,0.0,0.333333333333,0.666666666667,0.0
Smoking cessation,0.0,0.0,0.666666666667,0.333333333333
Nouns,0.333333333333,0.666666666667,0.0,0.0
Backward inhibition,0.0,0.0,1.0,0.0
Lyme disease,0.0,0.333333333333,0.666666666667,0.0
Sensorimotor cortex,0.0,0.0,0.666666666667,0.333333333333
Obstacle avoidance,0.333333333333,0.0,0.666666666667,0.0
Images,0.333333333333,0.0,0.666666666667,0.0
Men,0.0,0.333333333333,0.333333333333,0.333333333333
Empathizing,0.333333333333,0.333333333333,0.0,0.333333333333
Positive emotion,0.666666666667,0.333333333333,0.0,0.0
Emotional stimuli,0.333333333333,0.333333333333,0.333333333333,0.0
Visual short term memory,0.0,0.333333333333,0.666666666667,0.0
DHA,0.0,0.333333333333,0.666666666667,0.0
performance,0.333333333333,0.0,0.333333333333,0.333333333333
Expectations,0.0,0.333333333333,0.333333333333,0.333333333333
Hypothesis testing,0.333333333333,0.0,0.666666666667,0.0
Human experimentation,0.0,0.666666666667,0.0,0.333333333333
computer vision,0.0,0.666666666667,0.333333333333,0.0
Volumetric MRI,0.0,0.0,1.0,0.0
Blast injury,0.333333333333,0.333333333333,0.0,0.333333333333
Principal components analysis,0.333333333333,0.0,0.0,0.666666666667
Placebo effect,0.666666666667,0.333333333333,0.0,0.0
Lesion study,0.0,0.333333333333,0.333333333333,0.333333333333
Knockout,0.0,0.333333333333,0.666666666667,0.0
Social development,0.0,0.333333333333,0.666666666667,0.0
Motor skill,0.333333333333,0.333333333333,0.333333333333,0.0
Premature infants,0.0,0.0,0.666666666667,0.333333333333
V4,0.0,1.0,0.0,0.0
Intelligence quotient,0.0,0.0,0.666666666667,0.333333333333
Voice,0.0,0.333333333333,0.666666666667,0.0
Plasma levels,0.0,0.666666666667,0.333333333333,0.0
Affective prosody,0.0,0.0,0.666666666667,0.333333333333
Size estimation,0.0,0.666666666667,0.0,0.333333333333
Sensorimotor processing,0.666666666667,0.0,0.333333333333,0.0
Caregiving,0.0,0.333333333333,0.333333333333,0.333333333333
Tool,0.0,0.333333333333,0.666666666667,0.0
Support vector machine,0.0,0.0,0.666666666667,0.333333333333
tactile,0.333333333333,0.333333333333,0.0,0.333333333333
Contrast,0.0,0.0,1.0,0.0
Long-term follow-up,0.333333333333,0.666666666667,0.0,0.0
Self-representation,0.0,0.333333333333,0.333333333333,0.333333333333
Subarachnoid haemorrhage,0.333333333333,0.0,0.333333333333,0.333333333333
Cancellation task,0.333333333333,0.666666666667,0.0,0.0
Interference resolution,0.0,0.333333333333,0.666666666667,0.0
Visual span,0.0,0.333333333333,0.666666666667,0.0
electrophysiology,0.0,0.333333333333,0.666666666667,0.0
Physical disability,0.333333333333,0.333333333333,0.333333333333,0.0
Intracranial recording,0.666666666667,0.333333333333,0.0,0.0
cocoa,0.0,0.666666666667,0.333333333333,0.0
Gaming,0.333333333333,0.0,0.333333333333,0.333333333333
Learning/Memory,0.333333333333,0.666666666667,0.0,0.0
Synaesthesia/synesthesia,0.0,0.333333333333,0.666666666667,0.0
Observational learning,0.0,0.333333333333,0.666666666667,0.0
Fitness,0.0,0.333333333333,0.666666666667,0.0
Cell phone,0.0,0.333333333333,0.666666666667,0.0
Mental practice,0.666666666667,0.333333333333,0.0,0.0
time perception,0.0,0.666666666667,0.333333333333,0.0
Zebrafish,0.0,0.333333333333,0.666666666667,0.0
Negation,0.333333333333,0.333333333333,0.333333333333,0.0
Social function,0.333333333333,0.333333333333,0.333333333333,0.0
cerebral blood flow,0.333333333333,0.0,0.666666666667,0.0
amyloid-?,0.666666666667,0.333333333333,0.0,0.0
Hemispheric asymmetries,0.666666666667,0.333333333333,0.0,0.0
Emotional intelligence,0.0,1.0,0.0,0.0
Strategies,0.333333333333,0.333333333333,0.333333333333,0.0
Scenes,0.0,0.0,0.666666666667,0.333333333333
Progranulin,0.0,0.0,0.666666666667,0.333333333333
Neuropsychological study,0.0,0.666666666667,0.333333333333,0.0
amnestic mild cognitive impairment,0.333333333333,0.0,0.333333333333,0.333333333333
Top-down effect,0.0,0.666666666667,0.0,0.333333333333
Psychosocial functioning,0.0,0.333333333333,0.333333333333,0.333333333333
Melanopsin,0.333333333333,0.333333333333,0.333333333333,0.0
safety,0.666666666667,0.0,0.333333333333,0.0
vigilance,0.0,0.0,1.0,0.0
Resting-state functional magnetic resonance imaging,0.0,0.333333333333,0.333333333333,0.333333333333
Visual oddball,0.666666666667,0.333333333333,0.0,0.0
unilateral neglect,0.0,0.333333333333,0.333333333333,0.333333333333
Subjective visual vertical,0.0,0.333333333333,0.666666666667,0.0
risk factors,0.0,0.333333333333,0.666666666667,0.0
Nonagenarian,0.0,0.0,0.666666666667,0.333333333333
Adolescent development,0.333333333333,0.333333333333,0.0,0.333333333333
Veterans,0.666666666667,0.333333333333,0.0,0.0
Inversion effect,0.0,0.333333333333,0.666666666667,0.0
Visual fatigue,0.333333333333,0.333333333333,0.333333333333,0.0
Perceptual,0.333333333333,0.666666666667,0.0,0.0
P100,0.333333333333,0.333333333333,0.333333333333,0.0
Controlled processing,0.0,0.333333333333,0.333333333333,0.333333333333
EMG,0.333333333333,0.333333333333,0.333333333333,0.0
Glucocorticoid receptor,0.333333333333,0.333333333333,0.333333333333,0.0
Nitric oxide,0.0,0.0,0.666666666667,0.333333333333
Cognitive phenotype,0.333333333333,0.0,0.666666666667,0.0
"Cognition disorders,0.0,0.0,0.0,0.0
Introspection,0.666666666667,0.333333333333,0.0,0.0
spatial learning,0.333333333333,0.333333333333,0.333333333333,0.0
Parsing,0.333333333333,0.0,0.333333333333,0.333333333333
R.,0.0,0.0,0.666666666667,0.333333333333
Drivers,0.333333333333,0.0,0.333333333333,0.333333333333
cognitive bias,0.333333333333,0.0,0.333333333333,0.333333333333
Microbleeds,0.333333333333,0.333333333333,0.333333333333,0.0
Diet,0.0,0.666666666667,0.333333333333,0.0
Lateralisation,0.0,0.333333333333,0.333333333333,0.333333333333
Medication adherence,0.0,0.333333333333,0.333333333333,0.333333333333
Small-world,0.0,0.666666666667,0.333333333333,0.0
executive control,0.666666666667,0.0,0.333333333333,0.0
Dedifferentiation,0.333333333333,0.666666666667,0.0,0.0
Antipsychotic agents,0.333333333333,0.333333333333,0.333333333333,0.0
Open field,0.0,1.0,0.0,0.0
Analgesics,0.0,0.666666666667,0.333333333333,0.0
Theanine,0.666666666667,0.333333333333,0.0,0.0
Narratives,0.0,0.666666666667,0.0,0.333333333333
Facial identity,0.666666666667,0.333333333333,0.0,0.0
Test-retest reliability,0.0,0.666666666667,0.333333333333,0.0
self-regulation,0.0,0.0,0.333333333333,0.666666666667
Mini-mental state examination,0.0,0.0,0.666666666667,0.333333333333
Mesial temporal sclerosis,0.0,0.333333333333,0.666666666667,0.0
Receptive field,0.333333333333,0.666666666667,0.0,0.0
Transitivity,0.333333333333,0.0,0.666666666667,0.0
Grapheme-colour,0.0,0.666666666667,0.333333333333,0.0
Sulpiride,0.0,0.333333333333,0.666666666667,0.0
endophenotype,0.0,0.0,0.666666666667,0.333333333333
Pe,0.666666666667,0.0,0.333333333333,0.0
antisaccade,0.666666666667,0.333333333333,0.0,0.0
Visual spatial,0.0,0.0,1.0,0.0
Visual attention span,0.666666666667,0.0,0.333333333333,0.0
Discourse analysis,0.0,0.333333333333,0.666666666667,0.0
sensitivity,0.666666666667,0.0,0.0,0.333333333333
Lesion studies,0.0,0.333333333333,0.333333333333,0.333333333333
Causal perception,0.333333333333,0.666666666667,0.0,0.0
Central pain,0.333333333333,0.666666666667,0.0,0.0
Pharmacology,0.333333333333,0.0,0.666666666667,0.0
Category,0.333333333333,0.0,0.333333333333,0.333333333333
Executive processes,0.0,0.666666666667,0.333333333333,0.0
Prenatal drug exposure,0.0,0.333333333333,0.666666666667,0.0
Bupropion,0.0,1.0,0.0,0.0
Toluene,0.0,0.0,0.666666666667,0.333333333333
Voluntary movement,0.333333333333,0.0,0.666666666667,0.0
Familial,0.0,0.333333333333,0.666666666667,0.0
Wavelet,0.0,0.666666666667,0.333333333333,0.0
Amyotrophic lateral sclerosis,0.0,0.666666666667,0.333333333333,0.0
Vision loss,0.333333333333,0.0,0.666666666667,0.0
Carotid arteries,0.0,0.333333333333,0.666666666667,0.0
Intrusion,0.333333333333,0.333333333333,0.0,0.333333333333
binding,0.0,0.333333333333,0.333333333333,0.333333333333
Dexterity,0.666666666667,0.333333333333,0.0,0.0
driving safety,0.333333333333,0.333333333333,0.0,0.333333333333
Temporal perception,0.0,0.333333333333,0.333333333333,0.333333333333
Free choice,0.333333333333,0.666666666667,0.0,0.0
Cardiorespiratory fitness,0.0,0.666666666667,0.333333333333,0.0
OTS,0.666666666667,0.333333333333,0.0,0.0
Enriched environment,0.333333333333,0.333333333333,0.333333333333,0.0
Visceral pain,0.333333333333,0.333333333333,0.333333333333,0.0
Omega-3 fatty acids,0.0,0.333333333333,0.666666666667,0.0
Neural activation,0.333333333333,0.333333333333,0.333333333333,0.0
psychophysiology,0.0,0.333333333333,0.666666666667,0.0
Real-time fMRI,0.333333333333,0.333333333333,0.333333333333,0.0
Temporal lobectomy,0.0,0.666666666667,0.333333333333,0.0
Coherence of potentials,0.0,0.666666666667,0.333333333333,0.0
Response latency,0.0,0.0,1.0,0.0
In-vehicle information systems,0.0,0.333333333333,0.666666666667,0.0
Correlations,0.333333333333,0.0,0.333333333333,0.333333333333
Nursing home,0.333333333333,0.0,0.333333333333,0.333333333333
follow-up,0.333333333333,0.0,0.333333333333,0.333333333333
Electroretinogram,0.666666666667,0.0,0.333333333333,0.0
Electrical stimulation,0.0,0.0,1.0,0.0
Inferior temporal cortex,0.0,0.666666666667,0.333333333333,0.0
Five-choice serial reaction time task,0.0,0.666666666667,0.333333333333,0.0
Hippocampal atrophy,0.333333333333,0.333333333333,0.333333333333,0.0
Hemispheric differences,0.666666666667,0.0,0.333333333333,0.0
Event-related brain potential (ERP),0.0,0.333333333333,0.666666666667,0.0
Random number generation,0.333333333333,0.0,0.666666666667,0.0
Nutritional status,0.333333333333,0.333333333333,0.333333333333,0.0
Varenicline,0.0,0.333333333333,0.666666666667,0.0
Panic disorder,0.333333333333,0.333333333333,0.333333333333,0.0
Stereotype,0.666666666667,0.333333333333,0.0,0.0
Cocoa,0.333333333333,0.333333333333,0.333333333333,0.0
synaptic plasticity,0.0,0.333333333333,0.666666666667,0.0
Pattern classification,0.333333333333,0.333333333333,0.333333333333,0.0
Haptic feedback,0.0,0.666666666667,0.333333333333,0.0
Steroid hormones,0.0,1.0,0.0,0.0
Deferred imitation,0.333333333333,0.666666666667,0.0,0.0
automobile driving,0.333333333333,0.0,0.0,0.666666666667
Multivitamin,0.333333333333,0.0,0.666666666667,0.0
Resources,0.0,0.0,1.0,0.0
Dorsal premotor cortex,0.333333333333,0.333333333333,0.333333333333,0.0
Vigabatrin,0.666666666667,0.333333333333,0.0,0.0
Scanpath,1.0,0.0,0.0,0.0
User experience,0.666666666667,0.333333333333,0.0,0.0
Word retrieval,0.333333333333,0.0,0.666666666667,0.0
Body perception,0.333333333333,0.333333333333,0.333333333333,0.0
memory disorders,0.0,0.0,0.666666666667,0.333333333333
Problem-solving,0.666666666667,0.333333333333,0.0,0.0
Nonverbal,0.666666666667,0.0,0.333333333333,0.0
Word identification,0.666666666667,0.0,0.0,0.333333333333
Dorsal stream vulnerability,0.0,0.666666666667,0.333333333333,0.0
Visual preference,0.333333333333,0.333333333333,0.333333333333,0.0
Perceptual modality,0.0,0.0,0.5,0.5
Sexual abuse,0.0,0.5,0.5,0.0
Topography,0.0,0.0,1.0,0.0
preterm birth,0.0,0.5,0.5,0.0
Bilateral,0.0,0.0,1.0,0.0
Multimodal communication,0.0,0.5,0.5,0.0
Citalopram,0.0,0.0,1.0,0.0
P3 latency,0.0,0.0,1.0,0.0
Visual object recognition,0.0,0.5,0.5,0.0
Balint's syndrome,0.0,0.5,0.5,0.0
Resource,0.0,1.0,0.0,0.0
Cognitively high performing,0.0,0.0,0.5,0.5
Rhinal cortex,0.5,0.0,0.5,0.0
Design stance,0.0,0.0,0.5,0.5
Sympathetic nervous system,0.5,0.0,0.0,0.5
Craft,0.5,0.0,0.5,0.0
Social judgement,0.5,0.5,0.0,0.0
Veteran,0.0,0.5,0.5,0.0
Human infants,0.0,0.5,0.5,0.0
Syncope,0.0,0.0,0.5,0.5
Enhanced perceptual functioning model,0.0,1.0,0.0,0.0
Descending influences,0.0,0.0,1.0,0.0
Older,0.0,0.5,0.5,0.0
Ebbinghaus illusion,0.5,0.5,0.0,0.0
Toddler,0.5,0.5,0.0,0.0
HIV/AIDS,0.5,0.0,0.0,0.5
Task,0.5,0.0,0.5,0.0
mentalizing,0.0,0.5,0.5,0.0
Temporal resolution,0.5,0.0,0.5,0.0
crawling,0.5,0.5,0.0,0.0
Hydrogen sulfide,0.5,0.5,0.0,0.0
Angular gyrus,0.0,1.0,0.0,0.0
tau,0.5,0.5,0.0,0.0
Speed of information processing,0.0,0.0,0.5,0.5
networks,0.5,0.5,0.0,0.0
CNS Vital Signs,0.0,0.5,0.5,0.0
Borderline Personality Disorder,0.0,0.5,0.5,0.0
Auditory oddball,0.0,0.5,0.5,0.0
Endoscopic third ventriculostomy,0.0,0.0,0.5,0.5
Gist,0.0,0.0,0.0,1.0
EEG rhythms,0.5,0.0,0.5,0.0
affective intensity,0.0,1.0,0.0,0.0
Alzheimer dementia,0.0,1.0,0.0,0.0
Gestural communication,0.5,0.5,0.0,0.0
Emotional expressions,0.5,0.0,0.5,0.0
Mexican Americans,0.5,0.0,0.5,0.0
Daytime sleepiness,0.0,0.5,0.5,0.0
Maternal care,0.5,0.0,0.5,0.0
ERD/ERS,0.0,0.5,0.5,0.0
Elderly people,0.5,0.0,0.5,0.0
Pituitary adenoma,0.0,0.5,0.5,0.0
Free energy,0.0,1.0,0.0,0.0
Motion-onset VEPs,0.0,0.5,0.5,0.0
Self-other distinction,0.0,0.5,0.5,0.0
FMRI BOLD,0.5,0.0,0.5,0.0
letter position coding,0.0,1.0,0.0,0.0
Older population,0.5,0.5,0.0,0.0
Error-related negativity (ERN),0.5,0.0,0.5,0.0
orbitofrontal cortex,0.0,1.0,0.0,0.0
threat,0.5,0.5,0.0,0.0
Medication management,0.0,1.0,0.0,0.0
Complex,0.0,0.5,0.5,0.0
Duchenne Muscular Dystrophy,0.0,0.5,0.5,0.0
metabolic syndrome,0.0,1.0,0.0,0.0
Nicotine dependence,0.0,0.5,0.5,0.0
Neurobehavior,0.0,0.5,0.5,0.0
gamma oscillations,0.0,0.5,0.0,0.5
Audio-visual perception,0.0,0.5,0.5,0.0
Motion lines,0.0,0.0,1.0,0.0
Motion-in-depth,0.0,1.0,0.0,0.0
Internal models,0.0,1.0,0.0,0.0
Preclinical dementia,0.0,1.0,0.0,0.0
Multisensory processes,0.0,0.5,0.5,0.0
Darifenacin,0.0,0.5,0.5,0.0
Somatotopy,0.5,0.0,0.5,0.0
Neurodevelopmental outcome,1.0,0.0,0.0,0.0
Spectroscopy,0.0,0.5,0.5,0.0
Learning processes,0.5,0.0,0.5,0.0
Dexamethasone,0.0,0.0,0.5,0.5
Visual systems,0.5,0.5,0.0,0.0
Frontal Lobe,0.0,0.0,0.5,0.5
Religiosity,0.0,0.5,0.5,0.0
Genetic algorithms,0.5,0.5,0.0,0.0
Novel object recognition,0.0,0.0,0.5,0.5
social development,0.0,0.0,0.5,0.5
Neuropsychological performances,0.0,0.0,0.5,0.5
Psychiatry,0.0,0.0,1.0,0.0
Eyewitness identification,0.0,0.0,1.0,0.0
action simulation,0.0,0.5,0.5,0.0
Offside,0.0,1.0,0.0,0.0
PDD,0.0,0.5,0.5,0.0
3?-diol,0.0,0.0,1.0,0.0
DSM-IV-TR,0.0,0.5,0.0,0.5
Neurocognitive performance,0.0,0.0,1.0,0.0
Prospection,0.0,0.5,0.5,0.0
Intermediate phenotype,0.0,0.0,1.0,0.0
WIAT-II,0.0,0.5,0.0,0.5
Fear of negative evaluation,1.0,0.0,0.0,0.0
Type 1 diabetes mellitus,0.5,0.0,0.5,0.0
Somatosensory amplification,0.5,0.5,0.0,0.0
health education,0.5,0.0,0.5,0.0
Attention networks,0.0,0.5,0.0,0.5
FXTAS,0.0,0.0,1.0,0.0
Neural adaptation,0.0,0.5,0.0,0.5
Kindergarten children,0.5,0.0,0.0,0.5
Spatial stroop,0.5,0.5,0.0,0.0
Brain asymmetry,0.5,0.0,0.5,0.0
Hypotension,0.0,0.0,0.5,0.5
Individuation,0.0,0.0,0.5,0.5
Petrol,1.0,0.0,0.0,0.0
Birds,0.0,0.0,0.5,0.5
Robotics,0.5,0.0,0.5,0.0
Metrics,0.0,1.0,0.0,0.0
Selection-for-action,0.0,0.5,0.5,0.0
Reward processing,0.5,0.5,0.0,0.0
Cardiovascular diseases,0.0,0.5,0.5,0.0
Gender identity disorder,0.0,0.5,0.5,0.0
Cortical atrophy,0.0,0.5,0.5,0.0
comprehension,1.0,0.0,0.0,0.0
Event-related design,0.0,0.0,1.0,0.0
BA10,0.0,0.5,0.0,0.5
Japanese macaques,0.0,0.5,0.5,0.0
Volitional control,0.0,1.0,0.0,0.0
Text comprehension,0.0,0.0,0.5,0.5
Visual ability,0.0,1.0,0.0,0.0
Presentation modality,0.5,0.5,0.0,0.0
Prototypes,0.5,0.0,0.0,0.5
relapse,0.0,0.0,1.0,0.0
Operant learning,0.0,1.0,0.0,0.0
Numerical value,0.0,0.0,0.5,0.5
Clinical research,1.0,0.0,0.0,0.0
Equine,0.5,0.5,0.0,0.0
Traumatic Brain Injury,0.0,0.5,0.5,0.0
SAM,0.0,0.0,0.5,0.5
Ambiguous figure,0.0,0.5,0.5,0.0
Temporomandibular disorders,0.0,0.0,1.0,0.0
Winner-take-all,0.0,1.0,0.0,0.0
Young children,0.0,0.5,0.5,0.0
Regression,0.5,0.5,0.0,0.0
correlation,0.0,0.5,0.5,0.0
Spinal cord,0.5,0.5,0.0,0.0
Reversibility,0.0,0.0,0.5,0.5
Egocentric space,0.0,0.5,0.0,0.5
Altitude,0.0,0.5,0.5,0.0
Childhood adversity,0.0,0.0,1.0,0.0
Visual assessment,0.5,0.0,0.5,0.0
Independence,0.0,0.0,1.0,0.0
Mirror-neuron system,0.5,0.5,0.0,0.0
Pediatric bipolar disorder,0.0,0.0,1.0,0.0
Retraining,0.0,0.5,0.5,0.0
Susac's syndrome,1.0,0.0,0.0,0.0
Portion size,0.5,0.5,0.0,0.0
Tactile sensation,0.0,0.0,1.0,0.0
Vividness,1.0,0.0,0.0,0.0
Wheel running,0.0,0.0,1.0,0.0
Gravity perception,0.0,0.5,0.5,0.0
Quantitative discrimination,0.0,0.5,0.5,0.0
Asthenopia,0.5,0.5,0.0,0.0
Coffee,0.5,0.0,0.0,0.5
Phencyclidine,0.0,0.5,0.5,0.0
Anterior cingulate cortex (ACC),0.5,0.0,0.5,0.0
Psychometric evaluation,0.5,0.0,0.5,0.0
Neural correlates of consciousness,0.0,0.0,0.5,0.5
Image analysis,0.5,0.5,0.0,0.0
Memory task,0.0,1.0,0.0,0.0
Mechanism,0.0,0.5,0.5,0.0
Long-chain polyunsaturated fatty acids,0.0,0.0,0.5,0.5
Non-verbal communication,0.0,0.0,1.0,0.0
Heading,0.0,0.0,0.5,0.5
visual cortex,0.0,0.5,0.0,0.5
Cognition (general),0.5,0.5,0.0,0.0
Rapid visual information processing,0.0,0.5,0.0,0.5
computational modeling,0.0,0.5,0.5,0.0
peptide,0.0,0.0,0.5,0.5
Social anxiety disorder,0.5,0.0,0.5,0.0
Sleep disruption,0.5,0.5,0.0,0.0
social anxiety,0.5,0.0,0.5,0.0
Schizophreniform disorder,0.5,0.0,0.5,0.0
References,1.0,0.0,0.0,0.0
Enfacement illusion,0.0,1.0,0.0,0.0
CSF,0.0,0.0,0.5,0.5
Multimedia cartography,0.5,0.0,0.5,0.0
Retrosplenial cortex,0.5,0.0,0.0,0.5
Pergolide,1.0,0.0,0.0,0.0
Complications,0.0,1.0,0.0,0.0
Film comprehension,0.0,0.0,1.0,0.0
Visual display,0.5,0.5,0.0,0.0
Visual cognition behavior,0.0,0.5,0.0,0.5
Repeatable Battery for the Assessment of Neuropsychological Status,0.0,0.5,0.5,0.0
Gamma band activity,0.0,0.5,0.0,0.5
VLPFC,0.0,1.0,0.0,0.0
Symptomatology,0.0,0.5,0.5,0.0
body,0.0,0.0,1.0,0.0
Crossmodal interaction,0.0,0.0,1.0,0.0
Cognitive motivation,0.5,0.5,0.0,0.0
Tramadol,0.0,0.5,0.5,0.0
Interferon-?,0.0,0.5,0.5,0.0
subliminal perception,0.0,0.5,0.5,0.0
DRdengineering gene,1.0,0.0,0.0,0.0
Memory capacity,0.0,0.5,0.5,0.0
Barrier,0.5,0.0,0.5,0.0
Long-term outcome,0.5,0.0,0.5,0.0
Executive cognitive function,0.0,0.0,1.0,0.0
Response Inhibition,0.5,0.0,0.5,0.0
?-band activity,0.0,0.0,1.0,0.0
Cognitive coordination,0.0,0.5,0.0,0.5
Magnocellular visual pathway,0.5,0.5,0.0,0.0
Blinking,0.0,1.0,0.0,0.0
Brain evolution,0.5,0.0,0.5,0.0
Ecological psychology,0.0,0.5,0.5,0.0
Savings,0.5,0.5,0.0,0.0
youth,0.5,0.0,0.5,0.0
Go/NoGo task,1.0,0.0,0.0,0.0
Object choice task,0.5,0.0,0.0,0.5
Cultural difference,0.5,0.5,0.0,0.0
Stroop interference,0.0,0.5,0.5,0.0
Functions,0.0,0.0,0.5,0.5
Anticonvulsants,0.5,0.0,0.5,0.0
Retinal degeneration,0.0,0.0,1.0,0.0
Test bias,1.0,0.0,0.0,0.0
Emotional modulation,0.0,0.0,1.0,0.0
retrieval,0.0,0.5,0.5,0.0
Multi-sensory,0.5,0.0,0.0,0.5
Presenilin 1,0.0,0.5,0.5,0.0
Direction judgment,0.0,0.0,0.0,1.0
Kindergarten,0.0,0.5,0.5,0.0
LTD,0.5,0.0,0.5,0.0
chimpanzee,0.5,0.0,0.0,0.5
Mind reading,0.5,0.0,0.5,0.0
Fasting,0.0,0.0,0.5,0.5
Constructional abilities,1.0,0.0,0.0,0.0
Dextroamphetamine,0.0,0.5,0.5,0.0
Trajectory,0.0,0.5,0.5,0.0
erythropoietin,0.0,0.0,1.0,0.0
object grasping,0.0,0.5,0.0,0.5
Satisfaction,0.0,0.5,0.5,0.0
Facial affect processing,0.0,0.5,0.0,0.5
Social causality,0.0,0.5,0.5,0.0
Emergent literacy,0.5,0.5,0.0,0.0
Recurrence,0.0,0.5,0.5,0.0
Prodromal AD,0.0,1.0,0.0,0.0
Functional network connectivity,0.5,0.5,0.0,0.0
Gestalt perception,0.0,0.0,1.0,0.0
Interhemispheric transfer time,0.0,0.0,0.5,0.5
Mind-reading,0.0,1.0,0.0,0.0
Bistable perception,0.5,0.5,0.0,0.0
Numerical Stroop task,0.0,0.0,1.0,0.0
APOE e{open}4,0.0,0.0,0.5,0.5
Logistic regression,0.0,0.5,0.0,0.5
Electric stimulation,0.5,0.0,0.5,0.0
Regulation,0.0,0.0,1.0,0.0
Noninvasive brain stimulation,0.0,0.5,0.5,0.0
Orexin 1 receptor,0.5,0.5,0.0,0.0
Early detection,0.0,0.5,0.5,0.0
Visual enumeration,0.0,0.5,0.5,0.0
Healthy controls,0.0,0.5,0.0,0.5
Infantile spasms,1.0,0.0,0.0,0.0
Gaze direction perception,0.0,0.0,1.0,0.0
Self-reference effect,0.0,0.5,0.5,0.0
NIRS,0.5,0.5,0.0,0.0
DYNOPTA,0.5,0.0,0.5,0.0
Psychiatric,0.0,0.5,0.5,0.0
Voluntary,0.0,0.5,0.5,0.0
Expert performance,0.0,0.5,0.5,0.0
Overshoot,0.0,0.0,0.5,0.5
Alpha reactivity,0.0,1.0,0.0,0.0
Pareidolia,0.0,0.0,1.0,0.0
acetylcholine,0.5,0.5,0.0,0.0
Extreme male brain,1.0,0.0,0.0,0.0
Protocol,0.0,1.0,0.0,0.0
Useful Field of View,0.0,0.0,0.0,1.0
Randomized controlled trials,0.0,0.0,1.0,0.0
Offline,0.0,1.0,0.0,0.0
Ramadan fasting,0.0,0.0,1.0,0.0
rhesus monkeys,0.0,0.5,0.5,0.0
pain assessment,0.5,0.0,0.0,0.5
screening test,0.0,0.0,1.0,0.0
Abstract,0.0,0.0,0.5,0.5
VCFS,0.5,0.5,0.0,0.0
Split brain,0.0,0.0,1.0,0.0
Physical health,0.5,0.0,0.5,0.0
Health,0.0,0.5,0.5,0.0
Acute stroke,0.5,0.5,0.0,0.0
Pharmacogenetics,0.0,0.5,0.5,0.0
Cortical dynamics,1.0,0.0,0.0,0.0
Striatal,0.0,0.0,1.0,0.0
Colour vision,0.0,0.5,0.5,0.0
computer graphics,0.0,0.5,0.5,0.0
Same-different,0.0,0.5,0.0,0.5
Acute exercise,0.0,0.0,0.5,0.5
Motor programming,0.0,1.0,0.0,0.0
Presentation time,0.0,0.5,0.5,0.0
Stuttering,0.5,0.0,0.5,0.0
Neuropsychological test battery,0.5,0.0,0.5,0.0
Excitotoxicity,0.0,0.0,0.5,0.5
Modality-specific,0.0,0.5,0.5,0.0
eating disorder,0.0,0.0,0.5,0.5
graph theory,0.0,1.0,0.0,0.0
Incongruence,0.5,0.0,0.5,0.0
Memory confidence,0.0,0.0,0.5,0.5
Picture recognition,0.0,0.5,0.5,0.0
First episode schizophrenia,0.0,0.5,0.5,0.0
Computation,0.0,0.5,0.5,0.0
Cognitive state,0.0,1.0,0.0,0.0
Object and pattern recognition,0.0,0.5,0.5,0.0
MR imaging,0.0,0.0,0.5,0.0
Mathematical problem solving,0.0,0.0,0.5,0.5
Main sequence,0.0,0.5,0.5,0.0
Carbamazepine,0.5,0.5,0.0,0.0
Zebra finch,1.0,0.0,0.0,0.0
Assimilative illusions,0.0,1.0,0.0,0.0
Continuous quantity,0.0,1.0,0.0,0.0
Cerebellar type,0.0,0.5,0.5,0.0
Patients,0.5,0.5,0.0,0.0
Walking speed,0.5,0.0,0.5,0.0
Hydrostatic pressure,0.0,0.5,0.5,0.0
Carbon monoxide poisoning,0.5,0.0,0.0,0.5
Visual short-term memory (VSTM),0.0,1.0,0.0,0.0
Baroreflex,0.0,1.0,0.0,0.0
Bottleneck,0.5,0.0,0.5,0.0
Bilateral eye movements,0.5,0.0,0.5,0.0
Femininity,0.0,0.0,1.0,0.0
utility,0.5,0.0,0.5,0.0
Memory load,0.0,1.0,0.0,0.0
Numerical architecture,0.5,0.0,0.0,0.5
Prostate,0.0,0.5,0.5,0.0
Health effects,0.0,0.0,1.0,0.0
Visuospatial dysfunction,0.5,0.0,0.0,0.5
Non-action video games,0.0,1.0,0.0,0.0
sustained attention,1.0,0.0,0.0,0.0
Motor consolidation,0.0,1.0,0.0,0.0
Visual-spatial abilities,0.0,0.5,0.5,0.0
Emotional sensitization,0.0,0.0,1.0,0.0
Down Syndrome,0.0,0.0,1.0,0.0
Visual pathways,0.0,0.0,1.0,0.0
Cross-modal correspondences,0.5,0.0,0.5,0.0
Apoptosis,0.0,0.5,0.5,0.0
Myopathy,0.0,0.5,0.5,0.0
Graphics,0.0,0.0,0.5,0.5
Microgravity,0.5,0.0,0.5,0.0
Span,0.0,0.0,1.0,0.0
REM sleep,0.5,0.5,0.0,0.0
prospective,0.0,0.0,1.0,0.0
Vasopressin,0.0,0.5,0.5,0.0
Diabetic ketoacidosis,0.0,0.0,1.0,0.0
Akatinol memantine,0.0,0.0,1.0,0.0
Continuous performance test (CPT),0.5,0.0,0.0,0.5
neuropathic pain,0.0,0.5,0.5,0.0
Subliminal perception,0.0,0.0,1.0,0.0
Unsupervised learning,0.0,0.0,1.0,0.0
Stereotactic surgery,0.0,0.5,0.5,0.0
Wisconsin card sorting test,1.0,0.0,0.0,0.0
Spatial orienting,0.5,0.5,0.0,0.0
Attentional processes,0.5,0.5,0.0,0.0
Boston naming test,0.5,0.0,0.5,0.0
control,0.0,0.0,0.5,0.5
Language skills,0.0,0.5,0.0,0.5
brain stimulation,0.0,0.5,0.5,0.0
Strategy use,0.0,0.5,0.5,0.0
metaphor,0.0,0.5,0.0,0.5
Straight and inverse priming,0.5,0.0,0.5,0.0
Attentional biases,0.0,0.0,0.5,0.5
Information processing bias,0.5,0.0,0.0,0.5
Typeface,0.0,0.0,0.5,0.5
Cognitive ageing,0.0,0.5,0.5,0.0
Means-end,0.5,0.0,0.5,0.0
Metabolic disease,0.0,0.5,0.5,0.0
NCTB,0.5,0.5,0.0,0.0
Featural information,0.5,0.0,0.0,0.5
visual-spatial cognition,0.0,1.0,0.0,0.0
Experiential learning,0.0,0.0,1.0,0.0
Numerical development,0.0,0.5,0.5,0.0
Sexual selection,0.0,0.0,1.0,0.0
Mental transformation,0.0,0.5,0.5,0.0
Embedded figures task,0.5,0.0,0.0,0.5
Signal-to-noise ratio,0.5,0.0,0.5,0.0
RCT,0.5,0.0,0.5,0.0
type 1 diabetes,0.5,0.5,0.0,0.0
Dissociations,0.0,1.0,0.0,0.0
Ecological rationality,0.0,0.0,1.0,0.0
Neuroprotective agents,0.0,0.5,0.5,0.0
Attention control,0.5,0.0,0.0,0.5
Functional cerebral asymmetries,0.5,0.5,0.0,0.0
Holograms,0.5,0.5,0.0,0.0
sensory impairment,1.0,0.0,0.0,0.0
computerized cognitive testing,0.5,0.5,0.0,0.0
Contamination,0.0,0.0,0.5,0.5
ovariectomy,0.5,0.0,0.5,0.0
Serial-order,0.0,0.5,0.5,0.0
Comprehensive geriatric assessment,0.0,0.5,0.5,0.0
Information design,0.0,0.0,1.0,0.0
Length effect,0.5,0.0,0.0,0.5
cardiovascular,0.5,0.5,0.0,0.0
Speech-associated gestures,0.0,0.0,0.5,0.5
"Depression,0.0,0.0,0.0,0.0
Pan paniscus,0.5,0.0,0.5,0.0
Splenium,0.0,0.0,1.0,0.0
Manipulable objects,0.0,0.5,0.5,0.0
Fetal alcohol spectrum disorder (FASD),0.0,1.0,0.0,0.0
E-learning,0.5,0.5,0.0,0.0
Learning/memory,1.0,0.0,0.0,0.0
Sensorineural hearing loss,0.0,1.0,0.0,0.0
Forward model,0.0,1.0,0.0,0.0
Baboon,0.5,0.0,0.5,0.0
Social judgment,0.5,0.5,0.0,0.0
Intentional binding,0.5,0.5,0.0,0.0
Low birth weight,0.0,0.5,0.5,0.0
spatial abilities,0.0,0.0,0.0,1.0
Learning-set,0.0,1.0,0.0,0.0
Automatic modeling,0.0,0.5,0.0,0.5
Charles Bonnet Syndrome,0.0,0.0,0.5,0.5
Elasmobranch,0.0,0.5,0.0,0.5
Guidance of attention,0.0,0.5,0.0,0.5
Dopamine agonists,0.0,0.5,0.5,0.0
optic flow,0.0,0.0,1.0,0.0
Subliminal stimuli,0.0,0.0,0.5,0.5
visuospatial cognition,0.5,0.5,0.0,0.0
Sensory-perceptual-motor,0.0,0.5,0.5,0.0
Self-construal,0.5,0.5,0.0,0.0
ILF,0.0,0.5,0.5,0.0
Body Dysmorphic Disorder,0.5,0.5,0.0,0.0
Cinema,0.0,0.5,0.0,0.5
LDL,0.0,0.0,1.0,0.0
Computer games,0.0,0.0,1.0,0.0
cognitive abilities,0.0,0.5,0.0,0.5
Ultrabrief pulsewidth,0.0,0.0,1.0,0.0
Verbal learning,0.0,0.5,0.5,0.0
Sensory suppression,0.0,1.0,0.0,0.0
Factor structure,0.5,0.0,0.5,0.0
Quantifier,1.0,0.0,0.0,0.0
Cognitive mapping,0.5,0.5,0.0,0.0
Mirtazapine,0.0,0.0,1.0,0.0
Blink,0.0,0.5,0.5,0.0
Videos,0.5,0.5,0.0,0.0
Acculturation,0.0,0.0,1.0,0.0
Parent-child interaction,0.0,0.0,0.5,0.5
Sensory manipulation,0.0,0.0,1.0,0.0
Neurosteroids,0.0,0.0,1.0,0.0
Night shift,0.0,0.5,0.5,0.0
Adjuvant therapy,0.5,0.0,0.0,0.5
Traffic safety,0.5,0.5,0.0,0.0
Stimulus duration,0.5,0.0,0.5,0.0
Case reports,0.5,0.0,0.5,0.0
Endotoxin,0.0,0.0,1.0,0.0
emotional,0.0,0.5,0.5,0.0
Chronic cerebral hypoperfusion,0.0,0.5,0.5,0.0
Cognitive estimation,0.5,0.0,0.5,0.0
Numerical ability,0.0,0.0,1.0,0.0
Pharmacological treatment,0.5,0.5,0.0,0.0
Age factors,0.0,0.0,1.0,0.0
Impulse control disorder,0.0,0.0,1.0,0.0
Muscle fatigue,1.0,0.0,0.0,0.0
Fronto-temporal dementia,0.0,0.5,0.0,0.5
Nonmotor symptoms,0.0,1.0,0.0,0.0
Executive function (EF),0.0,0.5,0.0,0.5
methylphenidate,0.0,0.0,0.5,0.5
Perceptual development,1.0,0.0,0.0,0.0
Alzheimer's,0.0,0.5,0.5,0.0
socioemotional selectivity theory,0.0,0.5,0.5,0.0
Multimodal integration,1.0,0.0,0.0,0.0
Continuous performance task (CPT),0.0,0.5,0.5,0.0
Gifted,1.0,0.0,0.0,0.0
Visual word identification,0.0,0.0,1.0,0.0
network,0.0,0.5,0.5,0.0
meso-zeaxanthin,0.0,1.0,0.0,0.0
Posture control,0.0,0.5,0.5,0.0
Hormone replacement,0.5,0.0,0.0,0.5
Psychometric test,0.5,0.5,0.0,0.0
Eye,0.0,0.5,0.5,0.0
brain tumor,0.5,0.5,0.0,0.0
Sway,0.0,0.0,1.0,0.0
Facial emotion perception,0.0,0.0,0.5,0.5
Dynamic systems theory,0.0,0.0,0.5,0.5
Selectivity,0.0,1.0,0.0,0.0
Experimental pain,0.5,0.0,0.5,0.0
detoxification,0.0,0.0,1.0,0.0
Motor affordance,0.0,0.0,1.0,0.0
animal model,0.0,1.0,0.0,0.0
Audiovisual speech,0.0,0.5,0.0,0.5
top-down processing,0.5,0.0,0.5,0.0
Congruency effect,0.5,0.0,0.5,0.0
Conspecifics,0.0,0.5,0.5,0.0
semantic interaction,0.0,0.5,0.5,0.0
Multivoxel pattern analysis (MVPA),0.0,0.0,0.5,0.5
Wellbeing,0.0,0.5,0.5,0.0
Relevance theory,0.5,0.0,0.5,0.0
Cognitive systems,0.0,0.0,0.0,1.0
Eccentricity,0.0,1.0,0.0,0.0
Anterior prefrontal cortex,0.5,0.5,0.0,0.0
visual scale,0.5,0.0,0.5,0.0
Somatization,0.5,0.5,0.0,0.0
Visual selective attention,0.5,0.5,0.0,0.0
Vision screening,0.0,0.5,0.5,0.0
White matter disease,0.0,0.5,0.5,0.0
Anorthoscopic,0.0,1.0,0.0,0.0
Grey matter,0.0,0.0,0.5,0.5
Longitudinal analysis,0.5,0.0,0.5,0.0
SB-334867-A,0.5,0.5,0.0,0.0
Shape encoding,0.5,0.0,0.5,0.0
Ergonomics,0.0,0.5,0.5,0.0
Mushroom bodies,0.5,0.5,0.0,0.0
ITC,0.0,0.0,1.0,0.0
Adenotonsillectomy,0.0,0.5,0.0,0.5
Macaque monkeys,0.5,0.0,0.0,0.5
Instrumentation,0.5,0.0,0.0,0.0
Visual rehabilitation,0.5,0.0,0.0,0.0
behavioral neuropsychology,0.0,0.0,1.0,0.0
Spikes,0.0,0.0,0.5,0.5
fusiform gyrus,0.0,0.5,0.5,0.0
Reptile,0.0,0.0,1.0,0.0
Disease,0.0,0.0,1.0,0.0
Notation,0.0,0.0,1.0,0.0
Top-down influence,0.0,0.5,0.5,0.0
Reaching movements,0.5,0.0,0.0,0.5
Novelty preference,0.5,0.0,0.5,0.0
Nurse,0.0,0.0,1.0,0.0
Polybrominated diphenyl ethers,0.0,1.0,0.0,0.0
Cognitive neuropsychiatry,0.0,1.0,0.0,0.0
Flicker,0.0,0.5,0.0,0.5
Audiovisual interaction,0.5,0.0,0.5,0.0
Computer aided design,0.5,0.0,0.5,0.0
dog,0.0,0.5,0.5,0.0
Cytomegalovirus,0.5,0.0,0.0,0.0
Equus caballus,0.5,0.5,0.0,0.0
Retinoblastoma,0.5,0.5,0.0,0.0
Category-specific,0.5,0.5,0.0,0.0
Conceptual metaphor theory,0.5,0.0,0.0,0.5
Cerebral hemorrhage,1.0,0.0,0.0,0.0
Critical thinking,0.0,1.0,0.0,0.0
Classifiers,0.0,1.0,0.0,0.0
Goal-directed actions,0.0,0.0,1.0,0.0
Visual index,0.0,1.0,0.0,0.0
Memory function,0.0,0.0,1.0,0.0
Starvation,0.5,0.0,0.5,0.0
Visuo-spatial abilities,0.5,0.0,0.5,0.0
Vestibular system,0.5,0.5,0.0,0.0
Visual feature binding,0.0,0.5,0.5,0.0
Neurological diseases,0.0,0.5,0.5,0.0
Vitamin D,0.5,0.5,0.0,0.0
Vitamin A,0.0,1.0,0.0,0.0
Neighbourhood size,0.0,0.0,1.0,0.0
Mangina-Test,0.5,0.0,0.0,0.5
Chronic low back pain,0.5,0.0,0.5,0.0
Calcium imaging,0.0,0.5,0.5,0.0
Visuo-spatial neglect,0.5,0.5,0.0,0.0
Category-specific deficit,0.5,0.5,0.0,0.0
Lorazepam,0.0,0.0,1.0,0.0
Spoken language,0.0,0.5,0.5,0.0
Rationalism,0.0,0.5,0.5,0.0
Movement time,0.5,0.5,0.0,0.0
Intra-cerebral EEG recording in humans,0.0,0.0,1.0,0.0
HDL,0.0,0.0,1.0,0.0
coping,0.0,0.5,0.0,0.5
Labelling,0.0,0.0,1.0,0.0
Equivalence,0.0,0.5,0.5,0.0
Reading ability,0.0,0.5,0.5,0.0
Wayfinding strategies,0.0,0.0,1.0,0.0
Resilience,0.5,0.0,0.5,0.0
Alcohol-dependence,0.0,0.5,0.5,0.0
Auditory attention,0.5,0.0,0.5,0.0
Warmth,0.5,0.0,0.5,0.0
Childhood trauma,0.0,0.0,1.0,0.0
driving assessment,0.5,0.0,0.5,0.0
Blink rate,0.0,1.0,0.0,0.0
Low-contrast vision,0.5,0.0,0.5,0.0
Contextual interference,0.5,0.0,0.5,0.0
Obsessive-Compulsive Disorder,0.5,0.5,0.0,0.0
Neurocognitive development,0.5,0.0,0.5,0.0
Late effects of cancer treatment,0.0,0.0,0.5,0.5
Object categorisation,0.5,0.5,0.0,0.0
psychopharmacology,0.5,0.5,0.0,0.0
obsessive-compulsive disorder,0.5,0.0,0.5,0.0
Leiter-R,0.5,0.0,0.5,0.0
Manganese exposure,0.0,1.0,0.0,0.0
Sleepwalking,0.0,0.0,1.0,0.0
Displacement,0.0,0.5,0.5,0.0
Stable schizophrenia,0.0,0.5,0.5,0.0
Natalizumab,0.0,0.5,0.0,0.5
Deafferentation,0.0,1.0,0.0,0.0
Reflexivity,0.0,1.0,0.0,0.0
Formal thought disorder,0.0,0.5,0.5,0.0
Cognitive interference,0.5,0.0,0.5,0.0
Drinking water,0.0,0.0,1.0,0.0
Symbolic reasoning,0.0,1.0,0.0,0.0
Affective pictures,0.5,0.5,0.0,0.0
Incongruity,0.0,0.5,0.5,0.0
Split attention,0.5,0.0,0.5,0.0
Symbolic distance effect,0.0,0.0,1.0,0.0
Remembering,0.0,0.0,1.0,0.0
Controlled clinical trial,0.0,0.0,0.5,0.5
cognitive reserve,0.0,0.5,0.5,0.0
Crossmodal congruency,0.0,0.0,1.0,0.0
Synaptophysin,0.5,0.0,0.5,0.0
Cross-modal interactions,0.5,0.0,0.5,0.0
Medical neuropsychology,0.5,0.0,0.5,0.0
Occipito-temporal cortex,0.0,1.0,0.0,0.0
Syntactic ambiguity resolution,0.0,0.0,0.5,0.5
Semantic features,0.5,0.5,0.0,0.0
prediction,0.0,0.5,0.5,0.0
Pattern analysis,0.0,1.0,0.0,0.0
consolidation,1.0,0.0,0.0,0.0
Psychomotor function,0.0,0.5,0.5,0.0
Linear discriminant analysis,0.5,0.5,0.0,0.0
Cue use,0.0,0.0,1.0,0.0
Gene mutation,0.5,0.0,0.5,0.0
Human cerebral cortex,0.0,0.0,0.5,0.5
High density EEG,0.5,0.5,0.0,0.0
cardiopulmonary bypass,0.5,0.0,0.5,0.0
Hyponatremia,0.0,1.0,0.0,0.0
conflict monitoring,0.5,0.5,0.0,0.0
Bayes,0.5,0.5,0.0,0.0
Acute lymphoblastic leukemia,0.5,0.5,0.0,0.0
Audio-visual integration,0.0,1.0,0.0,0.0
Attention-deficit/hyperactivity disorder (ADHD),0.5,0.0,0.5,0.0
Novel object discrimination,0.0,0.5,0.5,0.0
Cerebellar cognitive affective syndrome,0.0,1.0,0.0,0.0
Human activities,0.0,0.0,0.5,0.5
Readiness potential,0.5,0.5,0.0,0.0
functional status,0.0,0.0,1.0,0.0
Visual analogue scale,0.0,0.5,0.5,0.0
Visual analysis,0.0,0.5,0.5,0.0
NMDAR,0.0,0.0,0.5,0.5
Processing fluency,0.0,0.5,0.5,0.0
Implicit/explicit cognition,0.5,0.5,0.0,0.0
Ambiguous stimuli,1.0,0.0,0.0,0.0
Heterotopagnosia,0.5,0.5,0.0,0.0
Sibling,0.0,0.0,1.0,0.0
False recognition,0.0,0.5,0.0,0.5
Frontoparietal network,0.0,1.0,0.0,0.0
Loneliness,0.0,0.0,0.5,0.5
cognitive change,1.0,0.0,0.0,0.0
Paranoid,0.5,0.5,0.0,0.0
Expectancy violation,0.5,0.0,0.0,0.5
NMDA receptor antagonists,0.0,0.5,0.0,0.5
Remifentanil,0.5,0.0,0.5,0.0
Food intake,0.5,0.5,0.0,0.0
Self-rating,0.5,0.0,0.5,0.0
Activity level,0.5,0.0,0.5,0.0
Praxis,0.0,0.5,0.5,0.0
Person,0.5,0.5,0.0,0.0
psychological,0.0,0.0,1.0,0.0
Thioperamide,0.5,0.0,0.5,0.0
Object mental representation,0.0,0.5,0.5,0.0
Moyamoya disease,0.0,0.5,0.5,0.0
Interference control,0.0,0.5,0.0,0.5
Early onset,0.0,0.5,0.5,0.0
Neurobehavioral testing,0.5,0.5,0.0,0.0
Supported employment,0.5,0.0,0.5,0.0
Catatonia,0.5,0.0,0.5,0.0
Abstract concept,0.0,1.0,0.0,0.0
testosterone,0.0,0.5,0.5,0.0
Mark test,0.0,0.5,0.5,0.0
Pregabalin,0.0,0.5,0.0,0.5
Bayesian analysis,0.0,0.0,0.5,0.5
Memory and learning,0.5,0.0,0.5,0.0
Finger tapping,0.0,0.0,1.0,0.0
Serial position effects,1.0,0.0,0.0,0.0
Aesthetic experience,0.0,0.5,0.5,0.0
Attentional cuing,0.0,0.5,0.5,0.0
Ischaemic stroke,0.5,0.0,0.5,0.0
Vascular dementia (VaD),0.5,0.5,0.0,0.0
Attention model,0.5,0.5,0.0,0.0
Child abuse,0.5,0.0,0.0,0.5
FDG,0.5,0.0,0.0,0.0
Primary somatosensory cortex,0.0,0.5,0.5,0.0
Echo-volumar imaging,0.0,0.0,1.0,0.0
Same-different task,0.0,0.0,0.5,0.5
Landscape,0.5,0.0,0.5,0.0
Working memory training,0.5,0.0,0.0,0.5
Lokomat,0.0,1.0,0.0,0.0
Human evolution,0.0,0.0,1.0,0.0
Biological markers,1.0,0.0,0.0,0.0
Alpha-synuclein,0.0,0.5,0.5,0.0
Virtual reality environment,0.0,0.0,0.5,0.5
Social brain network,0.5,0.5,0.0,0.0
N-acetylaspartate,0.0,0.0,1.0,0.0
attentional capture,0.0,0.5,0.0,0.5
Muscimol,0.0,0.5,0.5,0.0
McGill Pain Questionnaire,0.5,0.0,0.5,0.0
Cognitive interventions,0.0,0.0,0.0,1.0
Muscle strength,0.5,0.5,0.0,0.0
Utilization behavior,0.0,0.5,0.5,0.0
Common ground,0.0,0.5,0.5,0.0
Panic,0.5,0.5,0.0,0.0
Grief,0.0,0.0,0.5,0.5
Processing style,0.5,0.0,0.5,0.0
Functionalism,0.0,0.5,0.5,0.0
Indiplon,0.0,0.5,0.5,0.0
Event segmentation,0.5,0.5,0.0,0.0
Motor systems,0.0,0.0,0.5,0.5
Abstract painting,0.0,1.0,0.0,0.0
Adult ADHD,0.0,0.5,0.5,0.0
Prodromal,0.5,0.5,0.0,0.0
associations,0.5,0.0,0.0,0.5
Diffusion tensor imaging (DTI),1.0,0.0,0.0,0.0
Cognitive slowing,0.5,0.0,0.5,0.0
Arachnoid cyst,0.0,0.0,1.0,0.0
Low vision rehabilitation,0.0,0.0,1.0,0.0
Flash-lag effect,0.0,0.5,0.5,0.0
Sensitization,0.0,0.0,1.0,0.0
Sensory modulation,0.0,0.0,1.0,0.0
Cerebral,0.0,1.0,0.0,0.0
Speed,0.0,1.0,0.0,0.0
Corticohippocampal and frontothalamic integration systems,0.0,0.5,0.5,0.0
Conceptual processing,0.0,0.0,1.0,0.0
Road,0.0,0.5,0.5,0.0
eating disorders,0.5,0.0,0.5,0.0
Models,0.5,0.0,0.5,0.0
Neuropsychological predictors,0.0,1.0,0.0,0.0
Language understanding,0.0,0.5,0.5,0.0
Visual vertical,0.0,0.5,0.5,0.0
Nicotinic,0.5,0.5,0.0,0.0
Retinopathy,0.0,0.5,0.0,0.5
Structural,0.0,0.0,1.0,0.0
Nonagenarians,0.0,0.5,0.5,0.0
Food competition,1.0,0.0,0.0,0.0
Human-machine interaction,0.0,0.0,0.5,0.5
behaviour,0.0,0.5,0.0,0.5
Stereotypes,0.5,0.0,0.5,0.0
Neuro-oncology,0.0,0.0,1.0,0.0
linear perspective,0.0,1.0,0.0,0.0
Nonverbal learning disability,1.0,0.0,0.0,0.0
Object knowledge,0.0,0.0,1.0,0.0
Rostral prefrontal cortex,1.0,0.0,0.0,0.0
Peripersonal,0.0,0.0,1.0,0.0
Backward mask,0.0,0.0,1.0,0.0
Posterior,0.0,0.0,0.5,0.5
Alcohol intoxication,0.0,0.0,1.0,0.0
Operant behavior,0.0,1.0,0.0,0.0
Search asymmetry,0.0,1.0,0.0,0.0
Self-evaluation,0.0,0.5,0.5,0.0
Estrogen replacement therapy,0.5,0.0,0.0,0.5
Cold pressor test,0.5,0.0,0.5,0.0
neurofeedback,1.0,0.0,0.0,0.0
Traumatic axonal injury,0.5,0.5,0.0,0.0
Dysarthria,0.5,0.0,0.5,0.0
Cognitive failures,0.0,1.0,0.0,0.0
Preattentive,0.0,0.5,0.5,0.0
Physical,0.0,0.5,0.5,0.0
Verb generation,0.5,0.0,0.0,0.5
Cerebellar malformation,0.5,0.5,0.0,0.0
Problem drinking,0.0,1.0,0.0,0.0
Cognitive behaviour,0.0,0.5,0.5,0.0
Digit ratio,0.5,0.5,0.0,0.0
Population survey,0.0,0.0,1.0,0.0
Optic neuritis,1.0,0.0,0.0,0.0
Physostigmine,0.0,0.5,0.0,0.5
FreeSurfer,0.0,0.5,0.5,0.0
Ethnography,0.0,0.5,0.5,0.0
Neurotoxicity syndromes,0.0,0.0,0.5,0.5
cybernetics,0.0,0.0,1.0,0.0
Contingency,0.0,0.5,0.5,0.0
Calcarine,0.0,0.5,0.5,0.0
Attention Network Test,0.0,1.0,0.0,0.0
Feedforward sweep,0.0,0.5,0.5,0.0
Emotional experience,0.0,0.5,0.0,0.5
Chimeric faces,0.5,0.0,0.5,0.0
Center of pressure,0.0,0.0,0.5,0.5
Enaction,0.0,0.5,0.0,0.5
Family,0.5,0.5,0.0,0.0
sports,0.0,0.0,1.0,0.0
Motor behavior,0.0,0.0,0.5,0.5
neuropsychological profiles,0.5,0.5,0.0,0.0
Single-trial,0.0,1.0,0.0,0.0
Kinesiophobia,0.5,0.0,0.0,0.5
White-matter vascular lesion,0.5,0.0,0.5,0.0
Picture processing,0.0,0.0,1.0,0.0
Neuronal plasticity,0.0,0.0,1.0,0.0
Visual mismatch negativity (MMN),0.0,0.5,0.5,0.0
Vigilance decrement,0.0,0.0,0.5,0.5
N-back task,0.0,0.5,0.0,0.5
Gyrification,0.0,1.0,0.0,0.0
Subjective contour,0.0,0.5,0.0,0.5
Older women,0.5,0.0,0.0,0.5
Social anhedonia,0.5,0.5,0.0,0.0
Amplification,0.0,0.0,1.0,0.0
BDNF Val66Met polymorphism,0.0,0.0,0.5,0.5
Regional homogeneity,0.0,1.0,0.0,0.0
Personalized medicine,0.0,1.0,0.0,0.0
Male health,0.0,0.0,1.0,0.0
cross modal,0.5,0.0,0.0,0.5
Panax,0.0,0.0,1.0,0.0
Brain-behavior,0.0,0.5,0.5,0.0
Action syntax,0.0,0.5,0.5,0.0
valence,0.5,0.0,0.0,0.5
Physiological measures,0.5,0.0,0.5,0.0
Negative affect,0.0,0.0,1.0,0.0
Electrodermal,0.0,0.5,0.5,0.0
Orientation map,0.0,0.0,0.5,0.5
neuropsychiatric symptoms,0.0,0.0,0.5,0.5
Duration of untreated psychosis,0.0,0.0,1.0,0.0
Sense-making,0.0,0.5,0.5,0.0
Anxiety sensitivity,0.0,1.0,0.0,0.0
Inherited ataxias,0.0,0.5,0.5,0.0
A Quick Test of Cognitive Speed,0.5,0.5,0.0,0.0
Fringe consciousness,0.0,0.0,0.5,0.5
Natural language processing,0.5,0.0,0.5,0.0
Sensory discordance,0.0,0.0,1.0,0.0
Guide sign,0.5,0.5,0.0,0.0
Overactive bladder,0.0,0.5,0.5,0.0
Alternate forms,0.0,0.0,1.0,0.0
Visual probe,0.5,0.5,0.0,0.0
transcranial magnetic stimulation,0.5,0.0,0.5,0.0
Healthy older adults,0.5,0.0,0.5,0.0
Tryptophan depletion,0.5,0.5,0.0,0.0
Neurorehabilitation,0.0,0.0,1.0,0.0
and allied disciplines",0.0,0.0,0.0,0.0
Sparse coding,0.0,0.0,0.5,0.5
Daily living skills,0.0,1.0,0.0,0.0
Fearful face,0.5,0.0,0.5,0.0
structural MRI,0.0,0.0,1.0,0.0
Dual task paradigm,0.0,0.0,1.0,0.0
social neuroscience,0.5,0.0,0.5,0.0
memory span,0.0,0.0,1.0,0.0
Sequential effect,0.0,0.5,0.5,0.0
Autonomic function,0.0,0.0,0.5,0.5
Antagonistic pleiotropy,0.0,0.5,0.5,0.0
Confrontation naming,0.0,0.0,0.0,1.0
Relational similarity,0.0,0.5,0.5,0.0
late positive potential,0.0,0.0,1.0,0.0
monkeys,0.0,1.0,0.0,0.0
Oxymorphone,0.0,0.5,0.0,0.5
High-frequency oscillations (HFOs),0.5,0.5,0.0,0.0
Deliberation,0.5,0.0,0.0,0.5
Prognoses,0.5,0.5,0.0,0.0
Implied motion,0.0,1.0,0.0,0.0
Clinical dementia rating,0.0,0.5,0.5,0.0
Executive Function,0.0,0.5,0.0,0.5
Movement sequences,0.0,0.5,0.5,0.0
Sensation seeking,0.0,0.5,0.5,0.0
Cerebral infarction,0.5,0.0,0.5,0.0
Alerts,0.5,0.0,0.5,0.0
Carbohydrate,0.0,0.0,1.0,0.0
Perceptual cognition,0.0,1.0,0.0,0.0
vocabulary,0.0,0.5,0.5,0.0
Diagrammatic reasoning,0.0,1.0,0.0,0.0
Context effect,0.0,1.0,0.0,0.0
Cognitive correlates,0.5,0.0,0.5,0.0
Resonance,0.0,0.0,0.5,0.5
Gait training,0.0,0.0,1.0,0.0
Amphetamines,0.5,0.0,0.5,0.0
Quantitative trait loci,0.0,0.0,1.0,0.0
Startle blink,0.5,0.0,0.5,0.0
gaze,0.5,0.0,0.5,0.0
RAN,0.5,0.0,0.5,0.0
Acute care,0.0,0.0,1.0,0.0
Bilingual,0.0,0.5,0.0,0.5
Hypnotics,0.0,0.5,0.5,0.0
Cognitive test,0.0,0.5,0.0,0.0
Diagram,0.0,1.0,0.0,0.0
Rapid imaging,0.5,0.0,0.5,0.0
Genetic polymorphism,0.0,0.0,1.0,0.0
Putamen,0.0,0.5,0.5,0.0
electron microscopy,0.0,1.0,0.0,0.0
Apolipoprotein E4,0.5,0.0,0.5,0.0
cognitive science,0.0,0.0,1.0,0.0
Neuropathy,0.0,0.5,0.0,0.0
motor imagery,0.0,1.0,0.0,0.0
Skin cancer,0.5,0.5,0.0,0.0
Retrograde amnesia,0.0,0.0,1.0,0.0
exercise,0.5,0.0,0.5,0.0
Melancholic depression,0.0,0.0,1.0,0.0
Exercise intervention,0.5,0.0,0.5,0.0
attentional control,0.0,0.0,0.5,0.5
Decisions from experience,0.0,0.0,0.5,0.5
Macaque monkey,0.0,0.5,0.5,0.0
Man,0.0,0.0,0.0,0.0
Achievement,0.5,0.0,0.0,0.5
Masculinity,0.0,0.0,1.0,0.0
Computer graphics,0.5,0.5,0.0,0.0
Neurocognitive assessment,0.5,0.5,0.0,0.0
Allopregnanolone,0.0,0.0,0.5,0.5
Positivity effect,0.0,0.0,1.0,0.0
Aboriginal,0.5,0.0,0.5,0.0
Baseline assessment,0.5,0.5,0.0,0.0
cued recall,1.0,0.0,0.0,0.0
Theory,0.0,0.0,0.5,0.5
Mental chronometry,0.0,0.0,1.0,0.0
prevention,0.0,0.5,0.5,0.0
Unilateral neglect,0.0,0.0,1.0,0.0
Midazolam,0.0,1.0,0.0,0.0
Pain management,0.0,0.5,0.0,0.5
clinical fMRI,0.0,0.0,1.0,0.0
Mixed model,0.0,1.0,0.0,0.0
Intraindividual variability,0.5,0.0,0.5,0.0
Oxcarbazepine,0.5,0.0,0.5,0.0
Visual field asymmetry,0.5,0.0,0.0,0.5
Patterns,0.5,0.5,0.0,0.0
Developmental assessment,0.0,0.5,0.5,0.0
Confusion,0.5,0.0,0.5,0.0
Phenomenal consciousness,1.0,0.0,0.0,0.0
SMARC effect,0.5,0.0,0.0,0.5
PIB-PET,0.0,0.0,1.0,0.0
Mental states,0.0,0.5,0.5,0.0
Demyelinating diseases,0.5,0.0,0.5,0.0
Bulimia,0.5,0.0,0.5,0.0
Visual world paradigm,0.0,0.0,1.0,0.0
Oral contraceptives,0.0,0.0,1.0,0.0
pediatric liver transplantation,0.5,0.5,0.0,0.0
Web 2.0,0.5,0.0,0.5,0.0
Sevoflurane,0.0,0.5,0.5,0.0
Instruction,0.0,0.0,1.0,0.0
"Cognitive decline,0.0,0.0,0.0,0.0
View combination,0.0,0.5,0.5,0.0
Adult development,1.0,0.0,0.0,0.0
Homosexuality,0.0,0.0,1.0,0.0
Satiation,0.0,0.5,0.0,0.5
haloperidol,0.0,0.0,0.5,0.5
Mexican American,0.0,0.5,0.5,0.0
Temporal order judgement,0.0,0.5,0.0,0.5
N450,0.0,0.5,0.5,0.0
hip fracture,1.0,0.0,0.0,0.0
Cannabinoids,0.0,0.5,0.0,0.5
crossmodal,0.0,0.0,1.0,0.0
Endocrine,0.0,0.5,0.5,0.0
Physical function,0.5,0.0,0.0,0.5
Polyphenols,0.0,1.0,0.0,0.0
Bipolar Disorder,0.5,0.5,0.0,0.0
Organic solvents,0.0,0.5,0.0,0.5
Number line task,0.0,0.0,1.0,0.0
default-mode network,0.5,0.0,0.0,0.5
chimpanzees,0.5,0.5,0.0,0.0
Mixture models,0.5,0.5,0.0,0.0
Probe detection,0.0,0.0,1.0,0.0
Motor prediction,0.0,0.5,0.5,0.0
Cache protection,0.0,0.5,0.5,0.0
attentional bias,0.5,0.0,0.5,0.0
Brain structure,0.5,0.5,0.0,0.0
error-related negativity,0.5,0.0,0.5,0.0
Pineal gland,0.0,0.5,0.5,0.0
Selective visual attention,0.0,1.0,0.0,0.0
CANTAB,0.0,0.5,0.0,0.5
Visual interface,0.0,0.5,0.5,0.0
Juvenile myoclonic epilepsy,0.5,0.0,0.5,0.0
Reconfiguration,0.0,0.5,0.5,0.0
Primary motor cortex,0.0,0.0,1.0,0.0
Dementia with lewy bodies,0.0,0.5,0.0,0.5
map,0.0,0.0,0.5,0.5
Multichannel linear descriptors,0.0,0.5,0.5,0.0
Multisensory attention,0.0,1.0,0.0,0.0
Supplementary motor area,0.5,0.0,0.5,0.0
Technology,0.0,0.5,0.5,0.0
Very low birth weight infants,0.0,0.0,1.0,0.0
M1 mAChR,0.0,0.0,1.0,0.0
Word reading,1.0,0.0,0.0,0.0
Psychological function,0.5,0.0,0.0,0.5
CVLT,0.0,0.0,1.0,0.0
Monitor position,0.0,0.0,1.0,0.0
Cognitive plasticity,0.5,0.0,0.5,0.0
SYSBIO,0.0,0.5,0.5,0.0
Neural mechanisms,0.5,0.5,0.0,0.0
Reference standards,0.5,0.0,0.5,0.0
Parkinsons disease,0.0,0.0,0.5,0.5
Cannabinoid system,0.0,0.0,1.0,0.0
task switching,0.0,0.5,0.5,0.0
practice effects,0.5,0.0,0.5,0.0
illiteracy,0.0,0.0,0.0,1.0
Explicit cognition,0.0,0.5,0.5,0.0
Object correspondence,0.0,0.0,1.0,0.0
Elderly patients,0.0,0.0,1.0,0.0
N.Y. : 1991)",0.0,0.0,0.0,0.0
Alpha-band,0.5,0.5,0.0,0.0
Affective symptoms,0.5,0.0,0.5,0.0
Improvisation,1.0,0.0,0.0,0.0
Hominids,0.5,0.0,0.5,0.0
hallucination,0.0,0.0,0.0,1.0
Oculometrics,0.0,0.0,0.5,0.5
DLB,0.5,0.0,0.0,0.5
Basal-ganglia,0.0,0.5,0.5,0.0
Body fat,0.5,0.0,0.0,0.5
Social discrimination,0.0,0.0,0.5,0.5
testing effect,0.5,0.5,0.0,0.0
dynBSR,0.0,0.5,0.5,0.0
Artifact removal,0.0,0.0,0.0,1.0
Grammatical construction,0.0,0.0,1.0,0.0
Visual consciousness,0.0,0.0,1.0,0.0
Serial,0.0,0.0,0.0,1.0
Cognitive difficulties,0.0,0.5,0.5,0.0
Ventral visual stream,0.5,0.0,0.0,0.5
Strategic control,0.0,0.5,0.0,0.5
Aromatase inhibitors,0.0,0.5,0.5,0.0
Symptom severity,0.0,0.5,0.5,0.0
MST,0.0,0.5,0.0,0.5
acute tryptophan depletion,1.0,0.0,0.0,0.0
Rivalry,1.0,0.0,0.0,0.0
Second language,0.5,0.0,0.5,0.0
visual illusions,0.0,0.5,0.5,0.0
Belief reasoning,1.0,0.0,0.0,0.0
2D:4D,1.0,0.0,0.0,0.0
Skill,0.0,0.5,0.0,0.5
Transsexualism,0.0,0.0,1.0,0.0
unique entities,0.0,0.0,1.0,0.0
Event processing,0.0,0.5,0.5,0.0
Ventromedial,0.0,1.0,0.0,0.0
Event-related synchronization,0.0,0.0,1.0,0.0
Person identification,0.5,0.0,0.5,0.0
Face identification,0.5,0.5,0.0,0.0
Congenital prosopagnosia,0.0,0.0,1.0,0.0
Spatial frames of reference,0.0,0.5,0.5,0.0
Subthreshold response,0.0,0.0,0.5,0.5
Speechreading,0.0,0.0,0.5,0.5
Alzheimer's dementia,0.0,0.0,1.0,0.0
Enjoyment,0.5,0.0,0.5,0.0
Whorf,0.0,0.0,1.0,0.0
Trauma film paradigm,0.0,0.5,0.5,0.0
conceptual knowledge,0.0,0.0,0.5,0.5
Driving behavior,0.5,0.0,0.5,0.0
Brain infarction,0.5,0.0,0.0,0.5
Chronic pancreatitis,0.0,0.5,0.5,0.0
Model selection,0.0,1.0,0.0,0.0
smoking cessation,0.0,0.5,0.5,0.0
Augmentative and alternative communication,0.0,1.0,0.0,0.0
Hippocampal formation,0.0,0.5,0.0,0.5
Tumour,0.0,0.0,0.5,0.5
Visual noise,0.5,0.0,0.5,0.0
estradiol,0.0,0.5,0.5,0.0
Reorganization,0.0,0.5,0.0,0.5
Sequelae,0.0,1.0,0.0,0.0
Encoding strategy,0.5,0.0,0.0,0.5
Dynamic logic,0.0,1.0,0.0,0.0
Developmental delay,0.0,0.0,0.0,1.0
Lateralized readiness potential,0.0,0.0,1.0,0.0
Oblique effect,0.5,0.0,0.5,0.0
executive processes,0.5,0.0,0.5,0.0
Whiplash associated disorders,0.0,0.0,1.0,0.0
functional outcomes,0.5,0.0,0.5,0.0
Online,0.0,0.5,0.0,0.5
Productivity,0.0,1.0,0.0,0.0
Dehydration,0.5,0.0,0.5,0.0
Knowledge management,0.0,0.5,0.5,0.0
Lewy body,0.5,0.5,0.0,0.0
withdrawal,0.0,1.0,0.0,0.0
paranoia,0.0,0.5,0.0,0.5
Attribution of intentions,0.0,0.0,1.0,0.0
Visuomotor coordination,0.0,0.5,0.5,0.0
Prenatal,0.5,0.0,0.5,0.0
Sport concussion,0.0,0.5,0.5,0.0
Caspase-3,0.5,0.0,0.5,0.0
Test development,0.0,0.0,1.0,0.0
Occupational exposure,0.0,0.0,0.5,0.5
Nogo-P3,0.0,0.5,0.5,0.0
Design practice,0.5,0.0,0.5,0.0
DMS48,0.0,0.5,0.0,0.5
IL-6,1.0,0.0,0.0,0.0
Interpersonal coordination,0.0,0.0,1.0,0.0
Delayed response,0.5,0.0,0.5,0.0
Monocular,0.0,1.0,0.0,0.0
Redundancy gain,0.0,1.0,0.0,0.0
tRNS,0.0,0.5,0.5,0.0
self-report,0.5,0.0,0.5,0.0
Traumatic brain injuries,0.5,0.5,0.0,0.0
ichthyosis,0.5,0.0,0.5,0.0
Vision test,0.0,0.5,0.5,0.0
Tectum,0.0,0.5,0.0,0.5
BA 44,0.5,0.0,0.5,0.0
Social reward,0.0,0.0,0.5,0.5
Object classification,0.0,1.0,0.0,0.0
Blood-brain barrier,0.0,0.0,1.0,0.0
Very preterm,0.0,0.5,0.5,0.0
Survival,0.0,0.0,0.5,0.5
Facial perception,0.0,0.5,0.5,0.0
SEEG,0.5,0.0,0.5,0.0
Neurotransmitters,0.5,0.5,0.0,0.0
Broader autism phenotype,0.0,0.5,0.5,0.0
psychopathology,0.0,0.5,0.5,0.0
Dry eye,0.0,1.0,0.0,0.0
Diffusion,0.0,0.5,0.5,0.0
Executive memory,0.5,0.5,0.0,0.0
Cognitive augmentation,0.0,0.0,1.0,0.0
Legibility,0.0,0.0,0.5,0.5
Thought suppression,0.0,0.5,0.0,0.5
Longitudinal follow-up,0.5,0.5,0.0,0.0
Phase synchrony,0.5,0.0,0.0,0.5
Visual paired associates,0.5,0.0,0.0,0.5
Audiovisual processing,0.0,0.0,0.5,0.5
Simultaneity,1.0,0.0,0.0,0.0
In vitro fertilization (IVF),0.0,0.5,0.5,0.0
Age groups,0.0,0.0,1.0,0.0
Facial,0.5,0.0,0.5,0.0
Top-down effects,0.0,0.0,0.5,0.5
Competence,1.0,0.0,0.0,0.0
Devaluation,0.5,0.0,0.5,0.0
Fusiform,0.0,0.0,0.5,0.5
Psilocybin,0.0,0.5,0.5,0.0
Patching,0.0,0.0,1.0,0.0
Attentional resource,0.0,0.0,0.5,0.5
Human-dog interaction,0.0,0.5,0.5,0.0
Elementary education,0.0,0.0,0.5,0.5
Steadiness,1.0,0.0,0.0,0.0
Repetitive behaviors,0.5,0.5,0.0,0.0
Print reading,0.0,0.0,1.0,0.0
Lies,0.5,0.0,0.0,0.5
Coactivation,0.0,0.0,1.0,0.0
Invariance,0.0,1.0,0.0,0.0
subjectivity,0.0,0.5,0.5,0.0
UHR,0.0,0.0,1.0,0.0
Major Depressive Disorder,0.5,0.5,0.0,0.0
CIMS",0.0,0.0,0.0,0.0
Cognitive fatigue,0.5,0.5,0.0,0.0
Gliomas,0.5,0.0,0.5,0.0
Conjunctions,0.0,0.5,0.5,0.0
Dot probe,0.0,0.0,0.5,0.5
synaptophysin,0.0,0.5,0.5,0.0
Object learning,0.0,0.5,0.5,0.0
Dual-process model,0.0,0.5,0.5,0.0
Film theory,0.0,0.5,0.0,0.5
macaque,0.5,0.5,0.0,0.0
Modified Stroop,0.5,0.5,0.0,0.0
Distance,0.0,0.5,0.5,0.0
Topology,0.0,0.5,0.5,0.0
Risky choice,0.0,0.5,0.5,0.0
Blood oxygenation level-dependent,0.5,0.0,0.0,0.5
Visual modality,0.0,0.5,0.5,0.0
Weight loss,0.5,0.5,0.0,0.0
LC-NE system,0.0,0.5,0.5,0.0
Acuity,0.5,0.0,0.5,0.0
Child language,0.0,0.0,1.0,0.0
Stance,0.0,0.5,0.5,0.0
Intelligence quotient (IQ),0.0,0.5,0.5,0.0
Computers,0.5,0.5,0.0,0.0
Pruritus,0.5,0.0,0.0,0.5
Automatic vigilance,0.5,0.5,0.0,0.0
magnetoencephalography (MEG),0.0,0.0,0.0,1.0
Acute stress,0.5,0.0,0.5,0.0
Contextual modulation,0.0,0.5,0.5,0.0
Transcranial Doppler sonography,0.5,0.5,0.0,0.0
Neuropsychological syndrome,0.5,0.0,0.5,0.0
Visual stability,0.5,0.0,0.5,0.0
Turing patterns,0.0,0.0,0.0,1.0
Conflict frequency,0.0,0.5,0.5,0.0
Dynamic neural fields,0.0,0.5,0.5,0.0
Inferior parietal lobe,0.0,0.0,1.0,0.0
Inter-individual variability,0.0,1.0,0.0,0.0
Olfactory,0.0,0.5,0.0,0.5
Partial report,0.5,0.0,0.5,0.0
cognitive efficiency,0.0,0.5,0.5,0.0
semantic,0.0,0.5,0.5,0.0
Auditory space perception,0.5,0.5,0.0,0.0
Histology,0.5,0.5,0.0,0.0
Motor vehicles,0.0,0.0,1.0,0.0
Inferential reasoning,0.5,0.5,0.0,0.0
cognitive remediation,0.0,0.0,1.0,0.0
CAMCOG-R,1.0,0.0,0.0,0.0
Substantia nigra,0.5,0.0,0.5,0.0
motor development,0.0,0.5,0.5,0.0
Heroin,0.5,0.0,0.0,0.5
Segmentation,0.0,0.5,0.5,0.0
Collision detection,0.5,0.0,0.5,0.0
Distinctiveness,0.5,0.5,0.0,0.0
entorhinal cortex,0.0,0.0,0.5,0.5
Searchlight,0.0,1.0,0.0,0.0
interoception,0.0,0.5,0.5,0.0
Visual evoked potentials (VEPs),0.0,0.0,0.5,0.5
Iconology,0.0,0.5,0.5,0.0
brain aging,0.5,0.0,0.5,0.0
Music perception,0.0,0.0,0.5,0.5
CRT,0.0,0.5,0.0,0.5
conceptual,0.0,0.5,0.5,0.0
Digit Span,0.0,0.0,0.5,0.5
Novel object recognition test,0.0,1.0,0.0,0.0
Collective behavior,0.0,0.5,0.5,0.0
Self-focused attention,0.0,1.0,0.0,0.0
Surgical pathology,0.0,1.0,0.0,0.0
Cognitive task analysis,0.0,0.5,0.5,0.0
Business intelligence,0.5,0.5,0.0,0.0
Route learning,0.0,0.5,0.5,0.0
Music reading,0.0,0.5,0.5,0.0
GluN2B,0.0,0.0,0.0,1.0
GluN2A,0.0,0.0,0.0,1.0
Population based,0.0,0.0,1.0,0.0
Small vessel disease,0.5,0.0,0.5,0.0
Hot cognition,0.0,0.0,1.0,0.0
Rodent model,0.0,0.5,0.0,0.5
Nicotinic acetylcholine receptor,0.5,0.5,0.0,0.0
Figurative language,0.0,0.0,1.0,0.0
race,0.0,0.5,0.5,0.0
Developmental dyscalculia,0.5,0.5,0.0,0.0
Goldfish,0.5,0.0,0.5,0.0
Scene description,0.0,0.0,0.0,1.0
Data interpretation,0.5,0.0,0.0,0.5
analgesics,0.5,0.0,0.5,0.0
visuospatial,0.5,0.0,0.5,0.0
Rhesus macaques,0.0,0.5,0.5,0.0
audio description,0.0,0.5,0.5,0.0
visuoperception,0.0,0.0,1.0,0.0
PCBs,0.0,1.0,0.0,0.0
Support vector machine (SVM),0.5,0.5,0.0,0.0
Emotion understanding,0.0,1.0,0.0,0.0
Lesions,0.0,0.5,0.0,0.5
Information-processing speed,0.5,0.0,0.5,0.0
Point-light displays,0.5,0.5,0.0,0.0
Cognitive measures,0.0,0.5,0.5,0.0
Soy,0.5,0.0,0.5,0.0
Co-activations,0.5,0.0,0.0,0.5
Polypharmacy,0.0,0.5,0.5,0.0
Predator avoidance,0.0,1.0,0.0,0.0
Action identification,0.0,0.0,1.0,0.0
Knowledge corruption,0.0,0.0,1.0,0.0
Visual selection,0.0,0.0,1.0,0.0
Implicature,0.5,0.5,0.0,0.0
social interaction,0.5,0.0,0.5,0.0
Disease course,0.5,0.5,0.0,0.0
cognitive neuropsychology,1.0,0.0,0.0,0.0
Sleep loss,1.0,0.0,0.0,0.0
Antioxidants,0.0,0.5,0.5,0.0
Dizocilpine,0.5,0.0,0.0,0.5
user interface,0.0,1.0,0.0,0.0
Psychological trauma,0.0,0.0,0.5,0.5
Express saccades,0.5,0.0,0.5,0.0
Lapses,0.0,1.0,0.0,0.0
Laparoscopic,0.5,0.5,0.0,0.0
Quality-of-life,0.0,0.5,0.0,0.5
Mirror images,0.5,0.0,0.5,0.0
Control of attention,0.5,0.5,0.0,0.0
Inter-individual differences,0.5,0.0,0.0,0.5
Educational level,1.0,0.0,0.0,0.0
Cortical response field,0.0,0.0,0.5,0.5
Dynamic facial expressions,0.0,0.5,0.0,0.5
Social relevance,0.0,0.0,1.0,0.0
Copper,0.0,0.0,0.0,1.0
Field of view,0.0,1.0,0.0,0.0
Feeding,0.0,1.0,0.0,0.0
Bottom-up processing,0.0,0.0,1.0,0.0
Probabilistic inference,0.0,0.0,0.5,0.5
Anti-DNA antibodies,0.5,0.5,0.0,0.0
cannabis,0.5,0.0,0.5,0.0
HIV Infection,0.0,0.5,0.5,0.0
Rescorla-Wagner model,0.0,0.5,0.5,0.0
Trinucleotide repeats,0.0,0.5,0.5,0.0
Arousals,0.5,0.5,0.0,0.0
end-stage renal disease,0.5,0.5,0.0,0.0
Arsenic,0.0,0.5,0.5,0.0
Metastability,0.5,0.5,0.0,0.0
Wechsler scales,0.5,0.5,0.0,0.0
Social psychology,0.0,0.0,1.0,0.0
Anticipation-timing,0.0,0.0,1.0,0.0
Language switching,0.5,0.0,0.5,0.0
Interneurons,0.5,0.0,0.5,0.0
Sports-related concussion,0.0,0.5,0.5,0.0
Insight problem solving,0.0,0.5,0.0,0.5
Target selection,0.0,0.5,0.5,0.0
Nootropic,0.5,0.5,0.0,0.0
Globus pallidus,0.5,0.0,0.5,0.0
Amyotrophic lateral sclerosis (ALS),0.0,0.0,1.0,0.0
Cognitive behavioural treatment,0.5,0.0,0.5,0.0
Genotype,0.0,0.0,0.5,0.5
Context memory,0.0,1.0,0.0,0.0
Brazil,0.5,0.5,0.0,0.0
Ischemia,0.0,1.0,0.0,0.0
Source imaging,0.0,0.5,0.5,0.0
Go/No-Go,0.0,0.0,0.5,0.5
Fractions,0.5,0.0,0.5,0.0
Neuroergonomics,0.0,0.5,0.5,0.0
Brodmann area 19,0.5,0.0,0.0,0.5
Reading disorder,0.0,0.0,1.0,0.0
Working memory load,0.5,0.5,0.0,0.0
Symbolic distance,0.0,0.5,0.5,0.0
PET/CT,1.0,0.0,0.0,0.0
PSTS,1.0,0.0,0.0,0.0
Functional capacity,0.0,0.0,1.0,0.0
Beamformer,0.0,0.0,1.0,0.0
diagrammatic reasoning,0.0,1.0,0.0,0.0
American Sign Language,0.5,0.0,0.5,0.0
Visuomotor transformation,0.0,1.0,0.0,0.0
Egocentric reference,0.5,0.0,0.5,0.0
Event related oscillations,0.5,0.0,0.5,0.0
Paranormal belief,0.0,1.0,0.0,0.0
CNS tumors,0.0,0.0,0.0,1.0
Interhemispheric interaction,0.5,0.0,0.5,0.0
Behavioral inhibition,1.0,0.0,0.0,0.0
Compulsive,0.0,0.5,0.5,0.0
pregnancy,0.0,0.5,0.5,0.0
Embodied,0.0,0.5,0.5,0.0
Accumbens,0.0,0.0,0.5,0.5
Aerobic exercise,0.0,0.0,0.5,0.5
Comparative visual search,0.5,0.0,0.5,0.0
Lexical frequency,0.5,0.0,0.5,0.0
mood induction,0.0,0.0,1.0,0.0
Structural encoding,0.5,0.0,0.0,0.5
Microangiopathy,0.5,0.0,0.5,0.0
recognition memory,0.0,0.0,1.0,0.0
Default brain network,0.0,0.5,0.0,0.5
Word length,0.0,0.0,1.0,0.0
Synchrony perception,0.0,0.5,0.5,0.0
Insect navigation,0.0,0.5,0.5,0.0
auditory,0.0,0.5,0.5,0.0
Perceptual similarity,0.5,0.0,0.5,0.0
N400-P600,0.0,0.0,0.0,1.0
Auditory cues,0.5,0.5,0.0,0.0
Prosocial behavior,1.0,0.0,0.0,0.0
Local/global processing,0.0,0.5,0.5,0.0
Rule,0.0,0.5,0.0,0.5
Response times,0.5,0.5,0.0,0.0
Anomalous experiences,0.0,0.0,1.0,0.0
Car driving,0.5,0.5,0.0,0.0
Stochastic resonance,0.5,0.0,0.5,0.0
Refreshing,0.5,0.0,0.5,0.0
Distractor,0.0,0.0,1.0,0.0
Experimental aesthetics,0.0,1.0,0.0,0.0
Knowledge representation,0.0,0.0,1.0,0.0
visual feedback,0.0,0.5,0.5,0.0
infants,0.5,0.5,0.0,0.0
Visuospatial task,0.5,0.5,0.0,0.0
Unawareness,0.5,0.0,0.5,0.0
Somatoform disorders,0.0,0.0,1.0,0.0
Carotid artery stenosis,0.0,1.0,0.0,0.0
Parkinson's Disease,0.0,0.5,0.5,0.0
Extrapolation,0.0,0.5,0.5,0.0
Novelty distraction,0.0,0.5,0.0,0.5
Modality switching,0.0,0.0,1.0,0.0
Alarm calls,0.0,0.5,0.0,0.5
Structured interview,0.5,0.5,0.0,0.0
Reinvestment,0.5,0.0,0.5,0.0
Taiwan,0.0,0.5,0.0,0.5
Auditory-visual speech perception,0.0,0.5,0.5,0.0
Gesture production,0.0,0.5,0.5,0.0
bulimia nervosa,0.5,0.5,0.0,0.0
Domestication,0.0,0.5,0.5,0.0
Saliency map,0.5,0.5,0.0,0.0
blast injury,0.5,0.5,0.0,0.0
planning,0.0,0.0,1.0,0.0
Neuroendoscopy,0.0,0.0,1.0,0.0
chemotherapy,0.5,0.0,0.5,0.0
Motor execution,0.0,0.5,0.5,0.0
Incidental memory,0.0,0.5,0.5,0.0
ischemic stroke,0.0,0.0,0.5,0.5
Recognition potential,0.0,0.5,0.5,0.0
Patient-controlled,0.0,1.0,0.0,0.0
Letters,0.5,0.5,0.0,0.0
lesion,0.5,0.0,0.5,0.0
Feature,0.5,0.5,0.0,0.0
Multisensory enhancement,0.0,0.0,1.0,0.0
Qualitative reasoning,0.5,0.0,0.5,0.0
Foraging cognition,0.0,0.0,1.0,0.0
Williams syndrome (WS),0.0,0.5,0.5,0.0
Hodology,0.5,0.0,0.5,0.0
SIGNALING,0.0,0.5,0.5,0.0
Behavioral toxicology,0.0,0.5,0.5,0.0
ApoE genotype,0.0,0.5,0.0,0.5
Postnatal,0.5,0.0,0.5,0.0
Decision time,0.0,1.0,0.0,0.0
Psychometric assessment,0.5,0.0,0.5,0.0
Driving exposure,0.0,0.0,0.5,0.5
Fall prevention,0.0,0.0,1.0,0.0
Flanker effect,0.5,0.0,0.5,0.0
Stimulus degradation,0.0,0.5,0.5,0.0
deafness,0.0,0.5,0.5,0.0
Prospective,0.0,0.5,0.5,0.0
Insulin,0.0,0.5,0.5,0.0
Temporal preparation,0.5,0.5,0.0,0.0
Physical exercise,0.0,0.5,0.5,0.0
Piracetam,0.0,0.0,0.5,0.5
Fetal Alcohol Spectrum Disorder,0.5,0.0,0.5,0.0
Michotte,0.5,0.0,0.5,0.0
Minimal hepatic encephalopathy,0.0,0.5,0.5,0.0
Visuoperceptual,0.5,0.5,0.0,0.0
strategy,0.0,0.0,1.0,0.0
ANT,0.0,0.5,0.5,0.0
associative memory,0.5,0.5,0.0,0.0
Visual-spatial ability,0.0,0.5,0.5,0.0
Odor identification,0.0,0.5,0.5,0.0
associative learning,0.5,0.0,0.5,0.0
dizziness,0.0,0.0,0.5,0.5
Neural modeling,0.5,0.0,0.5,0.0
Health state valuation,0.0,0.5,0.5,0.0
Transsexual,0.5,0.5,0.0,0.0
Transfer of learning,0.5,0.5,0.0,0.0
Breastfeeding,0.5,0.5,0.0,0.0
Fetal Alcohol Syndrome,0.5,0.0,0.5,0.0
Autistic spectrum,0.5,0.0,0.0,0.5
neuropsychiatry,0.0,0.0,0.5,0.0
Artificial neural networks,0.0,0.0,0.5,0.5
Paired-associates learning,0.0,0.5,0.0,0.5
Metaanalysis,0.5,0.5,0.0,0.0
health,0.0,1.0,0.0,0.0
Heider-and-Simmel animations,0.0,0.0,0.5,0.5
principal component analysis,0.0,1.0,0.0,0.0
Latent variable analysis,0.0,0.5,0.5,0.0
armodafinil,0.0,0.5,0.5,0.0
Idiographic,0.0,0.5,0.5,0.0
biomarker,0.0,0.0,1.0,0.0
Item-specific effects,0.0,0.0,1.0,0.0
psychometric testing,0.0,0.0,0.5,0.5
prepulse inhibition,0.5,0.0,0.5,0.0
imitation,0.0,0.5,0.0,0.5
visuospatial memory,0.5,0.0,0.5,0.0
Nigeria,0.5,0.0,0.0,0.5
Late positive complex,0.0,0.5,0.5,0.0
Task effects,0.0,0.0,0.5,0.5
twin studies,0.0,0.0,1.0,0.0
design,0.5,0.0,0.5,0.0
Distractor inhibition,0.0,0.0,1.0,0.0
Recovery of function,0.0,0.0,1.0,0.0
Response priming,0.0,0.0,1.0,0.0
Minor,0.0,0.5,0.5,0.0
pigeon,0.5,0.0,0.5,0.0
Malnutrition,0.0,0.0,0.5,0.5
ICD,0.0,0.5,0.5,0.0
Memory processes,0.5,0.0,0.5,0.0
Spatial forms,0.5,0.5,0.0,0.0
Letter recognition,0.0,0.5,0.0,0.5
Pedestrian safety,0.0,0.0,1.0,0.0
Visuomotor conflict,0.0,0.5,0.5,0.0
RVIP,0.0,0.0,1.0,0.0
Attentional Blink,0.5,0.0,0.5,0.0
Placebo analgesia,0.5,0.0,0.5,0.0
Supramarginal gyrus,0.5,0.5,0.0,0.0
expertise,0.5,0.0,0.5,0.0
Ventral visual pathway,0.5,0.0,0.0,0.5
Knee,0.0,0.5,0.5,0.0
Visually guided action,0.5,0.5,0.0,0.0
Meta-Analysis,0.0,0.5,0.0,0.5
Chronic,0.5,0.0,0.5,0.0
fizioterapii,0.0,0.0,0.0,0.0
Nogo-N2,0.0,0.5,0.5,0.0
Emotional context,0.0,0.5,0.5,0.0
cortex,0.0,0.5,0.5,0.0
falls,0.5,0.0,0.5,0.0
Arterial spin labeling,0.0,0.5,0.5,0.0
Neuropsychologically normal,0.0,1.0,0.0,0.0
Knockout mice,0.0,0.0,1.0,0.0
Response control,0.0,0.5,0.5,0.0
SES,0.5,0.5,0.0,0.0
Rotation-related negativity,0.0,0.5,0.5,0.0
Obsessive-compulsive symptoms,0.0,0.0,1.0,0.0
Near space,1.0,0.0,0.0,0.0
Parity,0.5,0.0,0.5,0.0
High gamma,0.5,0.0,0.5,0.0
Hypnotic,0.0,0.5,0.5,0.0
TPJ,0.5,0.5,0.0,0.0
Spatial-numerical associations,0.0,0.0,1.0,0.0
Perception thresholds,0.0,0.5,0.5,0.0
Guide dogs,0.0,0.5,0.5,0.0
Marketing,0.0,1.0,0.0,0.0
Self-motion perception,0.0,0.0,1.0,0.0
Temporal order memory,0.0,0.0,1.0,0.0
Groundwater,0.0,0.0,1.0,0.0
neurophysiology,0.5,0.0,0.5,0.0
Automation,0.0,0.0,0.0,1.0
Posteromedial cortex,0.5,0.0,0.5,0.0
naturalistic,1.0,0.0,0.0,0.0
Early visual cortex,0.0,0.0,1.0,0.0
Sickle cell disease,0.5,0.0,0.5,0.0
Artificial Intelligence,0.0,0.5,0.5,0.0
Driver distraction,0.5,0.5,0.0,0.0
Preparatory set,0.0,0.5,0.5,0.0
Brain diseases,0.0,0.5,0.5,0.0
heat,0.0,0.5,0.5,0.0
Hemispheric interaction,0.0,0.0,1.0,0.0
Intra-parietal sulcus,0.5,0.0,0.5,0.0
Looming,0.0,0.5,0.5,0.0
Mild dementia,0.0,0.5,0.0,0.5
ERSP,0.0,0.0,0.5,0.5
"3,0.0,0.0,0.0,0.0
Pain modulation,0.0,0.0,0.5,0.5
Affordance perception,0.0,0.5,0.0,0.5
Autism spectrum quotient,0.0,0.0,0.5,0.5
visuospatial ability,0.0,0.5,0.5,0.0
Beliefs,0.5,0.0,0.5,0.0
Image recognition,0.0,0.5,0.5,0.0
Visual spatial task,0.0,0.0,1.0,0.0
Conversion,0.0,0.5,0.5,0.0
Lidocaine,0.5,0.0,0.5,0.0
Psychometric attributes,1.0,0.0,0.0,0.0
tool,0.5,0.0,0.5,0.0
Word meaning,0.5,0.5,0.0,0.0
Needs,0.0,0.0,1.0,0.0
Alignment,0.0,1.0,0.0,0.0
Psychological reasoning,0.5,0.0,0.0,0.5
Subjective,0.0,1.0,0.0,0.0
Ocular motor,0.0,0.5,0.5,0.0
Social exclusion,0.0,1.0,0.0,0.0
Lexical selection,0.0,0.5,0.5,0.0
Race model,0.0,0.0,1.0,0.0
Image clutter metric,1.0,0.0,0.0,0.0
Leisure activities,1.0,0.0,0.0,0.0
Visual complexity,0.0,0.0,0.5,0.5
Urgency,0.5,0.0,0.5,0.0
Specific language impairment (SLI),0.0,0.5,0.0,0.5
Idioms,0.0,0.0,1.0,0.0
Temporal window,0.0,0.5,0.5,0.0
healthy older adults,1.0,0.0,0.0,0.0
Neuropsychological deficits,0.5,0.5,0.0,0.0
Cantab,0.5,0.0,0.5,0.0
Marmoset,1.0,0.0,0.0,0.0
Sensory stimulation,0.0,0.0,0.0,1.0
Inductive reasoning,0.5,0.0,0.5,0.0
Visuo-spatial functioning,0.0,0.0,0.5,0.5
Neurology,0.0,0.0,0.5,0.5
Parcellation,0.0,0.5,0.5,0.0
Color cognition,0.5,0.0,0.5,0.0
Emotional reactivity,0.0,0.5,0.5,0.0
Focus + context,0.0,0.5,0.5,0.0
Secondary task,0.5,0.0,0.5,0.0
propofol,0.5,0.0,0.5,0.0
Inferior prefrontal cortex,0.5,0.5,0.0,0.0
Thalamotomy,0.5,0.0,0.5,0.0
Temporal discrimination,0.0,0.0,0.5,0.5
Brain mechanism,0.0,0.0,0.5,0.5
glycine,0.0,0.5,0.5,0.0
Order,0.5,0.0,0.5,0.0
Numerical symbols,0.0,0.0,1.0,0.0
Middle frontal gyrus,0.5,0.0,0.5,0.0
Hepatitis B virus,0.5,0.5,0.0,0.0
Distributed representations,0.5,0.5,0.0,0.0
Surround suppression,0.0,0.5,0.5,0.0
Bayesian statistics,0.0,0.5,0.5,0.0
Medications,0.5,0.0,0.5,0.0
Spatial clustering,0.0,1.0,0.0,0.0
CERAD,0.0,0.0,1.0,0.0
Information structure,0.5,0.5,0.0,0.0
Local-global processing,0.5,0.0,0.0,0.5
Domestic dog,0.0,0.0,1.0,0.0
glycine reuptake inhibitor,0.5,0.0,0.0,0.5
Hick's law,0.5,0.5,0.0,0.0
Contralateral,0.0,0.0,1.0,0.0
Minimally invasive surgery,0.0,0.5,0.5,0.0
Medial prefrontal cortex (mPFC),0.0,0.0,1.0,0.0
Learning to learn,0.0,1.0,0.0,0.0
Distance effects,0.5,0.0,0.5,0.0
Schizophrenia spectrum disorders,0.0,0.0,1.0,0.0
? rhythms,0.0,1.0,0.0,0.0
addiction,1.0,0.0,0.0,0.0
free recall,0.5,0.5,0.0,0.0
Disjunction,0.5,0.0,0.5,0.0
5-HT3,0.0,0.5,0.0,0.5
Attentional training,0.5,0.0,0.5,0.0
Mathematical development,0.0,0.0,0.5,0.5
Minimal detectable change,0.0,0.0,1.0,0.0
Proficiency,0.0,0.5,0.5,0.0
Recent-onset,0.0,0.0,1.0,0.0
QEEG,0.0,0.0,0.5,0.5
integration,0.0,0.5,0.5,0.0
Hemispheric processing,0.0,1.0,0.0,0.0
creativity,0.0,0.0,1.0,0.0
Posterior parietal,0.0,0.5,0.5,0.0
amnestic,0.0,0.0,1.0,0.0
Feature selection,0.5,0.5,0.0,0.0
Human action,0.5,0.5,0.0,0.0
Lexical quality,0.5,0.5,0.0,0.0
Interneuron,0.5,0.5,0.0,0.0
Palliative care,0.0,0.0,1.0,0.0
avian cognition,0.0,1.0,0.0,0.0
Referential communication,0.0,1.0,0.0,0.0
nursing home,0.0,0.0,1.0,0.0
l-Theanine,0.5,0.0,0.5,0.0
Canis familiaris,0.0,0.5,0.5,0.0
Visual-motor function,0.0,0.0,1.0,0.0
Back pain,0.0,0.5,0.5,0.0
Cognitive robotics,0.5,0.5,0.0,0.0
Event related potential,0.0,0.5,0.0,0.5
Conflict resolution,0.5,0.5,0.0,0.0
Simultagnosia,0.5,0.5,0.0,0.0
strategies,0.0,0.0,1.0,0.0
Posterior fossa syndrome,1.0,0.0,0.0,0.0
Affect perception,1.0,0.0,0.0,0.0
Contextual integration,0.0,0.5,0.0,0.5
Visual thinking,0.5,0.0,0.5,0.0
Learning disorders,0.0,0.0,1.0,0.0
Course,0.0,0.0,0.5,0.5
Viewpoint invariance,0.5,0.5,0.0,0.0
Word order,0.0,0.0,0.5,0.5
Place learning,0.0,1.0,0.0,0.0
Prefrontal lesion,0.0,0.5,0.0,0.5
Data mining,0.5,0.5,0.0,0.0
Facial information,0.5,0.0,0.5,0.0
mental imagery,0.0,0.5,0.5,0.0
Cholinergic hypothesis,0.5,0.0,0.5,0.0
BECTS,0.0,1.0,0.0,0.0
Systematic review,0.5,0.0,0.0,0.5
Synergism,0.0,0.5,0.5,0.0
High functioning autism,0.0,1.0,0.0,0.0
Object features,0.5,0.5,0.0,0.0
Exploratory search,0.0,0.0,1.0,0.0
Quantum mechanics,1.0,0.0,0.0,0.0
catastrophizing,0.0,0.5,0.5,0.0
Subjective memory complaint,0.0,0.0,1.0,0.0
Brain perfusion,0.0,0.5,0.5,0.0
Asthma,0.0,0.5,0.5,0.0
Stepping,0.5,0.0,0.5,0.0
"Brain,0.0,0.0,0.0,0.0
Saccade sequences,0.0,0.0,1.0,0.0
Interhemispheric communication,0.0,1.0,0.0,0.0
Support vector machines,0.0,1.0,0.0,0.0
Event-related desynchronization/synchronization,0.0,0.5,0.5,0.0
parkinsonism,0.0,0.5,0.5,0.0
Cross-modal plasticity,0.5,0.5,0.0,0.0
Numerical estimation,0.0,1.0,0.0,0.0
Glutamate antagonists,0.0,0.5,0.0,0.5
marijuana,0.0,0.5,0.0,0.5
Auditory evoked potentials,0.5,0.5,0.0,0.0
Atherosclerosis,0.0,0.5,0.5,0.0
single photon emission computed tomography,0.0,0.0,1.0,0.0
Chocolate craving,0.5,0.0,0.5,0.0
Drug cues,0.0,0.5,0.5,0.0
Basic science,0.0,0.0,1.0,0.0
Intuition,0.0,0.0,0.0,1.0
Working Memory,0.0,0.0,1.0,0.0
Mirror systems,0.5,0.0,0.5,0.0
P200,0.0,0.5,0.5,0.0
Grounded theory,0.5,0.5,0.0,0.0
Adaptive behavior,0.0,0.5,0.5,0.0
gesture,0.0,1.0,0.0,0.0
primate cognition,0.5,0.5,0.0,0.0
Iconicity judgment,0.0,0.0,1.0,0.0
Russia,0.0,0.5,0.5,0.0
Spider fear,0.5,0.0,0.5,0.0
Natural history,0.5,0.5,0.0,0.0
Retinal nerve fiber layer,0.0,0.5,0.5,0.0
Explicit,0.5,0.0,0.5,0.0
Duration discrimination,0.0,0.0,0.0,1.0
Impulsive behavior,0.5,0.0,0.5,0.0
Corticobasal syndrome,0.0,0.5,0.5,0.0
Air traffic control,0.0,0.0,1.0,0.0
cognitive neurology,0.0,0.0,1.0,0.0
Disabled persons,0.0,0.0,1.0,0.0
Diplopia,0.0,0.5,0.5,0.0
Twin study,0.5,0.0,0.5,0.0
Autism spectrum disorders (ASD),0.0,0.0,1.0,0.0
Conceptual metaphor,0.5,0.0,0.5,0.0
Structure-from-motion,0.5,0.5,0.0,0.0
Claustrum,0.0,0.5,0.5,0.0
Chocolate,0.0,0.5,0.5,0.0
Sensorimotor rhythm,0.5,0.5,0.0,0.0
Unverricht-Lundborg disease,0.0,0.0,1.0,0.0
Screening test,0.5,0.5,0.0,0.0
Alcohol expectancy,0.5,0.0,0.5,0.0
neurodegenerative disorder,0.0,1.0,0.0,0.0
Flavanols,0.0,0.0,1.0,0.0
Ultrasound,0.0,0.5,0.5,0.0
Category-learning,0.5,0.5,0.0,0.0
Neurobehavioral,0.0,0.5,0.5,0.0
Vibration,0.5,0.5,0.0,0.0
Gonadal hormones,0.5,0.0,0.0,0.5
Category induction,0.0,0.0,1.0,0.0
Postoperative,0.0,0.0,0.5,0.5
Scene representation,0.0,0.0,0.5,0.5
Cerebral lateralization,0.5,0.0,0.5,0.0
Pitch processing,0.0,0.5,0.0,0.5
Vestibular neuronitis,0.5,0.0,0.5,0.0
Postural Balance,0.0,0.5,0.0,0.5
Resource depletion,0.0,0.5,0.5,0.0
Visually impaired,1.0,0.0,0.0,0.0
Parvocellular pathway,0.0,0.5,0.0,0.5
Congenital adrenal hyperplasia,0.5,0.0,0.0,0.5
Specific Language Impairment,0.5,0.5,0.0,0.0
Learning process,0.0,1.0,0.0,0.0
saccade,0.0,0.5,0.5,0.0
adolescents,0.0,0.5,0.0,0.5
Motor imagery questionnaire,0.5,0.5,0.0,0.0
neurotoxicity,0.0,0.0,1.0,0.0
Essentialism,0.5,0.5,0.0,0.0
Functional hemispheric asymmetries,0.5,0.5,0.0,0.0
Brain-machine interface,0.0,1.0,0.0,0.0
Tacit knowledge,0.0,0.5,0.5,0.0
Touch screen,0.5,0.0,0.0,0.5
Weapon focus effect,0.0,0.0,0.5,0.5
Sentence,0.0,0.0,0.5,0.5
FEF,0.0,0.5,0.0,0.5
artificial intelligence,0.0,0.5,0.5,0.0
exposure,0.5,0.0,0.5,0.0
Switch costs,0.5,0.0,0.5,0.0
Locus of control,1.0,0.0,0.0,0.0
Hypothyroidism,0.5,0.5,0.0,0.0
Attraction,0.5,0.5,0.0,0.0
Baseline,0.0,1.0,0.0,0.0
Emotional attention,0.5,0.0,0.5,0.0
A?1-40,0.0,0.5,0.5,0.0
PPI,0.0,0.0,0.5,0.5
Cognitive processing speed,0.5,0.0,0.5,0.0
Age-related,0.0,0.0,1.0,0.0
Visual signal detection task,0.5,0.0,0.0,0.5
Skill acquisition,0.0,1.0,0.0,0.0
Neoplasm,0.0,0.5,0.5,0.0
Relevance,0.0,0.5,0.5,0.0
Neurocognitive impairment,0.0,0.0,1.0,0.0
assistive technology,0.0,0.5,0.5,0.0
Neuropsychological examination,0.5,0.0,0.5,0.0
Iron deficiency,0.0,0.0,0.0,1.0
Large-scale networks,0.0,0.5,0.5,0.0
MK801,0.0,0.0,0.5,0.5
Proportions,0.0,0.0,0.5,0.5
visual learning,0.0,0.5,0.5,0.0
Generation effect,0.0,1.0,0.0,0.0
Wechsler Adult Intelligence Scale-Fourth Edition,0.0,1.0,0.0,0.0
Neuropsychological functions,0.0,0.0,1.0,0.0
Electroconvulsive therapy (ECT),0.0,0.5,0.5,0.0
Serial reaction time,0.0,0.5,0.5,0.0
Spatial concepts,0.0,0.5,0.5,0.0
Add-on treatment,0.0,1.0,0.0,0.0
dynamic causal modeling,0.0,0.5,0.5,0.0
Brainstem auditory evoked potentials,0.0,0.0,0.5,0.5
Biologically-inspired,0.5,0.0,0.5,0.0
CRPS,0.0,0.5,0.5,0.0
Situational awareness,0.0,0.5,0.0,0.5
Phasic and tonic forms of cortical activation,0.0,0.5,0.5,0.0
Composite,0.0,0.0,1.0,0.0
Posterior parietal cortex (PPC),0.0,1.0,0.0,0.0
Film literacy,0.0,0.0,1.0,0.0
Functional relations,0.0,1.0,0.0,0.0
Football,0.5,0.0,0.5,0.0
Rorschach,0.0,0.5,0.0,0.5
Spatial reasoning,0.5,0.0,0.5,0.0
Surgical education,0.5,0.5,0.0,0.0
Implicit knowledge,0.0,0.5,0.5,0.0
visual integration,0.5,0.0,0.5,0.0
Neurocognitive deficits,0.0,0.0,1.0,0.0
maintenance,0.0,0.5,0.5,0.0
chronic kidney disease,0.0,0.0,0.5,0.5
Category-specific deficits,0.5,0.5,0.0,0.0
Cravings,0.5,0.5,0.0,0.0
plasticity,0.0,0.5,0.5,0.0
Visual feature,0.5,0.0,0.5,0.0
N2b,0.0,0.0,1.0,0.0
Environmental dependency,0.0,0.5,0.5,0.0
Spatial transformations,0.5,0.0,0.5,0.0
Cognitive profiles,0.0,0.5,0.0,0.5
Delta,0.0,0.0,1.0,0.0
deep brain stimulation,0.0,0.5,0.5,0.0
Cognits,0.5,0.5,0.0,0.0
Ampakines,0.0,0.5,0.5,0.0
Visuomotor mapping,1.0,0.0,0.0,0.0
food,0.0,0.5,0.5,0.0
Attentional dysfunction/cognition,0.0,1.0,0.0,0.0
Social deficits,0.0,0.5,0.5,0.0
Meditation,0.0,1.0,0.0,0.0
Numerical discrimination,0.0,0.5,0.5,0.0
Bipolar affective disorder,0.0,0.5,0.5,0.0
Parallel processing,0.0,0.0,0.5,0.5
Episodic buffer,0.0,0.5,0.5,0.0
Pain behavior,0.0,0.0,1.0,0.0
Functioning,0.5,0.0,0.0,0.5
Fear of progression,0.0,0.5,0.5,0.0
Visual signals,0.5,0.5,0.0,0.0
Visual displays,0.0,0.0,0.5,0.5
Dynamic causal modelling,0.5,0.5,0.0,0.0
Parvalbumin,0.0,0.0,1.0,0.0
mathematics,0.0,0.0,0.5,0.5
WMS-IV,0.0,0.0,0.5,0.5
Internal states,0.0,0.0,1.0,0.0
Geriatric rehabilitation,1.0,0.0,0.0,0.0
Two visual streams,0.0,0.0,0.5,0.5
Syllogistic reasoning,0.5,0.0,0.5,0.0
Interface,0.5,0.0,0.5,0.0
EPN,0.0,1.0,0.0,0.0
Cybernetics,1.0,0.0,0.0,0.0
Trospium,0.5,0.0,0.5,0.0
Visuospatial cognition,0.0,0.5,0.5,0.0
Two-visual systems,0.0,0.0,1.0,0.0
Access consciousness,1.0,0.0,0.0,0.0
Task representation,0.0,0.5,0.5,0.0
Tyrosine depletion,0.5,0.5,0.0,0.0
Substance-related disorders,0.0,0.5,0.0,0.5
Forensic,0.0,0.5,0.0,0.5
impairment,1.0,0.0,0.0,0.0
Covert orienting,0.0,0.0,1.0,0.0
fMRI-adaptation,0.0,0.5,0.0,0.5
Shape matching,0.0,0.5,0.5,0.0
midazolam,0.0,0.0,1.0,0.0
Prostate cancer,0.5,0.5,0.0,0.0
gray matter,0.5,0.5,0.0,0.0
Update,0.0,0.0,1.0,0.0
Angry,0.5,0.5,0.0,0.0
trial,0.0,0.5,0.5,0.0
Memory systems,0.0,0.0,1.0,0.0
Neural tube defects,0.0,0.0,0.5,0.5
heritability,0.0,0.5,0.0,0.5
Receptive vocabulary,1.0,0.0,0.0,0.0
Cell assembly,0.0,0.5,0.5,0.0
Attentional capacity,0.0,0.0,0.5,0.5
Presymptomatic,0.0,0.5,0.5,0.0
Fragile X Syndrome,0.5,0.5,0.0,0.0
Logical reasoning,0.0,0.0,1.0,0.0
Conceptual analysis,0.5,0.0,0.5,0.0
Lexicon,1.0,0.0,0.0,0.0
pharmacodynamics,1.0,0.0,0.0,0.0
Perception and action,0.0,1.0,0.0,0.0
Sequential,0.0,0.0,0.5,0.5
Lateral masking,0.0,0.5,0.5,0.0
Mind,0.0,0.5,0.5,0.0
Own-race bias,0.0,0.0,1.0,0.0
Structural connectivity,0.0,0.5,0.5,0.0
Amyloid-?,0.0,0.5,0.5,0.0
Subacute combined degeneration,0.0,0.5,0.5,0.0
Focus,0.0,0.5,0.5,0.0
false memory,0.5,0.5,0.0,0.0
Ts65Dn mice,0.0,0.5,0.5,0.0
Clinical reasoning,0.0,0.0,1.0,0.0
antidepressant,0.0,1.0,0.0,0.0
Rule-based,0.0,1.0,0.0,0.0
Indirect measures,0.0,0.5,0.5,0.0
Nausea,0.0,0.0,1.0,0.0
phencyclidine,0.0,0.5,0.5,0.0
VMI,0.0,0.5,0.5,0.0
Hemiplegia,0.5,0.0,0.0,0.5
hypermnesia,0.5,0.5,0.0,0.0
Light exposure,0.0,0.5,0.5,0.0
Florbetapir,0.5,0.5,0.0,0.0
Nonsmokers,0.5,0.0,0.5,0.0
Occipitotemporal cortex,0.5,0.0,0.5,0.0
Memory distortion,0.5,0.5,0.0,0.0
Lexical semantics,0.5,0.5,0.0,0.0
Interocular suppression,0.0,0.5,0.5,0.0
magnetic resonance spectroscopy,0.0,0.5,0.0,0.5
mania,0.5,0.0,0.5,0.0
Stress hormone,0.0,1.0,0.0,0.0
Montreal cognitive assessment,0.0,0.5,0.5,0.0
Endocannabinoid,0.0,0.5,0.5,0.0
Inductive inference,0.0,1.0,0.0,0.0
opioid,0.5,0.0,0.5,0.0
HIV-associated neurocognitive disorder,0.0,0.5,0.5,0.0
Biological movement,0.0,0.5,0.5,0.0
Adaptive Resonance Theory,0.0,0.0,0.0,1.0
Perceptual illusion,0.0,0.5,0.5,0.0
Early identification,0.0,0.5,0.5,0.0
Engineering and Technology",0.0,0.0,0.0,0.0
Neuropsychological Tests,0.0,0.5,0.5,0.0
Elevated plus maze,0.5,0.5,0.0,0.0
Event memory,0.5,0.5,0.0,0.0
Natural scene,0.0,0.5,0.5,0.0
Tobacco dependence,0.0,0.5,0.5,0.0
Cerebral blood flow velocity,0.5,0.0,0.0,0.5
Perceived control,0.0,0.0,1.0,0.0
brain SPECT,0.0,0.0,1.0,0.0
Instrumental activities of daily living,0.0,0.0,0.5,0.5
fusiform face area,0.0,0.5,0.5,0.0
sensory processing,0.5,0.0,0.5,0.0
Stimulation,0.0,1.0,0.0,0.0
Delay discounting,0.0,0.5,0.5,0.0
Sleep restriction,0.0,0.0,1.0,0.0
Drug effects,0.0,0.5,0.0,0.5
Myopia,0.0,0.5,0.0,0.0
reappraisal,0.5,0.0,0.5,0.0
isoflurane,0.5,0.0,0.5,0.0
Environmental cognition,0.5,0.0,0.5,0.0
Iron deficiency anemia,0.0,0.5,0.5,0.0
Energy,0.0,0.5,0.0,0.5
Memory and aging,0.0,0.5,0.5,0.0
Workload,0.0,0.0,0.5,0.5
Clock Drawing Test,0.0,1.0,0.0,0.0
vision impairment,0.0,0.5,0.5,0.0
Restless legs syndrome,0.0,1.0,0.0,0.0
Hypofrontality,0.0,0.0,0.5,0.5
Ostensive communication,0.0,0.5,0.5,0.0
Genetic disorders,0.5,0.0,0.5,0.0
Environmental perception,0.0,0.5,0.5,0.0
Representations,0.0,0.0,1.0,0.0
Randomized clinical trial,0.0,0.5,0.5,0.0
Representations of mathematics,0.0,0.0,0.5,0.5
Body-object interaction,0.5,0.0,0.5,0.0
Emotional contagion,0.5,0.5,0.0,0.0
Biological motion perception,1.0,0.0,0.0,0.0
Neurofibromatosis Type 1,0.0,0.0,1.0,0.0
Peripheral inflammation,0.0,0.0,1.0,0.0
Head trauma,0.5,0.5,0.0,0.0
Social action,0.0,0.5,0.0,0.5
Cigarette craving,0.0,0.5,0.5,0.0
Trait,0.0,0.5,0.5,0.0
Subcortical dementia,0.5,0.0,0.5,0.0
Visuo-spatial processing,0.0,0.0,0.5,0.5
sex,0.0,0.5,0.5,0.0
Gait disorders,0.5,0.0,0.0,0.5
Aesthetic,0.0,0.0,1.0,0.0
Orangutans,0.5,0.0,0.5,0.0
Singing,0.5,0.5,0.0,0.0
Euthymic,0.0,0.5,0.5,0.0
Conceptual blending,0.0,0.5,0.0,0.5
Young adulthood,0.0,0.0,0.5,0.5
Linguistics,0.5,0.0,0.5,0.0
Visual backward masking,0.5,0.0,0.5,0.0
Confirmation bias,0.5,0.5,0.0,0.0
Statins,0.5,0.0,0.5,0.0
N-methyl-d-aspartate receptor,0.0,1.0,0.0,0.0
psychology,0.0,0.0,1.0,0.0
IPS,0.0,0.0,1.0,0.0
Endoscopic,0.5,0.5,0.0,0.0
Mentalising,0.0,0.0,0.5,0.5
Process-dissociation procedure,0.0,0.0,1.0,0.0
Frontostriatal,1.0,0.0,0.0,0.0
3D visual fatigue,0.0,0.5,0.5,0.0
Insular cortex,0.0,1.0,0.0,0.0
human cognition,0.0,0.5,0.0,0.5
Grapheme-to-phoneme conversion,0.0,0.5,0.5,0.0
Compatibility effect,0.0,0.0,1.0,0.0
reasoning,0.0,0.0,1.0,0.0
Postdiction,0.0,0.0,1.0,0.0
Cataract,0.5,0.5,0.0,0.0
Progressive aphasia,0.0,1.0,0.0,0.0
Dual sensory loss,0.5,0.0,0.5,0.0
Meta-memory,0.0,0.5,0.5,0.0
Savantism,0.5,0.5,0.0,0.0
Rapid serial visual presentation (RSVP),0.0,1.0,0.0,0.0
Motor recovery,0.0,0.0,1.0,0.0
Overt attention,0.0,0.5,0.0,0.5
Caregivers,0.5,0.5,0.0,0.0
Diagnostics,0.0,0.5,0.5,0.0
Driving avoidance,0.0,0.0,0.5,0.5
Spirituality,0.5,0.0,0.5,0.0
Energetics,0.5,0.0,0.5,0.0
Listening effort,0.0,0.5,0.5,0.0
5-choice serial reaction time task,0.5,0.0,0.0,0.5
Agenesis of the corpus callosum,0.0,0.5,0.5,0.0
Visual cognitive style,0.0,0.0,1.0,0.0
Fluorouracil,0.0,0.0,0.5,0.5
Externalism,0.0,0.5,0.5,0.0
Genistein,0.0,0.0,1.0,0.0
walking,0.0,1.0,0.0,0.0
Auditory hallucinations,0.5,0.0,0.5,0.0
intraparietal sulcus,0.0,0.0,1.0,0.0
Fuzzy clustering,0.5,0.5,0.0,0.0
Precuing,1.0,0.0,0.0,0.0
Braille,0.0,0.0,0.5,0.0
Conventionality,0.0,0.5,0.5,0.0
Iowa gambling task,0.5,0.0,0.5,0.0
Direction,0.0,0.0,1.0,0.0
Feeling of knowing,0.0,0.0,1.0,0.0
Randomized trial,0.0,1.0,0.0,0.0
Task relevance,0.0,0.0,1.0,0.0
dmedicine receptors,0.5,0.5,0.0,0.0
Attention deficit disorder,0.5,0.0,0.5,0.0
Neurocognitive outcomes,0.0,0.5,0.0,0.5
Experimental,0.0,0.0,1.0,0.0
veterans,0.0,0.0,0.5,0.5
Perceptual span,0.0,0.5,0.5,0.0
disorganization,0.0,0.0,1.0,0.0
Retest learning,0.0,0.0,1.0,0.0
Poor effort,0.0,0.0,0.5,0.5
cognitive testing,0.0,0.5,0.5,0.0
Color categories,0.0,0.0,0.5,0.5
Eeg,0.0,1.0,0.0,0.0
SLAM,0.5,0.5,0.0,0.0
Neurocognitive test,1.0,0.0,0.0,0.0
Theta rhythm,0.5,0.0,0.5,0.0
Issue 56,0.5,0.5,0.0,0.0
Grasp,0.0,0.0,1.0,0.0
Successful aging,0.0,0.5,0.5,0.0
Relevance feedback,0.0,0.0,1.0,0.0
Event categories,0.0,1.0,0.0,0.0
Mobility limitation,0.0,1.0,0.0,0.0
child,0.5,0.0,0.5,0.0
PSW,0.0,0.0,0.5,0.5
early posterior negativity,0.0,0.5,0.5,0.0
TBSS,0.0,0.5,0.0,0.5
Implicit measures,0.0,0.5,0.5,0.0
Person knowledge,0.5,0.0,0.5,0.0
Switch cost,1.0,0.0,0.0,0.0
Schizotypal personality,0.5,0.5,0.0,0.0
Schooling,1.0,0.0,0.0,0.0
morality,0.5,0.0,0.5,0.0
Incidence,0.5,0.0,0.5,0.0
Functional connectivity MRI,0.0,0.0,1.0,0.0
Kanizsa,0.0,0.0,0.5,0.5
Postoperative delirium,0.5,0.5,0.0,0.0
Right TPJ,0.0,0.0,1.0,0.0
Global motion,0.5,0.5,0.0,0.0
Vascular disease,0.5,0.5,0.0,0.0
Intelligent virtual agent,0.0,0.0,0.5,0.5
methodology,0.0,0.5,0.5,0.0
Vestibulo-ocular reflex,0.0,0.5,0.0,0.5
Multinomial model,0.0,1.0,0.0,0.0
Automatic imitation,0.0,0.0,1.0,0.0
handedness,0.5,0.0,0.5,0.0
Neuropsychological development,0.5,0.5,0.0,0.0
Usability evaluation,0.0,0.0,1.0,0.0
Criminal offending,0.0,0.5,0.5,0.0
Feature conjunctions,0.0,0.5,0.0,0.5
Parkinson's disease (PD),0.0,1.0,0.0,0.0
Model of Alzheimer's disease,0.0,0.5,0.5,0.0
Ciproxifan,0.5,0.0,0.5,0.0
Task modeling,0.5,0.5,0.0,0.0
Experience sampling,0.0,0.0,0.5,0.5
Tension-type headache,0.0,0.5,0.0,0.5
Posttraumatic stress disorder (PTSD),0.0,0.5,0.5,0.0
Modulation,0.5,0.5,0.0,0.0
N270,0.0,0.5,0.5,0.0
data reduction,0.5,0.5,0.0,0.0
Dimension weighting,0.0,1.0,0.0,0.0
Follow-up study,0.0,0.5,0.5,0.0
identification,1.0,0.0,0.0,0.0
Hematocrit,0.5,0.0,0.5,0.0
HAART,0.0,0.0,1.0,0.0
Human memory,0.5,0.0,0.5,0.0
Augmented cognition,0.0,0.0,0.5,0.5
Rasch model,1.0,0.0,0.0,0.0
Actions,0.0,1.0,0.0,0.0
Spatial coding,0.5,0.5,0.0,0.0
Visual similarity,0.5,0.0,0.0,0.5
Neurotherapy,0.0,1.0,0.0,0.0
Capgras,0.0,0.0,0.5,0.5
neuroplasticity,0.0,0.5,0.0,0.5
Spatiotemporal response,0.0,0.0,0.5,0.5
SNAP-25,0.5,0.0,0.5,0.0
Extrastriate body area,0.0,0.0,0.5,0.5
Reliability and validity,0.0,0.5,0.0,0.5
Diffusion tensor,0.5,0.0,0.0,0.5
Intention understanding,0.0,0.0,1.0,0.0
Facial features,0.0,0.0,1.0,0.0
Neurobehavioral outcomes,0.5,0.5,0.0,0.0
Global precedence,0.0,0.5,0.5,0.0
Gaze processing,0.5,0.0,0.5,0.0
Cognitive interview,0.5,0.0,0.5,0.0
Facial expression processing,0.5,0.5,0.0,0.0
Mirror neuron system (MNS),0.0,0.0,1.0,0.0
Deductive reasoning,0.0,0.0,1.0,0.0
Action naming,0.0,0.5,0.0,0.5
Selective mutism,0.5,0.5,0.0,0.0
Progression,0.0,0.0,1.0,0.0
Extrasensory perception,0.5,0.5,0.0,0.0
Error trials,0.0,0.0,1.0,0.0
Prenatal alcohol exposure,0.0,0.5,0.5,0.0
Conscious awareness,0.5,0.5,0.0,0.0
Implicit priming,0.0,0.5,0.0,0.5
Cognitive resources,0.5,0.0,0.5,0.0
Basal forebrain,0.5,0.0,0.5,0.0
Obsessive-compulsive disorder (OCD),0.0,0.5,0.5,0.0
Bardet-Biedl syndrome,0.0,0.5,0.5,0.0
Micronutrients,0.0,0.0,1.0,0.0
Common cause hypothesis,0.0,0.0,1.0,0.0
Active inference,0.0,1.0,0.0,0.0
Duration estimation,0.5,0.5,0.0,0.0
Inference by exclusion,0.0,0.5,0.5,0.0
Discourse processing,0.5,0.5,0.0,0.0
Visual half field,0.0,0.5,0.5,0.0
Rational analysis,0.5,0.5,0.0,0.0
Verbal ability,1.0,0.0,0.0,0.0
Behavioral control,0.0,0.0,1.0,0.0
Tower of London,0.5,0.0,0.5,0.0
Human immunodeficiency virus,0.0,0.0,1.0,0.0
Estimated glomerular filtration rate,0.5,0.0,0.5,0.0
Visual perspective-taking,1.0,0.0,0.0,0.0
Fear of falling,0.5,0.5,0.0,0.0
Interaction analysis,0.0,0.5,0.5,0.0
Outcome assessment,0.0,0.0,0.5,0.5
Microglia,0.5,0.0,0.5,0.0
Source modeling,0.5,0.0,0.5,0.0
International adoption,0.5,0.5,0.0,0.0
Oral radiology,0.0,0.0,1.0,0.0
BrainMap,0.5,0.0,0.0,0.5
Interruption,0.0,0.5,0.0,0.5
Schizophrenia and psychosis,0.0,0.0,1.0,0.0
Saccade latency,0.0,0.0,1.0,0.0
Thrombolysis,0.0,0.0,0.5,0.5
Automatic processing,0.5,0.0,0.5,0.0
Cerebral aneurysm,1.0,0.0,0.0,0.0
reasoning biases,0.5,0.5,0.0,0.0
Attentional guidance,0.0,1.0,0.0,0.0
Digit ratios,0.0,1.0,0.0,0.0
Multiple Sclerosis,0.0,0.0,0.5,0.5
Adverse events,0.0,0.0,1.0,0.0
geometric module,0.5,0.0,0.5,0.0
Endogenous,0.5,0.5,0.0,0.0
Word problem solving,0.0,0.5,0.5,0.0
Expertise in raised line drawings,0.0,0.5,0.5,0.0
Sleep-related hormone,0.0,0.0,1.0,0.0
resting state,0.0,0.5,0.0,0.5
Binding in cognition,0.0,0.0,1.0,0.0
Proteomics,0.0,0.0,1.0,0.0
Quantitative,0.0,0.5,0.5,0.0
goal maintenance,0.0,0.5,0.5,0.0
Semantic vs. pragmatic processing,0.0,0.0,1.0,0.0
methamphetamine,0.0,0.5,0.5,0.0
Altruism,1.0,0.0,0.0,0.0
?-synuclein,0.5,0.5,0.0,0.0
Picture-object recognition,0.5,0.5,0.0,0.0
Enhancement,0.0,0.0,0.5,0.5
Medical education,0.0,0.0,1.0,0.0
negative affect,0.5,0.0,0.5,0.0
virtual environments,0.0,0.0,1.0,0.0
Head orientation,0.5,0.0,0.0,0.5
evolutionary psychology,0.0,0.0,1.0,0.0
Trichotillomania,0.5,0.0,0.5,0.0
Dominance,0.0,1.0,0.0,0.0
Sensory functioning,0.0,0.0,1.0,0.0
Predictor,0.5,0.5,0.0,0.0
Brain-computer interface (BCI),0.5,0.0,0.5,0.0
Figure-ground segregation,0.0,0.0,1.0,0.0
Self-concept,0.0,0.5,0.0,0.5
Parasites,0.0,0.0,1.0,0.0
PANAS,0.0,0.5,0.5,0.0
Pre-attention,0.0,0.0,1.0,0.0
Visual cue,0.5,0.5,0.0,0.0
Functional disability,0.0,1.0,0.0,0.0
Braille reading,0.0,0.0,1.0,0.0
usability,0.0,1.0,0.0,0.0
Blood phobia,0.0,0.0,1.0,0.0
Macular pigment optical density,0.5,0.0,0.5,0.0
Neural ensemble,0.5,0.0,0.5,0.0
Interaction design,1.0,0.0,0.0,0.0
Complex partial seizures,0.0,0.5,0.5,0.0
Imageability,0.5,0.0,0.5,0.0
Fluoxetine,0.5,0.5,0.0,0.0
Progressive myoclonus epilepsy,0.0,0.0,1.0,0.0
Forecasting,0.0,0.5,0.5,0.0
Cerebral Palsy (CP),0.0,0.0,0.5,0.5
Grammatical gender,0.0,0.5,0.5,0.0
Driving errors,0.0,0.0,1.0,0.0
Television,0.0,0.0,1.0,0.0
Intentional communication,0.5,0.0,0.5,0.0
principal components analysis,0.5,0.0,0.5,0.0
Neurological soft signs,0.0,0.5,0.5,0.0
Horses,1.0,0.0,0.0,0.0
Relational matching,0.0,0.5,0.0,0.5
Phonological skills,0.0,0.5,0.5,0.0
PAD model,0.5,0.0,0.5,0.0
Asperger,0.0,0.5,0.0,0.5
Scene context,0.5,0.0,0.0,0.5
Evoked synchronization/desynchronization,0.0,0.5,0.5,0.0
Multiple micronutrients,0.0,1.0,0.0,0.0
Probability,0.0,1.0,0.0,0.0
Memory span,0.0,1.0,0.0,0.0
Energy metabolism,0.0,0.0,0.5,0.5
Grammatical class,0.5,0.0,0.5,0.0
malingering,0.0,0.0,0.5,0.5
Physiology,1.0,0.0,0.0,0.0
Eye movement recordings,0.5,0.0,0.5,0.0
Graphic design,0.0,1.0,0.0,0.0
Cue validity,0.5,0.5,0.0,0.0
QOL,0.0,0.0,1.0,0.0
number concepts,0.0,0.0,1.0,0.0
Brain volumes,0.0,0.5,0.5,0.0
Vestibular compensation,0.0,0.5,0.5,0.0
Fatty acids,0.0,0.0,0.5,0.0
Transcranial,0.0,1.0,0.0,0.0
Amnesic,0.5,0.0,0.5,0.0
Chewing gum,0.0,0.5,0.5,0.0
Pediatric epilepsy,0.5,0.0,0.0,0.5
In utero,0.5,0.0,0.5,0.0
Brahmi,0.5,0.5,0.0,0.0
Brain morphology,1.0,0.0,0.0,0.0
Hydration,0.0,0.0,1.0,0.0
Autistic traits,0.0,0.0,1.0,0.0
Face space,0.5,0.5,0.0,0.0
Steering,0.5,0.5,0.0,0.0
Visual dependence,0.0,0.0,1.0,0.0
Supramodal,1.0,0.0,0.0,0.0
Craniosynostosis,0.5,0.0,0.0,0.5
Depletion,0.0,0.5,0.5,0.0
Spatial development,0.0,0.0,0.5,0.5
Age-related differences,0.0,1.0,0.0,0.0
Neurocognitive dysfunction,0.0,0.5,0.5,0.0
problem solving,0.0,0.5,0.5,0.0
infant development,0.0,0.5,0.5,0.0
Brain SPECT,0.5,0.0,0.5,0.0
Decision theory,0.5,0.0,0.5,0.0
Binswanger's disease,0.0,0.5,0.5,0.0
Non-motor,0.0,1.0,0.0,0.0
Singleton,0.0,0.5,0.5,0.0
Autonomous robots,0.0,0.0,1.0,0.0
motor learning,0.5,0.0,0.5,0.0
Arcuate fasciculus,0.5,0.0,0.5,0.0
Thailand,0.0,0.5,0.5,0.0
Optical imaging,0.5,0.5,0.0,0.0
Normal pressure hydrocephalus,0.0,0.5,0.5,0.0
Finnish,0.5,0.0,0.5,0.0
instrumented vehicle,0.0,0.5,0.5,0.0
Religion,0.0,0.5,0.5,0.0
Event-related desynchronization (ERD),1.0,0.0,0.0,0.0
Spatial organization,0.0,0.0,1.0,0.0
SSRI,0.0,0.0,0.5,0.5
Antimuscarinic,0.0,0.0,1.0,0.0
Anthropometry,0.5,0.0,0.0,0.5
Relational reasoning,0.0,0.0,1.0,0.0
Medication,0.0,0.0,1.0,0.0
Langerhans cell histiocytosis,0.0,1.0,0.0,0.0
Hindsight bias,0.5,0.5,0.0,0.0
Corticosteroids,0.5,0.0,0.5,0.0
Visuomotor rotation,0.5,0.0,0.5,0.0
Phytoestrogens,0.0,0.0,1.0,0.0
Pulvinar,0.5,0.5,0.0,0.0
Sensory-motor,1.0,0.0,0.0,0.0
long-term memory,0.0,0.0,1.0,0.0
Late positive potential (LPP),0.0,0.0,1.0,0.0
substance abuse,0.5,0.5,0.0,0.0
Body parts,0.0,0.0,0.5,0.5
Motor expertise,0.0,0.0,1.0,0.0
motion perception,0.0,1.0,0.0,0.0
Judgment of line orientation,0.5,0.5,0.0,0.0
Hemispheric specialisation,0.0,0.0,1.0,0.0
Mathematical abilities,0.0,0.5,0.0,0.5
Verniers,1.0,0.0,0.0,0.0
Visual-matching,0.0,1.0,0.0,0.0
Human visual perception,0.5,0.5,0.0,0.0
Mild intellectual disability,0.5,0.0,0.5,0.0
Ampakine,0.0,0.5,0.0,0.5
Lexical development,0.5,0.5,0.0,0.0
Line bisection task,0.0,0.5,0.5,0.0
Management,0.0,0.5,0.5,0.0
tool use,0.0,0.0,0.5,0.5
Aspirin,0.5,0.5,0.0,0.0
Delay,0.0,0.0,1.0,0.0
Lateral spread,0.0,0.0,0.5,0.5
Spasticity,0.5,0.0,0.5,0.0
Novice drivers,0.0,0.0,0.5,0.5
Female,0.0,0.0,1.0,0.0
Magic,0.0,0.0,0.5,0.5
Expert,0.0,1.0,0.0,0.0
Sensorimotor interactions,0.5,0.5,0.0,0.0
neurorehabilitation,0.0,0.5,0.5,0.0
evaluation,0.0,0.0,1.0,0.0
psychomotor,0.5,0.0,0.5,0.0
Nonspatial attention,0.0,0.0,0.5,0.5
Attentional orienting,0.0,1.0,0.0,0.0
Recognition (psychology),0.0,1.0,0.0,0.0
Anabolic-androgenic steroids,0.0,0.0,1.0,0.0
perirhinal cortex,0.0,0.0,0.0,1.0
Category-specificity,0.5,0.5,0.0,0.0
State marker,0.0,0.5,0.0,0.5
Aesthetic preference,0.5,0.5,0.0,0.0
Social understanding,1.0,0.0,0.0,0.0
Traffic sign,0.5,0.0,0.5,0.0
motor control,0.0,0.0,1.0,0.0
caffeine,0.0,1.0,0.0,0.0
Single-cell recordings,0.0,1.0,0.0,0.0
Anaesthesia,0.0,0.0,0.5,0.0
Mild head injury,0.0,0.0,1.0,0.0
Labels,0.5,0.0,0.5,0.0
Evaluation methods,0.0,0.5,0.5,0.0
Structure-mapping,0.0,0.0,1.0,0.0
Isoflavone,0.0,0.0,0.5,0.5
Bayesian learning,0.5,0.5,0.0,0.0
dmedicine receptor,0.0,0.0,1.0,0.0
Configuration,0.5,0.5,0.0,0.0
scene perception,0.5,0.5,0.0,0.0
images,0.0,0.0,1.0,0.0
Go/Nogo,0.0,0.0,0.5,0.5
Social complexity,0.5,0.0,0.5,0.0
Cognitive architectures,0.0,0.0,1.0,0.0
Hooper Visual Organization Test,0.5,0.0,0.5,0.0
Impulse control disorders,0.0,0.0,0.5,0.5
binocular rivalry,0.0,0.5,0.5,0.0
Processing Speed,0.5,0.5,0.0,0.0
External eating,0.5,0.0,0.5,0.0
Illiterate,0.5,0.5,0.0,0.0
Color perception,1.0,0.0,0.0,0.0
anterior temporal lobe,0.5,0.0,0.5,0.0
Illusory motion,0.0,0.0,1.0,0.0
Source localisation,0.5,0.0,0.0,0.5
Face encoding,0.0,0.0,1.0,0.0
specificity,0.5,0.0,0.0,0.5
Cambridge Neuropsychological Test Automated Battery,0.0,0.5,0.0,0.5
Sampling,0.0,0.0,0.5,0.5
Hemiparesis,0.0,0.5,0.5,0.0
Sleep quality,0.5,0.0,0.5,0.0
Nerve agents,0.5,0.0,0.0,0.5
Domain knowledge,0.0,1.0,0.0,0.0
Translational,1.0,0.0,0.0,0.0
Numerical magnitude,0.0,0.0,0.5,0.5
Heat,0.0,0.5,0.5,0.0
Body movement,0.0,0.5,0.5,0.0
Fidelity,0.0,0.0,0.5,0.5
Word segmentation,0.0,0.5,0.5,0.0
Dorsal striatum,0.0,0.5,0.5,0.0
Inverse effectiveness,0.5,0.0,0.5,0.0
Visual spatial attention,0.0,0.0,1.0,0.0
Hidden Markov model,0.5,0.0,0.0,0.5
Proactive interference,0.0,0.0,1.0,0.0
Self-relevance,0.0,0.5,0.5,0.0
Osteoporosis,0.5,0.0,0.5,0.0
Thyroid hormones,0.0,0.5,0.5,0.0
Visual object identification,0.5,0.5,0.0,0.0
Deprivation,0.0,1.0,0.0,0.0
V2,0.0,0.0,0.5,0.5
hormone replacement therapy,0.5,0.5,0.0,0.0
Schemas,0.5,0.0,0.5,0.0
Perceptual comparison,0.0,0.0,0.5,0.5
Sensory cues,0.0,0.5,0.5,0.0
Crime and Law",0.0,0.0,0.0,0.0
Semantic category,0.0,0.5,0.5,0.0
Creativity support tools,0.0,0.0,1.0,0.0
Reproducibility,0.5,0.0,0.5,0.0
Neuroethics,0.0,0.0,0.0,1.0
High-grade glioma,0.5,0.0,0.0,0.5
No-go,0.5,0.0,0.5,0.0
Scene interpretation,0.5,0.5,0.0,0.0
acute stroke,0.0,0.5,0.5,0.0
Visual and auditory number assays,0.5,0.0,0.0,0.5
Motor functions,0.0,0.0,1.0,0.0
Socialization,0.5,0.0,0.5,0.0
athletes,0.5,0.0,0.5,0.0
Serotonin transporter,0.0,0.0,0.5,0.5
Ontological categories,0.0,1.0,0.0,0.0
Psychological evaluation,0.5,0.0,0.5,0.0
Task design,0.5,0.0,0.5,0.0
Semantic cognition,0.5,0.5,0.0,0.0
Lipids,0.0,0.5,0.5,0.0
Cognitive disturbances,0.0,0.5,0.5,0.0
5-HTTLPR,0.0,0.5,0.5,0.0
Ventral prefrontal cortex,0.5,0.5,0.0,0.0
Gaze tracking,0.0,0.5,0.5,0.0
gait,0.5,0.5,0.0,0.0
Spinocerebellar ataxia,0.0,0.5,0.5,0.0
Internal noise,1.0,0.0,0.0,0.0
inflammation,0.0,0.5,0.5,0.0
Analog magnitude,0.0,0.5,0.0,0.5
Neural model,0.0,0.0,0.5,0.5
Affective state,0.0,0.0,1.0,0.0
Lithuania)",0.0,0.0,0.0,0.0
source monitoring,0.5,0.5,0.0,0.0
Theta oscillation,0.0,0.5,0.0,0.5
Leukemia,0.0,0.0,1.0,0.0
Visual structure,0.0,1.0,0.0,0.0
Insect cognition,0.0,0.5,0.5,0.0
Health Utilities Index,0.0,0.5,0.5,0.0
Functional mri,0.0,0.0,1.0,0.0
Visual P300,0.0,0.0,0.0,1.0
Zinc,0.5,0.0,0.0,0.5
Controllability,0.5,0.0,0.5,0.0
Negative mood,0.5,0.5,0.0,0.0
intelligent systems,0.0,0.0,1.0,0.0
Preclinical,0.0,0.0,1.0,0.0
Primary visual area,0.5,0.0,0.0,0.5
Interhemispheric balance,0.0,0.0,1.0,0.0
Coercion,0.0,0.5,0.5,0.0
Frontostriatal circuitry,0.5,0.0,0.5,0.0
Sports concussion,0.0,0.5,0.5,0.0
Onomatopoeia,0.0,0.5,0.0,0.5
Ego depletion,0.0,0.0,1.0,0.0
Embodied Cognition,0.0,0.0,1.0,0.0
Cue effect,0.5,0.0,0.5,0.0
Autoshaping,0.0,0.5,0.0,0.5
Language perception,0.0,0.5,0.0,0.5
arithmetic,0.0,0.5,0.5,0.0
visual pathways,0.5,0.5,0.0,0.0
Complex visual hallucinations,1.0,0.0,0.0,0.0
Verbal abilities,0.0,0.5,0.5,0.0
Psychosocial,0.5,0.0,0.5,0.0
Transient cognitive impairment,0.0,0.5,0.5,0.0
Precentral gyrus,0.0,1.0,0.0,0.0
Awake surgery,0.0,0.0,1.0,0.0
Multimodality,0.0,1.0,0.0,0.0
Blue light,0.5,0.0,0.5,0.0
McGurk effect,0.0,1.0,0.0,0.0
memantine,0.0,0.0,1.0,0.0
Skill learning,0.5,0.5,0.0,0.0
Traffic noise,0.0,0.0,0.5,0.5
Indigenous,0.0,0.0,0.5,0.5
Racism,0.0,0.0,0.5,0.5
Prader-Willi syndrome,0.0,0.5,0.5,0.0
REM sleep behaviour disorder,0.0,0.5,0.5,0.0
Adulthood,0.0,0.0,1.0,0.0
Math achievement,0.0,0.5,0.0,0.5
Orthographic processing,0.0,0.0,1.0,0.0
Visuospatial ability,0.0,0.5,0.5,0.0
Basis function,0.0,0.5,0.5,0.0
Transcranial Magnetic Stimulation (TMS),0.5,0.5,0.0,0.0
Simulated driving,0.0,0.5,0.5,0.0
Schizophrenia spectrum,0.5,0.0,0.5,0.0
culture,0.0,1.0,0.0,0.0
Internalism,0.0,0.5,0.5,0.0
Assessment methods,0.0,0.5,0.5,0.0
Trauma film,0.5,0.5,0.0,0.0
Visual literacy,0.0,0.0,1.0,0.0
Functional Magnetic Resonance Imaging (fMRI),0.0,0.0,1.0,0.0
Buspirone,0.0,0.0,1.0,0.0
Carotenoids,0.0,0.0,1.0,0.0
prematurity,0.0,0.0,1.0,0.0
Broad autism phenotype,0.0,0.5,0.5,0.0
Context updating,0.0,1.0,0.0,0.0
computer-based testing,0.0,0.0,0.5,0.5
Aesthetic preferences,0.5,0.0,0.5,0.0
Hebbian learning,0.0,0.0,1.0,0.0
Wechsler Memory Scale-Third Edition,0.0,0.5,0.0,0.5
Neuropsychiatric SLE,0.5,0.5,0.0,0.0
Adrenoleukodystrophy,0.0,0.0,1.0,0.0
Mobile phone,0.0,0.0,1.0,0.0
Social brain,0.5,0.0,0.0,0.5
Facial memory,0.0,0.0,1.0,0.0
Total sleep deprivation,0.0,0.5,0.0,0.5
Social misdirection,0.0,0.5,0.5,0.0
Fall,0.0,0.5,0.5,0.0
Telemetry,0.5,0.0,0.5,0.0
Rey-Osterrieth Complex Figure,0.0,0.0,0.5,0.5
LFP,0.0,0.0,0.5,0.5
sleep quality,0.0,0.5,0.5,0.0
distributed cognition,0.0,1.0,0.0,0.0
Performance feedback,1.0,0.0,0.0,0.0
Teleology,0.0,0.5,0.5,0.0
Korea,0.0,1.0,0.0,0.0
Intentional action,0.0,0.0,1.0,0.0
Neuroleptic,0.5,0.0,0.5,0.0
Postmenopausal,0.5,0.0,0.0,0.5
Developmental outcomes,0.5,0.5,0.0,0.0
Task development,0.0,0.5,0.0,0.5
Intrinsic frame of reference,0.0,0.5,0.5,0.0
Electrocorticography,0.0,0.0,1.0,0.0
Cognitive disorder,0.0,0.5,0.5,0.0
intervention,0.0,0.5,0.0,0.5
Attentional selection,0.0,0.5,0.5,0.0
Cingulate gyrus,0.5,0.0,0.5,0.0
Behavioral disorders,0.0,0.5,0.5,0.0
Relapsing-remitting multiple sclerosis,0.5,0.5,0.0,0.0
Neocortex,0.0,0.0,1.0,0.0
Mirror tracing,0.5,0.0,0.5,0.0
Ventriloquism,0.5,0.5,0.0,0.0
Sensorimotor function,0.0,0.0,1.0,0.0
Tolerance,0.5,0.5,0.0,0.0
Chronic illness,0.0,1.0,0.0,0.0
Status epilepticus,0.5,0.0,0.0,0.5
Epileptiform activity,0.5,0.0,0.0,0.5
Neurological function,0.0,0.5,0.5,0.0
Module,0.5,0.5,0.0,0.0
Journal of the Royal College of Physicians of London",0.0,0.0,0.0,0.0
Eastern Europe,0.5,0.0,0.5,0.0
Middle temporal gyrus,0.0,0.5,0.5,0.0
Primary sensorimotor cortex,0.5,0.5,0.0,0.0
attractiveness,0.0,0.5,0.5,0.0
Reference resolution,0.0,0.0,1.0,0.0
synaesthesia,0.0,0.5,0.5,0.0
Implicit social cognition,0.0,0.0,1.0,0.0
Medicine,0.5,0.5,0.0,0.0
Context effects,0.5,0.5,0.0,0.0
RT,0.5,0.5,0.0,0.0
Clock drawing,0.0,0.0,1.0,0.0
Unconscious processes,0.0,1.0,0.0,0.0
Sheep,0.0,0.5,0.5,0.0
dialysis,0.5,0.0,0.5,0.0
ERO,0.0,0.0,0.5,0.5
ERF,0.5,0.5,0.0,0.0
Gelastic seizures,0.0,0.0,1.0,0.0
computerized testing,0.0,0.0,0.5,0.5
Conjunction,0.0,0.5,0.5,0.0
Affective control,0.5,0.0,0.5,0.0
Standardized low-resolution brain electromagnetic tomography (sLORETA),0.0,0.5,0.5,0.0
Juvenile,0.5,0.0,0.5,0.0
Distribution,0.0,0.5,0.5,0.0
Object categorization,0.5,0.5,0.0,0.0
Form,0.0,1.0,0.0,0.0
Multimodal imaging,0.5,0.5,0.0,0.0
Velo-cardio-facial syndrome (VCFS),0.5,0.5,0.0,0.0
Lead toxicity,0.5,0.0,0.5,0.0
Obstructive sleep apnea syndrome,0.0,0.5,0.5,0.0
Mental representations,0.0,0.5,0.5,0.0
Humor appreciation,0.0,0.0,1.0,0.0
Functional map,0.0,1.0,0.0,0.0
Deviant detection,0.5,0.5,0.0,0.0
Behavioral ecology,0.5,0.0,0.5,0.0
jumping to conclusions,0.5,0.5,0.0,0.0
Multifractal,0.5,0.5,0.0,0.0
Partial directed coherence,0.0,0.5,0.5,0.0
Extremely low birth weight,0.5,0.0,0.5,0.0
Place recognition,0.0,0.5,0.5,0.0
Acrophobia,0.0,0.5,0.5,0.0
Auditory stimuli,0.0,0.5,0.5,0.0
Rhythmicity,0.0,0.5,0.5,0.0
Visual repetition priming,0.5,0.5,0.0,0.0
MOT,0.0,0.0,0.5,0.5
Clock drawing test,0.0,0.0,1.0,0.0
Psychomotor vigilance task,0.0,0.5,0.5,0.0
Happy,0.5,0.0,0.5,0.0
Very preterm infants,0.0,0.5,0.5,0.0
DCM,0.0,0.0,1.0,0.0
Photographs,0.0,1.0,0.0,0.0
Action processing,0.0,0.5,0.5,0.0
Ripples,0.5,0.5,0.0,0.0
Randomised controlled trial,0.0,0.5,0.5,0.0
Contrast threshold,0.0,0.5,0.0,0.5
psychological functioning,0.0,1.0,0.0,0.0
McCollough effect,0.0,0.0,0.5,0.5
Parenting,0.5,0.0,0.5,0.0
Pediatric epilepsy surgery,0.5,0.5,0.0,0.0
Relation,0.0,1.0,0.0,0.0
Inferior parietal cortex,0.0,0.0,1.0,0.0
Face identity,1.0,0.0,0.0,0.0
Number concepts,0.0,0.5,0.5,0.0
Burnout,0.5,0.5,0.0,0.0
Monocular vision,0.0,0.0,0.5,0.5
recovery,0.0,0.0,0.5,0.5
dynamical systems,0.5,0.0,0.0,0.5
cognitive architecture,0.5,0.5,0.0,0.0
Muscarinic receptors,1.0,0.0,0.0,0.0
eye disease,0.5,0.0,0.5,0.0
Hyperactivation,0.0,0.0,1.0,0.0
Self-organization,0.0,0.0,1.0,0.0
Functional fMRI,0.0,1.0,0.0,0.0
Military,0.5,0.5,0.0,0.0
Regional cerebral blood flow,0.0,0.5,0.5,0.0
Catecholamine,0.0,0.5,0.5,0.0
neurocognitive,0.0,0.0,1.0,0.0
Methotrexate,0.0,0.5,0.5,0.0
Image segmentation,0.0,0.0,0.5,0.5
Agents,0.0,0.5,0.5,0.0
Qualitative,0.0,0.5,0.5,0.0
Amodal completion,0.0,1.0,0.0,0.0
diabetes,0.0,0.5,0.0,0.5
Assessment and Disease Monitoring",0.0,0.0,0.0,0.0
Chess,0.0,0.5,0.5,0.0
cognitive reappraisal,0.5,0.0,0.5,0.0
Temporal recalibration,0.5,0.5,0.0,0.0
Area MT,0.0,0.5,0.5,0.0
Genetic association,0.0,0.0,0.5,0.5
Interspecific communication,0.0,0.5,0.5,0.0
Superior temporal cortex,0.0,0.5,0.5,0.0
Mental image,0.0,1.0,0.0,0.0
Geometric module,0.0,1.0,0.0,0.0
Health related quality of life,0.0,0.5,0.5,0.0
Cognitive strategy,0.5,0.0,0.5,0.0
Bayesian,0.0,0.5,0.5,0.0
Dynamic vision,0.0,0.0,0.5,0.5
Set size,0.0,0.5,0.0,0.5
Blood glucose,0.0,0.0,1.0,0.0
Environmental psychology,1.0,0.0,0.0,0.0
Visual orientation,0.5,0.0,0.0,0.5
Numerical distance,0.0,1.0,0.0,0.0
Negative emotion,0.5,0.5,0.0,0.0
Nonverbal learning disabilities,0.0,0.5,0.5,0.0
Lane change test,0.5,0.5,0.0,0.0
Auditory hallucination,0.0,0.5,0.5,0.0
Occupational functioning,0.0,0.5,0.0,0.5
hormones,0.0,0.0,1.0,0.0
optic neuropathy,0.0,1.0,0.0,0.0
Hypothalamus,0.0,1.0,0.0,0.0
Courtship,0.5,0.5,0.0,0.0
Superior parietal lobule,0.0,1.0,0.0,0.0
Visual distraction,0.5,0.5,0.0,0.0
Conceptual content,0.0,0.0,1.0,0.0
Intertrial priming,0.0,0.5,0.5,0.0
Frontal function,0.5,0.5,0.0,0.0
Free-viewing,0.0,0.0,1.0,0.0
Pesticides,0.0,0.5,0.5,0.0
Glutamate receptors,0.5,0.0,0.5,0.0
Medial temporal lobe atrophy,0.0,0.5,0.5,0.0
Age-related cognitive decline,0.0,0.0,1.0,0.0
Dolphin,1.0,0.0,0.0,0.0
Goal-directed action,0.0,1.0,0.0,0.0
Cardinal directions,0.0,0.0,1.0,0.0
functional imaging,0.0,1.0,0.0,0.0
Perceptual expertise,0.5,0.5,0.0,0.0
CC2007 - Seeding Creativity: Tools,0.0,0.0,0.0,0.0
Emotional memory,0.0,0.0,1.0,0.0
Epistemology,0.0,0.5,0.5,0.0
Directed transfer function,0.0,0.5,0.5,0.0
Brands,0.0,0.0,0.5,0.5
Item response theory,0.0,0.5,0.5,0.0
Inclusive design,0.5,0.0,0.5,0.0
Negativity bias,0.0,0.5,0.5,0.0
Subjective experience,0.0,1.0,0.0,0.0
Locomotor activity,0.0,1.0,0.0,0.0
Expectancies,0.0,0.0,1.0,0.0
Peripheral arterial disease,0.0,1.0,0.0,0.0
Rey Complex Figure,0.0,1.0,0.0,0.0
Inferior longitudinal fasciculus,0.0,0.0,1.0,0.0
Patient safety,0.0,0.5,0.5,0.0
Saturation,0.0,0.5,0.5,0.0
Comparative cognitive science,0.0,0.5,0.5,0.0
Data visualization,0.0,0.5,0.5,0.0
Neonatal,0.5,0.0,0.5,0.0
Persuasion,0.0,0.5,0.5,0.0
Surface-based morphometry,0.0,0.0,0.5,0.5
cerebral perfusion,0.0,0.0,1.0,0.0
Action representations,0.5,0.0,0.5,0.0
Cartoons,0.0,0.0,0.5,0.5
Dynamic simulation,0.0,0.5,0.0,0.5
Quantitative EEG,0.0,0.5,0.5,0.0
Blood oxygen level-dependent,0.0,0.5,0.5,0.0
Cognitive work analysis,0.0,0.5,0.5,0.0
Motor awareness,0.0,0.0,0.5,0.5
Cytoarchitecture,0.0,0.0,0.5,0.5
School-aged children,0.5,0.0,0.5,0.0
neuropsychological,0.5,0.0,0.0,0.5
Radiosurgery,0.0,0.0,1.0,0.0
Object matching,0.0,0.0,1.0,0.0
Goal-directed behavior,0.0,0.0,0.5,0.5
Typicality,0.5,0.0,0.5,0.0
healthy volunteers,0.0,0.0,1.0,0.0
"Attention,0.0,0.0,0.0,0.0
Inhibitory motor control,0.5,0.0,0.5,0.0
Geriatric depression,0.0,0.5,0.5,0.0
Gaze movement,0.5,0.0,0.0,0.5
visual acuity,0.5,0.0,0.5,0.0
Rey Complex Figure Test,0.0,0.5,0.5,0.0
Conspecific,0.5,0.5,0.0,0.0
Right prefrontal cortex,0.0,0.0,1.0,0.0
functional neuroimaging,0.5,0.0,0.5,0.0
experience,0.0,0.0,1.0,0.0
Semantic decision,0.0,0.5,0.5,0.0
Nondeclarative memory,0.5,0.5,0.0,0.0
Aripiprazole,0.0,0.5,0.5,0.0
Receptive language,0.5,0.0,0.5,0.0
yoga,0.0,0.0,1.0,0.0
Compulsive buying,0.5,0.0,0.5,0.0
hypertension,0.0,0.0,1.0,0.0
Blinks,0.0,0.0,0.5,0.5
Insect,0.0,0.5,0.5,0.0
Motor timing,0.0,0.0,1.0,0.0
First impressions,0.0,0.0,1.0,0.0
Motion extrapolation,0.0,1.0,0.0,0.0
Telemedicine,0.0,1.0,0.0,0.0
Cortical circuit,0.0,0.0,0.5,0.5
Cortical activity,0.5,0.5,0.0,0.0
Visual stimulation,0.5,0.0,0.5,0.0
Latent inhibition,0.5,0.5,0.0,0.0
Oxygen,0.0,0.0,1.0,0.0
Aerobic fitness,0.0,0.0,1.0,0.0
Profile,0.5,0.0,0.5,0.0
Size,0.0,0.0,0.5,0.5
Survivorship,0.5,0.5,0.0,0.0
Cognitive neuropsychology,0.0,0.0,1.0,0.0
Subgenual cingulate cortex,0.0,0.5,0.5,0.0
Carotid stenosis,0.0,0.5,0.0,0.5
Stability,0.5,0.5,0.0,0.0
Cortical plasticity,0.5,0.5,0.0,0.0
Unconscious priming,0.5,0.0,0.5,0.0
Optical topography,0.5,0.0,0.0,0.5
Signal detection task,0.0,0.0,0.5,0.5
Document examination,0.0,1.0,0.0,0.0
Transcranial direct current stimulation (tDCS),0.0,0.0,1.0,0.0
CFQ,0.0,1.0,0.0,0.0
Cognitive enhancer,0.5,0.0,0.5,0.0
Cognition and emotion,0.0,1.0,0.0,0.0
neglect,0.0,0.5,0.5,0.0
Bayesian model selection,0.5,0.0,0.5,0.0
Whiplash,0.5,0.0,0.0,0.5
trauma,0.0,0.0,1.0,0.0
Idiothetic navigation,0.0,0.5,0.0,0.5
Visual object,0.0,0.5,0.5,0.0
Maternal behavior,0.0,0.0,0.0,1.0
Extrastriate,0.0,0.5,0.5,0.0
Visuo-motor integration,0.0,0.5,0.5,0.0
MS,0.0,1.0,0.0,0.0
Entropy,0.0,0.5,0.5,0.0
Subclinical epileptiform EEG discharges,0.5,0.0,0.5,0.0
M.,0.5,0.0,0.5,0.0
Social influence,0.5,0.5,0.0,0.0
Object manipulation,0.0,0.0,1.0,0.0
complications,0.0,0.0,1.0,0.0
Map cognition,0.5,0.0,0.5,0.0
Medial frontal gyrus,0.0,0.5,0.5,0.0
grasping,0.5,0.5,0.0,0.0
Psychosocial impact,1.0,0.0,0.0,0.0
neuropsychological performance,0.5,0.5,0.0,0.0
Mental training,0.5,0.0,0.5,0.0
Movement kinematics,0.0,0.0,1.0,0.0
survival,0.5,0.5,0.0,0.0
delayed response,0.0,0.5,0.5,0.0
C57BL/6,0.0,0.5,0.5,0.0
Horizontal connections,0.0,0.0,0.5,0.5
Dietary supplement,0.5,0.0,0.5,0.0
Ontologies,0.5,0.5,0.0,0.0
Goal habituation,0.5,0.0,0.5,0.0
P400,0.5,0.0,0.5,0.0
Pseudoword,0.0,0.0,1.0,0.0
Visual processing speed,0.0,0.5,0.0,0.5
Ventral vs. dorsal pathways,0.0,0.0,1.0,0.0
somatosensory cortex,0.0,1.0,0.0,0.0
Electrode placement,0.0,0.5,0.5,0.0
Manual search,0.5,0.5,0.0,0.0
Food deprivation,0.5,0.5,0.0,0.0
Lateral prefrontal cortex,0.0,0.0,1.0,0.0
prediction error,0.0,0.5,0.5,0.0
Visual context,0.0,0.0,1.0,0.0
Pregnenolone-sulphate,0.5,0.0,0.5,0.0
Medulloblastoma,0.0,1.0,0.0,0.0
Amplitude of low-frequency fluctuation,0.5,0.0,0.0,0.5
Parietal reach region,0.5,0.5,0.0,0.0
social anxiety disorder,0.5,0.0,0.5,0.0
RCBF,0.0,0.5,0.5,0.0
Health behavior,0.0,0.0,0.5,0.5
Language generation,0.0,0.5,0.5,0.0
Go-NoGo,0.0,0.5,0.5,0.0
Electromyography (EMG),0.0,0.5,0.5,0.0
music,0.0,0.0,1.0,0.0
Feature overlap,0.0,1.0,0.0,0.0
Social structure,0.5,0.0,0.5,0.0
Older driver,0.0,0.0,1.0,0.0
Cerebral perfusion,0.5,0.0,0.5,0.0
GABAergic inhibition,0.0,0.5,0.5,0.0
Amyloid imaging,0.0,0.0,1.0,0.0
Social communication,0.0,0.0,0.0,1.0
Search image,0.0,0.0,1.0,0.0
Critical consciousness,1.0,0.0,0.0,0.0
Inhibitory tasks,0.0,1.0,0.0,0.0
Environmental etiology,1.0,0.0,0.0,0.0
Locus shifts,0.0,0.0,1.0,0.0
Multiplicative operations,0.0,1.0,0.0,0.0
Flupenthixol decanoate,0.0,1.0,0.0,0.0
Literacy,0.0,0.0,1.0,0.0
Continuous sensory properties,0.0,0.0,1.0,0.0
Posttraumatic Cognitions Inventory,0.0,1.0,0.0,0.0
Hospital care,0.0,0.0,1.0,0.0
Hotspots,0.0,1.0,0.0,0.0
Subsumption architectures,0.0,0.0,1.0,0.0
Macrophagic myofasciitis,0.0,1.0,0.0,0.0
integration of approaches,0.0,1.0,0.0,0.0
Psychology of self,0.0,1.0,0.0,0.0
affect sensing and analysis,0.0,0.0,1.0,0.0
Gathering,0.0,0.0,1.0,0.0
CSF biomarkers,0.0,1.0,0.0,0.0
Suggestion,0.0,1.0,0.0,0.0
Pars opercularis,0.0,1.0,0.0,0.0
Epnm,0.0,1.0,0.0,0.0
Cenozoic erathem,1.0,0.0,0.0,0.0
amnesia,0.0,1.0,0.0,0.0
Transcription factors,1.0,0.0,0.0,0.0
Ventricular arrhythmias,0.0,0.0,1.0,0.0
dizocilpine,0.0,0.0,1.0,0.0
Sensory timing,0.0,0.0,1.0,0.0
Lexical-semantic representation,0.0,1.0,0.0,0.0
Latin alphabets,0.0,0.0,1.0,0.0
Neurobiological,1.0,0.0,0.0,0.0
Predictions,0.0,1.0,0.0,0.0
Tolterodine,0.0,0.0,1.0,0.0
Haptic devices,0.0,1.0,0.0,0.0
Oral health care,0.0,1.0,0.0,0.0
Parietal lobes,0.0,0.0,1.0,0.0
Pattern learning,1.0,0.0,0.0,0.0
Safety pharmacology endpoints,0.0,1.0,0.0,0.0
Congenitally and late blind,0.0,1.0,0.0,0.0
Healthy persons,0.0,0.0,1.0,0.0
paediatric,1.0,0.0,0.0,0.0
RMET,0.0,0.0,1.0,0.0
Biological night,0.0,0.0,1.0,0.0
VPA Archival Management System (VAMS),1.0,0.0,0.0,0.0
Syndromic analysis,1.0,0.0,0.0,0.0
Rationality and variability,0.0,0.0,1.0,0.0
Perceptual-cognitive,1.0,0.0,0.0,0.0
P-glycoprotein,0.0,0.0,1.0,0.0
Spatial Cognition,0.0,0.0,1.0,0.0
Central auditory processing,1.0,0.0,0.0,0.0
Target learning,0.0,0.0,1.0,0.0
Choice overload,1.0,0.0,0.0,0.0
geropsychiatry,0.0,0.0,1.0,0.0
Norwood procedure,1.0,0.0,0.0,0.0
Sexual dimorphism,1.0,0.0,0.0,0.0
Bourdieu,1.0,0.0,0.0,0.0
Binflammation,1.0,0.0,0.0,0.0
Analytical reading,0.0,0.0,1.0,0.0
Feasibility studies,0.0,1.0,0.0,0.0
Visual-spatial functioning,0.0,1.0,0.0,0.0
Impulsiveness assessment,0.0,1.0,0.0,0.0
Non-specific outcomes,1.0,0.0,0.0,0.0
Leisure,0.0,1.0,0.0,0.0
Far,0.0,1.0,0.0,0.0
Hypercortisolemia,1.0,0.0,0.0,0.0
eating behaviour,0.0,0.0,0.0,1.0
Neuroscience other (neuropsychology),1.0,0.0,0.0,0.0
Cerebral haematoma,0.0,0.0,1.0,0.0
Rate of cognitive decline,0.0,0.0,1.0,0.0
Misfortune,0.0,0.0,1.0,0.0
rational adaptation,0.0,1.0,0.0,0.0
Ventrolateral,0.0,0.0,1.0,0.0
general linear modeling,0.0,0.0,1.0,0.0
Subtle seizures,0.0,1.0,0.0,0.0
Operation enduring freedom,1.0,0.0,0.0,0.0
Central adverse events,1.0,0.0,0.0,0.0
multisensory,0.0,0.0,1.0,0.0
MTL,1.0,0.0,0.0,0.0
visual probe task,0.0,0.0,0.0,1.0
child development,0.0,0.0,1.0,0.0
Spatial analysis,0.0,1.0,0.0,0.0
Treatment response,0.0,0.0,1.0,0.0
Dwell time,1.0,0.0,0.0,0.0
Karnofsky performance scale,1.0,0.0,0.0,0.0
Secondhand smoke,0.0,0.0,0.0,1.0
Face image,0.0,0.0,1.0,0.0
Facial emotion labelling,0.0,0.0,1.0,0.0
Alcohol Clamp,0.0,1.0,0.0,0.0
Vocal nuclei,0.0,1.0,0.0,0.0
Microsaccade detection,0.0,1.0,0.0,0.0
Visual-motor skills,0.0,0.0,1.0,0.0
491 A/T polymorphism,0.0,0.0,1.0,0.0
perseveration,0.0,1.0,0.0,0.0
Depicted events,0.0,1.0,0.0,0.0
Personal-trait judgments,1.0,0.0,0.0,0.0
England)",0.0,0.0,0.0,0.0
Respiratory threat,0.0,0.0,1.0,0.0
Serotonin receptor,0.0,1.0,0.0,0.0
Tau protein,0.0,0.0,1.0,0.0
processing efficiency theory,1.0,0.0,0.0,0.0
Benzene,0.0,0.0,0.0,1.0
Environmental exposure,0.0,1.0,0.0,0.0
Panic Disorder,1.0,0.0,0.0,0.0
Alcohol interaction,0.0,1.0,0.0,0.0
Do-as-I-do paradigm,0.0,1.0,0.0,0.0
Cognitive ability screening instrument,0.0,0.0,1.0,0.0
WMS-III,0.0,1.0,0.0,0.0
Spatial PCA,1.0,0.0,0.0,0.0
Visual-systems hypothesis,0.0,0.0,0.0,1.0
Control of spatial attention,1.0,0.0,0.0,0.0
Visual contrast sensitivity,0.0,0.0,1.0,0.0
Trade-off,1.0,0.0,0.0,0.0
Acetyl-cholinesterase: pesticide,0.0,0.0,1.0,0.0
social collaboration,0.0,0.0,1.0,0.0
Visual search for colors,0.0,0.0,1.0,0.0
Unimanual learning,0.0,1.0,0.0,0.0
Heat shock proteins,0.0,0.0,1.0,0.0
Informational masking,0.0,0.0,1.0,0.0
Perceptual-relational competition,0.0,0.0,1.0,0.0
Never-medicated,0.0,0.0,1.0,0.0
Acute solvent neurotoxicity,0.0,0.0,1.0,0.0
Elliptic motions,0.0,1.0,0.0,0.0
theta,0.0,0.0,0.0,1.0
lexical process,0.0,1.0,0.0,0.0
SatO2%,0.0,0.0,0.0,1.0
Emotional memory games,0.0,0.0,1.0,0.0
Parafovea,0.0,0.0,1.0,0.0
Number-space,0.0,0.0,1.0,0.0
Ambiguous pattern,0.0,0.0,1.0,0.0
Brainstem encephalitis,0.0,1.0,0.0,0.0
Psychological need,0.0,1.0,0.0,0.0
Reading and writing,1.0,0.0,0.0,0.0
Taxonomy,0.0,0.0,1.0,0.0
Verbal reports,0.0,0.0,1.0,0.0
logistic regression analysis,0.0,1.0,0.0,0.0
Whisker,0.0,0.0,1.0,0.0
words,0.0,0.0,0.0,1.0
ophthalmology,0.0,0.0,0.0,1.0
Intellectual outcomes,0.0,0.0,0.0,1.0
Maintenance of attention,0.0,0.0,1.0,0.0
vigor,0.0,0.0,1.0,0.0
Chemo-brain,0.0,0.0,1.0,0.0
Measures,0.0,0.0,1.0,0.0
Cochlear implanted patients,0.0,1.0,0.0,0.0
Cognitive Radar,0.0,1.0,0.0,0.0
Lingering,0.0,1.0,0.0,0.0
Perceptual comparisons,0.0,0.0,1.0,0.0
inspection time,1.0,0.0,0.0,0.0
Design methodology,0.0,0.0,1.0,0.0
Vascular,0.0,0.0,1.0,0.0
Cortical folding,0.0,1.0,0.0,0.0
Mouse models,0.0,0.0,1.0,0.0
Hyperphosphorylated tau,0.0,0.0,1.0,0.0
Waveforms,1.0,0.0,0.0,0.0
distributed practice effect,1.0,0.0,0.0,0.0
Monkey recognition,1.0,0.0,0.0,0.0
Steady-state visually evoked potential (SSVEP),0.0,0.0,1.0,0.0
Picture-word interference task,1.0,0.0,0.0,0.0
Gynecologic,0.0,0.0,0.0,0.0
Free recall,1.0,0.0,0.0,0.0
Distance confounds,1.0,0.0,0.0,0.0
Altered vision near the hands,0.0,0.0,1.0,0.0
Movement related cortical potentials,0.0,0.0,1.0,0.0
memory deterioration,0.0,0.0,1.0,0.0
Cognitive syndromes,0.0,0.0,1.0,0.0
Distractor P3 (P3a),0.0,0.0,1.0,0.0
Reaching trajectories,1.0,0.0,0.0,0.0
Maternal nutrition,1.0,0.0,0.0,0.0
Verb meaning,0.0,1.0,0.0,0.0
Number form,0.0,0.0,1.0,0.0
Neuroscience history,0.0,0.0,1.0,0.0
Stimulus level conflict,0.0,1.0,0.0,0.0
Intertextuality,0.0,1.0,0.0,0.0
Conduction speed,0.0,0.0,1.0,0.0
NR1 knock-down,1.0,0.0,0.0,0.0
Amnesic effect,0.0,0.0,1.0,0.0
drug information,1.0,0.0,0.0,0.0
erroneous reading,0.0,1.0,0.0,0.0
Pointing gesture,0.0,1.0,0.0,0.0
Psychomotor Speed,0.0,1.0,0.0,0.0
Social motivation,1.0,0.0,0.0,0.0
Standing balance,1.0,0.0,0.0,0.0
Assistive text display,1.0,0.0,0.0,0.0
conversation,1.0,0.0,0.0,0.0
Grammatical diversity,0.0,0.0,0.0,1.0
Head-up display,0.0,0.0,1.0,0.0
Propointing,0.0,1.0,0.0,0.0
Remote associate problems,0.0,0.0,1.0,0.0
Circumplex,0.0,0.0,1.0,0.0
Treatment decision making,0.0,0.0,1.0,0.0
acute migraine,0.0,1.0,0.0,0.0
RAGE,0.0,0.0,1.0,0.0
Neutropenia,0.0,0.0,1.0,0.0
Fibromyalgia impact questionnaire,0.0,0.0,1.0,0.0
Property-verification task,0.0,0.0,1.0,0.0
N190,0.0,1.0,0.0,0.0
Cross-network synchrony,0.0,0.0,1.0,0.0
Dimensionality,0.0,1.0,0.0,0.0
Arts,0.0,0.0,1.0,0.0
Cognitive accuracy,0.0,0.0,1.0,0.0
Maintenance therapy,0.0,0.0,1.0,0.0
computational cognition model,0.0,0.0,1.0,0.0
Visual constancy,0.0,0.0,1.0,0.0
eye-blink startle response,1.0,0.0,0.0,0.0
Task state,0.0,1.0,0.0,0.0
Target-absent base rate,0.0,0.0,1.0,0.0
Balint syndrome,0.0,1.0,0.0,0.0
Radical order,0.0,0.0,1.0,0.0
practice,0.0,0.0,1.0,0.0
L-Buthionine-(S,0.0,0.0,0.0,0.0
Patient selection,0.0,0.0,1.0,0.0
Subconcussive,0.0,0.0,0.0,1.0
Spatiotemporal attention,0.0,0.0,1.0,0.0
Coexisting disorders,0.0,0.0,1.0,0.0
Congeners,1.0,0.0,0.0,0.0
Physical activity pattern,1.0,0.0,0.0,0.0
Photographs-containing paper,0.0,0.0,1.0,0.0
Oscillatory brain rhythms,0.0,1.0,0.0,0.0
Maintaining readiness,0.0,0.0,0.0,1.0
Vascular endothelial growth factor a,0.0,0.0,0.0,1.0
Cognitive subtractions,0.0,1.0,0.0,0.0
Org 26576,0.0,0.0,1.0,0.0
Grant-supported paper,0.0,0.0,1.0,0.0
Motor overflow movements,0.0,1.0,0.0,0.0
Demyelinating disease,0.0,0.0,1.0,0.0
Tactical deception,0.0,0.0,1.0,0.0
West syndrome,0.0,1.0,0.0,0.0
Injury severity,0.0,1.0,0.0,0.0
Opponent processing,0.0,1.0,0.0,0.0
Primary visual pathway,0.0,0.0,1.0,0.0
Diffusion-weighted,1.0,0.0,0.0,0.0
Cognitive Connectome,1.0,0.0,0.0,0.0
Achievement gap,0.0,0.0,0.0,1.0
Middle-aged,0.0,0.0,1.0,0.0
Pioglitazone,0.0,0.0,1.0,0.0
Scanner effects on performance,0.0,1.0,0.0,0.0
Psychometry and assessments in psychiatry,0.0,0.0,1.0,0.0
Gaze orientation,0.0,0.0,0.0,1.0
Dishonesty,0.0,0.0,1.0,0.0
Faces Symbol Test,0.0,0.0,1.0,0.0
repetitive transcranial magnetic stimulation,1.0,0.0,0.0,0.0
FOLATE,1.0,0.0,0.0,0.0
Multimodal analysis,0.0,0.0,1.0,0.0
Overt language production,0.0,1.0,0.0,0.0
Rs9960767,0.0,0.0,1.0,0.0
Human computer interaction interface,0.0,0.0,1.0,0.0
Ape language,0.0,0.0,1.0,0.0
Behet's syndrome,1.0,0.0,0.0,0.0
Vision and haptics,1.0,0.0,0.0,0.0
Aflibercept,0.0,0.0,1.0,0.0
Novel,0.0,1.0,0.0,0.0
Hypoxic challenge testing,0.0,0.0,1.0,0.0
Circadian period,0.0,0.0,0.0,1.0
Fast rotation,0.0,0.0,1.0,0.0
Roll optokinetic stimulation,0.0,1.0,0.0,0.0
sensory functioning,0.0,1.0,0.0,0.0
visual communication,0.0,0.0,1.0,0.0
N400m,0.0,1.0,0.0,0.0
spices,0.0,0.0,1.0,0.0
Polysensory,0.0,0.0,1.0,0.0
Microembolism,0.0,0.0,1.0,0.0
CTG repeats,0.0,0.0,1.0,0.0
glycine transport inhibitors,0.0,0.0,1.0,0.0
Situation model,0.0,0.0,1.0,0.0
Word classes,0.0,1.0,0.0,0.0
Neuropsychological phenotype,0.0,0.0,1.0,0.0
IGF,0.0,1.0,0.0,0.0
Anterodorsal nucleus of the thalamus,0.0,1.0,0.0,0.0
Oxaliplatin,0.0,0.0,0.0,1.0
Adolesecents,0.0,0.0,1.0,0.0
Short screening,0.0,0.0,1.0,0.0
ILSE,1.0,0.0,0.0,0.0
Anterior plagiocephaly,1.0,0.0,0.0,0.0
Saposin,0.0,0.0,1.0,0.0
Vertical posture,0.0,0.0,1.0,0.0
Pacemaker-accumulator systems,1.0,0.0,0.0,0.0
Periventricular lesions,1.0,0.0,0.0,0.0
Haptic strategies,1.0,0.0,0.0,0.0
Chicks,0.0,0.0,1.0,0.0
(Tele-)presence,1.0,0.0,0.0,0.0
Growth hormone deficiency,0.0,1.0,0.0,0.0
Motor-intentional,0.0,0.0,1.0,0.0
candidate appraisal,0.0,0.0,1.0,0.0
MK-0343,0.0,1.0,0.0,0.0
Viewpoint,0.0,0.0,0.0,1.0
Glycogen,0.0,0.0,1.0,0.0
Additive factors,0.0,0.0,1.0,0.0
Orbicularis oculi,1.0,0.0,0.0,0.0
Velocardiofacial syndrome (VCFS),0.0,0.0,1.0,0.0
Pattern completion,0.0,1.0,0.0,0.0
Threshold effect,0.0,0.0,1.0,0.0
Emotional mental travel,0.0,0.0,0.0,1.0
Skills,1.0,0.0,0.0,0.0
Case-control study,0.0,0.0,1.0,0.0
Audiovisual temporal distortions,1.0,0.0,0.0,0.0
Multimodal MRI,1.0,0.0,0.0,0.0
Multiple incidence families,1.0,0.0,0.0,0.0
Goiter,0.0,1.0,0.0,0.0
left ventricular assist device,0.0,0.0,1.0,0.0
context processing,0.0,0.0,1.0,0.0
Taskswitching,0.0,0.0,1.0,0.0
Random switch,0.0,1.0,0.0,0.0
Representational,1.0,0.0,0.0,0.0
A?PP/PS1,0.0,0.0,1.0,0.0
Neuronal synchronization,0.0,1.0,0.0,0.0
Reliable change,0.0,0.0,1.0,0.0
Unmedicated,0.0,0.0,1.0,0.0
Gender effect,1.0,0.0,0.0,0.0
eclampsia,0.0,0.0,1.0,0.0
human mate selection,0.0,0.0,1.0,0.0
Alzheimer diseaSe,0.0,0.0,1.0,0.0
Alstrm syndrome (ALMS),1.0,0.0,0.0,0.0
Contextual analysis,0.0,0.0,1.0,0.0
SLUMS examination,0.0,1.0,0.0,0.0
Plethodontid,1.0,0.0,0.0,0.0
Voxel-based lesion-symptom mapping,0.0,0.0,1.0,0.0
Allocentric navigation,1.0,0.0,0.0,0.0
Phasic alerting,0.0,0.0,1.0,0.0
Visual-spatial dysfunction,0.0,1.0,0.0,0.0
A theory of visual attention,0.0,1.0,0.0,0.0
Learning Disabilities,1.0,0.0,0.0,0.0
Pottraumatic stress disorder,0.0,1.0,0.0,0.0
Taichong (LR3),0.0,0.0,0.0,1.0
Car accidents,0.0,0.0,1.0,0.0
Brief battery,0.0,0.0,0.0,1.0
Profound intellectual and multiple disabilities,0.0,0.0,1.0,0.0
Latrophilin 3 (LPHN3),0.0,1.0,0.0,0.0
Internet portal pages,0.0,0.0,1.0,0.0
Single photon-emission computerized tomography (SPECT),0.0,0.0,1.0,0.0
Shamanism,1.0,0.0,0.0,0.0
Web design conventions,0.0,1.0,0.0,0.0
Color association,0.0,0.0,1.0,0.0
Direct posture matching,0.0,1.0,0.0,0.0
Abstract working memory,1.0,0.0,0.0,0.0
Gamma hand phase synchrony,0.0,1.0,0.0,0.0
Learning models,1.0,0.0,0.0,0.0
Dual sensory impairment,0.0,0.0,1.0,0.0
Prostate carcinoma,0.0,0.0,1.0,0.0
Emotion-focused,0.0,0.0,1.0,0.0
Health policy,0.0,0.0,1.0,0.0
Priority map,0.0,1.0,0.0,0.0
Resveratrol,0.0,0.0,1.0,0.0
AKT,1.0,0.0,0.0,0.0
WML,0.0,0.0,0.0,1.0
Two-digit numbers,0.0,1.0,0.0,0.0
fieldwork,0.0,0.0,0.0,1.0
Real-time feedback,0.0,1.0,0.0,0.0
Encapsulated cell biodelivery,0.0,0.0,1.0,0.0
Task-based,0.0,1.0,0.0,0.0
Figural aftereffects,0.0,1.0,0.0,0.0
Task context,0.0,0.0,0.0,1.0
Guided search,0.0,1.0,0.0,0.0
Retrospection,0.0,1.0,0.0,0.0
Syntax-prosody mapping,0.0,0.0,1.0,0.0
Identification task,1.0,0.0,0.0,0.0
Cerebral Palsy,0.0,0.0,0.0,1.0
Focal epilepsy,0.0,1.0,0.0,0.0
40 Hz,0.0,1.0,0.0,0.0
Accommodative insufficiency,1.0,0.0,0.0,0.0
Auditory cue,1.0,0.0,0.0,0.0
Cross-task compatibility,1.0,0.0,0.0,0.0
Dioxins,0.0,0.0,1.0,0.0
Musculoskeletal equilibrium,0.0,0.0,1.0,0.0
Self-rated health,0.0,0.0,1.0,0.0
Contrast reversal,0.0,1.0,0.0,0.0
Visuomotor adaptation-learning,0.0,0.0,1.0,0.0
Visuospatial construction,0.0,1.0,0.0,0.0
Poisson noise,0.0,1.0,0.0,0.0
Birding,0.0,0.0,1.0,0.0
evoked (induced) responses,1.0,0.0,0.0,0.0
Japanese Kana,0.0,0.0,1.0,0.0
ethnicity,0.0,0.0,1.0,0.0
Uncertainty monitoring,0.0,0.0,1.0,0.0
diagnostic reasoning,0.0,0.0,1.0,0.0
City,1.0,0.0,0.0,0.0
Point to origin,0.0,1.0,0.0,0.0
And set testing,1.0,0.0,0.0,0.0
Sound localisation,1.0,0.0,0.0,0.0
Coldness,0.0,0.0,1.0,0.0
Perception engineering,0.0,0.0,1.0,0.0
Bereavement,0.0,0.0,1.0,0.0
Cognitive-behavioral therapy,0.0,0.0,1.0,0.0
Fat,0.0,1.0,0.0,0.0
Chinese sentence comprehension,1.0,0.0,0.0,0.0
3D-SSP SPECT,1.0,0.0,0.0,0.0
Perceived rotation,0.0,1.0,0.0,0.0
Stimulus sampling,0.0,1.0,0.0,0.0
Women's health,1.0,0.0,0.0,0.0
Imprinting,0.0,1.0,0.0,0.0
Non-psychotic,1.0,0.0,0.0,0.0
African,0.0,0.0,1.0,0.0
Positive words,0.0,0.0,1.0,0.0
Juvenile Parkinson,0.0,0.0,1.0,0.0
Transient information,0.0,1.0,0.0,0.0
Patient outcome,1.0,0.0,0.0,0.0
Transgenic,1.0,0.0,0.0,0.0
Eyewitness confidence,0.0,1.0,0.0,0.0
Lexical processes,0.0,1.0,0.0,0.0
Moderate drinking,1.0,0.0,0.0,0.0
Cognitive and functional impairment,0.0,0.0,1.0,0.0
Number sense impairment,0.0,1.0,0.0,0.0
opioid analgesics,0.0,0.0,1.0,0.0
2-Back task,1.0,0.0,0.0,0.0
Visuospatial short-term memory (STM),0.0,0.0,1.0,0.0
Figural analogies,0.0,0.0,1.0,0.0
Heading disorientation,0.0,0.0,0.0,1.0
art,1.0,0.0,0.0,0.0
affect regulation,0.0,0.0,0.0,1.0
Menopausal women,0.0,1.0,0.0,0.0
scanpaths,0.0,0.0,1.0,0.0
Faux pas,0.0,0.0,0.0,1.0
motion sickness,0.0,0.0,1.0,0.0
Tursiops truncatus,1.0,0.0,0.0,0.0
Proto-objects,1.0,0.0,0.0,0.0
Acetyl cholinesterase inhibitors,0.0,0.0,1.0,0.0
M-CHAT,0.0,1.0,0.0,0.0
steady-state visual evoked potentia,0.0,1.0,0.0,0.0
Attention deficit/hyperactivity disorder rating scale,0.0,0.0,1.0,0.0
Subjective confidence,0.0,0.0,1.0,0.0
Russell-Silver Syndrome,0.0,0.0,1.0,0.0
Magnet resonance imaging (MRI),0.0,0.0,1.0,0.0
Severe internal carotid artery stenosis,0.0,0.0,1.0,0.0
Gait variability,0.0,0.0,1.0,0.0
causality,0.0,1.0,0.0,0.0
geomatics,0.0,0.0,1.0,0.0
Cerebral hemispheres,0.0,1.0,0.0,0.0
Action sequence,0.0,0.0,1.0,0.0
Bitemporal,0.0,0.0,1.0,0.0
Serial position curve,0.0,0.0,1.0,0.0
Stimulus-dimension,0.0,1.0,0.0,0.0
Aided symbols,0.0,0.0,1.0,0.0
HMAX,0.0,1.0,0.0,0.0
preclinical phases,0.0,0.0,0.0,1.0
Informed consent,0.0,0.0,1.0,0.0
Late-onset Friedreich ataxia,1.0,0.0,0.0,0.0
Jeannerod,0.0,0.0,0.0,1.0
Parieto-prefrontal cortex,0.0,1.0,0.0,0.0
Visual evidence,0.0,0.0,1.0,0.0
Perceptual meanings,0.0,0.0,1.0,0.0
Locked in,0.0,0.0,1.0,0.0
Raven's Coloured Progressive Matrices,0.0,0.0,0.0,1.0
Systemic chemotherapy,0.0,0.0,0.0,1.0
3D hypermedia,0.0,0.0,0.0,1.0
Familiar people processing,0.0,1.0,0.0,0.0
Neonatal care,0.0,1.0,0.0,0.0
Midwifery,1.0,0.0,0.0,0.0
Overlap,0.0,1.0,0.0,0.0
spatial puzzle solving,0.0,1.0,0.0,0.0
APFC,0.0,0.0,1.0,0.0
RT variability,0.0,1.0,0.0,0.0
Motor learning-control,1.0,0.0,0.0,0.0
Joystick,0.0,1.0,0.0,0.0
Slit viewing,0.0,0.0,1.0,0.0
Dual process signal detection model,0.0,0.0,1.0,0.0
Visual analogue scale (VAS),0.0,1.0,0.0,0.0
Pain thresholds,0.0,0.0,1.0,0.0
MPTP,0.0,1.0,0.0,0.0
Synergetics,0.0,0.0,1.0,0.0
Activational effects,1.0,0.0,0.0,0.0
ISOFLAVONES,1.0,0.0,0.0,0.0
Emotional Stroop,0.0,0.0,1.0,0.0
Emotional processes,1.0,0.0,0.0,0.0
Partner-matching (PM),1.0,0.0,0.0,0.0
Precue activity,1.0,0.0,0.0,0.0
Vestibulo-ocular reflexe,0.0,0.0,1.0,0.0
Subjective alertness,0.0,0.0,1.0,0.0
Genetic syndrome,0.0,0.0,0.0,1.0
palliative care,1.0,0.0,0.0,0.0
Vestibular disorders,1.0,0.0,0.0,0.0
Chronic headaches,0.0,0.0,0.0,1.0
Facial stimuli,0.0,1.0,0.0,0.0
Anterior interhemispheric approach,0.0,0.0,1.0,0.0
Stereotactic neurosurgery,0.0,0.0,1.0,0.0
Depersonalization,1.0,0.0,0.0,0.0
Collapse,0.0,0.0,1.0,0.0
Doubling,0.0,1.0,0.0,0.0
Macronutrients,0.0,0.0,1.0,0.0
Choice-reaction task,1.0,0.0,0.0,0.0
C.957C > T polymorphism,1.0,0.0,0.0,0.0
Saliency model,0.0,0.0,1.0,0.0
Math skills,1.0,0.0,0.0,0.0
Sulcal patterns,0.0,0.0,0.0,1.0
Shape analysis,0.0,1.0,0.0,0.0
Mental travel,1.0,0.0,0.0,0.0
pointing movement,0.0,1.0,0.0,0.0
Sensori-motor integration,0.0,0.0,1.0,0.0
Cognitive trait,0.0,0.0,1.0,0.0
Frontal variant frontotemporal dementia,1.0,0.0,0.0,0.0
Lightning,0.0,1.0,0.0,0.0
Object tracking system,0.0,1.0,0.0,0.0
Parkinsonian syndrome,0.0,0.0,1.0,0.0
Mandarin,1.0,0.0,0.0,0.0
People with Parkinson's (PwPs),1.0,0.0,0.0,0.0
dietary supplementation,0.0,0.0,1.0,0.0
Oculomotor assessment,0.0,0.0,0.0,1.0
Darbepoetin,0.0,1.0,0.0,0.0
Nicotine Stroop,0.0,0.0,1.0,0.0
DAT1,0.0,1.0,0.0,0.0
Visuo-spatial learning and memory,0.0,1.0,0.0,0.0
Secondary school children,0.0,0.0,1.0,0.0
Neurobehavioral profile,0.0,1.0,0.0,0.0
ERD/ERS (event-related desynchronization/event-related synchronization),1.0,0.0,0.0,0.0
Refractory,1.0,0.0,0.0,0.0
Williams syndrome - psychology physiopathology,0.0,0.0,1.0,0.0
Subclinical phase,0.0,1.0,0.0,0.0
Childhood brain insult,0.0,0.0,1.0,0.0
time-frequency analysis,0.0,0.0,1.0,0.0
Cathepsin F,0.0,0.0,1.0,0.0
Verbal production,0.0,0.0,1.0,0.0
Diffuse Lewy body disease,0.0,1.0,0.0,0.0
Qualitative case study,0.0,0.0,1.0,0.0
SERMs,0.0,0.0,0.0,1.0
Serendipity,1.0,0.0,0.0,0.0
Multiple sklerosis,0.0,0.0,1.0,0.0
primate,0.0,0.0,1.0,0.0
Spatial familiarity,0.0,0.0,1.0,0.0
Control theory,0.0,1.0,0.0,0.0
Horizontal propagation,0.0,1.0,0.0,0.0
Barriers,0.0,0.0,1.0,0.0
Time-frequency representation,0.0,0.0,1.0,0.0
Docosahexaenoic acid (DHA),0.0,1.0,0.0,0.0
Critical flicker fusion,0.0,0.0,1.0,0.0
associative processes,0.0,1.0,0.0,0.0
hand orientation,1.0,0.0,0.0,0.0
Hick effect,1.0,0.0,0.0,0.0
Motor Free Visual-Perception Test (MVPT),0.0,0.0,1.0,0.0
Image retrieval,0.0,0.0,1.0,0.0
Spatial terms,0.0,0.0,1.0,0.0
Fitts'law,0.0,0.0,1.0,0.0
EEG delta activity,0.0,0.0,1.0,0.0
liver transplant,1.0,0.0,0.0,0.0
Psychosocial rehabilitation,0.0,0.0,1.0,0.0
Chorea,0.0,0.0,1.0,0.0
Necrotizing enterocolitis,1.0,0.0,0.0,0.0
myotonic dystrophy,0.0,1.0,0.0,0.0
the Legion of the Archangel Michael,1.0,0.0,0.0,0.0
Behavioural,0.0,1.0,0.0,0.0
dengineering/d-lifescience,0.0,1.0,0.0,0.0
Myocardial infarction,0.0,1.0,0.0,0.0
prosthetic hand,0.0,0.0,1.0,0.0
The senses,0.0,1.0,0.0,0.0
P300 components,0.0,0.0,1.0,0.0
Virtual partner interaction,0.0,0.0,1.0,0.0
functioning,0.0,0.0,0.0,1.0
Baroreceptor activity,1.0,0.0,0.0,0.0
tactile stimulator,0.0,0.0,0.0,1.0
Pancreatic cancer,0.0,0.0,1.0,0.0
basal forebrain,0.0,1.0,0.0,0.0
Temporoparietal cortex,0.0,0.0,1.0,0.0
Basic beliefs,0.0,1.0,0.0,0.0
Knowledges,0.0,1.0,0.0,0.0
Launch event,0.0,0.0,1.0,0.0
Shading,0.0,0.0,0.0,1.0
attentional deficits,0.0,0.0,0.0,1.0
Genetic syndromes,0.0,0.0,1.0,0.0
Temporal orienting,1.0,0.0,0.0,0.0
Event-related activity,0.0,0.0,0.0,1.0
Human robot interaction,1.0,0.0,0.0,0.0
Frame problem,0.0,0.0,0.0,1.0
Pictorial space,1.0,0.0,0.0,0.0
Acute episode,0.0,0.0,1.0,0.0
gaze correction,1.0,0.0,0.0,0.0
cognition-aware computing,0.0,0.0,1.0,0.0
Aversive pictures,0.0,0.0,1.0,0.0
First episode psychosis (FEP),0.0,0.0,1.0,0.0
Neuro-cognition,0.0,0.0,1.0,0.0
Cognitive predictors,0.0,1.0,0.0,0.0
CNS,0.0,0.0,1.0,0.0
Multiple cueing,0.0,0.0,1.0,0.0
procedural memory,0.0,0.0,1.0,0.0
drivingDriving,1.0,0.0,0.0,0.0
acute pain,0.0,1.0,0.0,0.0
Agrammatism,0.0,0.0,1.0,0.0
Corticospinal excitability,0.0,1.0,0.0,0.0
OCDS,0.0,0.0,0.0,1.0
ashwagandha,0.0,0.0,1.0,0.0
Empirical Bayes,0.0,0.0,0.0,1.0
Twin,0.0,1.0,0.0,0.0
cochlear implant,0.0,0.0,1.0,0.0
Task-oriented,0.0,0.0,0.0,1.0
Memory fMRI,0.0,0.0,0.0,1.0
demyelination,0.0,0.0,1.0,0.0
Ro 04-6790,0.0,0.0,1.0,0.0
RDK,0.0,0.0,1.0,0.0
Coupling,1.0,0.0,0.0,0.0
ODD,0.0,0.0,0.0,1.0
Gamma-aminobutyric acid,0.0,0.0,0.0,1.0
Hyperammonemia,0.0,0.0,1.0,0.0
Somnolence,1.0,0.0,0.0,0.0
Theta phase synchronization,0.0,0.0,0.0,1.0
hypothermia,0.0,0.0,1.0,0.0
Dementia with Lewy Bodies,1.0,0.0,0.0,0.0
hypothalamus,1.0,0.0,0.0,0.0
BCAA,1.0,0.0,0.0,0.0
Polyunsaturated fatty acids,0.0,1.0,0.0,0.0
Snakes,1.0,0.0,0.0,0.0
Insomnia related to a mental disorder,0.0,0.0,0.0,1.0
Parametric fMRI,0.0,0.0,1.0,0.0
Neglect simulation,1.0,0.0,0.0,0.0
Elderly outpatients,1.0,0.0,0.0,0.0
Navigation skill,0.0,0.0,0.0,1.0
film and memory,0.0,0.0,1.0,0.0
Peripheral luminance,0.0,0.0,1.0,0.0
Noninvasive telemetry,0.0,1.0,0.0,0.0
CAREN,0.0,0.0,1.0,0.0
Neuropsychology Cognition,0.0,1.0,0.0,0.0
Transgenic mouse models,0.0,0.0,1.0,0.0
Emotional stroop,1.0,0.0,0.0,0.0
Steady state visual evoked potentials,0.0,0.0,0.0,1.0
The binding problem,0.0,0.0,0.0,1.0
Telerehabilitation,0.0,1.0,0.0,0.0
Stimulus Onset Asynchrony,0.0,1.0,0.0,0.0
geriatrics,0.0,0.0,0.0,1.0
Driver's behavior,0.0,0.0,1.0,0.0
neural mechanism,0.0,0.0,1.0,0.0
Delusional misidentifications,0.0,0.0,1.0,0.0
Taste preferences,0.0,1.0,0.0,0.0
Early detection of cancer,0.0,0.0,1.0,0.0
Topiramate (TPM),1.0,0.0,0.0,0.0
analytical thinking,0.0,0.0,1.0,0.0
Anti-aquaporin-4 antibody,0.0,0.0,1.0,0.0
Applications,0.0,1.0,0.0,0.0
Dimensional overlap model,0.0,0.0,1.0,0.0
insular cortex,1.0,0.0,0.0,0.0
Object function,0.0,0.0,1.0,0.0
Dependent elderly people,0.0,1.0,0.0,0.0
Theta burst,1.0,0.0,0.0,0.0
episodic buffer,1.0,0.0,0.0,0.0
2D,1.0,0.0,0.0,0.0
Access to care,0.0,1.0,0.0,0.0
Trail-making Test,1.0,0.0,0.0,0.0
IT,0.0,1.0,0.0,0.0
Memory-based strategy,0.0,0.0,0.0,1.0
Context gain,0.0,0.0,1.0,0.0
Representation of senses,0.0,1.0,0.0,0.0
Interhemispheric collaboration,1.0,0.0,0.0,0.0
social problem solving,0.0,0.0,1.0,0.0
Content,0.0,1.0,0.0,0.0
Tone quality,0.0,0.0,1.0,0.0
Sensory function,0.0,0.0,1.0,0.0
Free space testing,1.0,0.0,0.0,0.0
Brain pathology,0.0,0.0,0.0,1.0
Backtracking,0.0,1.0,0.0,0.0
Weight judgment,1.0,0.0,0.0,0.0
Visual half-field task,0.0,0.0,0.0,1.0
dual-tasking,0.0,1.0,0.0,0.0
Point-light display,0.0,1.0,0.0,0.0
Complex networks,0.0,0.0,1.0,0.0
Way-finding training,1.0,0.0,0.0,0.0
Aniline compounds,1.0,0.0,0.0,0.0
Three-dimensional graphics and realism,0.0,0.0,0.0,1.0
Letter-position encoding,0.0,0.0,1.0,0.0
Creutzfeldt-Jacob disease,1.0,0.0,0.0,0.0
Semantic hub,0.0,0.0,1.0,0.0
conceptual understanding,0.0,1.0,0.0,0.0
Huprine X,0.0,1.0,0.0,0.0
Scoring,0.0,1.0,0.0,0.0
Bounded rationality,1.0,0.0,0.0,0.0
and cybernetics,0.0,0.0,1.0,0.0
Muscarinic antagonist,0.0,1.0,0.0,0.0
car-driving simulator,0.0,1.0,0.0,0.0
Alpha-amylase,0.0,0.0,0.0,1.0
Time representation,0.0,1.0,0.0,0.0
Contingent negative variation (CNV),0.0,0.0,0.0,1.0
linguistic categorization model,0.0,0.0,1.0,0.0
Crossmodal suppression,0.0,1.0,0.0,0.0
Cloninger,0.0,1.0,0.0,0.0
Modality-specific processing,1.0,0.0,0.0,0.0
Leukoencephalopathies,0.0,0.0,1.0,0.0
Free viewing,0.0,0.0,1.0,0.0
Constructive matching,0.0,0.0,1.0,0.0
Visual-spatial skills,0.0,0.0,1.0,0.0
"Magnetic resonance imaging,0.0,0.0,0.0,0.0
Judgement and decision-making,0.0,0.0,1.0,0.0
Mu rhythm suppression,0.0,0.0,0.0,1.0
Causal inference,0.0,0.0,1.0,0.0
Computational creativity,0.0,1.0,0.0,0.0
Vascular headaches,0.0,0.0,0.0,1.0
Hand stabilization,0.0,1.0,0.0,0.0
Implicit conceptual tests,0.0,0.0,1.0,0.0
Disease risk factors,0.0,0.0,1.0,0.0
Predator visual system,0.0,1.0,0.0,0.0
Featural,0.0,0.0,1.0,0.0
expectation,0.0,0.0,1.0,0.0
Violence,0.0,1.0,0.0,0.0
Rational constructivism,0.0,0.0,0.0,1.0
Word extension,0.0,0.0,1.0,0.0
Iconic displays,0.0,0.0,0.0,1.0
Perceptual deficit,1.0,0.0,0.0,0.0
Tomkins,1.0,0.0,0.0,0.0
Articulatory,0.0,0.0,0.0,1.0
Brief Repeatable Battery of Neuropsychological Tests,0.0,1.0,0.0,0.0
Voltage-sensitive dye,0.0,1.0,0.0,0.0
HBOT,0.0,0.0,1.0,0.0
Temporal position,1.0,0.0,0.0,0.0
Trichostatin A,0.0,0.0,0.0,1.0
Vinpocetine,0.0,0.0,1.0,0.0
non-visual cognition,0.0,0.0,1.0,0.0
Highly active antiretroviral therapy,0.0,0.0,1.0,0.0
Aversion,0.0,0.0,1.0,0.0
Centella asiatica,0.0,1.0,0.0,0.0
Total power,0.0,0.0,1.0,0.0
cultural cognition,0.0,0.0,0.0,1.0
Synaptic learning mechanisms,0.0,0.0,1.0,0.0
Questionable dementia,0.0,0.0,0.0,1.0
Theta-burst stimulation,0.0,0.0,1.0,0.0
Longitudinal investigation,0.0,0.0,1.0,0.0
Regularity detection,0.0,0.0,1.0,0.0
Perception",0.0,1.0,0.0,0.0
Basic number abilities,0.0,0.0,1.0,0.0
Visual-spatial memory,0.0,1.0,0.0,0.0
Memory Island,0.0,0.0,1.0,0.0
Dicyclomine,0.0,1.0,0.0,0.0
Intellectual impairment,1.0,0.0,0.0,0.0
Cost-benefit analysis,0.0,0.0,1.0,0.0
Mitochondria,0.0,1.0,0.0,0.0
IQ decline,0.0,0.0,1.0,0.0
Zllner illusion,0.0,1.0,0.0,0.0
Conscious visual awareness,0.0,0.0,1.0,0.0
Behavioural contagion,0.0,0.0,1.0,0.0
motion,1.0,0.0,0.0,0.0
Illinois Agility Test,0.0,1.0,0.0,0.0
Visual culture,0.0,0.0,1.0,0.0
Ideomotor apraxia,1.0,0.0,0.0,0.0
Learning from television,0.0,1.0,0.0,0.0
antihistamines,0.0,1.0,0.0,0.0
food deprivation,0.0,1.0,0.0,0.0
biased competition,0.0,1.0,0.0,0.0
Typewriting,0.0,0.0,1.0,0.0
Visual information pick-up,1.0,0.0,0.0,0.0
Real-time modeling,0.0,0.0,1.0,0.0
Decision-making skills,0.0,1.0,0.0,0.0
NADPH oxidase,0.0,1.0,0.0,0.0
Transient visual preference,0.0,0.0,1.0,0.0
Sexual assault,1.0,0.0,0.0,0.0
Adrenergic blockade,1.0,0.0,0.0,0.0
Kenya,0.0,0.0,1.0,0.0
Time assessment,0.0,1.0,0.0,0.0
Face categorization,0.0,1.0,0.0,0.0
N-Acetylaspartate,0.0,1.0,0.0,0.0
Bevacizumab,0.0,0.0,1.0,0.0
Speech comprehension,1.0,0.0,0.0,0.0
pyridoxine,1.0,0.0,0.0,0.0
Cognitive Radio,0.0,1.0,0.0,0.0
Spatial frames,1.0,0.0,0.0,0.0
Deaf subjects,0.0,0.0,0.0,1.0
Ocularcentrism,0.0,0.0,1.0,0.0
Populations at risk,0.0,1.0,0.0,0.0
Central monitoring,0.0,1.0,0.0,0.0
5-HT1A,0.0,0.0,1.0,0.0
5-HT1B,0.0,0.0,1.0,0.0
Spatial resolution,0.0,0.0,1.0,0.0
Periventricular hyperintensities,0.0,0.0,1.0,0.0
Quantitative reasoning,0.0,0.0,1.0,0.0
Seizure disorders,0.0,0.0,1.0,0.0
Elite karate athletes,0.0,0.0,1.0,0.0
Social perceptual processes,0.0,1.0,0.0,0.0
Task negative,0.0,0.0,1.0,0.0
Schema theory,0.0,0.0,0.0,1.0
Dark chamber,0.0,0.0,1.0,0.0
Rhesus Monkey,0.0,0.0,0.0,1.0
Attention function,0.0,0.0,0.0,1.0
Triptan,0.0,1.0,0.0,0.0
Latency to persistent sleep,0.0,0.0,1.0,0.0
Reaching space,0.0,1.0,0.0,0.0
Visual saccades,0.0,1.0,0.0,0.0
Corrugator EMG,1.0,0.0,0.0,0.0
Audio-visual contribution,1.0,0.0,0.0,0.0
proactive interference,0.0,0.0,1.0,0.0
Behavioral disorder,0.0,1.0,0.0,0.0
Light wavelength,1.0,0.0,0.0,0.0
Social signals,0.0,1.0,0.0,0.0
Clock-Drawing Task (Clock Test),0.0,0.0,1.0,0.0
HINT (hearing in noise test),0.0,1.0,0.0,0.0
ERS/ERD,1.0,0.0,0.0,0.0
Automatic face processing,0.0,0.0,1.0,0.0
Agonist treatment,0.0,0.0,1.0,0.0
psychomotor impairment,1.0,0.0,0.0,0.0
apolipoprotein E,0.0,1.0,0.0,0.0
Linguistic conventions,0.0,0.0,1.0,0.0
Multiple foci of attention,0.0,0.0,1.0,0.0
Moral psychology,0.0,1.0,0.0,0.0
Ego- and allocentrism,0.0,0.0,1.0,0.0
joint factor analysis,0.0,0.0,0.0,1.0
Columnar processing,0.0,1.0,0.0,0.0
Ovarian hormones,1.0,0.0,0.0,0.0
Magnetic fields,0.0,0.0,1.0,0.0
RFID,0.0,0.0,0.0,1.0
Inflexibility,0.0,0.0,1.0,0.0
Spatial structure,1.0,0.0,0.0,0.0
Stereotactic radiotherapy,0.0,0.0,1.0,0.0
Clinical neurophysiology,0.0,0.0,1.0,0.0
Visual-spatial sketchpad,0.0,0.0,1.0,0.0
nicotine dependence,0.0,0.0,1.0,0.0
Neuroepidemiology,0.0,0.0,1.0,0.0
Block design task,0.0,1.0,0.0,0.0
Preschoolers' cognition,0.0,0.0,1.0,0.0
Post concussion,0.0,1.0,0.0,0.0
Obstructive sleep apnoea syndrome,0.0,0.0,1.0,0.0
Perceived risk,1.0,0.0,0.0,0.0
Ad hoc categories,1.0,0.0,0.0,0.0
Visual perception and cognition,0.0,1.0,0.0,0.0
Singular,0.0,0.0,1.0,0.0
Orofacial pain,0.0,0.0,1.0,0.0
Thatcher's illusion,1.0,0.0,0.0,0.0
Category-specific responses,1.0,0.0,0.0,0.0
Analog-based neurofeedback,0.0,1.0,0.0,0.0
computation,0.0,1.0,0.0,0.0
Steady-state responses,1.0,0.0,0.0,0.0
3D surface and shape perception,0.0,1.0,0.0,0.0
visual function and dry eye,0.0,1.0,0.0,0.0
subliminal priming,1.0,0.0,0.0,0.0
Magnetic field tomography (MFT),0.0,0.0,1.0,0.0
Pursuit Aiming (PAT),1.0,0.0,0.0,0.0
extremely low birth weight,0.0,0.0,1.0,0.0
Narrative transportation,0.0,1.0,0.0,0.0
life-expectancy,1.0,0.0,0.0,0.0
Interferon-alpha,0.0,1.0,0.0,0.0
Conceptual representation,0.0,0.0,0.0,1.0
symbolic development,0.0,1.0,0.0,0.0
height fear,0.0,1.0,0.0,0.0
Barprobe,0.0,0.0,0.0,1.0
Dissociative states,0.0,0.0,0.0,1.0
Large-scale cortical networks,0.0,0.0,1.0,0.0
Alzheimer's patients,0.0,1.0,0.0,0.0
adenosine,0.0,0.0,1.0,0.0
teachers cognition,0.0,0.0,0.0,1.0
premotor cortex,0.0,0.0,1.0,0.0
Visual evoked alpha oscillations,0.0,1.0,0.0,0.0
Agency attribution,0.0,0.0,1.0,0.0
Late blind,0.0,0.0,0.0,1.0
Fepsy,0.0,1.0,0.0,0.0
"fMRI,0.0,0.0,0.0,0.0
Theta waves,0.0,0.0,1.0,0.0
Melodic intonation therapy,0.0,0.0,1.0,0.0
effective connectivity,0.0,1.0,0.0,0.0
Fixations identification,0.0,0.0,1.0,0.0
Interactive learning environments,0.0,1.0,0.0,0.0
Race differences,0.0,0.0,1.0,0.0
17-beta Estradiol,0.0,0.0,1.0,0.0
Control over environment,0.0,0.0,1.0,0.0
Kidney,0.0,0.0,1.0,0.0
Concurrent motor task,0.0,1.0,0.0,0.0
compensatory chanisms,0.0,0.0,1.0,0.0
Theories,0.0,0.0,1.0,0.0
Pedestrians,0.0,0.0,1.0,0.0
The Montreal Cognitive Assessment,0.0,1.0,0.0,0.0
Aripirazole,0.0,1.0,0.0,0.0
Concept hierarchy,0.0,1.0,0.0,0.0
Perceptual event prediction,0.0,1.0,0.0,0.0
object-background relations,0.0,1.0,0.0,0.0
evoked desynchronization,0.0,0.0,1.0,0.0
Soft bipolar spectrum,0.0,0.0,1.0,0.0
Individualization,0.0,0.0,1.0,0.0
On-line processing,0.0,0.0,0.0,1.0
neurovascular coupling,0.0,0.0,1.0,0.0
Atropine,1.0,0.0,0.0,0.0
Developmental cognitive neuroscience,0.0,0.0,0.0,1.0
Visuospatial peak,0.0,0.0,0.0,1.0
Place classification,0.0,1.0,0.0,0.0
Visual lateralization,1.0,0.0,0.0,0.0
Discrimination entropy,0.0,1.0,0.0,0.0
Cascaded,0.0,0.0,1.0,0.0
Health practices,0.0,1.0,0.0,0.0
Seniors,0.0,0.0,1.0,0.0
Autistic behavior,0.0,0.0,1.0,0.0
Task interference,0.0,0.0,0.0,1.0
Gaze-contingent display changes,0.0,0.0,1.0,0.0
Racial identity,0.0,0.0,1.0,0.0
Late-preterm,0.0,0.0,1.0,0.0
Bleulerian autism,0.0,1.0,0.0,0.0
Raven,0.0,1.0,0.0,0.0
Plural,0.0,0.0,1.0,0.0
Postural adjustment,0.0,1.0,0.0,0.0
Hastening,0.0,1.0,0.0,0.0
Psychophysical methods,0.0,1.0,0.0,0.0
Model-based neuroscience,1.0,0.0,0.0,0.0
Scaling laws,1.0,0.0,0.0,0.0
Pattern Comparison Processing Speed Test,1.0,0.0,0.0,0.0
cognitive workload,1.0,0.0,0.0,0.0
Change of pose,0.0,0.0,1.0,0.0
Bonobo,0.0,0.0,1.0,0.0
Recognition of facial expression,0.0,0.0,1.0,0.0
Glaucoma/suspect,1.0,0.0,0.0,0.0
Time-frequency-topography,0.0,1.0,0.0,0.0
Eye movement pattern,1.0,0.0,0.0,0.0
Regulatory focus,0.0,0.0,1.0,0.0
antidepressants,0.0,0.0,1.0,0.0
Neurocognitive factor structures,0.0,0.0,1.0,0.0
And justice for all,1.0,0.0,0.0,0.0
Pharmacovigilance,1.0,0.0,0.0,0.0
Cognitive side effects,0.0,0.0,1.0,0.0
action selection,0.0,0.0,0.0,1.0
Iron-folate supplementation,0.0,1.0,0.0,0.0
miRNA,0.0,0.0,1.0,0.0
D-cycloserine,1.0,0.0,0.0,0.0
Mathematics Intervention,1.0,0.0,0.0,0.0
Predicting,1.0,0.0,0.0,0.0
binge,0.0,1.0,0.0,0.0
Cognitive Penetrability of Perception,0.0,0.0,1.0,0.0
lexical-semantic rehabilitation,0.0,0.0,1.0,0.0
VRS,0.0,0.0,1.0,0.0
Alzheimers,0.0,0.0,1.0,0.0
Multi-domain MCI,0.0,0.0,1.0,0.0
Dorso-lateral prefrontal cortex,0.0,1.0,0.0,0.0
Hemispheric contribution,0.0,1.0,0.0,0.0
Multiple-demand network,0.0,1.0,0.0,0.0
One-trial learning,0.0,1.0,0.0,0.0
Brain natriuretic peptide,1.0,0.0,0.0,0.0
Audiovisual speech integration,1.0,0.0,0.0,0.0
Adult mice,0.0,0.0,0.0,1.0
Synaptotagmin,0.0,0.0,1.0,0.0
startle,1.0,0.0,0.0,0.0
Conceptual neuroplasticity,1.0,0.0,0.0,0.0
acute disseminated encephalomyelitis,0.0,0.0,1.0,0.0
Ego-rotation,0.0,0.0,1.0,0.0
Visuoperceptual skills,1.0,0.0,0.0,0.0
Seizure duration,0.0,0.0,1.0,0.0
Leukoencephalopathy,0.0,1.0,0.0,0.0
Time-resolved decoding,0.0,0.0,1.0,0.0
"Cerebrovascular disorders,0.0,0.0,0.0,0.0
Contemporary education system,0.0,0.0,1.0,0.0
Sexual interest,0.0,0.0,1.0,0.0
""Novel"" metaphors,0.0,0.0,1.0,0.0
Giants of geriatric medicine,0.0,0.0,1.0,0.0
Dysarthria-clumsy hand,0.0,0.0,1.0,0.0
Unintentional injury,0.0,0.0,1.0,0.0
Erp-validation of subtyped risks,0.0,0.0,0.0,1.0
mind perception,0.0,0.0,0.0,1.0
Multi-Criteria Decision Making (MCDM),0.0,0.0,1.0,0.0
Visual metacognition,1.0,0.0,0.0,0.0
Disparity,0.0,0.0,1.0,0.0
Poor outcome,0.0,1.0,0.0,0.0
Controlled rearing,0.0,0.0,0.0,1.0
Sex pheromones,0.0,1.0,0.0,0.0
Emergency Management of Sudden Disasters,1.0,0.0,0.0,0.0
Markov chain,0.0,1.0,0.0,0.0
Grade IV intraventricular hemorrhage,0.0,0.0,0.0,1.0
Software design,0.0,0.0,1.0,0.0
bimanual response,1.0,0.0,0.0,0.0
Event-related field,0.0,1.0,0.0,0.0
Search strategy,0.0,0.0,1.0,0.0
Fingerprint analysis,0.0,1.0,0.0,0.0
Action-understanding,0.0,0.0,1.0,0.0
Transparency,0.0,0.0,0.0,1.0
Sphingomyelin lipidosis,0.0,0.0,1.0,0.0
audition,1.0,0.0,0.0,0.0
Slaughter,0.0,0.0,1.0,0.0
Learning assessment,0.0,0.0,1.0,0.0
Psychic,0.0,0.0,1.0,0.0
Developmental follow-up,0.0,1.0,0.0,0.0
Event-related brain potentials (ERP),0.0,1.0,0.0,0.0
zero,0.0,1.0,0.0,0.0
Eovked potentials,1.0,0.0,0.0,0.0
Haptico-visual transfert,0.0,0.0,1.0,0.0
Phosphodiester,0.0,0.0,1.0,0.0
Swimming activity,0.0,1.0,0.0,0.0
Stochastic processes,1.0,0.0,0.0,0.0
holistic versus analytic cognition,0.0,0.0,1.0,0.0
mercury,0.0,1.0,0.0,0.0
Processing styles,0.0,0.0,1.0,0.0
Non-resonance parametric amplification,0.0,0.0,1.0,0.0
Brain and behavior,1.0,0.0,0.0,0.0
N4 potential,1.0,0.0,0.0,0.0
A theory of magnitude (ATOM),0.0,1.0,0.0,0.0
Local reference,1.0,0.0,0.0,0.0
Cognitive changes,0.0,1.0,0.0,0.0
Maze-learning,0.0,0.0,0.0,1.0
GCC,0.0,0.0,1.0,0.0
Hierarchical clustering analysis independent component analysis,0.0,0.0,1.0,0.0
Visual prosthesis,0.0,0.0,1.0,0.0
backward masking,0.0,0.0,1.0,0.0
emphysema,0.0,1.0,0.0,0.0
Psychosis-proneness,0.0,1.0,0.0,0.0
Real time,1.0,0.0,0.0,0.0
Phobias,1.0,0.0,0.0,0.0
Analytic/nonanalytic cognition,0.0,1.0,0.0,0.0
Premutation,0.0,1.0,0.0,0.0
Copying,0.0,0.0,1.0,0.0
Childhood development,0.0,0.0,0.0,1.0
independent,0.0,1.0,0.0,0.0
Transport,0.0,0.0,1.0,0.0
Developmental psychopathology,0.0,0.0,1.0,0.0
choir,1.0,0.0,0.0,0.0
Visual Attention,0.0,0.0,1.0,0.0
Computer based assessment,0.0,0.0,1.0,0.0
Judaism,0.0,0.0,1.0,0.0
Spain,1.0,0.0,0.0,0.0
writing,0.0,0.0,1.0,0.0
Neural-swarm models,0.0,0.0,1.0,0.0
Bispectrum,0.0,0.0,1.0,0.0
Social representation,0.0,1.0,0.0,0.0
physical activity smoking,0.0,1.0,0.0,0.0
Word and pseudoword decoding,0.0,0.0,0.0,1.0
Internal working models,1.0,0.0,0.0,0.0
Chromosome 17p,1.0,0.0,0.0,0.0
interpretation,0.0,0.0,1.0,0.0
Consumer risk,0.0,0.0,1.0,0.0
Dichotomous,0.0,1.0,0.0,0.0
Alcohol prime dose,0.0,0.0,1.0,0.0
pseudoneglect,0.0,0.0,1.0,0.0
Learning technology,1.0,0.0,0.0,0.0
cognitive intervention,1.0,0.0,0.0,0.0
Re-orienting negativity (RON),1.0,0.0,0.0,0.0
Visual-motor control,0.0,0.0,1.0,0.0
Approach-withdrawal,0.0,0.0,1.0,0.0
Chimpanzees (Pan troglodytes),0.0,1.0,0.0,0.0
Disease-specific quality of life,0.0,0.0,0.0,0.0
Cognitive effort,1.0,0.0,0.0,0.0
relational reasoning,0.0,0.0,0.0,1.0
Cholinergic treatment,0.0,0.0,1.0,0.0
cognitive style,1.0,0.0,0.0,0.0
Cognitive fluctuation,0.0,0.0,0.0,1.0
Composite effect,0.0,1.0,0.0,0.0
appraisal,0.0,0.0,0.0,1.0
Think and No-Think task,0.0,0.0,1.0,0.0
Perceptual judgements,0.0,1.0,0.0,0.0
Distance estimation,0.0,0.0,1.0,0.0
Silver generation,0.0,0.0,1.0,0.0
Premutation status,0.0,0.0,1.0,0.0
Phonological facilitation,0.0,0.0,1.0,0.0
Mood-change,1.0,0.0,0.0,0.0
Body composition,1.0,0.0,0.0,0.0
EEG gamma activity,0.0,0.0,1.0,0.0
Contour interpolation,0.0,1.0,0.0,0.0
Bimodality,0.0,0.0,1.0,0.0
Social foraging,0.0,0.0,1.0,0.0
Taurine,0.0,1.0,0.0,0.0
Flexible behavior,1.0,0.0,0.0,0.0
Firefighter,0.0,1.0,0.0,0.0
FK962,0.0,1.0,0.0,0.0
Support,1.0,0.0,0.0,0.0
Adaptive systems,0.0,0.0,1.0,0.0
Painful physical symptoms,0.0,1.0,0.0,0.0
chronic lung disease glucocorticoids,1.0,0.0,0.0,0.0
Theta burst stimulation,0.0,0.0,1.0,0.0
Minimally invasive surgical procedures,0.0,0.0,1.0,0.0
Thalamic lesion,0.0,1.0,0.0,0.0
Visual spatial function,0.0,0.0,1.0,0.0
Top-down extension,1.0,0.0,0.0,0.0
ethanol,1.0,0.0,0.0,0.0
Psychological stress,0.0,1.0,0.0,0.0
Keywords Dyslexia,0.0,0.0,1.0,0.0
Behavioral and psychological symptoms of dementia,0.0,0.0,1.0,0.0
Spatial pooling,0.0,1.0,0.0,0.0
Visual models,1.0,0.0,0.0,0.0
Neurophysiological pattern,0.0,1.0,0.0,0.0
Beta oscillations neurocognitive functioning,1.0,0.0,0.0,0.0
Medial orbitofrontal,0.0,1.0,0.0,0.0
Implicit timing,0.0,0.0,1.0,0.0
Spatial-representation,1.0,0.0,0.0,0.0
Everyday-living skills,0.0,0.0,1.0,0.0
driver distraction,0.0,1.0,0.0,0.0
Practical art,0.0,0.0,1.0,0.0
Stress hormones,0.0,1.0,0.0,0.0
Go,0.0,1.0,0.0,0.0
Executive abilities,0.0,1.0,0.0,0.0
system control,1.0,0.0,0.0,0.0
subcortical vascular cognitive impairment,0.0,0.0,1.0,0.0
Embodied theory,0.0,1.0,0.0,0.0
Objecthood,0.0,1.0,0.0,0.0
Drug monitoring,0.0,0.0,1.0,0.0
Head movements,0.0,0.0,1.0,0.0
Timing mechanism,0.0,1.0,0.0,0.0
Art-making,0.0,1.0,0.0,0.0
Deductive process,0.0,0.0,1.0,0.0
Passive avoidance,0.0,0.0,1.0,0.0
Color trails,0.0,0.0,1.0,0.0
Training tools for rehabilitation,0.0,1.0,0.0,0.0
LIFG,0.0,0.0,0.0,1.0
SCPE,0.0,1.0,0.0,0.0
Computational aesthetics,1.0,0.0,0.0,0.0
Executive functioning and processing speed,0.0,0.0,1.0,0.0
test usage,0.0,1.0,0.0,0.0
Multi-unit activity,0.0,0.0,1.0,0.0
SSVEP neural network,0.0,0.0,1.0,0.0
Light-from-above,0.0,0.0,0.0,1.0
Gastrin,0.0,0.0,1.0,0.0
interhemispheric communication,0.0,0.0,1.0,0.0
stimulant,1.0,0.0,0.0,0.0
Postmodern,1.0,0.0,0.0,0.0
RAND/UCLA appropriateness method,0.0,0.0,1.0,0.0
Age-related vision disorders,1.0,0.0,0.0,0.0
Contextual cuing,0.0,0.0,1.0,0.0
Mental functions,1.0,0.0,0.0,0.0
Visual organization,0.0,0.0,0.0,1.0
Information-source markers,0.0,1.0,0.0,0.0
WISC-III,0.0,0.0,1.0,0.0
Cost of illness,0.0,0.0,0.0,0.0
Sam68,0.0,0.0,1.0,0.0
Space constancy,0.0,0.0,0.0,1.0
Mesocorticolimbic dopaminergic system,1.0,0.0,0.0,0.0
Temporal segmentation,1.0,0.0,0.0,0.0
Search organization,0.0,0.0,1.0,0.0
Stepping response,0.0,0.0,1.0,0.0
Political cartoons,0.0,0.0,1.0,0.0
local and global processing,0.0,0.0,1.0,0.0
Screening for school entry,0.0,1.0,0.0,0.0
Cytopathology,0.0,1.0,0.0,0.0
Visual regularity,0.0,0.0,1.0,0.0
H3 antagonist,0.0,1.0,0.0,0.0
Severe major depression,0.0,1.0,0.0,0.0
chronic,1.0,0.0,0.0,0.0
Mirror masking,1.0,0.0,0.0,0.0
Receptive fields,0.0,0.0,1.0,0.0
D-dimer,0.0,1.0,0.0,0.0
Kapalabhathi,1.0,0.0,0.0,0.0
RDoC,0.0,1.0,0.0,0.0
Hemodynamics,1.0,0.0,0.0,0.0
conflict N2,0.0,1.0,0.0,0.0
Nausea and vomiting,1.0,0.0,0.0,0.0
Visual choice,1.0,0.0,0.0,0.0
Computational modelling,0.0,1.0,0.0,0.0
noise,0.0,1.0,0.0,0.0
Longitudinal MR imaging,1.0,0.0,0.0,0.0
Rural development,0.0,0.0,1.0,0.0
Sensory information,0.0,1.0,0.0,0.0
Useful Field of View Test,0.0,0.0,1.0,0.0
Subjective appetite,0.0,0.0,1.0,0.0
Movement imitation,0.0,1.0,0.0,0.0
Motor nerve,1.0,0.0,0.0,0.0
Psychotropic medication,1.0,0.0,0.0,0.0
Gaze feedback,1.0,0.0,0.0,0.0
Bayley Scales of Infant and Toddler Development,0.0,0.0,0.0,0.0
Rey-Osterrieth Complex Figure test,0.0,0.0,1.0,0.0
Ergogenic aid,0.0,1.0,0.0,0.0
Vascular mild cognitive impairment,0.0,0.0,1.0,0.0
CIND,0.0,0.0,1.0,0.0
Noise assessment,0.0,1.0,0.0,0.0
Neurodevelopmental deficits,0.0,0.0,0.0,1.0
Digimon/Pokmon,1.0,0.0,0.0,0.0
Cortico-cortical axons,0.0,1.0,0.0,0.0
Negative BOLD responses,0.0,0.0,0.0,1.0
VITAMIN B12,1.0,0.0,0.0,0.0
tactile display,0.0,0.0,0.0,1.0
executive,1.0,0.0,0.0,0.0
Semantic networks,0.0,1.0,0.0,0.0
Dually diagnosed patients,1.0,0.0,0.0,0.0
Metabotropic glutamate receptor,1.0,0.0,0.0,0.0
ICA-dual regression,0.0,0.0,1.0,0.0
Universal design,0.0,0.0,1.0,0.0
Hemispheric perfusion asymmetries,0.0,0.0,1.0,0.0
Hyperglycemia,0.0,1.0,0.0,0.0
judgment,0.0,0.0,1.0,0.0
Teachers,0.0,0.0,1.0,0.0
Verbal irony,0.0,0.0,1.0,0.0
traumatic brain injury rehabilitation,1.0,0.0,0.0,0.0
long-term follow-up,0.0,1.0,0.0,0.0
Top-down feedback,0.0,0.0,1.0,0.0
Naming speed,1.0,0.0,0.0,0.0
Normative cognition,0.0,0.0,1.0,0.0
Visual pattern understanding,0.0,0.0,1.0,0.0
false-positive error,1.0,0.0,0.0,0.0
Endogenous cue,0.0,0.0,1.0,0.0
Motility,0.0,0.0,1.0,0.0
Anticipatory activity,1.0,0.0,0.0,0.0
Attentional interference,1.0,0.0,0.0,0.0
Neurodevelopmental,0.0,1.0,0.0,0.0
Equol,0.0,0.0,1.0,0.0
basolateral amygdala,0.0,0.0,1.0,0.0
Emotion preference,1.0,0.0,0.0,0.0
EEG bands activity,0.0,0.0,1.0,0.0
pain catastrophizing,0.0,1.0,0.0,0.0
A-412997,0.0,1.0,0.0,0.0
BCCD HET mice,0.0,1.0,0.0,0.0
Military Veterans,1.0,0.0,0.0,0.0
Posterior fossa tumor,0.0,0.0,1.0,0.0
multiple colors,0.0,0.0,1.0,0.0
Intermittent Theta Burst Stimulation (TBS),0.0,1.0,0.0,0.0
Diagnostic imaging,1.0,0.0,0.0,0.0
Attention disorders,0.0,1.0,0.0,0.0
Reference space,0.0,0.0,1.0,0.0
Dltion 22q11.2,0.0,1.0,0.0,0.0
Psychometric hepatic encephalopathy score,0.0,1.0,0.0,0.0
Subjective probability,0.0,0.0,1.0,0.0
Attentional orientation,1.0,0.0,0.0,0.0
RGB colour space,0.0,1.0,0.0,0.0
Coordinate frames,0.0,1.0,0.0,0.0
Durability,0.0,0.0,1.0,0.0
Epinastine,0.0,1.0,0.0,0.0
Time-on-task,0.0,1.0,0.0,0.0
Recurrent depression,1.0,0.0,0.0,0.0
Electropalatography,0.0,1.0,0.0,0.0
"""red win effect"",0.0,0.0,1.0,0.0
Innate factors,0.0,0.0,1.0,0.0
Visiospatial attention,1.0,0.0,0.0,0.0
distractor,0.0,1.0,0.0,0.0
State-dependent,0.0,0.0,1.0,0.0
Waking electroencephalogram,0.0,0.0,1.0,0.0
Clock paradigm,1.0,0.0,0.0,0.0
Connectomics,0.0,0.0,1.0,0.0
Auditory performances,0.0,0.0,1.0,0.0
Stimulant dependence,0.0,1.0,0.0,0.0
Generalize,0.0,0.0,1.0,0.0
Source signals,0.0,1.0,0.0,0.0
Types of meaning,0.0,1.0,0.0,0.0
Ability focused,0.0,0.0,1.0,0.0
Mllerian mimicry,0.0,0.0,1.0,0.0
Postconcussive syndrome,0.0,1.0,0.0,0.0
protocol analysis,0.0,0.0,1.0,0.0
Monocular blindness,0.0,0.0,1.0,0.0
Work of art,0.0,1.0,0.0,0.0
Stimulus velocity,0.0,0.0,0.0,1.0
Conscientiousness,0.0,0.0,1.0,0.0
Illuminant estimation,0.0,0.0,1.0,0.0
Intraventricular,0.0,1.0,0.0,0.0
Theory of Event Coding,1.0,0.0,0.0,0.0
Uhrp,0.0,0.0,1.0,0.0
sickle cell,0.0,0.0,0.0,1.0
selection,0.0,0.0,0.0,1.0
Reverse-correlation,1.0,0.0,0.0,0.0
Rey complex figure test,0.0,0.0,1.0,0.0
Steady-state auditory evoked potentials,0.0,0.0,1.0,0.0
Emotional processing bias,0.0,0.0,1.0,0.0
Laparoscopic surgery,1.0,0.0,0.0,0.0
Rural,0.0,0.0,1.0,0.0
Workload assessment,1.0,0.0,0.0,0.0
Body iron,0.0,0.0,1.0,0.0
Takashima study,1.0,0.0,0.0,0.0
Transient visual evoked potentials,1.0,0.0,0.0,0.0
Strain comparison,0.0,0.0,1.0,0.0
Learning mechanisms,0.0,0.0,0.0,1.0
Field setting,0.0,0.0,0.0,1.0
Noise correlation,0.0,0.0,1.0,0.0
preterm,0.0,1.0,0.0,0.0
Rostral anterior cingulate cortex,1.0,0.0,0.0,0.0
Ginkgo,0.0,0.0,1.0,0.0
modified Telephone Interview of Cognitive Status,0.0,0.0,1.0,0.0
Emotion-cognition interactions,0.0,0.0,1.0,0.0
locomotor pointing,0.0,1.0,0.0,0.0
Subjective sleepiness,0.0,0.0,0.0,1.0
UNIQUE HUES,1.0,0.0,0.0,0.0
Trap-jaw ants,0.0,0.0,1.0,0.0
Microbiota,0.0,0.0,1.0,0.0
compensation,1.0,0.0,0.0,0.0
Delayed match-to-sample (DMS),0.0,1.0,0.0,0.0
Genetic correlation,1.0,0.0,0.0,0.0
Attention deficit and hyperactivity disorder,0.0,0.0,0.0,1.0
Lacune,0.0,1.0,0.0,0.0
Cross-modal representation,0.0,0.0,1.0,0.0
Between-subject variance,0.0,1.0,0.0,0.0
Ankle,0.0,0.0,0.0,1.0
Discriminability of alternatives,0.0,0.0,0.0,1.0
Semantic impairment,0.0,0.0,1.0,0.0
Precedence effect,0.0,0.0,1.0,0.0
baroreflex sensitivity,0.0,1.0,0.0,0.0
CSv,0.0,1.0,0.0,0.0
Telephone Inventory for Cognitive Status,0.0,1.0,0.0,0.0
Sephanoides sephaniodes,0.0,0.0,1.0,0.0
Cognitive Assessment System,0.0,1.0,0.0,0.0
preschool evaluation,1.0,0.0,0.0,0.0
Working memory",0.0,1.0,0.0,0.0
Reliable,1.0,0.0,0.0,0.0
Cerebral maturation,0.0,0.0,1.0,0.0
CSE,0.0,0.0,0.0,1.0
JAK2/STAT3,0.0,0.0,1.0,0.0
Rabin,0.0,1.0,0.0,0.0
language and visual arts,0.0,0.0,0.0,1.0
Omitted stimuli,0.0,1.0,0.0,0.0
Subclinical,0.0,0.0,0.0,1.0
Maternal prenatal depression,0.0,0.0,1.0,0.0
Bilateral activation,0.0,1.0,0.0,0.0
Number processing development,0.0,0.0,1.0,0.0
Autonomic,0.0,1.0,0.0,0.0
Social identity,1.0,0.0,0.0,0.0
ADORA2A,1.0,0.0,0.0,0.0
Cognition disturbance,0.0,1.0,0.0,0.0
Aged 65 and older,0.0,0.0,1.0,0.0
Goal-oriented navigation,0.0,0.0,1.0,0.0
Sleep-wake,0.0,0.0,1.0,0.0
Mechanical-operators,0.0,0.0,1.0,0.0
Discirculatory encephalopathy,0.0,0.0,1.0,0.0
Neurosonemic field,0.0,0.0,1.0,0.0
Human associative learning,0.0,1.0,0.0,0.0
Classification problem solving,1.0,0.0,0.0,0.0
Diabetes Mellitus,0.0,1.0,0.0,0.0
Multi-modality,0.0,0.0,1.0,0.0
lateralization,1.0,0.0,0.0,0.0
ocular motor disorders,0.0,1.0,0.0,0.0
Closing-in,1.0,0.0,0.0,0.0
relativity,1.0,0.0,0.0,0.0
Exposure in vivo,0.0,1.0,0.0,0.0
antipsychotic,0.0,0.0,1.0,0.0
Postoperative cognitive recovery,1.0,0.0,0.0,0.0
Graph isomorphism,0.0,1.0,0.0,0.0
Eye metrics,0.0,0.0,1.0,0.0
EEG and cognitive abilities,0.0,1.0,0.0,0.0
community mass care,0.0,0.0,1.0,0.0
semantic variant of primary progressive aphasia,0.0,1.0,0.0,0.0
ABR,0.0,1.0,0.0,0.0
P3 amplitude,0.0,0.0,1.0,0.0
Clustering fMRI time series,0.0,0.0,1.0,0.0
Short-term spectral patterns,0.0,0.0,0.0,1.0
Spatial binding,0.0,0.0,1.0,0.0
Resting state connectivity,0.0,0.0,1.0,0.0
Change analysis,0.0,0.0,0.0,1.0
Response execution,0.0,1.0,0.0,0.0
Extrapyramidal symptoms,0.0,0.0,1.0,0.0
High-functioning pervasive developmental disorders,0.0,1.0,0.0,0.0
[F-18]fluorodeoxyglucose-PET imaging,1.0,0.0,0.0,0.0
Pilates,0.0,1.0,0.0,0.0
memory working,0.0,1.0,0.0,0.0
Quantitative electroencephalography,0.0,1.0,0.0,0.0
Behavioral variant of frontotemporal dementia,1.0,0.0,0.0,0.0
HTR3A,0.0,0.0,0.0,1.0
HTR3C,0.0,0.0,0.0,1.0
HTR3B,0.0,0.0,0.0,1.0
HTR3E,0.0,0.0,0.0,1.0
HTR3D,0.0,0.0,0.0,1.0
Congenital heart disease/defects,0.0,1.0,0.0,0.0
Memory deficit,0.0,0.0,1.0,0.0
Stimulus unmasking,1.0,0.0,0.0,0.0
Gerstmann syndrome,0.0,1.0,0.0,0.0
MDS,0.0,0.0,1.0,0.0
alcohol drinking,0.0,0.0,1.0,0.0
Spatial strategies,1.0,0.0,0.0,0.0
MDD,0.0,1.0,0.0,0.0
Trajectory encoding,0.0,0.0,0.0,1.0
MDA,0.0,1.0,0.0,0.0
stereo display,0.0,0.0,1.0,0.0
Mirrored letters,0.0,0.0,1.0,0.0
Phenomenal,0.0,0.0,1.0,0.0
Null,0.0,0.0,1.0,0.0
Electrical source imaging,0.0,1.0,0.0,0.0
Opportunistic browsing,1.0,0.0,0.0,0.0
Psychopathological,1.0,0.0,0.0,0.0
Neurofibromatosis,1.0,0.0,0.0,0.0
Vestibular-autonomic response,0.0,1.0,0.0,0.0
Neuropsychological bedside screening,1.0,0.0,0.0,0.0
Voluntary saccades,1.0,0.0,0.0,0.0
Rare stimulus,0.0,0.0,1.0,0.0
Short-term visual memory,0.0,0.0,1.0,0.0
DEHYDROEPIANDROSTERONE,1.0,0.0,0.0,0.0
Maintenance treatment,0.0,1.0,0.0,0.0
"Accommodation,0.0,0.0,0.0,0.0
Diffuse Lewy body dementia,0.0,0.0,1.0,0.0
Cross-modal PRP paradigm,1.0,0.0,0.0,0.0
Cue processing,0.0,0.0,1.0,0.0
Search images,1.0,0.0,0.0,0.0
Rey-Osterrieth Complex Figure Test,0.0,1.0,0.0,0.0
Non-spatial memory,0.0,0.0,1.0,0.0
Egocentric referencing,0.0,1.0,0.0,0.0
Analytical-techniques,0.0,1.0,0.0,0.0
Rasmussen's encephalitis,0.0,0.0,1.0,0.0
Asenapine,0.0,1.0,0.0,0.0
Strategic filtering,1.0,0.0,0.0,0.0
Dorsomedial prefrontal cortex,0.0,0.0,1.0,0.0
noninvasive neurostimulation,0.0,1.0,0.0,0.0
Complication,0.0,0.0,0.0,1.0
Spout-lever,0.0,0.0,1.0,0.0
age-related macular degeneration,1.0,0.0,0.0,0.0
oddball N2,0.0,1.0,0.0,0.0
Non affective,0.0,0.0,1.0,0.0
Bump modeling,0.0,1.0,0.0,0.0
Non-genomic,1.0,0.0,0.0,0.0
Geometry of space,0.0,0.0,0.0,1.0
Visual abilities,0.0,0.0,1.0,0.0
Picks disease,1.0,0.0,0.0,0.0
Acute central nervous system effects,0.0,1.0,0.0,0.0
Zazen,0.0,0.0,1.0,0.0
Neurobehavioral functions,0.0,0.0,1.0,0.0
Young novice drivers,1.0,0.0,0.0,0.0
Lapses of attention,0.0,0.0,0.0,1.0
Information transfer,1.0,0.0,0.0,0.0
Hemiplegic cerebral palsy,0.0,0.0,1.0,0.0
Derogatory appraisal,0.0,0.0,1.0,0.0
brief repeatable battery of neuropsychological tests,0.0,0.0,1.0,0.0
Prise en charge,0.0,1.0,0.0,0.0
Cognition and perception theory,0.0,0.0,1.0,0.0
action observation,0.0,1.0,0.0,0.0
Estrogen receptor,0.0,0.0,1.0,0.0
Intelligence analysis,0.0,0.0,1.0,0.0
Soy isoflavones,0.0,0.0,1.0,0.0
Traveling salesperson problem,0.0,0.0,1.0,0.0
pesticides,0.0,0.0,0.0,1.0
Critical time window hypothesis,1.0,0.0,0.0,0.0
humanities,0.0,0.0,0.0,1.0
fluency,0.0,0.0,1.0,0.0
Infrared image,1.0,0.0,0.0,0.0
Eyeblink,0.0,1.0,0.0,0.0
General intelligence,0.0,0.0,1.0,0.0
Brain source estimation,0.0,1.0,0.0,0.0
Displays and controls,0.0,0.0,1.0,0.0
Hemiplegia-hemiconvulsion-epilepsy syndrome,0.0,0.0,1.0,0.0
assisted living facilities (ALFs),0.0,1.0,0.0,0.0
Neurobehavioral tests,1.0,0.0,0.0,0.0
Attentional scaling,0.0,1.0,0.0,0.0
PDE4 inhibition,0.0,0.0,0.0,1.0
Panax ginseng,0.0,0.0,1.0,0.0
1/f noise,0.0,1.0,0.0,0.0
Numerical comparison,1.0,0.0,0.0,0.0
New Caledonian crows,1.0,0.0,0.0,0.0
PACAP27,0.0,1.0,0.0,0.0
Mozart effect,0.0,0.0,1.0,0.0
Auditory cognitive dysfunction,1.0,0.0,0.0,0.0
Mental stress,0.0,0.0,0.0,1.0
Crowd Simulation,1.0,0.0,0.0,0.0
Bistable percepts,1.0,0.0,0.0,0.0
Spatial transformation ability,0.0,1.0,0.0,0.0
Stage 2,0.0,0.0,1.0,0.0
Computerized neuropsychological test,0.0,0.0,1.0,0.0
Literal,0.0,0.0,1.0,0.0
Wechsler Memory Scale - III,0.0,1.0,0.0,0.0
Tangible interfaces,1.0,0.0,0.0,0.0
Attentional breadth,0.0,1.0,0.0,0.0
Emotion-attention interactions,1.0,0.0,0.0,0.0
Rapid decay,1.0,0.0,0.0,0.0
Ciliary function,0.0,1.0,0.0,0.0
Trajectory control,0.0,0.0,0.0,1.0
Cross-sensory,0.0,1.0,0.0,0.0
"Anaesthesia,0.0,0.0,0.0,0.0
Prescription labelling,0.0,0.0,0.0,1.0
Pantomime grasps,0.0,0.0,1.0,0.0
Nonverbal cognition,0.0,0.0,1.0,0.0
Connectivity analysis,0.0,0.0,1.0,0.0
Pupil dynamics,0.0,1.0,0.0,0.0
pictorial stimuli,0.0,1.0,0.0,0.0
glycosylation,0.0,1.0,0.0,0.0
brain polarization,0.0,0.0,1.0,0.0
Relative clause attachment ambiguity,0.0,0.0,0.0,1.0
Shared representations,0.0,1.0,0.0,0.0
Auditory instructions,0.0,1.0,0.0,0.0
prototyping,0.0,0.0,1.0,0.0
Interpersonal behavior,0.0,0.0,0.0,1.0
SMEI borderline cases,0.0,1.0,0.0,0.0
Composite reliability,0.0,1.0,0.0,0.0
Time pressure,0.0,0.0,1.0,0.0
Ze 117,0.0,1.0,0.0,0.0
Multimodal feedback,0.0,1.0,0.0,0.0
Bimodal bilingualism,0.0,0.0,1.0,0.0
Frontal dysfunction,0.0,0.0,1.0,0.0
vitritis,0.0,1.0,0.0,0.0
phenomenology,0.0,0.0,1.0,0.0
Diagnostic systems,0.0,0.0,0.0,1.0
neuro-oncology,1.0,0.0,0.0,0.0
Security visualization,0.0,1.0,0.0,0.0
medroxyprogesterone,0.0,0.0,1.0,0.0
multisecond oscillations,0.0,0.0,1.0,0.0
Insight problems,1.0,0.0,0.0,0.0
Anaphoric processing,1.0,0.0,0.0,0.0
Word superiority effect,0.0,0.0,1.0,0.0
Semantic congruity,0.0,0.0,1.0,0.0
Sensory-motor system,0.0,0.0,0.0,1.0
Mental manipulation,0.0,1.0,0.0,0.0
Eye-gaze,0.0,0.0,1.0,0.0
retinal vessel calibre,1.0,0.0,0.0,0.0
Visual-perception,0.0,0.0,1.0,0.0
Long-acting opioids,0.0,1.0,0.0,0.0
Visual scanpath,0.0,1.0,0.0,0.0
Action video game,1.0,0.0,0.0,0.0
cognitive bias modification,0.0,0.0,0.0,1.0
Cerebral ventricle,0.0,0.0,1.0,0.0
Instrumental discrimination,0.0,1.0,0.0,0.0
Transverse diffusivity,0.0,1.0,0.0,0.0
Cardiac cycle,1.0,0.0,0.0,0.0
Receiver Operating Curve,0.0,1.0,0.0,0.0
NMDA receptor activity,0.0,1.0,0.0,0.0
Temporal Lobe Epilepsy (TLE),0.0,0.0,1.0,0.0
Current source density reconstruction (CDR),0.0,1.0,0.0,0.0
Synbiotics,0.0,0.0,1.0,0.0
Cognitive insight,0.0,0.0,1.0,0.0
Portable eye-tracking technology,0.0,0.0,1.0,0.0
A lexical decision task,0.0,1.0,0.0,0.0
Analytical databases,0.0,1.0,0.0,0.0
frontal-parietal networks,0.0,1.0,0.0,0.0
Humour,0.0,0.0,1.0,0.0
Partial-report,0.0,1.0,0.0,0.0
Vis--Vis,0.0,1.0,0.0,0.0
human children,1.0,0.0,0.0,0.0
Ethology,0.0,0.0,1.0,0.0
Arithmetic rules,0.0,0.0,1.0,0.0
Escames,1.0,0.0,0.0,0.0
Visuo-constructive function,0.0,0.0,1.0,0.0
Stability and support operations,0.0,0.0,1.0,0.0
Syndrome vlocardiofacial,0.0,1.0,0.0,0.0
vmPFC,0.0,1.0,0.0,0.0
Logics,0.0,1.0,0.0,0.0
hydrogen proton magnetic resonance spectroscopy,1.0,0.0,0.0,0.0
Traumatic diffusion tensor imaging,0.0,1.0,0.0,0.0
reinforcement learning,0.0,1.0,0.0,0.0
Recent falls,0.0,0.0,0.0,1.0
Ideas of reference,1.0,0.0,0.0,0.0
Response-mapping,0.0,1.0,0.0,0.0
Seasonal darkness,0.0,1.0,0.0,0.0
Dog-Human Interaction,0.0,1.0,0.0,0.0
Intrinsic motivation,0.0,0.0,1.0,0.0
Gait rehabilitation,0.0,0.0,1.0,0.0
Ocal processing,0.0,0.0,1.0,0.0
neurodegenerative disease,0.0,1.0,0.0,0.0
psychophysiological measurement,1.0,0.0,0.0,0.0
Reading Chinese,0.0,0.0,1.0,0.0
Interhemispheric processing,0.0,1.0,0.0,0.0
Digit Symbol,0.0,0.0,1.0,0.0
Spatial demonstratives,0.0,0.0,1.0,0.0
ventromedial prefrontal,0.0,0.0,1.0,0.0
Cognitive control and switching,0.0,0.0,1.0,0.0
Face-visibility,0.0,0.0,1.0,0.0
Harmonic response,0.0,1.0,0.0,0.0
Perceptual analysis of direction and spatial orientation,0.0,0.0,0.0,1.0
Anticholinergic challenge,0.0,1.0,0.0,0.0
Affective valence,0.0,0.0,0.0,1.0
Boxing,0.0,0.0,1.0,0.0
Wechsler Memory Scale-Revised (WMS-R),1.0,0.0,0.0,0.0
Chronopharmacology,0.0,0.0,0.0,1.0
Seasonal pattern,0.0,0.0,0.0,1.0
treatment-resistant depression,0.0,0.0,0.0,1.0
Temporal vision,0.0,0.0,1.0,0.0
Non dioxin-like,0.0,1.0,0.0,0.0
Life space,0.0,1.0,0.0,0.0
Frontoparietal activity,0.0,0.0,1.0,0.0
Viral gene transfer,0.0,0.0,1.0,0.0
Sexual difference,1.0,0.0,0.0,0.0
Cross-Sex Hormone Therapy,0.0,0.0,1.0,0.0
Hepatic cirrhosis,0.0,0.0,1.0,0.0
Hypothesis generation,0.0,0.0,1.0,0.0
Math fluency,0.0,0.0,1.0,0.0
Temporal network,0.0,1.0,0.0,0.0
predictive coding,0.0,0.0,1.0,0.0
Bimanual processing,1.0,0.0,0.0,0.0
Intelligence test,1.0,0.0,0.0,0.0
Mean diffusivity,0.0,0.0,1.0,0.0
Energetic masking,0.0,0.0,1.0,0.0
Episode,0.0,0.0,0.0,1.0
redes,1.0,0.0,0.0,0.0
hub-and-spoke,0.0,0.0,1.0,0.0
Quantities processing,0.0,1.0,0.0,0.0
Cognitive mismatch,0.0,0.0,1.0,0.0
Misalignment,0.0,1.0,0.0,0.0
Subregions,0.0,0.0,0.0,1.0
Steady state visually evoked potential,1.0,0.0,0.0,0.0
Social skills training,1.0,0.0,0.0,0.0
confirmatory factor analysis,0.0,0.0,0.0,1.0
CB1,0.0,0.0,1.0,0.0
?6 Nicotinic acetylcholine receptor,0.0,1.0,0.0,0.0
Atrioventricular nodal reentry tachycardia,0.0,1.0,0.0,0.0
Viewer-independent coordinates,1.0,0.0,0.0,0.0
music stimulation,0.0,0.0,1.0,0.0
NIHTB,1.0,0.0,0.0,0.0
Cognition decline during aging,1.0,0.0,0.0,0.0
Exploratory Factorial Analysis,0.0,0.0,1.0,0.0
Scholar cartography,0.0,0.0,1.0,0.0
Caudal block,0.0,1.0,0.0,0.0
Graphical displays,0.0,0.0,1.0,0.0
Multiple target encoding,0.0,0.0,1.0,0.0
9-month-old infants,0.0,0.0,1.0,0.0
Right-hemisphere dominance,0.0,1.0,0.0,0.0
Traumatic public event,0.0,1.0,0.0,0.0
Social perception and cognition,0.0,0.0,1.0,0.0
brainstem,0.0,0.0,1.0,0.0
Chromosome 22,0.0,0.0,0.0,1.0
Spatial visualization,1.0,0.0,0.0,0.0
Right frontotemporal region,1.0,0.0,0.0,0.0
Multimedia drawing,0.0,1.0,0.0,0.0
unfamiliar visual objects,1.0,0.0,0.0,0.0
Ventriloquist effect,0.0,1.0,0.0,0.0
Sleep diary,0.0,0.0,0.0,1.0
Word Repeating Technique,0.0,0.0,1.0,0.0
PRESS,0.0,1.0,0.0,0.0
Child Neurodevelopment,0.0,1.0,0.0,0.0
Generalized flash suppression,1.0,0.0,0.0,0.0
Ventral and dorsal visual streams,1.0,0.0,0.0,0.0
Attention direction,0.0,0.0,1.0,0.0
Abstract and concrete processing,0.0,1.0,0.0,0.0
late effects,0.0,0.0,1.0,0.0
house,0.0,0.0,0.0,1.0
cognitive maps,1.0,0.0,0.0,0.0
Vascular load,0.0,0.0,0.0,1.0
Deep hypothermic circulatory arrest,0.0,1.0,0.0,0.0
Social wasps,1.0,0.0,0.0,0.0
Classical fear conditioning,0.0,0.0,1.0,0.0
Hemianopsia,0.0,1.0,0.0,0.0
Behavioural reversal,1.0,0.0,0.0,0.0
Memory networks,0.0,1.0,0.0,0.0
detour,0.0,1.0,0.0,0.0
Wechsler,0.0,1.0,0.0,0.0
Knowledge structures,1.0,0.0,0.0,0.0
Congenital lesion,0.0,0.0,1.0,0.0
Cognitive arousal,0.0,0.0,1.0,0.0
Brain-behavior correlation,0.0,1.0,0.0,0.0
Attention selection,0.0,1.0,0.0,0.0
Display familiarity,0.0,1.0,0.0,0.0
Norm-based coding,0.0,1.0,0.0,0.0
pp. 618-623,0.0,0.0,0.0,1.0
infant,1.0,0.0,0.0,0.0
Sensory neglect,0.0,1.0,0.0,0.0
property verification,0.0,0.0,0.0,1.0
Unconscious primes,0.0,0.0,1.0,0.0
Frontostriatal systems,0.0,1.0,0.0,0.0
Estrogen receptor beta,0.0,0.0,1.0,0.0
Measles virus,0.0,0.0,1.0,0.0
AD (Alzheimer disease),0.0,0.0,1.0,0.0
Facial electromyography (EMG),0.0,0.0,1.0,0.0
Radial frequency pattern,1.0,0.0,0.0,0.0
Action-goal,0.0,0.0,1.0,0.0
skin conductance,1.0,0.0,0.0,0.0
Assessment tools,1.0,0.0,0.0,0.0
Long range correlations,0.0,0.0,1.0,0.0
Event-coding theory,0.0,1.0,0.0,0.0
Sensory domains,0.0,0.0,1.0,0.0
dissimilarity metric (DSIM),1.0,0.0,0.0,0.0
LTM,0.0,1.0,0.0,0.0
Vagus nerve stimulation,0.0,0.0,1.0,0.0
Pear Film,0.0,1.0,0.0,0.0
LTP,0.0,0.0,1.0,0.0
Driving assessment,0.0,1.0,0.0,0.0
Language learning,0.0,1.0,0.0,0.0
Alpha activity,0.0,1.0,0.0,0.0
Auditory processing disorder,0.0,1.0,0.0,0.0
Subjective threshold,1.0,0.0,0.0,0.0
delayed response task,0.0,0.0,0.0,1.0
social facilitation,1.0,0.0,0.0,0.0
Chlordecone,1.0,0.0,0.0,0.0
Apostatic selection,0.0,0.0,1.0,0.0
Table-top interaction,1.0,0.0,0.0,0.0
Anterior medial prefrontal cortex,0.0,0.0,0.0,1.0
tethered displays,0.0,0.0,1.0,0.0
Hypericum perforatum,0.0,1.0,0.0,0.0
B-group vitamins,1.0,0.0,0.0,0.0
Evolutionary esthetics,0.0,1.0,0.0,0.0
Vagal tone,0.0,1.0,0.0,0.0
Power mobility,0.0,1.0,0.0,0.0
Dynamic visualizations,0.0,0.0,1.0,0.0
Chimeras,0.0,1.0,0.0,0.0
INRI,1.0,0.0,0.0,0.0
Slalom walking,0.0,0.0,0.0,1.0
Slowing of processing,0.0,0.0,0.0,1.0
Flavonoid,0.0,0.0,1.0,0.0
Vas,0.0,0.0,0.0,1.0
Development of navigational skills,0.0,1.0,0.0,0.0
medial temporal atrophy,1.0,0.0,0.0,0.0
refractive error,1.0,0.0,0.0,0.0
Childhood epilepsy with occipital paroxysms (CEOP) P300,1.0,0.0,0.0,0.0
visual process,0.0,0.0,0.0,1.0
resolution,1.0,0.0,0.0,0.0
environmental science education,0.0,0.0,1.0,0.0
Perceptual decision making,1.0,0.0,0.0,0.0
Nutritional risk,0.0,1.0,0.0,0.0
Reasons,0.0,1.0,0.0,0.0
Social conditioning,0.0,0.0,0.0,1.0
functional disability,0.0,1.0,0.0,0.0
Survival analysis,0.0,0.0,1.0,0.0
Glycyrrhiza,1.0,0.0,0.0,0.0
Song lyrics,1.0,0.0,0.0,0.0
Algebra,1.0,0.0,0.0,0.0
melatonin,0.0,0.0,1.0,0.0
pediatric liver disease,0.0,1.0,0.0,0.0
Mini-Cog,0.0,1.0,0.0,0.0
Acceptance,0.0,0.0,1.0,0.0
Second langauge reading,0.0,0.0,1.0,0.0
Preclinical Alzheimer disease,1.0,0.0,0.0,0.0
Movement artifact,0.0,0.0,0.0,1.0
Event-related functional magnetic resonance imaging,0.0,0.0,0.0,1.0
Construction grammar,0.0,0.0,0.0,1.0
carbon monoxide intake,0.0,1.0,0.0,0.0
Memory cell,0.0,0.0,1.0,0.0
High-calorie foods,0.0,0.0,1.0,0.0
Integrated model of usability evaluation,0.0,0.0,1.0,0.0
Freud,0.0,1.0,0.0,0.0
Lane changes,0.0,0.0,1.0,0.0
Cognitive workload,0.0,0.0,1.0,0.0
Cross-case transfer,0.0,1.0,0.0,0.0
Artwork,0.0,0.0,1.0,0.0
Time course data,0.0,0.0,1.0,0.0
Dropout,0.0,1.0,0.0,0.0
Oral surgery,0.0,1.0,0.0,0.0
Mixed cryoglobulinemia,0.0,0.0,0.0,0.0
Gaze interpretation,0.0,0.0,0.0,1.0
Visual grouping in human parietal cortex (2007) Proceedings of the National Academy of Sciences of the United States of America,1.0,0.0,0.0,0.0
cetirizine,0.0,1.0,0.0,0.0
Mental imagery (visual auditory,0.0,0.0,0.0,0.0
Modulated noise,0.0,0.0,0.0,1.0
Avian brain,0.0,0.0,1.0,0.0
Motor fluctuations,0.0,1.0,0.0,0.0
microelectrodes,0.0,1.0,0.0,0.0
Economic game,0.0,1.0,0.0,0.0
buckling,1.0,0.0,0.0,0.0
egocentric,0.0,1.0,0.0,0.0
Strategy acquisition,1.0,0.0,0.0,0.0
Cue duration,0.0,0.0,1.0,0.0
Assimilation,0.0,0.0,0.0,0.0
TV watching,0.0,0.0,1.0,0.0
Independent components analysis,0.0,0.0,1.0,0.0
oxazepam,0.0,1.0,0.0,0.0
mean corpuscular volume,1.0,0.0,0.0,0.0
Circular reaction,0.0,0.0,1.0,0.0
hemispheric asymmetry,0.0,0.0,1.0,0.0
Computerized neuropsychological test battery (CANTAB),1.0,0.0,0.0,0.0
DRdengineering C957T,1.0,0.0,0.0,0.0
Veridicality,0.0,0.0,1.0,0.0
Memory-retrieval processes,1.0,0.0,0.0,0.0
Touch-screen procedure,0.0,1.0,0.0,0.0
Aposematic signal,1.0,0.0,0.0,0.0
Monocular deprivation,0.0,0.0,0.0,1.0
Aged rats,0.0,0.0,1.0,0.0
Cognitive map theorx,0.0,0.0,1.0,0.0
intergroup relations,0.0,1.0,0.0,0.0
Brain decoding,0.0,0.0,1.0,0.0
Criticality,0.0,0.0,1.0,0.0
Global-local features,0.0,0.0,0.0,1.0
Emotion sensitivity,0.0,1.0,0.0,0.0
Left BA44,0.0,0.0,1.0,0.0
Paleoneurology,0.0,0.0,0.0,1.0
Learned fear,1.0,0.0,0.0,0.0
Iaps,0.0,0.0,1.0,0.0
Neurocognitive sequelae,1.0,0.0,0.0,0.0
Cerebral malaria,0.0,0.0,1.0,0.0
Trade-offs,0.0,1.0,0.0,0.0
Pragmatic context,0.0,0.0,1.0,0.0
Test-retest effects,0.0,0.0,0.0,1.0
Allocentric neglect,0.0,1.0,0.0,0.0
Temporal ventriloquism,0.0,0.0,1.0,0.0
Faculty of language,1.0,0.0,0.0,0.0
Paraphasia,0.0,0.0,1.0,0.0
Power wheelchair,0.0,0.0,1.0,0.0
Hymenoptera,0.0,0.0,1.0,0.0
Diffusional kurtosis imaging,0.0,1.0,0.0,0.0
Memory lateralization,0.0,1.0,0.0,0.0
peripersonal space,0.0,0.0,0.0,1.0
Dementia instruments,0.0,1.0,0.0,0.0
Old-old age,0.0,0.0,1.0,0.0
tactile processing,0.0,1.0,0.0,0.0
Depressive-like behaviour,1.0,0.0,0.0,0.0
Spatial style,0.0,0.0,1.0,0.0
Asymptomatic multiple sclerosis,0.0,1.0,0.0,0.0
Hominin,0.0,0.0,1.0,0.0
Apolipoprotein E 4,0.0,0.0,0.0,0.0
Magnetization resonance imaging,0.0,0.0,1.0,0.0
Means-end actions,0.0,0.0,1.0,0.0
Semantic concept,0.0,0.0,1.0,0.0
meal size,0.0,0.0,0.0,1.0
travel routes,0.0,0.0,1.0,0.0
Deep learning,0.0,0.0,1.0,0.0
apolipoprotein E ?4,1.0,0.0,0.0,0.0
Helplessness,0.0,0.0,1.0,0.0
Pedestrian conspicuity,0.0,1.0,0.0,0.0
Schizotypy personality disorder,1.0,0.0,0.0,0.0
Spontaneous and planned lies,0.0,0.0,1.0,0.0
Angiotensin I converting enzyme,0.0,1.0,0.0,0.0
Low-resolution electromagnetic brain tomography (LORETA),0.0,0.0,0.0,1.0
Crossmodal timing,1.0,0.0,0.0,0.0
Cardiff acuity test,0.0,0.0,0.0,1.0
visual word recognition,0.0,1.0,0.0,0.0
traffic visual measurement,0.0,0.0,1.0,0.0
psychedelics,1.0,0.0,0.0,0.0
Vascular dementia (VD),0.0,1.0,0.0,0.0
In situ hybridization,0.0,0.0,1.0,0.0
action in the dark,0.0,0.0,0.0,1.0
Vocally disruptive behavior,0.0,0.0,1.0,0.0
Delusional Misidentification Syndrome,0.0,0.0,1.0,0.0
Csash1,0.0,0.0,1.0,0.0
Prosimii,0.0,0.0,1.0,0.0
Engineering Education (EE),1.0,0.0,0.0,0.0
Storage,1.0,0.0,0.0,0.0
Search asymmetries,0.0,1.0,0.0,0.0
Violation-of-expectation task,0.0,1.0,0.0,0.0
Visual orienting,1.0,0.0,0.0,0.0
Lysosome,0.0,0.0,1.0,0.0
Cognate,0.0,1.0,0.0,0.0
Spatiotemporal filtering,0.0,1.0,0.0,0.0
HAT,0.0,0.0,1.0,0.0
Developmental continuity,1.0,0.0,0.0,0.0
Developmental and learning disabilities,0.0,0.0,1.0,0.0
Body rotations,0.0,1.0,0.0,0.0
Alzheimer disease pathogenesis,0.0,0.0,1.0,0.0
Nonsymbolic number processing,0.0,1.0,0.0,0.0
Visual improvement,0.0,1.0,0.0,0.0
Puzzle box,0.0,0.0,1.0,0.0
modality-switch effect,0.0,0.0,0.0,1.0
Musical priming,0.0,0.0,1.0,0.0
Microembolization,0.0,1.0,0.0,0.0
Perceptual completion,0.0,1.0,0.0,0.0
Copy task,0.0,1.0,0.0,0.0
Signalling,0.0,0.0,1.0,0.0
Cost-effectiveness analysis,0.0,1.0,0.0,0.0
Rotation related negativity,0.0,0.0,1.0,0.0
Test,0.0,0.0,1.0,0.0
posterolateral cerebellum,0.0,1.0,0.0,0.0
Chronodisruption,0.0,0.0,1.0,0.0
D',0.0,1.0,0.0,0.0
Within-class representation,0.0,1.0,0.0,0.0
Healthy,1.0,0.0,0.0,0.0
Computer game,0.0,0.0,1.0,0.0
green,0.0,0.0,0.0,1.0
Neural Gas,0.0,1.0,0.0,0.0
Herbs,0.0,1.0,0.0,0.0
Cardiac catheterization,0.0,0.0,1.0,0.0
Left cradling,1.0,0.0,0.0,0.0
York Tumbling Room,0.0,0.0,1.0,0.0
Dm,0.0,0.0,1.0,0.0
Hurler-Scheie syndrome,0.0,1.0,0.0,0.0
Computer-assisted cognitive remediation,0.0,0.0,1.0,0.0
Clinical onset,1.0,0.0,0.0,0.0
DF,0.0,0.0,0.0,1.0
Legal system,1.0,0.0,0.0,0.0
Top-down volitional control,1.0,0.0,0.0,0.0
Juvenile multiple sclerosis,0.0,0.0,1.0,0.0
Replacement,0.0,0.0,1.0,0.0
Rare target,1.0,0.0,0.0,0.0
Skull base meningioma,0.0,1.0,0.0,0.0
multiple t-maze,1.0,0.0,0.0,0.0
Ovarian suppression,0.0,1.0,0.0,0.0
Spatial differentiation,1.0,0.0,0.0,0.0
frontal functions,0.0,0.0,1.0,0.0
Multimodality and cognition,1.0,0.0,0.0,0.0
item-specific processing,0.0,0.0,1.0,0.0
Neckcr cube,0.0,1.0,0.0,0.0
Implicit cognitions,1.0,0.0,0.0,0.0
Microarray analysis,0.0,0.0,1.0,0.0
Dorsal visual pathway,0.0,0.0,0.0,1.0
Image labelling,0.0,0.0,1.0,0.0
Interpolating-vector,0.0,0.0,1.0,0.0
Parietooccipital atrophy,1.0,0.0,0.0,0.0
Environmental frame of reference,0.0,0.0,1.0,0.0
desirability bias,0.0,1.0,0.0,0.0
Chasing,0.0,0.0,0.0,1.0
Nonconvulsive status epilepticus,1.0,0.0,0.0,0.0
Kirtan kriya,0.0,0.0,1.0,0.0
Visual navigation,1.0,0.0,0.0,0.0
teacher interpretation,0.0,0.0,0.0,1.0
Outpatient,1.0,0.0,0.0,0.0
FPGA,0.0,0.0,1.0,0.0
Contours,0.0,1.0,0.0,0.0
Cortico-cortical interactions,0.0,0.0,1.0,0.0
Object decision,1.0,0.0,0.0,0.0
famous face naming,0.0,1.0,0.0,0.0
Subarachanoid hemorrhage,0.0,0.0,0.0,1.0
Neonatal resuscitation,0.0,0.0,0.0,1.0
2340 cognitive processes,0.0,0.0,1.0,0.0
Event,0.0,0.0,1.0,0.0
Low-level-functions,0.0,0.0,1.0,0.0
Visuomotor performance,0.0,0.0,1.0,0.0
Logical inference,0.0,1.0,0.0,0.0
semiotics,0.0,0.0,1.0,0.0
ANTICIPATION,0.0,0.0,0.0,1.0
Free viewing of video,0.0,0.0,1.0,0.0
Bubbles,1.0,0.0,0.0,0.0
immediate-release morphine,1.0,0.0,0.0,0.0
Incident,0.0,0.0,0.0,1.0
race stereotypes,1.0,0.0,0.0,0.0
fluorodeoxyglucose,1.0,0.0,0.0,0.0
Emblematic gestures,0.0,0.0,1.0,0.0
Visual spatial ability,0.0,1.0,0.0,0.0
Neural noise,0.0,0.0,0.0,1.0
Laterality indices,0.0,1.0,0.0,0.0
The Middlesex Elderly Assessment of Mental State (MEAMS),0.0,1.0,0.0,0.0
Viewpoint interpolation,0.0,1.0,0.0,0.0
Nicotinic agonists,1.0,0.0,0.0,0.0
Flavonoids,0.0,1.0,0.0,0.0
Korsakoff,0.0,0.0,0.0,1.0
Work quality,0.0,0.0,1.0,0.0
Hypnotic analogues,0.0,0.0,1.0,0.0
total intravenous anesthesia,0.0,0.0,1.0,0.0
Open monitoring meditation (OMM),0.0,1.0,0.0,0.0
Bother,1.0,0.0,0.0,0.0
Positive and negative valence,0.0,0.0,1.0,0.0
Coordinated movements,1.0,0.0,0.0,0.0
Chinese numbers,1.0,0.0,0.0,0.0
pain modulation,0.0,1.0,0.0,0.0
dyspnoea,0.0,0.0,0.0,1.0
Cognitive Impairments,0.0,0.0,1.0,0.0
Grounding,0.0,0.0,0.0,1.0
High field MRI,0.0,1.0,0.0,0.0
Jurisprudence,1.0,0.0,0.0,0.0
real-time fMRI,0.0,0.0,0.0,1.0
Gamma-band,0.0,0.0,1.0,0.0
Shape similarity,0.0,0.0,1.0,0.0
Extended evolutionary game theory,0.0,1.0,0.0,0.0
Efficiency of attention,0.0,0.0,1.0,0.0
Detail on Demand,0.0,1.0,0.0,0.0
Sociological method,0.0,1.0,0.0,0.0
Mental switching,0.0,1.0,0.0,0.0
principal sulcus,1.0,0.0,0.0,0.0
Rey-osterrieth complex figure test,0.0,0.0,0.0,1.0
Block Design Test (BDT),1.0,0.0,0.0,0.0
Numbers needed to treat,0.0,1.0,0.0,0.0
neurodevelopmental profile,0.0,0.0,1.0,0.0
Sleep pattern,0.0,1.0,0.0,0.0
Autonomic response,0.0,0.0,1.0,0.0
Neurological reorganization,0.0,0.0,0.0,1.0
Dynamic rotation,0.0,1.0,0.0,0.0
Visual selectivity,0.0,1.0,0.0,0.0
Coincident spiking,1.0,0.0,0.0,0.0
flexibility,0.0,1.0,0.0,0.0
Deployment of attention,0.0,0.0,1.0,0.0
neurodevelopmental disorders,0.0,0.0,1.0,0.0
Word-list recall,0.0,1.0,0.0,0.0
risk communication,0.0,0.0,1.0,0.0
Cognitive neuroprosthetics,0.0,1.0,0.0,0.0
Gravity bias,1.0,0.0,0.0,0.0
Assembly devices,0.0,1.0,0.0,0.0
chronic migraine,0.0,1.0,0.0,0.0
Spike threshold,0.0,0.0,1.0,0.0
Cognitive reaction time,0.0,0.0,1.0,0.0
Computer visualization,0.0,0.0,1.0,0.0
High-altitude,0.0,0.0,1.0,0.0
Young soldiers,0.0,0.0,1.0,0.0
Dynamic vantage point,0.0,0.0,1.0,0.0
Disuse syndrome,0.0,0.0,1.0,0.0
Reading span,0.0,0.0,0.0,1.0
Zolpidem,0.0,0.0,1.0,0.0
Privileged information,0.0,1.0,0.0,0.0
Educational media,1.0,0.0,0.0,0.0
category bias,0.0,0.0,0.0,1.0
IVA-CPT,0.0,0.0,1.0,0.0
Ecologically unrelated,0.0,0.0,1.0,0.0
Affective episode,0.0,0.0,1.0,0.0
induced gamma oscillatory response,0.0,0.0,0.0,1.0
Tendon vibration,0.0,0.0,0.0,1.0
Processing Time,0.0,0.0,1.0,0.0
gaze-following,0.0,0.0,0.0,1.0
Cognitive control mechanisms,0.0,0.0,1.0,0.0
Heuristics,0.0,0.0,1.0,0.0
FIM,0.0,0.0,1.0,0.0
Repetition-enhancement,0.0,1.0,0.0,0.0
Rapid fMRI,0.0,0.0,1.0,0.0
Item recognition,0.0,1.0,0.0,0.0
Cytochrome c oxidase,0.0,1.0,0.0,0.0
unpleasant,0.0,0.0,0.0,1.0
Brooding,0.0,0.0,1.0,0.0
High-functioning,0.0,1.0,0.0,0.0
Visual social perception,0.0,0.0,1.0,0.0
suicide,0.0,0.0,1.0,0.0
Consumer reports,1.0,0.0,0.0,0.0
mild,0.0,1.0,0.0,0.0
Multiple categorizations,1.0,0.0,0.0,0.0
Picture word interference task,1.0,0.0,0.0,0.0
Pars triangularis,0.0,1.0,0.0,0.0
2.5D display,0.0,0.0,1.0,0.0
Dendrite,0.0,0.0,0.0,1.0
Drosophila,0.0,0.0,1.0,0.0
Steady State Visual Evoked Potential,0.0,1.0,0.0,0.0
Solvents,1.0,0.0,0.0,0.0
Parametric,0.0,0.0,1.0,0.0
Arts education,0.0,1.0,0.0,0.0
Cortical distance,1.0,0.0,0.0,0.0
Near-Infrared Spectroscopy,0.0,0.0,1.0,0.0
Neurobehavioural manifestations,0.0,0.0,1.0,0.0
Self-restriction,0.0,0.0,1.0,0.0
Featural identity,0.0,0.0,0.0,1.0
Dehydroepiandrosterone,0.0,0.0,1.0,0.0
Inrtracranial aneurysms,0.0,1.0,0.0,0.0
Posner paradigm,0.0,0.0,1.0,0.0
Population studies,0.0,0.0,1.0,0.0
poor readers,0.0,1.0,0.0,0.0
Observer evaluation,0.0,1.0,0.0,0.0
A theory of magnitude,1.0,0.0,0.0,0.0
One-back working memory task,0.0,0.0,1.0,0.0
Hunter-gatherer theory,0.0,0.0,1.0,0.0
Motion-in-plane,0.0,1.0,0.0,0.0
DNA,0.0,1.0,0.0,0.0
Vocational outcomes,1.0,0.0,0.0,0.0
Motion-3D,0.0,1.0,0.0,0.0
Conceptual Metaphor Theory,0.0,0.0,1.0,0.0
Neurologic dysfunction,0.0,1.0,0.0,0.0
Spatial visual attention,1.0,0.0,0.0,0.0
Ability islands,0.0,1.0,0.0,0.0
Number-size congruity effect,0.0,0.0,1.0,0.0
Human behavior,0.0,0.0,0.0,1.0
Calendar,0.0,1.0,0.0,0.0
Cognitive improvement,0.0,0.0,1.0,0.0
Photo-questionnaire,0.0,0.0,1.0,0.0
Energy drink,0.0,1.0,0.0,0.0
Substance use disorder,0.0,0.0,0.0,1.0
Movement direction,0.0,0.0,1.0,0.0
invertebrate,0.0,0.0,1.0,0.0
Chemical repellent,1.0,0.0,0.0,0.0
Rapid eye movement sleep behavior disorder,0.0,0.0,1.0,0.0
family caregiver,1.0,0.0,0.0,0.0
SSRI partial response,0.0,1.0,0.0,0.0
Visual-task inference,1.0,0.0,0.0,0.0
Alphanumeric characters,0.0,0.0,1.0,0.0
Structural priming,1.0,0.0,0.0,0.0
Step-initiation,0.0,0.0,1.0,0.0
Genetic algorithm,0.0,1.0,0.0,0.0
Retrieval success,0.0,1.0,0.0,0.0
Visual motion extrapolation,0.0,0.0,1.0,0.0
Checklists,0.0,1.0,0.0,0.0
Phonological working memory,0.0,0.0,0.0,1.0
Fixation-based event related fMRI,0.0,0.0,1.0,0.0
Hermeneutics,1.0,0.0,0.0,0.0
Teenagers,1.0,0.0,0.0,0.0
Stage marker,1.0,0.0,0.0,0.0
Semantic Cluster Analysis,1.0,0.0,0.0,0.0
Perception threshold,0.0,0.0,1.0,0.0
Stereoscopic vision,0.0,1.0,0.0,0.0
Improvement pattern,0.0,0.0,1.0,0.0
Surface perception,0.0,0.0,0.0,1.0
Associative processes,0.0,1.0,0.0,0.0
Mood disorder,0.0,0.0,1.0,0.0
Higher order thinking,0.0,0.0,1.0,0.0
Extrapyramidal signs in dementia,0.0,0.0,1.0,0.0
Voxelbased-morphometry,0.0,1.0,0.0,0.0
IT industry,0.0,1.0,0.0,0.0
Spoken language processing,0.0,0.0,1.0,0.0
Spaceflight analog,1.0,0.0,0.0,0.0
Concept possession,0.0,0.0,1.0,0.0
visual disability,0.0,0.0,1.0,0.0
User error,0.0,0.0,1.0,0.0
Visual reaction time (VRT),1.0,0.0,0.0,0.0
Premotor neglect,0.0,0.0,0.0,1.0
circadian rhythm,1.0,0.0,0.0,0.0
Prolonged wakefulness,0.0,0.0,1.0,0.0
Variation,1.0,0.0,0.0,0.0
Radiology teaching,1.0,0.0,0.0,0.0
Ego-centered networks,0.0,0.0,1.0,0.0
d-amphetamine,1.0,0.0,0.0,0.0
Vertical occipital fasciculus,0.0,1.0,0.0,0.0
Nap,0.0,1.0,0.0,0.0
Hawk/goose experiments,1.0,0.0,0.0,0.0
Shikake anatomy,0.0,1.0,0.0,0.0
Ki-67,0.0,0.0,1.0,0.0
Kidney function,0.0,0.0,1.0,0.0
Fuzzy sets,0.0,0.0,1.0,0.0
balance,0.0,1.0,0.0,0.0
Genetic high risk,0.0,1.0,0.0,0.0
Event-related desynchronization/ synchronization,1.0,0.0,0.0,0.0
Visuo-spatial referencing,0.0,0.0,1.0,0.0
Learning dynamics,0.0,0.0,1.0,0.0
reality distortion,0.0,0.0,1.0,0.0
Regions-of-interest,0.0,0.0,1.0,0.0
CD,0.0,0.0,1.0,0.0
processing strategy,0.0,0.0,1.0,0.0
machine consciousness,0.0,1.0,0.0,0.0
Model testing,0.0,0.0,1.0,0.0
C1,0.0,0.0,1.0,0.0
Cross-notation priming,1.0,0.0,0.0,0.0
C.,0.0,0.0,1.0,0.0
Think/no-think task,0.0,1.0,0.0,0.0
naturalistic scenes,0.0,0.0,1.0,0.0
Labor aids,0.0,0.0,1.0,0.0
Driving Evaluation,0.0,1.0,0.0,0.0
Route finding,1.0,0.0,0.0,0.0
exemplars,0.0,1.0,0.0,0.0
? rhythm,1.0,0.0,0.0,0.0
Anoxic encephalopathy,0.0,0.0,1.0,0.0
Associative semantic knowledge,1.0,0.0,0.0,0.0
Uncertainty buildup,1.0,0.0,0.0,0.0
xenon ventilation computed tomography,0.0,0.0,0.0,1.0
Processing dynamics,0.0,1.0,0.0,0.0
Random effects analysis,1.0,0.0,0.0,0.0
Traditional Negev Arabic,0.0,0.0,1.0,0.0
Neurobehavioral symptoms,0.0,0.0,1.0,0.0
RESPIRE study,1.0,0.0,0.0,0.0
Visual word form recognition,0.0,1.0,0.0,0.0
brain signal variability,0.0,1.0,0.0,0.0
Apophenia,0.0,1.0,0.0,0.0
Benign Rolandic Epilepsy,0.0,1.0,0.0,0.0
Handedness recognition,1.0,0.0,0.0,0.0
Behavioral phenotype,0.0,0.0,1.0,0.0
District,0.0,0.0,1.0,0.0
STATIS,0.0,1.0,0.0,0.0
Interaction-dominance,0.0,0.0,1.0,0.0
Wandering,0.0,1.0,0.0,0.0
Environment learning,0.0,1.0,0.0,0.0
Response time (RT),0.0,0.0,1.0,0.0
Lesion correlation,0.0,1.0,0.0,0.0
Grey parrot,0.0,1.0,0.0,0.0
Social fish species,0.0,0.0,1.0,0.0
Chinese children,0.0,0.0,1.0,0.0
invisible displacement,1.0,0.0,0.0,0.0
C-reactive protein,0.0,1.0,0.0,0.0
Negative symptom,0.0,0.0,0.0,1.0
Camouflage,0.0,1.0,0.0,0.0
Narrative construction,0.0,0.0,1.0,0.0
Congenital heart disease,0.0,0.0,0.0,1.0
Conditional reasoning,0.0,0.0,1.0,0.0
Propranolol,1.0,0.0,0.0,0.0
Adjustment disorders,0.0,1.0,0.0,0.0
COVD-QOL,0.0,1.0,0.0,0.0
Crow,1.0,0.0,0.0,0.0
Lewis and Clark,0.0,0.0,1.0,0.0
Arabic numbers,0.0,0.0,1.0,0.0
Meningitis,0.0,0.0,1.0,0.0
Charles Bonnet syndrome plus,0.0,1.0,0.0,0.0
Asymmetry effect,0.0,1.0,0.0,0.0
Interstitial deletion,1.0,0.0,0.0,0.0
Criterion shifting,1.0,0.0,0.0,0.0
Schizoaffective,0.0,1.0,0.0,0.0
Multilevel modeling,0.0,0.0,1.0,0.0
Cognitive Control,0.0,1.0,0.0,0.0
Event-related desynchronization/synchronization (ERD/ERS),1.0,0.0,0.0,0.0
Very preterm birth,0.0,0.0,0.0,1.0
Visuo-spatial orienting,0.0,0.0,1.0,0.0
Anterior N2,1.0,0.0,0.0,0.0
Antihypertensive treatment,0.0,0.0,1.0,0.0
E.A.,0.0,0.0,0.0,1.0
Neuropsychiatric,0.0,1.0,0.0,0.0
Auditory-motor mapping,0.0,1.0,0.0,0.0
Rhesus macaque (Macaca mulatta),0.0,1.0,0.0,0.0
Presurgical evaluation,0.0,0.0,1.0,0.0
Craig,1.0,0.0,0.0,0.0
Serial reproduction,0.0,1.0,0.0,0.0
shRNA,0.0,0.0,1.0,0.0
Verbosity,0.0,1.0,0.0,0.0
Molar tooth sign,0.0,1.0,0.0,0.0
Prenatal cocaine exposure,0.0,1.0,0.0,0.0
Mental and behavioral disorders,0.0,0.0,1.0,0.0
Cattell-Horn-Carroll theory,0.0,1.0,0.0,0.0
Perceptual selectivity,0.0,1.0,0.0,0.0
Audiovisual speech recognition,0.0,0.0,1.0,0.0
Developmental mixed dyslexia,1.0,0.0,0.0,0.0
Indiviudal differences,0.0,0.0,0.0,1.0
Part perception in infancy,0.0,0.0,0.0,1.0
Neuroesthetics,0.0,0.0,1.0,0.0
Rehabilitation outcome,1.0,0.0,0.0,0.0
military performance,0.0,0.0,1.0,0.0
Dual-coding theory,0.0,0.0,1.0,0.0
Retro-cue,0.0,1.0,0.0,0.0
Streams,0.0,1.0,0.0,0.0
Dyslexic adults,0.0,1.0,0.0,0.0
Coronary artery bypass graft (CABG),0.0,0.0,1.0,0.0
Mullen scores,0.0,0.0,1.0,0.0
Feature listing,0.0,0.0,1.0,0.0
Visually evoked cognitive potentials,1.0,0.0,0.0,0.0
Intermodal processes,0.0,1.0,0.0,0.0
Factor,0.0,0.0,1.0,0.0
Integration rules,0.0,0.0,1.0,0.0
Stop signal,0.0,1.0,0.0,0.0
Military operations,0.0,1.0,0.0,0.0
SNAC,1.0,0.0,0.0,0.0
dissociative experiences,1.0,0.0,0.0,0.0
High-density event-related potentials,0.0,0.0,1.0,0.0
Retrieval monitoring,1.0,0.0,0.0,0.0
Scrupulosity,0.0,0.0,1.0,0.0
fixation,0.0,1.0,0.0,0.0
Late selection,0.0,0.0,1.0,0.0
Add-if-silent,0.0,0.0,1.0,0.0
cognitive paradigms,0.0,0.0,1.0,0.0
Serial-spatial memory span,0.0,0.0,0.0,1.0
Arduino,0.0,0.0,1.0,0.0
Event segmentation theory,0.0,1.0,0.0,0.0
PANSS,1.0,0.0,0.0,0.0
Learning effects,0.0,0.0,1.0,0.0
pervasive developmental disorders,0.0,1.0,0.0,0.0
Prey crypticity,0.0,0.0,1.0,0.0
Self-poisoning,0.0,1.0,0.0,0.0
Design fluency,0.0,0.0,1.0,0.0
Baby face expression,1.0,0.0,0.0,0.0
Response elimination,0.0,0.0,1.0,0.0
inactivity,1.0,0.0,0.0,0.0
Mind-sets,0.0,0.0,0.0,1.0
Writing disorder,0.0,0.0,1.0,0.0
premature menopause,1.0,0.0,0.0,0.0
Tablet pc,0.0,1.0,0.0,0.0
Conceptual primitives,0.0,1.0,0.0,0.0
Age-related memory loss,0.0,1.0,0.0,0.0
Letter transpositions,1.0,0.0,0.0,0.0
SPECT in SLE,0.0,1.0,0.0,0.0
Implicit emotion processing,0.0,0.0,1.0,0.0
Third ventricle,0.0,0.0,1.0,0.0
Alcohol effects,0.0,0.0,1.0,0.0
Low grade gliomas,0.0,0.0,0.0,1.0
Lip,1.0,0.0,0.0,0.0
indignados,1.0,0.0,0.0,0.0
clinical study,0.0,0.0,1.0,0.0
Desflurane,1.0,0.0,0.0,0.0
Postoperative complications,0.0,1.0,0.0,0.0
Draw-a-person test,1.0,0.0,0.0,0.0
Chronic electrophysiological recordings,0.0,0.0,1.0,0.0
Stem cells,0.0,1.0,0.0,0.0
Visual Information Processing,0.0,0.0,0.0,1.0
Visuo-motor coupling,0.0,0.0,1.0,0.0
Word class ambiguity,1.0,0.0,0.0,0.0
Dti,0.0,0.0,1.0,0.0
Parental stress,0.0,1.0,0.0,0.0
Game desig,0.0,0.0,0.0,1.0
Amnestic syndrome,1.0,0.0,0.0,0.0
Phonological representations,0.0,1.0,0.0,0.0
Learned helplessness,1.0,0.0,0.0,0.0
Adjusting-PSAT,0.0,0.0,0.0,1.0
longitudinal data,0.0,1.0,0.0,0.0
Aromatase inhibitor,0.0,0.0,1.0,0.0
Arm motor performance,0.0,0.0,1.0,0.0
Recombinant GH,0.0,0.0,1.0,0.0
schooling,0.0,0.0,0.0,1.0
Action decomposition,0.0,1.0,0.0,0.0
Architectural design process,0.0,0.0,1.0,0.0
Processing bias,1.0,0.0,0.0,0.0
Transcranial Doppler ultrasound,1.0,0.0,0.0,0.0
Hair,0.0,1.0,0.0,0.0
Secondary mania,1.0,0.0,0.0,0.0
visual literacy,0.0,1.0,0.0,0.0
Sickness behavior,0.0,0.0,1.0,0.0
Baseline testing,0.0,0.0,1.0,0.0
Structural knowledge,0.0,0.0,1.0,0.0
Audiovisual synchrony,0.0,0.0,1.0,0.0
Classical aversive conditioning,0.0,1.0,0.0,0.0
Compositionality,0.0,0.0,1.0,0.0
Animals vs plant-life vs artifact categories,0.0,0.0,1.0,0.0
On-Time,1.0,0.0,0.0,0.0
Fuzzy set,0.0,0.0,1.0,0.0
Human eye blink frequency,0.0,0.0,1.0,0.0
Agriculture and Environment",0.0,0.0,0.0,0.0
Single word reading,0.0,0.0,1.0,0.0
Error-related activity,0.0,1.0,0.0,0.0
music training,1.0,0.0,0.0,0.0
Synonymous,1.0,0.0,0.0,0.0
Cortical cholinergic pathways,0.0,0.0,1.0,0.0
Goal directed,0.0,0.0,1.0,0.0
Early affective discrimination,0.0,1.0,0.0,0.0
skills,0.0,0.0,1.0,0.0
Social dominance,0.0,0.0,1.0,0.0
Special educational needs,0.0,1.0,0.0,0.0
Audio-visual Integration,0.0,0.0,1.0,0.0
theory comparison,0.0,1.0,0.0,0.0
Number comparison abilities,0.0,0.0,1.0,0.0
Affective system,0.0,0.0,1.0,0.0
Motivational relevance,0.0,0.0,1.0,0.0
2D advertising,0.0,0.0,1.0,0.0
Tobacco chippers,0.0,0.0,1.0,0.0
Object detectors,0.0,1.0,0.0,0.0
Valproate acid,0.0,1.0,0.0,0.0
teaching,0.0,0.0,1.0,0.0
Infant Behavior Questionnaire,0.0,0.0,1.0,0.0
Incentives,0.0,1.0,0.0,0.0
Improvement,0.0,0.0,1.0,0.0
Hypoxic emergencies,0.0,0.0,1.0,0.0
similarity,0.0,0.0,1.0,0.0
Vitamins,0.0,0.0,1.0,0.0
Point of view,0.0,1.0,0.0,0.0
Spatial realignment,0.0,1.0,0.0,0.0
Lexical skills,0.0,1.0,0.0,0.0
neurocognitive impairment,0.0,1.0,0.0,0.0
Pretherapy,0.0,0.0,1.0,0.0
Male sexual arousal,0.0,1.0,0.0,0.0
Temporary cognitive disorder,0.0,0.0,1.0,0.0
Directionality,0.0,0.0,1.0,0.0
Mental alignment,0.0,1.0,0.0,0.0
Sensory error,0.0,1.0,0.0,0.0
Neurobiochemical markers,1.0,0.0,0.0,0.0
Neuropharmacology,0.0,1.0,0.0,0.0
psychosocial difficulties (PSD),0.0,1.0,0.0,0.0
Outdoor access,0.0,1.0,0.0,0.0
logopenic progressive aphasia,0.0,0.0,0.0,1.0
Genes,1.0,0.0,0.0,0.0
Butalbital,0.0,0.0,1.0,0.0
Lingual gyrus,1.0,0.0,0.0,0.0
excessive sleepiness,0.0,0.0,1.0,0.0
Maturation,0.0,1.0,0.0,0.0
Antidepressant drugs,0.0,1.0,0.0,0.0
Bayesian data analysis,0.0,0.0,1.0,0.0
Pharmacological manipulation,1.0,0.0,0.0,0.0
Mini mental status exam,0.0,0.0,0.0,1.0
Probes,0.0,1.0,0.0,0.0
Psychoneuroimmunology,0.0,0.0,0.0,1.0
Regression analysis,0.0,0.0,1.0,0.0
Omega-3,0.0,1.0,0.0,0.0
SYSTEMATIC REVIEW,1.0,0.0,0.0,0.0
Erotic stimuli,0.0,1.0,0.0,0.0
Functional predictors,0.0,0.0,1.0,0.0
subjective,0.0,1.0,0.0,0.0
inter-subjectivity,0.0,0.0,1.0,0.0
Cross-cultural difference,0.0,0.0,1.0,0.0
Difficulty,0.0,0.0,1.0,0.0
Trauma-related exposure therapy,0.0,1.0,0.0,0.0
Injured athletes,0.0,0.0,1.0,0.0
mental processes,0.0,0.0,1.0,0.0
Vision rehabilitation,0.0,0.0,1.0,0.0
Trajectory recognition,0.0,0.0,0.0,1.0
Subtotal surgery,0.0,1.0,0.0,0.0
Fabry disease,0.0,1.0,0.0,0.0
Longevity,0.0,0.0,0.0,1.0
Scene-linking,0.0,0.0,1.0,0.0
Outcome and process assessment (health care),0.0,0.0,1.0,0.0
Number - space synesthesia,0.0,1.0,0.0,0.0
motor congruence,0.0,1.0,0.0,0.0
Blood lead concentration,0.0,1.0,0.0,0.0
Attentional flexibility,0.0,0.0,1.0,0.0
Hospices,0.0,0.0,1.0,0.0
Epileptic seizure,0.0,0.0,0.0,1.0
body checking,0.0,0.0,1.0,0.0
New World monkey,0.0,0.0,1.0,0.0
pp. 997-1008,0.0,1.0,0.0,0.0
Habenular nuclei,0.0,0.0,1.0,0.0
Pied currawong,0.0,0.0,1.0,0.0
Rejected-aggressive children,0.0,1.0,0.0,0.0
Social closeness,0.0,0.0,1.0,0.0
anxiety and depression,0.0,0.0,1.0,0.0
Delayed non-matching,1.0,0.0,0.0,0.0
Trap table,1.0,0.0,0.0,0.0
Eye-gaze methodology,1.0,0.0,0.0,0.0
Sustained left anterior negativity,0.0,0.0,1.0,0.0
Entitling,0.0,0.0,1.0,0.0
Switch positivity,0.0,1.0,0.0,0.0
valacyclovir,1.0,0.0,0.0,0.0
Sspastic diplegia,1.0,0.0,0.0,0.0
Somatoform disorder,1.0,0.0,0.0,0.0
child sexual abuse,0.0,0.0,1.0,0.0
Compulsive checking,0.0,0.0,0.0,1.0
Resting state FMRI,0.0,0.0,1.0,0.0
BD,0.0,0.0,1.0,0.0
Employment status,0.0,1.0,0.0,0.0
Nonvisual,1.0,0.0,0.0,0.0
Informing,0.0,0.0,1.0,0.0
N-methyl-d-aspartate (NMDA),0.0,1.0,0.0,0.0
Deficit schizophrenia,0.0,0.0,1.0,0.0
Preclinical diagnosis,1.0,0.0,0.0,0.0
Laban Movement Analysis,0.0,1.0,0.0,0.0
ASRT,0.0,0.0,1.0,0.0
Cardiac surgery-outcome,0.0,0.0,1.0,0.0
TFEQ-R21,0.0,0.0,0.0,1.0
model-based reasoning,0.0,1.0,0.0,0.0
Engagement,0.0,0.0,0.0,1.0
Caprylic triglyceride,0.0,0.0,1.0,0.0
Cognitive retraining,0.0,1.0,0.0,0.0
Upper limb motor function,0.0,0.0,1.0,0.0
Translational models,0.0,1.0,0.0,0.0
Drug related problems,1.0,0.0,0.0,0.0
kava,0.0,1.0,0.0,0.0
Longitudinal diffusivity,0.0,1.0,0.0,0.0
Vicarious agency,1.0,0.0,0.0,0.0
Mental-physical causality,1.0,0.0,0.0,0.0
Shikake principle,0.0,1.0,0.0,0.0
Automation reliability,0.0,1.0,0.0,0.0
Physical and Engineering Sciences",0.0,0.0,0.0,0.0
social cognitions,1.0,0.0,0.0,0.0
Left hemispherectomy,0.0,0.0,1.0,0.0
Social adaptability,0.0,0.0,1.0,0.0
Neuromuscular,0.0,1.0,0.0,0.0
Linear vs. nonlinear timescales,1.0,0.0,0.0,0.0
Aegean,1.0,0.0,0.0,0.0
Myotonic dystrophy,0.0,0.0,1.0,0.0
Cognition and cultural,1.0,0.0,0.0,0.0
Food storing,1.0,0.0,0.0,0.0
Dawn simulation light,0.0,0.0,1.0,0.0
Motion cognition,0.0,0.0,1.0,0.0
L238Q,0.0,1.0,0.0,0.0
Recombination,0.0,0.0,1.0,0.0
Surprising events,0.0,0.0,1.0,0.0
Old age assistance,0.0,1.0,0.0,0.0
Affordance control,0.0,0.0,0.0,1.0
Reading training,0.0,0.0,1.0,0.0
Homes for the aged,0.0,1.0,0.0,0.0
Network timing,0.0,0.0,0.0,1.0
computer,0.0,1.0,0.0,0.0
Hierarchical linear modeling,0.0,0.0,1.0,0.0
multimodality,0.0,0.0,1.0,0.0
thalamic,0.0,1.0,0.0,0.0
Visual motor integration,1.0,0.0,0.0,0.0
Genetic vulnerability,0.0,0.0,1.0,0.0
Cognitive tunnelling,0.0,0.0,1.0,0.0
SCN1A gene,0.0,0.0,1.0,0.0
Pulse synchronization,0.0,0.0,1.0,0.0
Athletic performance,0.0,0.0,0.0,1.0
Blood-oxygenation-level-dependent,1.0,0.0,0.0,0.0
motor timing,0.0,0.0,1.0,0.0
Mask pursuit,0.0,0.0,1.0,0.0
Development of neural networks,1.0,0.0,0.0,0.0
functional needs,0.0,0.0,1.0,0.0
HIV-1 infection,0.0,0.0,1.0,0.0
cognitive model,0.0,1.0,0.0,0.0
Semantic-instructed viewing,0.0,0.0,1.0,0.0
Late slow wave,0.0,0.0,1.0,0.0
well-being,1.0,0.0,0.0,0.0
d-galactose,0.0,0.0,1.0,0.0
Stimulus-response binding,0.0,0.0,1.0,0.0
Psychological assessment,0.0,0.0,0.0,1.0
Cognitive Remediation Therapy,0.0,0.0,1.0,0.0
Visuo-motor control,0.0,0.0,1.0,0.0
parenting,0.0,0.0,1.0,0.0
Associative inference,0.0,0.0,1.0,0.0
Cognitive behavioral therapy,0.0,1.0,0.0,0.0
Ill-posed problems,0.0,1.0,0.0,0.0
Short-term effect,1.0,0.0,0.0,0.0
bistable perception,0.0,0.0,1.0,0.0
Response inhibition. environ health perspect 120:608-615 (2012). http://dx.doi.org/10.1289/ehp.1103828,0.0,0.0,1.0,0.0
Analytic,0.0,1.0,0.0,0.0
GINKGO BILOBA,1.0,0.0,0.0,0.0
Person-perception,1.0,0.0,0.0,0.0
Incentive sensitization,0.0,1.0,0.0,0.0
Emotional vulnerability,0.0,1.0,0.0,0.0
Attentional asymmetry,0.0,0.0,1.0,0.0
Reflexive pronoun,1.0,0.0,0.0,0.0
Trust game,0.0,0.0,1.0,0.0
Visual Search,0.0,1.0,0.0,0.0
Adaptive resonance theory,0.0,0.0,1.0,0.0
Neuropsychological Assessment,0.0,0.0,1.0,0.0
dual sensory impairment,0.0,1.0,0.0,0.0
relations,0.0,0.0,0.0,1.0
Biologic markers,1.0,0.0,0.0,0.0
High dissociators,0.0,1.0,0.0,0.0
Older Mexican Americans,1.0,0.0,0.0,0.0
Intrathecal baclofen,1.0,0.0,0.0,0.0
Temporal information,1.0,0.0,0.0,0.0
Tuberous sclerosis complex,1.0,0.0,0.0,0.0
Object-rotation,0.0,0.0,1.0,0.0
Wild hummingbirds,0.0,0.0,1.0,0.0
Internal speech,1.0,0.0,0.0,0.0
Delayed neuropsychiatric sequelae,0.0,0.0,0.0,1.0
Raven matrices,0.0,0.0,1.0,0.0
Nose poke,1.0,0.0,0.0,0.0
Automatic interpretation,0.0,0.0,1.0,0.0
Intentionality bias,0.0,0.0,1.0,0.0
Higher-order thought theory,0.0,0.0,1.0,0.0
Wernicke's aphasia,0.0,0.0,1.0,0.0
Projection screen,0.0,1.0,0.0,0.0
seniors,1.0,0.0,0.0,0.0
Global and local cues,0.0,0.0,1.0,0.0
Congenital toxoplasmosis,0.0,1.0,0.0,0.0
Visual Memory Performance,0.0,0.0,1.0,0.0
Proprioceptive feedback,1.0,0.0,0.0,0.0
mean squared error,0.0,0.0,1.0,0.0
reaching to grasp,0.0,0.0,0.0,1.0
Generalized linear mixed models,0.0,1.0,0.0,0.0
Topical lidocaine,0.0,0.0,1.0,0.0
Histidine,0.0,0.0,0.0,1.0
Specific deficits,0.0,1.0,0.0,0.0
Stereotype inhibition,0.0,0.0,1.0,0.0
Predictors of birth defects,0.0,0.0,1.0,0.0
Intertrial effects,0.0,0.0,1.0,0.0
Vitality,0.0,1.0,0.0,0.0
Gabor stimuli,0.0,1.0,0.0,0.0
Event knowledge,0.0,1.0,0.0,0.0
Time processing,0.0,0.0,0.0,1.0
TOMM,0.0,0.0,0.0,1.0
Human inhalation exposure,0.0,1.0,0.0,0.0
Verbal Fluency Test,0.0,1.0,0.0,0.0
cognitive impairments,1.0,0.0,0.0,0.0
Prosody lateralization,0.0,0.0,1.0,0.0
Real-time functional MRI,0.0,0.0,1.0,0.0
Passive viewing,0.0,1.0,0.0,0.0
Type 2 sensitivity,0.0,1.0,0.0,0.0
Cognition in infancy,0.0,1.0,0.0,0.0
Action observation network,0.0,0.0,1.0,0.0
Spatial imagery,0.0,1.0,0.0,0.0
Anticipatory eye movements,0.0,0.0,1.0,0.0
infant numerical abilities,1.0,0.0,0.0,0.0
conformity,0.0,0.0,0.0,1.0
Vote,0.0,0.0,1.0,0.0
Type-2 blindsight,0.0,1.0,0.0,0.0
Action relations,0.0,0.0,1.0,0.0
Comparative research,0.0,0.0,1.0,0.0
Conditional behavior,0.0,0.0,1.0,0.0
Magnocellular pathways,0.0,0.0,1.0,0.0
Object use understanding,0.0,1.0,0.0,0.0
Neuronal hipoperfusin,0.0,0.0,0.0,1.0
Active males,0.0,1.0,0.0,0.0
Cortical gray matter,0.0,1.0,0.0,0.0
Feedback-related negativity (FRN),0.0,0.0,1.0,0.0
autonomic nervous system,0.0,1.0,0.0,0.0
graphical displays,1.0,0.0,0.0,0.0
Temporal filter,0.0,1.0,0.0,0.0
Hand function,0.0,1.0,0.0,0.0
Brain ischemia,0.0,0.0,1.0,0.0
Sensory ecology,0.0,0.0,1.0,0.0
Speech discrimination,0.0,0.0,1.0,0.0
Legends,0.0,0.0,1.0,0.0
Face coding,0.0,1.0,0.0,0.0
Bipolar dimensions,0.0,0.0,0.0,1.0
Psychomotor stimulants,0.0,0.0,0.0,1.0
Pediatric leukemia,0.0,0.0,0.0,1.0
Parkinsonian type,0.0,0.0,1.0,0.0
Treatment-free interval,0.0,1.0,0.0,0.0
Dorsal anterior cingulated cortex,0.0,0.0,0.0,1.0
Image schemas,0.0,0.0,1.0,0.0
Oxygenated hemoglobin,0.0,0.0,1.0,0.0
Modality transfer,0.0,1.0,0.0,0.0
Human response,0.0,0.0,1.0,0.0
Action and perception,0.0,0.0,0.0,1.0
Egocentric mental transformation,0.0,0.0,1.0,0.0
"Blood-brain barrier,0.0,0.0,0.0,0.0
Treatment choices for exudative AMD,0.0,0.0,1.0,0.0
paraneoplastic syndrome,0.0,1.0,0.0,0.0
Error correction,0.0,1.0,0.0,0.0
Children of bipolar parents,0.0,1.0,0.0,0.0
Umbilical cord blood,0.0,0.0,1.0,0.0
intelligent transportation systems,1.0,0.0,0.0,0.0
DBDs,0.0,0.0,1.0,0.0
Functional development in childhood,0.0,0.0,1.0,0.0
C Hen/Transactions of the Japan Society of Mechanical Engineers,0.0,0.0,0.0,0.0
Language-to-cognition correlation,0.0,0.0,1.0,0.0
Glia/neuron ratio,1.0,0.0,0.0,0.0
Event-related potential (ERPs),0.0,0.0,1.0,0.0
Serial position,0.0,0.0,1.0,0.0
Venture investment screening decisions,0.0,1.0,0.0,0.0
Movement intention,1.0,0.0,0.0,0.0
Paracingulate sulcus,0.0,1.0,0.0,0.0
Carisoprodol,0.0,0.0,1.0,0.0
food cravings,0.0,1.0,0.0,0.0
Superior intraparietal sulcus,0.0,0.0,0.0,1.0
Factual memory,0.0,1.0,0.0,0.0
(2006) The Orbitofrontal Cortex,0.0,1.0,0.0,0.0
Equivalence class,1.0,0.0,0.0,0.0
Middle temporal gyrus (MTG),1.0,0.0,0.0,0.0
General anaesthesia,0.0,0.0,1.0,0.0
grid cells,1.0,0.0,0.0,0.0
A.,0.0,0.0,1.0,0.0
Rotation of a reference object,0.0,1.0,0.0,0.0
IPSC,0.0,1.0,0.0,0.0
Genetic heterogeneity,0.0,0.0,0.0,1.0
Adult neurogenesis,0.0,0.0,1.0,0.0
Atrial fibrillation-cognition-cognitive performance-male-cardiovascular diseases-cardiovascular epidemiology,0.0,1.0,0.0,0.0
Inferences,0.0,0.0,1.0,0.0
attention cascade model,1.0,0.0,0.0,0.0
Sexual processing,0.0,0.0,1.0,0.0
Perceptual style,0.0,1.0,0.0,0.0
Power spectra,1.0,0.0,0.0,0.0
Geographic information retrieval,1.0,0.0,0.0,0.0
Hypnotisability,0.0,1.0,0.0,0.0
Deese-Roediger-McDermott,0.0,0.0,1.0,0.0
Vocalization,0.0,0.0,0.0,1.0
Haptic exploration,0.0,0.0,1.0,0.0
Muller-Lyer,0.0,1.0,0.0,0.0
Context-dependent memory,1.0,0.0,0.0,0.0
Winner-kill-loser,0.0,1.0,0.0,0.0
Depression in the elderly,0.0,1.0,0.0,0.0
Vocational,0.0,1.0,0.0,0.0
Predictive validity,1.0,0.0,0.0,0.0
Automatic speech recognition,1.0,0.0,0.0,0.0
Agiotensins,0.0,0.0,1.0,0.0
Volitional processes,1.0,0.0,0.0,0.0
behavioral studies,0.0,0.0,1.0,0.0
simulation,0.0,0.0,1.0,0.0
pp. 89-98,0.0,0.0,1.0,0.0
State change,1.0,0.0,0.0,0.0
Awake mapping,0.0,0.0,0.0,1.0
Cognition - correlation - very low birth weight,0.0,0.0,1.0,0.0
Virtual reality therapy,0.0,1.0,0.0,0.0
Fitts's Law,0.0,0.0,1.0,0.0
Empowerment,1.0,0.0,0.0,0.0
Perceptual abilities,0.0,1.0,0.0,0.0
Early-onset schizophrenia,0.0,0.0,0.0,1.0
Coordinated school health programs,0.0,0.0,0.0,1.0
High-Fat Meal,0.0,0.0,0.0,1.0
[11C]NNC 112,1.0,0.0,0.0,0.0
Avian intelligence,0.0,1.0,0.0,0.0
Fears,0.0,0.0,1.0,0.0
Mixed-initiative systems,0.0,0.0,1.0,0.0
Phase-locking synchronization,0.0,0.0,0.0,1.0
Episodic future thinking,0.0,0.0,1.0,0.0
Social networking sites,0.0,0.0,1.0,0.0
implicit self-esteem,0.0,0.0,1.0,0.0
Observation-execution,0.0,0.0,1.0,0.0
AECA,1.0,0.0,0.0,0.0
Explicit processing,1.0,0.0,0.0,0.0
Music retrieval,0.0,0.0,1.0,0.0
motor planning,0.0,0.0,1.0,0.0
Menire's disease,0.0,0.0,1.0,0.0
SLE autoantibodies,0.0,1.0,0.0,0.0
FN400,0.0,0.0,0.0,1.0
Impossible figures,0.0,0.0,1.0,0.0
Precueing,0.0,1.0,0.0,0.0
collectivism,0.0,1.0,0.0,0.0
Letter-specific processing,0.0,0.0,1.0,0.0
Semantic and syntactic violations,0.0,0.0,0.0,1.0
Interjudge reliability,0.0,1.0,0.0,0.0
Complex sensorimotor coordination,1.0,0.0,0.0,0.0
Obsessions,0.0,0.0,1.0,0.0
Mild unpleasant stimulus,1.0,0.0,0.0,0.0
Cotton-top tamarins,0.0,1.0,0.0,0.0
Postoperative quality of life,0.0,1.0,0.0,0.0
J.C.,1.0,0.0,0.0,0.0
Reaction time analysis,0.0,0.0,1.0,0.0
Quality of Life,1.0,0.0,0.0,0.0
Connections,0.0,0.0,1.0,0.0
Communicative supertypes,0.0,0.0,0.0,0.0
Cortical thinning,1.0,0.0,0.0,0.0
Wrist,0.0,0.0,1.0,0.0
Active learning,0.0,0.0,1.0,0.0
EGb 761,0.0,0.0,1.0,0.0
sleep disturbance,1.0,0.0,0.0,0.0
Imaging biomarker,0.0,0.0,1.0,0.0
Eye movements and reading,0.0,0.0,1.0,0.0
Blind mathematics learners,0.0,0.0,1.0,0.0
safety errors,0.0,1.0,0.0,0.0
Gaze duration,0.0,0.0,1.0,0.0
Heart arrest,0.0,1.0,0.0,0.0
Line drawing of a hand,0.0,0.0,1.0,0.0
Chronic abdominal pain,0.0,0.0,1.0,0.0
Semantic composition,0.0,0.0,1.0,0.0
Cytoprotection,0.0,0.0,0.0,1.0
Fiber tract,0.0,0.0,1.0,0.0
gestalt,0.0,0.0,1.0,0.0
Smartphone device,1.0,0.0,0.0,0.0
QTL approach,0.0,1.0,0.0,0.0
Addenbrooke's cognitive examination,0.0,1.0,0.0,0.0
Richardson's syndrome,0.0,0.0,1.0,0.0
Lights,0.0,0.0,1.0,0.0
Oscillatory synchronization,0.0,0.0,1.0,0.0
Numerical processing of currency,0.0,0.0,1.0,0.0
Rhythmic entrainment,0.0,0.0,1.0,0.0
Gazing behaviour,0.0,1.0,0.0,0.0
Dissociation.,0.0,0.0,1.0,0.0
Auditory reaction time (ART),1.0,0.0,0.0,0.0
chronic fatigue syndrome (CFS),0.0,0.0,1.0,0.0
Motor evoked potentials,0.0,0.0,0.0,1.0
Magnetoencephalo-graphy,0.0,0.0,1.0,0.0
Lumbar puncture,1.0,0.0,0.0,0.0
Heart rhythm pattern,0.0,0.0,1.0,0.0
EEG ERP,1.0,0.0,0.0,0.0
free classification,0.0,0.0,1.0,0.0
Neuro-Behcet's disease,0.0,0.0,1.0,0.0
Endometrial cancer,0.0,0.0,1.0,0.0
Ferritin,0.0,0.0,0.0,1.0
Acute leukemia,0.0,0.0,1.0,0.0
Feminist visual methodology,0.0,1.0,0.0,0.0
Event related P300 potentials,0.0,0.0,1.0,0.0
DRdengineering,0.0,0.0,1.0,0.0
Predictive saccadic tracking,0.0,0.0,1.0,0.0
Spatiality,0.0,0.0,1.0,0.0
Random,1.0,0.0,0.0,0.0
Access,0.0,0.0,1.0,0.0
Chronoenhancement,0.0,0.0,1.0,0.0
Polarity correspondence,0.0,1.0,0.0,0.0
Mini-mental test,0.0,0.0,1.0,0.0
follow-up studies,0.0,0.0,1.0,0.0
alcohol dependence,0.0,0.0,1.0,0.0
Anthocyanin,0.0,0.0,1.0,0.0
Pervasive developmental disorder not otherwise specified,1.0,0.0,0.0,0.0
Keywords Head injury,0.0,0.0,1.0,0.0
Perceptual modalities,0.0,1.0,0.0,0.0
Spatial similarity,0.0,1.0,0.0,0.0
Ratio,0.0,0.0,1.0,0.0
Orienting network,0.0,1.0,0.0,0.0
autistic disorders,0.0,1.0,0.0,0.0
Kinetic exercises,1.0,0.0,0.0,0.0
Pediatric kidney transplantation,0.0,0.0,1.0,0.0
alpha,0.0,0.0,0.0,1.0
Optimism,0.0,0.0,0.0,1.0
Greebles,1.0,0.0,0.0,0.0
Functional MR imaging,0.0,0.0,1.0,0.0
Two-alternative forced choice,0.0,1.0,0.0,0.0
Facially expressed emotion,0.0,0.0,1.0,0.0
Unimanual,0.0,0.0,1.0,0.0
Cognitive avoidance,0.0,0.0,1.0,0.0
Face flanker,1.0,0.0,0.0,0.0
Mode level cognitive subtraction,0.0,0.0,1.0,0.0
and Vision",0.0,0.0,0.0,0.0
Action affordance,1.0,0.0,0.0,0.0
DWI lesions,0.0,0.0,1.0,0.0
Event probability,0.0,1.0,0.0,0.0
Conceptual fluency,0.0,0.0,1.0,0.0
carbon monoxide intoxication,0.0,0.0,1.0,0.0
Gestational cocaine exposure,0.0,1.0,0.0,0.0
Representative task design,0.0,1.0,0.0,0.0
Objectification,0.0,0.0,0.0,1.0
Pink noise,1.0,0.0,0.0,0.0
Data warehouses,0.0,1.0,0.0,0.0
Imitation-inhibition,0.0,0.0,1.0,0.0
MapX,0.0,1.0,0.0,0.0
Bumblebees,0.0,1.0,0.0,0.0
RT distributional analyses,0.0,1.0,0.0,0.0
Cervical vertebrea,0.0,0.0,1.0,0.0
Power grasp,0.0,0.0,1.0,0.0
Geriatric conditions,0.0,1.0,0.0,0.0
Task-shift type,0.0,1.0,0.0,0.0
Telepresence robots,0.0,1.0,0.0,0.0
Emotional dysregulation,0.0,0.0,1.0,0.0
School based intervention,0.0,0.0,1.0,0.0
Modality-specific conceptual representations,0.0,1.0,0.0,0.0
Emotional salience,0.0,1.0,0.0,0.0
Hispanic Americans,0.0,0.0,1.0,0.0
Cognitive tempo,1.0,0.0,0.0,0.0
accidental falls,0.0,0.0,1.0,0.0
Automatic emotion processing,0.0,0.0,1.0,0.0
Traveled distances,0.0,1.0,0.0,0.0
Space perception,1.0,0.0,0.0,0.0
Targeting performance,1.0,0.0,0.0,0.0
impression formation,1.0,0.0,0.0,0.0
ADAN,0.0,0.0,1.0,0.0
Stimulant medication,0.0,1.0,0.0,0.0
Global and local processing,0.0,0.0,1.0,0.0
cognitive processing speed,1.0,0.0,0.0,0.0
Lateral vision,0.0,1.0,0.0,0.0
S-LANSS,1.0,0.0,0.0,0.0
Slow-acting compression,0.0,0.0,0.0,1.0
Error Processing,0.0,0.0,1.0,0.0
age of onset,0.0,1.0,0.0,0.0
nonhuman primates,0.0,0.0,1.0,0.0
Extreme male brain theory,0.0,0.0,1.0,0.0
Sensorineural hearing impairment,0.0,0.0,0.0,1.0
Sensorimotor skills,1.0,0.0,0.0,0.0
Mixed effects multilevel analysis (MEMA),0.0,1.0,0.0,0.0
Spatiotemporal maps,0.0,0.0,1.0,0.0
Offenders,0.0,1.0,0.0,0.0
Electrical brain activity,0.0,0.0,1.0,0.0
genetic syndromes,0.0,0.0,1.0,0.0
Auditory (verbal) representation,0.0,0.0,1.0,0.0
Underwater vehicle,0.0,0.0,1.0,0.0
Visual disturbance,0.0,0.0,1.0,0.0
Putting,0.0,0.0,0.0,1.0
Mule,0.0,0.0,1.0,0.0
Task purity,0.0,1.0,0.0,0.0
Internet-based assessment,0.0,0.0,1.0,0.0
Differential deficit,0.0,0.0,1.0,0.0
Generation of referring expressions,0.0,1.0,0.0,0.0
Boundaries,1.0,0.0,0.0,0.0
Developmental trajectories,0.0,0.0,1.0,0.0
Within-subject variability,0.0,0.0,1.0,0.0
Arachnoid cysts,0.0,0.0,1.0,0.0
Dual-process theory of dopamine function,0.0,1.0,0.0,0.0
Region of interest,0.0,0.0,1.0,0.0
Lesion anatomy,0.0,1.0,0.0,0.0
Sensing,1.0,0.0,0.0,0.0
Language and Information",0.0,0.0,0.0,0.0
Maternal uniparental disomy,0.0,0.0,1.0,0.0
Male sex,0.0,0.0,0.0,1.0
Cognitive foraging,0.0,1.0,0.0,0.0
Domestic chicks,0.0,0.0,1.0,0.0
Event-related de/synchronization,0.0,1.0,0.0,0.0
Physical functioning,0.0,1.0,0.0,0.0
Posterior temporal areas,1.0,0.0,0.0,0.0
Drowsiness,0.0,1.0,0.0,0.0
MRSI,0.0,0.0,0.0,1.0
RU38486,0.0,1.0,0.0,0.0
Central bottleneck,0.0,1.0,0.0,0.0
Useful field of view test,1.0,0.0,0.0,0.0
corridor illusion,0.0,1.0,0.0,0.0
Psychosomatic dermatology,0.0,0.0,0.0,1.0
Shape bias,0.0,0.0,1.0,0.0
The connectome,0.0,0.0,0.0,1.0
physical ability,1.0,0.0,0.0,0.0
Interferon ?,0.0,0.0,1.0,0.0
Neurobehavioral toxicity,0.0,1.0,0.0,0.0
Conceptual difficulty,0.0,0.0,1.0,0.0
prolonged febrile seizures,1.0,0.0,0.0,0.0
Corpus callosum thinning,0.0,0.0,0.0,1.0
Spindles,0.0,0.0,1.0,0.0
Unnatural kinematics,0.0,1.0,0.0,0.0
Falls in elderly subjects,0.0,0.0,1.0,0.0
Visual Probe Task,0.0,1.0,0.0,0.0
Functional covariance,1.0,0.0,0.0,0.0
North Americans,0.0,0.0,1.0,0.0
Methionine,0.0,1.0,0.0,0.0
Concurrent TMS-fMRI,0.0,0.0,0.0,1.0
Two-alternative choice pitch discrimination task,1.0,0.0,0.0,0.0
Brightness agnosia,0.0,1.0,0.0,0.0
Secondary memory,1.0,0.0,0.0,0.0
Mathematical models,0.0,1.0,0.0,0.0
Cognitive breadth,1.0,0.0,0.0,0.0
Simultaneity threshold,0.0,0.0,1.0,0.0
PGRN,0.0,0.0,1.0,0.0
object function,0.0,1.0,0.0,0.0
Prodromal psychosis,0.0,0.0,1.0,0.0
Perception-cognition,0.0,1.0,0.0,0.0
Priming effects,0.0,1.0,0.0,0.0
wine information preference,0.0,0.0,1.0,0.0
Dispositional inference,0.0,0.0,1.0,0.0
Cortical map,0.0,1.0,0.0,0.0
prospective cohort,0.0,1.0,0.0,0.0
Alpha lateralization,0.0,1.0,0.0,0.0
virtual environment,0.0,0.0,1.0,0.0
Kinesthetic treatment,0.0,0.0,1.0,0.0
XYY,0.0,1.0,0.0,0.0
Pain measurements/standards,1.0,0.0,0.0,0.0
Seasonal,0.0,1.0,0.0,0.0
Three-dimensional double-inversion recovery,1.0,0.0,0.0,0.0
P301S TAU gene mutation,0.0,0.0,1.0,0.0
Subjective awareness,0.0,1.0,0.0,0.0
time monitoring,0.0,0.0,1.0,0.0
Dorsal hippocampus,0.0,0.0,1.0,0.0
Long-distance reference,1.0,0.0,0.0,0.0
Cotard delusion,0.0,1.0,0.0,0.0
icons,0.0,0.0,1.0,0.0
conditioned place aversion,1.0,0.0,0.0,0.0
Event roles,0.0,1.0,0.0,0.0
Aggressive behavior,0.0,1.0,0.0,0.0
Cerebral venous thrombosis,0.0,0.0,0.0,1.0
SOCIAL ENGAGEMENT,1.0,0.0,0.0,0.0
HMPAO,1.0,0.0,0.0,0.0
Body-specificity hypothesis,0.0,0.0,1.0,0.0
Cognitive advantage,0.0,1.0,0.0,0.0
Mexican,0.0,0.0,1.0,0.0
Histamine H3 receptor,1.0,0.0,0.0,0.0
Religious orders study,0.0,1.0,0.0,0.0
Outcomes.,1.0,0.0,0.0,0.0
Training-induced activation,1.0,0.0,0.0,0.0
Behavioral assay,0.0,0.0,1.0,0.0
Silent vocalization,1.0,0.0,0.0,0.0
instance learning,0.0,1.0,0.0,0.0
clinical intervention,0.0,0.0,1.0,0.0
Numerical,1.0,0.0,0.0,0.0
Modal completion,0.0,1.0,0.0,0.0
power law,0.0,0.0,1.0,0.0
Kittiwake,0.0,0.0,1.0,0.0
growth mixture models,0.0,1.0,0.0,0.0
Coreference,1.0,0.0,0.0,0.0
Nursing home research,0.0,0.0,1.0,0.0
Idiopathic cerebellar ataxia,1.0,0.0,0.0,0.0
Image watermarking,0.0,0.0,1.0,0.0
Clinical pathological findings,0.0,0.0,1.0,0.0
Chronic cerebrospinal venous insufficiency,0.0,1.0,0.0,0.0
Artifact rejection,1.0,0.0,0.0,0.0
Transitory cognitive impairment,1.0,0.0,0.0,0.0
Multivariate pattern classification,0.0,1.0,0.0,0.0
Perpendicular fasciculus,0.0,1.0,0.0,0.0
Sports,0.0,1.0,0.0,0.0
multitasking,0.0,0.0,1.0,0.0
Cognitively intact,0.0,1.0,0.0,0.0
Split-brain,0.0,1.0,0.0,0.0
Comorbid ADHD with learning disabilities,1.0,0.0,0.0,0.0
Implicit evaluation,0.0,0.0,1.0,0.0
Visual motionperception,0.0,0.0,1.0,0.0
Processing efficacy,0.0,0.0,0.0,1.0
Ocular motor apraxia,0.0,0.0,1.0,0.0
Androgen deprivation therapy,1.0,0.0,0.0,0.0
Causal,1.0,0.0,0.0,0.0
Motor overflow,0.0,1.0,0.0,0.0
Connected text,0.0,1.0,0.0,0.0
Antisaccade striatum,1.0,0.0,0.0,0.0
comparison,0.0,0.0,1.0,0.0
Synchronous oscillation,1.0,0.0,0.0,0.0
hypo-self,0.0,0.0,1.0,0.0
Dual task performance,0.0,0.0,1.0,0.0
Effect size calculations,0.0,1.0,0.0,0.0
Neuropsychological and psychophysical tests,0.0,0.0,1.0,0.0
Flavanol,1.0,0.0,0.0,0.0
Facial fearful expression,1.0,0.0,0.0,0.0
Cultural learning,0.0,0.0,1.0,0.0
Visually impaired persons,1.0,0.0,0.0,0.0
Redundancy effects,0.0,0.0,1.0,0.0
Preserved cognition,0.0,0.0,1.0,0.0
Fine motor skill,0.0,0.0,1.0,0.0
socioeconomic status,1.0,0.0,0.0,0.0
Compensatory responses,1.0,0.0,0.0,0.0
Subjective ratings,0.0,1.0,0.0,0.0
Aged 80 and over,0.0,1.0,0.0,0.0
Adult survivors of childhood sexual abuse,1.0,0.0,0.0,0.0
Training of basic functions,0.0,0.0,1.0,0.0
Hierarchical shape decomposition,1.0,0.0,0.0,0.0
Segregation,0.0,0.0,1.0,0.0
Prefrontal damage,0.0,1.0,0.0,0.0
Eye-fixation-related potentials,0.0,1.0,0.0,0.0
Stimulus categorization,1.0,0.0,0.0,0.0
Ginkgo biloba extract,0.0,0.0,0.0,1.0
The urban vacant land,0.0,0.0,1.0,0.0
Gain-Loss,0.0,1.0,0.0,0.0
Fitts' Law,0.0,0.0,0.0,1.0
Sensorimotor cognition,0.0,0.0,1.0,0.0
Macroergonomics,1.0,0.0,0.0,0.0
Emotional intensity,0.0,1.0,0.0,0.0
Nose and Throat Journal",0.0,0.0,0.0,0.0
Personal significance,0.0,0.0,0.0,1.0
Natural/artifactual dissociation,0.0,0.0,1.0,0.0
NSW,0.0,0.0,0.0,1.0
Parallel distributed processing,0.0,0.0,0.0,1.0
Blood alcohol concentration (BAC) curve,0.0,0.0,1.0,0.0
NSF,0.0,1.0,0.0,0.0
Semantic similarity,0.0,0.0,0.0,1.0
empty sets,0.0,1.0,0.0,0.0
Gene-environment interaction,1.0,0.0,0.0,0.0
Neuromuscular diseases,0.0,1.0,0.0,0.0
Concentration and perceptual disturbance,0.0,0.0,1.0,0.0
Basal ganglia hemorrhage,0.0,0.0,0.0,1.0
Delayed match-to-sample,1.0,0.0,0.0,0.0
Polynesia,0.0,0.0,1.0,0.0
Digeorge syndrome,0.0,0.0,1.0,0.0
Global information processing,1.0,0.0,0.0,0.0
"Blood phobia,0.0,0.0,0.0,0.0
MocA test,1.0,0.0,0.0,0.0
Chronic hypoxia,0.0,0.0,1.0,0.0
Repeated masking method,0.0,1.0,0.0,0.0
Temporal systems,0.0,1.0,0.0,0.0
Pre-eclampsia,0.0,0.0,1.0,0.0
Clinically definite multiple sclerosis,0.0,0.0,1.0,0.0
Capgras syndrome,0.0,0.0,1.0,0.0
Confidence rating,0.0,1.0,0.0,0.0
Concept priming,0.0,0.0,1.0,0.0
"Correctness,0.0,0.0,0.0,0.0
Stroop color-word interference test,0.0,1.0,0.0,0.0
Generalized dystonia,0.0,0.0,0.0,1.0
Antipredator behaviour,0.0,1.0,0.0,0.0
sports concussion,0.0,0.0,1.0,0.0
Dorsal-ventral,0.0,1.0,0.0,0.0
Exclusion failure paradigm,1.0,0.0,0.0,0.0
Self-observation,0.0,1.0,0.0,0.0
postoperative pain,0.0,0.0,1.0,0.0
Neural simulation,0.0,0.0,1.0,0.0
Comparative study,1.0,0.0,0.0,0.0
Neurite orientation dispersion,0.0,0.0,1.0,0.0
Gillespie syndrome,0.0,1.0,0.0,0.0
Social withdrawal,0.0,1.0,0.0,0.0
Non-symbolic number,0.0,1.0,0.0,0.0
Step over,0.0,0.0,0.0,1.0
Action observation system,0.0,0.0,1.0,0.0
Medical illness,0.0,0.0,1.0,0.0
Posterior superior parietal lobe (PSPL),0.0,1.0,0.0,0.0
automatic/implicit processes,1.0,0.0,0.0,0.0
disaster planning,0.0,0.0,1.0,0.0
Visual duration threshold,0.0,1.0,0.0,0.0
Functional cluster analysis,0.0,1.0,0.0,0.0
Mixed effects models,0.0,1.0,0.0,0.0
Product image,0.0,1.0,0.0,0.0
laterality,0.0,0.0,1.0,0.0
Rehabilitation outcomes,1.0,0.0,0.0,0.0
Heschl's gyrus,0.0,1.0,0.0,0.0
Visuo spatial dysfunction,0.0,0.0,1.0,0.0
Top-down perception,0.0,0.0,1.0,0.0
Anti-oxidents,0.0,0.0,1.0,0.0
Physical attribution,0.0,0.0,1.0,0.0
Collision Avoidance,1.0,0.0,0.0,0.0
pervasive computing,0.0,0.0,1.0,0.0
BASIC,0.0,0.0,1.0,0.0
Double scope networks,0.0,0.0,0.0,1.0
CRIB,0.0,0.0,1.0,0.0
[18F]FDG,0.0,1.0,0.0,0.0
Low-grade inflammation,1.0,0.0,0.0,0.0
Orbital prefrontal cortex,0.0,0.0,1.0,0.0
Sepia officinalis,0.0,0.0,1.0,0.0
Gestational age,0.0,0.0,0.0,1.0
virtual body,0.0,0.0,1.0,0.0
semantics,1.0,0.0,0.0,0.0
Repeated evaluation technique,0.0,0.0,1.0,0.0
EGCG,1.0,0.0,0.0,0.0
Medication labels,0.0,0.0,0.0,1.0
Expectation-maximization,0.0,1.0,0.0,0.0
Heterospecific,1.0,0.0,0.0,0.0
First-rank symptoms,0.0,0.0,1.0,0.0
Superior and inferior colliculus,1.0,0.0,0.0,0.0
Dedifferentiation theory of aging,1.0,0.0,0.0,0.0
fatigue and dry eye,0.0,1.0,0.0,0.0
Diffusion spectrum imaging,0.0,0.0,1.0,0.0
Biased emotion recognition,0.0,0.0,1.0,0.0
Left hemispheric function,0.0,0.0,1.0,0.0
Methylenedioxymethamphetamine,0.0,0.0,0.0,1.0
Alcohol Cues,0.0,1.0,0.0,0.0
neocortical junctions,0.0,0.0,1.0,0.0
Angioplasty and stenting,0.0,0.0,0.0,1.0
emotional state,0.0,0.0,1.0,0.0
pediatric bipolar disorder,0.0,1.0,0.0,0.0
Practical rationality,0.0,0.0,1.0,0.0
cross-cultural,0.0,0.0,1.0,0.0
Pyrethroids,0.0,0.0,1.0,0.0
Mini mental state examination,0.0,0.0,1.0,0.0
Lift force,0.0,0.0,1.0,0.0
Cholesteryl exchange transfer protein,0.0,1.0,0.0,0.0
Evidentials,0.0,1.0,0.0,0.0
Acoustic landmarks,1.0,0.0,0.0,0.0
Visual-related knowledge,0.0,0.0,1.0,0.0
Synaptic mechanisms,1.0,0.0,0.0,0.0
Emotional self-awareness,0.0,0.0,1.0,0.0
Cross modal effects,0.0,0.0,0.0,1.0
Color identification,0.0,0.0,1.0,0.0
physical appearance,0.0,0.0,1.0,0.0
Tower,0.0,1.0,0.0,0.0
Common marmoset,0.0,0.0,1.0,0.0
Viewer-dependent coordinates,1.0,0.0,0.0,0.0
Dorsal and ventral streams,1.0,0.0,0.0,0.0
Consomic,0.0,1.0,0.0,0.0
Amitriptyline,0.0,1.0,0.0,0.0
probabilistic inference,0.0,0.0,1.0,0.0
Anticipatory motor control,0.0,1.0,0.0,0.0
Negative hallucination,0.0,0.0,1.0,0.0
Hearing disability,0.0,0.0,1.0,0.0
Single-cell recording,1.0,0.0,0.0,0.0
Fuzzy neural network,0.0,1.0,0.0,0.0
Storytelling,0.0,1.0,0.0,0.0
hard problem,0.0,1.0,0.0,0.0
Neck pain,0.0,0.0,1.0,0.0
Distribution and Consumer Research",0.0,0.0,0.0,0.0
?7,1.0,0.0,0.0,0.0
Oscillatory synchrony,0.0,0.0,1.0,0.0
Galactose,0.0,0.0,1.0,0.0
Senior Drivers,0.0,0.0,1.0,0.0
trait marker,0.0,1.0,0.0,0.0
Right hemispheric function,0.0,0.0,1.0,0.0
nystagmus,0.0,1.0,0.0,0.0
Shaken baby syndrome,1.0,0.0,0.0,0.0
Context categorization,0.0,0.0,1.0,0.0
Voxel-based analysis,0.0,0.0,1.0,0.0
Beta rebound,0.0,0.0,1.0,0.0
Transparent motion,0.0,1.0,0.0,0.0
Predictive factors,0.0,0.0,1.0,0.0
Feedforward and feedback architectures,0.0,0.0,1.0,0.0
Three-dimensional models,1.0,0.0,0.0,0.0
Signal/interference,0.0,0.0,0.0,1.0
Oculomotor performance,0.0,0.0,0.0,1.0
Short-term memory limits,0.0,0.0,1.0,0.0
Health disparities,0.0,1.0,0.0,0.0
Mineralocorticoid and glucocorticoid receptor,0.0,1.0,0.0,0.0
Brain microstates,0.0,0.0,0.0,1.0
Orbitofrontal cortex (OFC),0.0,1.0,0.0,0.0
Scalar inference,1.0,0.0,0.0,0.0
Transdermal scopolamine,0.0,0.0,1.0,0.0
Children with autism spectrum disorder,0.0,1.0,0.0,0.0
Transfer (psychology),0.0,1.0,0.0,0.0
Global slowing,0.0,0.0,1.0,0.0
Pseudo-haptics,0.0,0.0,1.0,0.0
Tea polyphenol,0.0,0.0,0.0,1.0
Perceptual closure,0.0,1.0,0.0,0.0
GLM,0.0,1.0,0.0,0.0
Controlled attention,1.0,0.0,0.0,0.0
SSIMS,0.0,0.0,1.0,0.0
Causation,1.0,0.0,0.0,0.0
Modelling and Management",0.0,0.0,0.0,0.0
Scrub jays,1.0,0.0,0.0,0.0
Homemaker services,0.0,1.0,0.0,0.0
nonamnestic,0.0,0.0,1.0,0.0
Mood dimensions,0.0,1.0,0.0,0.0
Crossmodal perception,0.0,0.0,1.0,0.0
Hierarchically organized stimuli,0.0,0.0,1.0,0.0
Adaptive cognition,0.0,0.0,1.0,0.0
ASEO,1.0,0.0,0.0,0.0
Multi-channel recording,1.0,0.0,0.0,0.0
Constructive apraxia,0.0,0.0,1.0,0.0
TgCRND8 mice,0.0,0.0,1.0,0.0
MIBG,1.0,0.0,0.0,0.0
Proportion effect,0.0,1.0,0.0,0.0
Jokes,0.0,0.0,1.0,0.0
Left primary motor cortex,0.0,0.0,1.0,0.0
Ankle-brachial index,0.0,1.0,0.0,0.0
Intraoperative complication,1.0,0.0,0.0,0.0
Social PRP,0.0,0.0,1.0,0.0
cerebral vasculitis,1.0,0.0,0.0,0.0
Contextual priming,0.0,1.0,0.0,0.0
Principle-component analysis,1.0,0.0,0.0,0.0
Transition cues,0.0,0.0,1.0,0.0
EOG,0.0,0.0,1.0,0.0
Functional connection,0.0,0.0,1.0,0.0
muscarinic,0.0,1.0,0.0,0.0
COMT polymorphism,0.0,0.0,1.0,0.0
Movement coordination,0.0,0.0,1.0,0.0
Anticipatory scaling,0.0,0.0,1.0,0.0
Notation effect,1.0,0.0,0.0,0.0
Threat-processing,0.0,1.0,0.0,0.0
Auditory discrimination,1.0,0.0,0.0,0.0
Task-based control,0.0,0.0,1.0,0.0
Short-time psychoeducational intervention,0.0,0.0,0.0,1.0
right hemisphere,1.0,0.0,0.0,0.0
Behavior Modification,0.0,0.0,1.0,0.0
HLHS,0.0,1.0,0.0,0.0
Retrieval-induced forgetting,0.0,0.0,1.0,0.0
N1 potential,1.0,0.0,0.0,0.0
evoked potentials,0.0,0.0,1.0,0.0
Dental hygiene education,0.0,0.0,1.0,0.0
Craniocerebral trauma,0.0,0.0,1.0,0.0
Evaluacin Neuropsicolgica Infantil [Child Neuropsychological Assessment],0.0,1.0,0.0,0.0
Mini mental state exam,0.0,0.0,1.0,0.0
Movement performance,0.0,0.0,1.0,0.0
Carbon monoxide intoxication,0.0,1.0,0.0,0.0
Cystatin c,0.0,0.0,0.0,1.0
co-administration,0.0,0.0,1.0,0.0
germ cell tumors,1.0,0.0,0.0,0.0
Beef,0.0,0.0,1.0,0.0
Command and control,0.0,0.0,1.0,0.0
Holistic face perception,1.0,0.0,0.0,0.0
Diseasemodifying therapy,1.0,0.0,0.0,0.0
Pleasant mood,0.0,0.0,1.0,0.0
prisoners,0.0,0.0,1.0,0.0
Metrical organization,0.0,0.0,1.0,0.0
Neural marker,0.0,1.0,0.0,0.0
Psychophysiological model,0.0,1.0,0.0,0.0
AM404,0.0,0.0,1.0,0.0
School,1.0,0.0,0.0,0.0
geocoding,0.0,0.0,1.0,0.0
Borderline intellectual disability,0.0,0.0,1.0,0.0
self-stereotype,0.0,1.0,0.0,0.0
Initial negative dip,0.0,0.0,1.0,0.0
object discrimination,0.0,0.0,0.0,1.0
humor,0.0,1.0,0.0,0.0
Visual word processing,1.0,0.0,0.0,0.0
Healthcare working systems,0.0,1.0,0.0,0.0
ALA-D inhibition,1.0,0.0,0.0,0.0
POLR3B gene,0.0,0.0,1.0,0.0
Vision-based attention,0.0,0.0,1.0,0.0
Genomic conflict,0.0,0.0,1.0,0.0
?-Synuclein-immunohistochemistry,0.0,0.0,1.0,0.0
Amino acid,0.0,0.0,1.0,0.0
Social-affective network,0.0,0.0,1.0,0.0
P3/P3d,0.0,1.0,0.0,0.0
Acoustic distraction,1.0,0.0,0.0,0.0
XBAM,1.0,0.0,0.0,0.0
?-L-iduronidase,0.0,1.0,0.0,0.0
General functioning,0.0,1.0,0.0,0.0
intellectually and developmentally disabled people,0.0,0.0,1.0,0.0
Single-dose administration,0.0,0.0,1.0,0.0
action context,0.0,1.0,0.0,0.0
evoked synchronization,0.0,0.0,1.0,0.0
Gap,0.0,1.0,0.0,0.0
Neuropsychologic impairment,0.0,1.0,0.0,0.0
Picture memory,0.0,0.0,1.0,0.0
driving behavior,1.0,0.0,0.0,0.0
Harris,0.0,1.0,0.0,0.0
Hybrid fuzzy-neuro model,0.0,0.0,1.0,0.0
Behavioural relevance,1.0,0.0,0.0,0.0
Etho-psychology,0.0,0.0,1.0,0.0
Gamma-band activity,1.0,0.0,0.0,0.0
Visual science of art,0.0,0.0,1.0,0.0
Visuomotor learning,0.0,1.0,0.0,0.0
Common cause,0.0,0.0,1.0,0.0
visual notation,1.0,0.0,0.0,0.0
Field study,0.0,0.0,1.0,0.0
Homeopathy,0.0,1.0,0.0,0.0
User evaluation,1.0,0.0,0.0,0.0
Neuropsychological brain mapping battery,1.0,0.0,0.0,0.0
sensorimotor intelligence,0.0,0.0,1.0,0.0
Maternal prenatal diet,0.0,1.0,0.0,0.0
feature-based attention,0.0,1.0,0.0,0.0
Cranial radiation therapy,0.0,0.0,1.0,0.0
APD (auditory processing disorders),0.0,1.0,0.0,0.0
Peak performance,0.0,1.0,0.0,0.0
operational vehicle control,0.0,1.0,0.0,0.0
Episodic future thought,0.0,1.0,0.0,0.0
Symbolic numbers,0.0,0.0,1.0,0.0
HIV therapy,0.0,0.0,1.0,0.0
Spatial orientation-retention,1.0,0.0,0.0,0.0
Cardiac magnetic resonance imaging,1.0,0.0,0.0,0.0
Cognitive bias task,0.0,0.0,0.0,1.0
adverse effects,1.0,0.0,0.0,0.0
Associative areas of the cortex,0.0,0.0,1.0,0.0
Collusion,0.0,0.0,1.0,0.0
Self-perceived global health,0.0,1.0,0.0,0.0
Detoxification,0.0,0.0,0.0,0.0
Motor reaction times,0.0,0.0,0.0,1.0
Colon cancer,0.0,0.0,0.0,1.0
Neuroimaging findings,0.0,1.0,0.0,0.0
Tactile maps,0.0,0.0,1.0,0.0
Transcranial random noise stimulation (tRNS),0.0,0.0,1.0,0.0
Xanthoceraside,0.0,0.0,1.0,0.0
HIV-associated neurocognitive disorders,1.0,0.0,0.0,0.0
Goal attribution,0.0,1.0,0.0,0.0
Ratio effects,0.0,0.0,1.0,0.0
ETV,0.0,0.0,1.0,0.0
Maximum likelihood,0.0,1.0,0.0,0.0
Concrete words,0.0,1.0,0.0,0.0
Furosemide,0.0,0.0,0.0,1.0
Kryger MH,0.0,1.0,0.0,0.0
Emotional empathy,0.0,0.0,1.0,0.0
Reorienting negativity (RON),1.0,0.0,0.0,0.0
Stereoscopic depth manipulation,0.0,1.0,0.0,0.0
Evidence-based practice,0.0,1.0,0.0,0.0
Frontal activation,0.0,0.0,1.0,0.0
Renewal rate,1.0,0.0,0.0,0.0
Vitamin B6,1.0,0.0,0.0,0.0
Cognitive self-consciousness,0.0,0.0,1.0,0.0
Choice task,0.0,0.0,1.0,0.0
Dynamic images,1.0,0.0,0.0,0.0
Process dissociation,1.0,0.0,0.0,0.0
Sensitive period,0.0,0.0,1.0,0.0
Spontaneous blink rate,0.0,1.0,0.0,0.0
Modified Thorington,1.0,0.0,0.0,0.0
Frontal lobe lesions,0.0,1.0,0.0,0.0
Performance impairment,1.0,0.0,0.0,0.0
Maximum tolerated dose,0.0,1.0,0.0,0.0
at risk,1.0,0.0,0.0,0.0
Stress coping,0.0,0.0,1.0,0.0
Macaque development,0.0,1.0,0.0,0.0
Word frequency effects,0.0,0.0,1.0,0.0
Generativity,0.0,1.0,0.0,0.0
Child behaviour,0.0,1.0,0.0,0.0
Interactive memory systems,0.0,1.0,0.0,0.0
Water immersion,0.0,0.0,1.0,0.0
Dichotic listening,0.0,0.0,1.0,0.0
Latent growth models,0.0,0.0,1.0,0.0
screening,0.0,1.0,0.0,0.0
dry eye,0.0,1.0,0.0,0.0
Change-detection,1.0,0.0,0.0,0.0
Visuomotor process,0.0,0.0,1.0,0.0
Talker adaptation,0.0,0.0,0.0,1.0
Object represention,0.0,0.0,1.0,0.0
Cluster headache,0.0,1.0,0.0,0.0
inferior frontal gyrus,0.0,1.0,0.0,0.0
Benign brain tumors,0.0,0.0,1.0,0.0
Externalisation,0.0,1.0,0.0,0.0
Subcutaneous apomorphine infusion,1.0,0.0,0.0,0.0
movement maintenance,0.0,0.0,1.0,0.0
Configural-rule learning,0.0,1.0,0.0,0.0
Collisionavoidance power wheelchair,0.0,1.0,0.0,0.0
Stray fields,1.0,0.0,0.0,0.0
Hand dynamics,0.0,0.0,1.0,0.0
Photoreceptors,0.0,0.0,1.0,0.0
or requested a lawyer,0.0,0.0,1.0,0.0
Spatial model,0.0,1.0,0.0,0.0
Milnacipran,1.0,0.0,0.0,0.0
reading development,0.0,0.0,1.0,0.0
Graphic format,0.0,1.0,0.0,0.0
image analysis,0.0,1.0,0.0,0.0
Traditional linear training,0.0,1.0,0.0,0.0
Gamma-band synchronization,0.0,0.0,1.0,0.0
Uncinate fasciculus,0.0,1.0,0.0,0.0
Artistic activity,0.0,1.0,0.0,0.0
Part-whole relation,0.0,0.0,1.0,0.0
TVA based assessment,0.0,1.0,0.0,0.0
Confirmative Factor Analysis,0.0,0.0,1.0,0.0
Information quantity,1.0,0.0,0.0,0.0
Cultural education,0.0,1.0,0.0,0.0
Digital curation,0.0,0.0,1.0,0.0
Analytic information processing style,0.0,0.0,1.0,0.0
Primary task,0.0,0.0,1.0,0.0
combat disorders,1.0,0.0,0.0,0.0
Diurnal variability,0.0,1.0,0.0,0.0
Eye-hand coordination,0.0,0.0,1.0,0.0
Trauma memories,0.0,0.0,0.0,1.0
Multisensory information,0.0,0.0,1.0,0.0
Scatter hoarding,0.0,0.0,1.0,0.0
Social judgements,0.0,0.0,1.0,0.0
Pain-motor interaction,0.0,1.0,0.0,0.0
Type 2 diabetes mellitus (DM),0.0,0.0,1.0,0.0
Anatomic imitation,0.0,1.0,0.0,0.0
Natural language descriptions,0.0,0.0,1.0,0.0
Bare Phrase Structure,0.0,1.0,0.0,0.0
Ratio sensitivity,0.0,1.0,0.0,0.0
Associative memory and cognition,0.0,0.0,1.0,0.0
Chronic non-malignant pain,0.0,0.0,1.0,0.0
Motor theory of action recognition,0.0,1.0,0.0,0.0
Choking,1.0,0.0,0.0,0.0
parahippocampal place area,0.0,0.0,1.0,0.0
Handedness inheritance,0.0,0.0,1.0,0.0
Efficient coding,0.0,0.0,0.0,1.0
Posterior evaluation,0.0,0.0,1.0,0.0
Dravet syndrome spectrum,0.0,0.0,1.0,0.0
Passenger tracking,1.0,0.0,0.0,0.0
Arrow,1.0,0.0,0.0,0.0
Public attitudes,0.0,1.0,0.0,0.0
Survivor,0.0,0.0,1.0,0.0
Visual arts education,0.0,1.0,0.0,0.0
Motor neglect,0.0,1.0,0.0,0.0
Multi-sensory integration,1.0,0.0,0.0,0.0
Emotional confusion,0.0,1.0,0.0,0.0
Geriatric Depression Scale,1.0,0.0,0.0,0.0
New route learning,1.0,0.0,0.0,0.0
Spontaneous trait inferences,0.0,0.0,1.0,0.0
Intracranial pressure,0.0,1.0,0.0,0.0
Pigtail macaque,0.0,0.0,1.0,0.0
monochromatic design views,0.0,0.0,1.0,0.0
Selective estrogen receptor modulator,1.0,0.0,0.0,0.0
pain management,0.0,1.0,0.0,0.0
Inhibitory,1.0,0.0,0.0,0.0
Speed-accuracy trade-offs,0.0,0.0,1.0,0.0
Singleton search mode,0.0,1.0,0.0,0.0
Epidural,0.0,0.0,1.0,0.0
Event-structure coding,0.0,0.0,1.0,0.0
Latent variable modeling,0.0,1.0,0.0,0.0
Auditory landmarks,1.0,0.0,0.0,0.0
Training social cognition,0.0,0.0,1.0,0.0
First-degree relatives,0.0,0.0,1.0,0.0
Visualization taxonomies and models,0.0,0.0,1.0,0.0
memorability,0.0,0.0,1.0,0.0
Attentional boost,0.0,1.0,0.0,0.0
Pursuit stimuli,1.0,0.0,0.0,0.0
Home for the aged,0.0,0.0,1.0,0.0
vulnerability,0.0,0.0,1.0,0.0
Virtual,0.0,0.0,1.0,0.0
Autonomic space,0.0,0.0,1.0,0.0
Rs6277,1.0,0.0,0.0,0.0
Salivary biomarker,0.0,0.0,0.0,1.0
Eye movement control,0.0,1.0,0.0,0.0
retinal nerve fiber layer,0.0,0.0,0.0,1.0
Neurite outgrowth,0.0,0.0,1.0,0.0
False feedback,1.0,0.0,0.0,0.0
Evoked oscillations,0.0,0.0,1.0,0.0
Outdoor recreation,0.0,1.0,0.0,0.0
Eye activity,0.0,0.0,1.0,0.0
Waist-hip ratio,0.0,0.0,1.0,0.0
Object-place associative memory,1.0,0.0,0.0,0.0
medial frontal cortex,1.0,0.0,0.0,0.0
Capuchin monkey,0.0,0.0,1.0,0.0
Goal setting,0.0,0.0,0.0,1.0
Randomized controlled study,1.0,0.0,0.0,0.0
Somatosensory-evoked potentials,0.0,0.0,1.0,0.0
Web-based learning environment,0.0,0.0,1.0,0.0
Social groups,0.0,1.0,0.0,0.0
Delayed-response task,0.0,1.0,0.0,0.0
Haematological malignancies,0.0,0.0,1.0,0.0
Conspicuity eigen-features,0.0,0.0,1.0,0.0
CTE,0.0,0.0,0.0,1.0
dACC,0.0,1.0,0.0,0.0
Paced Auditory Serial Addition Task,0.0,0.0,0.0,1.0
Sameness,0.0,1.0,0.0,0.0
minimally invasive cardiac surgery,0.0,1.0,0.0,0.0
First generation antipsychotics,0.0,1.0,0.0,0.0
Re-enactment of intention paradigm,0.0,1.0,0.0,0.0
Implicit detection system,0.0,1.0,0.0,0.0
Orthoptic re-education,0.0,0.0,1.0,0.0
Perception and visual-spatial abilities,0.0,0.0,1.0,0.0
Intraventricular hemorrhage,0.0,1.0,0.0,0.0
Self and other,1.0,0.0,0.0,0.0
Cocoa flavanols,0.0,1.0,0.0,0.0
Ensemble of classifiers,0.0,1.0,0.0,0.0
Stimulus representations,1.0,0.0,0.0,0.0
Dementia with Lewy body,1.0,0.0,0.0,0.0
Action experience,1.0,0.0,0.0,0.0
Auditory interference,0.0,0.0,1.0,0.0
Paintings,0.0,1.0,0.0,0.0
MAE,1.0,0.0,0.0,0.0
Fluid analogies,0.0,0.0,1.0,0.0
spatial processing,0.0,1.0,0.0,0.0
neuronal plasticity,0.0,0.0,1.0,0.0
Testing the limits,0.0,0.0,0.0,1.0
Obstacle detection and classification,1.0,0.0,0.0,0.0
Object-centered simon effect,0.0,0.0,0.0,1.0
Accommodative microfluctuation,0.0,1.0,0.0,0.0
Speed/accuracy trade-off,0.0,0.0,1.0,0.0
Instrumental helping,1.0,0.0,0.0,0.0
incentive salience,0.0,0.0,1.0,0.0
[18F]FDOPA,1.0,0.0,0.0,0.0
transforaminal,0.0,0.0,0.0,1.0
App icon,0.0,0.0,1.0,0.0
Cortices,0.0,1.0,0.0,0.0
Rehabilitation robotics,0.0,0.0,1.0,0.0
perihand space,0.0,0.0,0.0,1.0
Writing systems,1.0,0.0,0.0,0.0
sensory motor,0.0,0.0,1.0,0.0
Computerized training,0.0,1.0,0.0,0.0
Levetiracteam,0.0,0.0,0.0,1.0
BBS4,0.0,1.0,0.0,0.0
Genetic risk,0.0,0.0,1.0,0.0
Prey recognition,1.0,0.0,0.0,0.0
assimilation effects,0.0,0.0,1.0,0.0
Loss,0.0,0.0,0.0,1.0
Self-control technique,0.0,1.0,0.0,0.0
BMAC,1.0,0.0,0.0,0.0
Predictive accuracy,0.0,1.0,0.0,0.0
Classroom observational assessment,1.0,0.0,0.0,0.0
Anterior negativities,1.0,0.0,0.0,0.0
Relapsing-remitting,0.0,0.0,1.0,0.0
Serial recall,1.0,0.0,0.0,0.0
Co-occurrence model,0.0,0.0,1.0,0.0
Agricultural workers,0.0,0.0,1.0,0.0
Flanker test,1.0,0.0,0.0,0.0
Cogniform disorder,0.0,0.0,1.0,0.0
Ambient infovis,1.0,0.0,0.0,0.0
Background noise,0.0,0.0,0.0,1.0
Event-related de/synchronization ERD/S,0.0,0.0,1.0,0.0
Nativism,1.0,0.0,0.0,0.0
dorsal stream,0.0,1.0,0.0,0.0
Task set reconfiguration,1.0,0.0,0.0,0.0
Spontaneously hypertensive rat,0.0,1.0,0.0,0.0
participatory design,1.0,0.0,0.0,0.0
Linguistic factors,0.0,0.0,1.0,0.0
Feeding behavior,1.0,0.0,0.0,0.0
Computerized test administration,0.0,1.0,0.0,0.0
Dynamic choice,1.0,0.0,0.0,0.0
Cross-cortical interaction,0.0,0.0,1.0,0.0
hemodialysis,0.0,1.0,0.0,0.0
Retinal slip,0.0,0.0,1.0,0.0
conscious visual perception,0.0,1.0,0.0,0.0
Mechanical systems,0.0,0.0,1.0,0.0
b Test,0.0,0.0,1.0,0.0
Retest effects,0.0,1.0,0.0,0.0
brain training,0.0,1.0,0.0,0.0
"Blind,0.0,0.0,0.0,0.0
Effectiveness,0.0,1.0,0.0,0.0
NLsemantics,0.0,0.0,1.0,0.0
Static & dynamic connectivity,1.0,0.0,0.0,0.0
Multiphasic screening,0.0,0.0,1.0,0.0
Interpersonal synchrony,0.0,0.0,1.0,0.0
Auditory scene,1.0,0.0,0.0,0.0
Mid-level module,0.0,0.0,1.0,0.0
Cognitive function test,0.0,1.0,0.0,0.0
Set shifting task,0.0,1.0,0.0,0.0
Psychological essentialism,0.0,0.0,1.0,0.0
Influence of experience,0.0,1.0,0.0,0.0
Drawing talent,0.0,0.0,1.0,0.0
Readout,0.0,0.0,0.0,1.0
Cue-based adjustments,0.0,0.0,1.0,0.0
Cognitive Testing,0.0,0.0,1.0,0.0
computer version,0.0,0.0,1.0,0.0
Information seeking,0.0,0.0,0.0,1.0
Temporal structuring,0.0,0.0,0.0,1.0
Executive deficits,0.0,0.0,1.0,0.0
Object persistence,0.0,0.0,1.0,0.0
Visuo-motor transformation,0.0,1.0,0.0,0.0
Subvocal speech,0.0,1.0,0.0,0.0
Matching,0.0,0.0,1.0,0.0
Challenges,1.0,0.0,0.0,0.0
Sociability,0.0,0.0,1.0,0.0
Tissue volumetry,1.0,0.0,0.0,0.0
Chocolate odor,0.0,0.0,1.0,0.0
Rupatadine,0.0,0.0,1.0,0.0
go/nogo,1.0,0.0,0.0,0.0
Eye movement tracking,0.0,1.0,0.0,0.0
ertapenem,0.0,0.0,1.0,0.0
Medical,0.0,0.0,1.0,0.0
life expectancy,0.0,1.0,0.0,0.0
Psychobiosocial view,0.0,1.0,0.0,0.0
Action and emotion,0.0,0.0,1.0,0.0
three-dimensional multiple object tracking speed task,0.0,0.0,1.0,0.0
Lower alpha 1,1.0,0.0,0.0,0.0
Visuospatial cognitive function,0.0,0.0,1.0,0.0
Brain areas,0.0,0.0,0.0,1.0
uncertainty,0.0,0.0,1.0,0.0
X-linked adrenoleukodystrophy,0.0,0.0,1.0,0.0
APP23 mice,0.0,0.0,1.0,0.0
Tele-immersion,0.0,0.0,1.0,0.0
Quality of feedback,1.0,0.0,0.0,0.0
Fluctuation,0.0,0.0,1.0,0.0
Patient education as topic,0.0,0.0,1.0,0.0
graphics,0.0,1.0,0.0,0.0
carpal tunnel syndrome,0.0,1.0,0.0,0.0
Visuo-spatial competencies,0.0,0.0,1.0,0.0
Heart-rate,0.0,1.0,0.0,0.0
apolipoprotein-4,1.0,0.0,0.0,0.0
Intuitive dualism,0.0,0.0,0.0,1.0
Perspectival experience,0.0,0.0,0.0,1.0
mixed methods,1.0,0.0,0.0,0.0
language rules,0.0,0.0,0.0,0.0
Inhibition of Return (IOR),1.0,0.0,0.0,0.0
doxycycline,0.0,0.0,1.0,0.0
Stair walking,1.0,0.0,0.0,0.0
nociceptor sensitization,1.0,0.0,0.0,0.0
Resting state network,0.0,1.0,0.0,0.0
Pediatric oncology,0.0,0.0,0.0,1.0
Osteoarthritis,0.0,0.0,1.0,0.0
ECAS,0.0,0.0,1.0,0.0
Infant undernutrition,0.0,1.0,0.0,0.0
selective attention.,0.0,0.0,1.0,0.0
Methylmalonic,0.0,0.0,1.0,0.0
Postsurgical neuropsychological evolution,1.0,0.0,0.0,0.0
Generative grammar of action,0.0,1.0,0.0,0.0
Procyclidine,0.0,0.0,0.0,1.0
Metaphoric gestures,0.0,0.0,0.0,1.0
Corticofugal,1.0,0.0,0.0,0.0
Dental care utilization,0.0,1.0,0.0,0.0
dyadic attention,1.0,0.0,0.0,0.0
Botnet detection,0.0,1.0,0.0,0.0
Motor outcome,1.0,0.0,0.0,0.0
Auditory verbal imagery,0.0,0.0,1.0,0.0
FBA,0.0,0.0,0.0,1.0
Linguistic stimuli,0.0,0.0,1.0,0.0
Persistent vegetative state,1.0,0.0,0.0,0.0
aromatase inhibitors,0.0,0.0,1.0,0.0
Down syndrome (DS),0.0,0.0,1.0,0.0
Eye-lid apraxia,1.0,0.0,0.0,0.0
Micro-Category,0.0,0.0,1.0,0.0
Source,0.0,0.0,1.0,0.0
Sleep duration,0.0,1.0,0.0,0.0
Guidance,0.0,1.0,0.0,0.0
destination therapy,0.0,0.0,1.0,0.0
origins of art,0.0,0.0,0.0,1.0
postural sway regularity,0.0,0.0,0.0,1.0
EDAN,0.0,0.0,1.0,0.0
Design agencies,0.0,1.0,0.0,0.0
Look-say/phonic approach,0.0,0.0,1.0,0.0
T gondii,0.0,1.0,0.0,0.0
Afference,0.0,0.0,1.0,0.0
Man-machine interaction,0.0,1.0,0.0,0.0
ERP measures assay the degree of expectancy violation in harmonic contexts in music (1995) Journal of Cognitive Neuroscience,0.0,0.0,1.0,0.0
Single unit recording,0.0,0.0,1.0,0.0
PARK2,0.0,0.0,1.0,0.0
skill development,0.0,0.0,1.0,0.0
PARK1,0.0,0.0,1.0,0.0
Sensory-motor conflict,1.0,0.0,0.0,0.0
Vigor,0.0,0.0,1.0,0.0
Partial volume effects,0.0,0.0,1.0,0.0
Minimalist grammar,0.0,1.0,0.0,0.0
Conceptual disorganization,0.0,1.0,0.0,0.0
Contingency learning,0.0,1.0,0.0,0.0
Descartes,0.0,1.0,0.0,0.0
late-life,0.0,0.0,0.0,1.0
return to play,0.0,0.0,1.0,0.0
Expressive enhancement,1.0,0.0,0.0,0.0
Bimanual,0.0,0.0,1.0,0.0
Social competition,1.0,0.0,0.0,0.0
Innate behavior,0.0,0.0,1.0,0.0
major depressive disorder,0.0,0.0,1.0,0.0
Memory formation,0.0,1.0,0.0,0.0
News memory,0.0,1.0,0.0,0.0
Diurnal variation,0.0,0.0,0.0,1.0
post-traumatic cognition,0.0,0.0,1.0,0.0
Bone marrow transplantation,0.0,0.0,1.0,0.0
Horse-Race model,0.0,1.0,0.0,0.0
Message sensation value,0.0,0.0,0.0,1.0
Drawings,0.0,0.0,1.0,0.0
ROI-based fMRI analysis,0.0,0.0,1.0,0.0
frontotemporal,0.0,0.0,1.0,0.0
Alpha amylase,0.0,0.0,0.0,1.0
Temporal binding,0.0,1.0,0.0,0.0
Parkinson?s disease,0.0,0.0,1.0,0.0
RIII-reflex,0.0,0.0,1.0,0.0
Taixi (KI3),0.0,0.0,0.0,1.0
visuo-spatial awareness,0.0,1.0,0.0,0.0
Electrodermal arousal,0.0,1.0,0.0,0.0
Point light displays,0.0,1.0,0.0,0.0
Visual rating scales,0.0,1.0,0.0,0.0
Computed tomography,0.0,0.0,0.0,1.0
visual discrimination,0.0,1.0,0.0,0.0
neural progenitor cell niches,0.0,1.0,0.0,0.0
Memory complaints inventory,0.0,0.0,1.0,0.0
multidisciplinary approach,0.0,0.0,1.0,0.0
electromyographic recording (EMG),0.0,0.0,1.0,0.0
Frontolimbic,0.0,0.0,0.0,1.0
Natural vision,0.0,0.0,1.0,0.0
Cerebellar theory,0.0,1.0,0.0,0.0
East Asian,0.0,1.0,0.0,0.0
illness onset,0.0,0.0,1.0,0.0
Miryoku Engineering,0.0,0.0,1.0,0.0
craving,0.0,0.0,1.0,0.0
Speed-Accuracy Trade-Off,0.0,1.0,0.0,0.0
chronic nonspecific low back pain,0.0,0.0,0.0,1.0
Mirror-image imitation,0.0,1.0,0.0,0.0
Pre-stimulus activity,0.0,0.0,0.0,1.0
novel object recognition test,0.0,0.0,1.0,0.0
category learning,0.0,1.0,0.0,0.0
Floral choice,0.0,1.0,0.0,0.0
Verb agreement,1.0,0.0,0.0,0.0
Severe traumatic brain injury,0.0,0.0,1.0,0.0
Breast,0.0,1.0,0.0,0.0
Verb,1.0,0.0,0.0,0.0
STAI,0.0,1.0,0.0,0.0
statin,0.0,1.0,0.0,0.0
Perceptual categorization and identification,0.0,1.0,0.0,0.0
functional MRI resting state,1.0,0.0,0.0,0.0
Alzheimers's disease,1.0,0.0,0.0,0.0
Hong Kong Chinese,0.0,1.0,0.0,0.0
Metacognitive,0.0,0.0,1.0,0.0
ALE-meta-analysis,0.0,0.0,1.0,0.0
Personal pronouns,0.0,1.0,0.0,0.0
Gebhard,1.0,0.0,0.0,0.0
World-centred reference frame,0.0,0.0,1.0,0.0
Shared plans,0.0,0.0,1.0,0.0
Alcohol consumption,1.0,0.0,0.0,0.0
Speed-of-processing,0.0,0.0,1.0,0.0
Item structuring,1.0,0.0,0.0,0.0
Multinomial models,0.0,1.0,0.0,0.0
music therapy,1.0,0.0,0.0,0.0
Reading developments,0.0,1.0,0.0,0.0
Trial evaluation,0.0,0.0,1.0,0.0
Pranayama,0.0,1.0,0.0,0.0
high-resolution displays,0.0,0.0,1.0,0.0
Motion-induced blindness,1.0,0.0,0.0,0.0
Chronic conditions,1.0,0.0,0.0,0.0
Target finding,1.0,0.0,0.0,0.0
Category effect,1.0,0.0,0.0,0.0
Frontal shift,0.0,1.0,0.0,0.0
hepatitis C,1.0,0.0,0.0,0.0
Community functioning,0.0,0.0,1.0,0.0
Anti-extinction,0.0,1.0,0.0,0.0
generative model,0.0,0.0,1.0,0.0
geriatric psychiatry,0.0,1.0,0.0,0.0
Intrinsic optical signals,1.0,0.0,0.0,0.0
Specialists vs. generalists,0.0,0.0,1.0,0.0
Visual anticipation,1.0,0.0,0.0,0.0
BCAO,0.0,1.0,0.0,0.0
olopatadine,0.0,1.0,0.0,0.0
Perceptual symbol systems,0.0,1.0,0.0,0.0
Quaternion,0.0,1.0,0.0,0.0
Antihistamines,0.0,0.0,1.0,0.0
Medial prefrontal,0.0,0.0,0.0,1.0
perfusion,0.0,1.0,0.0,0.0
Dynamic information flow,0.0,1.0,0.0,0.0
BOLD-fMRI,1.0,0.0,0.0,0.0
stroke recovery,0.0,1.0,0.0,0.0
Motivational salience,1.0,0.0,0.0,0.0
Visual social cognition,1.0,0.0,0.0,0.0
Contiguity effect,1.0,0.0,0.0,0.0
Loss of inhibition,0.0,0.0,1.0,0.0
face network,0.0,0.0,1.0,0.0
Cognition.,0.0,1.0,0.0,0.0
Information foraging,0.0,0.0,1.0,0.0
low frequency movement induced time-varying magnetic fields (TVMF),1.0,0.0,0.0,0.0
coenzyme Q10,0.0,0.0,1.0,0.0
Semantic judgements,0.0,0.0,1.0,0.0
Restrained eating,0.0,0.0,1.0,0.0
Food cue reactivity,1.0,0.0,0.0,0.0
Cognitive task/Respiratory gases/Heart rate/Personality traits,0.0,1.0,0.0,0.0
Real-life,0.0,0.0,0.0,1.0
visuospatial abilities,0.0,0.0,1.0,0.0
Visual expectation paradigm,0.0,1.0,0.0,0.0
Onset,1.0,0.0,0.0,0.0
Radiation,0.0,0.0,1.0,0.0
Endoscopy,0.0,0.0,1.0,0.0
Biorobotics,0.0,1.0,0.0,0.0
Post-acute stage of the illness,0.0,1.0,0.0,0.0
SCOPA-psychosocial,1.0,0.0,0.0,0.0
Rapid Visual Information Processing task,1.0,0.0,0.0,0.0
Temporal discriminability,0.0,1.0,0.0,0.0
Rhythmic movements,0.0,0.0,1.0,0.0
Painmatcher,1.0,0.0,0.0,0.0
Subgroup,0.0,1.0,0.0,0.0
PI-release,0.0,0.0,1.0,0.0
abduction,0.0,0.0,1.0,0.0
Bottom-up control,0.0,0.0,1.0,0.0
Skin colour,0.0,1.0,0.0,0.0
Older Drivers,0.0,1.0,0.0,0.0
Alpha frequency band,0.0,0.0,1.0,0.0
QLQ-BN20,0.0,1.0,0.0,0.0
QLQ-BN21,0.0,0.0,1.0,0.0
klotho gene,0.0,0.0,1.0,0.0
Adaptive discriminations,1.0,0.0,0.0,0.0
Self-cognition,0.0,0.0,1.0,0.0
Multi-segment sequences,1.0,0.0,0.0,0.0
Waist-to-hip ratio,1.0,0.0,0.0,0.0
psychiatry,0.0,1.0,0.0,0.0
Mellanby effect,0.0,0.0,1.0,0.0
Incremental thematic role disambiguation,0.0,1.0,0.0,0.0
Bacopa monniera,0.0,1.0,0.0,0.0
perceptual-cognitive training,0.0,0.0,1.0,0.0
Lateral display,0.0,1.0,0.0,0.0
Bacopa monnieri,1.0,0.0,0.0,0.0
Gender Identity Disorder,0.0,0.0,1.0,0.0
Timescales,1.0,0.0,0.0,0.0
Secondary art,0.0,0.0,1.0,0.0
Chaining,0.0,1.0,0.0,0.0
Parallel vs. serial search,0.0,0.0,1.0,0.0
Infant-directed speech,0.0,0.0,1.0,0.0
Letter position assignment,0.0,1.0,0.0,0.0
Vestibulitis,1.0,0.0,0.0,0.0
Neurobiology of pain experiences,0.0,1.0,0.0,0.0
oddity,0.0,1.0,0.0,0.0
Image schema,0.0,1.0,0.0,0.0
Arteriosclerosis,0.0,0.0,1.0,0.0
Intracytoplasmic sperm injection (ICSI),0.0,0.0,1.0,0.0
dEEG,0.0,1.0,0.0,0.0
Cortical motor system,0.0,1.0,0.0,0.0
Obstacle interference,0.0,1.0,0.0,0.0
Refractoriness,0.0,0.0,1.0,0.0
Representational resolution,0.0,0.0,1.0,0.0
Disabilities,0.0,1.0,0.0,0.0
Morph,0.0,0.0,1.0,0.0
Driving performance measures,1.0,0.0,0.0,0.0
Aetiology,0.0,1.0,0.0,0.0
Subjective cognitive impairment,0.0,1.0,0.0,0.0
Errors of commission,0.0,1.0,0.0,0.0
Digital radiography,0.0,0.0,1.0,0.0
recognition of masked visual images,0.0,0.0,1.0,0.0
Phase locking,1.0,0.0,0.0,0.0
Casual information visualization,1.0,0.0,0.0,0.0
Pre-ejection period,0.0,0.0,1.0,0.0
Blind education,0.0,0.0,1.0,0.0
avian vision,0.0,1.0,0.0,0.0
Recognition discriminability,0.0,1.0,0.0,0.0
Outcomes assessment (health care),1.0,0.0,0.0,0.0
Domain,0.0,0.0,1.0,0.0
Development in childhood,0.0,0.0,1.0,0.0
stimulus-driven capture,1.0,0.0,0.0,0.0
Multivoxel pattern analysis,0.0,0.0,0.0,1.0
Middle aged,1.0,0.0,0.0,0.0
veterinary,0.0,0.0,1.0,0.0
Rated effort,0.0,1.0,0.0,0.0
MiniMental State Examination,0.0,1.0,0.0,0.0
Accidental action,0.0,0.0,1.0,0.0
acute tolerance,1.0,0.0,0.0,0.0
Manual tracking,0.0,0.0,1.0,0.0
Trap tube,1.0,0.0,0.0,0.0
Estrus,1.0,0.0,0.0,0.0
Cerebello-oculo-renal syndromes,0.0,0.0,1.0,0.0
Sex perception,0.0,0.0,1.0,0.0
Invisible object displacement,0.0,1.0,0.0,0.0
"Emotional processing,0.0,0.0,0.0,0.0
Cognition and aging,0.0,0.0,1.0,0.0
Second-level analysis,0.0,1.0,0.0,0.0
Reisberg Global Deterioration Scale,0.0,0.0,1.0,0.0
Age-associated cognitive impairment,0.0,0.0,1.0,0.0
Amyotrophic Lateral Sclerosis (ALS),0.0,0.0,1.0,0.0
Lewy bodies dementia,0.0,0.0,1.0,0.0
Emotion regulation emotional blunting,0.0,0.0,1.0,0.0
Cognitive feelings,0.0,0.0,0.0,1.0
Communicative intention,0.0,1.0,0.0,0.0
Brief informant-based measure,1.0,0.0,0.0,0.0
fMRL,0.0,0.0,1.0,0.0
Theoretical framework,0.0,1.0,0.0,0.0
Numeric quantity stimuli,1.0,0.0,0.0,0.0
Female faces,1.0,0.0,0.0,0.0
Amalgam,0.0,1.0,0.0,0.0
Chronic eosinophilic leukaemia,1.0,0.0,0.0,0.0
Multilingualism,0.0,0.0,1.0,0.0
Resource-limited settings,1.0,0.0,0.0,0.0
hierarchical stimuli,1.0,0.0,0.0,0.0
Gaze shifts,0.0,1.0,0.0,0.0
asomatognosia,0.0,1.0,0.0,0.0
magnetic resonance imaging (MRI),1.0,0.0,0.0,0.0
Pre-school child,1.0,0.0,0.0,0.0
Postcode,0.0,1.0,0.0,0.0
VMI scores,1.0,0.0,0.0,0.0
Old,0.0,0.0,1.0,0.0
AD-ACL,0.0,0.0,1.0,0.0
Brain response,0.0,0.0,1.0,0.0
Multi-source interference task,1.0,0.0,0.0,0.0
BEM-based SMS-LORETA,0.0,1.0,0.0,0.0
Inhibitory control training,1.0,0.0,0.0,0.0
Biological inspiration,0.0,0.0,1.0,0.0
Virtual globes,0.0,1.0,0.0,0.0
Social integration,1.0,0.0,0.0,0.0
Childhood fitness,1.0,0.0,0.0,0.0
Map use,0.0,1.0,0.0,0.0
Risk screening,0.0,1.0,0.0,0.0
tanezumab.,1.0,0.0,0.0,0.0
Human rearing,0.0,0.0,1.0,0.0
Intralesional corticosteroid injections,0.0,1.0,0.0,0.0
Testing behavior,0.0,0.0,1.0,0.0
load,0.0,0.0,1.0,0.0
cognitive modeling,0.0,0.0,0.0,1.0
Vitamin d,0.0,0.0,1.0,0.0
Speed dating,1.0,0.0,0.0,0.0
Fissurization,0.0,1.0,0.0,0.0
Epidemiologic study,0.0,0.0,1.0,0.0
Panhypopituitarism,0.0,0.0,1.0,0.0
Vitamin C,1.0,0.0,0.0,0.0
Catastrophising,0.0,1.0,0.0,0.0
global-local processing,1.0,0.0,0.0,0.0
Dangerous objects,0.0,0.0,1.0,0.0
Mood state,1.0,0.0,0.0,0.0
Spongiform,0.0,0.0,0.0,1.0
tripchlorolide,0.0,0.0,1.0,0.0
Cortico-striatal system,0.0,0.0,1.0,0.0
Visuospatial attention shift,0.0,0.0,1.0,0.0
Directed transfer function method (DTF),0.0,1.0,0.0,0.0
Ventromedial prefrontal,0.0,0.0,0.0,1.0
Affective startle modulation,0.0,0.0,1.0,0.0
dysautonomia,0.0,0.0,1.0,0.0
Gamma-band frequency,0.0,0.0,1.0,0.0
Cardiff Acuity Test,1.0,0.0,0.0,0.0
Arboreal ants,0.0,0.0,1.0,0.0
Drawing performance,0.0,0.0,1.0,0.0
STin2 polymorphism,0.0,0.0,0.0,1.0
Emulation,0.0,0.0,1.0,0.0
Penile erection,0.0,1.0,0.0,0.0
CNS depressants,0.0,1.0,0.0,0.0
Sexual Pain,1.0,0.0,0.0,0.0
CDRI08,1.0,0.0,0.0,0.0
Bright light,0.0,0.0,1.0,0.0
Art therapy treatment,0.0,1.0,0.0,0.0
Late effects of treatment,0.0,0.0,0.0,1.0
Genetic covariance,1.0,0.0,0.0,0.0
Hole-board task,1.0,0.0,0.0,0.0
Western Europe,0.0,0.0,1.0,0.0
Silent brain infarct,0.0,0.0,1.0,0.0
Visuoconstructional function,0.0,0.0,0.0,1.0
Math precociousness,0.0,1.0,0.0,0.0
Competing-risk analysis,0.0,1.0,0.0,0.0
Coherent motion perception,0.0,1.0,0.0,0.0
Knowledge identification,0.0,1.0,0.0,0.0
CLASS,1.0,0.0,0.0,0.0
Array CGH,0.0,0.0,1.0,0.0
Five choice serial reaction time task,0.0,1.0,0.0,0.0
Chemical cues,0.0,1.0,0.0,0.0
Embodiment rating,0.0,1.0,0.0,0.0
Automatic classification,0.0,0.0,1.0,0.0
Peck tracking,0.0,0.0,1.0,0.0
Genetic disorder,0.0,1.0,0.0,0.0
Psychophysical dynamics,0.0,1.0,0.0,0.0
Eye Size,1.0,0.0,0.0,0.0
Mental transformations,0.0,1.0,0.0,0.0
vocal,0.0,1.0,0.0,0.0
Night driving,0.0,0.0,1.0,0.0
Young-old adults,0.0,1.0,0.0,0.0
Frequency trajectory,0.0,0.0,1.0,0.0
Cortical pattern matching,0.0,0.0,1.0,0.0
Longitudinal birth cohort study,0.0,0.0,1.0,0.0
Cholinergic Pathway HyperIntensity Scale (CHIPS),0.0,0.0,1.0,0.0
Task practice,1.0,0.0,0.0,0.0
Medical diagnosis,0.0,1.0,0.0,0.0
Transportation,0.0,0.0,1.0,0.0
Psychology of perception,0.0,0.0,1.0,0.0
Fornix,0.0,0.0,0.0,1.0
Auditory categorization,0.0,1.0,0.0,0.0
Components of the location probability effect in visual search tasks (1988) Journal of Experimental Psychology: Human Perception and Performance,1.0,0.0,0.0,0.0
Probabilistic feedback,0.0,1.0,0.0,0.0
Sound-symbolism,1.0,0.0,0.0,0.0
white matter anatomy,0.0,1.0,0.0,0.0
object-decision test,1.0,0.0,0.0,0.0
Visual naming,1.0,0.0,0.0,0.0
Human communicative cues,0.0,0.0,0.0,1.0
Glucose tolerance,0.0,0.0,1.0,0.0
Local/global bias,1.0,0.0,0.0,0.0
Adrenoleukodystrophy (ALD),0.0,0.0,1.0,0.0
Group dynamics,0.0,0.0,0.0,1.0
Growth mixture modeling,1.0,0.0,0.0,0.0
posterior fossa syndrome,0.0,1.0,0.0,0.0
WGTA,0.0,0.0,1.0,0.0
Mental competency,1.0,0.0,0.0,0.0
Auditory neuroscience,1.0,0.0,0.0,0.0
Human perception,0.0,1.0,0.0,0.0
Image-making,0.0,0.0,1.0,0.0
Spatial source memory and fMRI,0.0,0.0,1.0,0.0
fractal dimension,1.0,0.0,0.0,0.0
Magnocellular/parvocellular,0.0,0.0,1.0,0.0
Lung function,0.0,0.0,1.0,0.0
Theta/beta ratio,0.0,0.0,1.0,0.0
Circadian desynchronization,0.0,0.0,0.0,1.0
high frequency oscillations,0.0,0.0,0.0,1.0
Postural stability,0.0,1.0,0.0,0.0
complementary actions,0.0,1.0,0.0,0.0
computer systems,0.0,0.0,1.0,0.0
naming speed,0.0,1.0,0.0,0.0
Image reversal,0.0,0.0,1.0,0.0
Predator-prey,1.0,0.0,0.0,0.0
ReyOsterrieth Complex Figure Test,0.0,1.0,0.0,0.0
Francis Crick,0.0,0.0,1.0,0.0
Sensation-seeking,0.0,0.0,0.0,1.0
Finger-numeral representation,1.0,0.0,0.0,0.0
Neurobrucellosis,0.0,0.0,0.0,1.0
Behavioural outcomes,1.0,0.0,0.0,0.0
Cascaded processing,0.0,0.0,1.0,0.0
Bengalese finch,0.0,0.0,0.0,1.0
Stimulus attribute,0.0,0.0,0.0,1.0
sleep homeostasis,0.0,0.0,1.0,0.0
Parafoveal preview,0.0,1.0,0.0,0.0
Temporal context,1.0,0.0,0.0,0.0
Nae Ionescu,1.0,0.0,0.0,0.0
Malignancy,0.0,0.0,1.0,0.0
Clinical assessment,0.0,0.0,1.0,0.0
META-ANALYSIS,1.0,0.0,0.0,0.0
Intelligent tutoring systems,1.0,0.0,0.0,0.0
N-3 polyunsaturated fatty acid,0.0,1.0,0.0,0.0
ATP13A2,0.0,0.0,1.0,0.0
Adjunctive therapy,0.0,0.0,1.0,0.0
Fetal growth restriction (FGR),0.0,0.0,1.0,0.0
Sex change,1.0,0.0,0.0,0.0
neuroepidemiology,0.0,0.0,1.0,0.0
Posterior cortical dysfunction,0.0,0.0,1.0,0.0
Collinear grouping,1.0,0.0,0.0,0.0
Movie of the Assessment of Social Cognition,0.0,0.0,1.0,0.0
Work outcome,0.0,0.0,1.0,0.0
haemodialysis,0.0,0.0,1.0,0.0
Psychostimulant,1.0,0.0,0.0,0.0
Middle cerebral artery,0.0,0.0,1.0,0.0
Severe sepsis and septic shock,0.0,0.0,1.0,0.0
Bignotto,0.0,0.0,1.0,0.0
Cost-effectiveness,0.0,1.0,0.0,0.0
progressive aphasia,0.0,1.0,0.0,0.0
Pattern search,0.0,0.0,1.0,0.0
Sensori motor function,0.0,0.0,1.0,0.0
Brain cancer,0.0,0.0,1.0,0.0
hormone treatment,1.0,0.0,0.0,0.0
DMS-48,0.0,0.0,1.0,0.0
creative design,0.0,0.0,1.0,0.0
Facioscapulohumeral muscular dystrophy,1.0,0.0,0.0,0.0
social,0.0,1.0,0.0,0.0
Edge-based,0.0,1.0,0.0,0.0
Attentional system,0.0,1.0,0.0,0.0
Dual task interference,0.0,0.0,1.0,0.0
neuropsychologic outcome,1.0,0.0,0.0,0.0
Fast categorization,0.0,0.0,1.0,0.0
Frameworks,1.0,0.0,0.0,0.0
Humour deficit,0.0,1.0,0.0,0.0
James-Lange theory,0.0,1.0,0.0,0.0
Specific information processing,1.0,0.0,0.0,0.0
the binding problem,0.0,0.0,1.0,0.0
Microvascular decompression,0.0,0.0,1.0,0.0
Action-related language,0.0,0.0,1.0,0.0
probability reasoning,0.0,0.0,1.0,0.0
Basic numerical skills,0.0,0.0,1.0,0.0
gustation,0.0,0.0,0.0,1.0
Auditory emotion,1.0,0.0,0.0,0.0
Maximal exercise,0.0,0.0,0.0,1.0
Acute aerobic exercise,0.0,0.0,0.0,1.0
Intrusive images,0.0,0.0,0.0,1.0
Distraction in driving,0.0,1.0,0.0,0.0
Mental process,0.0,1.0,0.0,0.0
Self-related information,0.0,1.0,0.0,0.0
Magnetoencephlography (MEG),0.0,0.0,1.0,0.0
Feeling of body ownership,1.0,0.0,0.0,0.0
Chemical Education Research,0.0,0.0,1.0,0.0
Silent word recognition task,0.0,0.0,1.0,0.0
Current source density (CSD),0.0,1.0,0.0,0.0
Design education,1.0,0.0,0.0,0.0
Primary intersubjectivity,0.0,1.0,0.0,0.0
Cognitex,0.0,0.0,1.0,0.0
Postural damping,0.0,0.0,1.0,0.0
limbic system,0.0,0.0,1.0,0.0
Perspective change,0.0,0.0,1.0,0.0
Urban design,0.0,0.0,1.0,0.0
Sound frequency,0.0,1.0,0.0,0.0
In-group/out-group,0.0,0.0,1.0,0.0
Binge drink,0.0,0.0,1.0,0.0
Ecological acoustics,0.0,0.0,0.0,1.0
ERP (event related potential),0.0,1.0,0.0,0.0
Task-dependent state,0.0,1.0,0.0,0.0
Gapping,0.0,0.0,1.0,0.0
Visuo-striatal circuit,0.0,0.0,1.0,0.0
Vision-action compatibility,1.0,0.0,0.0,0.0
Numerosity discrimination,1.0,0.0,0.0,0.0
Auditory association cortex,0.0,0.0,1.0,0.0
Cortical interactive network,0.0,0.0,1.0,0.0
Object-centered coding,0.0,1.0,0.0,0.0
MindStreams,0.0,1.0,0.0,0.0
Gaze-contingent control,0.0,1.0,0.0,0.0
Batesian mimicry,0.0,0.0,1.0,0.0
cognitive distortion,0.0,0.0,1.0,0.0
reproductive period,0.0,1.0,0.0,0.0
Cross-sectional analysis,1.0,0.0,0.0,0.0
technologies,0.0,0.0,1.0,0.0
Focus groups,1.0,0.0,0.0,0.0
Issue 91,1.0,0.0,0.0,0.0
Cognitive Functioning,0.0,1.0,0.0,0.0
Additive stages,0.0,0.0,1.0,0.0
child neuropsychology,1.0,0.0,0.0,0.0
Dysmetria,0.0,0.0,1.0,0.0
Number words,0.0,1.0,0.0,0.0
Distractor-based retrieval,0.0,0.0,1.0,0.0
Ability to drive,0.0,0.0,1.0,0.0
Ipsilateral,0.0,0.0,0.0,1.0
Population groups,1.0,0.0,0.0,0.0
assessment/diagnosis,1.0,0.0,0.0,0.0
mental practice,0.0,0.0,1.0,0.0
Discourse processes,0.0,0.0,1.0,0.0
Right hemisphere damage,0.0,1.0,0.0,0.0
ROI template,0.0,0.0,1.0,0.0
Aversive stimuli,0.0,0.0,0.0,1.0
morphological processing,0.0,1.0,0.0,0.0
Atypical drugs,0.0,1.0,0.0,0.0
Neighborhood density,0.0,0.0,1.0,0.0
Principal sulcus,0.0,0.0,1.0,0.0
Venus effect,0.0,0.0,1.0,0.0
point-light biological motion (BM),0.0,0.0,1.0,0.0
Plasma exchange,0.0,1.0,0.0,0.0
Landscape perception,0.0,1.0,0.0,0.0
Structural neuroimaging,0.0,0.0,1.0,0.0
casuality,1.0,0.0,0.0,0.0
Calcium signals,0.0,0.0,1.0,0.0
premenopause,1.0,0.0,0.0,0.0
Calcium channel blockers,1.0,0.0,0.0,0.0
Amplitude,0.0,0.0,1.0,0.0
Parallel and distributed cognition,1.0,0.0,0.0,0.0
Neural specialization,1.0,0.0,0.0,0.0
Prosopagnosia/developmental,0.0,1.0,0.0,0.0
Aprepitant,0.0,1.0,0.0,0.0
Self-referencing,0.0,0.0,1.0,0.0
Path detection and tracking,0.0,0.0,1.0,0.0
Similarity measures,1.0,0.0,0.0,0.0
Listener reaction,1.0,0.0,0.0,0.0
Alpha2-agonist,1.0,0.0,0.0,0.0
Subacute myelo-optico-neuropathy,0.0,0.0,1.0,0.0
Interictal epileptiform spikes,1.0,0.0,0.0,0.0
Damasio,1.0,0.0,0.0,0.0
Advertising rhetoric,0.0,0.0,0.0,1.0
Unimodel,0.0,0.0,0.0,1.0
Spatial description,0.0,1.0,0.0,0.0
GD in elderly,0.0,0.0,0.0,1.0
Goal oriented actions,0.0,1.0,0.0,0.0
Pre-school children.,0.0,0.0,1.0,0.0
Sulcal morphology,0.0,1.0,0.0,0.0
Motion VEPs,0.0,0.0,0.0,1.0
ventrolateral prefrontal,0.0,0.0,1.0,0.0
Cerebral protection,0.0,0.0,1.0,0.0
Memory assessment,0.0,0.0,0.0,1.0
PWS,0.0,1.0,0.0,0.0
emociones,1.0,0.0,0.0,0.0
Pediatric brain injury,0.0,1.0,0.0,0.0
Social interactions,0.0,1.0,0.0,0.0
delayed-recognition task,0.0,1.0,0.0,0.0
Face selectivity,0.0,1.0,0.0,0.0
Brain weight,0.0,0.0,0.0,1.0
Motion direction,0.0,1.0,0.0,0.0
Looking,0.0,1.0,0.0,0.0
prevalence,1.0,0.0,0.0,0.0
Spatial compatible practice,1.0,0.0,0.0,0.0
Biologically relevant stimuli,0.0,0.0,0.0,1.0
Luciferase,0.0,0.0,1.0,0.0
Topological perception,0.0,0.0,1.0,0.0
Low intelligent quotient children,0.0,0.0,1.0,0.0
cross-sectional design,0.0,1.0,0.0,0.0
computer-aided detection (CAD),0.0,0.0,1.0,0.0
Poor sleep quality in cirrhosis,0.0,1.0,0.0,0.0
Kidney replacement therapy,1.0,0.0,0.0,0.0
Symbolic processing,0.0,0.0,1.0,0.0
?2C-adrenoceptor,1.0,0.0,0.0,0.0
Cervicogenic headaches,0.0,0.0,0.0,1.0
Translational neuroscience,0.0,0.0,1.0,0.0
Traditional Chinese medicine,0.0,0.0,1.0,0.0
Convergence insufficiency,1.0,0.0,0.0,0.0
Chaotic itinerancy,0.0,0.0,0.0,1.0
Behavioural approach/inhibition system,1.0,0.0,0.0,0.0
Child nutrition,0.0,1.0,0.0,0.0
Inhalant abuse,1.0,0.0,0.0,0.0
Prophylactic nap,1.0,0.0,0.0,0.0
Error taxonomy,0.0,1.0,0.0,0.0
Rate dependency,0.0,1.0,0.0,0.0
Human and nonhuman primate cortex,1.0,0.0,0.0,0.0
Veridical metric distances,1.0,0.0,0.0,0.0
Goats,0.0,1.0,0.0,0.0
Memory-guided saccades,0.0,1.0,0.0,0.0
Figural after-effects,1.0,0.0,0.0,0.0
pain measurement,0.0,0.0,1.0,0.0
Cetirizine,0.0,0.0,1.0,0.0
Perceived exertion,0.0,0.0,1.0,0.0
Familiar face recognition,0.0,0.0,1.0,0.0
Non-pharmacological intervention,0.0,1.0,0.0,0.0
Surgical treatment,1.0,0.0,0.0,0.0
Alpha-lactalbumin,0.0,0.0,1.0,0.0
Nde,0.0,0.0,0.0,1.0
Ndl,0.0,0.0,0.0,1.0
CogTool,0.0,0.0,1.0,0.0
Upper limb function,0.0,1.0,0.0,0.0
Physics education,0.0,0.0,0.0,1.0
evoked potential mapping.,1.0,0.0,0.0,0.0
Cognition and quantum mechanics,0.0,0.0,1.0,0.0
Curriculum,0.0,0.0,0.0,1.0
Nursing home admission,0.0,0.0,1.0,0.0
Tinnitus,0.0,1.0,0.0,0.0
Mirror recognition,0.0,0.0,1.0,0.0
15-objects test,0.0,0.0,1.0,0.0
nAChR,0.0,1.0,0.0,0.0
caregiver burden,1.0,0.0,0.0,0.0
Mild stroke,0.0,1.0,0.0,0.0
Animation-static comparison,0.0,1.0,0.0,0.0
artist,0.0,0.0,0.0,1.0
Monochromatic,1.0,0.0,0.0,0.0
Clinical study,0.0,0.0,1.0,0.0
Home care services,0.0,0.0,1.0,0.0
Decision-making task,0.0,1.0,0.0,0.0
Irrationality,0.0,0.0,1.0,0.0
Proteasome inhibitors,0.0,0.0,0.0,1.0
Wisconsin card sorting task,0.0,0.0,1.0,0.0
Male mice,1.0,0.0,0.0,0.0
resting-state functional magnetic resonance imaging,0.0,0.0,0.0,1.0
Relational displays,0.0,0.0,0.0,1.0
Setting of care,0.0,0.0,1.0,0.0
Risk group,1.0,0.0,0.0,0.0
Short sleep duration,0.0,0.0,1.0,0.0
Ballistocardiographic artifact,0.0,0.0,0.0,1.0
Visual search strategy,0.0,0.0,1.0,0.0
Biomodel neurons,0.0,1.0,0.0,0.0
APOE polymorphisms,0.0,1.0,0.0,0.0
Prenatal sex steroids,1.0,0.0,0.0,0.0
Haemophilia,0.0,1.0,0.0,0.0
process model,1.0,0.0,0.0,0.0
Inductive biases,0.0,1.0,0.0,0.0
pp. 397-413,0.0,1.0,0.0,0.0
Brain-machine interface (BMI),0.0,0.0,0.0,1.0
Emotion reading,0.0,0.0,0.0,1.0
Visual embellishments,0.0,0.0,1.0,0.0
shift work disorder,0.0,0.0,1.0,0.0
Ultra-high field,1.0,0.0,0.0,0.0
Fixation time,0.0,0.0,1.0,0.0
Numerosity judgment,1.0,0.0,0.0,0.0
Type A behavior,0.0,0.0,1.0,0.0
High density EEG/ERP,0.0,0.0,0.0,1.0
Sensory cognition,1.0,0.0,0.0,0.0
"Asphyxia neonatorum - complications,0.0,0.0,0.0,0.0
Virtual and physical learning environment,0.0,1.0,0.0,0.0
Abstract verbs,0.0,1.0,0.0,0.0
Linguistic markedness,1.0,0.0,0.0,0.0
Anterograde amnesia,0.0,0.0,1.0,0.0
Catechol-o-methyltransferase,0.0,1.0,0.0,0.0
Wisconsin Card Sorting test,0.0,1.0,0.0,0.0
Mozart,0.0,0.0,1.0,0.0
Portrait dialogue,0.0,1.0,0.0,0.0
rule-based item design,0.0,1.0,0.0,0.0
Environmental spatial cognition,0.0,0.0,1.0,0.0
Malingered neurocognitive deficit,0.0,1.0,0.0,0.0
Dopamine transmission,0.0,0.0,1.0,0.0
random coefficient modeling,0.0,1.0,0.0,0.0
Spatio-temporal PCA,1.0,0.0,0.0,0.0
accuracy rate,0.0,0.0,1.0,0.0
American Indian,0.0,0.0,1.0,0.0
Self-reported road crashes,0.0,0.0,1.0,0.0
ATD,0.0,1.0,0.0,0.0
Anosmia,0.0,1.0,0.0,0.0
Biology and Medicine",0.0,0.0,0.0,0.0
Narration,1.0,0.0,0.0,0.0
Autobiographical,0.0,0.0,1.0,0.0
Task-oriented dialog,0.0,1.0,0.0,0.0
training,0.0,0.0,1.0,0.0
Endocast,0.0,0.0,0.0,1.0
Identity concept,0.0,0.0,1.0,0.0
Viewer-centered coding,0.0,1.0,0.0,0.0
Chronic knee pain,0.0,1.0,0.0,0.0
Cone-excitation ratios,0.0,0.0,1.0,0.0
Dual-processing theory,0.0,0.0,1.0,0.0
Distributional reaction time analyses,0.0,1.0,0.0,0.0
Early stage,0.0,0.0,1.0,0.0
Gender Differences,0.0,0.0,1.0,0.0
Written production,0.0,1.0,0.0,0.0
ACT,0.0,0.0,1.0,0.0
Levopoda,0.0,1.0,0.0,0.0
Periodic synchronous discharges (PSD),0.0,0.0,1.0,0.0
Performance scales,0.0,1.0,0.0,0.0
place cells,0.0,0.0,1.0,0.0
Verbal working memory load,1.0,0.0,0.0,0.0
Anarchic hand syndrome,0.0,0.0,0.0,1.0
task performance,0.0,0.0,1.0,0.0
Mixing-costs,0.0,1.0,0.0,0.0
Visuo-perception,0.0,0.0,1.0,0.0
Retrieval task,0.0,1.0,0.0,0.0
Delayed intracranial hemorrhage,0.0,0.0,1.0,0.0
Dementia of Alzheimer's type (DAT),1.0,0.0,0.0,0.0
Linguistic labels,0.0,0.0,1.0,0.0
Ocular-visual-postural strategy,0.0,0.0,0.0,1.0
secondary care,1.0,0.0,0.0,0.0
Dynamic field neural networks,1.0,0.0,0.0,0.0
recreational cocaine use,0.0,0.0,1.0,0.0
NCC,1.0,0.0,0.0,0.0
NCL,0.0,0.0,1.0,0.0
"Brain infarction,0.0,0.0,0.0,0.0
Temporal bisection task,1.0,0.0,0.0,0.0
Food viewing,1.0,0.0,0.0,0.0
stress,1.0,0.0,0.0,0.0
Sex and cognition,0.0,1.0,0.0,0.0
TgCRND8,0.0,0.0,1.0,0.0
Self-conscious emotion,0.0,0.0,1.0,0.0
"Bimanual actions,0.0,0.0,0.0,0.0
Resting state functional MRI,1.0,0.0,0.0,0.0
Special education,0.0,1.0,0.0,0.0
Perceptual confidence,0.0,0.0,1.0,0.0
Mokken scaling model,0.0,0.0,1.0,0.0
Functional somatic symptoms,1.0,0.0,0.0,0.0
Threshold-free cluster enhancement,1.0,0.0,0.0,0.0
lactic acidosis and stroke-like episodes,0.0,0.0,1.0,0.0
academic performance,0.0,1.0,0.0,0.0
NR1 overexpression,1.0,0.0,0.0,0.0
Antennal lobe,0.0,0.0,1.0,0.0
Exploratory factor analysis,0.0,0.0,1.0,0.0
alexithymia,0.0,0.0,1.0,0.0
Organohalogens,0.0,1.0,0.0,0.0
Medication therapy management,0.0,0.0,1.0,0.0
culture differences,0.0,0.0,1.0,0.0
ordinality,0.0,0.0,1.0,0.0
Allocentric reference frame,0.0,1.0,0.0,0.0
Finger montring,0.0,1.0,0.0,0.0
Frequency of hypoglycemia,1.0,0.0,0.0,0.0
Pre-reflective body representation,0.0,0.0,1.0,0.0
Visuoperceptual task,0.0,0.0,1.0,0.0
Forced-choice recognition,0.0,1.0,0.0,0.0
Distributed attention,0.0,0.0,0.0,1.0
unmanned vehicle,1.0,0.0,0.0,0.0
Cognitive screening test,1.0,0.0,0.0,0.0
Whole-brain fMRI,0.0,1.0,0.0,0.0
Voltage-sensitive dye imaging,1.0,0.0,0.0,0.0
Sensorimotor timing,0.0,1.0,0.0,0.0
IV Alcohol,0.0,1.0,0.0,0.0
Critical branching,1.0,0.0,0.0,0.0
Dynamic balance control,1.0,0.0,0.0,0.0
Embedded figures test,1.0,0.0,0.0,0.0
DNAJC5,0.0,0.0,1.0,0.0
Non-word repetition,0.0,0.0,1.0,0.0
Computational,0.0,1.0,0.0,0.0
D.A.,0.0,0.0,1.0,0.0
Normalized word length,0.0,0.0,1.0,0.0
Auditory naming,1.0,0.0,0.0,0.0
infants at risk,0.0,0.0,0.0,1.0
Cognitivism,0.0,0.0,1.0,0.0
Vividness of motor imagery,0.0,1.0,0.0,0.0
Approach-avoidance,0.0,1.0,0.0,0.0
N280,1.0,0.0,0.0,0.0
psychosocial,0.0,0.0,0.0,1.0
Deficit,0.0,0.0,1.0,0.0
8-foot walk time,0.0,1.0,0.0,0.0
Label,0.0,1.0,0.0,0.0
central nervous system neoplasms - etiology,0.0,1.0,0.0,0.0
Motor learning and control,1.0,0.0,0.0,0.0
Physical height,1.0,0.0,0.0,0.0
Independent Component Analysis,0.0,0.0,1.0,0.0
emotion identification,0.0,1.0,0.0,0.0
Attention Biases,0.0,1.0,0.0,0.0
Sentence comprehension motion perception,0.0,0.0,1.0,0.0
Drug development,0.0,0.0,1.0,0.0
Counterpulsation/methods,0.0,0.0,1.0,0.0
PCDFs,0.0,1.0,0.0,0.0
motions,1.0,0.0,0.0,0.0
Compliance aid,0.0,1.0,0.0,0.0
Peer,0.0,1.0,0.0,0.0
Sub-ordinate level,0.0,1.0,0.0,0.0
11C-PIB PET,1.0,0.0,0.0,0.0
Data stream mining,0.0,1.0,0.0,0.0
Size judgement,1.0,0.0,0.0,0.0
Minor physical anomalies,1.0,0.0,0.0,0.0
longtailed macaques,0.0,1.0,0.0,0.0
Fine motor function,0.0,0.0,1.0,0.0
VLBW children,1.0,0.0,0.0,0.0
Parallel Distributed Processing,0.0,0.0,1.0,0.0
time,1.0,0.0,0.0,0.0
early detection,0.0,0.0,1.0,0.0
Early numeracy,0.0,0.0,1.0,0.0
Analytic cognitive style,1.0,0.0,0.0,0.0
Hematopoietic,0.0,0.0,1.0,0.0
Cortico-thalamic area,0.0,0.0,1.0,0.0
Texture features,0.0,0.0,1.0,0.0
Partial sight,0.0,0.0,1.0,0.0
lexical frequency,1.0,0.0,0.0,0.0
User-centered design,1.0,0.0,0.0,0.0
mouvements sociaux,1.0,0.0,0.0,0.0
retinal eccentricity,0.0,0.0,1.0,0.0
Dwi,0.0,0.0,1.0,0.0
SSRI response,0.0,0.0,1.0,0.0
Visual P3,0.0,1.0,0.0,0.0
Neuropsychological symptom dimensions,0.0,1.0,0.0,0.0
Visual patterns,1.0,0.0,0.0,0.0
CIAT plus,0.0,1.0,0.0,0.0
Cortical area,0.0,0.0,1.0,0.0
Hedonic,0.0,0.0,1.0,0.0
Motor bias,0.0,0.0,1.0,0.0
Volatile organic compounds,0.0,0.0,1.0,0.0
motor vehicle collisions,0.0,0.0,1.0,0.0
Spike correlation,1.0,0.0,0.0,0.0
Hand,0.0,0.0,1.0,0.0
Brain laterality,0.0,0.0,1.0,0.0
Current self-related thoughts,0.0,0.0,1.0,0.0
cognitive improvement,1.0,0.0,0.0,0.0
Human-computer interface,0.0,1.0,0.0,0.0
Prospective processing,0.0,1.0,0.0,0.0
Visual motor ability,1.0,0.0,0.0,0.0
Phenotypic variation,0.0,1.0,0.0,0.0
Automated and visual scoring methods,1.0,0.0,0.0,0.0
Dichotomous thinking,0.0,1.0,0.0,0.0
Negative reinforcement,0.0,1.0,0.0,0.0
Letter-sound knowledge,0.0,0.0,1.0,0.0
First,0.0,0.0,0.0,0.0
Neural delays,0.0,0.0,1.0,0.0
cognitive enhancement,0.0,0.0,1.0,0.0
Ganzfeld,1.0,0.0,0.0,0.0
VETSA,0.0,1.0,0.0,0.0
Cinematographic brain dynamics,0.0,0.0,0.0,1.0
3TD,1.0,0.0,0.0,0.0
sensory aids,0.0,0.0,1.0,0.0
Short-term memory of rule,0.0,1.0,0.0,0.0
older people,0.0,0.0,1.0,0.0
Vivid dream,0.0,0.0,0.0,1.0
Behavioural measurement,1.0,0.0,0.0,0.0
Cause-specific mortality,1.0,0.0,0.0,0.0
Retinal branch occlusion,1.0,0.0,0.0,0.0
Nonliteral language,0.0,0.0,1.0,0.0
Formal thought,0.0,0.0,1.0,0.0
artificial life,0.0,0.0,0.0,1.0
Mother-Infant Interaction,0.0,0.0,0.0,1.0
Language testing,0.0,0.0,1.0,0.0
construct validity,0.0,0.0,1.0,0.0
Non-photorealistic rendering,0.0,1.0,0.0,0.0
Multiple-face tracking,0.0,0.0,0.0,1.0
Predementia,0.0,1.0,0.0,0.0
Converging methods,1.0,0.0,0.0,0.0
neurobehavioral changes in critical illness,0.0,1.0,0.0,0.0
Multi-dimensional task,0.0,0.0,1.0,0.0
prison,0.0,0.0,1.0,0.0
Moderately preterm,1.0,0.0,0.0,0.0
Visual evaluative task,0.0,0.0,0.0,1.0
Neurocysticercosis,0.0,1.0,0.0,0.0
similarity judgment,0.0,0.0,0.0,1.0
Longitudinal testing,0.0,1.0,0.0,0.0
ERP topography,0.0,0.0,0.0,1.0
Rotational invariance,1.0,0.0,0.0,0.0
Cognitive brain function,0.0,1.0,0.0,0.0
Arm activity,0.0,0.0,1.0,0.0
ownership,0.0,1.0,0.0,0.0
curriculum change,0.0,0.0,0.0,1.0
Congenital HHV-6 infection,1.0,0.0,0.0,0.0
Neuropsychological markers,0.0,0.0,0.0,1.0
Amelia,0.0,0.0,1.0,0.0
Cortical maps,0.0,0.0,1.0,0.0
Spatial manipulation,0.0,0.0,1.0,0.0
Infralimbic cortex,0.0,1.0,0.0,0.0
mental arithmetic task,1.0,0.0,0.0,0.0
Incentive,0.0,1.0,0.0,0.0
IFOF,0.0,0.0,1.0,0.0
Respiratory distress,0.0,1.0,0.0,0.0
Logophysics,1.0,0.0,0.0,0.0
perceptual decoupling,0.0,1.0,0.0,0.0
Left brain,0.0,1.0,0.0,0.0
Third-party intervention behaviour,0.0,1.0,0.0,0.0
Dynamic stability,0.0,0.0,1.0,0.0
Congruency sequence effect,0.0,1.0,0.0,0.0
SRT,1.0,0.0,0.0,0.0
cognitive abilityCognitive ability,1.0,0.0,0.0,0.0
Somatoform,0.0,1.0,0.0,0.0
Semantic categorization task,0.0,0.0,1.0,0.0
Image transformation,0.0,1.0,0.0,0.0
Interstitial radiosurgery,0.0,0.0,1.0,0.0
Cognitive dysmetria,0.0,1.0,0.0,0.0
Conceptual innovation,0.0,1.0,0.0,0.0
Surface form,0.0,1.0,0.0,0.0
Columns,0.0,1.0,0.0,0.0
Method,0.0,0.0,1.0,0.0
Early blind,0.0,0.0,0.0,1.0
Paternal,0.0,0.0,1.0,0.0
Prenatal exposures,1.0,0.0,0.0,0.0
Deictic behaviour,0.0,0.0,1.0,0.0
Area discrimination,0.0,0.0,0.0,1.0
High-density electrical mapping,0.0,1.0,0.0,0.0
"Alcohol use disorder,0.0,0.0,0.0,0.0
Familial vulnerability,1.0,0.0,0.0,0.0
Beep-probe task,0.0,1.0,0.0,0.0
Missense mutation,0.0,1.0,0.0,0.0
Temporal course,0.0,1.0,0.0,0.0
image description,0.0,0.0,1.0,0.0
Missing data,0.0,1.0,0.0,0.0
autism/social cognition,0.0,1.0,0.0,0.0
Neurocognitive Functioning,0.0,0.0,1.0,0.0
Non-verbal narratives,0.0,0.0,1.0,0.0
Sensitive periods,1.0,0.0,0.0,0.0
Detection task,0.0,0.0,0.0,1.0
Coping style,0.0,1.0,0.0,0.0
Temporal lobe volume,0.0,0.0,1.0,0.0
Blinking bursts,0.0,0.0,1.0,0.0
Colour constancy,0.0,0.0,1.0,0.0
Inequity aversion,0.0,1.0,0.0,0.0
Treatment satisfaction,0.0,0.0,1.0,0.0
Usability data,0.0,0.0,1.0,0.0
CSP?,0.0,0.0,1.0,0.0
Perceptual closure task,0.0,1.0,0.0,0.0
Primary adrenal insufficiency,0.0,1.0,0.0,0.0
Superior frontal gyrus,1.0,0.0,0.0,0.0
Distributional analysis,0.0,1.0,0.0,0.0
Styling,0.0,0.0,1.0,0.0
Odontostomatognatic function,0.0,0.0,0.0,1.0
Attentional control sets,0.0,0.0,1.0,0.0
Semantic control,1.0,0.0,0.0,0.0
Health economics methods,0.0,1.0,0.0,0.0
Normativity,0.0,0.0,1.0,0.0
acoustic noise,0.0,1.0,0.0,0.0
Visual screening,0.0,0.0,1.0,0.0
Critical period,0.0,0.0,1.0,0.0
brain size,0.0,0.0,1.0,0.0
Task support hypothesis,1.0,0.0,0.0,0.0
Behavioral maturation,0.0,0.0,1.0,0.0
object,1.0,0.0,0.0,0.0
Posterior MTG,0.0,0.0,1.0,0.0
Calligraphic landscape,1.0,0.0,0.0,0.0
Non local perception,1.0,0.0,0.0,0.0
Test-retest,0.0,1.0,0.0,0.0
object solidity,1.0,0.0,0.0,0.0
Spacing,1.0,0.0,0.0,0.0
Action-related visual and auditory stimulation,0.0,1.0,0.0,0.0
Text-World Theory,0.0,0.0,1.0,0.0
Bayesian network,0.0,0.0,1.0,0.0
Visual front-end module,0.0,0.0,1.0,0.0
hue,0.0,0.0,0.0,1.0
Dopamine transporters,0.0,1.0,0.0,0.0
Object shape,0.0,0.0,1.0,0.0
head injury,0.0,0.0,1.0,0.0
Long-range functional interactions,0.0,1.0,0.0,0.0
late preterm,0.0,0.0,0.0,1.0
Informational encapsulation,0.0,0.0,1.0,0.0
Fuchs' endothelial corneal dystrophy,1.0,0.0,0.0,0.0
I.3.3 [Computer Graphics]: Picture/Image Generation - Display algorithms,0.0,1.0,0.0,0.0
automatic processes,0.0,0.0,0.0,1.0
John Dewey,0.0,1.0,0.0,0.0
Frequencies of 1-20 Hz and the gamma range,1.0,0.0,0.0,0.0
Dominant-plane detection,1.0,0.0,0.0,0.0
Symbolic goods,0.0,0.0,1.0,0.0
Skills training,1.0,0.0,0.0,0.0
Developmental disability,0.0,0.0,1.0,0.0
Auditory responses,0.0,1.0,0.0,0.0
Hypersensitivity,0.0,0.0,1.0,0.0
Affective sharing,0.0,0.0,1.0,0.0
Noncommunicable diseases,0.0,1.0,0.0,0.0
Visual error,1.0,0.0,0.0,0.0
General linear model (GLM),0.0,1.0,0.0,0.0
Frequency discrimination,1.0,0.0,0.0,0.0
Benign rolandic epilepsy,1.0,0.0,0.0,0.0
the sacred,1.0,0.0,0.0,0.0
wavelet spectra,1.0,0.0,0.0,0.0
Amatitlania nigrofasciatus,0.0,0.0,1.0,0.0
Nonconscious cognition,0.0,1.0,0.0,0.0
CA: Academic Press,1.0,0.0,0.0,0.0
Visual and auditory attention,0.0,1.0,0.0,0.0
Rheumatology,1.0,0.0,0.0,0.0
Emotional functions,0.0,0.0,1.0,0.0
Pointing movements,0.0,0.0,0.0,1.0
Stroboscopic,0.0,0.0,1.0,0.0
Detoxication,0.0,1.0,0.0,0.0
SET,0.0,1.0,0.0,0.0
Music listening,0.0,0.0,1.0,0.0
Mnemonic strategy,0.0,0.0,1.0,0.0
Rabbit,0.0,0.0,1.0,0.0
Affective psychosis,0.0,1.0,0.0,0.0
Jackson pollock,0.0,1.0,0.0,0.0
Incidental versus intentional processing,0.0,0.0,1.0,0.0
Meta-cognitive beliefs,0.0,0.0,1.0,0.0
Neurocognitive abilities,0.0,0.0,1.0,0.0
Bayesian classification,0.0,1.0,0.0,0.0
Orientation column,1.0,0.0,0.0,0.0
Professional development programme,0.0,0.0,1.0,0.0
Recency effect,1.0,0.0,0.0,0.0
perception-action,0.0,1.0,0.0,0.0
Naming environmental sounds,1.0,0.0,0.0,0.0
Phonology and reading,0.0,0.0,1.0,0.0
Know,0.0,0.0,1.0,0.0
BRAINnet,0.0,0.0,1.0,0.0
Cerebellar dysfunction,0.0,0.0,1.0,0.0
Escape response,0.0,1.0,0.0,0.0
Sequences,0.0,0.0,1.0,0.0
Vision research,0.0,0.0,1.0,0.0
ICIT,0.0,0.0,1.0,0.0
Later negativity (LN),0.0,0.0,1.0,0.0
Susac's Syndrome,1.0,0.0,0.0,0.0
Addition-subtraction,1.0,0.0,0.0,0.0
Display change,0.0,0.0,1.0,0.0
Reactive,1.0,0.0,0.0,0.0
Daily activities,1.0,0.0,0.0,0.0
Orthographic encoding,0.0,1.0,0.0,0.0
Positive,0.0,0.0,1.0,0.0
C-Fos,0.0,0.0,0.0,1.0
Attentional inhibition,0.0,0.0,0.0,1.0
L-amphetamine sulfate,0.0,0.0,1.0,0.0
Treatment phase,0.0,1.0,0.0,0.0
Default-mode,0.0,1.0,0.0,0.0
Poststreptococcal glomerulonephritis,1.0,0.0,0.0,0.0
Feature extraction,0.0,0.0,0.0,1.0
Text,1.0,0.0,0.0,0.0
Traveling Salesman Problem (TSP),1.0,0.0,0.0,0.0
Mouse model,1.0,0.0,0.0,0.0
Crossmodal attention,0.0,1.0,0.0,0.0
Praxia,0.0,0.0,1.0,0.0
rseaux,1.0,0.0,0.0,0.0
Logopenic variant,0.0,0.0,1.0,0.0
Faces subtest,0.0,1.0,0.0,0.0
psychiatric signs,0.0,0.0,0.0,1.0
Visual tests,0.0,0.0,1.0,0.0
Tool-use,0.0,0.0,1.0,0.0
Mask inhibition,1.0,0.0,0.0,0.0
Hominoidea,0.0,1.0,0.0,0.0
Dose-response assessment,0.0,0.0,1.0,0.0
Stroke-related outcomes,0.0,1.0,0.0,0.0
naltrindole,0.0,0.0,1.0,0.0
Scrambling negativity,0.0,0.0,1.0,0.0
source memory,0.0,1.0,0.0,0.0
Mobile Web browsing,1.0,0.0,0.0,0.0
Motor vehicle safety,0.0,1.0,0.0,0.0
Amygdale,0.0,0.0,0.0,1.0
Item ambiguity,1.0,0.0,0.0,0.0
geriatric depression,0.0,1.0,0.0,0.0
Mathematical model,1.0,0.0,0.0,0.0
Neurologic manifestations,0.0,0.0,1.0,0.0
Learning support system,0.0,1.0,0.0,0.0
Neurocognitive endophenotypes,0.0,1.0,0.0,0.0
Attributional style,0.0,1.0,0.0,0.0
Individual performance,1.0,0.0,0.0,0.0
Task decoding,0.0,0.0,1.0,0.0
Dimebon,0.0,1.0,0.0,0.0
Melancholic features,0.0,1.0,0.0,0.0
Music training,0.0,0.0,0.0,1.0
Raven's CPM,0.0,0.0,0.0,1.0
Axon propagation,0.0,0.0,1.0,0.0
Social causal attribution,0.0,0.0,1.0,0.0
Gamma aminobutyric acid,0.0,1.0,0.0,0.0
Restrained eaters,0.0,0.0,1.0,0.0
Visual variant of Alzheimer's disease,0.0,0.0,1.0,0.0
MRI global brain volumetry,0.0,1.0,0.0,0.0
Moving scenes,0.0,0.0,1.0,0.0
Bay-Richter,0.0,0.0,1.0,0.0
processing styles,0.0,0.0,1.0,0.0
emotional expressions,0.0,1.0,0.0,0.0
Structural characteristics,0.0,0.0,1.0,0.0
Contingency detection,0.0,1.0,0.0,0.0
Cognitive skill,1.0,0.0,0.0,0.0
Resistant hypertension,0.0,0.0,1.0,0.0
Nonmotor,1.0,0.0,0.0,0.0
Heights,0.0,1.0,0.0,0.0
Cardiac failure,0.0,0.0,1.0,0.0
Key words Bipolar disorder,0.0,1.0,0.0,0.0
Representative task simulation,0.0,0.0,1.0,0.0
Shooting,0.0,1.0,0.0,0.0
Human sexuality,1.0,0.0,0.0,0.0
Chemosomatosensory,0.0,0.0,0.0,1.0
Diagnostic criteria,0.0,1.0,0.0,0.0
Graph theoretical analysis,0.0,1.0,0.0,0.0
Interespecific communication,0.0,0.0,1.0,0.0
family resemblance,0.0,1.0,0.0,0.0
Real objects,1.0,0.0,0.0,0.0
N400-LPN,0.0,0.0,0.0,1.0
Duchenne smile,0.0,1.0,0.0,0.0
Eyeblink conditioning,0.0,0.0,1.0,0.0
Proper nouns,1.0,0.0,0.0,0.0
Neural correlates,1.0,0.0,0.0,0.0
Route,0.0,0.0,1.0,0.0
Emotional expression of faces,0.0,0.0,1.0,0.0
Brain disorder,0.0,1.0,0.0,0.0
Banner,0.0,0.0,1.0,0.0
Inter-ocular competition,0.0,1.0,0.0,0.0
Auto-associative and hetero-associative networks,0.0,0.0,1.0,0.0
Methamphetamine abuse,0.0,0.0,1.0,0.0
Dissociative disorders,0.0,1.0,0.0,0.0
cerebellar tumor,0.0,1.0,0.0,0.0
Self-touch,0.0,1.0,0.0,0.0
Multi-sensory approach,0.0,0.0,1.0,0.0
optical coherence tomography,0.0,0.0,0.0,1.0
Longitudinal survey,0.0,0.0,1.0,0.0
bilingualism,1.0,0.0,0.0,0.0
Remitted depression,0.0,0.0,1.0,0.0
Simulated vision,0.0,1.0,0.0,0.0
T2 MRI,0.0,0.0,1.0,0.0
Understanding attention,1.0,0.0,0.0,0.0
Hand selection,0.0,1.0,0.0,0.0
enactive cognitive science,0.0,0.0,0.0,1.0
DNMS,1.0,0.0,0.0,0.0
DNMP,0.0,1.0,0.0,0.0
auditory perception,1.0,0.0,0.0,0.0
Verbal fluency test,0.0,1.0,0.0,0.0
visual mismatch negativity,0.0,1.0,0.0,0.0
Algorithmic lateral inhibition,0.0,1.0,0.0,0.0
Point-light action,0.0,1.0,0.0,0.0
SPCN,1.0,0.0,0.0,0.0
Reaction time distribution analysis,0.0,0.0,1.0,0.0
Li,0.0,1.0,0.0,0.0
Point-light,0.0,0.0,1.0,0.0
Visual information design,0.0,0.0,1.0,0.0
category specificity,1.0,0.0,0.0,0.0
Blue mountains eye study,0.0,0.0,1.0,0.0
Multivoxel connectivity analysis (MVCA),0.0,0.0,1.0,0.0
Task selection,1.0,0.0,0.0,0.0
Referential behaviours,0.0,0.0,1.0,0.0
MacArthur Competence Assessment Tool for Treatment,0.0,0.0,1.0,0.0
Autism Spectrum Disorders,0.0,0.0,1.0,0.0
External representation,0.0,1.0,0.0,0.0
Circulatory system,0.0,0.0,1.0,0.0
Sleep disturbances,0.0,1.0,0.0,0.0
Color code,0.0,0.0,1.0,0.0
language disorders,0.0,0.0,0.0,1.0
Dopamine synthesis capacity,0.0,0.0,1.0,0.0
Transcutaneous electrical nerve stimulation,0.0,0.0,0.0,1.0
Short-latency afferent inhibition,0.0,0.0,0.0,1.0
Social leisure activities,0.0,0.0,1.0,0.0
Parkinson's disease/parkinsonism,0.0,0.0,0.0,1.0
FTLD,0.0,0.0,1.0,0.0
Information technology (IT),1.0,0.0,0.0,0.0
Institution,0.0,0.0,1.0,0.0
Keywords Adolescence,0.0,0.0,1.0,0.0
Diagnostic,0.0,1.0,0.0,0.0
feeding desire,0.0,0.0,0.0,1.0
Pragmatic impairment,0.0,1.0,0.0,0.0
High-field MRI,1.0,0.0,0.0,0.0
Risk management,0.0,1.0,0.0,0.0
Leisure activity,0.0,0.0,1.0,0.0
error-correcting response,1.0,0.0,0.0,0.0
Visual processing bias,1.0,0.0,0.0,0.0
Transjugular intrahepatic portosystemic shunt,0.0,0.0,1.0,0.0
MEMORY,1.0,0.0,0.0,0.0
Target unlearning,0.0,0.0,1.0,0.0
mindfulness meditation,0.0,0.0,0.0,1.0
automation,1.0,0.0,0.0,0.0
Amplitude asymmetry,0.0,1.0,0.0,0.0
Information load,0.0,0.0,1.0,0.0
implicit memory,1.0,0.0,0.0,0.0
knowledge acquisition,0.0,0.0,1.0,0.0
Impulsive,0.0,1.0,0.0,0.0
enumeration,0.0,0.0,1.0,0.0
Glycine transporter inhibitor,0.0,1.0,0.0,0.0
hyperpallium,0.0,1.0,0.0,0.0
Fall risk,1.0,0.0,0.0,0.0
AACD,1.0,0.0,0.0,0.0
Spaced retrieval training,0.0,0.0,1.0,0.0
Psychometric meta-analysis,0.0,1.0,0.0,0.0
Time-to-contact,0.0,0.0,1.0,0.0
Provoked Vestibulodynia,1.0,0.0,0.0,0.0
RHEA,1.0,0.0,0.0,0.0
neural prosthesis,0.0,1.0,0.0,0.0
Letter case,0.0,1.0,0.0,0.0
Analgesic medications,0.0,0.0,1.0,0.0
Interpersonal reactivity index (IRI),0.0,0.0,1.0,0.0
probabilistic cognition,0.0,0.0,0.0,1.0
Cortical networks,1.0,0.0,0.0,0.0
Effects,0.0,0.0,1.0,0.0
S-D Marketing,0.0,0.0,1.0,0.0
Ciclosporin,0.0,0.0,0.0,0.0
Facial resemblance,0.0,0.0,1.0,0.0
Task demand,0.0,0.0,1.0,0.0
Drug pharmacology,0.0,1.0,0.0,0.0
Accuracy feedback,0.0,1.0,0.0,0.0
Persistent activity,0.0,1.0,0.0,0.0
Alcohol drinking,0.0,0.0,0.0,1.0
endogenous eczema,1.0,0.0,0.0,0.0
Situated simulation,0.0,1.0,0.0,0.0
Bodily representation,0.0,0.0,1.0,0.0
Psychological impact of the WEB,0.0,0.0,1.0,0.0
Contrast sensitivity (CS),0.0,0.0,1.0,0.0
Music and language,0.0,0.0,1.0,0.0
laboratory studies,0.0,1.0,0.0,0.0
Computer-based cognitive training,0.0,1.0,0.0,0.0
Object unity,0.0,0.0,1.0,0.0
Community-dwelling,0.0,0.0,1.0,0.0
Experimental esthetic,0.0,0.0,1.0,0.0
Script,0.0,0.0,1.0,0.0
neurocognitive late effects,1.0,0.0,0.0,0.0
Episodic-like memory,0.0,0.0,1.0,0.0
postmenopause,1.0,0.0,0.0,0.0
Basal ganglia pathology,1.0,0.0,0.0,0.0
Rule learning,0.0,0.0,1.0,0.0
Relational complexity,0.0,1.0,0.0,0.0
Central lateral,0.0,1.0,0.0,0.0
PDD-NOS,0.0,1.0,0.0,0.0
Negative valence,0.0,0.0,1.0,0.0
Interpersonal factor,0.0,0.0,1.0,0.0
Gestalt principles,0.0,1.0,0.0,0.0
Taylor hand function test,1.0,0.0,0.0,0.0
Retinoid system,0.0,0.0,0.0,1.0
CogState,0.0,0.0,0.0,1.0
Alpha2 desynchronization,1.0,0.0,0.0,0.0
Mydriatic solutions,1.0,0.0,0.0,0.0
AIPSS,0.0,0.0,1.0,0.0
Pylyshyn,0.0,0.0,1.0,0.0
Gray/White matter,0.0,1.0,0.0,0.0
Bariatric surgery,1.0,0.0,0.0,0.0
Remember-Know paradigm,0.0,0.0,1.0,0.0
SAMP-8 mice,0.0,0.0,0.0,1.0
Individual differences in judgments on food safety,0.0,1.0,0.0,0.0
Neglect dyslexia,1.0,0.0,0.0,0.0
Visual dot-probe task,0.0,1.0,0.0,0.0
Implicit attentional processing,0.0,0.0,1.0,0.0
Child psychology,0.0,1.0,0.0,0.0
Response to novelty,0.0,0.0,1.0,0.0
Aesthetic classification,1.0,0.0,0.0,0.0
EEG-fMRI,0.0,0.0,0.0,1.0
Response level conflict,0.0,1.0,0.0,0.0
fixation avoidance,0.0,0.0,1.0,0.0
3 T,0.0,1.0,0.0,0.0
Granger causality analysis,0.0,0.0,1.0,0.0
FERET database,0.0,0.0,1.0,0.0
Post-synaptic potentials,0.0,0.0,0.0,1.0
drugs and driving,1.0,0.0,0.0,0.0
Prescribing,0.0,0.0,0.0,1.0
Reminding,1.0,0.0,0.0,0.0
PMC,0.0,0.0,1.0,0.0
Social cues,0.0,1.0,0.0,0.0
Multimodal sensory cues,0.0,1.0,0.0,0.0
ERP components peak amplitude and latency,0.0,0.0,0.0,1.0
Flash-lag illusion,1.0,0.0,0.0,0.0
personality and cognitive features,0.0,0.0,1.0,0.0
Musical ability,0.0,0.0,1.0,0.0
stop-signal task,1.0,0.0,0.0,0.0
State-switching,0.0,1.0,0.0,0.0
Concreteness effect,1.0,0.0,0.0,0.0
Spatio-visual skills,1.0,0.0,0.0,0.0
School girls,0.0,1.0,0.0,0.0
Stereotypic behaviour,0.0,0.0,1.0,0.0
Associative processing,0.0,1.0,0.0,0.0
Cue combination,0.0,0.0,0.0,1.0
Perceptual familiarity,0.0,0.0,1.0,0.0
New world primates,0.0,1.0,0.0,0.0
Dressing apraxia,0.0,0.0,1.0,0.0
Number generation,0.0,1.0,0.0,0.0
Predator confusion effect,0.0,1.0,0.0,0.0
Cognitive neural network,0.0,0.0,1.0,0.0
branch retinal artery occlusion,1.0,0.0,0.0,0.0
Thyroid function,1.0,0.0,0.0,0.0
private speech,0.0,1.0,0.0,0.0
Face-Symbol Test,1.0,0.0,0.0,0.0
Pulse wave velocity,0.0,0.0,1.0,0.0
Joint spatial attention,0.0,0.0,1.0,0.0
myelin,1.0,0.0,0.0,0.0
Go/Nogo task,0.0,0.0,1.0,0.0
sensory and cognitive interaction,0.0,1.0,0.0,0.0
Gaze-contingent display,1.0,0.0,0.0,0.0
Head direction cell,0.0,1.0,0.0,0.0
Occupational function,0.0,0.0,1.0,0.0
Molecular therapeutic,1.0,0.0,0.0,0.0
Bcomplex vitamins,0.0,1.0,0.0,0.0
Standard normal photographs,0.0,1.0,0.0,0.0
Hallucinatory experiences,0.0,0.0,1.0,0.0
Older and younger readers,1.0,0.0,0.0,0.0
Image maintenance,0.0,1.0,0.0,0.0
Dose proportionality,0.0,1.0,0.0,0.0
Slow progression,0.0,0.0,1.0,0.0
Perceived social support,0.0,0.0,1.0,0.0
LCPUFA,0.0,0.0,1.0,0.0
Older hospitalised patients,0.0,1.0,0.0,0.0
Nerve block,0.0,0.0,0.0,1.0
synchronization,0.0,1.0,0.0,0.0
Social problem solving,0.0,0.0,1.0,0.0
Distance comparison effect,1.0,0.0,0.0,0.0
Mirroring,0.0,0.0,1.0,0.0
Hemolytic uremic syndrome,1.0,0.0,0.0,0.0
Preactivation,0.0,0.0,1.0,0.0
Ondansetron,0.0,1.0,0.0,0.0
Alexia with agraphia,0.0,0.0,1.0,0.0
Continuity,1.0,0.0,0.0,0.0
Ion channel,0.0,1.0,0.0,0.0
Aesthetic perceptions,0.0,0.0,1.0,0.0
Amusia,0.0,0.0,1.0,0.0
flavonol,0.0,1.0,0.0,0.0
ALL,1.0,0.0,0.0,0.0
Folic acid,1.0,0.0,0.0,0.0
Cingulo-frontal-parietal cognitive/attention network,1.0,0.0,0.0,0.0
pp. 2891-2901,1.0,0.0,0.0,0.0
Chinese orthography,0.0,1.0,0.0,0.0
Food consistency,0.0,1.0,0.0,0.0
Brain functioning,0.0,1.0,0.0,0.0
Acquisition of orthographic knowledge,1.0,0.0,0.0,0.0
image understanding,0.0,1.0,0.0,0.0
Quantum phenomena,0.0,1.0,0.0,0.0
Dynamic attention,0.0,0.0,1.0,0.0
Effect expectancies,0.0,0.0,1.0,0.0
Animal/non-animal categorization,0.0,0.0,1.0,0.0
Spatial frequencies,0.0,0.0,1.0,0.0
Definitions,0.0,0.0,1.0,0.0
Relative quantity judgment,0.0,0.0,1.0,0.0
Arousal level,0.0,0.0,1.0,0.0
Felt presence,0.0,0.0,1.0,0.0
cognitive/cognition,0.0,0.0,1.0,0.0
Neocortical development,0.0,0.0,0.0,1.0
Deep transcranial magnetic stimulation (dTMS),0.0,0.0,1.0,0.0
reward sensitivity,0.0,1.0,0.0,0.0
Gleason,0.0,1.0,0.0,0.0
distance cognitive,0.0,1.0,0.0,0.0
dynamic stimuli,1.0,0.0,0.0,0.0
hippocampal atrophy,0.0,1.0,0.0,0.0
Rapidly progressive dementia,0.0,1.0,0.0,0.0
DTM,0.0,0.0,0.0,1.0
Identity negative priming,0.0,0.0,1.0,0.0
?,0.0,0.0,0.0,1.0
Age-matched normal controls,1.0,0.0,0.0,0.0
modified Stroop task,0.0,0.0,0.0,1.0
Auditory evoked field,0.0,0.0,1.0,0.0
Taboo,0.0,1.0,0.0,0.0
Perceptual ambiguity,0.0,0.0,1.0,0.0
Ongoing,0.0,0.0,1.0,0.0
Attention-deficit hyperactivity disorder (ADHD),0.0,1.0,0.0,0.0
mutation,1.0,0.0,0.0,0.0
mental representation,0.0,0.0,1.0,0.0
Model-based cluster analysis,0.0,1.0,0.0,0.0
Fast-mapping,1.0,0.0,0.0,0.0
Visuo-spatial code,0.0,0.0,1.0,0.0
"Cerebral palsy,0.0,0.0,0.0,0.0
Parental behaviour,1.0,0.0,0.0,0.0
Children and adolescents,1.0,0.0,0.0,0.0
Dihydropyrrolizines,0.0,1.0,0.0,0.0
Mental own-body imagery,0.0,1.0,0.0,0.0
Distractor suppression,1.0,0.0,0.0,0.0
Partial concurrent think aloud,0.0,0.0,1.0,0.0
Hayling,0.0,1.0,0.0,0.0
Rule-based behavior,1.0,0.0,0.0,0.0
Paradoxical sleep,1.0,0.0,0.0,0.0
M. mulatta,0.0,0.0,1.0,0.0
Cognitive domains,1.0,0.0,0.0,0.0
Dorsal medial prefrontal cortex,0.0,1.0,0.0,0.0
Adaptivity,0.0,0.0,1.0,0.0
Single trial analysis,1.0,0.0,0.0,0.0
Timbre,0.0,0.0,1.0,0.0
Guarany indian,1.0,0.0,0.0,0.0
Anterior cingulate gyrus,0.0,1.0,0.0,0.0
cognitive dissonance,0.0,0.0,1.0,0.0
Transcranial electrical stimulation,0.0,1.0,0.0,0.0
Poggendorff illusion,0.0,0.0,1.0,0.0
On-line psychophysical data collection,0.0,0.0,0.0,1.0
Multimodal motherese,0.0,1.0,0.0,0.0
Psychological distance,0.0,0.0,1.0,0.0
Glass pattern,0.0,0.0,1.0,0.0
low back pain,0.0,0.0,0.0,1.0
attentional set shifting,1.0,0.0,0.0,0.0
positive emotion,0.0,0.0,1.0,0.0
Morphing,0.0,1.0,0.0,0.0
sex difference,0.0,1.0,0.0,0.0
Dorsolateral,0.0,0.0,1.0,0.0
Probabilistic models of cognition,0.0,0.0,0.0,1.0
Everyday scenes,1.0,0.0,0.0,0.0
ERP methodologies,0.0,0.0,1.0,0.0
Cerebrovasular events,0.0,1.0,0.0,0.0
Inaction,0.0,0.0,1.0,0.0
Face aftereffect,0.0,1.0,0.0,0.0
allometry,0.0,1.0,0.0,0.0
Phenotype-genotype correlation,0.0,0.0,1.0,0.0
dengineering receptors,1.0,0.0,0.0,0.0
golf exercises,0.0,1.0,0.0,0.0
gamma,0.0,0.0,1.0,0.0
Oxadiazole,0.0,1.0,0.0,0.0
MS-Line!,0.0,0.0,1.0,0.0
Response strategy,0.0,0.0,1.0,0.0
Interhemispheric transmission,0.0,0.0,1.0,0.0
Hand preference,0.0,0.0,1.0,0.0
Space categorization,1.0,0.0,0.0,0.0
Abstinence length,0.0,1.0,0.0,0.0
Eye use bias,1.0,0.0,0.0,0.0
Tdcs,0.0,1.0,0.0,0.0
Reinforcer devaluation,0.0,1.0,0.0,0.0
orbital frontal,0.0,0.0,1.0,0.0
PCTA,0.0,0.0,1.0,0.0
Frontal hypothesis,1.0,0.0,0.0,0.0
Rapid learning,0.0,1.0,0.0,0.0
reward learning,0.0,0.0,1.0,0.0
Alex Endert,0.0,1.0,0.0,0.0
visual screening test,1.0,0.0,0.0,0.0
shapes,1.0,0.0,0.0,0.0
Knowledge for action,0.0,0.0,1.0,0.0
Albania,0.0,1.0,0.0,0.0
Spatial congruency,1.0,0.0,0.0,0.0
Two-process model,0.0,0.0,1.0,0.0
cerebral cortex,0.0,0.0,1.0,0.0
Intracranial stenosis,0.0,0.0,1.0,0.0
Justice,0.0,0.0,1.0,0.0
Type I diabetes mellitus,0.0,1.0,0.0,0.0
Spatio-contextual memory,1.0,0.0,0.0,0.0
Territory,0.0,1.0,0.0,0.0
Contralateral delay activity (CDA),0.0,0.0,1.0,0.0
Math skills training,0.0,0.0,0.0,1.0
Third world,1.0,0.0,0.0,0.0
Kinematic,0.0,0.0,1.0,0.0
finite impulse response (FIR) least-square filter,0.0,0.0,1.0,0.0
Abstract attitude,0.0,0.0,1.0,0.0
Information access cost,0.0,0.0,1.0,0.0
Number of alternatives,1.0,0.0,0.0,0.0
Homotopic,0.0,0.0,0.0,1.0
Personal healthrecord,0.0,0.0,1.0,0.0
?4?2,1.0,0.0,0.0,0.0
Neural complexity,0.0,1.0,0.0,0.0
medical neuropsychology,0.0,0.0,1.0,0.0
evidence,0.0,0.0,0.0,1.0
Headgear,0.0,0.0,1.0,0.0
vascular risk factors,0.0,1.0,0.0,0.0
Healthy young adults,0.0,0.0,1.0,0.0
Individual variability,1.0,0.0,0.0,0.0
orthography,0.0,1.0,0.0,0.0
Italy,1.0,0.0,0.0,0.0
Reasoning ability,0.0,0.0,1.0,0.0
Gateway hypothesis,1.0,0.0,0.0,0.0
Devic's syndrome,0.0,0.0,1.0,0.0
Creutzfeldt-Jakob,0.0,0.0,0.0,1.0
ALDH7A1,1.0,0.0,0.0,0.0
Neural oscillation,0.0,1.0,0.0,0.0
Out-of-body experiences,0.0,0.0,1.0,0.0
learning from instructions,0.0,0.0,0.0,1.0
Continental Population Groups,0.0,1.0,0.0,0.0
Neurocognitive profiles,0.0,0.0,0.0,1.0
MATLAB,0.0,0.0,1.0,0.0
Simulation fidelity,0.0,1.0,0.0,0.0
Ventrolateral prefrontal cortex (VLPFC),0.0,1.0,0.0,0.0
Primitive neuroectodermal tumors,0.0,1.0,0.0,0.0
Evoked,0.0,0.0,1.0,0.0
Preemptive analgesia,0.0,1.0,0.0,0.0
Parental alcohol use,0.0,1.0,0.0,0.0
Happiness,0.0,0.0,1.0,0.0
Partition lattice,0.0,0.0,1.0,0.0
Facial feedback,0.0,0.0,1.0,0.0
Transfer-appropriate processing,0.0,0.0,0.0,1.0
Vasovagal,0.0,0.0,1.0,0.0
Neocortical areas,0.0,0.0,1.0,0.0
acquisition,0.0,0.0,1.0,0.0
Active externalism,0.0,0.0,1.0,0.0
Central hyperexcitability,0.0,0.0,1.0,0.0
Visual perceptual learning (VPL),0.0,0.0,1.0,0.0
Service use,0.0,0.0,1.0,0.0
Cultural universal,0.0,0.0,1.0,0.0
Laminar architecture,1.0,0.0,0.0,0.0
Gray matter atrophy,0.0,0.0,1.0,0.0
Subunit c,0.0,0.0,1.0,0.0
High-level adaptation,0.0,1.0,0.0,0.0
Long-term retention,0.0,1.0,0.0,0.0
Shooting angle,1.0,0.0,0.0,0.0
ABR (Auditory Brainstem Response),0.0,1.0,0.0,0.0
free brain concentration,0.0,0.0,1.0,0.0
Fitts's law,0.0,0.0,1.0,0.0
Human body,0.0,1.0,0.0,0.0
Medial temporal lobes,0.0,1.0,0.0,0.0
Akinetopsia,0.0,0.0,1.0,0.0
ACh immunohistochemistry,1.0,0.0,0.0,0.0
Taste cognition,0.0,0.0,1.0,0.0
Residual switch costs,0.0,0.0,1.0,0.0
genetic conditions,0.0,0.0,1.0,0.0
continuum,0.0,0.0,0.0,1.0
Patterns discrimination,1.0,0.0,0.0,0.0
Presenilin-1,0.0,0.0,1.0,0.0
Psychometric characteristics,0.0,1.0,0.0,0.0
proton therapy,0.0,0.0,1.0,0.0
gross motor,0.0,1.0,0.0,0.0
Continuity editing,0.0,0.0,1.0,0.0
Serotonergic system,0.0,0.0,1.0,0.0
Auditory space,0.0,0.0,1.0,0.0
interval timing,0.0,0.0,1.0,0.0
Pre-attentive processing,1.0,0.0,0.0,0.0
Main dilept' metabolite (GZR-125),0.0,0.0,1.0,0.0
Natural images,0.0,0.0,1.0,0.0
Health and Sexuality",0.0,0.0,0.0,0.0
ISPC effect,0.0,1.0,0.0,0.0
Aperture size,1.0,0.0,0.0,0.0
LGN,0.0,0.0,0.0,1.0
Sensorimotor coupling,0.0,1.0,0.0,0.0
attentional visual field,1.0,0.0,0.0,0.0
Goal-directed behaviour,0.0,1.0,0.0,0.0
Oxygen deprivation,0.0,0.0,1.0,0.0
cigarette,0.0,0.0,1.0,0.0
Strategic regions,0.0,1.0,0.0,0.0
Matching law,1.0,0.0,0.0,0.0
Topographical orientation,0.0,0.0,1.0,0.0
Benign childhood epilepsy with rolandic spikes,0.0,1.0,0.0,0.0
Refrigerator light illusion,1.0,0.0,0.0,0.0
Red,0.0,0.0,1.0,0.0
7T,0.0,1.0,0.0,0.0
MINDFULNESS,1.0,0.0,0.0,0.0
Translational research,0.0,0.0,0.0,1.0
COREtext model,0.0,0.0,1.0,0.0
Informativeness,0.0,0.0,1.0,0.0
Perceptual upright,0.0,0.0,1.0,0.0
Steady-state visual evoked fields,0.0,1.0,0.0,0.0
Rightward bias,0.0,0.0,1.0,0.0
Jebsen,1.0,0.0,0.0,0.0
Subcortical vascular lesion,0.0,0.0,1.0,0.0
instructional design,0.0,0.0,1.0,0.0
Protocerebrum,0.0,0.0,1.0,0.0
Paullinia cupana,0.0,0.0,1.0,0.0
Vineland,0.0,0.0,1.0,0.0
Pregnancy mothers,0.0,0.0,0.0,1.0
caffeine use questionnaire,1.0,0.0,0.0,0.0
cognitive symptoms,1.0,0.0,0.0,0.0
Mircea Eliade,1.0,0.0,0.0,0.0
Medication-resistant depressive disorder,1.0,0.0,0.0,0.0
Central executive task,0.0,0.0,1.0,0.0
Brain perfusion scintigraphy,0.0,0.0,0.0,1.0
Deaf literacy,1.0,0.0,0.0,0.0
Rolandic operculum,0.0,1.0,0.0,0.0
Phase-relation,1.0,0.0,0.0,0.0
attention system,0.0,0.0,1.0,0.0
22q11 deletion syndrome,1.0,0.0,0.0,0.0
Music player,0.0,0.0,1.0,0.0
Compulsivity,0.0,0.0,0.0,0.0
Memory Disorders,0.0,0.0,0.0,1.0
Low-sensory areas,0.0,0.0,1.0,0.0
Optimal performance,0.0,0.0,1.0,0.0
CNS malignancies,0.0,0.0,1.0,0.0
3D reaching movements,0.0,1.0,0.0,0.0
EEG (electroencephalography),1.0,0.0,0.0,0.0
Gaze pattern,0.0,0.0,0.0,1.0
Attentive skills,0.0,1.0,0.0,0.0
Distracter,0.0,1.0,0.0,0.0
Home care population,0.0,1.0,0.0,0.0
Tactical skill,0.0,0.0,0.0,1.0
Adenylyl cyclase,0.0,1.0,0.0,0.0
Pneumatic stimulator,0.0,0.0,0.0,1.0
Surface area,1.0,0.0,0.0,0.0
Repression,0.0,0.0,1.0,0.0
Computerized cognitive testing,0.0,1.0,0.0,0.0
Flight experience,0.0,0.0,1.0,0.0
Dark attention,0.0,1.0,0.0,0.0
visual processing speed,0.0,0.0,1.0,0.0
Neuro-Behet's disease,1.0,0.0,0.0,0.0
Losing,1.0,0.0,0.0,0.0
Mutifocal visual evoked potential,0.0,0.0,1.0,0.0
Enrichment,0.0,0.0,1.0,0.0
eye movement,0.0,0.0,1.0,0.0
Thyroperoxidase antibodies,0.0,0.0,1.0,0.0
Novelty-P3,0.0,0.0,1.0,0.0
Visual construction,0.0,0.0,1.0,0.0
anti-inflammatory,0.0,0.0,1.0,0.0
Sequential effects,1.0,0.0,0.0,0.0
Falling memory,0.0,0.0,1.0,0.0
Relationships,0.0,0.0,1.0,0.0
Power law,1.0,0.0,0.0,0.0
Beat,1.0,0.0,0.0,0.0
affective environmental sounds,1.0,0.0,0.0,0.0
Multisensory and multimodal system,0.0,1.0,0.0,0.0
pain scales,0.0,0.0,0.0,1.0
Downtown plaza,0.0,1.0,0.0,0.0
Temporal coding,0.0,0.0,1.0,0.0
Posterior child lesional epilepsy,1.0,0.0,0.0,0.0
Forced desynchrony,0.0,0.0,1.0,0.0
Oxygen availability,0.0,0.0,1.0,0.0
brain-gut interactions,0.0,0.0,1.0,0.0
LPP-M,0.0,1.0,0.0,0.0
Symbol Digit,0.0,0.0,1.0,0.0
Categorical/coordinate spatial relations,0.0,0.0,1.0,0.0
observation scale,0.0,1.0,0.0,0.0
forensic psychiatry,0.0,0.0,1.0,0.0
Corsi task,0.0,0.0,0.0,1.0
tobacco addiction,0.0,0.0,1.0,0.0
Lacunar infarct,0.0,0.0,1.0,0.0
Conditional discrimination,0.0,0.0,0.0,1.0
Rooks,1.0,0.0,0.0,0.0
N250r,0.0,1.0,0.0,0.0
Anticipatory control,0.0,0.0,0.0,1.0
Specific deficit,1.0,0.0,0.0,0.0
InI,1.0,0.0,0.0,0.0
Visualization model,0.0,0.0,1.0,0.0
Lexical search,0.0,0.0,1.0,0.0
ToM,0.0,1.0,0.0,0.0
Liver,0.0,0.0,1.0,0.0
Symptom Validity Tests,0.0,0.0,0.0,1.0
Adaptive timing,0.0,0.0,0.0,1.0
Memory Workload Paradigm,1.0,0.0,0.0,0.0
Short-term memory (STM),0.0,0.0,0.0,1.0
Imagery thinking,0.0,1.0,0.0,0.0
Yoga,1.0,0.0,0.0,0.0
stroke scales,0.0,0.0,1.0,0.0
Speech segmentation,0.0,1.0,0.0,0.0
White spirit,0.0,1.0,0.0,0.0
Peripersonnal space,0.0,1.0,0.0,0.0
Baby schema,0.0,0.0,1.0,0.0
Revised Hasegawa dementia scale,0.0,0.0,1.0,0.0
Dot probe task,1.0,0.0,0.0,0.0
MSCEIT,0.0,0.0,1.0,0.0
Neurobehavioural performance,0.0,0.0,1.0,0.0
Path complexity,0.0,1.0,0.0,0.0
Anticholinesterases,0.0,1.0,0.0,0.0
Scene space,0.0,1.0,0.0,0.0
SCA14,1.0,0.0,0.0,0.0
central nervous system,0.0,0.0,1.0,0.0
Long-term-care home,0.0,1.0,0.0,0.0
Illusory line motion,0.0,0.0,1.0,0.0
beta-interferon,0.0,1.0,0.0,0.0
Disconnectivity,0.0,0.0,1.0,0.0
Prior entry,0.0,1.0,0.0,0.0
Blind individuals,1.0,0.0,0.0,0.0
gestational age,1.0,0.0,0.0,0.0
Auditory localization,1.0,0.0,0.0,0.0
Novelty seeking,0.0,0.0,1.0,0.0
?-thalassemia,0.0,1.0,0.0,0.0
color environment,1.0,0.0,0.0,0.0
Biolinguistics,0.0,1.0,0.0,0.0
Human occipital cortex,0.0,0.0,1.0,0.0
object affordance,0.0,1.0,0.0,0.0
Bile duct,1.0,0.0,0.0,0.0
Weight gain,0.0,0.0,1.0,0.0
6-sulphatoxymelatonin,0.0,0.0,1.0,0.0
Ocular following,0.0,0.0,1.0,0.0
Steady-state visual evoked potentials,0.0,0.0,1.0,0.0
Onset-age,0.0,0.0,1.0,0.0
Cognitive impairment no dementia,0.0,1.0,0.0,0.0
GIS,0.0,1.0,0.0,0.0
Intraneocortical connections,0.0,0.0,0.0,1.0
Hospitalization,0.0,0.0,1.0,0.0
Somatosensory processing,0.0,0.0,1.0,0.0
Recollection and familiarity,0.0,1.0,0.0,0.0
Breed,0.0,1.0,0.0,0.0
Operant response task,0.0,0.0,1.0,0.0
Task-irrelevant emotional distraction,0.0,0.0,0.0,1.0
late childhood,0.0,0.0,0.0,1.0
Modeling EEG,0.0,1.0,0.0,0.0
WRAT-3 reading,0.0,0.0,1.0,0.0
Attachment and relational networks,0.0,0.0,1.0,0.0
Firm routines,0.0,1.0,0.0,0.0
Mental impairment,0.0,0.0,1.0,0.0
ERP measure,0.0,0.0,0.0,1.0
Helping,0.0,0.0,1.0,0.0
Theory of Visual Attention,0.0,1.0,0.0,0.0
Multiplication facts,0.0,0.0,1.0,0.0
Spoken language interaction,0.0,0.0,1.0,0.0
Frontoinsula,0.0,0.0,1.0,0.0
Place attachment,0.0,1.0,0.0,0.0
Financial capacity,0.0,1.0,0.0,0.0
Treatment retention,0.0,0.0,0.0,1.0
Sleep spindle,0.0,0.0,0.0,1.0
Memory for detail,1.0,0.0,0.0,0.0
S-O-R framework,0.0,0.0,0.0,1.0
Interstimulus interval,0.0,0.0,1.0,0.0
ELF,0.0,1.0,0.0,0.0
Remember,0.0,0.0,1.0,0.0
Interceptive actions,0.0,0.0,1.0,0.0
Cortical/striatal/cerebellar network,1.0,0.0,0.0,0.0
Microcontroller,0.0,0.0,1.0,0.0
Bichromatic,1.0,0.0,0.0,0.0
Functional near infrared Spectroscopy,0.0,1.0,0.0,0.0
Low-resolution brain electromagnetic tomography (LORETA),0.0,0.0,0.0,1.0
Guppies,1.0,0.0,0.0,0.0
Five-point Test,0.0,0.0,1.0,0.0
Keyword-based image retrieval,0.0,0.0,1.0,0.0
Torsion drift,0.0,1.0,0.0,0.0
Emotional neuroscience,0.0,0.0,1.0,0.0
Narrative speech comprehension,0.0,0.0,1.0,0.0
TRT,1.0,0.0,0.0,0.0
TRP,0.0,0.0,1.0,0.0
Neuropsychologic functioning,0.0,0.0,1.0,0.0
Video cases,0.0,0.0,1.0,0.0
Visual integration,0.0,1.0,0.0,0.0
Cluster-randomized controlled trial,1.0,0.0,0.0,0.0
Discrete variety of the switching-related activity,0.0,1.0,0.0,0.0
Benign joint hypermobility syndrome,0.0,1.0,0.0,0.0
Complicated,0.0,1.0,0.0,0.0
multitask performance,1.0,0.0,0.0,0.0
Goal oriented imagination,1.0,0.0,0.0,0.0
Sjgren Syndrome,0.0,0.0,1.0,0.0
mental health,1.0,0.0,0.0,0.0
Postural regulation,0.0,0.0,1.0,0.0
CADASIL,0.0,0.0,1.0,0.0
Bilateral advantage,0.0,0.0,1.0,0.0
C3H,0.0,1.0,0.0,0.0
schizoaffective disorder,1.0,0.0,0.0,0.0
EEG spectral analysis,0.0,1.0,0.0,0.0
Letter position encoding,0.0,0.0,1.0,0.0
Nonsymbolic magnitude comparison,0.0,0.0,1.0,0.0
Dopamine function,0.0,1.0,0.0,0.0
positivity effect,0.0,1.0,0.0,0.0
Duration of illness,0.0,0.0,0.0,1.0
Aphasia treatment,0.0,1.0,0.0,0.0
Executive function/dysfunction,1.0,0.0,0.0,0.0
Neuropsychological scores,0.0,1.0,0.0,0.0
Electrocardiogram,0.0,1.0,0.0,0.0
Implicit and explicit knowledge,0.0,1.0,0.0,0.0
Psychological,0.0,1.0,0.0,0.0
Exemplar,0.0,0.0,1.0,0.0
dedifferentiation,0.0,1.0,0.0,0.0
Tele-rehabilitation,0.0,0.0,1.0,0.0
Interrai,1.0,0.0,0.0,0.0
Gustatory,0.0,1.0,0.0,0.0
Migraine aura,0.0,1.0,0.0,0.0
Linguistic,1.0,0.0,0.0,0.0
Drug utilization,0.0,1.0,0.0,0.0
Degraded speech perception,0.0,0.0,0.0,1.0
visuospatial impairment,1.0,0.0,0.0,0.0
Pronoun resolution,0.0,0.0,1.0,0.0
Crossover,0.0,0.0,0.0,1.0
BacoMind,0.0,0.0,1.0,0.0
Pituitary,0.0,0.0,1.0,0.0
single-nucleotide polymorphism,0.0,1.0,0.0,0.0
Evo-devo,1.0,0.0,0.0,0.0
carbon dioxide inhalation,1.0,0.0,0.0,0.0
Positive emotions,1.0,0.0,0.0,0.0
Body context,0.0,0.0,1.0,0.0
Collaborative teacher practice,0.0,0.0,1.0,0.0
Standard Gamble,0.0,1.0,0.0,0.0
Raclopride,0.0,1.0,0.0,0.0
APOE promoter haplotype,0.0,0.0,1.0,0.0
ambiguous figures,0.0,1.0,0.0,0.0
65,0.0,1.0,0.0,0.0
64,0.0,0.0,1.0,0.0
Time series analysis,0.0,0.0,1.0,0.0
Design cognition,0.0,0.0,1.0,0.0
Neurofibromatosis type I,0.0,1.0,0.0,0.0
Gabapentin,1.0,0.0,0.0,0.0
3D map,0.0,1.0,0.0,0.0
paired-associate learning,0.0,0.0,1.0,0.0
Low-trauma femur fracture,0.0,1.0,0.0,0.0
MTL volume,0.0,0.0,1.0,0.0
Natural,0.0,1.0,0.0,0.0
Explanation-based learning,0.0,1.0,0.0,0.0
Respiratory chain dysfunction,0.0,0.0,1.0,0.0
Paired associated learning,0.0,0.0,1.0,0.0
Infant visual recognition memory,1.0,0.0,0.0,0.0
CBI-R,1.0,0.0,0.0,0.0
contour integration,0.0,0.0,1.0,0.0
South Asian,0.0,0.0,1.0,0.0
Descriptors: Memory,0.0,1.0,0.0,0.0
tool-switching paradigm,0.0,0.0,0.0,1.0
rule-governed behavior,0.0,0.0,1.0,0.0
Concealment,0.0,0.0,1.0,0.0
Antipsychotic medication,0.0,0.0,1.0,0.0
Simulated altitude,1.0,0.0,0.0,0.0
Verbal responses,0.0,0.0,1.0,0.0
Collinear,0.0,1.0,0.0,0.0
Cross-recurrence quantification analysis,0.0,0.0,1.0,0.0
Categorical and coordinate spatial relations,0.0,0.0,0.0,1.0
Doors and People Test,0.0,1.0,0.0,0.0
National Adult Reading,0.0,0.0,1.0,0.0
Crossculture neuropsychology,1.0,0.0,0.0,0.0
Non-syndromic,0.0,0.0,1.0,0.0
Creative neurocognition,0.0,0.0,1.0,0.0
Spatial-cognition,1.0,0.0,0.0,0.0
Hearing aid,0.0,0.0,1.0,0.0
OpenGL,0.0,1.0,0.0,0.0
Synchronization likelihood,0.0,1.0,0.0,0.0
Somesthesic mechanosensitivity,0.0,0.0,0.0,1.0
Clock test,0.0,0.0,1.0,0.0
Fagerstrm Tolerance Questionnaire (FTQ),0.0,0.0,1.0,0.0
Hypoplasia,0.0,0.0,0.0,1.0
Visual analysis in neuroscience,1.0,0.0,0.0,0.0
Heartbeat,0.0,1.0,0.0,0.0
Multisensory interactions,0.0,0.0,1.0,0.0
Benign paroxysmal positional vertigo,0.0,1.0,0.0,0.0
single nucleotide polymorphism,0.0,0.0,1.0,0.0
Supervision,0.0,0.0,1.0,0.0
Ross Information Processing Test-Geriatric,1.0,0.0,0.0,0.0
Sleep propensity,0.0,0.0,1.0,0.0
Long-term treatment,0.0,0.0,1.0,0.0
Mnemonics,0.0,0.0,1.0,0.0
Normal controls,0.0,1.0,0.0,0.0
Psychogenic anterograde amnesia,0.0,1.0,0.0,0.0
Unilateral vestibular neurotomy,0.0,1.0,0.0,0.0
Social infovis,1.0,0.0,0.0,0.0
colloid cyst,0.0,0.0,0.0,1.0
IntelliCage,0.0,1.0,0.0,0.0
Spider phobia,0.0,1.0,0.0,0.0
Cognitive capture,1.0,0.0,0.0,0.0
brain scintigraphy,0.0,0.0,1.0,0.0
Chromosome 22q11.2,0.0,1.0,0.0,0.0
cognitive stimulation,0.0,0.0,1.0,0.0
ADHD characteristics,0.0,0.0,1.0,0.0
Gap amendment,1.0,0.0,0.0,0.0
hypnotics,1.0,0.0,0.0,0.0
Carotid atherosclerosis,0.0,1.0,0.0,0.0
Intraparietal sulcus (IPS),0.0,1.0,0.0,0.0
Brain trauma,0.0,0.0,1.0,0.0
Bone transplantation,0.0,0.0,1.0,0.0
Restoration of function,0.0,1.0,0.0,0.0
Mitochondrial disorders,0.0,0.0,1.0,0.0
Epilepsia partialis continua,0.0,0.0,1.0,0.0
Gender stereotypes,0.0,0.0,0.0,1.0
Choice reaction time,0.0,0.0,1.0,0.0
childhood,0.0,1.0,0.0,0.0
Simple visual matching task,1.0,0.0,0.0,0.0
?-lactalbumin,0.0,0.0,1.0,0.0
Young hypogonadal men,0.0,0.0,1.0,0.0
Dendrite arbor,0.0,0.0,0.0,1.0
bumblebees,0.0,0.0,1.0,0.0
rating scales,1.0,0.0,0.0,0.0
Music processing,1.0,0.0,0.0,0.0
Arithmetic training,0.0,0.0,1.0,0.0
Encephalograph frequencies,1.0,0.0,0.0,0.0
OCD/obsessive-compulsive disorder,0.0,0.0,1.0,0.0
PET imaging,0.0,1.0,0.0,0.0
omega-3 fatty acids,0.0,0.0,1.0,0.0
Neural aging,0.0,0.0,1.0,0.0
Parallel timing,1.0,0.0,0.0,0.0
Body focus,0.0,1.0,0.0,0.0
CATIE-AD,0.0,1.0,0.0,0.0
positive affect,1.0,0.0,0.0,0.0
Forensic neuropsychology,0.0,0.0,1.0,0.0
Musical-space synesthesia,1.0,0.0,0.0,0.0
Fashion design knowledge,0.0,1.0,0.0,0.0
Response exclusion,0.0,0.0,1.0,0.0
D 3 receptor,0.0,0.0,1.0,0.0
Semantic deficit,1.0,0.0,0.0,0.0
gaze perception,0.0,0.0,1.0,0.0
tobacco,0.0,1.0,0.0,0.0
Paired helical filament,0.0,0.0,1.0,0.0
IL-1?,1.0,0.0,0.0,0.0
Continuous drug delivery,1.0,0.0,0.0,0.0
DYRK1A,0.0,1.0,0.0,0.0
numerical typing,0.0,0.0,1.0,0.0
Psychomotor vigilance test (PVT),0.0,0.0,0.0,1.0
Age-related decay,0.0,1.0,0.0,0.0
Selectionist learning,1.0,0.0,0.0,0.0
On-site landscape perception,0.0,1.0,0.0,0.0
conduct disorder,0.0,1.0,0.0,0.0
Classification learning,0.0,0.0,1.0,0.0
PAOFI,0.0,0.0,1.0,0.0
Auditory neglect,1.0,0.0,0.0,0.0
Color configuration,0.0,0.0,1.0,0.0
Canonical neurons,0.0,0.0,1.0,0.0
Iodine,0.0,1.0,0.0,0.0
Optic nerve,0.0,1.0,0.0,0.0
1,0.0,1.0,0.0,0.0
Consensus features,0.0,0.0,1.0,0.0
Ecstasy (MDMA),0.0,1.0,0.0,0.0
A? amyloid,0.0,1.0,0.0,0.0
Prenatal lead exposure,1.0,0.0,0.0,0.0
Age-matched controls,1.0,0.0,0.0,0.0
Autoimmune disease,0.0,1.0,0.0,0.0
Mirror mechanism,0.0,0.0,0.0,1.0
sport",0.0,0.0,1.0,0.0
Frontocentral cortex,0.0,0.0,0.0,1.0
Word comprehension,0.0,1.0,0.0,0.0
Behavioral test,1.0,0.0,0.0,0.0
Image generation,0.0,1.0,0.0,0.0
Active coping,0.0,1.0,0.0,0.0
free-energy principle,0.0,0.0,1.0,0.0
Reliable change index,0.0,1.0,0.0,0.0
Neuropsychologic efficiency,0.0,1.0,0.0,0.0
Pituitary tumors,0.0,0.0,1.0,0.0
somatic growth,0.0,0.0,0.0,1.0
GFTA,0.0,1.0,0.0,0.0
Health-risk perception,0.0,0.0,0.0,1.0
Self-Administered Interview,0.0,1.0,0.0,0.0
MEDITERRANEAN DIET,1.0,0.0,0.0,0.0
D-KEFS,1.0,0.0,0.0,0.0
Visual hemifield,0.0,0.0,1.0,0.0
subtle cognitive impairment test,0.0,0.0,0.0,1.0
Category organization,0.0,1.0,0.0,0.0
Primary auditory cortex,0.0,0.0,0.0,1.0
Intracranial haemorrhage,0.0,1.0,0.0,0.0
subjective memory complaints,0.0,1.0,0.0,0.0
Phonological deficits,0.0,0.0,1.0,0.0
healthy,1.0,0.0,0.0,0.0
Motion selectivity,0.0,1.0,0.0,0.0
Sustained posterior contralateral negativity,0.0,1.0,0.0,0.0
Tentorium,0.0,1.0,0.0,0.0
Childhood onset schizophrenia,0.0,0.0,1.0,0.0
Checking,0.0,1.0,0.0,0.0
Mitochondrial myopathy,0.0,0.0,1.0,0.0
Visual misidentification,0.0,0.0,1.0,0.0
Cognitive symptom validity,0.0,0.0,1.0,0.0
Sketch understanding,1.0,0.0,0.0,0.0
2-back task,0.0,0.0,1.0,0.0
Gaze orienting,1.0,0.0,0.0,0.0
Severity of symptoms,0.0,1.0,0.0,0.0
Point-based data,1.0,0.0,0.0,0.0
indigenous Australian languages,0.0,0.0,1.0,0.0
Abductive inference,0.0,0.0,1.0,0.0
Upper limb,0.0,1.0,0.0,0.0
Spastic paraplegia,0.0,0.0,0.0,1.0
Physicality,0.0,0.0,1.0,0.0
Morphometric,0.0,1.0,0.0,0.0
Prelinguistic infants,0.0,1.0,0.0,0.0
environment,0.0,0.0,0.0,1.0
Raine Study,0.0,0.0,1.0,0.0
Supramodal cortical organization,0.0,1.0,0.0,0.0
Segmentation rule,0.0,0.0,1.0,0.0
Landau-Kleffner Syndrome,0.0,1.0,0.0,0.0
Antiepileptic medication,0.0,0.0,1.0,0.0
selective and sustained attention,0.0,1.0,0.0,0.0
Texture segmentation,1.0,0.0,0.0,0.0
Motor-perceptual interactions,0.0,1.0,0.0,0.0
Usher syndrome type 1,0.0,1.0,0.0,0.0
aCGH,0.0,0.0,1.0,0.0
dynamic systems,1.0,0.0,0.0,0.0
Abstract visual stimuli,0.0,0.0,0.0,1.0
Paclitaxel,0.0,1.0,0.0,0.0
Digit naming,0.0,1.0,0.0,0.0
High-risk siblings,0.0,1.0,0.0,0.0
Indigenous Australian,0.0,0.0,1.0,0.0
Autopsy,0.0,1.0,0.0,0.0
Novelty-seeking,0.0,1.0,0.0,0.0
Theta-band activity,0.0,1.0,0.0,0.0
Supramodal integration,0.0,0.0,1.0,0.0
Color memory,0.0,1.0,0.0,0.0
Cross-over randomized double-blind trial,0.0,0.0,1.0,0.0
Emotional,0.0,0.0,1.0,0.0
Endocannabinoids,0.0,0.0,1.0,0.0
Cognitive/linguistic assessment,0.0,1.0,0.0,0.0
ADR,0.0,0.0,1.0,0.0
Visuoperceptual Priming,0.0,0.0,1.0,0.0
Mild Parkinson's disease dementia,0.0,1.0,0.0,0.0
Information processes,1.0,0.0,0.0,0.0
AD8,1.0,0.0,0.0,0.0
Census-based survey,0.0,1.0,0.0,0.0
Familiality,0.0,1.0,0.0,0.0
Intellectual outcome,0.0,0.0,1.0,0.0
Neuronal hypertrophy,0.0,0.0,1.0,0.0
Acupuncture,0.0,0.0,0.0,1.0
Prism treatment,0.0,0.0,1.0,0.0
Visual Narrative Grammar,0.0,1.0,0.0,0.0
Cortical response,1.0,0.0,0.0,0.0
?-Opioid receptor,1.0,0.0,0.0,0.0
Optimal display,0.0,1.0,0.0,0.0
schizotypal personality disorder,0.0,0.0,0.0,1.0
Significant others,0.0,0.0,1.0,0.0
Red light,1.0,0.0,0.0,0.0
Multicomponent signaling,0.0,1.0,0.0,0.0
Derived,1.0,0.0,0.0,0.0
Radiation oncology,0.0,0.0,0.0,1.0
Drawing teaching,0.0,1.0,0.0,0.0
Item processing,0.0,0.0,1.0,0.0
Categorizaton,0.0,0.0,1.0,0.0
Diachronic object unity,0.0,0.0,1.0,0.0
implicit-explicit cognition,0.0,1.0,0.0,0.0
time-of-day,1.0,0.0,0.0,0.0
Bipolar disorder (BPD),0.0,0.0,1.0,0.0
Signtree,0.0,0.0,1.0,0.0
Flower complexity,1.0,0.0,0.0,0.0
Quinpirole,0.0,1.0,0.0,0.0
Genetic linkage,0.0,0.0,1.0,0.0
Social cognitive neuroscience: A review of core processes (2007) Annu. Rev. Psychol,0.0,1.0,0.0,0.0
Fetal alcohol effects,0.0,0.0,1.0,0.0
Vineland adaptive behaviour scales,1.0,0.0,0.0,0.0
Embodiment and grounded cognition,1.0,0.0,0.0,0.0
RIII reflex,0.0,0.0,1.0,0.0
Extended touch,0.0,0.0,1.0,0.0
Violation-of-expectation,0.0,1.0,0.0,0.0
forced desynchrony,0.0,0.0,1.0,0.0
Quantitative MR,0.0,0.0,1.0,0.0
L-Dopa infusion,0.0,1.0,0.0,0.0
Biomechanical constraints,0.0,1.0,0.0,0.0
nonelemental learning,0.0,0.0,1.0,0.0
children and adolescents,1.0,0.0,0.0,0.0
auditoryvisual perception,1.0,0.0,0.0,0.0
Slow cortical potential,0.0,1.0,0.0,0.0
Self-propelled objects,0.0,0.0,1.0,0.0
Cognition and culture,0.0,0.0,1.0,0.0
Communicative cues,0.0,1.0,0.0,0.0
Feigning-like behaviour,0.0,0.0,1.0,0.0
Shoal choice,0.0,0.0,1.0,0.0
Primary dystonia,0.0,0.0,0.0,1.0
Time reproduction task,0.0,0.0,1.0,0.0
Conceptual Content Cognitive Map,0.0,0.0,1.0,0.0
Beery-Buktenica Developmental Test of Visual-Motor Integration,0.0,1.0,0.0,0.0
Probabilistic environment,0.0,0.0,1.0,0.0
Developmental profiles,0.0,0.0,1.0,0.0
Neurocognitive profile,0.0,0.0,1.0,0.0
White matter anatomy,1.0,0.0,0.0,0.0
parallel distributed processing,0.0,0.0,0.0,1.0
Thickness of the cerebral cortex,0.0,1.0,0.0,0.0
Social-cognitive development,0.0,0.0,1.0,0.0
AD and neuropsychology,0.0,0.0,1.0,0.0
Chelation,0.0,0.0,1.0,0.0
Cry,0.0,0.0,1.0,0.0
Freehand sketch,1.0,0.0,0.0,0.0
Action-perception cycle,0.0,1.0,0.0,0.0
submarine,0.0,1.0,0.0,0.0
Frontal lesions,1.0,0.0,0.0,0.0
Absolute identification,0.0,1.0,0.0,0.0
conflict control,0.0,0.0,1.0,0.0
N-methyl-D-aspartate,0.0,0.0,1.0,0.0
Cardiopulmonary assessment,0.0,0.0,1.0,0.0
Atypical antipsychotic,0.0,1.0,0.0,0.0
Human planning,0.0,0.0,1.0,0.0
Simultaneous discrimination,0.0,0.0,0.0,1.0
image labeling,0.0,1.0,0.0,0.0
Neuromuscular disorder,0.0,0.0,1.0,0.0
Limb,0.0,0.0,1.0,0.0
akinetic mutism,1.0,0.0,0.0,0.0
AGNG,0.0,0.0,1.0,0.0
Hypoxia ischemia,0.0,0.0,0.0,1.0
Small world networks,0.0,0.0,0.0,1.0
Auditory display,1.0,0.0,0.0,0.0
Partietal cortex,0.0,1.0,0.0,0.0
Neural field model,0.0,1.0,0.0,0.0
reading rate,0.0,1.0,0.0,0.0
Parasympathetic nervous system,0.0,0.0,1.0,0.0
Multi-sensory working memory,1.0,0.0,0.0,0.0
Intralaminar thalamus,0.0,1.0,0.0,0.0
cataplexy,0.0,1.0,0.0,0.0
Teleost,0.0,0.0,1.0,0.0
Preschool child,0.0,0.0,0.0,1.0
Geriatric neuropsychiatry,0.0,0.0,1.0,0.0
Olfactory discrimination task,0.0,0.0,1.0,0.0
Turns,0.0,0.0,1.0,0.0
Majority strategy,0.0,1.0,0.0,0.0
Corporeal self,0.0,0.0,1.0,0.0
continuity,0.0,0.0,0.0,1.0
Substitution,0.0,0.0,1.0,0.0
Perceptual-motor feedback,0.0,0.0,1.0,0.0
Australian longitudinal study of aging,0.0,0.0,1.0,0.0
Eating disorder,1.0,0.0,0.0,0.0
Egocentric viewpoint,0.0,1.0,0.0,0.0
perceptual learning,0.0,1.0,0.0,0.0
Design history,0.0,1.0,0.0,0.0
Arrestins,1.0,0.0,0.0,0.0
Virtual humans,0.0,1.0,0.0,0.0
Active passive,0.0,0.0,0.0,1.0
Object action,0.0,0.0,1.0,0.0
sensory memory,0.0,1.0,0.0,0.0
Visual Cognition,1.0,0.0,0.0,0.0
Mind-mindedness,0.0,0.0,0.0,1.0
dialysis volume,0.0,1.0,0.0,0.0
Efference,0.0,0.0,1.0,0.0
motor-visual priming,0.0,1.0,0.0,0.0
learning systems,0.0,0.0,1.0,0.0
Dual EEG,0.0,0.0,1.0,0.0
Ovariectomy,0.0,0.0,1.0,0.0
Neuromotor,0.0,1.0,0.0,0.0
TAI CHI,1.0,0.0,0.0,0.0
Molar tooth,0.0,0.0,1.0,0.0
Perceptual identification,0.0,0.0,1.0,0.0
Dopamine overdose,1.0,0.0,0.0,0.0
Food-related cues,1.0,0.0,0.0,0.0
Psychoses,0.0,0.0,1.0,0.0
Circadian light,0.0,0.0,1.0,0.0
Attention operating characteristic,1.0,0.0,0.0,0.0
Mini cardiopulmonary bypass,0.0,0.0,0.0,1.0
"Attentional control,0.0,0.0,0.0,0.0
intersemiotic,0.0,1.0,0.0,0.0
Time-course,0.0,0.0,1.0,0.0
History of art,0.0,1.0,0.0,0.0
diffusion-weighted imaging,0.0,0.0,1.0,0.0
unrealistic optimism,0.0,1.0,0.0,0.0
Pictorial relief,0.0,0.0,1.0,0.0
calorie,0.0,1.0,0.0,0.0
computerized cognitive assessment,0.0,1.0,0.0,0.0
Adaptive coding,0.0,1.0,0.0,0.0
Barth syndrome,0.0,0.0,1.0,0.0
Directional tuning,0.0,1.0,0.0,0.0
Non-visual tasks,1.0,0.0,0.0,0.0
Neurological insult,0.0,1.0,0.0,0.0
Cohort,0.0,1.0,0.0,0.0
embodiment large,0.0,0.0,1.0,0.0
Insects,0.0,0.0,0.0,1.0
body representation,0.0,0.0,1.0,0.0
conflict response inhibition,0.0,0.0,1.0,0.0
Macaco mulatta,0.0,0.0,1.0,0.0
Mental lexicon,0.0,1.0,0.0,0.0
Carcinoma,0.0,1.0,0.0,0.0
"Deoxygenated hemoglobin (deoxyHb,0.0,0.0,0.0,0.0
Structure of reaching,0.0,0.0,1.0,0.0
Temporal gradient,0.0,0.0,0.0,1.0
Center of gravity,0.0,1.0,0.0,0.0
Bilateral vestibular hypofunction,0.0,1.0,0.0,0.0
ageing,0.0,0.0,1.0,0.0
Dynamic properties,0.0,0.0,0.0,1.0
Dysfunctional attitudes scale,0.0,0.0,1.0,0.0
Sensory rearrangement,0.0,1.0,0.0,0.0
Disease progression,0.0,0.0,1.0,0.0
lower extremity,0.0,1.0,0.0,0.0
Chronic Pain,0.0,0.0,1.0,0.0
Polyglandular autoimmune syndrome,1.0,0.0,0.0,0.0
Hand strength,0.0,0.0,1.0,0.0
Web-based,0.0,1.0,0.0,0.0
Intracarotid amobarbital test,0.0,1.0,0.0,0.0
Sensory perceptions,0.0,0.0,0.0,1.0
Grid technology,0.0,0.0,1.0,0.0
Movement correction,0.0,1.0,0.0,0.0
"Brain injuries,0.0,0.0,0.0,0.0
near-lethal self-harm,0.0,0.0,1.0,0.0
Embedded cognition,0.0,0.0,1.0,0.0
Video coding,0.0,0.0,0.0,1.0
Defense mechanism,0.0,0.0,1.0,0.0
cholesteryl exchange transfer protein,0.0,1.0,0.0,0.0
Apraxias,0.0,0.0,1.0,0.0
Ventral premotor,0.0,0.0,1.0,0.0
Soluble A-amyloid,0.0,0.0,1.0,0.0
Information integration,0.0,0.0,1.0,0.0
Developmental differences,0.0,0.0,1.0,0.0
context gain,1.0,0.0,0.0,0.0
High-school athlete,1.0,0.0,0.0,0.0
Goal-directed cognition,0.0,0.0,1.0,0.0
Mean opinion score prediction,0.0,0.0,1.0,0.0
reserpine,0.0,0.0,0.0,1.0
bHLH transcription factors,0.0,0.0,1.0,0.0
Restless legs syndrome (RLS),0.0,0.0,1.0,0.0
Generics,0.0,1.0,0.0,0.0
D-Amphetamine,1.0,0.0,0.0,0.0
Frailty of elderly,0.0,0.0,1.0,0.0
Holistic vs. Analytic thought,0.0,0.0,1.0,0.0
"Neurocognitive function,0.0,0.0,0.0,0.0
acrophobia,0.0,1.0,0.0,0.0
Orthographic neighbours,0.0,0.0,1.0,0.0
Saccade suppression,0.0,0.0,1.0,0.0
Prenatal alcohol,0.0,0.0,1.0,0.0
PHYSICAL EXERCISE,1.0,0.0,0.0,0.0
Comparative evaluation,0.0,1.0,0.0,0.0
Interactive activation model,0.0,1.0,0.0,0.0
Cantab visual search,0.0,0.0,0.0,1.0
Packaging design,0.0,0.0,1.0,0.0
Single neuron,0.0,1.0,0.0,0.0
Health-related quality-of-life,0.0,0.0,1.0,0.0
teachers,0.0,0.0,0.0,1.0
Narrative cognition,0.0,0.0,1.0,0.0
Right hemisphere lesion,0.0,0.0,1.0,0.0
visuospatial activity,0.0,0.0,0.0,1.0
Interactive information,0.0,0.0,1.0,0.0
perceptual fluency,0.0,1.0,0.0,0.0
Local-motion pooling,1.0,0.0,0.0,0.0
Cadherin,1.0,0.0,0.0,0.0
Technology use,0.0,0.0,1.0,0.0
Semple,1.0,0.0,0.0,0.0
Hallucinatory color,0.0,0.0,0.0,1.0
Fine discrimination,0.0,0.0,0.0,1.0
Residential environment,0.0,1.0,0.0,0.0
Musical education,0.0,0.0,0.0,1.0
Matched control group,0.0,1.0,0.0,0.0
Knowledge communication,0.0,0.0,1.0,0.0
Operant,0.0,0.0,1.0,0.0
gray matter thickness,0.0,0.0,1.0,0.0
theanine,0.0,1.0,0.0,0.0
White matter disconnection,1.0,0.0,0.0,0.0
frailty,0.0,0.0,1.0,0.0
P3 subcomponents,0.0,0.0,1.0,0.0
multiple sleep latency test,0.0,0.0,1.0,0.0
Poecilia reticulata,0.0,0.0,1.0,0.0
Visual scanning test,1.0,0.0,0.0,0.0
Extraretinal modulation,0.0,0.0,1.0,0.0
Ex-Gaussian analyses,0.0,1.0,0.0,0.0
Holistic representation,0.0,0.0,0.0,1.0
Color combination,0.0,0.0,1.0,0.0
Burgess,0.0,0.0,1.0,0.0
Sensorimotor memory,0.0,0.0,1.0,0.0
Geography,0.0,1.0,0.0,0.0
metaanalysis,0.0,1.0,0.0,0.0
Bentontest,0.0,1.0,0.0,0.0
Neuronal,0.0,0.0,1.0,0.0
Approximate Number System,0.0,0.0,1.0,0.0
Cultural influence,1.0,0.0,0.0,0.0
Late posterior negativity (LPN),0.0,0.0,1.0,0.0
Medial thalamus,0.0,0.0,1.0,0.0
Lophocebus albigena,0.0,0.0,1.0,0.0
Hybrid analogies,0.0,1.0,0.0,0.0
Emotional sounds,0.0,0.0,0.0,1.0
Steven's law,0.0,0.0,1.0,0.0
Carotid artery stenting,1.0,0.0,0.0,0.0
movement execution,0.0,0.0,1.0,0.0
QEEG-based neurofeedback,0.0,1.0,0.0,0.0
Vestibular disorder,0.0,1.0,0.0,0.0
Classification criteria,1.0,0.0,0.0,0.0
Coping styles,0.0,1.0,0.0,0.0
State anxiety,0.0,0.0,1.0,0.0
Low-beam headlights,0.0,0.0,1.0,0.0
Viewing behavior,0.0,1.0,0.0,0.0
Sensory profiles,1.0,0.0,0.0,0.0
Prism disorientation,0.0,0.0,0.0,1.0
culture-specific cognition,1.0,0.0,0.0,0.0
Central vestibular disorders,0.0,0.0,0.0,1.0
Mathematics education,0.0,1.0,0.0,0.0
partial least square analyses,0.0,0.0,1.0,0.0
Neuronal survival,0.0,1.0,0.0,0.0
Ventral pathway,0.0,0.0,1.0,0.0
polycythemia,0.0,0.0,1.0,0.0
Self-location,0.0,0.0,0.0,1.0
Skill formation,0.0,0.0,1.0,0.0
Mountains,1.0,0.0,0.0,0.0
Verbal working memory capacity,1.0,0.0,0.0,0.0
Interest and excitement,1.0,0.0,0.0,0.0
Attitude construction,1.0,0.0,0.0,0.0
Visual motor coordination,1.0,0.0,0.0,0.0
Aged > 80,0.0,0.0,1.0,0.0
Hypoxia signature,0.0,0.0,1.0,0.0
Brain susceptibility,1.0,0.0,0.0,0.0
Chronic Nonmalignant Pain,0.0,0.0,0.0,1.0
Generation,0.0,1.0,0.0,0.0
Novelty oddball,0.0,0.0,0.0,1.0
Tool use behaviour,0.0,0.0,1.0,0.0
facial affection,0.0,1.0,0.0,0.0
acquired equivalence,0.0,1.0,0.0,0.0
Heartbeat perception,0.0,1.0,0.0,0.0
size incongruity effect,0.0,0.0,1.0,0.0
nulticenter study,1.0,0.0,0.0,0.0
Cerebral hemodynamics,0.0,0.0,1.0,0.0
Early experience,1.0,0.0,0.0,0.0
Psychological research,0.0,0.0,1.0,0.0
Knowledge awareness,0.0,0.0,1.0,0.0
Basic level,0.0,1.0,0.0,0.0
Central nervous system tumors,1.0,0.0,0.0,0.0
screening mammography,0.0,0.0,1.0,0.0
incident stroke,1.0,0.0,0.0,0.0
Intrusive memory,1.0,0.0,0.0,0.0
Comfort,0.0,1.0,0.0,0.0
Independent-component analysis,1.0,0.0,0.0,0.0
Movement-related brain macropotentials,0.0,1.0,0.0,0.0
Incongruence effect,0.0,0.0,0.0,1.0
Prey versus predator paradigm,0.0,0.0,1.0,0.0
Naturalistic action,0.0,0.0,1.0,0.0
Loved faces,0.0,1.0,0.0,0.0
Ethnomethodology,0.0,1.0,0.0,0.0
Histone H3 acetylation,0.0,0.0,0.0,1.0
Fragmented Pictures,0.0,0.0,1.0,0.0
Retinal nerve fiber layer thickness,0.0,0.0,0.0,1.0
Ratios,0.0,1.0,0.0,0.0
Shared experience,0.0,1.0,0.0,0.0
Mind perception,1.0,0.0,0.0,0.0
Repetition proportion,0.0,0.0,1.0,0.0
Brodmann,0.0,1.0,0.0,0.0
Glass patterns,0.0,0.0,1.0,0.0
One-Touch Stockings of Cambridge Task,1.0,0.0,0.0,0.0
pediatric cognitive screen,0.0,0.0,0.0,1.0
Beta-band activity,0.0,1.0,0.0,0.0
film archives,0.0,0.0,1.0,0.0
Waking EEG,0.0,0.0,1.0,0.0
minocycline,0.0,0.0,1.0,0.0
Abstract Letter case,0.0,1.0,0.0,0.0
Reflections,1.0,0.0,0.0,0.0
2-AG,0.0,1.0,0.0,0.0
Social-perceptual component,0.0,0.0,0.0,1.0
National football league,0.0,0.0,1.0,0.0
metamorphopsia,0.0,1.0,0.0,0.0
Parent-proxy,0.0,0.0,1.0,0.0
Multichannel near-infrared spectroscopy,0.0,0.0,1.0,0.0
age ranking,0.0,1.0,0.0,0.0
Bimodal evoked potentials,0.0,0.0,0.0,1.0
Psychological refractory period paradigm,0.0,0.0,1.0,0.0
GAD,0.0,1.0,0.0,0.0
Alcohol Dependence,0.0,1.0,0.0,0.0
Environmental spatial strategies,0.0,0.0,1.0,0.0
Motor symptoms,0.0,1.0,0.0,0.0
Map navigation,0.0,1.0,0.0,0.0
Beads-task,0.0,0.0,1.0,0.0
Modality-specific interference,0.0,0.0,1.0,0.0
Learning constraints,0.0,0.0,1.0,0.0
Stress sensation,0.0,0.0,0.0,1.0
physical exercise,0.0,1.0,0.0,0.0
Letter visual-similarity/confusability matrix,0.0,0.0,1.0,0.0
calculus learning,0.0,0.0,1.0,0.0
Hole-filter,0.0,1.0,0.0,0.0
Professional,0.0,1.0,0.0,0.0
Recovered depressed,0.0,1.0,0.0,0.0
Korsakoff Syndrome,0.0,0.0,1.0,0.0
Two-point discrimination,1.0,0.0,0.0,0.0
ALFF,0.0,0.0,1.0,0.0
Neuropathic,0.0,1.0,0.0,0.0
Sex categorization,1.0,0.0,0.0,0.0
Attentional shifts,0.0,1.0,0.0,0.0
Representational similarity,0.0,1.0,0.0,0.0
Games for learning,0.0,0.0,0.0,1.0
Cognitive illusion,1.0,0.0,0.0,0.0
Functional Activities Questionnaire,0.0,1.0,0.0,0.0
Androstenedione,0.0,0.0,1.0,0.0
Chinese idiom,0.0,1.0,0.0,0.0
Spontaneous selective attention,0.0,0.0,1.0,0.0
Cortical infarction,0.0,1.0,0.0,0.0
Sight reading,0.0,0.0,1.0,0.0
Non-actual motion,0.0,0.0,1.0,0.0
Brain/mind issue,0.0,0.0,1.0,0.0
Dance/movement therapy,0.0,0.0,1.0,0.0
Illness behavior,0.0,0.0,1.0,0.0
Light at night,0.0,0.0,1.0,0.0
Mood stability,0.0,1.0,0.0,0.0
Virtual instrument,0.0,0.0,1.0,0.0
Linguistic processing speed,1.0,0.0,0.0,0.0
V1 deactivation,0.0,1.0,0.0,0.0
Blood lead,1.0,0.0,0.0,0.0
static magnetic stray fields,1.0,0.0,0.0,0.0
Morris water task,0.0,1.0,0.0,0.0
Narziss Ach,0.0,0.0,1.0,0.0
Cognitive reflection test,0.0,1.0,0.0,0.0
Deixis,0.0,1.0,0.0,0.0
Supramarginal gyrus (SMG),0.0,1.0,0.0,0.0
Text-speak,0.0,0.0,1.0,0.0
End-stage liver disease,0.0,0.0,1.0,0.0
hepatolenticular degeneration,0.0,0.0,0.0,1.0
Encapsulation,0.0,0.0,0.0,1.0
Strategic functioning,0.0,0.0,0.0,1.0
Subcortex,1.0,0.0,0.0,0.0
Table tennis,1.0,0.0,0.0,0.0
Ocular,1.0,0.0,0.0,0.0
cognitive domains,0.0,0.0,1.0,0.0
MACFIMS,0.0,1.0,0.0,0.0
Charles S. Peirce,0.0,0.0,1.0,0.0
BESA,0.0,0.0,1.0,0.0
Local geometry,0.0,1.0,0.0,0.0
Constriction,0.0,0.0,0.0,0.0
Torelyuch,0.0,0.0,1.0,0.0
graphs,0.0,1.0,0.0,0.0
(OFA) the occipital face area,0.0,0.0,1.0,0.0
Letrozole,0.0,0.0,1.0,0.0
Multisensory research,0.0,0.0,1.0,0.0
Magical thinking,1.0,0.0,0.0,0.0
Self-teaching,0.0,0.0,1.0,0.0
Hopfield networks,1.0,0.0,0.0,0.0
Cortical network,0.0,0.0,1.0,0.0
Chiloscyllium griseum,0.0,0.0,0.0,1.0
Frontal syndrome,1.0,0.0,0.0,0.0
symptom control,0.0,0.0,1.0,0.0
Cognitive functioning dynamics,1.0,0.0,0.0,0.0
Weighted directed graph,0.0,1.0,0.0,0.0
The graded salience hypothesis,0.0,0.0,1.0,0.0
Gene carriers,0.0,0.0,1.0,0.0
Antipointing,0.0,1.0,0.0,0.0
Canonical pattern,0.0,1.0,0.0,0.0
Speech signals,1.0,0.0,0.0,0.0
pedigrees,0.0,0.0,1.0,0.0
Auditory evoked potential (AEP),1.0,0.0,0.0,0.0
Information and Control",0.0,0.0,0.0,0.0
Halving,0.0,1.0,0.0,0.0
semantic cueing,0.0,0.0,1.0,0.0
Giftedness,1.0,0.0,0.0,0.0
interface design,0.0,1.0,0.0,0.0
Attention deficit hyperactivity disorder adults,1.0,0.0,0.0,0.0
neurodegenerative diseases,0.0,0.0,1.0,0.0
Perceptual processing speed,0.0,1.0,0.0,0.0
Visual imagery and perception,1.0,0.0,0.0,0.0
Statistical methods,0.0,0.0,1.0,0.0
Predator recognition,0.0,0.0,0.0,1.0
Kanji deconstruction level,0.0,1.0,0.0,0.0
interaction,0.0,1.0,0.0,0.0
Visual orientation perception,0.0,1.0,0.0,0.0
mere effort,1.0,0.0,0.0,0.0
Motor response,1.0,0.0,0.0,0.0
Community dwelling individuals,0.0,1.0,0.0,0.0
Metric shape,0.0,0.0,1.0,0.0
additional loading on working memory,1.0,0.0,0.0,0.0
Somatoparaphrenia,0.0,1.0,0.0,0.0
Menopausal status,0.0,0.0,1.0,0.0
Metabolic control,0.0,0.0,1.0,0.0
Event-Related Potentials (ERPs),0.0,0.0,0.0,1.0
Oligomers,0.0,1.0,0.0,0.0
Left ventricular mass,0.0,0.0,1.0,0.0
Learning approach,0.0,1.0,0.0,0.0
Spatio-temporal events,0.0,1.0,0.0,0.0
Struggling readers,0.0,0.0,1.0,0.0
Interaction theory,0.0,0.0,1.0,0.0
Mother,0.0,0.0,1.0,0.0
Whole saliva,0.0,0.0,1.0,0.0
Internet training,1.0,0.0,0.0,0.0
Emotion modulation/regulation,0.0,0.0,1.0,0.0
spatial language,0.0,0.0,0.0,1.0
SPST,1.0,0.0,0.0,0.0
Psychoacoustics,0.0,0.0,1.0,0.0
Scheffe's paired comparison,0.0,0.0,1.0,0.0
Blueberry,0.0,0.0,1.0,0.0
graphic composition,1.0,0.0,0.0,0.0
Bioluminescent photons,0.0,0.0,0.0,1.0
Neuroimaging meta-analysis,0.0,1.0,0.0,0.0
Landscape preferences,0.0,1.0,0.0,0.0
Audiovisual perception,0.0,0.0,1.0,0.0
Cannabinoid,0.0,0.0,1.0,0.0
Kidney disease quality of life short form,0.0,0.0,1.0,0.0
Driving outcome,0.0,1.0,0.0,0.0
Constipation,0.0,0.0,1.0,0.0
Nonlinear data analysis,0.0,1.0,0.0,0.0
Human Experimentation,0.0,0.0,1.0,0.0
Omega-3 fatty Acids,0.0,0.0,1.0,0.0
subcam,0.0,0.0,1.0,0.0
Feet representation,0.0,0.0,1.0,0.0
Phonological encoding,0.0,0.0,1.0,0.0
355 (3),0.0,1.0,0.0,0.0
Wilkins reading test,0.0,1.0,0.0,0.0
presbyopia,0.0,0.0,1.0,0.0
Mirror-touch synaesthesia,1.0,0.0,0.0,0.0
context memory,0.0,1.0,0.0,0.0
Spatio-temporal activity,0.0,1.0,0.0,0.0
Alerting network,0.0,1.0,0.0,0.0
Nutritional deficiency,0.0,0.0,1.0,0.0
SKF81297,0.0,0.0,1.0,0.0
Ophthalmological findings,0.0,1.0,0.0,0.0
Brain training,0.0,0.0,0.0,1.0
Relational property,0.0,0.0,1.0,0.0
sensorimotor cortex,0.0,0.0,1.0,0.0
Image value,0.0,1.0,0.0,0.0
Person identity network,0.0,1.0,0.0,0.0
Exploratory eye movement,0.0,0.0,1.0,0.0
Diffuse noxious inhibitory controls (DNIC),0.0,0.0,0.0,1.0
Computer vision syndrome,0.0,1.0,0.0,0.0
Number-related processes in the parietal lobes,1.0,0.0,0.0,0.0
"""Pure"" ADHD,1.0,0.0,0.0,0.0
Neurodevelopmental disorders,0.0,1.0,0.0,0.0
Bayesian vision,0.0,0.0,1.0,0.0
transient,1.0,0.0,0.0,0.0
Colour preference,0.0,0.0,1.0,0.0
Personal Mastery,0.0,0.0,1.0,0.0
Age-related change,1.0,0.0,0.0,0.0
Visual perceptual processes,0.0,0.0,1.0,0.0
Active touch,0.0,1.0,0.0,0.0
Child neurodevelopment,1.0,0.0,0.0,0.0
MSFC,0.0,1.0,0.0,0.0
Polarity,0.0,1.0,0.0,0.0
MTLE,0.0,0.0,1.0,0.0
video game,0.0,0.0,1.0,0.0
dysembryoplastic neuroepithelial tumors (DNETs),1.0,0.0,0.0,0.0
neural responses,1.0,0.0,0.0,0.0
type 2 diabetes,0.0,1.0,0.0,0.0
Obstructive,1.0,0.0,0.0,0.0
FTD,0.0,0.0,0.0,0.0
advanced old age,0.0,1.0,0.0,0.0
time estimation,0.0,1.0,0.0,0.0
Osteoporotic hip fracture,0.0,1.0,0.0,0.0
Delay-period activity,0.0,1.0,0.0,0.0
Magnetic resonance image,0.0,0.0,1.0,0.0
Size congruity effect,0.0,0.0,1.0,0.0
Sagittal craniosynostosis,1.0,0.0,0.0,0.0
Norway,0.0,1.0,0.0,0.0
Cognition system,0.0,0.0,1.0,0.0
Parafascicular,0.0,1.0,0.0,0.0
Tagging theories,0.0,0.0,1.0,0.0
Nonlinear,0.0,0.0,1.0,0.0
Suburban fringe,0.0,0.0,1.0,0.0
neurobehavioral performance,0.0,0.0,1.0,0.0
Hypothesis rejection,0.0,0.0,1.0,0.0
prototypes,0.0,1.0,0.0,0.0
Orthoptics,0.0,0.0,0.0,1.0
CalCAP,0.0,0.0,1.0,0.0
Shift of spatial attention,0.0,0.0,0.0,1.0
automotive,0.0,0.0,0.0,1.0
Hemispheric division,0.0,0.0,1.0,0.0
Crossmodal links,0.0,0.0,1.0,0.0
Central sensitization,0.0,0.0,1.0,0.0
Right-hemisphere,0.0,0.0,1.0,0.0
Reflexive-identity,0.0,0.0,1.0,0.0
memory training,0.0,0.0,1.0,0.0
Visual tactile integration,0.0,0.0,1.0,0.0
Auditory Stroop,1.0,0.0,0.0,0.0
autonomous robots,0.0,0.0,0.0,1.0
Rural children,1.0,0.0,0.0,0.0
Visuoconstruction,0.0,0.0,1.0,0.0
Surface interpolation,0.0,1.0,0.0,0.0
Multiple task learning,0.0,0.0,0.0,1.0
Asian,1.0,0.0,0.0,0.0
Posterior cranial fossa,0.0,1.0,0.0,0.0
dimensions,0.0,0.0,1.0,0.0
ERD/S,1.0,0.0,0.0,0.0
Threat bias,0.0,1.0,0.0,0.0
Early stages,0.0,0.0,1.0,0.0
Computed tomograph,0.0,1.0,0.0,0.0
vehicle segmentation,0.0,0.0,1.0,0.0
Reinstatement,0.0,1.0,0.0,0.0
Conners' CPT,0.0,0.0,1.0,0.0
Neurofunctions,0.0,1.0,0.0,0.0
Murder,0.0,1.0,0.0,0.0
Clefts,0.0,1.0,0.0,0.0
Holistic education in art,0.0,1.0,0.0,0.0
Intersensory redundancy,0.0,0.0,1.0,0.0
Probed recall,0.0,0.0,0.0,1.0
Healthy life expectancy,0.0,1.0,0.0,0.0
Consonants_vowels,0.0,0.0,0.0,1.0
Structure-from-motion perception,0.0,1.0,0.0,0.0
Omega-3 fatty-acids,0.0,0.0,1.0,0.0
exploration,0.0,0.0,1.0,0.0
Genetically modified mice,0.0,0.0,1.0,0.0
repetition priming,0.0,1.0,0.0,0.0
Neuropsychological batteries,0.0,0.0,0.0,1.0
scene decomposition,1.0,0.0,0.0,0.0
integration masking,0.0,0.0,1.0,0.0
Digital eye strain,0.0,1.0,0.0,0.0
Cognitive adaptation training,0.0,1.0,0.0,0.0
Phenology,0.0,0.0,1.0,0.0
design processes,0.0,0.0,1.0,0.0
Body orientation,0.0,0.0,1.0,0.0
Frequencies,1.0,0.0,0.0,0.0
Ordered information,0.0,1.0,0.0,0.0
cognition(s),0.0,0.0,0.0,1.0
Signaling regulation,1.0,0.0,0.0,0.0
spontaneous object recognition,0.0,0.0,0.0,1.0
Oddball detection,0.0,1.0,0.0,0.0
Postherpetic neuralgia,0.0,0.0,1.0,0.0
Emotional facial expressions identification,0.0,0.0,1.0,0.0
Tonsil,0.0,0.0,1.0,0.0
Development of reaching,0.0,0.0,1.0,0.0
Distractor frequency,0.0,0.0,1.0,0.0
Systemic Lupus Erythematosus,0.0,1.0,0.0,0.0
Irritability,0.0,0.0,1.0,0.0
Sequential movement,1.0,0.0,0.0,0.0
Motion detection,0.0,0.0,1.0,0.0
MROM-p,0.0,1.0,0.0,0.0
spatial navigation,0.0,0.0,1.0,0.0
Body dysmorphic disorder,0.0,0.0,1.0,0.0
nonhuman primate,0.0,1.0,0.0,0.0
Barr,0.0,0.0,1.0,0.0
Obvious cognitive impairment,0.0,1.0,0.0,0.0
Treatment-options,0.0,0.0,1.0,0.0
Addiction memory,0.0,0.0,1.0,0.0
information-rich versus information-limited products,0.0,0.0,1.0,0.0
Analogical mapping,0.0,0.0,1.0,0.0
Dementia in Parkinson,0.0,1.0,0.0,0.0
Temporo-occipital connections,0.0,1.0,0.0,0.0
haptics,1.0,0.0,0.0,0.0
Baso-lateral nucleus,0.0,0.0,1.0,0.0
mismatching,0.0,0.0,0.0,1.0
Crack-cocaine,0.0,1.0,0.0,0.0
response to intervention,0.0,1.0,0.0,0.0
Volvulus,0.0,0.0,1.0,0.0
Haptic line drawing perception,0.0,1.0,0.0,0.0
Attention orienting,0.0,1.0,0.0,0.0
cognitive processing,0.0,0.0,0.0,1.0
Color naming,0.0,1.0,0.0,0.0
"""actor-observer bias"",0.0,0.0,0.0,1.0
Neuropsychiatrie symptoms,0.0,1.0,0.0,0.0
Pictorial memory,0.0,0.0,1.0,0.0
Ubiquitin-positive inclusions,0.0,0.0,1.0,0.0
Bottlenose dolphin,0.0,0.0,1.0,0.0
Anti-VEGF therapy,0.0,0.0,1.0,0.0
Contextual responses,0.0,0.0,1.0,0.0
Number line estimation,0.0,1.0,0.0,0.0
Rural health,0.0,1.0,0.0,0.0
occupational exposure,0.0,0.0,0.0,1.0
visual comparison,1.0,0.0,0.0,0.0
Magnitude representations,0.0,0.0,1.0,0.0
Fusiform body area (FBA),0.0,1.0,0.0,0.0
Farm workers,1.0,0.0,0.0,0.0
bottom-up processing,1.0,0.0,0.0,0.0
pattern recognition,0.0,1.0,0.0,0.0
Neurocognitive tests,1.0,0.0,0.0,0.0
Dementia Rating Scale,0.0,1.0,0.0,0.0
Acetylsalicylic acid,0.0,0.0,0.0,1.0
transgenic mice,0.0,0.0,1.0,0.0
Musculoskeletal symptoms and performance,0.0,0.0,1.0,0.0
combined methods,1.0,0.0,0.0,0.0
Subdural hematoma,0.0,1.0,0.0,0.0
visual narrative,0.0,1.0,0.0,0.0
Field theory,0.0,0.0,0.0,1.0
Playing cards,0.0,0.0,1.0,0.0
Visual-to-auditory priming,0.0,0.0,1.0,0.0
Phonological coding,0.0,0.0,1.0,0.0
Enhanced discrimination,0.0,0.0,1.0,0.0
Psychomotor skill,0.0,1.0,0.0,0.0
Correction instruction,1.0,0.0,0.0,0.0
NMRI mice,1.0,0.0,0.0,0.0
spatial vision,0.0,0.0,1.0,0.0
Co-morbidity,1.0,0.0,0.0,0.0
State-dependence,0.0,0.0,1.0,0.0
Face-like patterns,0.0,1.0,0.0,0.0
Brief repeatable battery,0.0,0.0,1.0,0.0
Growth impairment,0.0,0.0,1.0,0.0
Perceptual neglect,0.0,0.0,1.0,0.0
Response modalities,0.0,0.0,1.0,0.0
Premotor potential,0.0,0.0,1.0,0.0
15O-water PET,0.0,0.0,1.0,0.0
Low-functioning autism,0.0,1.0,0.0,0.0
Henry Schaefer-Simmern,0.0,1.0,0.0,0.0
Visuo-perceptual ability,1.0,0.0,0.0,0.0
Psychedelics,0.0,0.0,1.0,0.0
Cognition and motivation,0.0,1.0,0.0,0.0
Exposure duration,0.0,0.0,1.0,0.0
Antisymmetry,0.0,0.0,1.0,0.0
Spatial pattern,0.0,1.0,0.0,0.0
circadian rhythm disorders,0.0,0.0,1.0,0.0
Trans-sphenoidal approach,0.0,0.0,1.0,0.0
chess expertise,1.0,0.0,0.0,0.0
Chronic itch,0.0,0.0,0.0,1.0
Dendritic translation,0.0,0.0,1.0,0.0
degenerative disease,1.0,0.0,0.0,0.0
Load theory,0.0,1.0,0.0,0.0
Technology change,1.0,0.0,0.0,0.0
Delayed visual feedback,1.0,0.0,0.0,0.0
Anisotropy,0.0,0.0,1.0,0.0
threaded cognition,0.0,0.0,1.0,0.0
Canonical correlation,1.0,0.0,0.0,0.0
Exaggeration,0.0,0.0,1.0,0.0
Social inference,0.0,0.0,1.0,0.0
Subliminal and supraliminal priming,1.0,0.0,0.0,0.0
self-face prioritization,0.0,0.0,1.0,0.0
Cortical hyperexcitability,0.0,1.0,0.0,0.0
Behavior disorders/problems,1.0,0.0,0.0,0.0
DCCS,1.0,0.0,0.0,0.0
infant siblings,0.0,0.0,1.0,0.0
Unpleasant pictures,0.0,0.0,1.0,0.0
morris water maze,0.0,0.0,1.0,0.0
bimanual synchrony,1.0,0.0,0.0,0.0
smoking-related stimuli,0.0,0.0,1.0,0.0
Nickel sulphate,0.0,1.0,0.0,0.0
Home range,0.0,0.0,1.0,0.0
Forced choice paradigm,1.0,0.0,0.0,0.0
STOP task,0.0,1.0,0.0,0.0
dissociative fugue,0.0,1.0,0.0,0.0
Extraversion,0.0,0.0,1.0,0.0
Object grouping,0.0,0.0,1.0,0.0
visual memory capacity,1.0,0.0,0.0,0.0
endophenotypes,0.0,1.0,0.0,0.0
Foetal alcohol spectrum disorder,1.0,0.0,0.0,0.0
Cerebral angiography,0.0,1.0,0.0,0.0
Visually evoked potential (VEP),1.0,0.0,0.0,0.0
Vision neuroscience,0.0,0.0,1.0,0.0
fMR,0.0,0.0,1.0,0.0
Phenomenological,0.0,0.0,1.0,0.0
Synchronous lesion,0.0,0.0,1.0,0.0
N2PC,1.0,0.0,0.0,0.0
Cerebral A? burden,1.0,0.0,0.0,0.0
Visual gnosis,0.0,0.0,1.0,0.0
screening heart failure,0.0,1.0,0.0,0.0
Antiepileptic drug,0.0,1.0,0.0,0.0
brain circuits,0.0,1.0,0.0,0.0
Alternating attention,1.0,0.0,0.0,0.0
Slow-wave sleep,0.0,0.0,1.0,0.0
Imitative learning,0.0,0.0,1.0,0.0
Pattern perception,0.0,1.0,0.0,0.0
action intention,0.0,1.0,0.0,0.0
Language/cognitive deficits,1.0,0.0,0.0,0.0
Extended release,0.0,0.0,1.0,0.0
LORETA inverse solution,0.0,0.0,0.0,1.0
Object-context interactions,0.0,0.0,1.0,0.0
Cerebral calcifications,0.0,1.0,0.0,0.0
Hypnotic suggestibility,0.0,0.0,0.0,1.0
Location matching,0.0,0.0,1.0,0.0
separability,1.0,0.0,0.0,0.0
Winner-take-all network,0.0,1.0,0.0,0.0
SNR (signal-to-noise ratio),0.0,1.0,0.0,0.0
Optimality models,0.0,0.0,1.0,0.0
Genetic architecture,1.0,0.0,0.0,0.0
Belgium,0.0,0.0,1.0,0.0
Spatial cognition hypothesis,0.0,1.0,0.0,0.0
Stereotype threat,1.0,0.0,0.0,0.0
cognicin,1.0,0.0,0.0,0.0
Animism,0.0,0.0,1.0,0.0
Physical conditioning program,0.0,1.0,0.0,0.0
Eye fixation,1.0,0.0,0.0,0.0
Childrens literature,0.0,0.0,1.0,0.0
Sensory weight,1.0,0.0,0.0,0.0
Dialysis,1.0,0.0,0.0,0.0
Older cancer patients,0.0,1.0,0.0,0.0
Manner,0.0,1.0,0.0,0.0
Understanding of video,0.0,1.0,0.0,0.0
Cognitive remediation therapy,0.0,1.0,0.0,0.0
Nonpharmacological interventions,0.0,0.0,1.0,0.0
Reward devaluation,0.0,0.0,1.0,0.0
Delayed visual maturation,0.0,0.0,1.0,0.0
Theory of Mind (ToM),0.0,0.0,1.0,0.0
hyperintensities,0.0,1.0,0.0,0.0
Performance measurement,0.0,1.0,0.0,0.0
motor symptoms,1.0,0.0,0.0,0.0
human factors in surgery,0.0,0.0,1.0,0.0
Atlantic forest,0.0,0.0,1.0,0.0
Sequential predictability,0.0,0.0,1.0,0.0
Phonemic awareness,0.0,0.0,1.0,0.0
Spontaneous neuronal activity,0.0,0.0,1.0,0.0
cebus apella,0.0,0.0,1.0,0.0
R6/1 mice,0.0,0.0,1.0,0.0
Problem structure,0.0,0.0,1.0,0.0
Visuospatial perspective taking,1.0,0.0,0.0,0.0
COP-COM,0.0,0.0,1.0,0.0
Dual route,1.0,0.0,0.0,0.0
Granulation,0.0,0.0,1.0,0.0
Botanical knowledge,0.0,0.0,1.0,0.0
Gestalt psychology,0.0,1.0,0.0,0.0
Health outcomes,0.0,0.0,1.0,0.0
static posturography,0.0,1.0,0.0,0.0
Usage-based theory,1.0,0.0,0.0,0.0
Visual stimulator,0.0,0.0,1.0,0.0
Chronobiological type,1.0,0.0,0.0,0.0
SB269.970,1.0,0.0,0.0,0.0
Mimic word,0.0,0.0,0.0,1.0
Action performance,0.0,0.0,1.0,0.0
Eavesdropping,0.0,1.0,0.0,0.0
cross cultural differences,1.0,0.0,0.0,0.0
Global/local,0.0,1.0,0.0,0.0
Hemoglobin,0.0,1.0,0.0,0.0
Mild traumatic brain injury (TBI),1.0,0.0,0.0,0.0
Eye closure sensitivity,0.0,0.0,1.0,0.0
Psychological functioning,0.0,0.0,1.0,0.0
Phase coherence,0.0,0.0,1.0,0.0
Reading subtypes,0.0,0.0,1.0,0.0
Cognitive endophenotype,1.0,0.0,0.0,0.0
voluntary switching,1.0,0.0,0.0,0.0
Kansei interface,0.0,0.0,1.0,0.0
Somatic markers,0.0,1.0,0.0,0.0
voxel-based specific regional analysis system for Alzheimer's disease,0.0,0.0,1.0,0.0
Non-symbolic comparison,0.0,0.0,1.0,0.0
3-back working memory task,0.0,0.0,1.0,0.0
Interceptive task,0.0,0.0,1.0,0.0
Braille-like recognition task,0.0,1.0,0.0,0.0
cognition disorders - etiology,0.0,1.0,0.0,0.0
Nonsymbolic arithmetic,0.0,0.0,0.0,1.0
Mental scanning and spatial cognition,0.0,0.0,1.0,0.0
Neocortical cell number,1.0,0.0,0.0,0.0
Life after stroke,0.0,1.0,0.0,0.0
Real-life setting,0.0,0.0,1.0,0.0
Healthy females,0.0,0.0,0.0,1.0
Potentials,0.0,0.0,1.0,0.0
Social attainment,0.0,1.0,0.0,0.0
Europe,0.0,0.0,1.0,0.0
GO/NO-GO task,0.0,1.0,0.0,0.0
Motor neuron disease,0.0,0.0,1.0,0.0
Canine cognition,0.0,1.0,0.0,0.0
Symbol learning,0.0,0.0,1.0,0.0
food services,1.0,0.0,0.0,0.0
Semantic aphasia,0.0,1.0,0.0,0.0
Cognitive competence,0.0,0.0,1.0,0.0
Argumentation,0.0,1.0,0.0,0.0
Neonate start state,1.0,0.0,0.0,0.0
Response competition,0.0,0.0,1.0,0.0
Ritalin,0.0,0.0,0.0,1.0
Extradimensional shifts,0.0,0.0,0.0,1.0
Dimension,0.0,1.0,0.0,0.0
Mathematics difficulty,0.0,0.0,1.0,0.0
Executive ability,1.0,0.0,0.0,0.0
Spatial discrimination,0.0,1.0,0.0,0.0
Symbolic cognition,0.0,1.0,0.0,0.0
Mirror networks,0.0,0.0,0.0,1.0
Cultural,0.0,0.0,1.0,0.0
Behavioral inhibition system,1.0,0.0,0.0,0.0
Face identity aftereffects,0.0,1.0,0.0,0.0
Facial familiarity,0.0,1.0,0.0,0.0
Sun protection,1.0,0.0,0.0,0.0
Timed up and go test,1.0,0.0,0.0,0.0
Fear relevance,0.0,0.0,1.0,0.0
Susac syndrome,1.0,0.0,0.0,0.0
Semantic object,0.0,0.0,1.0,0.0
Picture selection,0.0,1.0,0.0,0.0
Weber's Law,0.0,1.0,0.0,0.0
Physician,0.0,0.0,1.0,0.0
Phosphomonoester,0.0,0.0,1.0,0.0
Antisocial personality disorder,1.0,0.0,0.0,0.0
Mathematics/Numbers,1.0,0.0,0.0,0.0
School age,1.0,0.0,0.0,0.0
Neuronal modifications,0.0,0.0,1.0,0.0
Cortical visual system,0.0,1.0,0.0,0.0
caching development,0.0,0.0,1.0,0.0
Event related potential (ERP),0.0,0.0,1.0,0.0
time course,0.0,0.0,0.0,1.0
Posterior cerebral artery,1.0,0.0,0.0,0.0
response bias,0.0,1.0,0.0,0.0
Social cognitive development,0.0,1.0,0.0,0.0
Concealed questions,0.0,0.0,1.0,0.0
synesthesia,0.0,1.0,0.0,0.0
Vestibular loss,0.0,1.0,0.0,0.0
Inference generation,0.0,0.0,1.0,0.0
ChAT activity,1.0,0.0,0.0,0.0
Active place avoidance,0.0,1.0,0.0,0.0
Indoor air pollution,1.0,0.0,0.0,0.0
Object visibility,1.0,0.0,0.0,0.0
motion-2d,0.0,1.0,0.0,0.0
Visitor-employed photography,0.0,1.0,0.0,0.0
Retrospective pre-test,1.0,0.0,0.0,0.0
Cognitive neuroscience of categorization,0.0,0.0,1.0,0.0
Predictive forward models,0.0,1.0,0.0,0.0
Bag-of-features,0.0,1.0,0.0,0.0
Integrator,0.0,0.0,1.0,0.0
Quantifiers,0.0,0.0,1.0,0.0
subcortical,0.0,1.0,0.0,0.0
intoxication,0.0,0.0,1.0,0.0
Functional amnesia,0.0,0.0,1.0,0.0
Non-verbal sound,0.0,0.0,0.0,1.0
smoking abstinence,0.0,1.0,0.0,0.0
Brief intervention,0.0,1.0,0.0,0.0
Evolutionary model of loneliness,0.0,0.0,0.0,1.0
Functional neurological symptoms,1.0,0.0,0.0,0.0
Selective developmental disorders,0.0,1.0,0.0,0.0
High-resolution electroencephalography (EEG),0.0,1.0,0.0,0.0
error detection,1.0,0.0,0.0,0.0
Temporal lobe epilepsy surgery,0.0,1.0,0.0,0.0
neuropathology,1.0,0.0,0.0,0.0
Optic lobe,0.0,0.0,1.0,0.0
Warfarin,0.0,0.0,1.0,0.0
Global inhibition,1.0,0.0,0.0,0.0
Deep sources,0.0,0.0,1.0,0.0
CLAIR,0.0,1.0,0.0,0.0
Long-term survival,0.0,1.0,0.0,0.0
Sports related concussion,0.0,0.0,1.0,0.0
Sentence production,1.0,0.0,0.0,0.0
Associative priming,0.0,1.0,0.0,0.0
Neutral mood induction,0.0,0.0,1.0,0.0
Talmyan perspective point (PP),0.0,1.0,0.0,0.0
Power spectrum,0.0,1.0,0.0,0.0
Cognitive subtypes,0.0,0.0,0.0,1.0
matching,0.0,0.0,0.0,1.0
Konzo,0.0,0.0,1.0,0.0
VDU,0.0,0.0,1.0,0.0
Coronary angiography,0.0,0.0,1.0,0.0
competitive queuing,0.0,1.0,0.0,0.0
longitudinal study,0.0,0.0,1.0,0.0
Vision problems,0.0,1.0,0.0,0.0
Follow up studies,1.0,0.0,0.0,0.0
dual-task performance,0.0,0.0,1.0,0.0
Topological-metric mapping,0.0,0.0,1.0,0.0
Development of calculation abilities,1.0,0.0,0.0,0.0
Jackdaws,0.0,1.0,0.0,0.0
Cocaine infants,0.0,1.0,0.0,0.0
'Theory of mind',0.0,0.0,1.0,0.0
HPLC,0.0,0.0,1.0,0.0
temporal integration,0.0,1.0,0.0,0.0
oropharyngeal virome,0.0,1.0,0.0,0.0
Case mixing,1.0,0.0,0.0,0.0
Interspecific,1.0,0.0,0.0,0.0
Lewy Body disease,0.0,1.0,0.0,0.0
Root-mean-square,0.0,0.0,0.0,1.0
Operational Momentum,1.0,0.0,0.0,0.0
visuospatial processing,0.0,1.0,0.0,0.0
Magneto-encephalography,0.0,0.0,0.0,1.0
Rapid auditory processing,0.0,0.0,0.0,1.0
Modules,0.0,0.0,1.0,0.0
speech,0.0,0.0,0.0,1.0
serial and parallel processing,1.0,0.0,0.0,0.0
Imprecise computation,1.0,0.0,0.0,0.0
Classroom teaching,0.0,1.0,0.0,0.0
genodermatosis,0.0,0.0,1.0,0.0
AChe inhibitor,0.0,0.0,1.0,0.0
SAT,0.0,0.0,1.0,0.0
Sertraline,1.0,0.0,0.0,0.0
Response interference,0.0,1.0,0.0,0.0
Evaluative conditioning,0.0,0.0,0.0,1.0
Hedonic valence,0.0,1.0,0.0,0.0
Implicit theory of mind,0.0,0.0,0.0,1.0
Composite face paradigm,1.0,0.0,0.0,0.0
fMri,1.0,0.0,0.0,0.0
ALSPAC,0.0,0.0,0.0,1.0
Fish Health risks,0.0,0.0,1.0,0.0
gaze visualization,0.0,1.0,0.0,0.0
Phonological neighborhood,0.0,1.0,0.0,0.0
PCA-IV,1.0,0.0,0.0,0.0
grandmother cell,0.0,0.0,1.0,0.0
Area TE,0.0,0.0,1.0,0.0
Perceptual speed,0.0,0.0,1.0,0.0
Cigarette smokers,0.0,0.0,1.0,0.0
self-propulsion,1.0,0.0,0.0,0.0
Protein tyrosine phosphatase,0.0,0.0,1.0,0.0
Normal MRI,0.0,0.0,1.0,0.0
EEG microstates,0.0,0.0,1.0,0.0
Acquired prosopagnosia,0.0,0.0,1.0,0.0
Motor facilitation,0.0,0.0,1.0,0.0
birth weight,1.0,0.0,0.0,0.0
behavioral slowing,0.0,0.0,1.0,0.0
Knowledge exchange,0.0,1.0,0.0,0.0
glycerophosphocholine,0.0,0.0,1.0,0.0
Allosteric modulators,0.0,0.0,1.0,0.0
infant locomotion,0.0,1.0,0.0,0.0
Delayed matching-to-sample task,0.0,1.0,0.0,0.0
Ventral and dorsal stream,0.0,0.0,1.0,0.0
Mental map,0.0,1.0,0.0,0.0
Health care system,0.0,0.0,1.0,0.0
paediatric refractive surgery,0.0,0.0,0.0,1.0
Medial pallium,1.0,0.0,0.0,0.0
Visuoperceptual abilities,1.0,0.0,0.0,0.0
orthographic processing,0.0,1.0,0.0,0.0
phosphatidylserine,0.0,0.0,1.0,0.0
Eye preference,1.0,0.0,0.0,0.0
Competitive parallelism,0.0,1.0,0.0,0.0
Fruit finding strategies,0.0,0.0,1.0,0.0
Traffic monitoring,1.0,0.0,0.0,0.0
Conditional learning,0.0,0.0,0.0,1.0
Misattribution,0.0,1.0,0.0,0.0
Constructive praxis,0.0,0.0,1.0,0.0
Moderator effects,0.0,1.0,0.0,0.0
open data,0.0,0.0,0.0,1.0
Serial task,0.0,1.0,0.0,0.0
In-vehicle radio,0.0,0.0,1.0,0.0
Drift diffusion model,0.0,0.0,1.0,0.0
Representational conflict,0.0,0.0,0.0,1.0
domestic violence,0.0,0.0,1.0,0.0
switching,0.0,0.0,1.0,0.0
Center of pressure movement,1.0,0.0,0.0,0.0
An event-related fMRI study of the neural networks underlying the encoding,0.0,1.0,0.0,0.0
Duration of untreated illness,0.0,0.0,1.0,0.0
3-D SSP,0.0,0.0,1.0,0.0
SWM,1.0,0.0,0.0,0.0
Dj-v,0.0,1.0,0.0,0.0
22q11.2 Deletion Syndrome,0.0,0.0,1.0,0.0
Generalization (cognitive),1.0,0.0,0.0,0.0
Learning-to-learn,0.0,0.0,0.0,1.0
SNA (social network analysis),1.0,0.0,0.0,0.0
Robot cognition,0.0,0.0,0.0,1.0
11,0.0,0.0,1.0,0.0
Temporal lobe regions,1.0,0.0,0.0,0.0
Auditory-visual interactions,0.0,0.0,1.0,0.0
Patient-reported outcome,0.0,1.0,0.0,0.0
Distractors,1.0,0.0,0.0,0.0
Gamma band EEG activity,0.0,1.0,0.0,0.0
Ecological,0.0,1.0,0.0,0.0
Polychloroprene solvent,0.0,1.0,0.0,0.0
Iconic,1.0,0.0,0.0,0.0
KABC-II,0.0,0.0,0.0,1.0
Human figures,0.0,1.0,0.0,0.0
Cross-cultural maternal naming,0.0,1.0,0.0,0.0
Sensorimotor theory,0.0,1.0,0.0,0.0
Topological graph,0.0,1.0,0.0,0.0
second life,0.0,0.0,1.0,0.0
Panayiotopoulos syndrome,0.0,1.0,0.0,0.0
Visual self-recognition,1.0,0.0,0.0,0.0
Exercise psychology,0.0,1.0,0.0,0.0
Music origins,0.0,0.0,1.0,0.0
Task-rule congruency,0.0,0.0,0.0,1.0
Approach and withdrawal-related emotions,0.0,0.0,0.0,1.0
neurotrophin,0.0,0.0,1.0,0.0
Health Utilities Index Mark 3,0.0,0.0,1.0,0.0
Health Utilities Index Mark 2,0.0,0.0,1.0,0.0
Association learning,0.0,0.0,1.0,0.0
British Sign Language,0.0,0.0,1.0,0.0
Perceptual Expertise,0.0,0.0,1.0,0.0
ChAT,0.0,1.0,0.0,0.0
multiple-object tracking,1.0,0.0,0.0,0.0
Hemianoptic complication,0.0,0.0,1.0,0.0
Gallus gallus domesticus,0.0,1.0,0.0,0.0
Coronary artery bypass grafting,0.0,1.0,0.0,0.0
Randomised-controlled trial,0.0,0.0,1.0,0.0
Functional lateralization,0.0,0.0,1.0,0.0
Attention-Deficit-Hyperactivity Disorder,0.0,0.0,1.0,0.0
Phallometry,0.0,0.0,1.0,0.0
Poly-diagnostic approach,0.0,0.0,0.0,1.0
Girardinus falcatus,0.0,1.0,0.0,0.0
Simple,0.0,1.0,0.0,0.0
Dual-process models,0.0,0.0,1.0,0.0
attorneys,0.0,0.0,1.0,0.0
youth offender,0.0,0.0,1.0,0.0
facial composites,0.0,0.0,0.0,1.0
Body growth,0.0,0.0,1.0,0.0
Systematic Review,0.0,1.0,0.0,0.0
Chasing scene,0.0,0.0,1.0,0.0
Patient-provider communication,0.0,0.0,1.0,0.0
Visuospatial context,1.0,0.0,0.0,0.0
Novel object recognition task,0.0,1.0,0.0,0.0
mesial temporal lobe,0.0,0.0,0.0,1.0
Pointing-speech coordination,0.0,1.0,0.0,0.0
Augmentative and Alternative Communication,0.0,0.0,1.0,0.0
man,0.0,0.0,1.0,0.0
Oral propranolol,0.0,1.0,0.0,0.0
Language disorders,0.0,0.0,1.0,0.0
The event related optical signal (EROS),0.0,1.0,0.0,0.0
Decision signal,0.0,1.0,0.0,0.0
Orientational metaphors,0.0,0.0,1.0,0.0
Predicative metaphors,0.0,1.0,0.0,0.0
Skilled music training,0.0,0.0,0.0,1.0
single-trial analysis,0.0,0.0,1.0,0.0
Marsh tit,0.0,0.0,1.0,0.0
Score,0.0,0.0,0.0,1.0
Meat inspection,0.0,0.0,1.0,0.0
Referential cognition,0.0,1.0,0.0,0.0
Talnetant,1.0,0.0,0.0,0.0
Color-naming interference,0.0,0.0,1.0,0.0
group administration,0.0,0.0,1.0,0.0
Lampropeltis,1.0,0.0,0.0,0.0
Sensory and perceptual impairment,0.0,1.0,0.0,0.0
1H MRS,0.0,1.0,0.0,0.0
Stop signal task,0.0,0.0,1.0,0.0
Serial memory,0.0,0.0,1.0,0.0
Functional cognition,1.0,0.0,0.0,0.0
Transcranial random noise stimulation,1.0,0.0,0.0,0.0
aspirin,0.0,0.0,1.0,0.0
Temporal coupling,0.0,0.0,1.0,0.0
Magnetic imaging,0.0,1.0,0.0,0.0
immediate memory,1.0,0.0,0.0,0.0
basic combinatorics,1.0,0.0,0.0,0.0
Temporal Order Judgment,0.0,0.0,1.0,0.0
Classroom questions,0.0,0.0,1.0,0.0
Subcortical vascular lesions,0.0,1.0,0.0,0.0
Complex system,0.0,0.0,1.0,0.0
Broca's aphasia,1.0,0.0,0.0,0.0
Small number preference,0.0,0.0,1.0,0.0
somatic,1.0,0.0,0.0,0.0
Executive control network,0.0,1.0,0.0,0.0
Hematopoietic stem cell transplantation,0.0,0.0,0.0,1.0
isoflavones,0.0,1.0,0.0,0.0
Emotional regulation,0.0,0.0,1.0,0.0
Heuristic evaluation,1.0,0.0,0.0,0.0
eating rate,0.0,0.0,0.0,1.0
Semantic competence,1.0,0.0,0.0,0.0
neuropsychology tests,0.0,0.0,0.0,1.0
Frequency estimation,0.0,0.0,1.0,0.0
localist representation,0.0,0.0,0.0,1.0
Area comparison abilities,0.0,0.0,1.0,0.0
Dynamic fMRI,0.0,0.0,1.0,0.0
Univalent stimuli,0.0,1.0,0.0,0.0
Neurostimulation,1.0,0.0,0.0,0.0
Retinal ganglion cell,1.0,0.0,0.0,0.0
Training length,1.0,0.0,0.0,0.0
Attention network task,1.0,0.0,0.0,0.0
Contagious yawning,0.0,0.0,0.0,1.0
Functional hierarchy,1.0,0.0,0.0,0.0
Hyperphagia,0.0,0.0,0.0,1.0
Old world monkey,0.0,0.0,1.0,0.0
Cortical hierarchies,0.0,1.0,0.0,0.0
Neuroaesthetics,0.0,0.0,1.0,0.0
Premotor association area,0.0,0.0,1.0,0.0
Metaphorical cognition,0.0,1.0,0.0,0.0
emotional face,0.0,1.0,0.0,0.0
Cue detection,1.0,0.0,0.0,0.0
school-age children,0.0,0.0,1.0,0.0
Involuntary memories,0.0,0.0,1.0,0.0
Transcallosal,1.0,0.0,0.0,0.0
brain-derived neurotrophic factor Val66Met,0.0,1.0,0.0,0.0
Intersensory interaction,0.0,1.0,0.0,0.0
Locomotor trajectories,0.0,1.0,0.0,0.0
Size perception,1.0,0.0,0.0,0.0
Allergic rhinitis,0.0,0.0,1.0,0.0
rejection of care,0.0,0.0,1.0,0.0
Intension,0.0,0.0,0.0,1.0
coronary artery bypass crafting,0.0,1.0,0.0,0.0
crossover trial,0.0,1.0,0.0,0.0
Medication packaging,0.0,1.0,0.0,0.0
Trail Making Tests,0.0,1.0,0.0,0.0
Magnetic resonance,0.0,0.0,0.0,1.0
Stop Signal Task,1.0,0.0,0.0,0.0
Overlapping figure,0.0,1.0,0.0,0.0
first-degree relatives,0.0,0.0,1.0,0.0
Kleine-Levin syndrome,0.0,0.0,0.0,1.0
Attention switching,0.0,0.0,1.0,0.0
View space,0.0,1.0,0.0,0.0
Cholinergic deficit,0.0,0.0,1.0,0.0
Visual-field effects,1.0,0.0,0.0,0.0
Odor naming,0.0,0.0,1.0,0.0
Dorsal,1.0,0.0,0.0,0.0
Typical development,0.0,1.0,0.0,0.0
CHRM1-5,0.0,0.0,1.0,0.0
Orang-utan,0.0,0.0,1.0,0.0
Reproductive tract infection,0.0,1.0,0.0,0.0
Renal denervation,0.0,0.0,1.0,0.0
Disorders,0.0,0.0,1.0,0.0
Mood stabilizers,0.0,1.0,0.0,0.0
forensic psychology,0.0,0.0,1.0,0.0
Fragile X tremor and ataxia syndrome,0.0,0.0,1.0,0.0
Relaxation response training,1.0,0.0,0.0,0.0
BPRS,1.0,0.0,0.0,0.0
Motor cogniton,1.0,0.0,0.0,0.0
Ontogenesis,1.0,0.0,0.0,0.0
Ventral visual cortex,1.0,0.0,0.0,0.0
CRMP5,0.0,1.0,0.0,0.0
Face working memory,1.0,0.0,0.0,0.0
Self-identity,0.0,1.0,0.0,0.0
University students,0.0,0.0,1.0,0.0
Temporal-lobe epilepsy,0.0,0.0,1.0,0.0
Stimulus classes,1.0,0.0,0.0,0.0
Non-parametric bayes,0.0,1.0,0.0,0.0
UV photography,1.0,0.0,0.0,0.0
delayed task,1.0,0.0,0.0,0.0
Abstract relation,1.0,0.0,0.0,0.0
Neural dynamics,1.0,0.0,0.0,0.0
Stroop colour word task,0.0,0.0,1.0,0.0
Inpatient,0.0,1.0,0.0,0.0
Imitative processing,1.0,0.0,0.0,0.0
Bottom-up effect,0.0,1.0,0.0,0.0
occipital lobe,1.0,0.0,0.0,0.0
Saccade planning,0.0,1.0,0.0,0.0
Y maze,0.0,1.0,0.0,0.0
CIRC model,0.0,1.0,0.0,0.0
auto nomous mental development,0.0,0.0,1.0,0.0
Social functions,0.0,0.0,0.0,1.0
Calvinism,0.0,0.0,1.0,0.0
sensory-motor gating,0.0,1.0,0.0,0.0
Mesiotemporal lobe epilepsy,0.0,0.0,1.0,0.0
Visual awareness negativity,0.0,0.0,1.0,0.0
co-morbidity,1.0,0.0,0.0,0.0
Peripheral,0.0,1.0,0.0,0.0
Manga,0.0,0.0,1.0,0.0
Domains,0.0,1.0,0.0,0.0
Cognitive function following stroke,1.0,0.0,0.0,0.0
list discrimination,0.0,0.0,0.0,1.0
hMT,0.0,1.0,0.0,0.0
neurotropic viruses,1.0,0.0,0.0,0.0
Bombus terrestris (Linnaeus 1758),0.0,0.0,1.0,0.0
Misdirection,0.0,1.0,0.0,0.0
Quantum brain dynamics,0.0,0.0,0.0,1.0
Antidromic,1.0,0.0,0.0,0.0
Neurooncology practice,1.0,0.0,0.0,0.0
Positive/negative subtype,0.0,1.0,0.0,0.0
Geospatial databases,1.0,0.0,0.0,0.0
Spatial-orientation,1.0,0.0,0.0,0.0
Great tit,0.0,0.0,1.0,0.0
Alexander disease,0.0,0.0,1.0,0.0
Non-human primate perception,0.0,1.0,0.0,0.0
abstract concepts,0.0,0.0,0.0,1.0
Human body shape,0.0,1.0,0.0,0.0
Defensive behaviour,0.0,0.0,1.0,0.0
Late positivity,0.0,1.0,0.0,0.0
Post-stroke depression,0.0,1.0,0.0,0.0
efficacy,0.0,0.0,1.0,0.0
Mohawk,1.0,0.0,0.0,0.0
Visual object priming,1.0,0.0,0.0,0.0
Experience projection,1.0,0.0,0.0,0.0
Gyrus supramarginalis,0.0,1.0,0.0,0.0
Face-name retrieval,1.0,0.0,0.0,0.0
Nicotinic receptor,0.0,0.0,1.0,0.0
nonmotoric symptoms,0.0,0.0,1.0,0.0
Organochlorine pesticide,1.0,0.0,0.0,0.0
arsenic,0.0,0.0,1.0,0.0
height,0.0,0.0,0.0,1.0
Nonepisodic memory cognitive functions,0.0,0.0,1.0,0.0
Stereoacuity,0.0,1.0,0.0,0.0
Children with ASD,1.0,0.0,0.0,0.0
Fellous,0.0,0.0,1.0,0.0
M1-M5,0.0,0.0,1.0,0.0
Flumazenil,1.0,0.0,0.0,0.0
Pavlovian conditioning,0.0,0.0,0.0,1.0
Hospitality,0.0,0.0,1.0,0.0
Excessive daytime sleepiness,1.0,0.0,0.0,0.0
F35 fighter,0.0,0.0,1.0,0.0
Vocal responses,0.0,0.0,0.0,1.0
Musical imagery,0.0,1.0,0.0,0.0
Cognition Disorders,0.0,0.0,1.0,0.0
baboon,0.0,1.0,0.0,0.0
Microrecording,0.0,0.0,1.0,0.0
Memory dissociation,0.0,0.0,0.0,1.0
Function judgment,0.0,0.0,0.0,1.0
Diagnostic accuracy,0.0,0.0,1.0,0.0
Locomotor control,0.0,0.0,1.0,0.0
Motor perception,0.0,0.0,1.0,0.0
Non-psychopathic violent juvenile offenders,0.0,0.0,1.0,0.0
Box removal,0.0,0.0,1.0,0.0
Hospital,0.0,0.0,1.0,0.0
Iodized oil,0.0,1.0,0.0,0.0
Visual cognitive memory,0.0,0.0,0.0,1.0
Completion,1.0,0.0,0.0,0.0
Soundscape,0.0,1.0,0.0,0.0
Facial inversion effect,1.0,0.0,0.0,0.0
numerical estimation,0.0,1.0,0.0,0.0
Overview,0.0,1.0,0.0,0.0
Middle-age adulthood,0.0,0.0,0.0,1.0
Chromosome 22q11.2 deletion syndrome (22q11.2ds),0.0,0.0,1.0,0.0
Voting,0.0,0.0,1.0,0.0
Border of viability,0.0,0.0,1.0,0.0
Conceptual limitations,0.0,0.0,1.0,0.0
Corsi test,1.0,0.0,0.0,0.0
4-DDC,1.0,0.0,0.0,0.0
Convergence,0.0,1.0,0.0,0.0
Dual-task walking,0.0,1.0,0.0,0.0
CACNA1A,0.0,1.0,0.0,0.0
Serum anticholinergic activity,0.0,0.0,0.0,1.0
Clinically relevant pain reduction,0.0,1.0,0.0,0.0
syntax,0.0,1.0,0.0,0.0
Picture encoding,0.0,0.0,0.0,1.0
EEG/EP,0.0,1.0,0.0,0.0
Deafness-dystonia-optic neuronopathy (DDON) syndrome,0.0,0.0,0.0,1.0
Preterm preschoolers,0.0,1.0,0.0,0.0
Optics,0.0,0.0,1.0,0.0
Benton,0.0,0.0,0.0,1.0
Prosaccade errors,0.0,1.0,0.0,0.0
maternal employment and child outcomes,0.0,0.0,1.0,0.0
gaze cueing,0.0,0.0,1.0,0.0
Electronic healthcare,0.0,0.0,1.0,0.0
Number bisection task,0.0,0.0,1.0,0.0
Prodromale cognition,0.0,0.0,1.0,0.0
Prestimulus alpha activity,0.0,0.0,1.0,0.0
Driver attention,0.0,1.0,0.0,0.0
Schizo-OCD,0.0,0.0,0.0,1.0
Movements,0.0,0.0,1.0,0.0
Singleton distractor interference,0.0,0.0,1.0,0.0
action monitoring,0.0,0.0,1.0,0.0
Interactive animated map,0.0,0.0,1.0,0.0
distance,0.0,0.0,0.0,1.0
Skepticism,0.0,1.0,0.0,0.0
Orthographic input coding,0.0,0.0,1.0,0.0
Physiological rhythms,0.0,0.0,0.0,1.0
primary care,1.0,0.0,0.0,0.0
Short-term storage,0.0,1.0,0.0,0.0
Event-based prospective memory,1.0,0.0,0.0,0.0
field learning,0.0,0.0,0.0,1.0
Cognitive variability,0.0,1.0,0.0,0.0
Theta and alpha potentials,0.0,1.0,0.0,0.0
Letter perception,0.0,0.0,1.0,0.0
multi-voxel pattern analysis (MVPA),0.0,1.0,0.0,0.0
Tone sequence,0.0,0.0,0.0,1.0
Corporal experience,0.0,1.0,0.0,0.0
Infantile nutrition,0.0,0.0,1.0,0.0
Orthographic depth,0.0,0.0,1.0,0.0
Automatic stereotyping,1.0,0.0,0.0,0.0
Logical thinking,0.0,1.0,0.0,0.0
Selfmonitoring,1.0,0.0,0.0,0.0
Display rule knowledge,0.0,0.0,1.0,0.0
N-3 fatty acids,0.0,0.0,0.0,1.0
Thought disturbance,0.0,1.0,0.0,0.0
Discovery,1.0,0.0,0.0,0.0
Positive symptom,0.0,0.0,1.0,0.0
Classroom networking,0.0,1.0,0.0,0.0
olfaction,1.0,0.0,0.0,0.0
Multimodal audio-visual information processing,0.0,0.0,0.0,1.0
Cognitive informatics,0.0,0.0,1.0,0.0
Conspicuity,1.0,0.0,0.0,0.0
rosemary,0.0,0.0,1.0,0.0
Blocking paradigm,0.0,0.0,0.0,1.0
Stereo EEG,0.0,1.0,0.0,0.0
School readiness,1.0,0.0,0.0,0.0
Cortico-spinal coherence,0.0,0.0,1.0,0.0
Premotor reaction time,0.0,1.0,0.0,0.0
Teaching and learning activities (TLAs),0.0,0.0,1.0,0.0
atherosclerosis,1.0,0.0,0.0,0.0
Mobile conjugate,0.0,1.0,0.0,0.0
Affective judgements,0.0,0.0,1.0,0.0
Multi-stable perception,0.0,1.0,0.0,0.0
Cd-lifescience,0.0,1.0,0.0,0.0
End-state comfort,1.0,0.0,0.0,0.0
Jumping to conclusions,0.0,0.0,1.0,0.0
Long-Evans rat,0.0,0.0,1.0,0.0
Math anxiety,0.0,1.0,0.0,0.0
attentional tunneling,1.0,0.0,0.0,0.0
Approximate,0.0,0.0,1.0,0.0
structure invariance,0.0,1.0,0.0,0.0
vestibular function,0.0,1.0,0.0,0.0
Electroencephalogram signal classification,0.0,1.0,0.0,0.0
Computer-animated characters,0.0,0.0,0.0,1.0
Fluency effect,1.0,0.0,0.0,0.0
social semiotics,0.0,0.0,1.0,0.0
Line-motion illusion,1.0,0.0,0.0,0.0
Fraction processing,0.0,1.0,0.0,0.0
P.Y.,0.0,0.0,1.0,0.0
Visual ERPs,0.0,1.0,0.0,0.0
3D map symbol,0.0,0.0,0.0,1.0
5-HT6 antagonist,1.0,0.0,0.0,0.0
dronabinol,0.0,0.0,1.0,0.0
Task-set switching,0.0,0.0,0.0,1.0
Lower extremity,0.0,0.0,0.0,1.0
Electronic paper,0.0,0.0,1.0,0.0
Simultaneous prompting,0.0,1.0,0.0,0.0
Subject preference,1.0,0.0,0.0,0.0
"artificial intelligence,0.0,0.0,1.0,0.0
9-Hole box,0.0,0.0,1.0,0.0
Gender variation,1.0,0.0,0.0,0.0
Amphibian cognition,1.0,0.0,0.0,0.0
Sleep fragmentation,1.0,0.0,0.0,0.0
Investigative interviewing,0.0,0.0,1.0,0.0
Learning from pictures,0.0,1.0,0.0,0.0
Type II diabetes mellitus,0.0,0.0,0.0,1.0
Bayesian and biologically inspired models,0.0,0.0,1.0,0.0
Emotional responsivity,0.0,0.0,1.0,0.0
Poverty of speech,0.0,1.0,0.0,0.0
Nurse therapy,1.0,0.0,0.0,0.0
spatial memory bias,0.0,0.0,0.0,1.0
Obese,1.0,0.0,0.0,0.0
Social salience,0.0,0.0,1.0,0.0
observational approach,0.0,1.0,0.0,0.0
microdialysis,0.0,1.0,0.0,0.0
Relations,0.0,0.0,1.0,0.0
Bird orientation,0.0,0.0,0.0,0.0
102,0.0,0.0,1.0,0.0
Rod bisection,0.0,0.0,1.0,0.0
Prognostic factor,1.0,0.0,0.0,0.0
Self-paced reading,0.0,1.0,0.0,0.0
Consequences for psychotherapeutic treatment,0.0,0.0,1.0,0.0
Crossover effect,1.0,0.0,0.0,0.0
orienteering,0.0,1.0,0.0,0.0
Fluctuations in consciousness,1.0,0.0,0.0,0.0
Hierarchical clustering,0.0,1.0,0.0,0.0
ADReS,0.0,1.0,0.0,0.0
preferences,1.0,0.0,0.0,0.0
Lemon balm,0.0,1.0,0.0,0.0
Default mode of brain function,0.0,0.0,1.0,0.0
Bender,0.0,0.0,1.0,0.0
Clinician-Administered Post-traumatic Stress Disorder Scale,0.0,1.0,0.0,0.0
Contextual associations,0.0,0.0,1.0,0.0
Arabic orthography,1.0,0.0,0.0,0.0
Numerical quantity,0.0,1.0,0.0,0.0
tangible user interfaces,0.0,1.0,0.0,0.0
gamma1 and gamma2 frequencies,1.0,0.0,0.0,0.0
Frequency doubling technology (FDT),0.0,0.0,1.0,0.0
Late parietal positivity (LPP),0.0,0.0,1.0,0.0
voxel-based specific regional analysis for Alzheimer's disease,0.0,0.0,1.0,0.0
Cultural/ethnic diversity,0.0,0.0,0.0,1.0
subcortical ischemic vascular disease,0.0,0.0,1.0,0.0
temporal context-based prediction,0.0,1.0,0.0,0.0
Point-light animations,0.0,0.0,1.0,0.0
English language learner (ELL),0.0,1.0,0.0,0.0
Risk for AD,0.0,0.0,1.0,0.0
Statistical models,0.0,1.0,0.0,0.0
Temporal organization,0.0,0.0,1.0,0.0
Oestrous cycle,0.0,0.0,0.0,1.0
Arbitrary cues,1.0,0.0,0.0,0.0
Psychomotor slowing,0.0,0.0,1.0,0.0
Social housing,0.0,0.0,0.0,1.0
Local stability,0.0,0.0,1.0,0.0
dynamic rank scale,0.0,0.0,1.0,0.0
Cerebral plasticity,0.0,1.0,0.0,0.0
Case-based learning,1.0,0.0,0.0,0.0
game.Game,1.0,0.0,0.0,0.0
Psychological tests,0.0,0.0,1.0,0.0
Primary care,0.0,1.0,0.0,0.0
Keywords: Chronic pain,0.0,1.0,0.0,0.0
Face Recognition,0.0,0.0,1.0,0.0
Taste coding,0.0,1.0,0.0,0.0
Spike count correlation,0.0,0.0,1.0,0.0
H1-receptor antagonist,0.0,1.0,0.0,0.0
MSI,0.0,0.0,1.0,0.0
Empty sets,0.0,1.0,0.0,0.0
The battery of computer testsCNS-VS,0.0,0.0,1.0,0.0
X-linked mental retardation,0.0,0.0,1.0,0.0
Stimulus equivalence,0.0,0.0,0.0,1.0
Preventive strategies,1.0,0.0,0.0,0.0
Cortical attention systems,0.0,0.0,1.0,0.0
group hunting,0.0,0.0,1.0,0.0
Rasagiline,0.0,0.0,1.0,0.0
Disease duration,0.0,0.0,1.0,0.0
Post lumbar-puncture headache,1.0,0.0,0.0,0.0
goals,0.0,0.0,1.0,0.0
Visual-motor learning,0.0,1.0,0.0,0.0
Clozapine,1.0,0.0,0.0,0.0
Cortiospinal tract,1.0,0.0,0.0,0.0
Familial dyslexia risk,0.0,0.0,1.0,0.0
Autoregressive time series analysis,0.0,1.0,0.0,0.0
Approach,0.0,1.0,0.0,0.0
GBSS,0.0,0.0,1.0,0.0
PMd,0.0,0.0,1.0,0.0
Functional homogeneity,1.0,0.0,0.0,0.0
Own-anchor effect,0.0,0.0,1.0,0.0
Gender dimorphism,0.0,1.0,0.0,0.0
Divergent thinking,0.0,1.0,0.0,0.0
duloxetine,0.0,0.0,1.0,0.0
Spatial properties,0.0,0.0,0.0,1.0
Evolution of speech,1.0,0.0,0.0,0.0
Contest behaviour,0.0,1.0,0.0,0.0
computer game,0.0,0.0,1.0,0.0
individualism,0.0,1.0,0.0,0.0
Error distribution,0.0,0.0,1.0,0.0
Auditory cuing,1.0,0.0,0.0,0.0
BDI,0.0,0.0,1.0,0.0
Visual half-field presentation,0.0,1.0,0.0,0.0
Illusion of control,0.0,0.0,1.0,0.0
Prepulse,0.0,0.0,0.0,1.0
Spatial location,0.0,0.0,1.0,0.0
Action capabilities,0.0,1.0,0.0,0.0
Running wheel,0.0,0.0,1.0,0.0
Disinhibited inhibitory surround,0.0,1.0,0.0,0.0
cognitive model of psychosis,0.0,0.0,1.0,0.0
Systemic lupus erythematosus (SLE),1.0,0.0,0.0,0.0
Soccer heading,1.0,0.0,0.0,0.0
Couple Therapy,1.0,0.0,0.0,0.0
immediate serial recall,0.0,1.0,0.0,0.0
Randomized,0.0,0.0,0.0,0.0
Goal-derived categories,1.0,0.0,0.0,0.0
Coherence analysis,0.0,1.0,0.0,0.0
Letter fluency test,1.0,0.0,0.0,0.0
?-amino-butyric acid,0.0,0.0,1.0,0.0
Eslicarbazepine acetate,0.0,0.0,1.0,0.0
congenital blindness,0.0,1.0,0.0,0.0
Computer based instruction,0.0,0.0,1.0,0.0
Activation differences,0.0,0.0,1.0,0.0
Visual impaired navigation assistant,1.0,0.0,0.0,0.0
Pure-tone audiogram,0.0,0.0,0.0,1.0
Structure-galaxies,0.0,1.0,0.0,0.0
Novice,0.0,1.0,0.0,0.0
5-HT,0.0,0.0,1.0,0.0
Antisaccade task,0.0,0.0,1.0,0.0
Accumulative computation,0.0,1.0,0.0,0.0
Configural learning,0.0,0.0,0.0,1.0
Prototype distortion task,1.0,0.0,0.0,0.0
Extrinsic Affective Simon Task,0.0,0.0,0.0,1.0
artificial neural networks,0.0,1.0,0.0,0.0
Hierarchical generative models,0.0,0.0,1.0,0.0
action-observation,0.0,0.0,0.0,1.0
Neuromotor abilities,0.0,0.0,0.0,1.0
Hedonic value,1.0,0.0,0.0,0.0
Zaborszky,0.0,1.0,0.0,0.0
Knowledge asymmetries,0.0,0.0,1.0,0.0
Watermaze,0.0,0.0,1.0,0.0
risk factor,1.0,0.0,0.0,0.0
Automated ICA component identification,1.0,0.0,0.0,0.0
forensic interviews,0.0,1.0,0.0,0.0
Reading fluency task,0.0,0.0,1.0,0.0
capture,0.0,1.0,0.0,0.0
Cognition in the blind,1.0,0.0,0.0,0.0
Movement error,0.0,0.0,0.0,1.0
Cleft,0.0,0.0,1.0,0.0
Sexual Function,1.0,0.0,0.0,0.0
Klver-Bucy syndrome,0.0,1.0,0.0,0.0
motor coordination,1.0,0.0,0.0,0.0
SOCCER,0.0,0.0,0.0,1.0
Patient care planning,0.0,0.0,1.0,0.0
Young onset,0.0,0.0,0.0,1.0
EPESE,1.0,0.0,0.0,0.0
ERK/CaMKII/CREB signaling,0.0,1.0,0.0,0.0
Ultrasonic vocalizations,0.0,0.0,1.0,0.0
Intellectual stimulation,0.0,0.0,1.0,0.0
Low,0.0,1.0,0.0,0.0
Cognition of color image,1.0,0.0,0.0,0.0
Parietal eye field,0.0,0.0,1.0,0.0
Macular disease,0.0,0.0,1.0,0.0
EEG biofeedback,0.0,0.0,1.0,0.0
Smokers,1.0,0.0,0.0,0.0
Temporal entrainment,1.0,0.0,0.0,0.0
Low prevalence effect,0.0,0.0,1.0,0.0
set formation and test stages,0.0,0.0,1.0,0.0
Pilocarpine,0.0,1.0,0.0,0.0
First language,1.0,0.0,0.0,0.0
Social neural network (SNN),0.0,0.0,1.0,0.0
humans,0.0,1.0,0.0,0.0
d-Amphetamine,0.0,0.0,0.0,1.0
intraventricular hemorrhage,0.0,0.0,1.0,0.0
Bottom-up process,1.0,0.0,0.0,0.0
Intraclass correlation,0.0,1.0,0.0,0.0
Post-operative outcome assessment,0.0,0.0,1.0,0.0
Imagined movements,1.0,0.0,0.0,0.0
Body expressions,0.0,0.0,0.0,1.0
Homonymous hemianopia,0.0,0.0,1.0,0.0
Multivitamin/mineral,0.0,0.0,1.0,0.0
laboratory test,1.0,0.0,0.0,0.0
Auditory input,0.0,1.0,0.0,0.0
Substance P,1.0,0.0,0.0,0.0
Voxel-based morphometry (VBM),0.0,1.0,0.0,0.0
social network,0.0,0.0,1.0,0.0
Visual Communication,0.0,1.0,0.0,0.0
stereotyped attitudes,0.0,0.0,1.0,0.0
Substance p,0.0,1.0,0.0,0.0
attention mechanisms,1.0,0.0,0.0,0.0
Physical illness,0.0,1.0,0.0,0.0
LISN (listening in spatialized noise),0.0,1.0,0.0,0.0
Bilinguals,0.0,0.0,1.0,0.0
Age effect,0.0,0.0,1.0,0.0
Proton beam radiation,1.0,0.0,0.0,0.0
Developmental Eye Movement (DEM) test,0.0,0.0,1.0,0.0
Mechanical problem solving,0.0,0.0,1.0,0.0
Cognitive phenotypes,0.0,1.0,0.0,0.0
Leiter,0.0,0.0,1.0,0.0
prospective follow-up,0.0,1.0,0.0,0.0
mere exposure effect,0.0,1.0,0.0,0.0
entheaty,0.0,0.0,1.0,0.0
Collective behaviour,0.0,0.0,1.0,0.0
Basic level categorization,0.0,0.0,1.0,0.0
natural scenes,0.0,1.0,0.0,0.0
Reward systems,0.0,1.0,0.0,0.0
Auditory rhythm,1.0,0.0,0.0,0.0
Gestalt Laws,0.0,1.0,0.0,0.0
Overestimation of threat,0.0,1.0,0.0,0.0
Executive fuction,0.0,0.0,1.0,0.0
Binary cues,0.0,0.0,1.0,0.0
periventricular lesions,0.0,0.0,1.0,0.0
"Congenital infection,0.0,0.0,0.0,0.0
Bottom-up attention,1.0,0.0,0.0,0.0
Frontopolar cortex,0.0,0.0,1.0,0.0
Gender discrimination,0.0,0.0,1.0,0.0
Disinhibition,0.0,0.0,1.0,0.0
Spatial accuracy,0.0,0.0,0.0,1.0
Right brain,0.0,1.0,0.0,0.0
Computerized assessment,1.0,0.0,0.0,0.0
cognition disorder,1.0,0.0,0.0,0.0
Temporal order judgments,0.0,1.0,0.0,0.0
Mishkin,0.0,1.0,0.0,0.0
Goldman Fristoe Test of Articulation 2,0.0,1.0,0.0,0.0
Typically developing children,0.0,0.0,1.0,0.0
Psychosocial well-being,0.0,1.0,0.0,0.0
Objective coercion,0.0,0.0,1.0,0.0
Kappa agonist,0.0,0.0,1.0,0.0
egomotion,0.0,0.0,1.0,0.0
Stimulus context,0.0,1.0,0.0,0.0
training experience,0.0,0.0,1.0,0.0
Chinese words,0.0,0.0,1.0,0.0
visual representation understanding,1.0,0.0,0.0,0.0
Associative concepts,0.0,1.0,0.0,0.0
Local attention,0.0,1.0,0.0,0.0
Decision inefficiency,1.0,0.0,0.0,0.0
Social Participation,0.0,1.0,0.0,0.0
NMDA-R,0.0,0.0,0.0,1.0
Computer supported collaborative learning,0.0,0.0,1.0,0.0
Extra-striate cortex,0.0,1.0,0.0,0.0
Gene polymorphism,0.0,0.0,0.0,1.0
Longitudinal cognitive course,0.0,0.0,0.0,1.0
Museums,1.0,0.0,0.0,0.0
Task dependency,0.0,0.0,1.0,0.0
NRTI,0.0,1.0,0.0,0.0
implicit associations,0.0,1.0,0.0,0.0
Landscape aesthetics,0.0,1.0,0.0,0.0
Vestibular cognition,0.0,0.0,0.0,1.0
Refractory epilepsy,0.0,0.0,1.0,0.0
All cognitive disorders/dementia,0.0,1.0,0.0,0.0
Indicative mood,0.0,1.0,0.0,0.0
Affective regulation,0.0,1.0,0.0,0.0
Digital aging,0.0,0.0,1.0,0.0
Sufentanil,1.0,0.0,0.0,0.0
Pediatric stroke,0.0,1.0,0.0,0.0
Weight control,0.0,1.0,0.0,0.0
Non-verbal learning disability,0.0,1.0,0.0,0.0
Reciprocal altruism,1.0,0.0,0.0,0.0
Iowa Gambling Task,1.0,0.0,0.0,0.0
Multi-alternatives forced choice task,0.0,0.0,0.0,1.0
Metric learning,1.0,0.0,0.0,0.0
Newborn cognition,0.0,1.0,0.0,0.0
Effective preparation,0.0,1.0,0.0,0.0
Object search,0.0,0.0,1.0,0.0
Differential susceptibility,1.0,0.0,0.0,0.0
Microsurgical,1.0,0.0,0.0,0.0
7.5% CO2,1.0,0.0,0.0,0.0
pituitary function,0.0,0.0,1.0,0.0
Unified modeling language,0.0,1.0,0.0,0.0
Size congruity,0.0,0.0,1.0,0.0
Srensen,0.0,1.0,0.0,0.0
Opioid dependence,0.0,1.0,0.0,0.0
Film perception,0.0,0.0,1.0,0.0
Supervisor system,0.0,1.0,0.0,0.0
Catastrophe theory,0.0,0.0,1.0,0.0
domestic chicks,0.0,0.0,1.0,0.0
Delusions of influence,0.0,0.0,1.0,0.0
Tetrahydrobiopterin,0.0,0.0,1.0,0.0
video quality,0.0,0.0,1.0,0.0
arrangement,1.0,0.0,0.0,0.0
Backward walking,0.0,1.0,0.0,0.0
Matching degree,0.0,0.0,0.0,1.0
Category training,0.0,0.0,0.0,1.0
Rasch-scaling of the BVRT,0.0,1.0,0.0,0.0
Athletic injuries,0.0,1.0,0.0,0.0
Phospholipid,0.0,0.0,1.0,0.0
Syntactic agreement violations,0.0,0.0,0.0,1.0
Transcranial treatment,0.0,1.0,0.0,0.0
Liminal perception,0.0,1.0,0.0,0.0
Mller-Lyer Illusion,1.0,0.0,0.0,0.0
Inferior temporal lobe,0.0,1.0,0.0,0.0
Visual N1,0.0,0.0,1.0,0.0
Blocked/mixed,1.0,0.0,0.0,0.0
microvascular changes,1.0,0.0,0.0,0.0
global-local precedence,0.0,1.0,0.0,0.0
Reflection,1.0,0.0,0.0,0.0
infant categorization,0.0,0.0,0.0,1.0
Field perspective,0.0,0.0,1.0,0.0
Neuropsychiatric diseases,0.0,1.0,0.0,0.0
artiflex,0.0,0.0,0.0,1.0
Breathing,1.0,0.0,0.0,0.0
Androgen,0.0,1.0,0.0,0.0
Sexual Satisfaction,1.0,0.0,0.0,0.0
French,0.0,1.0,0.0,0.0
Receptive field logic,1.0,0.0,0.0,0.0
Neural connectivity,0.0,0.0,1.0,0.0
Reciprocal social behavior,0.0,0.0,1.0,0.0
Visual Impairment,0.0,1.0,0.0,0.0
Depressed mood,0.0,0.0,1.0,0.0
White matter lesion,0.0,0.0,0.0,1.0
cross-modal,1.0,0.0,0.0,0.0
ANEW database,1.0,0.0,0.0,0.0
pediatrics,0.0,0.0,0.0,1.0
Social difficulties,0.0,0.0,1.0,0.0
generalized magnitude system,0.0,0.0,0.0,1.0
Parity-judgment task,0.0,0.0,1.0,0.0
alprazolam,0.0,1.0,0.0,0.0
Great vessels,0.0,0.0,1.0,0.0
sensory conspicuity,0.0,1.0,0.0,0.0
CSWS,0.0,0.0,1.0,0.0
High-spatial resolution MRI,0.0,0.0,0.0,1.0
contingent capture,0.0,0.0,1.0,0.0
Referents,0.0,1.0,0.0,0.0
Simultaneous EEG-FMRI,0.0,1.0,0.0,0.0
Partner,1.0,0.0,0.0,0.0
Brucellosis,0.0,0.0,0.0,1.0
"Comparative study,0.0,0.0,0.0,0.0
Anterior and posterior hippocampus,1.0,0.0,0.0,0.0
Multisensory emotion processing,0.0,0.0,1.0,0.0
Palestinian refugees,0.0,0.0,1.0,0.0
Cognition function,1.0,0.0,0.0,0.0
Infestation,0.0,1.0,0.0,0.0
eLORETA,0.0,0.0,1.0,0.0
Trauma-related cues,0.0,1.0,0.0,0.0
Clock checking,0.0,0.0,1.0,0.0
Motor skill memory,0.0,1.0,0.0,0.0
Self-ordered spatial search,0.0,1.0,0.0,0.0
Childhood amnesia,1.0,0.0,0.0,0.0
False beliefs,0.0,1.0,0.0,0.0
Visuo-spatial coding,0.0,1.0,0.0,0.0
Cambridge Neuropsychological Test Automated Battery (CANTAB),0.0,1.0,0.0,0.0
Presynaptic marker,1.0,0.0,0.0,0.0
Dementive diseases,0.0,0.0,0.0,1.0
Anesthesia recovery period,0.0,1.0,0.0,0.0
Neurometrics,0.0,0.0,1.0,0.0
Posterior superior temporal sulcus and temporoparietal junction,0.0,1.0,0.0,0.0
wellbeing,0.0,1.0,0.0,0.0
Posthypnotic suggestion,0.0,1.0,0.0,0.0
cuttlefish,0.0,0.0,1.0,0.0
Acquired savant syndrome,0.0,1.0,0.0,0.0
Tickertape,1.0,0.0,0.0,0.0
postconcussion symptoms,0.0,0.0,1.0,0.0
Intention memory,1.0,0.0,0.0,0.0
Motor speech,0.0,0.0,1.0,0.0
Concussion testing,0.0,0.0,1.0,0.0
Abacus,0.0,0.0,1.0,0.0
Non-reinforcement,1.0,0.0,0.0,0.0
Oldest-old age,0.0,0.0,1.0,0.0
Pathway-in-the-sky,0.0,0.0,1.0,0.0
Endonasal,0.0,1.0,0.0,0.0
SogICA,0.0,0.0,0.0,1.0
Coactivation model,0.0,0.0,1.0,0.0
metabotropic glutamate receptor,1.0,0.0,0.0,0.0
Essential fatty acids,0.0,1.0,0.0,0.0
"Alzheimer disease,0.0,0.0,0.0,0.0
Agrammatic,0.0,1.0,0.0,0.0
Ecological momentary assessment,0.0,0.0,0.0,1.0
Resting-state magnetic resonance imaging,0.0,1.0,0.0,0.0
Strategic goals,1.0,0.0,0.0,0.0
Abacus training,0.0,1.0,0.0,0.0
Psychosis proneness,0.0,0.0,1.0,0.0
Conceptual organization,0.0,0.0,1.0,0.0
Go-No-go task,0.0,1.0,0.0,0.0
Spontaneous switching,0.0,1.0,0.0,0.0
Perception of intentions and actions,1.0,0.0,0.0,0.0
Schizophrenia spectrum disorder,1.0,0.0,0.0,0.0
Alpha-band activity,0.0,1.0,0.0,0.0
post-weaning social isolation,0.0,0.0,0.0,1.0
Phosphodiesterase inhibitors,0.0,1.0,0.0,0.0
Labeling strategies,0.0,0.0,1.0,0.0
E-C mapping model,0.0,0.0,1.0,0.0
semantic processing,0.0,1.0,0.0,0.0
knowledge-based solution strategies,0.0,0.0,1.0,0.0
hands-on interaction,0.0,1.0,0.0,0.0
Flight simulator,0.0,0.0,1.0,0.0
Paracontrast,0.0,0.0,1.0,0.0
medical comorbidity,0.0,1.0,0.0,0.0
animal learning,1.0,0.0,0.0,0.0
Visuo-motor,0.0,1.0,0.0,0.0
Cue stimuli,0.0,1.0,0.0,0.0
Vergence,0.0,0.0,1.0,0.0
"Behavioral flexibility,0.0,0.0,0.0,0.0
Integrated health,0.0,0.0,1.0,0.0
Activation-likelihood estimation,0.0,1.0,0.0,0.0
Perception of bodily functions,0.0,0.0,0.0,1.0
Chronic back pain,0.0,1.0,0.0,0.0
Communication development,1.0,0.0,0.0,0.0
qualitative,0.0,0.0,1.0,0.0
cerebellar cognitive affective syndrome,0.0,1.0,0.0,0.0
Self-care function,1.0,0.0,0.0,0.0
Rodent,0.0,0.0,1.0,0.0
Task classification,1.0,0.0,0.0,0.0
Cryoglobulinemia,0.0,0.0,1.0,0.0
Selective habituation,1.0,0.0,0.0,0.0
Patient education,0.0,0.0,1.0,0.0
Functional vs. perceptual judgment,0.0,1.0,0.0,0.0
Theatrical semiosphere,1.0,0.0,0.0,0.0
Genetic code,1.0,0.0,0.0,0.0
Neuroanaesthesia,1.0,0.0,0.0,0.0
Motor rehabilitation training,0.0,0.0,1.0,0.0
Child pedestrian education,0.0,1.0,0.0,0.0
tolerability,1.0,0.0,0.0,0.0
ApoE4,0.0,0.0,1.0,0.0
Operative,1.0,0.0,0.0,0.0
Bladder obsession,0.0,1.0,0.0,0.0
Anatomical MRI,1.0,0.0,0.0,0.0
Vitamin D receptor,0.0,1.0,0.0,0.0
Information search,0.0,0.0,1.0,0.0
Bilateral hemorrhages,0.0,0.0,1.0,0.0
social novelty discrimination procedure,0.0,0.0,1.0,0.0
Androsterone,0.0,0.0,1.0,0.0
ovulatory (menstrual) cycle,0.0,1.0,0.0,0.0
Retinal imaging,0.0,0.0,1.0,0.0
Neuroleptic drugs,0.0,1.0,0.0,0.0
Cataract surgery,1.0,0.0,0.0,0.0
Nosology,1.0,0.0,0.0,0.0
ROCF,1.0,0.0,0.0,0.0
Seizure localization,0.0,0.0,1.0,0.0
Centres and parametres of embodiment,0.0,1.0,0.0,0.0
Conduct problems,0.0,1.0,0.0,0.0
indoor pollution,0.0,1.0,0.0,0.0
Nonmotor fluctuations,1.0,0.0,0.0,0.0
cross-modal priming,1.0,0.0,0.0,0.0
Brain functional connectivity,1.0,0.0,0.0,0.0
paediatric multiple sclerosis,0.0,0.0,1.0,0.0
Elemental mercury,1.0,0.0,0.0,0.0
Visual recognition and learning,0.0,0.0,1.0,0.0
Papio ursinus,0.0,0.0,1.0,0.0
Error-/Correct-related negativities,0.0,0.0,1.0,0.0
visual reasoning,0.0,1.0,0.0,0.0
Childhood absence epilepsy,0.0,0.0,1.0,0.0
Major surgery,0.0,0.0,1.0,0.0
Idling,0.0,0.0,1.0,0.0
Cross-modal extinction,0.0,0.0,0.0,1.0
10 pictures reminding test,0.0,1.0,0.0,0.0
Fine-motor fluency,0.0,0.0,1.0,0.0
Evolving spiking neural networks,0.0,0.0,0.0,1.0
Alpha phase locking,0.0,1.0,0.0,0.0
Social stimuli,0.0,0.0,1.0,0.0
Blue Mountains Eye Study,0.0,1.0,0.0,0.0
Anastrozole,0.0,1.0,0.0,0.0
Behavioral pricing,0.0,0.0,1.0,0.0
Callosum transfer time.,1.0,0.0,0.0,0.0
Pedagogical issues,0.0,1.0,0.0,0.0
Herpes Simplex,1.0,0.0,0.0,0.0
Error management,0.0,0.0,1.0,0.0
Negative bias,0.0,0.0,1.0,0.0
Visual perception cognitive processes,1.0,0.0,0.0,0.0
neurocognitive testing,0.0,0.0,1.0,0.0
Musculoskeletal relaxant,0.0,0.0,1.0,0.0
Go/no-go test,0.0,0.0,0.0,1.0
Hypothesis generation skills,1.0,0.0,0.0,0.0
Cross modal perception,0.0,1.0,0.0,0.0
Deep sleep,0.0,0.0,1.0,0.0
Novel noun generalization,0.0,0.0,1.0,0.0
Visual functions,0.0,0.0,1.0,0.0
Hearing aid use,0.0,1.0,0.0,0.0
Dorsal lateral prefrontal cortex,0.0,1.0,0.0,0.0
Alzheimers,1.0,0.0,0.0,0.0
schizophrenic,0.0,1.0,0.0,0.0
Sensory conspicuity,0.0,0.0,1.0,0.0
Visual dorsal stream,0.0,1.0,0.0,0.0
Retrieval support,0.0,1.0,0.0,0.0
Time reproduction,1.0,0.0,0.0,0.0
Late-onset sepsis,0.0,0.0,1.0,0.0
Memory malingering,0.0,1.0,0.0,0.0
Preoperative assessment,1.0,0.0,0.0,0.0
DASS,0.0,0.0,1.0,0.0
Conditioned responses,0.0,0.0,1.0,0.0
Dopamine receptor agonists,1.0,0.0,0.0,0.0
Itemspecific-processing,0.0,0.0,0.0,1.0
Statistical modeling,0.0,0.0,1.0,0.0
Sclerotherapy,0.0,1.0,0.0,0.0
Cognitive dysfunction in SLE,0.0,1.0,0.0,0.0
classifiers,1.0,0.0,0.0,0.0
Atypical depression,0.0,0.0,1.0,0.0
baseline testing,0.0,0.0,1.0,0.0
Self-expansion model,0.0,0.0,0.0,1.0
Enhanced cued recall,0.0,1.0,0.0,0.0
Degenerative brain disease,0.0,0.0,0.0,1.0
Moving objects detection,0.0,0.0,1.0,0.0
Evoked coherence,1.0,0.0,0.0,0.0
Health anxiety,0.0,0.0,1.0,0.0
Chickadee,0.0,1.0,0.0,0.0
flicker,1.0,0.0,0.0,0.0
Categorical,0.0,0.0,1.0,0.0
speed/time constancy,0.0,1.0,0.0,0.0
Sodium-calcium exchanger,0.0,0.0,1.0,0.0
Delivery room,0.0,0.0,0.0,1.0
Reading Disabilities,1.0,0.0,0.0,0.0
Dieting,0.0,1.0,0.0,0.0
Odor pleasantness,0.0,0.0,0.0,1.0
Phonological comparisons,1.0,0.0,0.0,0.0
Mentally disabled persons,0.0,0.0,0.0,1.0
Stroop color-word test,1.0,0.0,0.0,0.0
L-theanine,0.0,0.0,1.0,0.0
Medical decision-making,1.0,0.0,0.0,0.0
Functional connectomics,0.0,1.0,0.0,0.0
Demographics,0.0,1.0,0.0,0.0
Trail Making (TMT),1.0,0.0,0.0,0.0
Cognitive rigidity,1.0,0.0,0.0,0.0
Autonomic failure,0.0,0.0,1.0,0.0
Context and language,0.0,0.0,1.0,0.0
EC-IC bypass,0.0,0.0,1.0,0.0
Scoring system,0.0,1.0,0.0,0.0
Glycine transporter,0.0,1.0,0.0,0.0
homophones,0.0,0.0,1.0,0.0
Birmingham University Cognitive Screen,0.0,0.0,0.0,1.0
Neurological disorders,0.0,1.0,0.0,0.0
"*Cognition,0.0,0.0,0.0,0.0
Tongue,0.0,1.0,0.0,0.0
n-back working-memory task,1.0,0.0,0.0,0.0
older driver,1.0,0.0,0.0,0.0
Time waves,1.0,0.0,0.0,0.0
Low-grade glioma,0.0,0.0,0.0,1.0
Dietary intake,1.0,0.0,0.0,0.0
Perceptual foundations,0.0,0.0,1.0,0.0
Inferior pariental lobule,0.0,1.0,0.0,0.0
Psychomotor skills,0.0,1.0,0.0,0.0
cerebral ischaemia,0.0,1.0,0.0,0.0
Tip-of-the-tongue,0.0,0.0,1.0,0.0
word learning,0.0,0.0,1.0,0.0
Stroboscopic training,0.0,0.0,1.0,0.0
AP-5,0.0,1.0,0.0,0.0
Attention and perception,1.0,0.0,0.0,0.0
IDED,1.0,0.0,0.0,0.0
3-D object relocation,0.0,0.0,1.0,0.0
Short-term effects,0.0,0.0,1.0,0.0
Maze task,0.0,0.0,1.0,0.0
memory search,0.0,0.0,1.0,0.0
Color category,0.0,0.0,0.0,1.0
Material-specific memory,0.0,0.0,1.0,0.0
Modal,0.0,0.0,1.0,0.0
Foetal nutrition,0.0,0.0,1.0,0.0
Conscious,0.0,0.0,1.0,0.0
Predator-prey coevolution,0.0,1.0,0.0,0.0
volume rendering,0.0,1.0,0.0,0.0
Preclinical AD,0.0,1.0,0.0,0.0
Haptic repetition priming,1.0,0.0,0.0,0.0
Post-concussion syndrome,1.0,0.0,0.0,0.0
Anterior callosal section,0.0,0.0,1.0,0.0
Linguistic Context,0.0,0.0,1.0,0.0
Recruitment,0.0,0.0,1.0,0.0
Strategic planning,0.0,0.0,1.0,0.0
Naming banknotes,0.0,0.0,0.0,1.0
Contrast response function,0.0,0.0,1.0,0.0
Time-pitch interdependence,0.0,0.0,1.0,0.0
Image type,0.0,1.0,0.0,0.0
trustworthiness,0.0,0.0,1.0,0.0
Error rate,0.0,1.0,0.0,0.0
Delaunay triangulation,0.0,1.0,0.0,0.0
single-color,0.0,0.0,1.0,0.0
Verbal and spatial interference,0.0,0.0,0.0,1.0
"""Word blindness"",0.0,1.0,0.0,0.0
diagnosis and treatment of acute stroke (ischemia),0.0,0.0,1.0,0.0
Scalar expectancy theory,0.0,1.0,0.0,0.0
Object-processing,1.0,0.0,0.0,0.0
Sensorimotor dynamics,0.0,1.0,0.0,0.0
hierarchy,0.0,0.0,1.0,0.0
Shape space,0.0,1.0,0.0,0.0
landmarks,0.0,0.0,1.0,0.0
Adolescent risk factors,0.0,0.0,0.0,1.0
Approach behavior,0.0,0.0,0.0,1.0
Global/local information interference,1.0,0.0,0.0,0.0
Premenstrual symptoms,0.0,1.0,0.0,0.0
centrotemporal spikes,0.0,1.0,0.0,0.0
Visual EEG,0.0,0.0,1.0,0.0
Cognitive capacity,1.0,0.0,0.0,0.0
action-simulation,0.0,0.0,0.0,1.0
Error positivity,0.0,0.0,1.0,0.0
Conditioned suppression,0.0,0.0,1.0,0.0
Pragmatic comprehension,0.0,0.0,1.0,0.0
Motivation-related biases,0.0,1.0,0.0,0.0
Stimulus pairing training,0.0,1.0,0.0,0.0
living/artifact categories,0.0,0.0,1.0,0.0
CAS,0.0,1.0,0.0,0.0
Generalist gene,0.0,0.0,1.0,0.0
ions,0.0,1.0,0.0,0.0
Material sensation,0.0,0.0,1.0,0.0
Spatial Frames of Reference,0.0,0.0,1.0,0.0
Muscarinic antagonists,0.0,1.0,0.0,0.0
Simulator training,1.0,0.0,0.0,0.0
Wechsler Memory Scale,1.0,0.0,0.0,0.0
Intergroup categorization,0.0,0.0,1.0,0.0
Psychosocial risk,0.0,0.0,1.0,0.0
Domain-general cognitive abilities,0.0,0.0,1.0,0.0
Life span,0.0,1.0,0.0,0.0
Neural Computation,0.0,0.0,1.0,0.0
Own-age bias,0.0,0.0,1.0,0.0
Low-grade pontine glioma,0.0,0.0,1.0,0.0
Voluntary eye movement,0.0,0.0,1.0,0.0
Memorization,0.0,1.0,0.0,0.0
vasopressin,0.0,0.0,1.0,0.0
Parahippocampal cortex (PHC),0.0,1.0,0.0,0.0
Learning preferences,0.0,1.0,0.0,0.0
cognitive changes,1.0,0.0,0.0,0.0
Low-level lead exposure,0.0,0.0,1.0,0.0
Children with high functioning autism,0.0,1.0,0.0,0.0
Dorsal/ventral visual streams,0.0,0.0,0.0,1.0
Sniffing,0.0,0.0,1.0,0.0
Demand characteristics,0.0,0.0,0.0,1.0
Autobiographical memories,0.0,1.0,0.0,0.0
Body language,0.0,0.0,1.0,0.0
Enhanced pre- and post-natal study,0.0,0.0,1.0,0.0
Unobservable causality,0.0,0.0,1.0,0.0
Subjunctive mood,0.0,1.0,0.0,0.0
Multi-modal integration,0.0,0.0,0.0,1.0
Landmark navigation,0.0,0.0,1.0,0.0
facial features,1.0,0.0,0.0,0.0
Community dwelling,1.0,0.0,0.0,0.0
Object intrinsic properties,1.0,0.0,0.0,0.0
Dermatology,0.0,0.0,1.0,0.0
Parafoveal processing,0.0,0.0,1.0,0.0
BA 45,0.0,0.0,1.0,0.0
physical variables,0.0,0.0,1.0,0.0
Tortoises,0.0,0.0,1.0,0.0
Consumer behaviour,0.0,0.0,1.0,0.0
Refresh,0.0,0.0,1.0,0.0
NART-R,0.0,0.0,1.0,0.0
Verbal fluency deficit,0.0,0.0,1.0,0.0
HIRREM,0.0,0.0,1.0,0.0
attribution,0.0,0.0,0.0,1.0
Hemibody,0.0,1.0,0.0,0.0
Cognitive Performance,0.0,0.0,0.0,1.0
Frontal systems,0.0,1.0,0.0,0.0
Object-category,0.0,1.0,0.0,0.0
Story recall,1.0,0.0,0.0,0.0
task goals,0.0,1.0,0.0,0.0
Right hemispherical functions,1.0,0.0,0.0,0.0
VSSR,0.0,0.0,1.0,0.0
Empathy for pain,1.0,0.0,0.0,0.0
Minority elderly adults,0.0,0.0,1.0,0.0
Worrying,1.0,0.0,0.0,0.0
Relative time,0.0,0.0,1.0,0.0
Feed-forward model,0.0,0.0,1.0,0.0
Association cortices,1.0,0.0,0.0,0.0
Environmental factors,0.0,0.0,1.0,0.0
Intonation,0.0,0.0,1.0,0.0
Reach,0.0,0.0,1.0,0.0
Sensorimotor disorders,0.0,1.0,0.0,0.0
California verbal learning test,1.0,0.0,0.0,0.0
Sinsign,0.0,0.0,1.0,0.0
reliability,0.0,1.0,0.0,0.0
Ibotenic acid,0.0,1.0,0.0,0.0
Treatment guidelines,0.0,0.0,1.0,0.0
Omega 3 (?3),0.0,0.0,1.0,0.0
sadness,1.0,0.0,0.0,0.0
Sensory-perceptual deficits,0.0,0.0,1.0,0.0
Nigerians,0.0,1.0,0.0,0.0
Mania and bipolar disorder,1.0,0.0,0.0,0.0
Problem-based learning,0.0,1.0,0.0,0.0
Coping behavior,0.0,0.0,1.0,0.0
Low-resolution electromagnetic tomography (LORETA),0.0,0.0,1.0,0.0
Categorical thinking,0.0,0.0,1.0,0.0
Event-related magnetic fields,0.0,0.0,1.0,0.0
Framing,0.0,1.0,0.0,0.0
distance perception,1.0,0.0,0.0,0.0
Combination,0.0,0.0,1.0,0.0
Pair recognition,0.0,1.0,0.0,0.0
Mental status,0.0,1.0,0.0,0.0
Anticipatory muscle tensing,0.0,0.0,1.0,0.0
Cryptogenic,1.0,0.0,0.0,0.0
Hierarchical stimuli,0.0,1.0,0.0,0.0
anticonvulsants,0.0,1.0,0.0,0.0
Personal identity,0.0,1.0,0.0,0.0
Dataframe mode,0.0,0.0,1.0,0.0
wheal,0.0,1.0,0.0,0.0
Minimal clinically important difference,0.0,0.0,1.0,0.0
Math learning disability,0.0,1.0,0.0,0.0
Affective illness,1.0,0.0,0.0,0.0
A? peptide,0.0,0.0,1.0,0.0
Primary school,0.0,0.0,1.0,0.0
Concurrent awareness,0.0,0.0,1.0,0.0
Diagrams,1.0,0.0,0.0,0.0
Orthographic overlap,0.0,0.0,1.0,0.0
Fast optical signal,0.0,1.0,0.0,0.0
albuminuria,1.0,0.0,0.0,0.0
Otolith,1.0,0.0,0.0,0.0
P350,0.0,1.0,0.0,0.0
Bipolar disorder cognition,1.0,0.0,0.0,0.0
Child visual motor abilities,0.0,0.0,1.0,0.0
Collaborative visual search,0.0,0.0,0.0,1.0
Diabetic-related factors,0.0,0.0,1.0,0.0
Retrograde memory,0.0,0.0,0.0,1.0
Contextual guidance,1.0,0.0,0.0,0.0
chronic disease management,1.0,0.0,0.0,0.0
Computational Theory of Mind,0.0,1.0,0.0,0.0
rules,0.0,1.0,0.0,0.0
Attention (general),1.0,0.0,0.0,0.0
Human figure drawing,1.0,0.0,0.0,0.0
Impaired performance,0.0,1.0,0.0,0.0
Non-spatial attention,0.0,1.0,0.0,0.0
Real-time data acquisition,0.0,0.0,1.0,0.0
Sleep-wake disturbances,0.0,1.0,0.0,0.0
DC modeling,0.0,1.0,0.0,0.0
Psychologization,0.0,0.0,1.0,0.0
multimodal discrimination,0.0,0.0,0.0,1.0
Semantic data analysis,0.0,0.0,1.0,0.0
Protective factors,0.0,1.0,0.0,0.0
Integrated visual and auditory continuous performance test,0.0,0.0,0.0,1.0
AIM,0.0,0.0,1.0,0.0
Remember-know,0.0,0.0,1.0,0.0
inference learning,0.0,1.0,0.0,0.0
Sharing,1.0,0.0,0.0,0.0
Cognitive speed of processing training,1.0,0.0,0.0,0.0
Functional genomics,0.0,0.0,1.0,0.0
Mapping understanding,0.0,1.0,0.0,0.0
kidney disease,1.0,0.0,0.0,0.0
Glatiramer acetate,0.0,1.0,0.0,0.0
Object rotation,0.0,0.0,0.0,1.0
School meal,0.0,0.0,1.0,0.0
Eye movement measurements,1.0,0.0,0.0,0.0
Thiazoles,1.0,0.0,0.0,0.0
Amalyan,0.0,0.0,1.0,0.0
Cross-Race Effect,0.0,0.0,0.0,1.0
Lexical ambiguity,0.0,0.0,1.0,0.0
Asynchronous,0.0,0.0,1.0,0.0
Community detection,0.0,1.0,0.0,0.0
Discrete movements,0.0,0.0,1.0,0.0
Thought-action fusion,0.0,0.0,0.0,1.0
Imitation ability,1.0,0.0,0.0,0.0
Praxias,0.0,0.0,1.0,0.0
Methodology and techniques,0.0,0.0,0.0,1.0
General population,0.0,0.0,1.0,0.0
Local processing bias,0.0,0.0,1.0,0.0
Pigtail macaques,0.0,1.0,0.0,0.0
Psychophysiological stress factors,0.0,1.0,0.0,0.0
Computer software,0.0,0.0,1.0,0.0
Luminance discrimination,0.0,1.0,0.0,0.0
Unrelatedness,0.0,0.0,0.0,1.0
material-semiotics,1.0,0.0,0.0,0.0
Implicit categorization,0.0,0.0,1.0,0.0
Point-of-gaze location,0.0,0.0,1.0,0.0
Implicit processes,0.0,1.0,0.0,0.0
Emotional interpretation,0.0,0.0,1.0,0.0
Afrikaner-ancestry,1.0,0.0,0.0,0.0
Embodiment factors,0.0,0.0,1.0,0.0
Nicotine Replacement Therapy,0.0,1.0,0.0,0.0
Polymorphisms,0.0,1.0,0.0,0.0
bromocriptine,0.0,1.0,0.0,0.0
color contrast,0.0,1.0,0.0,0.0
subcortical ischemic vascular dementia,1.0,0.0,0.0,0.0
sensitivity and specificity,0.0,0.0,1.0,0.0
Motor imagery therapy,0.0,1.0,0.0,0.0
VEGF,1.0,0.0,0.0,0.0
Behavioral problems,0.0,0.0,0.0,1.0
visuo-spatial cognition,1.0,0.0,0.0,0.0
Event recognition,0.0,0.0,1.0,0.0
Spaced retrieval,0.0,1.0,0.0,0.0
Adult literacy acquisition,0.0,0.0,0.0,1.0
Preterm Magnetoencephalography Neural oscillation Neonatal pain Cognitive outcome Spontaneous brain activity Visual perception Prematurity Spontaneous brain activity Child development Resting-state Pain Cognition Perception Development,0.0,0.0,1.0,0.0
Warning sound,0.0,1.0,0.0,0.0
Gray matter structure,1.0,0.0,0.0,0.0
Visual-Spatial performance,1.0,0.0,0.0,0.0
Perception of postural instability,0.0,1.0,0.0,0.0
Occipitotemporal,0.0,0.0,0.0,1.0
sinusoidal gratings,0.0,0.0,1.0,0.0
appraisals,0.0,0.0,1.0,0.0
Splenial fibres,0.0,0.0,1.0,0.0
Children questionnaires,0.0,1.0,0.0,0.0
Bistable,1.0,0.0,0.0,0.0
Gestural inventory,1.0,0.0,0.0,0.0
African American health disparities,1.0,0.0,0.0,0.0
Embodied neuroscience,0.0,0.0,1.0,0.0
MMSE-blind,1.0,0.0,0.0,0.0
Vascular cognitive impairment no dementia,0.0,0.0,1.0,0.0
Trial history,0.0,0.0,1.0,0.0
Capacity-free processing,0.0,0.0,1.0,0.0
Neuronal damage,0.0,0.0,1.0,0.0
HIV-associated dementia,1.0,0.0,0.0,0.0
Near and far space,0.0,0.0,1.0,0.0
Therapeutics,0.0,1.0,0.0,0.0
Starling,0.0,0.0,1.0,0.0
Phoneme edit distance,1.0,0.0,0.0,0.0
Delayed non-matching to position,0.0,1.0,0.0,0.0
Same-different judgments,0.0,0.0,1.0,0.0
CB receptor,0.0,1.0,0.0,0.0
Integrative medicine,0.0,0.0,1.0,0.0
Visual scene exploration,0.0,0.0,0.0,1.0
Perceptual attunement,0.0,0.0,0.0,1.0
Real time fMRI,0.0,1.0,0.0,0.0
0.1-Hz resonance,0.0,1.0,0.0,0.0
Mirrored self-identification,0.0,0.0,1.0,0.0
Brain potentials,0.0,0.0,0.0,1.0
Interoceptive exposure therapy,0.0,1.0,0.0,0.0
Vertical,0.0,0.0,0.0,1.0
Time-window-of-integration,0.0,0.0,1.0,0.0
Clinical rating scale,1.0,0.0,0.0,0.0
Spatial extinction,0.0,0.0,0.0,1.0
Task preparation,0.0,1.0,0.0,0.0
Interregional correlations,0.0,1.0,0.0,0.0
Gene-spiking neural networks,0.0,0.0,0.0,1.0
Polydrug use,0.0,1.0,0.0,0.0
associative deficit,0.0,0.0,0.0,1.0
Animal temperament,0.0,1.0,0.0,0.0
Batten disease,0.0,0.0,1.0,0.0
Unresponsive wakefulness syndrome,0.0,0.0,0.0,1.0
Matched filtration,0.0,0.0,0.0,1.0
Muscarinic receptor,1.0,0.0,0.0,0.0
Supplementation through food,0.0,1.0,0.0,0.0
Hearing-impaired,0.0,0.0,1.0,0.0
Conditioning awareness,0.0,0.0,1.0,0.0
Emotional disturbances,1.0,0.0,0.0,0.0
Distracting environment,1.0,0.0,0.0,0.0
Probability distortion,0.0,0.0,1.0,0.0
amusement,0.0,0.0,1.0,0.0
Discriminability,0.0,0.0,0.0,1.0
computational and artificial intelligence,0.0,0.0,1.0,0.0
Younger and older adults,0.0,0.0,1.0,0.0
Language lateralization,0.0,0.0,0.0,1.0
Brain neuroimaging,0.0,0.0,1.0,0.0
domain,0.0,0.0,1.0,0.0
Pupil dilations,1.0,0.0,0.0,0.0
Eye blinks,0.0,0.0,1.0,0.0
Novelty habituation,1.0,0.0,0.0,0.0
face-identity,0.0,1.0,0.0,0.0
Media discourse,0.0,0.0,1.0,0.0
Clinical high risk for psychosis,0.0,0.0,1.0,0.0
relational processing,0.0,0.0,1.0,0.0
Personal space,0.0,0.0,1.0,0.0
Preclinical decline,1.0,0.0,0.0,0.0
Memory outcome,0.0,0.0,1.0,0.0
Geometric illusion,0.0,1.0,0.0,0.0
Referee,0.0,0.0,1.0,0.0
Elderly person,0.0,0.0,1.0,0.0
Practice guideline,0.0,0.0,1.0,0.0
Neuregulin 1,1.0,0.0,0.0,0.0
Neural context,0.0,0.0,1.0,0.0
academic achievement,0.0,0.0,0.0,1.0
Left occipitotemporal cortex,0.0,0.0,1.0,0.0
Hand area,0.0,1.0,0.0,0.0
Residence characteristics,0.0,1.0,0.0,0.0
Frontal asymmetry,0.0,0.0,1.0,0.0
Ventromedial frontal cortex,0.0,0.0,1.0,0.0
Specific reading disabilities,0.0,0.0,1.0,0.0
Mercury toxicity,0.0,0.0,1.0,0.0
Neuron,0.0,0.0,0.0,1.0
Comorbid alcohol abuse,0.0,1.0,0.0,0.0
Product assessment,0.0,0.0,1.0,0.0
Feature search mode,0.0,1.0,0.0,0.0
Transporter,0.0,0.0,0.0,1.0
salience network,0.0,0.0,1.0,0.0
Gain,0.0,1.0,0.0,0.0
International affective picture system (IAPS),0.0,0.0,1.0,0.0
dantrolene,1.0,0.0,0.0,0.0
Orthographically similar,1.0,0.0,0.0,0.0
Design technology,0.0,1.0,0.0,0.0
visually directed walking task,0.0,1.0,0.0,0.0
Snoring,0.0,1.0,0.0,0.0
Errors of omission,0.0,1.0,0.0,0.0
Intracranial aneurysm,1.0,0.0,0.0,0.0
Repetition-priming,0.0,1.0,0.0,0.0
machine learning,0.0,0.0,1.0,0.0
Plasma homocysteine,0.0,0.0,1.0,0.0
uridine-5?-monophosphate,0.0,0.0,1.0,0.0
V5/MT +,0.0,0.0,0.0,1.0
Fragile X mental retardation protein,0.0,1.0,0.0,0.0
atrial fibrillation,0.0,0.0,1.0,0.0
Visual scenes,0.0,1.0,0.0,0.0
Types of sensory information,1.0,0.0,0.0,0.0
BSL,0.0,1.0,0.0,0.0
Military flying,0.0,0.0,1.0,0.0
Continuous extent,1.0,0.0,0.0,0.0
Psychogenic disorders,1.0,0.0,0.0,0.0
Video retrieval,0.0,0.0,1.0,0.0
Grounded-cognition,0.0,0.0,1.0,0.0
Sleep stages,0.0,1.0,0.0,0.0
California Verbal Learning Test,1.0,0.0,0.0,0.0
Hand laterality task,0.0,0.0,1.0,0.0
environmental enrichment,0.0,0.0,1.0,0.0
ISBD-BANC,0.0,1.0,0.0,0.0
Homotopy,1.0,0.0,0.0,0.0
International public health,1.0,0.0,0.0,0.0
Spiking neural networks,0.0,0.0,0.0,1.0
Cerebellar modules,0.0,0.0,1.0,0.0
MAP kinases,1.0,0.0,0.0,0.0
inverse effectiveness,0.0,0.0,1.0,0.0
Low-grade,0.0,0.0,1.0,0.0
Academic outcome,0.0,1.0,0.0,0.0
Lifestyle,1.0,0.0,0.0,0.0
Computer-mediated communication,0.0,0.0,1.0,0.0
Febrile convulsions,0.0,0.0,1.0,0.0
affiliation,0.0,0.0,1.0,0.0
Multivariate decoding,0.0,1.0,0.0,0.0
GABA-mediated intracortical inhibition,0.0,0.0,1.0,0.0
three-dimensional,0.0,0.0,1.0,0.0
Category specific impairments,0.0,1.0,0.0,0.0
Point-light walkers,0.0,0.0,1.0,0.0
Arbitrary mapping hypothesis,0.0,1.0,0.0,0.0
anisotropy,0.0,0.0,1.0,0.0
long-term treatment,1.0,0.0,0.0,0.0
Parker,0.0,0.0,0.0,1.0
Substitution masking,0.0,0.0,1.0,0.0
Regional brain volume,0.0,0.0,0.0,1.0
Hypochondria,0.0,0.0,1.0,0.0
photovoice,0.0,1.0,0.0,0.0
Medial prefrontal network,0.0,0.0,1.0,0.0
Importance,0.0,1.0,0.0,0.0
"""topos"",0.0,1.0,0.0,0.0
Disgust sensitivity,0.0,0.0,1.0,0.0
Synaptic neurotransmission,0.0,0.0,1.0,0.0
Neuro-aesthetics,0.0,0.0,1.0,0.0
Associative cue,0.0,0.0,1.0,0.0
VSL,0.0,0.0,1.0,0.0
Constrained optimization,1.0,0.0,0.0,0.0
Contexual cueing,0.0,0.0,1.0,0.0
Degeneracy,1.0,0.0,0.0,0.0
Hemorrhagic stroke,0.0,0.0,1.0,0.0
Social-cognitive toolbox,0.0,0.0,1.0,0.0
autonomic,1.0,0.0,0.0,0.0
Speeded detection,0.0,0.0,0.0,1.0
fornix,0.0,0.0,1.0,0.0
Grey matter density,0.0,0.0,1.0,0.0
Numerical reasoning,0.0,0.0,1.0,0.0
Visual sense of numbers,1.0,0.0,0.0,0.0
Protagonist,0.0,1.0,0.0,0.0
Nutrition disorders,0.0,0.0,1.0,0.0
Task Switching,0.0,0.0,1.0,0.0
AIBL,1.0,0.0,0.0,0.0
Attribution styles,0.0,0.0,1.0,0.0
Fiction feeling hypothesis,0.0,0.0,1.0,0.0
Spatial visual memories,0.0,1.0,0.0,0.0
Voice prosody,0.0,0.0,1.0,0.0
Action perception links,0.0,0.0,1.0,0.0
Knowledge of results,0.0,1.0,0.0,0.0
Low vision aids,0.0,0.0,1.0,0.0
Patience,1.0,0.0,0.0,0.0
Global-local,0.0,1.0,0.0,0.0
emic,0.0,0.0,1.0,0.0
Parameter estimation,1.0,0.0,0.0,0.0
Location of prediction window,0.0,0.0,1.0,0.0
Left,0.0,1.0,0.0,0.0
Hypobaric hypoxia,0.0,0.0,0.0,1.0
nonconscious perception,1.0,0.0,0.0,0.0
Physical computation,1.0,0.0,0.0,0.0
Behavioural neurology,1.0,0.0,0.0,0.0
Picture viewing,0.0,1.0,0.0,0.0
Humancomputer interaction,0.0,1.0,0.0,0.0
Genetic biomarkers,0.0,0.0,1.0,0.0
Neuropsychology matched cohort study,0.0,1.0,0.0,0.0
fusiform body area,0.0,0.0,1.0,0.0
self-confrontation,0.0,0.0,1.0,0.0
Non-symbolic numerical comparison,0.0,0.0,1.0,0.0
Grasp cueing,0.0,0.0,1.0,0.0
Gambling addiction,1.0,0.0,0.0,0.0
Event duration,1.0,0.0,0.0,0.0
Super-cavit,0.0,0.0,1.0,0.0
glycogen synthase kinase-3,0.0,0.0,1.0,0.0
Perceptuomotor experiences,0.0,1.0,0.0,0.0
Rapid Visual Information Processing Task,0.0,0.0,1.0,0.0
Classical conditioning,1.0,0.0,0.0,0.0
Behavioural observation,0.0,1.0,0.0,0.0
Flare,0.0,0.0,1.0,0.0
Psychological distress,0.0,1.0,0.0,0.0
Piaget's adaptation mechanism,0.0,1.0,0.0,0.0
Remote eye-tracking technology,0.0,0.0,1.0,0.0
Bangladesh,1.0,0.0,0.0,0.0
ST segment depression,0.0,1.0,0.0,0.0
Anxiety Disorders,0.0,0.0,1.0,0.0
Inverse models,0.0,0.0,1.0,0.0
hepatic,0.0,0.0,0.0,1.0
Mating success,0.0,1.0,0.0,0.0
ALE meta-analysis,0.0,1.0,0.0,0.0
Physical functions,0.0,0.0,1.0,0.0
physical environment,0.0,0.0,1.0,0.0
Space syntax,0.0,1.0,0.0,0.0
Subjective strategies,0.0,0.0,1.0,0.0
Resting fMRI,0.0,1.0,0.0,0.0
Histone,0.0,1.0,0.0,0.0
Natural resource management,0.0,0.0,1.0,0.0
Spike,0.0,0.0,1.0,0.0
Imagery neglect,0.0,0.0,1.0,0.0
Masked transposition priming,0.0,0.0,1.0,0.0
Visualized evaluation,1.0,0.0,0.0,0.0
Mental flexibility,0.0,1.0,0.0,0.0
Object file,1.0,0.0,0.0,0.0
Computational neurostimulation,0.0,0.0,1.0,0.0
Basic emotions,0.0,1.0,0.0,0.0
Cross-modal illusions,0.0,1.0,0.0,0.0
Structure-function relationship,1.0,0.0,0.0,0.0
Virtual geographic map,0.0,0.0,1.0,0.0
Young adult stroke patients,0.0,0.0,1.0,0.0
Communication supports,0.0,0.0,1.0,0.0
D-Camphor,0.0,0.0,1.0,0.0
Orbitofrontal ventromedial areas,0.0,0.0,1.0,0.0
Surgery Gynaecological,1.0,0.0,0.0,0.0
Area perception,0.0,0.0,1.0,0.0
Alpha asymmetry,1.0,0.0,0.0,0.0
VARK,0.0,1.0,0.0,0.0
Age-related vision impairment,0.0,0.0,1.0,0.0
Autistic spectrum disorders,1.0,0.0,0.0,0.0
Intrinsic activity,0.0,1.0,0.0,0.0
Gyral typology,1.0,0.0,0.0,0.0
Cognitive neurology,0.0,0.0,0.0,1.0
Autoassociative neural networks,1.0,0.0,0.0,0.0
Directed forgetting,0.0,0.0,1.0,0.0
Color measurement,0.0,0.0,1.0,0.0
Written word recognition,0.0,0.0,1.0,0.0
Neophobia,0.0,0.0,1.0,0.0
Dysfunctional cognitive allocation,0.0,0.0,0.0,1.0
Frontal operculum (FO),1.0,0.0,0.0,0.0
Diffusion Tensor Imaging,0.0,0.0,1.0,0.0
Action-perception link,0.0,0.0,0.0,1.0
cognitive processing resources,0.0,1.0,0.0,0.0
Task engagement,0.0,1.0,0.0,0.0
Retrospective reports,0.0,0.0,1.0,0.0
Minimal cognitive impairment,0.0,0.0,1.0,0.0
seizure,1.0,0.0,0.0,0.0
identidad,1.0,0.0,0.0,0.0
Schizophrnie,0.0,1.0,0.0,0.0
High-affinity melatonin MT1/MT2 receptor,0.0,1.0,0.0,0.0
Voluntary controls,1.0,0.0,0.0,0.0
Fetal exposure,0.0,0.0,1.0,0.0
Spoken picture naming,0.0,0.0,1.0,0.0
Referential and modal representations,0.0,1.0,0.0,0.0
Non-organic vision loss,0.0,1.0,0.0,0.0
Postmenopausal period,0.0,0.0,0.0,1.0
Functional Independence Measure,0.0,0.0,1.0,0.0
Elderly healthy volunteers,0.0,0.0,0.0,1.0
Adrenal insufficiency,1.0,0.0,0.0,0.0
Functional impairment,0.0,0.0,1.0,0.0
Forebrain asymmetry,0.0,1.0,0.0,0.0
Space scale,0.0,0.0,1.0,0.0
Non-paralysed,0.0,0.0,0.0,1.0
Oral movements,0.0,1.0,0.0,0.0
Community-based seniors,0.0,1.0,0.0,0.0
Discontinuous consciousness,1.0,0.0,0.0,0.0
Face representation,0.0,1.0,0.0,0.0
ROI based study,0.0,0.0,0.0,1.0
Pain intensity,0.0,0.0,1.0,0.0
Temporal correlations,1.0,0.0,0.0,0.0
Semantic development,0.0,0.0,1.0,0.0
Post-hypnotic suggestion,0.0,0.0,0.0,1.0
4H leukodystrophy,0.0,0.0,1.0,0.0
Amygdalar volume,0.0,0.0,1.0,0.0
Post-concussion,1.0,0.0,0.0,0.0
Xenopus,0.0,1.0,0.0,0.0
Cognitive Bias Modification,0.0,0.0,1.0,0.0
Scene,0.0,0.0,1.0,0.0
Dynamic,0.0,0.0,1.0,0.0
responder,1.0,0.0,0.0,0.0
UPSIT,0.0,1.0,0.0,0.0
Functional magnetic-resonance imaging,0.0,1.0,0.0,0.0
Cognition processes,0.0,1.0,0.0,0.0
Therapist characteristics,0.0,1.0,0.0,0.0
Language context,0.0,0.0,1.0,0.0
Natural scene categorization,1.0,0.0,0.0,0.0
Neural basis of reaching,0.0,0.0,1.0,0.0
memory retrieval,0.0,0.0,1.0,0.0
Pediatric neuro-oncology,1.0,0.0,0.0,0.0
Multistable attractors,0.0,0.0,1.0,0.0
standardized assessment,1.0,0.0,0.0,0.0
Intelligent systems,0.0,1.0,0.0,0.0
minimally conscious state,0.0,0.0,1.0,0.0
Hierarchical organization,1.0,0.0,0.0,0.0
dot distortions,0.0,0.0,1.0,0.0
scenes,0.0,1.0,0.0,0.0
Retrieval induced forgetting,0.0,0.0,1.0,0.0
Cerebral revascularization,0.0,0.0,1.0,0.0
Nondeficit schizophrenia,0.0,0.0,1.0,0.0
Offspring of alcoholics,1.0,0.0,0.0,0.0
Brain imaging techniques,0.0,0.0,1.0,0.0
Clinical case,0.0,1.0,0.0,0.0
brain ischemia,0.0,1.0,0.0,0.0
Neural system,1.0,0.0,0.0,0.0
iconic memory,0.0,1.0,0.0,0.0
Justification of beliefs,0.0,1.0,0.0,0.0
Abstract and concrete words,0.0,0.0,0.0,1.0
Eyespots,0.0,0.0,0.0,1.0
Ear movement,0.0,1.0,0.0,0.0
Self-referential,0.0,0.0,1.0,0.0
Cholinergic network,0.0,0.0,1.0,0.0
Human visual system,0.0,1.0,0.0,0.0
Visual ascending pathway,0.0,1.0,0.0,0.0
Attention-illiteracy,1.0,0.0,0.0,0.0
Dorsal and ventral stream,0.0,0.0,1.0,0.0
social rank,0.0,0.0,1.0,0.0
subjective effects,0.0,0.0,1.0,0.0
Outcome scale,0.0,0.0,0.0,1.0
Skin temperature,0.0,0.0,1.0,0.0
Corticopontine tract,1.0,0.0,0.0,0.0
levocetirizine,0.0,1.0,0.0,0.0
Egocentric updating,0.0,1.0,0.0,0.0
Motor interference,0.0,0.0,1.0,0.0
KWISC-III,0.0,0.0,1.0,0.0
duration of untreated psychosis (DUP),0.0,1.0,0.0,0.0
Abstract-concept learning,0.0,1.0,0.0,0.0
steady-state visual evoked potential (ssVEP),0.0,0.0,1.0,0.0
polytrauma,0.0,0.0,0.0,1.0
Latent Markov models,1.0,0.0,0.0,0.0
epistemic actions,0.0,1.0,0.0,0.0
Self-other understanding,0.0,0.0,1.0,0.0
Analysis,0.0,0.0,1.0,0.0
Space memory,0.0,1.0,0.0,0.0
Face cognition,0.0,0.0,1.0,0.0
Perceptual analysis of size and dimension,0.0,0.0,0.0,1.0
Hodotopic model,1.0,0.0,0.0,0.0
Visual working memory capacity,1.0,0.0,0.0,0.0
Mild TBI,0.0,1.0,0.0,0.0
Specialization,0.0,0.0,1.0,0.0
Natural categories,0.0,1.0,0.0,0.0
Correlation analysis,1.0,0.0,0.0,0.0
Social cognitive deficits,0.0,0.0,1.0,0.0
Lower-level cognitive processing,0.0,0.0,0.0,1.0
Prenatal testosterone,1.0,0.0,0.0,0.0
Taste acuity,0.0,1.0,0.0,0.0
Small-scale spaces,1.0,0.0,0.0,0.0
Spoken language comprehension,0.0,0.0,1.0,0.0
Romanized text,0.0,1.0,0.0,0.0
Self-affirmation,1.0,0.0,0.0,0.0
Mohr-Tranebjaerg syndrome,0.0,0.0,0.0,1.0
Hierarchical systems,0.0,0.0,1.0,0.0
Disorganization symptom,0.0,0.0,0.0,1.0
Visual detection,1.0,0.0,0.0,0.0
Speed and accuracy of information processing,1.0,0.0,0.0,0.0
Ingroup love,1.0,0.0,0.0,0.0
Functional transcranial Doppler ultrasound (fTCD),0.0,0.0,1.0,0.0
High School/Introductory Chemistry,0.0,0.0,1.0,0.0
Adaptive neural response,0.0,0.0,0.0,1.0
Angry superiority effect,0.0,0.0,1.0,0.0
Aided augmentative and alternative communication,1.0,0.0,0.0,0.0
precuneus,0.0,1.0,0.0,0.0
Phonological Awareness,1.0,0.0,0.0,0.0
Implicit/explicit processing,0.0,0.0,1.0,0.0
Reaching and grasping,0.0,1.0,0.0,0.0
Naive theories,0.0,1.0,0.0,0.0
hyperbaric oxygen treatment,1.0,0.0,0.0,0.0
Motor variability,1.0,0.0,0.0,0.0
moderate activity,0.0,0.0,1.0,0.0
V3 +,0.0,0.0,0.0,1.0
text representation,0.0,0.0,1.0,0.0
Whole-cell,0.0,1.0,0.0,0.0
Verbal stimulation,0.0,0.0,1.0,0.0
cognitive rehabilitation tools,0.0,0.0,1.0,0.0
Channel selection,0.0,1.0,0.0,0.0
AFQ056,0.0,0.0,0.0,1.0
quality of life/well-being,1.0,0.0,0.0,0.0
Observer reference framework,0.0,0.0,1.0,0.0
Amplitude variation,0.0,0.0,0.0,1.0
early-onset,0.0,0.0,0.0,1.0
Visual process,1.0,0.0,0.0,0.0
learning trajectory,1.0,0.0,0.0,0.0
Functional microstates,1.0,0.0,0.0,0.0
Cerebral cortical atrophy,0.0,0.0,1.0,0.0
Ataxic hemiparesis,0.0,0.0,1.0,0.0
Creative thinking,0.0,0.0,1.0,0.0
Intrahemispheric processing,0.0,1.0,0.0,0.0
social novelty discrimination,0.0,0.0,1.0,0.0
calcium,1.0,0.0,0.0,0.0
DARTEL,0.0,1.0,0.0,0.0
Fitness-to-drive,0.0,0.0,1.0,0.0
Long-range coordination,0.0,0.0,1.0,0.0
New onset artistic behavior,0.0,0.0,1.0,0.0
Northern bald ibis,0.0,0.0,1.0,0.0
Visual motor control,0.0,1.0,0.0,0.0
Topological manifold,0.0,0.0,1.0,0.0
Cognitive understanding of remote systems,0.0,1.0,0.0,0.0
Elbow flexor muscles,1.0,0.0,0.0,0.0
Agitation,1.0,0.0,0.0,0.0
Verb fluency,0.0,0.0,1.0,0.0
Brodmann's areas,0.0,1.0,0.0,0.0
Psychotherapy integration,0.0,1.0,0.0,0.0
Trajectory analyses,0.0,0.0,0.0,1.0
Presentation duration,0.0,0.0,1.0,0.0
Generic circuit,0.0,0.0,1.0,0.0
Hemophilia,1.0,0.0,0.0,0.0
Fronto-parietal circuits,0.0,1.0,0.0,0.0
Neuropsychological correlates,1.0,0.0,0.0,0.0
Social coordination,0.0,0.0,1.0,0.0
Neonatal enteral glutamine,1.0,0.0,0.0,0.0
Trauma witness model,0.0,1.0,0.0,0.0
Energy model,0.0,0.0,1.0,0.0
Cognitive planning,0.0,0.0,0.0,1.0
Low-carbohydrate diet,0.0,0.0,1.0,0.0
Core number system,1.0,0.0,0.0,0.0
Dysgenic,0.0,1.0,0.0,0.0
Semi-Structured Interviews,0.0,1.0,0.0,0.0
Invertebrates,1.0,0.0,0.0,0.0
Long-term spatial memory,0.0,0.0,1.0,0.0
Cross-section,0.0,1.0,0.0,0.0
Childhood cognitive development,0.0,0.0,1.0,0.0
Maturity,1.0,0.0,0.0,0.0
Pictorial stimuli,0.0,0.0,1.0,0.0
Negative cognitive style,0.0,0.0,1.0,0.0
neuroblastoma,0.0,0.0,1.0,0.0
High throughput,0.0,0.0,1.0,0.0
Insecure attachment style,0.0,0.0,1.0,0.0
Behavioral genetic,0.0,0.0,1.0,0.0
Hazard proximity,1.0,0.0,0.0,0.0
Asymmetric posterior cortical atrophy,0.0,0.0,1.0,0.0
Consumer goods,0.0,1.0,0.0,0.0
Brain computer interface (BCI),0.0,1.0,0.0,0.0
n-ANOVA,0.0,0.0,0.0,1.0
Cholinergic structures,0.0,1.0,0.0,0.0
Moderate exercise,1.0,0.0,0.0,0.0
Real-world visual stimuli,0.0,0.0,1.0,0.0
Similarity in object recognition,0.0,1.0,0.0,0.0
Acoustic startle,1.0,0.0,0.0,0.0
anesthesia,0.0,1.0,0.0,0.0
Cholinergic agents,0.0,0.0,1.0,0.0
Retinal and extraretinal components,1.0,0.0,0.0,0.0
Rhombencephalon,0.0,0.0,1.0,0.0
Imagery ability,0.0,0.0,1.0,0.0
Neuronal activation,0.0,0.0,1.0,0.0
Luminance verification,0.0,1.0,0.0,0.0
Intra-Extra Dimensional Set-Shift (IED) test,0.0,0.0,1.0,0.0
Computation paradigms,0.0,0.0,1.0,0.0
Spatial Attention,0.0,0.0,1.0,0.0
Focal spikes,0.0,0.0,1.0,0.0
Blood oxygen level-dependent contrast,1.0,0.0,0.0,0.0
Significant configuration,0.0,0.0,1.0,0.0
Visual threshold,0.0,0.0,1.0,0.0
Symbolic effect,0.0,1.0,0.0,0.0
cerebellar affective syndrome,0.0,1.0,0.0,0.0
ecologically valid stimuli,0.0,0.0,1.0,0.0
Relational binding,0.0,1.0,0.0,0.0
Visuo-spatial dysfunction,0.0,0.0,0.0,1.0
Semantic distance,0.0,1.0,0.0,0.0
Computer aid training,0.0,1.0,0.0,0.0
Biological significance,0.0,1.0,0.0,0.0
Visual area angle histogram,0.0,0.0,1.0,0.0
Subcortical hyperintensities,0.0,0.0,1.0,0.0
Basal ganglia disorders,0.0,0.0,1.0,0.0
Amputation,1.0,0.0,0.0,0.0
Inter-modal attention,0.0,1.0,0.0,0.0
sketching,0.0,0.0,1.0,0.0
G Factor,0.0,0.0,1.0,0.0
Maltreatment children,1.0,0.0,0.0,0.0
Diffuse axonal injury (DAI),1.0,0.0,0.0,0.0
Pediatric multiple sclerosis,1.0,0.0,0.0,0.0
Operational momentum,0.0,1.0,0.0,0.0
Motor disability scores,0.0,1.0,0.0,0.0
Naive Bayes classifier,0.0,0.0,1.0,0.0
Spinning silhouette,1.0,0.0,0.0,0.0
Empiricism,0.0,0.0,1.0,0.0
Specialized learning,0.0,1.0,0.0,0.0
Computer monitor,1.0,0.0,0.0,0.0
therapeutic,0.0,1.0,0.0,0.0
Rapid automatized naming (RAN),0.0,0.0,0.0,1.0
Lateral body tilt,0.0,0.0,0.0,1.0
Schwartz,0.0,1.0,0.0,0.0
Dual use,0.0,0.0,1.0,0.0
Teacher education,0.0,0.0,0.0,1.0
Epistemology of testimony,0.0,1.0,0.0,0.0
Risk and Society",0.0,0.0,0.0,0.0
Exposure to violence,1.0,0.0,0.0,0.0
Fetal Alcohol Spectrum Disorder (FASD),0.0,0.0,0.0,1.0
Older patient,1.0,0.0,0.0,0.0
Contextual (colour) cues,0.0,1.0,0.0,0.0
Virtual Environment,0.0,0.0,0.0,1.0
Evoked responses,0.0,1.0,0.0,0.0
Centro-medial nucleus,0.0,0.0,1.0,0.0
lupus,1.0,0.0,0.0,0.0
Spatial span test,0.0,0.0,1.0,0.0
Midas,1.0,0.0,0.0,0.0
Cross-cultural neuropsychology,1.0,0.0,0.0,0.0
Olfactory perception,0.0,0.0,0.0,1.0
Dialyzing solution,0.0,0.0,1.0,0.0
Images in assessments,0.0,0.0,1.0,0.0
Asch,1.0,0.0,0.0,0.0
depth perception,0.0,0.0,1.0,0.0
Eye movements and attention,0.0,0.0,1.0,0.0
Subtemporal amygdalohippocampectomy,0.0,1.0,0.0,0.0
Cognitive impairment and cirrhosis,0.0,1.0,0.0,0.0
movement-effect compatibility,0.0,0.0,0.0,1.0
Self-attribution,0.0,0.0,1.0,0.0
EEG-based emotion recognition,0.0,1.0,0.0,0.0
Approximate entropy (ApEn),0.0,1.0,0.0,0.0
Neural mechanism,0.0,0.0,1.0,0.0
Emotional Stroop task,1.0,0.0,0.0,0.0
Longitudinal structural equation modeling,0.0,0.0,1.0,0.0
Adults ages 18-55 years,0.0,0.0,0.0,1.0
Normative model,0.0,1.0,0.0,0.0
Metric spatial representation,0.0,0.0,1.0,0.0
Covert,1.0,0.0,0.0,0.0
Angry expression,0.0,0.0,1.0,0.0
Auto test equipment,0.0,0.0,1.0,0.0
Mirror reading,0.0,1.0,0.0,0.0
Glycyrrhizic acid,1.0,0.0,0.0,0.0
Profile of Mood States (POMS),0.0,0.0,0.0,1.0
TNF-? polymorphism,1.0,0.0,0.0,0.0
Histoplasmosis,0.0,1.0,0.0,0.0
Second-order relations,0.0,0.0,1.0,0.0
Kojima,1.0,0.0,0.0,0.0
Attentional allocation,0.0,0.0,1.0,0.0
streams,1.0,0.0,0.0,0.0
Astrocytes,0.0,1.0,0.0,0.0
Unimodal processing,0.0,0.0,1.0,0.0
Gain-field modulation,0.0,0.0,1.0,0.0
Cerebral hemiatrophy,1.0,0.0,0.0,0.0
Evolution-methods,0.0,1.0,0.0,0.0
VO2max,0.0,0.0,1.0,0.0
autonomic function,0.0,1.0,0.0,0.0
Mesocaval interposition shunt,0.0,1.0,0.0,0.0
boundary extension,1.0,0.0,0.0,0.0
Intravenous,0.0,0.0,1.0,0.0
Sexual dimorphic abilities,1.0,0.0,0.0,0.0
Rule task,0.0,1.0,0.0,0.0
Technical expertise,0.0,1.0,0.0,0.0
Paranormal beliefs,0.0,1.0,0.0,0.0
CRP,0.0,1.0,0.0,0.0
Primary progressive multiple sclerosis,0.0,0.0,1.0,0.0
cognitive remediation therapy,0.0,0.0,0.0,1.0
ventromedial prefrontal cortex,0.0,0.0,1.0,0.0
Rey Visual Design Learning Test,1.0,0.0,0.0,0.0
Continuous Performance Task,0.0,0.0,1.0,0.0
k-means clustering,1.0,0.0,0.0,0.0
Inhibition response,0.0,1.0,0.0,0.0
Cortico-cortical pathways,0.0,0.0,1.0,0.0
Weber-Fechner law,0.0,0.0,0.0,1.0
Aggressive mimicry,0.0,0.0,1.0,0.0
Sleep spindles,1.0,0.0,0.0,0.0
Mechanisms of perceptual learning,0.0,0.0,0.0,0.0
Severity,0.0,1.0,0.0,0.0
Acquaintance,1.0,0.0,0.0,0.0
Diamorphine,0.0,0.0,1.0,0.0
Abstract stimuli,1.0,0.0,0.0,0.0
Neanderthals,1.0,0.0,0.0,0.0
Childhood brain tumor,0.0,0.0,1.0,0.0
Congruent saccade,0.0,0.0,1.0,0.0
Visual semantic processing,1.0,0.0,0.0,0.0
cognitive inhibition,0.0,1.0,0.0,0.0
famous faces recognition,0.0,0.0,0.0,1.0
Hippocampal plasticity,0.0,0.0,1.0,0.0
Attentional deployment,0.0,0.0,1.0,0.0
Spinning dancer,1.0,0.0,0.0,0.0
AAC,0.0,0.0,1.0,0.0
Angle,0.0,0.0,1.0,0.0
Multi-modal cognition,0.0,0.0,1.0,0.0
health promotion,0.0,0.0,1.0,0.0
Smoking cue,1.0,0.0,0.0,0.0
mismatch negativity,0.0,1.0,0.0,0.0
Pancreatitis,1.0,0.0,0.0,0.0
Family History,0.0,1.0,0.0,0.0
Post-menopausal,0.0,1.0,0.0,0.0
Recognition of humans,1.0,0.0,0.0,0.0
Perceptual judgement,0.0,0.0,1.0,0.0
Phenobarbitone,0.0,1.0,0.0,0.0
Subcortical vascular dementia,0.0,0.0,1.0,0.0
mixed-design,0.0,0.0,1.0,0.0
Recombinant erythropoietin,0.0,1.0,0.0,0.0
Interleukin-1 alpha,0.0,0.0,1.0,0.0
Macaca tonkeana,0.0,0.0,1.0,0.0
Single photon emission computed tomography (SPECT),0.0,0.0,1.0,0.0
Facial identification,1.0,0.0,0.0,0.0
Task demands,0.0,1.0,0.0,0.0
Intentional agency,1.0,0.0,0.0,0.0
movimientos sociales,1.0,0.0,0.0,0.0
Sensory experience ratings (SERs),0.0,0.0,1.0,0.0
Knowledge organization,0.0,0.0,1.0,0.0
Backwards masking,0.0,0.0,1.0,0.0
Biopsychosocial characteristics,0.0,0.0,1.0,0.0
Neuromorphic,0.0,0.0,1.0,0.0
Intellectual decline,0.0,0.0,1.0,0.0
Epileptogenic zone,0.0,0.0,1.0,0.0
Noisy,0.0,1.0,0.0,0.0
Crossover Study,0.0,0.0,0.0,1.0
Hippocampal,0.0,0.0,1.0,0.0
Cruise control,0.0,0.0,0.0,1.0
Harmine,0.0,0.0,1.0,0.0
Auditory spatial task,0.0,0.0,1.0,0.0
Radial-arm maze,0.0,0.0,1.0,0.0
Flower visitors,0.0,1.0,0.0,0.0
Postural prioritization,0.0,0.0,1.0,0.0
Reproducibility of results,0.0,0.0,0.0,1.0
Functional hemispheric asymmetry,0.0,0.0,1.0,0.0
Analogue,1.0,0.0,0.0,0.0
mushroom bodies,0.0,1.0,0.0,0.0
Dynamic aphasia,0.0,0.0,1.0,0.0
Shallow and consolidation learning phases,0.0,0.0,1.0,0.0
Logopenic,0.0,1.0,0.0,0.0
Logopenia,0.0,0.0,1.0,0.0
Antisaccadic,0.0,1.0,0.0,0.0
Facial expression identification,0.0,1.0,0.0,0.0
High-level vision,0.0,1.0,0.0,0.0
Near vision,1.0,0.0,0.0,0.0
chunk familiarity,0.0,0.0,1.0,0.0
Spatial visual search,0.0,1.0,0.0,0.0
Partial aniridia,0.0,1.0,0.0,0.0
Speed words,0.0,0.0,1.0,0.0
Dendritic spine,1.0,0.0,0.0,0.0
Major depressive disorder (MDD),0.0,0.0,1.0,0.0
Fampridine,0.0,0.0,1.0,0.0
APP/PS1,1.0,0.0,0.0,0.0
sigma-1 receptor,0.0,0.0,1.0,0.0
Disinhibitory disorders,0.0,0.0,0.0,1.0
stereotype threat,1.0,0.0,0.0,0.0
frail elderly,0.0,0.0,1.0,0.0
visual event-related potential,0.0,0.0,1.0,0.0
HUI2,0.0,0.0,1.0,0.0
Spin Echo,0.0,1.0,0.0,0.0
uncertainty monitoring,1.0,0.0,0.0,0.0
cAMP-responsive element-binding protein (CREB),0.0,1.0,0.0,0.0
Lacunar stroke,0.0,0.0,1.0,0.0
Cueing paradigm,0.0,1.0,0.0,0.0
Secondary representation,0.0,1.0,0.0,0.0
Successful ageing,0.0,0.0,1.0,0.0
Cookstove,1.0,0.0,0.0,0.0
HSP70,1.0,0.0,0.0,0.0
Constant routine,0.0,0.0,1.0,0.0
Transition frequency,0.0,1.0,0.0,0.0
Spatial encoding,0.0,0.0,1.0,0.0
Interrater reliability,0.0,1.0,0.0,0.0
Multisensory enhancement and suppression,0.0,0.0,1.0,0.0
Opioid-Tolerant Subjects,0.0,0.0,0.0,1.0
Autonomic nervous activity,0.0,0.0,1.0,0.0
diffuse tensor imaging,0.0,0.0,1.0,0.0
Voluntary memory,1.0,0.0,0.0,0.0
PANSS five-factor model,0.0,1.0,0.0,0.0
Physical fitness,0.0,1.0,0.0,0.0
numerosity,0.0,1.0,0.0,0.0
Audio-visual interaction,0.0,0.0,1.0,0.0
Allocentric representation,1.0,0.0,0.0,0.0
Plaid,0.0,1.0,0.0,0.0
Audio-visual approach,0.0,1.0,0.0,0.0
Categorical feature,0.0,0.0,1.0,0.0
Occupational capacity,0.0,0.0,1.0,0.0
Phantoms,0.0,0.0,1.0,0.0
MRI spectroscopy,0.0,0.0,1.0,0.0
Grammatical function,0.0,0.0,1.0,0.0
Orthographic regularity,0.0,0.0,1.0,0.0
Leading,0.0,0.0,1.0,0.0
Rhythm perception,0.0,0.0,1.0,0.0
trauma surgery training,0.0,1.0,0.0,0.0
Gibson,1.0,0.0,0.0,0.0
Prior,0.0,0.0,0.0,1.0
Prion,0.0,0.0,0.0,1.0
pp. 2156-2166,0.0,0.0,1.0,0.0
Incongruent saccade,0.0,0.0,1.0,0.0
Reed,0.0,1.0,0.0,0.0
L-amphetamine,0.0,0.0,1.0,0.0
number line,0.0,1.0,0.0,0.0
Graphomotor test,1.0,0.0,0.0,0.0
Reportability,1.0,0.0,0.0,0.0
Field dependence,1.0,0.0,0.0,0.0
Mild cognitive MCI,0.0,0.0,1.0,0.0
Adolescent blind individuals,1.0,0.0,0.0,0.0
Sense-sound continuum,0.0,0.0,1.0,0.0
Yogic meditation,0.0,0.0,1.0,0.0
Surface,0.0,1.0,0.0,0.0
apprentissage spatial,0.0,1.0,0.0,0.0
Parallel computing,1.0,0.0,0.0,0.0
Fingertip,0.0,1.0,0.0,0.0
Hierarchical relationship,0.0,1.0,0.0,0.0
CNS cholinergic defect,0.0,1.0,0.0,0.0
Continuous visual properties,1.0,0.0,0.0,0.0
clinical utility,0.0,1.0,0.0,0.0
Rivermead Postconcussion Questionnaire,1.0,0.0,0.0,0.0
Coma-therapy,0.0,0.0,1.0,0.0
Frontal lobe function,1.0,0.0,0.0,0.0
Atypicality,0.0,0.0,1.0,0.0
Healthy volunteer,0.0,0.0,1.0,0.0
Imitation learning,0.0,0.0,1.0,0.0
natural image categorization,1.0,0.0,0.0,0.0
Sleight-of-hand,0.0,0.0,1.0,0.0
Dyspareunia,1.0,0.0,0.0,0.0
agraphesthesia,0.0,0.0,1.0,0.0
FACS,0.0,0.0,1.0,0.0
self-reported pain,1.0,0.0,0.0,0.0
Titration,0.0,0.0,0.0,1.0
Linguistic morphology,1.0,0.0,0.0,0.0
Reading acquisition,0.0,0.0,1.0,0.0
"Cognitive disorders,0.0,0.0,0.0,0.0
Predation threat,0.0,1.0,0.0,0.0
Hand grip strength,0.0,0.0,0.0,1.0
visual social cognition,0.0,0.0,0.0,1.0
Bottom-up feature,1.0,0.0,0.0,0.0
Neural basis,0.0,1.0,0.0,0.0
Laser,0.0,0.0,0.0,1.0
Direct costs,0.0,0.0,1.0,0.0
Vector state space,1.0,0.0,0.0,0.0
Reading and/or spelling,1.0,0.0,0.0,0.0
internal representation,0.0,0.0,1.0,0.0
Anesthesia general,0.0,0.0,0.0,1.0
Sexual drives,0.0,0.0,1.0,0.0
Cross-language aspects,0.0,0.0,1.0,0.0
Anterograde memory,1.0,0.0,0.0,0.0
Pineal region,0.0,0.0,1.0,0.0
Dual-process theory,0.0,0.0,1.0,0.0
Pharmacoepidemiology,0.0,0.0,0.0,1.0
Neuropsychological dysfunctions,0.0,1.0,0.0,0.0
Fusiform face area (FFA),1.0,0.0,0.0,0.0
Dementias,0.0,0.0,1.0,0.0
IVF,0.0,0.0,1.0,0.0
Visual object segregation,0.0,0.0,0.0,1.0
Functional magnetic resonance tomography,0.0,0.0,0.0,1.0
Levels of processing,0.0,1.0,0.0,0.0
10 decades,1.0,0.0,0.0,0.0
Virtual rehabilitation,1.0,0.0,0.0,0.0
Microcephaly,1.0,0.0,0.0,0.0
Diagrammatic problem solving,1.0,0.0,0.0,0.0
Shape perception,0.0,0.0,1.0,0.0
Predictive sentence processing,0.0,0.0,1.0,0.0
View-based matching,0.0,1.0,0.0,0.0
Last resort strategy,0.0,1.0,0.0,0.0
Low dose prenatal mercury exposure,0.0,1.0,0.0,0.0
bounded optimality,0.0,1.0,0.0,0.0
Cognitive illusion of length,0.0,0.0,0.0,1.0
Psychosocial outcome,0.0,1.0,0.0,0.0
Chemosensation,0.0,1.0,0.0,0.0
Palliative radiation,0.0,0.0,1.0,0.0
Age of onset,1.0,0.0,0.0,0.0
Poffenberger,0.0,0.0,1.0,0.0
Natural gender,0.0,1.0,0.0,0.0
Bias (epidemiology),0.0,0.0,1.0,0.0
Subjective fatigue,1.0,0.0,0.0,0.0
Gist-based memory,0.0,0.0,0.0,1.0
Consilience,1.0,0.0,0.0,0.0
Performance variability,0.0,1.0,0.0,0.0
representation aiding,0.0,0.0,1.0,0.0
Prefrontal cortex (PFC),0.0,0.0,1.0,0.0
Notation-dependent,1.0,0.0,0.0,0.0
spatial alternation,1.0,0.0,0.0,0.0
Labor,1.0,0.0,0.0,0.0
Inferior-temporal cortex,0.0,0.0,1.0,0.0
environmental exposure,0.0,0.0,1.0,0.0
spatial learning and memory,0.0,0.0,1.0,0.0
Single-system memory,0.0,1.0,0.0,0.0
Decision making support,1.0,0.0,0.0,0.0
Reading difficulties,0.0,0.0,1.0,0.0
Genetic risk score,1.0,0.0,0.0,0.0
Attention and emotion,1.0,0.0,0.0,0.0
nouns,0.0,0.0,1.0,0.0
Physical ability,0.0,0.0,1.0,0.0
Biological motionperception,0.0,0.0,1.0,0.0
Face expressions,0.0,0.0,1.0,0.0
PROTEINS,1.0,0.0,0.0,0.0
Optokinetic,0.0,0.0,0.0,1.0
Yuval-Greenberg,1.0,0.0,0.0,0.0
Reactivation,0.0,0.0,1.0,0.0
Motor dysfunction,0.0,1.0,0.0,0.0
Musical expertise,0.0,1.0,0.0,0.0
Psychophysiological responding,0.0,0.0,1.0,0.0
Self-Efficacy,1.0,0.0,0.0,0.0
Drug overdose,0.0,1.0,0.0,0.0
Pretreatment,0.0,0.0,0.0,1.0
Symbolic dynamics,0.0,1.0,0.0,0.0
Association football,0.0,1.0,0.0,0.0
Nature-based tourism,1.0,0.0,0.0,0.0
VSTM maintenance,0.0,0.0,0.0,1.0
Adaptive testing,0.0,1.0,0.0,0.0
Medicated,1.0,0.0,0.0,0.0
Dorsal-ventral and frontal model,0.0,0.0,1.0,0.0
Autism-Spectrum Quotient,0.0,0.0,1.0,0.0
Vicarious reinforcement,1.0,0.0,0.0,0.0
Truly interactive paradigms,1.0,0.0,0.0,0.0
number comprehension,0.0,1.0,0.0,0.0
Prestimulus brain activity,0.0,0.0,1.0,0.0
Physical intuition,0.0,1.0,0.0,0.0
Body selectivity,0.0,0.0,0.0,1.0
Tabes dorsalis,0.0,1.0,0.0,0.0
toxicology,1.0,0.0,0.0,0.0
Retinal projections,0.0,0.0,1.0,0.0
Timing in the brain,0.0,1.0,0.0,0.0
Keywords learning models,0.0,1.0,0.0,0.0
Learning styles,0.0,1.0,0.0,0.0
Interaction techniques,0.0,0.0,0.0,1.0
Spacing effect,0.0,0.0,1.0,0.0
Niacin flush,0.0,0.0,1.0,0.0
Ecological intervention,1.0,0.0,0.0,0.0
Visvospatial,0.0,0.0,1.0,0.0
Response modulation,0.0,0.0,1.0,0.0
Natural pedagogy,0.0,0.0,1.0,0.0
Cognitive function testing (SCAG),0.0,0.0,1.0,0.0
Knowledge management system,0.0,1.0,0.0,0.0
L-ornitin-L-aspartate,0.0,0.0,1.0,0.0
Static matching,0.0,1.0,0.0,0.0
Number of episodes,0.0,0.0,1.0,0.0
ZENK (zif268,0.0,0.0,0.0,0.0
Mental tracing,0.0,1.0,0.0,0.0
Methiocarb,1.0,0.0,0.0,0.0
Neuropsychiatric disease,0.0,1.0,0.0,0.0
progressive,0.0,0.0,0.0,1.0
Functional ANOVA,0.0,1.0,0.0,0.0
Ultraviolet radiation,0.0,0.0,1.0,0.0
Ethnographic studies,1.0,0.0,0.0,0.0
Negative dip,0.0,0.0,1.0,0.0
Intoxication,0.0,0.0,1.0,0.0
Spatial exploration,0.0,0.0,0.0,1.0
Phonological similarity,1.0,0.0,0.0,0.0
Perceptual spaces,1.0,0.0,0.0,0.0
Mini-Mental state examination (MMSE),0.0,0.0,1.0,0.0
Brain fractional ratio,0.0,1.0,0.0,0.0
Adaptive gating,0.0,0.0,1.0,0.0
Treatment Target Test Dementia,1.0,0.0,0.0,0.0
Cost,0.0,1.0,0.0,0.0
Emotion matching,1.0,0.0,0.0,0.0
Somatosensory evoked potential,1.0,0.0,0.0,0.0
Taking a walk,0.0,0.0,1.0,0.0
Hyperfrontality,0.0,0.0,1.0,0.0
Sneaky mating,0.0,0.0,1.0,0.0
fear conditioning,0.0,0.0,1.0,0.0
Cognitive manifestations,0.0,1.0,0.0,0.0
Risk perception,0.0,0.0,1.0,0.0
psychomotor slowing,0.0,1.0,0.0,0.0
Coronary artery bypass,0.0,1.0,0.0,0.0
Calorie restriction,0.0,0.0,0.0,1.0
Processing phases,0.0,0.0,1.0,0.0
pedestrian,0.0,0.0,1.0,0.0
Movie,0.0,0.0,0.0,1.0
Intermediate group,0.0,1.0,0.0,0.0
Time reference,0.0,0.0,1.0,0.0
LIP-FEF,0.0,1.0,0.0,0.0
S-R compatibility,0.0,0.0,1.0,0.0
perceptual matching,0.0,1.0,0.0,0.0
Gamma coherence,0.0,0.0,1.0,0.0
APOE ?4,1.0,0.0,0.0,0.0
Collective decision making,1.0,0.0,0.0,0.0
Perceptual unit,0.0,0.0,1.0,0.0
Contingency awareness,1.0,0.0,0.0,0.0
Involuntary browsing,1.0,0.0,0.0,0.0
Temporal bisection,0.0,1.0,0.0,0.0
Visual scanning training,0.0,0.0,1.0,0.0
Chronic solvent encephalopathy,0.0,0.0,1.0,0.0
SemRep,0.0,0.0,0.0,1.0
Low-grade gliomas,0.0,0.0,1.0,0.0
Video quality,0.0,0.0,1.0,0.0
Hypobaric,0.0,0.0,1.0,0.0
engagement,0.0,0.0,1.0,0.0
Causal asymmetry,0.0,1.0,0.0,0.0
developmental robotics,0.0,0.0,1.0,0.0
Spans,0.0,0.0,1.0,0.0
Sensory/functional theory (SFT),0.0,1.0,0.0,0.0
Spatial Stroop,0.0,1.0,0.0,0.0
Posttraumatic headaches,0.0,0.0,0.0,1.0
bottom-up,0.0,1.0,0.0,0.0
United States,0.0,0.0,1.0,0.0
Observation,0.0,0.0,1.0,0.0
SHR,0.0,1.0,0.0,0.0
reading span,0.0,0.0,1.0,0.0
intractable epilepsy,1.0,0.0,0.0,0.0
Canonical bicoherence (CBC),0.0,1.0,0.0,0.0
Blood alcohol concentration curve,1.0,0.0,0.0,0.0
Behavioral disturbance,0.0,0.0,1.0,0.0
Fast & frugal heuristics,0.0,0.0,1.0,0.0
Eye contact effect,0.0,1.0,0.0,0.0
measurement,0.0,0.0,1.0,0.0
CO poisoning,0.0,0.0,0.0,1.0
Masked negative priming,0.0,0.0,1.0,0.0
Conjunction search,0.0,0.0,1.0,0.0
Metal ionophore,0.0,0.0,0.0,1.0
Child language disorder,0.0,1.0,0.0,0.0
Interhemispheric inhibition,0.0,1.0,0.0,0.0
Grammar,0.0,0.0,0.0,1.0
Sound,0.0,0.0,0.0,1.0
Featural and configural processing,0.0,0.0,0.0,1.0
Image matching,0.0,1.0,0.0,0.0
Potamotrygon castexi,1.0,0.0,0.0,0.0
Psychogenic nonepileptic seizures,1.0,0.0,0.0,0.0
kidney replacement therapy,0.0,0.0,1.0,0.0
Forensic toxicology,0.0,1.0,0.0,0.0
Visual impressions,1.0,0.0,0.0,0.0
Hebrew,1.0,0.0,0.0,0.0
MOLNEURO,0.0,1.0,0.0,0.0
rolandic epilepsy,0.0,1.0,0.0,0.0
behavioral assessment,0.0,1.0,0.0,0.0
online emotion regulation,0.0,0.0,1.0,0.0
Surgical procedures,1.0,0.0,0.0,0.0
n-back,0.0,0.0,1.0,0.0
human information processing,0.0,0.0,1.0,0.0
Visuomotor and motor neurons,1.0,0.0,0.0,0.0
cognitive performances,1.0,0.0,0.0,0.0
FMRI adaptation,0.0,0.0,0.0,1.0
Home base,0.0,1.0,0.0,0.0
Chinese compounds,0.0,1.0,0.0,0.0
Kinks,0.0,0.0,1.0,0.0
Psychometric tests,0.0,1.0,0.0,0.0
Aspects of mood,0.0,1.0,0.0,0.0
Prototyping,1.0,0.0,0.0,0.0
Motor response inhibition,0.0,1.0,0.0,0.0
Subjective report,0.0,1.0,0.0,0.0
objective analysis,0.0,0.0,1.0,0.0
Disease-modifying therapy,0.0,0.0,1.0,0.0
Other-race,0.0,0.0,1.0,0.0
Spatial search task,0.0,0.0,1.0,0.0
Nrf2,1.0,0.0,0.0,0.0
Political science,0.0,0.0,1.0,0.0
Brain adaptation,0.0,0.0,1.0,0.0
Nicotinic partial agonists,0.0,0.0,1.0,0.0
Androstadienone,1.0,0.0,0.0,0.0
Diphenhydramine,0.0,0.0,1.0,0.0
Lateral interaction,0.0,1.0,0.0,0.0
Letter migration errors,0.0,0.0,1.0,0.0
Asymptotic test,0.0,0.0,1.0,0.0
intraindividual variability,0.0,0.0,1.0,0.0
Placing,0.0,0.0,1.0,0.0
agomelatine,0.0,0.0,0.0,1.0
"Child development,0.0,0.0,0.0,0.0
Crocuta crocuta,0.0,0.0,1.0,0.0
Topographic Mapping of Event-Related Brain Potentials",1.0,0.0,0.0,0.0
brain volumes,0.0,1.0,0.0,0.0
HUI2/3,0.0,0.0,1.0,0.0
design research,0.0,0.0,1.0,0.0
Action judgement,0.0,1.0,0.0,0.0
Disorientation,1.0,0.0,0.0,0.0
Direct mapping,0.0,0.0,1.0,0.0
Labrune syndrome,0.0,1.0,0.0,0.0
Circadian rhythm of blood pressure,0.0,0.0,1.0,0.0
Rehabilitation/methods,0.0,0.0,1.0,0.0
Distributional effects,1.0,0.0,0.0,0.0
I{dotless}sland living,0.0,1.0,0.0,0.0
Top-down factors,0.0,0.0,0.0,1.0
Reading and spelling,1.0,0.0,0.0,0.0
Children's intuitions,0.0,0.0,1.0,0.0
EXPRESS,0.0,0.0,0.0,1.0
Stimulus specificity,0.0,1.0,0.0,0.0
Zen meditation,0.0,0.0,1.0,0.0
delayed alternation task,0.0,0.0,0.0,1.0
Late negative component,1.0,0.0,0.0,0.0
Cognitive conspicuity,0.0,0.0,1.0,0.0
Motor disorders,0.0,0.0,1.0,0.0
Congenital heart defect,0.0,1.0,0.0,0.0
Parental longevity,0.0,0.0,0.0,1.0
High funtioning autism,1.0,0.0,0.0,0.0
Inuit health,0.0,1.0,0.0,0.0
Cytokine,0.0,1.0,0.0,0.0
Steady-state visual evoked potentials (SSVEP),0.0,1.0,0.0,0.0
Serial search,0.0,1.0,0.0,0.0
Grounding cognition in perception,0.0,0.0,0.0,1.0
Recognition-without-recall,0.0,0.0,0.0,1.0
Affective and cognitive disorders,1.0,0.0,0.0,0.0
Animate/inanimate dichotomy,0.0,1.0,0.0,0.0
Ketotifen,0.0,1.0,0.0,0.0
neural coding,0.0,0.0,1.0,0.0
interaction design,0.0,0.0,1.0,0.0
Perception and psychophysics,0.0,0.0,1.0,0.0
Cancellation tests,0.0,1.0,0.0,0.0
Hormonal therapy,1.0,0.0,0.0,0.0
Digital communications network,1.0,0.0,0.0,0.0
Beta patterns,0.0,0.0,1.0,0.0
Landmark and route knowledge,0.0,0.0,1.0,0.0
Adverse drug reaction,0.0,0.0,1.0,0.0
D-amphetamine,0.0,0.0,1.0,0.0
Impression Formation,1.0,0.0,0.0,0.0
Modulation transfer functions,0.0,0.0,1.0,0.0
Personal protective equipment,0.0,0.0,1.0,0.0
Visuoconstructional disability,0.0,0.0,1.0,0.0
Semantic preview benefit,0.0,1.0,0.0,0.0
Sensory-dependent knowledge,0.0,0.0,1.0,0.0
Conflict and Survival",0.0,0.0,0.0,0.0
Grip strength,0.0,0.0,1.0,0.0
Event representation,0.0,0.0,1.0,0.0
Polydipsia,0.0,1.0,0.0,0.0
Markov random field,0.0,1.0,0.0,0.0
Contrast sensitivity function,0.0,0.0,1.0,0.0
Visual marking,0.0,0.0,1.0,0.0
Normative estimates,1.0,0.0,0.0,0.0
hearing impairment,0.0,1.0,0.0,0.0
Tear break-up time,0.0,1.0,0.0,0.0
clusterin,0.0,0.0,1.0,0.0
East Asians,0.0,0.0,1.0,0.0
Art therapy protocol,0.0,1.0,0.0,0.0
Ischemic heart disease,0.0,1.0,0.0,0.0
Brain-damaged patients,0.0,0.0,1.0,0.0
Decorum,0.0,0.0,1.0,0.0
Mobility limitations,1.0,0.0,0.0,0.0
Nootropic drugs,0.0,1.0,0.0,0.0
General cognitive slowing,0.0,1.0,0.0,0.0
affect discrimination,0.0,0.0,0.0,1.0
Cognitive processing and virtual environments,0.0,1.0,0.0,0.0
Selection negativity,0.0,0.0,0.0,1.0
Spatial orientation-acquisition,1.0,0.0,0.0,0.0
Structural salience,0.0,0.0,0.0,1.0
Search task,1.0,0.0,0.0,0.0
Go/nogo,0.0,0.0,1.0,0.0
Nonamnestic,1.0,0.0,0.0,0.0
Sleep mention,0.0,1.0,0.0,0.0
Spatial correspondence,1.0,0.0,0.0,0.0
Neuropsychological tests accuracy,0.0,0.0,1.0,0.0
Epigallocatechin gallate,1.0,0.0,0.0,0.0
Stable tubule-only polypeptide (STOP),0.0,0.0,1.0,0.0
transcranial magnetotherapy,0.0,0.0,0.0,1.0
Positive airway pressure,0.0,1.0,0.0,0.0
cognitive deficit,0.0,1.0,0.0,0.0
Contemporary,0.0,0.0,1.0,0.0
functional capacity,0.0,0.0,1.0,0.0
Scaling factor,0.0,0.0,1.0,0.0
Linguistic theory,1.0,0.0,0.0,0.0
heuristic and biases,0.0,0.0,1.0,0.0
Temporal reference,0.0,0.0,1.0,0.0
Stroke subtypes,0.0,0.0,0.0,1.0
Olomouc,0.0,0.0,0.0,0.0
Discrimination learning with errors representations,0.0,0.0,1.0,0.0
Primacy effect,1.0,0.0,0.0,0.0
Brain rewiring,0.0,1.0,0.0,0.0
WWC1,1.0,0.0,0.0,0.0
Visual working memory with categorization,1.0,0.0,0.0,0.0
Hippocampal cortex,0.0,0.0,0.0,1.0
Allocentric space,0.0,1.0,0.0,0.0
Bottom-up and top-down,0.0,1.0,0.0,0.0
HBO,0.0,0.0,1.0,0.0
Coronary bypass grafting,1.0,0.0,0.0,0.0
EEG-rhythms,1.0,0.0,0.0,0.0
Long-acting beta agonists (LABA),0.0,1.0,0.0,0.0
Weaning,0.0,0.0,1.0,0.0
Visual information representation,0.0,0.0,1.0,0.0
Learning ability,0.0,1.0,0.0,0.0
in vivo,0.0,1.0,0.0,0.0
Visual shape perception,1.0,0.0,0.0,0.0
Markov random fields,0.0,1.0,0.0,0.0
Brain stem,0.0,0.0,1.0,0.0
Rhyming,0.0,0.0,1.0,0.0
pyridoxine-dependent epilepsy,1.0,0.0,0.0,0.0
statistical genetics,0.0,0.0,1.0,0.0
Perceptual focus,0.0,1.0,0.0,0.0
Global alexia,0.0,0.0,1.0,0.0
"Cholinesterase inhibitors,0.0,0.0,0.0,0.0
Cooking,0.0,0.0,0.0,1.0
Transient sounds,0.0,0.0,1.0,0.0
Visuotactile interactions,0.0,0.0,1.0,0.0
Biometrics,0.0,0.0,1.0,0.0
Robotic-assisted rehabilitation,0.0,1.0,0.0,0.0
Visual and Auditory Stimuli,0.0,0.0,1.0,0.0
Configural face processing,0.0,0.0,1.0,0.0
Computer experience,0.0,0.0,1.0,0.0
Eye dominance,1.0,0.0,0.0,0.0
Machado-Joseph disease,1.0,0.0,0.0,0.0
Psychomotor effects,0.0,1.0,0.0,0.0
Developmental systems theory,0.0,0.0,1.0,0.0
gist,0.0,1.0,0.0,0.0
?2 nAChR,0.0,1.0,0.0,0.0
Single-nucleotide polymorphism,1.0,0.0,0.0,0.0
GTF2I gene,0.0,0.0,0.0,1.0
neuropsychological deficits,0.0,1.0,0.0,0.0
Persistent firing,0.0,1.0,0.0,0.0
Functional ability,0.0,1.0,0.0,0.0
REM sleep atonia,0.0,0.0,0.0,1.0
Auditory brainstem implant,0.0,0.0,1.0,0.0
rightward bias,0.0,0.0,1.0,0.0
Semantic action representation,0.0,1.0,0.0,0.0
Upper limb aplasia,0.0,0.0,1.0,0.0
Tunnel exit,1.0,0.0,0.0,0.0
Partial onset seizures,1.0,0.0,0.0,0.0
Many-to-one matching,0.0,1.0,0.0,0.0
Visual discomfort,0.0,0.0,0.0,1.0
psychological stress,0.0,0.0,0.0,1.0
Trust-based deferential beliefs,0.0,0.0,1.0,0.0
Thai,0.0,1.0,0.0,0.0
Manipulability,0.0,1.0,0.0,0.0
Map seeking circuit,1.0,0.0,0.0,0.0
D 2 receptor,0.0,0.0,1.0,0.0
Math disabilities,0.0,0.0,1.0,0.0
Hyposmia,0.0,0.0,0.0,1.0
Task analysis,1.0,0.0,0.0,0.0
Behavioral sensitization,0.0,0.0,1.0,0.0
CNS toxicity,0.0,0.0,1.0,0.0
Orientation and mobility training,0.0,0.0,1.0,0.0
Active maintenance,0.0,1.0,0.0,0.0
Agency detection,0.0,1.0,0.0,0.0
Agraphia,0.0,0.0,1.0,0.0
Chinsese characters,1.0,0.0,0.0,0.0
Multielectrode recordings,0.0,1.0,0.0,0.0
REM sleep deprivation,0.0,1.0,0.0,0.0
Psychological experiment,0.0,1.0,0.0,0.0
post-concussion syndrome,0.0,0.0,1.0,0.0
Neurobehavioral performances,1.0,0.0,0.0,0.0
Transient global amnesia,0.0,0.0,1.0,0.0
Autism Disorder (AD),0.0,0.0,1.0,0.0
Online experiments,0.0,1.0,0.0,0.0
Systems,0.0,1.0,0.0,0.0
Data visualisation,0.0,0.0,1.0,0.0
Neuroimaging (functional),0.0,0.0,1.0,0.0
Beta band,0.0,0.0,1.0,0.0
Parieto-medial temporal pathway,0.0,1.0,0.0,0.0
Alternating-switch costs,0.0,0.0,1.0,0.0
Chronic stress,0.0,1.0,0.0,0.0
Math across life span,0.0,0.0,1.0,0.0
Graphical modeling,0.0,0.0,1.0,0.0
Occasion setting,1.0,0.0,0.0,0.0
Group delay (GD),0.0,1.0,0.0,0.0
Nonlesional MRI,1.0,0.0,0.0,0.0
Environmental tobacco smoke,0.0,0.0,0.0,1.0
Breadth of attention,0.0,0.0,1.0,0.0
Early effects,1.0,0.0,0.0,0.0
Scientific and intellectual movements,0.0,0.0,1.0,0.0
Reward prediction,1.0,0.0,0.0,0.0
Syllable segmentation,1.0,0.0,0.0,0.0
Ventrolateral PFC,1.0,0.0,0.0,0.0
Audio description,0.0,0.0,1.0,0.0
Worked examples,0.0,0.0,0.0,1.0
FINST,0.0,0.0,1.0,0.0
Phenotyping,1.0,0.0,0.0,0.0
Convex polygon,1.0,0.0,0.0,0.0
Peripheral biomarker,0.0,1.0,0.0,0.0
Composite dental resin,0.0,0.0,0.0,1.0
Cognitive and behavioral neuroscience,1.0,0.0,0.0,0.0
Manual interception,0.0,0.0,1.0,0.0
Reliability and Validity,0.0,1.0,0.0,0.0
Intermittently binge,0.0,0.0,1.0,0.0
Hmd,0.0,0.0,1.0,0.0
Motor action recognition,0.0,1.0,0.0,0.0
Speech audiometry,0.0,1.0,0.0,0.0
cusp catastrophe,1.0,0.0,0.0,0.0
Reliability of the Visual Retention Test,0.0,1.0,0.0,0.0
Judgments under uncertainty,1.0,0.0,0.0,0.0
Handicap principle,0.0,1.0,0.0,0.0
Moving Shapes,0.0,1.0,0.0,0.0
Low-grade astrocytoma,0.0,1.0,0.0,0.0
go/no-go visual reaction time,1.0,0.0,0.0,0.0
Kabuki syndrome,0.0,0.0,0.0,1.0
Deficiency,0.0,1.0,0.0,0.0
cognitive distance,0.0,1.0,0.0,0.0
symptomatic domain,1.0,0.0,0.0,0.0
Conscious flow,0.0,0.0,1.0,0.0
"""Vague-to-crisp"",0.0,1.0,0.0,0.0
Action production,0.0,0.0,1.0,0.0
Identity aftereffects,0.0,0.0,1.0,0.0
Task constraints,1.0,0.0,0.0,0.0
Applied cognition,0.0,0.0,1.0,0.0
Disconnection syndrome,0.0,0.0,1.0,0.0
Sensory loss,0.0,1.0,0.0,0.0
Nisual evoked potential,0.0,1.0,0.0,0.0
Neutralization,0.0,0.0,1.0,0.0
Immunoadsorption,0.0,0.0,1.0,0.0
action comprehension,0.0,1.0,0.0,0.0
RHP,0.0,0.0,1.0,0.0
Category-based reasoning,0.0,0.0,1.0,0.0
Visual analogy,0.0,1.0,0.0,0.0
Packaging screening,0.0,1.0,0.0,0.0
COLOUR,1.0,0.0,0.0,0.0
Benton-Test,0.0,1.0,0.0,0.0
2340-Cognitive Processes,0.0,1.0,0.0,0.0
Three dimensions,0.0,0.0,1.0,0.0
Neurovisceral integration model,1.0,0.0,0.0,0.0
Activity Restriction,0.0,0.0,1.0,0.0
MAO-A,0.0,0.0,1.0,0.0
Disorganised,1.0,0.0,0.0,0.0
Environmental health,0.0,0.0,0.0,1.0
Brain monitoring,0.0,1.0,0.0,0.0
Inferential processes,0.0,0.0,1.0,0.0
Motion-2D,1.0,0.0,0.0,0.0
Experience level,0.0,1.0,0.0,0.0
Spatial processes,1.0,0.0,0.0,0.0
Assistive robotics,0.0,0.0,1.0,0.0
Differential benefits of training,0.0,0.0,1.0,0.0
Sensitive,0.0,1.0,0.0,0.0
Extrapyramidal cognitive impairment,1.0,0.0,0.0,0.0
neurocysticercosis,0.0,1.0,0.0,0.0
Spatial signature,0.0,0.0,0.0,1.0
Task-set reconfiguration,0.0,1.0,0.0,0.0
monitoring,1.0,0.0,0.0,0.0
Art theory,1.0,0.0,0.0,0.0
Hypermedia,0.0,0.0,1.0,0.0
Match-to-sample,0.0,0.0,1.0,0.0
Lesion load,0.0,0.0,1.0,0.0
Sage,0.0,0.0,1.0,0.0
N2 amplitude,0.0,0.0,1.0,0.0
Induced gamma band,1.0,0.0,0.0,0.0
Visual guidance,0.0,0.0,1.0,0.0
Visual-world eye tracking,0.0,0.0,1.0,0.0
Go-NoGo task,0.0,1.0,0.0,0.0
Fluctuation analysis,0.0,0.0,1.0,0.0
Offset capture,1.0,0.0,0.0,0.0
dose-effect profile,0.0,0.0,1.0,0.0
Asterix,0.0,0.0,1.0,0.0
Oniomania,0.0,0.0,1.0,0.0
Neuropsychological screening,0.0,0.0,0.0,1.0
Feedback-feedforward,0.0,0.0,1.0,0.0
Brodmann area 18,0.0,0.0,0.0,1.0
Brodmann area 10,0.0,1.0,0.0,0.0
Brodmann area 11,0.0,0.0,0.0,1.0
passengers,0.0,0.0,0.0,1.0
Medication organiser,0.0,1.0,0.0,0.0
SynWin,0.0,0.0,1.0,0.0
Information requirements,0.0,1.0,0.0,0.0
Equality,1.0,0.0,0.0,0.0
Sensory feedback,0.0,1.0,0.0,0.0
Usability Engineering (UE),1.0,0.0,0.0,0.0
Self-motives,0.0,0.0,1.0,0.0
Non-consumptive effects,0.0,1.0,0.0,0.0
Low-need residents,0.0,0.0,0.0,1.0
Hierarchically organized distributed cortical networks,1.0,0.0,0.0,0.0
Laterality effect,0.0,0.0,0.0,1.0
Life function,0.0,0.0,1.0,0.0
video coding,0.0,0.0,1.0,0.0
Engineering design,0.0,1.0,0.0,0.0
Regulatory policy,0.0,1.0,0.0,0.0
Arrow pointing,1.0,0.0,0.0,0.0
Logos,0.0,0.0,0.0,1.0
Methylphenidate-OROS,0.0,0.0,1.0,0.0
recurrence,1.0,0.0,0.0,0.0
Stressors,0.0,0.0,1.0,0.0
Obsessive-compulsive disorders,0.0,1.0,0.0,0.0
Verbal fluency task,1.0,0.0,0.0,0.0
Highrisk,0.0,1.0,0.0,0.0
Simple schizophrenia,1.0,0.0,0.0,0.0
Exercise environments,0.0,0.0,1.0,0.0
Map learning,0.0,1.0,0.0,0.0
15M,1.0,0.0,0.0,0.0
Timefrequency analysis,0.0,1.0,0.0,0.0
Infant temperament,0.0,0.0,1.0,0.0
Neurotoxicology,0.0,0.0,1.0,0.0
allocentric,0.0,1.0,0.0,0.0
Illicit drugs,0.0,1.0,0.0,0.0
Subtype,0.0,1.0,0.0,0.0
Madness,0.0,0.0,1.0,0.0
Children's language comprehension,0.0,0.0,0.0,1.0
"Alzheimer Disease Assessment Scale,0.0,0.0,0.0,0.0
Stop N2/P3,0.0,0.0,1.0,0.0
Local and global processing,0.0,0.0,1.0,0.0
CIAIS systems,0.0,0.0,1.0,0.0
Maya,0.0,0.0,1.0,0.0
Predictive gaze,0.0,0.0,0.0,1.0
Central Europe,0.0,0.0,1.0,0.0
Real-time head localization,0.0,0.0,1.0,0.0
spatial awareness,0.0,0.0,1.0,0.0
Incident delirium,0.0,1.0,0.0,0.0
cortical areas,1.0,0.0,0.0,0.0
Political evaluation,0.0,0.0,1.0,0.0
action video game,0.0,1.0,0.0,0.0
Hormonotherapy,0.0,1.0,0.0,0.0
transsaccadic memory,1.0,0.0,0.0,0.0
design task,0.0,0.0,1.0,0.0
Index of multiple deprivation,0.0,1.0,0.0,0.0
interaction technique,0.0,1.0,0.0,0.0
N-methyl-D-aspartate receptor,0.0,0.0,1.0,0.0
Spinocerebellar ataxia type 6,0.0,0.0,1.0,0.0
Global local,0.0,1.0,0.0,0.0
Spinocerebellar ataxia type 2,0.0,0.0,1.0,0.0
ice hockey,0.0,0.0,1.0,0.0
Hepatic insufficiency,0.0,1.0,0.0,0.0
Compensation strategies,0.0,1.0,0.0,0.0
Falls risk,0.0,1.0,0.0,0.0
DWI lesion,1.0,0.0,0.0,0.0
Regional brain metabolism,0.0,0.0,1.0,0.0
Fetal Alcohol Spectrum Disorders,1.0,0.0,0.0,0.0
soy,0.0,1.0,0.0,0.0
Comprehension strategies,0.0,0.0,1.0,0.0
ADHA,0.0,1.0,0.0,0.0
Scottishness,0.0,0.0,0.0,1.0
psychological and social aspects,1.0,0.0,0.0,0.0
Somatic code,0.0,0.0,1.0,0.0
Fed,0.0,0.0,0.0,1.0
Creatinine,0.0,0.0,1.0,0.0
Mean directional error,1.0,0.0,0.0,0.0
MPH,1.0,0.0,0.0,0.0
Real and imaginary,0.0,0.0,1.0,0.0
Visuoconstructional disorders,0.0,1.0,0.0,0.0
Word similarity,1.0,0.0,0.0,0.0
Obstructive sleep apnea syndrome (OSAS),0.0,1.0,0.0,0.0
Social self-esteem,0.0,0.0,1.0,0.0
Disappearing text,1.0,0.0,0.0,0.0
Higher order visual cortices,1.0,0.0,0.0,0.0
Stroke Drivers Screening Assessment,0.0,1.0,0.0,0.0
null trials,0.0,0.0,1.0,0.0
Time forms,0.0,1.0,0.0,0.0
Transmitter receptors,0.0,0.0,1.0,0.0
Expressive power,0.0,0.0,1.0,0.0
Smoking abstinence,0.0,0.0,1.0,0.0
Semantic frames,0.0,1.0,0.0,0.0
Idiom,0.0,0.0,1.0,0.0
RNA sequencing,0.0,0.0,1.0,0.0
Greyscales,0.0,0.0,1.0,0.0
Context-awareness,0.0,1.0,0.0,0.0
Predicting cues,0.0,1.0,0.0,0.0
adaptive combination,0.0,0.0,1.0,0.0
IReST reading test,0.0,1.0,0.0,0.0
Gestalt organizational principles,0.0,0.0,1.0,0.0
EEG Coherence,1.0,0.0,0.0,0.0
Expectancy challenge,1.0,0.0,0.0,0.0
Inertial perturbation,0.0,1.0,0.0,0.0
Cue-target paradigm,1.0,0.0,0.0,0.0
delayed matching-to-sample,0.0,0.0,1.0,0.0
visual representation,0.0,0.0,1.0,0.0
Life style,0.0,0.0,1.0,0.0
Polydrug,0.0,0.0,1.0,0.0
diffrences bases sur le sexe,0.0,1.0,0.0,0.0
Catheter ablation,0.0,0.0,0.0,1.0
Spatial layout,0.0,0.0,1.0,0.0
DRC,1.0,0.0,0.0,0.0
Situation management factor,0.0,0.0,1.0,0.0
Global cerebral ischemia,0.0,1.0,0.0,0.0
Organizational memory,0.0,1.0,0.0,0.0
Sex chromosome,0.0,1.0,0.0,0.0
Community structure,0.0,1.0,0.0,0.0
live video,0.0,0.0,1.0,0.0
VGLUT1,0.0,0.0,1.0,0.0
Activity-dependent neuroprotective protein,0.0,0.0,1.0,0.0
Treatment modeling,1.0,0.0,0.0,0.0
Protention,0.0,0.0,1.0,0.0
Audiovisual priming,0.0,0.0,0.0,1.0
Phonological consistency,0.0,0.0,1.0,0.0
High-density EEG,0.0,1.0,0.0,0.0
Caricatures,0.0,1.0,0.0,0.0
measures of abuse potential,1.0,0.0,0.0,0.0
Good gestalt,1.0,0.0,0.0,0.0
Red blood cell transfusion,1.0,0.0,0.0,0.0
perceptual tightness,0.0,0.0,1.0,0.0
Linguistic distributional knowledge,0.0,1.0,0.0,0.0
Vehicle theory,0.0,0.0,1.0,0.0
Subarachnoid haemorrhage (SAH),0.0,1.0,0.0,0.0
Python,0.0,0.0,0.0,1.0
Oral health,0.0,0.0,1.0,0.0
Deactivations,1.0,0.0,0.0,0.0
Western scrub-jays,0.0,0.0,1.0,0.0
Painters,0.0,0.0,0.0,1.0
Electroencephalo-graphy,0.0,0.0,1.0,0.0
Positive valence,0.0,0.0,1.0,0.0
Oppositional behavior,0.0,1.0,0.0,0.0
NMO,1.0,0.0,0.0,0.0
Central nervous system diseases,0.0,0.0,1.0,0.0
Genetic overlap,1.0,0.0,0.0,0.0
HMG-CoA reductase inhibitor,0.0,0.0,1.0,0.0
Functional compensation,0.0,0.0,1.0,0.0
Power density,0.0,0.0,1.0,0.0
Novel environment,0.0,0.0,0.0,1.0
Steady-state potential,0.0,1.0,0.0,0.0
Infant looking,0.0,1.0,0.0,0.0
Tacit-knowledge,1.0,0.0,0.0,0.0
Right-neglect,1.0,0.0,0.0,0.0
LOR- ETA,0.0,0.0,0.0,1.0
Subjective memory impairment,0.0,0.0,1.0,0.0
Infection,0.0,1.0,0.0,0.0
"Children,0.0,0.0,0.0,0.0
Blocks,0.0,1.0,0.0,0.0
Xanomeline,0.0,0.0,1.0,0.0
Transparent barrier,0.0,1.0,0.0,0.0
?-oscillations,0.0,0.0,1.0,0.0
Serial prediction task,0.0,0.0,1.0,0.0
Executive processing,0.0,1.0,0.0,0.0
Functional observational battery,0.0,1.0,0.0,0.0
Gap-filling,1.0,0.0,0.0,0.0
Personality attribution,0.0,1.0,0.0,0.0
visual arts,0.0,1.0,0.0,0.0
Developmental right hemisphere syndrome,0.0,0.0,0.0,1.0
Dopamine d-lifescience receptor,0.0,1.0,0.0,0.0
Voriconazole,0.0,0.0,1.0,0.0
digital sketching environment,0.0,0.0,1.0,0.0
affective illness,1.0,0.0,0.0,0.0
Function words,1.0,0.0,0.0,0.0
Wechsler memory scale-revised,0.0,0.0,1.0,0.0
Human olfactory system,0.0,0.0,1.0,0.0
Stem cell,0.0,0.0,1.0,0.0
lPFC,0.0,0.0,1.0,0.0
Stress disorders,0.0,0.0,1.0,0.0
attention deficit,0.0,0.0,1.0,0.0
age-based testing (ABT),0.0,0.0,1.0,0.0
MCI Alzheimer,0.0,1.0,0.0,0.0
Proportion,0.0,0.0,1.0,0.0
Alpha-lactalbulmin,0.0,1.0,0.0,0.0
short-latency ERP component,0.0,0.0,1.0,0.0
CogSport,0.0,0.0,0.0,1.0
Flame retardant,0.0,0.0,1.0,0.0
Food hedonics,0.0,1.0,0.0,0.0
Prognostic factors,0.0,1.0,0.0,0.0
Cytochrome P-450 enzyme system,0.0,1.0,0.0,0.0
D.C.,0.0,1.0,0.0,0.0
Visual line bisection,0.0,0.0,1.0,0.0
Pop out effect,0.0,0.0,1.0,0.0
Alcoholics,0.0,0.0,1.0,0.0
maturation,0.0,0.0,1.0,0.0
B-mode ultrasound,0.0,0.0,1.0,0.0
?Amyloid,0.0,0.0,1.0,0.0
Sharing platform,0.0,1.0,0.0,0.0
spatial perception,0.0,1.0,0.0,0.0
Matching familiar figures test,0.0,0.0,1.0,0.0
Space and motion discomfort,0.0,0.0,1.0,0.0
visual variant of Alzheimer's disease,1.0,0.0,0.0,0.0
Breath Alcohol Concentration (BrAC),0.0,0.0,1.0,0.0
Letter access,0.0,1.0,0.0,0.0
Prism bar vergences,1.0,0.0,0.0,0.0
Repetitive behavior,0.0,1.0,0.0,0.0
Subcortical pathway,0.0,1.0,0.0,0.0
Accumulator models,0.0,1.0,0.0,0.0
Amygdalohippocampectomy,0.0,0.0,0.0,1.0
Motricity,0.0,0.0,1.0,0.0
Pursuit,1.0,0.0,0.0,0.0
View matching,0.0,0.0,1.0,0.0
Vehicle emissions,0.0,0.0,1.0,0.0
Physical strength,0.0,0.0,1.0,0.0
Cognates,1.0,0.0,0.0,0.0
Neurospychology,0.0,0.0,1.0,0.0
Automobile,0.0,1.0,0.0,0.0
Object-decision task,0.0,0.0,1.0,0.0
Task-based activation,1.0,0.0,0.0,0.0
aftereffects,0.0,1.0,0.0,0.0
Eye Movement,0.0,0.0,0.0,1.0
facial affect processing,1.0,0.0,0.0,0.0
Automatic comparison,0.0,1.0,0.0,0.0
Gunnison's prairie dogs,0.0,1.0,0.0,0.0
Visual streams,0.0,1.0,0.0,0.0
fluvoxamine,0.0,0.0,1.0,0.0
self-concept,0.0,1.0,0.0,0.0
Bright light exposure,0.0,0.0,0.0,1.0
Fetal alcohol syndrome (FAS),0.0,0.0,1.0,0.0
Multilevel analysis,0.0,0.0,1.0,0.0
Infant growth,0.0,0.0,1.0,0.0
sensory-mental task,0.0,0.0,1.0,0.0
3D topographic map,0.0,0.0,0.0,1.0
Developmental Test of Visual Perception - Adolescents and Adults (DTVP-A),0.0,1.0,0.0,0.0
Cross cultural differences,0.0,1.0,0.0,0.0
Arousal and valence,1.0,0.0,0.0,0.0
Inferior frontal cortex,0.0,0.0,0.0,1.0
Aspergers Syndrome,0.0,0.0,1.0,0.0
Infectious diseases,0.0,1.0,0.0,0.0
Troms Study,1.0,0.0,0.0,0.0
Medical students,0.0,1.0,0.0,0.0
social movements,1.0,0.0,0.0,0.0
Brief psychotic disorder,1.0,0.0,0.0,0.0
Thatcher illusion,0.0,0.0,1.0,0.0
Beta-blocker,1.0,0.0,0.0,0.0
Ocular motor delayed response,0.0,0.0,1.0,0.0
Hyperopia,0.0,0.0,1.0,0.0
Very low birth weight children,1.0,0.0,0.0,0.0
Ventriculoperitoneal shunt,0.0,0.0,0.0,1.0
Hollow-face illusion,0.0,1.0,0.0,0.0
Semantic categorization,0.0,0.0,1.0,0.0
Neurodevelopmental disorder,1.0,0.0,0.0,0.0
schools,1.0,0.0,0.0,0.0
emergent features,0.0,1.0,0.0,0.0
Perceived arousal,0.0,1.0,0.0,0.0
Neurodevelopmental model,0.0,0.0,1.0,0.0
Ventriculomegaly,0.0,1.0,0.0,0.0
sodium valproate,0.0,0.0,1.0,0.0
Global cognitive status,0.0,0.0,1.0,0.0
Tilt,0.0,0.0,0.0,1.0
Global field power,0.0,1.0,0.0,0.0
Socioemotional difficulties,1.0,0.0,0.0,0.0
neurocognitive assessment,0.0,0.0,1.0,0.0
Scyllo-inositol,0.0,0.0,1.0,0.0
Communication device for hearing impaired,1.0,0.0,0.0,0.0
Interference task,0.0,0.0,0.0,1.0
Nogo,0.0,0.0,1.0,0.0
3Rs,0.0,1.0,0.0,0.0
Invasive recordings,0.0,1.0,0.0,0.0
Utility maximization,1.0,0.0,0.0,0.0
Paediatrics,1.0,0.0,0.0,0.0
BALB/c,0.0,1.0,0.0,0.0
Interpretative phenomenological analysis,0.0,0.0,1.0,0.0
Cognitive enrichment,0.0,1.0,0.0,0.0
Human body movement,0.0,0.0,1.0,0.0
Dynamic scenes,1.0,0.0,0.0,0.0
Female rats,1.0,0.0,0.0,0.0
Chunk decomposition,0.0,1.0,0.0,0.0
Spatial pattern classification,0.0,0.0,1.0,0.0
Auditory space cognition,1.0,0.0,0.0,0.0
Cognitive disorders/dementia,0.0,0.0,1.0,0.0
Persistence,0.0,1.0,0.0,0.0
component phenotype,0.0,0.0,1.0,0.0
Acute stress disorder,0.0,1.0,0.0,0.0
Cognitive simulation,1.0,0.0,0.0,0.0
Compensatory activity,0.0,0.0,1.0,0.0
Course of illness,0.0,0.0,0.0,1.0
Spatial awareness,0.0,0.0,1.0,0.0
sumatriptan-naproxen,0.0,1.0,0.0,0.0
Biathlon shooting,1.0,0.0,0.0,0.0
Parent-child relationships,1.0,0.0,0.0,0.0
Video goggles,0.0,1.0,0.0,0.0
substantia nigra,0.0,1.0,0.0,0.0
Reflectance,0.0,0.0,1.0,0.0
Implicit face processing,0.0,1.0,0.0,0.0
single trial,1.0,0.0,0.0,0.0
Serial Reaction Time,1.0,0.0,0.0,0.0
females,0.0,0.0,1.0,0.0
Audience effect,0.0,1.0,0.0,0.0
School atlas,1.0,0.0,0.0,0.0
Oddball detection task,0.0,0.0,0.0,1.0
Same-different judgment,0.0,1.0,0.0,0.0
Neurotoxic disease,0.0,0.0,1.0,0.0
Brain's orbits,1.0,0.0,0.0,0.0
Vegetation detection,0.0,0.0,1.0,0.0
Inner language,0.0,0.0,0.0,1.0
Continence,0.0,0.0,1.0,0.0
neighborhood size,1.0,0.0,0.0,0.0
Mayer-salovey-caruso emotional intelligence test (MSCEIT),0.0,1.0,0.0,0.0
False photograph,0.0,1.0,0.0,0.0
NMO-IgG,0.0,1.0,0.0,0.0
Opto-cinetic system,0.0,0.0,1.0,0.0
etiology,0.0,0.0,1.0,0.0
Multi-system manifestation,1.0,0.0,0.0,0.0
GRK,1.0,0.0,0.0,0.0
GRN,0.0,0.0,1.0,0.0
neuroendocrine function,0.0,0.0,1.0,0.0
Cortical control,0.0,0.0,0.0,1.0
Acoustic cues,0.0,0.0,1.0,0.0
subitizing,0.0,0.0,1.0,0.0
inferior parietal lobule,0.0,0.0,1.0,0.0
Cognitive tunneling,0.0,1.0,0.0,0.0
Cholinergic innervation,0.0,0.0,1.0,0.0
Dioxin,0.0,0.0,1.0,0.0
Connexin,1.0,0.0,0.0,0.0
ASSR,0.0,0.0,1.0,0.0
Eyedness,0.0,0.0,1.0,0.0
Sit-to-stand,1.0,0.0,0.0,0.0
Mental-state,0.0,1.0,0.0,0.0
Paus,0.0,1.0,0.0,0.0
Visualiser,0.0,1.0,0.0,0.0
frontal areas,0.0,0.0,1.0,0.0
Online embodiment,0.0,0.0,1.0,0.0
continuous flash suppression,0.0,1.0,0.0,0.0
Target rarity,0.0,1.0,0.0,0.0
Alternative transportation,1.0,0.0,0.0,0.0
Insulin pump therapy,0.0,1.0,0.0,0.0
analysis of error behavior,0.0,0.0,1.0,0.0
Hard-of-hearing,0.0,0.0,1.0,0.0
Biological sciences",0.0,0.0,0.0,0.0
6-[18F]fluoro-l-dopa (Fdopa),0.0,1.0,0.0,0.0
visual photo stimuli,0.0,0.0,0.0,1.0
locus coeruleus,0.0,1.0,0.0,0.0
well being,0.0,1.0,0.0,0.0
Shared circuits,0.0,0.0,1.0,0.0
Calcitrol,0.0,0.0,1.0,0.0
Manual localization,0.0,0.0,1.0,0.0
Imaginary reality,1.0,0.0,0.0,0.0
Temporal sequence,0.0,1.0,0.0,0.0
spatial reference frames,0.0,1.0,0.0,0.0
Cyclohexylamine,0.0,1.0,0.0,0.0
Phytoestrogen,0.0,0.0,1.0,0.0
Temporal lobe function,1.0,0.0,0.0,0.0
reorientation,0.0,0.0,1.0,0.0
micronized progesterone,0.0,1.0,0.0,0.0
mGluR1,0.0,1.0,0.0,0.0
Symbol-Digit Test,1.0,0.0,0.0,0.0
Chronic obstructive pulmonary disease (COPD),0.0,1.0,0.0,0.0
Cyber-ostracism,0.0,1.0,0.0,0.0
Flexible remembering,1.0,0.0,0.0,0.0
Spatio-temporal waves,0.0,0.0,1.0,0.0
age difference,0.0,0.0,1.0,0.0
Interest in infants,0.0,0.0,1.0,0.0
Stimulant medications,0.0,0.0,1.0,0.0
D-Serine,0.0,1.0,0.0,0.0
Pseudohomophones,0.0,1.0,0.0,0.0
Compensation of disturbances of balance,0.0,0.0,1.0,0.0
Dual State Theory,0.0,1.0,0.0,0.0
common representation,0.0,0.0,0.0,1.0
Polysubstance,0.0,1.0,0.0,0.0
Scientific communication,0.0,0.0,1.0,0.0
Science,0.0,1.0,0.0,0.0
breeding,1.0,0.0,0.0,0.0
Visual atrophy rating scale,0.0,0.0,1.0,0.0
Motor comand,0.0,0.0,1.0,0.0
Diversity,0.0,1.0,0.0,0.0
Face area,0.0,1.0,0.0,0.0
Task co-occurrence,0.0,0.0,0.0,1.0
Harbour seal,0.0,1.0,0.0,0.0
Multisensory processing,0.0,1.0,0.0,0.0
Somatostatin,0.0,1.0,0.0,0.0
Kanji learning approach,0.0,1.0,0.0,0.0
WAIS-R scores,0.0,1.0,0.0,0.0
Plasma amyloid,0.0,1.0,0.0,0.0
atypical antipsychotic drugs,0.0,1.0,0.0,0.0
Visual world,0.0,1.0,0.0,0.0
Multidisciplinary approach,1.0,0.0,0.0,0.0
motor expertise,0.0,1.0,0.0,0.0
Fish cognition,1.0,0.0,0.0,0.0
Interpersonal information processing,0.0,0.0,1.0,0.0
Spatial scale,0.0,0.0,1.0,0.0
Human milk,0.0,1.0,0.0,0.0
Eq-5d,1.0,0.0,0.0,0.0
Multivariate regression,0.0,1.0,0.0,0.0
Face module,1.0,0.0,0.0,0.0
Surgical resection,0.0,0.0,0.0,1.0
electroencephalography (EEG),1.0,0.0,0.0,0.0
Neurocognitive evaluation,0.0,0.0,1.0,0.0
Transitional landscaping,0.0,0.0,1.0,0.0
Elephants,0.0,0.0,1.0,0.0
Negative pictures,0.0,0.0,0.0,1.0
Affect induction,0.0,0.0,1.0,0.0
Interhemispheric connection,0.0,0.0,1.0,0.0
Molecular interaction networks,0.0,1.0,0.0,0.0
Work disability,0.0,1.0,0.0,0.0
Object parts,0.0,0.0,1.0,0.0
Attention guidance,0.0,0.0,1.0,0.0
emotional congruence,1.0,0.0,0.0,0.0
2320,0.0,0.0,1.0,0.0
Temperature,0.0,1.0,0.0,0.0
KeenMind,0.0,1.0,0.0,0.0
Information fusion,0.0,0.0,0.0,1.0
language switching,1.0,0.0,0.0,0.0
Spatial-information processing,0.0,1.0,0.0,0.0
high-risk,0.0,0.0,0.0,1.0
SCA2,0.0,1.0,0.0,0.0
modality specificity,1.0,0.0,0.0,0.0
Moral,0.0,0.0,1.0,0.0
Tourist Maps,0.0,1.0,0.0,0.0
Beta coherence,0.0,0.0,1.0,0.0
Stereology,1.0,0.0,0.0,0.0
Movement trajectories,1.0,0.0,0.0,0.0
3 T static magnetic field,0.0,0.0,0.0,1.0
Monetary judgments,0.0,0.0,1.0,0.0
Avatar,0.0,0.0,1.0,0.0
SIVD,0.0,0.0,1.0,0.0
emotion overgeneralization,1.0,0.0,0.0,0.0
Memory updating,1.0,0.0,0.0,0.0
cognitive therapy,1.0,0.0,0.0,0.0
Single case study design methods,0.0,1.0,0.0,0.0
visual awareness,0.0,0.0,1.0,0.0
Delinquency,0.0,0.0,1.0,0.0
Neural development,0.0,0.0,1.0,0.0
prolonged intensive care,0.0,1.0,0.0,0.0
PRSD,0.0,1.0,0.0,0.0
Affective variable,0.0,1.0,0.0,0.0
Premenstrual dysphoric disorder,0.0,0.0,1.0,0.0
Capacity limitations,0.0,1.0,0.0,0.0
Spontaneous percept switch,1.0,0.0,0.0,0.0
Object use,0.0,0.0,1.0,0.0
SVLs,0.0,0.0,0.0,1.0
independent functioning,0.0,1.0,0.0,0.0
Visual metaphors,0.0,0.0,0.0,1.0
Driving visual demand,0.0,0.0,1.0,0.0
Force,0.0,1.0,0.0,0.0
Zinc: Cognition,0.0,0.0,0.0,1.0
Corollary discharge,0.0,0.0,1.0,0.0
assisted-living,1.0,0.0,0.0,0.0
Learner roles,0.0,1.0,0.0,0.0
Purposive vision,0.0,0.0,1.0,0.0
Intrahippocampal,0.0,0.0,1.0,0.0
Visual primitives,0.0,0.0,1.0,0.0
Word mapping,0.0,1.0,0.0,0.0
Generalized learning,0.0,0.0,1.0,0.0
Letter flanker,1.0,0.0,0.0,0.0
Crossmodal congruency effects,0.0,1.0,0.0,0.0
Visual hemisphere,0.0,0.0,1.0,0.0
22q11.2,1.0,0.0,0.0,0.0
Mental operations,1.0,0.0,0.0,0.0
Strain,0.0,0.0,1.0,0.0
Attractor networks,0.0,0.0,1.0,0.0
Cognitive Dynamic Systems,0.0,1.0,0.0,0.0
Cooperative breeding,1.0,0.0,0.0,0.0
Fludrocortisone,0.0,1.0,0.0,0.0
Complex systems,0.0,0.0,1.0,0.0
CT scan,1.0,0.0,0.0,0.0
Substantia nigra/VTA,1.0,0.0,0.0,0.0
Inferences of manipulative intent,0.0,1.0,0.0,0.0
feature-holistic processing,1.0,0.0,0.0,0.0
Attentional control theory,0.0,0.0,1.0,0.0
fatty acids,0.0,0.0,1.0,0.0
Quetiapine extended release,0.0,0.0,1.0,0.0
Behavioral psychology,1.0,0.0,0.0,0.0
Cognitive practice,0.0,0.0,1.0,0.0
The reach and the grasp,0.0,0.0,1.0,0.0
Projector,0.0,0.0,1.0,0.0
Descriptive judgments,0.0,1.0,0.0,0.0
Cassava,0.0,0.0,1.0,0.0
Nave,1.0,0.0,0.0,0.0
Verbal Learning,0.0,0.0,0.0,1.0
System engineering,0.0,0.0,1.0,0.0
D-serine,0.0,1.0,0.0,0.0
nabilone,0.0,0.0,1.0,0.0
Gamma wave,0.0,0.0,1.0,0.0
SternbergWagner self-assessment inventory,0.0,0.0,1.0,0.0
Catastrophizing,1.0,0.0,0.0,0.0
Cerebral MRI,0.0,0.0,0.0,1.0
Traffic accident,0.0,0.0,1.0,0.0
lithium treatment,0.0,0.0,1.0,0.0
Vicarious trial-and-error behavior,1.0,0.0,0.0,0.0
Orthographic representations,0.0,0.0,1.0,0.0
Instrumented vehicle,0.0,0.0,1.0,0.0
Electrocorticogram,0.0,0.0,1.0,0.0
Masking by pattern,0.0,1.0,0.0,0.0
Psychiatric nursing,0.0,1.0,0.0,0.0
Fragile X permutation,0.0,1.0,0.0,0.0
agility,0.0,0.0,1.0,0.0
Synaptosome,0.0,1.0,0.0,0.0
Cold air exposure,0.0,1.0,0.0,0.0
Knowledge structure,0.0,0.0,1.0,0.0
Ostensive-communicative demonstration,0.0,1.0,0.0,0.0
Proper name anomia,0.0,1.0,0.0,0.0
Traffic accident prevention,0.0,0.0,1.0,0.0
Neurological effects of recombinant human interferon (1983) Br Med J (Clin Res Ed),0.0,0.0,1.0,0.0
Crossmodal influence,0.0,0.0,1.0,0.0
Multifaceted,0.0,0.0,0.0,1.0
Postoperative recovery,0.0,1.0,0.0,0.0
GIS (Geographic Information System),0.0,1.0,0.0,0.0
Focused crawler,0.0,0.0,1.0,0.0
MCI-PD,0.0,0.0,1.0,0.0
Real-world,1.0,0.0,0.0,0.0
Speed-accuracy tradeoffs,0.0,0.0,0.0,1.0
Visual scanpath (VSP),0.0,1.0,0.0,0.0
Lung transplantation,1.0,0.0,0.0,0.0
Long-term effect,1.0,0.0,0.0,0.0
EFRP,0.0,0.0,1.0,0.0
problem state,0.0,0.0,1.0,0.0
cognitive impulsivity,1.0,0.0,0.0,0.0
narrative,0.0,0.0,1.0,0.0
Modality exclusivity,0.0,0.0,1.0,0.0
Judgments of learning,0.0,0.0,1.0,0.0
Bilateral auditory stimuli,1.0,0.0,0.0,0.0
cross-modal plasticity,0.0,1.0,0.0,0.0
Land cover,0.0,0.0,1.0,0.0
Consumers,1.0,0.0,0.0,0.0
L-Theanine,0.0,1.0,0.0,0.0
Attention Network Test (ANT),0.0,0.0,1.0,0.0
Autobiographical memory specificity,0.0,1.0,0.0,0.0
Worker assistance,0.0,0.0,1.0,0.0
analogical transfer,0.0,0.0,1.0,0.0
Human visual system (HVS),0.0,0.0,0.0,1.0
GOMS,0.0,0.0,0.0,1.0
Novelty Seeking,0.0,0.0,1.0,0.0
Automatic thoughts,0.0,0.0,1.0,0.0
Head-on-trunk signals,1.0,0.0,0.0,0.0
Task-evoked pupillary responses,0.0,0.0,1.0,0.0
Muscarinic cholinergic,0.0,0.0,1.0,0.0
Posterior middle temporal-occipital (MT),1.0,0.0,0.0,0.0
Perceptual asymmetry,0.0,0.0,1.0,0.0
estimating,0.0,1.0,0.0,0.0
CATEGORIZATION,1.0,0.0,0.0,0.0
multi-dimensional,0.0,0.0,1.0,0.0
Absolute pitch,0.0,1.0,0.0,0.0
Ranibizumab,0.0,0.0,1.0,0.0
Lures,1.0,0.0,0.0,0.0
Myopia progression,1.0,0.0,0.0,0.0
Social Stroop,0.0,0.0,0.0,1.0
Homocystinuria,0.0,0.0,1.0,0.0
Beliefs about beliefs: Representation and constraining function of wrong beliefs in young children's understanding of deception (1983) Cognition,0.0,0.0,1.0,0.0
Mobile phone emission,1.0,0.0,0.0,0.0
child and adolescent,0.0,1.0,0.0,0.0
prognosis,0.0,0.0,1.0,0.0
Information compression,0.0,0.0,1.0,0.0
Cogniton,0.0,0.0,1.0,0.0
Details,0.0,0.0,0.0,1.0
behavioral science,0.0,0.0,1.0,0.0
Perceived effort,1.0,0.0,0.0,0.0
Health status indicators,0.0,1.0,0.0,0.0
Hypotensive therapy,0.0,1.0,0.0,0.0
In utero exposure,0.0,0.0,1.0,0.0
egocentric strategies,1.0,0.0,0.0,0.0
Motivational significance,0.0,0.0,1.0,0.0
Middle-age and older adults,0.0,0.0,1.0,0.0
EGb 761,0.0,0.0,0.0,1.0
Nicaraguan sign language,0.0,1.0,0.0,0.0
Spatio-temporal segmentation,0.0,0.0,1.0,0.0
Double-touching,0.0,0.0,0.0,1.0
Egg recognition,0.0,1.0,0.0,0.0
infection,0.0,1.0,0.0,0.0
Research and Practice",0.0,0.0,0.0,0.0
Herpes Simplex Virus,1.0,0.0,0.0,0.0
Learning/cognition,1.0,0.0,0.0,0.0
Pseudo-word,0.0,0.0,0.0,1.0
Irregular and unstructured grids,1.0,0.0,0.0,0.0
Acute hypoxia,0.0,0.0,1.0,0.0
CLN6,0.0,0.0,1.0,0.0
Females,1.0,0.0,0.0,0.0
Hazard detection,0.0,1.0,0.0,0.0
Pesticide exposure,0.0,0.0,1.0,0.0
Traumatic brain injury patients,1.0,0.0,0.0,0.0
Pairing,0.0,1.0,0.0,0.0
Real world scene,1.0,0.0,0.0,0.0
Selfother distinction,0.0,0.0,1.0,0.0
eye-hand coordination,0.0,0.0,1.0,0.0
Generative fMRI models,0.0,0.0,1.0,0.0
CBS,0.0,0.0,0.0,1.0
Sensory experience rating,0.0,0.0,1.0,0.0
CBD,1.0,0.0,0.0,0.0
CBF,0.0,0.0,0.0,1.0
Central bottleneck theory,0.0,0.0,1.0,0.0
Succinate,0.0,0.0,1.0,0.0
Evoked magnetic responses,0.0,0.0,1.0,0.0
World Health Organization,0.0,1.0,0.0,0.0
Boundary objects,0.0,1.0,0.0,0.0
Memory tests,0.0,1.0,0.0,0.0
12-month-old infants,0.0,0.0,1.0,0.0
Brain magnetic resonance imaging,0.0,1.0,0.0,0.0
collaborative cognition,0.0,0.0,0.0,1.0
Cholinergic receptor,0.0,0.0,1.0,0.0
Sympathetic hyperactivity,1.0,0.0,0.0,0.0
State,0.0,0.0,1.0,0.0
multidimensional generalization,1.0,0.0,0.0,0.0
auditory/visual,1.0,0.0,0.0,0.0
repetition suppression,0.0,0.0,1.0,0.0
Acute organophosphate poisoning,0.0,0.0,1.0,0.0
Feelings,0.0,0.0,0.0,1.0
Visual time discrimination,0.0,0.0,0.0,1.0
drinking,0.0,1.0,0.0,0.0
Collateral sulcus,1.0,0.0,0.0,0.0
Intermodal attention,0.0,0.0,1.0,0.0
Natural stimuli,0.0,1.0,0.0,0.0
Fine Postural System,0.0,0.0,0.0,1.0
Fragile  syndrome,0.0,1.0,0.0,0.0
Describing the present,0.0,1.0,0.0,0.0
Geographic context,0.0,1.0,0.0,0.0
TSNR,0.0,1.0,0.0,0.0
Subjective interpretation,0.0,0.0,1.0,0.0
J.D.,0.0,0.0,0.0,1.0
Macaca fascicularis,0.0,1.0,0.0,0.0
Imipramine,1.0,0.0,0.0,0.0
Literacy skills,0.0,0.0,1.0,0.0
Xp11.22p11.23 duplication,0.0,0.0,1.0,0.0
S1RA (E-52862),0.0,0.0,0.0,1.0
Visual acuity of the elderly,1.0,0.0,0.0,0.0
Sequence,0.0,0.0,1.0,0.0
Cross-species generalizations,0.0,1.0,0.0,0.0
Kleine-Levin Syndrome,0.0,0.0,1.0,0.0
AMCI (amnestic mild cognitive impairment),0.0,0.0,1.0,0.0
Parkinsonian disorders,0.0,0.0,1.0,0.0
Heidenhain variant,0.0,0.0,1.0,0.0
Snapshot memory,0.0,0.0,1.0,0.0
Biofunctional understanding,0.0,0.0,0.0,1.0
Matrix reasoning,1.0,0.0,0.0,0.0
Cortical visual impairment,0.0,1.0,0.0,0.0
VAChT,0.0,1.0,0.0,0.0
Amygdala theory of autism,0.0,0.0,1.0,0.0
Beta-gamma EEG oscillations,0.0,0.0,0.0,1.0
Perfect timesharing,0.0,1.0,0.0,0.0
copy of pentagons,0.0,0.0,1.0,0.0
white-matter connectivity,0.0,0.0,1.0,0.0
Typification,0.0,0.0,1.0,0.0
Medial septum,0.0,0.0,1.0,0.0
Temporal variability,1.0,0.0,0.0,0.0
Postural adaptation,0.0,1.0,0.0,0.0
BA 10,0.0,0.0,1.0,0.0
D 2 receptors,0.0,0.0,0.0,1.0
Higher CNS functions,1.0,0.0,0.0,0.0
Visual phenomenology,0.0,0.0,1.0,0.0
two-year follow-up,0.0,0.0,1.0,0.0
Schizotypal,0.0,0.0,1.0,0.0
Sequential presentation,0.0,0.0,1.0,0.0
Acute ischaemic stroke,0.0,0.0,1.0,0.0
Epn,0.0,1.0,0.0,0.0
HIV I clade C,0.0,1.0,0.0,0.0
visual displays,0.0,0.0,1.0,0.0
embodied interaction,0.0,1.0,0.0,0.0
Infant nutrition,0.0,0.0,1.0,0.0
Task-irrelevant information,1.0,0.0,0.0,0.0
Glucose homeostasis,0.0,1.0,0.0,0.0
debrief,0.0,0.0,1.0,0.0
Possession,0.0,0.0,1.0,0.0
Glance behaviour,0.0,0.0,0.0,1.0
Choice response time,1.0,0.0,0.0,0.0
Typing,1.0,0.0,0.0,0.0
BRNB,0.0,1.0,0.0,0.0
Infant brain development,0.0,0.0,1.0,0.0
Literacy acquisition,0.0,0.0,1.0,0.0
Toothache,0.0,1.0,0.0,0.0
Affective empathy,0.0,0.0,1.0,0.0
Healthy elderly,0.0,1.0,0.0,0.0
Hand gesture imitation,0.0,0.0,0.0,1.0
Human Computer Interaction (HCI),1.0,0.0,0.0,0.0
Cognitive event-related potential,0.0,0.0,0.0,1.0
Adaboost,0.0,1.0,0.0,0.0
Isoparaffins,0.0,1.0,0.0,0.0
Argument structure,1.0,0.0,0.0,0.0
Dama dama,0.0,1.0,0.0,0.0
Total intravenous anaesthesia,1.0,0.0,0.0,0.0
Neural capacity,0.0,0.0,1.0,0.0
Inhibitory process,0.0,1.0,0.0,0.0
Environment and Urban Systems",0.0,0.0,0.0,0.0
genetic high-risk,0.0,0.0,0.0,1.0
Thyroid testing,0.0,0.0,1.0,0.0
Offline embodiment,0.0,0.0,1.0,0.0
Sensory gain,1.0,0.0,0.0,0.0
Appearance-reality,0.0,1.0,0.0,0.0
Food appetency,0.0,0.0,1.0,0.0
Nonconscious processes,0.0,0.0,1.0,0.0
Forest planning and management,0.0,1.0,0.0,0.0
Multi-modal neuroimaging integration,0.0,0.0,1.0,0.0
Open source,0.0,0.0,0.0,1.0
Social hierarchy,1.0,0.0,0.0,0.0
Symptom reporting,0.0,1.0,0.0,0.0
phase coherence,0.0,0.0,0.0,1.0
Constituent order ambiguity,0.0,0.0,1.0,0.0
GuesserKnower task,0.0,0.0,1.0,0.0
Shades of color,1.0,0.0,0.0,0.0
Visual evoked flow response,0.0,0.0,1.0,0.0
Care requirements,0.0,0.0,1.0,0.0
School educated and college educated,0.0,0.0,1.0,0.0
Attitude change,1.0,0.0,0.0,0.0
Legacy,0.0,1.0,0.0,0.0
Pantomime,1.0,0.0,0.0,0.0
grandmother cells,0.0,0.0,0.0,1.0
Cognitive test performance,0.0,0.0,1.0,0.0
Critical illness,1.0,0.0,0.0,0.0
Longitudinal change,0.0,0.0,1.0,0.0
Knowledge-based systems,1.0,0.0,0.0,0.0
High grade gliomas,0.0,0.0,0.0,1.0
Laminar organization,1.0,0.0,0.0,0.0
Cognition science,1.0,0.0,0.0,0.0
temperament,0.0,0.0,1.0,0.0
questionable dementia,0.0,0.0,1.0,0.0
Art history methods,0.0,1.0,0.0,0.0
Implementation intentions,0.0,1.0,0.0,0.0
Reality distortion,0.0,1.0,0.0,0.0
ARMD,0.0,0.0,0.0,1.0
Cortical reorganisation,0.0,1.0,0.0,0.0
Computerized,0.0,0.0,1.0,0.0
ARMS,0.0,0.0,1.0,0.0
Mathematics achievement,0.0,1.0,0.0,0.0
pp,1.0,0.0,0.0,0.0
Configurational theory,0.0,1.0,0.0,0.0
focus group,1.0,0.0,0.0,0.0
MELD,0.0,0.0,1.0,0.0
Fundus fluorescein angiography,1.0,0.0,0.0,0.0
Elderly Falls,1.0,0.0,0.0,0.0
Intentional control,0.0,0.0,0.0,1.0
Orangutan,0.0,0.0,1.0,0.0
Pre-motor cortex and supplementary motor cortex,1.0,0.0,0.0,0.0
Social affordances,0.0,0.0,1.0,0.0
Multiple representations,0.0,1.0,0.0,0.0
Framingham Heart Study,0.0,0.0,0.0,1.0
Mu-opioid,0.0,1.0,0.0,0.0
Face neurons,1.0,0.0,0.0,0.0
indirect tasks,1.0,0.0,0.0,0.0
relational memory,1.0,0.0,0.0,0.0
Scrolling-text,0.0,1.0,0.0,0.0
Hypofractionation,0.0,0.0,0.0,1.0
Methylphenidate (MPH),0.0,0.0,1.0,0.0
Oral language,0.0,0.0,1.0,0.0
Object-related actions,1.0,0.0,0.0,0.0
Wilkie,1.0,0.0,0.0,0.0
older population,0.0,1.0,0.0,0.0
Remember/Know,1.0,0.0,0.0,0.0
Low contrast visual acuity,0.0,1.0,0.0,0.0
Drawing abilities,1.0,0.0,0.0,0.0
Anoxia-hypoxia,0.0,1.0,0.0,0.0
Peripheral neuropathy,0.0,1.0,0.0,0.0
genetic association,0.0,1.0,0.0,0.0
Correspondence maximization,1.0,0.0,0.0,0.0
effect size,0.0,1.0,0.0,0.0
Spatial discounting,0.0,0.0,1.0,0.0
Low SES,0.0,1.0,0.0,0.0
Perievent histogram,0.0,0.0,0.0,1.0
Participatory decision-making,0.0,1.0,0.0,0.0
Accident,0.0,1.0,0.0,0.0
Gycemic control,0.0,1.0,0.0,0.0
Retinotectal,1.0,0.0,0.0,0.0
Human-horse interaction,1.0,0.0,0.0,0.0
Sight-word instruction,0.0,1.0,0.0,0.0
aggregated maps,0.0,1.0,0.0,0.0
Open inguinal hernia repair,0.0,0.0,1.0,0.0
Balance assessment,0.0,0.0,0.0,1.0
Diffusion process,0.0,0.0,1.0,0.0
Spatial selective attention,0.0,0.0,1.0,0.0
Syndrome-general deficiency,0.0,0.0,0.0,1.0
Modern Attitudes,0.0,1.0,0.0,0.0
Corticocentrism,0.0,0.0,1.0,0.0
Cognitive compatibility,0.0,0.0,0.0,1.0
Facial information processing,0.0,0.0,1.0,0.0
Diffusion tensor MRI,1.0,0.0,0.0,0.0
Aprosodia,0.0,0.0,1.0,0.0
situation awareness,0.0,0.0,1.0,0.0
Network analysis,0.0,0.0,1.0,0.0
Frontal epilepsy,1.0,0.0,0.0,0.0
Anticonvulsant,0.0,0.0,1.0,0.0
Basic-level categorization,0.0,1.0,0.0,0.0
Mergin in-vehilce technology,0.0,1.0,0.0,0.0
Diagnostic sensitivity and specificity,0.0,1.0,0.0,0.0
Radiation injury,1.0,0.0,0.0,0.0
information theory,0.0,1.0,0.0,0.0
Chinese preschool children,0.0,0.0,1.0,0.0
Lexical constraints,0.0,0.0,1.0,0.0
Exogenous,0.0,1.0,0.0,0.0
Stimulus detection,0.0,1.0,0.0,0.0
Psicotic features,0.0,1.0,0.0,0.0
Person memory,0.0,0.0,1.0,0.0
Precursor functions,0.0,1.0,0.0,0.0
Neurologization,0.0,0.0,1.0,0.0
Physical context,0.0,0.0,1.0,0.0
Antibodies,0.0,0.0,1.0,0.0
Trafalgar effect,0.0,1.0,0.0,0.0
Hidden Figures Task (HFT),0.0,0.0,1.0,0.0
Scaling,0.0,1.0,0.0,0.0
Stingray,1.0,0.0,0.0,0.0
"Eye,0.0,0.0,0.0,0.0
Semantic prominence,0.0,0.0,1.0,0.0
Scene design,0.0,0.0,1.0,0.0
White-matter,0.0,0.0,1.0,0.0
Computational cognition,0.0,1.0,0.0,0.0
Neurosensory function,0.0,0.0,1.0,0.0
PCL-M,0.0,0.0,1.0,0.0
Prospero,0.0,0.0,1.0,0.0
PCL-C,0.0,0.0,1.0,0.0
Harm Avoidance,0.0,0.0,0.0,1.0
Hemispheric independence,0.0,0.0,1.0,0.0
Prophylactics,0.0,0.0,0.0,1.0
Donor,1.0,0.0,0.0,0.0
Enterovirus 71,0.0,1.0,0.0,0.0
autobiographical,0.0,0.0,1.0,0.0
Right-hemisphere syndrome,1.0,0.0,0.0,0.0
Mean curvature,0.0,1.0,0.0,0.0
Pre-morbid adjustment,0.0,1.0,0.0,0.0
Complex adaptive system,0.0,0.0,1.0,0.0
Climate change,0.0,0.0,1.0,0.0
Morphine equivalent dose,0.0,0.0,1.0,0.0
Potential inappropriate medications (PIMs),0.0,0.0,1.0,0.0
Stroop.,0.0,1.0,0.0,0.0
Deliquency,0.0,0.0,1.0,0.0
Patient compliance,1.0,0.0,0.0,0.0
Manual reaction time,1.0,0.0,0.0,0.0
Dorsal premotor area,0.0,1.0,0.0,0.0
Picture integration,0.0,1.0,0.0,0.0
Cognitive expectation,0.0,1.0,0.0,0.0
ANK3,1.0,0.0,0.0,0.0
Craniofacial development,0.0,0.0,1.0,0.0
Digits,0.0,1.0,0.0,0.0
Akt,0.0,0.0,1.0,0.0
Seafood,0.0,0.0,0.0,1.0
Supplementary eye field,0.0,1.0,0.0,0.0
IADLs,0.0,1.0,0.0,0.0
Non-consumers,1.0,0.0,0.0,0.0
Road network,1.0,0.0,0.0,0.0
Pervasive developmental disorder not otherwise specified (PDD-NOS),0.0,0.0,1.0,0.0
Sleep paralysis,0.0,0.0,1.0,0.0
Hirsch index,0.0,0.0,1.0,0.0
Relationship cognition,1.0,0.0,0.0,0.0
Task performance criteria,0.0,0.0,0.0,1.0
N150,0.0,0.0,1.0,0.0
Limited capacity of processing,0.0,0.0,1.0,0.0
Schizophrenic psychopathology,0.0,1.0,0.0,0.0
Cognitive-affective syndrome,1.0,0.0,0.0,0.0
C1 component,0.0,1.0,0.0,0.0
Wada,0.0,1.0,0.0,0.0
Working memory deficits,0.0,1.0,0.0,0.0
Lucifer Yellow,1.0,0.0,0.0,0.0
Involuntariness,0.0,0.0,0.0,1.0
Schizotypal-trait,0.0,0.0,1.0,0.0
fibrate,0.0,1.0,0.0,0.0
Covariation bias,0.0,0.0,1.0,0.0
Task space,0.0,0.0,1.0,0.0
Fallacies,0.0,0.0,1.0,0.0
Antisocial,1.0,0.0,0.0,0.0
cognitive fatigue,0.0,1.0,0.0,0.0
Sickle cell anemia,1.0,0.0,0.0,0.0
Cue repetition benefit,1.0,0.0,0.0,0.0
Polysomnographic study,0.0,0.0,1.0,0.0
Dynamic neural field models,0.0,1.0,0.0,0.0
RV-coefficient,0.0,1.0,0.0,0.0
Indexical cues,0.0,1.0,0.0,0.0
keratoconus,1.0,0.0,0.0,0.0
Context integration,0.0,1.0,0.0,0.0
Style,0.0,0.0,1.0,0.0
Vision cognitive,1.0,0.0,0.0,0.0
Ritanserin,0.0,0.0,1.0,0.0
cognitive trajectories,0.0,0.0,1.0,0.0
Cognitive epidemiology,0.0,0.0,1.0,0.0
Specific developmental disorders of educational ability,0.0,0.0,1.0,0.0
Epilepsy imaging,0.0,0.0,1.0,0.0
machine vision,0.0,1.0,0.0,0.0
multiple testing,0.0,0.0,1.0,0.0
guns,1.0,0.0,0.0,0.0
Menstrual Cycle,0.0,0.0,1.0,0.0
Stroke guidelines,0.0,1.0,0.0,0.0
High functioning autism spectrum disorder,0.0,0.0,1.0,0.0
Measuring empathy,0.0,1.0,0.0,0.0
Morpheme,0.0,0.0,1.0,0.0
Negative words,0.0,0.0,1.0,0.0
sevoflurane,1.0,0.0,0.0,0.0
vestibular system,0.0,0.0,0.0,1.0
Implicit memory.,0.0,1.0,0.0,0.0
Atmospherics,1.0,0.0,0.0,0.0
Multifocal attention,1.0,0.0,0.0,0.0
Retinotopically organized visual areas,0.0,0.0,0.0,1.0
NPI,0.0,0.0,1.0,0.0
Non-venomous coral snake,0.0,0.0,1.0,0.0
Ocular torsion,0.0,1.0,0.0,0.0
Text analysis,1.0,0.0,0.0,0.0
human studies,0.0,1.0,0.0,0.0
11C-6-OH-BTA-1,0.0,0.0,1.0,0.0
Object-centered space,0.0,0.0,0.0,1.0
Finding process,1.0,0.0,0.0,0.0
Dimensional and categorical models of schizotypy,0.0,1.0,0.0,0.0
Short-term working memory,0.0,0.0,1.0,0.0
Cooperative relationship,0.0,0.0,1.0,0.0
technology-mediated cognition,0.0,0.0,1.0,0.0
Blind football,0.0,0.0,1.0,0.0
Decision aids,0.0,0.0,1.0,0.0
Lyme neuroborreliosis,0.0,0.0,1.0,0.0
Lexical-semantic system,0.0,0.0,1.0,0.0
Autoimmune diseases,0.0,0.0,1.0,0.0
Cognitive arithmetic,0.0,0.0,1.0,0.0
Anti-epileptic drug,1.0,0.0,0.0,0.0
Scientific expertise,0.0,0.0,0.0,1.0
Verbal recall,0.0,0.0,1.0,0.0
hyperinsulinemia,0.0,0.0,1.0,0.0
"Alcohol dependence,0.0,0.0,0.0,0.0
Dementia symptoms,0.0,0.0,1.0,0.0
Epigenetics,0.0,0.0,1.0,0.0
IES,0.0,0.0,1.0,0.0
Priority setting,0.0,1.0,0.0,0.0
Wechsler intelligence scale,0.0,0.0,1.0,0.0
Direct human recordings,1.0,0.0,0.0,0.0
Asymmetries,0.0,1.0,0.0,0.0
Japanese cohort,1.0,0.0,0.0,0.0
Color-word Stroop,0.0,1.0,0.0,0.0
Process control,0.0,1.0,0.0,0.0
Peak frequency,0.0,1.0,0.0,0.0
Motion segregation,0.0,0.0,1.0,0.0
CCALD,0.0,0.0,1.0,0.0
LEQ,1.0,0.0,0.0,0.0
Ferrets,0.0,0.0,0.0,1.0
LED,0.0,0.0,1.0,0.0
Surface-based normalization,0.0,1.0,0.0,0.0
Gulf war illness,0.0,0.0,1.0,0.0
Deafblindness,1.0,0.0,0.0,0.0
Psychosocial intervention,0.0,0.0,0.0,1.0
Mifepristone,0.0,0.0,1.0,0.0
Physiological noise,0.0,1.0,0.0,0.0
Graphemic buffer,0.0,0.0,1.0,0.0
Rod and frame test,0.0,1.0,0.0,0.0
Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings (1994) Proc. Natl. Acad. Sci.,0.0,0.0,1.0,0.0
affective stimuli,0.0,0.0,1.0,0.0
Equipment design,0.0,1.0,0.0,0.0
Hedonic tone,0.0,0.0,1.0,0.0
Neurorehabilitation team,0.0,1.0,0.0,0.0
Contour attributes,1.0,0.0,0.0,0.0
Pharmacological MRI,0.0,0.0,1.0,0.0
GABAA receptor,0.0,1.0,0.0,0.0
Vascular moderate cognitive impairment,0.0,0.0,1.0,0.0
Relative phase,1.0,0.0,0.0,0.0
Tetralogy of Fallot,0.0,1.0,0.0,0.0
subtypes,0.0,0.0,1.0,0.0
Systematic processing,1.0,0.0,0.0,0.0
dental care,0.0,1.0,0.0,0.0
Fibrinogen,0.0,1.0,0.0,0.0
random effects,0.0,1.0,0.0,0.0
Pattern visual evoked potentials,0.0,1.0,0.0,0.0
Multidimensional Inventory of Subjective Cognitive Impairment (MISCI),0.0,0.0,1.0,0.0
Mass spectrometry,0.0,0.0,1.0,0.0
Neuropsychologic deficits,0.0,0.0,0.0,1.0
Re-education,0.0,0.0,0.0,1.0
acute central nervous system depression,0.0,0.0,1.0,0.0
Grip aperture,0.0,1.0,0.0,0.0
Speaker intent,0.0,0.0,1.0,0.0
Cardiovascular Health Study,0.0,1.0,0.0,0.0
Motor potential,1.0,0.0,0.0,0.0
Early interaction,1.0,0.0,0.0,0.0
Time processing ability,0.0,1.0,0.0,0.0
clinically isolated syndromes,1.0,0.0,0.0,0.0
Recursive embedding,0.0,1.0,0.0,0.0
Geriatrician,0.0,0.0,1.0,0.0
emotion processing,0.0,1.0,0.0,0.0
Actor-orientation,0.0,0.0,1.0,0.0
functional vision,0.0,0.0,1.0,0.0
Pontocerebellar hypoplasia,1.0,0.0,0.0,0.0
Community-based rehabilitation,1.0,0.0,0.0,0.0
Chromatic vision,0.0,0.0,1.0,0.0
Pair-comparison task,1.0,0.0,0.0,0.0
visual segmentation,0.0,0.0,1.0,0.0
Akinetic mutism,1.0,0.0,0.0,0.0
model,0.0,0.0,1.0,0.0
Own group bias,0.0,0.0,0.0,1.0
Judgment processes,0.0,1.0,0.0,0.0
Head Injury,0.0,1.0,0.0,0.0
Eyewitness accuracy,0.0,1.0,0.0,0.0
Nonfluent variant,0.0,0.0,1.0,0.0
parvocellular,1.0,0.0,0.0,0.0
Scanpath theory,0.0,0.0,1.0,0.0
peripheral inflammation,0.0,1.0,0.0,0.0
Craving intensity,0.0,0.0,0.0,1.0
masked priming,0.0,0.0,1.0,0.0
Emergent orthography,0.0,1.0,0.0,0.0
Medication overuse,1.0,0.0,0.0,0.0
Motivational intensity,0.0,1.0,0.0,0.0
sports injury,0.0,0.0,1.0,0.0
Magnetization transfer ratio,0.0,0.0,1.0,0.0
Time-varying CBC,0.0,1.0,0.0,0.0
Microstructure,1.0,0.0,0.0,0.0
script-driven imagery,0.0,0.0,1.0,0.0
cognition-action trade-off,0.0,1.0,0.0,0.0
visual knowledge discovery,0.0,0.0,1.0,0.0
Second malignancy,1.0,0.0,0.0,0.0
Body actions,0.0,0.0,1.0,0.0
Gallus gallus,0.0,0.0,0.0,1.0
Maternal smoking,0.0,0.0,0.0,1.0
Positive and negative symptoms,0.0,0.0,1.0,0.0
Grain size,0.0,0.0,1.0,0.0
Affective touch,0.0,0.0,1.0,0.0
Posttarget nontarget,1.0,0.0,0.0,0.0
intellectual disability,0.0,0.0,1.0,0.0
Construction of knowledge,1.0,0.0,0.0,0.0
Subliminal processing,0.0,0.0,1.0,0.0
sampling,0.0,0.0,0.0,1.0
Movement statistics,0.0,0.0,1.0,0.0
Perceptual causality,0.0,0.0,1.0,0.0
Community integration,0.0,1.0,0.0,0.0
Beta oscillation,0.0,0.0,0.0,1.0
Gender identity,0.0,1.0,0.0,0.0
WMT,0.0,0.0,0.0,1.0
Symbolic magnitude comparison,0.0,0.0,1.0,0.0
Velocity threshold algorithm,0.0,0.0,1.0,0.0
Norway : 1992)",0.0,0.0,0.0,0.0
Equus asinus,0.0,1.0,0.0,0.0
Phonological memory,0.0,1.0,0.0,0.0
venlafaxine,0.0,1.0,0.0,0.0
concurrent processing,0.0,0.0,1.0,0.0
"Contact Lenses,0.0,0.0,0.0,0.0
Verbal response selection,0.0,0.0,1.0,0.0
Specific phobia,0.0,1.0,0.0,0.0
Counterfactual reasoning,1.0,0.0,0.0,0.0
Neuroimpairments,0.0,0.0,0.0,1.0
Sidedness Effect,0.0,0.0,1.0,0.0
Sensory feature,0.0,1.0,0.0,0.0
Speed perception,0.0,1.0,0.0,0.0
Alcohol cue reactivity,0.0,0.0,0.0,1.0
Auditory function,0.0,1.0,0.0,0.0
Visual workload,1.0,0.0,0.0,0.0
primates,0.0,1.0,0.0,0.0
Landscape assessment,0.0,0.0,0.0,1.0
Myelomeningocele,0.0,0.0,0.0,1.0
neurocognitive screening measure,0.0,0.0,0.0,1.0
Nucleus subthalamicus,0.0,0.0,1.0,0.0
Oddball ERPs,0.0,0.0,1.0,0.0
Emotional labor,0.0,0.0,1.0,0.0
Global dynamics,0.0,1.0,0.0,0.0
Oscillator strength,0.0,0.0,0.0,1.0
Object attention,0.0,0.0,0.0,1.0
Mnemonic scotoma,0.0,1.0,0.0,0.0
Memory strategies,0.0,0.0,0.0,1.0
Response reversal,0.0,0.0,1.0,0.0
Reflexive versus volitional,0.0,1.0,0.0,0.0
Insulin injection device,1.0,0.0,0.0,0.0
Behavioural geography,1.0,0.0,0.0,0.0
SCIT,0.0,0.0,0.0,1.0
Presupposition,0.0,0.0,1.0,0.0
electroencephalogram (EEG),0.0,0.0,1.0,0.0
dendritic spines,0.0,1.0,0.0,0.0
Nonlesional,0.0,1.0,0.0,0.0
Joint centred,0.0,0.0,1.0,0.0
remote ischemic preconditioning,1.0,0.0,0.0,0.0
Localization task,0.0,0.0,0.0,1.0
stem cell transplantation,1.0,0.0,0.0,0.0
cognition assessment,0.0,0.0,1.0,0.0
ROC curve,0.0,0.0,1.0,0.0
Monocrotaline,0.0,1.0,0.0,0.0
street-crossing,0.0,0.0,1.0,0.0
Mild to moderate level,1.0,0.0,0.0,0.0
affect heuristic,0.0,1.0,0.0,0.0
Paediatric stroke,0.0,1.0,0.0,0.0
Perception of pain,0.0,1.0,0.0,0.0
Neuro-conductive tests,0.0,0.0,1.0,0.0
Neuropsychiatric assessment,0.0,1.0,0.0,0.0
Pragmatic,0.0,0.0,1.0,0.0
Gestural knowledge,0.0,0.0,0.0,1.0
stimulation,0.0,1.0,0.0,0.0
SEP,0.0,0.0,1.0,0.0
School connectedness,0.0,0.0,0.0,1.0
Walk screen,0.0,0.0,0.0,1.0
cognitive capacity,0.0,1.0,0.0,0.0
Cynomolgus monkey,0.0,0.0,1.0,0.0
Parental deletion,0.0,0.0,1.0,0.0
Group awareness,0.0,0.0,1.0,0.0
Probability density function,0.0,1.0,0.0,0.0
Cognitive and functional decline,0.0,0.0,0.0,1.0
Blindfolding,0.0,0.0,1.0,0.0
Graphics/image,0.0,1.0,0.0,0.0
Advance information,0.0,0.0,1.0,0.0
Brain Stimulation,0.0,0.0,1.0,0.0
Mental calculation,1.0,0.0,0.0,0.0
Environmental contaminant,0.0,1.0,0.0,0.0
Rapid naming,0.0,1.0,0.0,0.0
theory,0.0,1.0,0.0,0.0
Pattern mixture model,0.0,1.0,0.0,0.0
Physical load,0.0,1.0,0.0,0.0
Cycle duration,0.0,0.0,1.0,0.0
Subthreshold exposure,0.0,0.0,1.0,0.0
Crossmodulation frequencies,1.0,0.0,0.0,0.0
ELORETA,0.0,0.0,1.0,0.0
Suggestibility,0.0,1.0,0.0,0.0
frontoparietal network,0.0,0.0,0.0,1.0
Chronic whiplash,0.0,0.0,1.0,0.0
Insula network,0.0,1.0,0.0,0.0
Perception of motion,1.0,0.0,0.0,0.0
Thematic roles,1.0,0.0,0.0,0.0
Fesoterodine,0.0,0.0,1.0,0.0
Neural activity,1.0,0.0,0.0,0.0
Disease screening,0.0,0.0,1.0,0.0
AVRT,1.0,0.0,0.0,0.0
dental materials,0.0,1.0,0.0,0.0
Object location task (OLT),1.0,0.0,0.0,0.0
HRV,0.0,1.0,0.0,0.0
TPA,0.0,1.0,0.0,0.0
self-control,1.0,0.0,0.0,0.0
Collinear facilitation,0.0,1.0,0.0,0.0
Visual demand,1.0,0.0,0.0,0.0
Posterior cingulated cortex,0.0,1.0,0.0,0.0
Role taking,0.0,0.0,1.0,0.0
Situated observer,0.0,1.0,0.0,0.0
Episodic recognition,1.0,0.0,0.0,0.0
Starter professional athletes,0.0,1.0,0.0,0.0
Initial demyelinating event,1.0,0.0,0.0,0.0
Dual-interaction space,0.0,1.0,0.0,0.0
Shared gaze,0.0,0.0,0.0,1.0
Inhibitory dysfunction,0.0,0.0,1.0,0.0
Cotinine,0.0,0.0,1.0,0.0
Group ICA,1.0,0.0,0.0,0.0
Hashimoto,0.0,0.0,1.0,0.0
medical images,0.0,1.0,0.0,0.0
Health status disparity,0.0,0.0,1.0,0.0
emotional processing,1.0,0.0,0.0,0.0
Injury,0.0,1.0,0.0,0.0
Auditory objects,0.0,1.0,0.0,0.0
Cognitive adaptation,0.0,0.0,1.0,0.0
Measurement invariance,0.0,1.0,0.0,0.0
Coats plus syndrome,0.0,1.0,0.0,0.0
Fish benefits,0.0,0.0,1.0,0.0
Action perception circuit,0.0,0.0,1.0,0.0
Postnatal growth,0.0,1.0,0.0,0.0
flavanol,0.0,1.0,0.0,0.0
Glasgow Coma Scale,0.0,1.0,0.0,0.0
PI3K,0.0,0.0,1.0,0.0
Dual-process,0.0,0.0,1.0,0.0
visual agnosia,0.0,1.0,0.0,0.0
Alpha oscillation,0.0,0.0,1.0,0.0
criteria,0.0,1.0,0.0,0.0
fall risk factors,0.0,0.0,1.0,0.0
Attention development,0.0,0.0,1.0,0.0
Dishabituation,0.0,0.0,1.0,0.0
Magnocellular theory,0.0,1.0,0.0,0.0
Modality-switch cost,0.0,0.0,1.0,0.0
Catholicism,0.0,0.0,1.0,0.0
Reading habit Bidirectional reading,0.0,0.0,1.0,0.0
Local inhibition,1.0,0.0,0.0,0.0
Cystinosis,1.0,0.0,0.0,0.0
EEG and cognition,1.0,0.0,0.0,0.0
Cortical activation,0.0,1.0,0.0,0.0
Selective neuronal vulnerability,0.0,0.0,1.0,0.0
Adrenocorticotropic hormone,1.0,0.0,0.0,0.0
Dopaminergic,0.0,0.0,1.0,0.0
Child psychiatry,0.0,0.0,1.0,0.0
Rey,0.0,0.0,1.0,0.0
Central processing bottleneck,0.0,1.0,0.0,0.0
Verbal cognition,0.0,0.0,0.0,1.0
Subtractive inhibition,0.0,0.0,0.0,1.0
self-evaluation,0.0,0.0,1.0,0.0
Visuospatial neglect,0.0,0.0,1.0,0.0
Attention deficit disorder with hyperactivity (ADHD),0.0,0.0,1.0,0.0
Cognitive stimulation,0.0,0.0,0.0,1.0
Temporally structured component analysis,1.0,0.0,0.0,0.0
Epileptiform EEG discharges,0.0,1.0,0.0,0.0
Motion aftereffect,0.0,1.0,0.0,0.0
Alpha synchronization,0.0,1.0,0.0,0.0
occupational exposure limits,0.0,0.0,1.0,0.0
Prosimians,0.0,0.0,1.0,0.0
Conflict effect,1.0,0.0,0.0,0.0
Dot-probe task,0.0,1.0,0.0,0.0
phonological loop,0.0,1.0,0.0,0.0
delayed nonmatching-to-sample task,0.0,0.0,0.0,1.0
Sports car,0.0,1.0,0.0,0.0
Mental imagery cognition,0.0,1.0,0.0,0.0
Semantic judgment,0.0,0.0,1.0,0.0
Visual rating system,0.0,0.0,1.0,0.0
Costs,0.0,1.0,0.0,0.0
Cognitive variable,0.0,1.0,0.0,0.0
Secondary parkinsonism,1.0,0.0,0.0,0.0
Tong Luo Jiu Nao,0.0,1.0,0.0,0.0
Place fields,0.0,0.0,0.0,1.0
Patient perspective,0.0,0.0,1.0,0.0
Modality-switch effect,0.0,0.0,1.0,0.0
Domestic pig,0.0,0.0,1.0,0.0
Conditional visuo-motor associations,0.0,0.0,1.0,0.0
Spatial ability for STEM domains: Aligning over 50 years of cumulative psychological knowledge solidifies its importance (2009) Journal of Educational Psychology,0.0,1.0,0.0,0.0
social support,1.0,0.0,0.0,0.0
V5/MT+ visual cortex,0.0,1.0,0.0,0.0
APOE and cognitive profile,0.0,0.0,1.0,0.0
visual evoked potentials,0.0,1.0,0.0,0.0
Warm-supplementing kidney yang (WSKY) capsule,0.0,0.0,1.0,0.0
Feature-based selection,1.0,0.0,0.0,0.0
African American,1.0,0.0,0.0,0.0
Cranial irradiation therapy,0.0,0.0,1.0,0.0
video game training,1.0,0.0,0.0,0.0
trauma exposure,0.0,0.0,1.0,0.0
Linguistic metaphor,0.0,0.0,1.0,0.0
recognition of emotions,0.0,0.0,1.0,0.0
Event related brain potentials (ERPs),0.0,0.0,1.0,0.0
bimanual coordination,1.0,0.0,0.0,0.0
Hormonal contraception,0.0,1.0,0.0,0.0
Short-cut rule,0.0,1.0,0.0,0.0
External carotid-internal carotid (EC/IC) bypass surgery,0.0,0.0,1.0,0.0
Amyloid?-protein precursor,0.0,0.0,1.0,0.0
Temporal construal,0.0,0.0,1.0,0.0
Visual disturbances,0.0,1.0,0.0,0.0
Prismatic effect,1.0,0.0,0.0,0.0
parent-report measures,1.0,0.0,0.0,0.0
Semantic network,0.0,0.0,1.0,0.0
Olive oil,0.0,0.0,1.0,0.0
behavioral control,0.0,1.0,0.0,0.0
cortical stimulation,0.0,0.0,1.0,0.0
Glycemia,0.0,0.0,1.0,0.0
H 1-antagonist,0.0,1.0,0.0,0.0
Life span cognitive development,0.0,1.0,0.0,0.0
Late-onset Parkinson,0.0,0.0,1.0,0.0
Sample entropy,0.0,0.0,1.0,0.0
CTIP,0.0,0.0,0.0,1.0
Ruisson,0.0,0.0,0.0,1.0
visual span,1.0,0.0,0.0,0.0
Intransitive action,0.0,1.0,0.0,0.0
Motor action,0.0,0.0,1.0,0.0
Calculation skills,0.0,0.0,1.0,0.0
spectral power,0.0,1.0,0.0,0.0
Graphical models,0.0,1.0,0.0,0.0
MTBI,0.0,0.0,1.0,0.0
Lynx1,0.0,0.0,1.0,0.0
lexical processing,0.0,0.0,0.0,0.0
Presymptomatic gene carriers,1.0,0.0,0.0,0.0
Health literacy,1.0,0.0,0.0,0.0
Dissociative fugue,0.0,0.0,1.0,0.0
work load,1.0,0.0,0.0,0.0
Artificial selection,1.0,0.0,0.0,0.0
Hemisphere autonomy,1.0,0.0,0.0,0.0
Bilateral Electrodermal Activity,1.0,0.0,0.0,0.0
intradimensional-extradimensional shift,1.0,0.0,0.0,0.0
Computer displays,0.0,0.0,1.0,0.0
Inchianti,0.0,0.0,1.0,0.0
Paraplegia,0.0,0.0,0.0,1.0
Region fuzzily understanding,0.0,1.0,0.0,0.0
Visual cognitive processes,0.0,0.0,1.0,0.0
mental efficacy workload test,0.0,1.0,0.0,0.0
False belief reasoning,0.0,0.0,1.0,0.0
verbal processes,0.0,1.0,0.0,0.0
Preterm child,0.0,0.0,1.0,0.0
Medicine containers,0.0,1.0,0.0,0.0
Imaginal coding,0.0,1.0,0.0,0.0
Direction effects,1.0,0.0,0.0,0.0
Bispectral index,0.0,1.0,0.0,0.0
Recurrent excitation,0.0,1.0,0.0,0.0
Delayed matching-to-sample (DMS) task,0.0,1.0,0.0,0.0
Effortful processing,0.0,1.0,0.0,0.0
response times,0.0,1.0,0.0,0.0
Visuoperceptual Learning,0.0,0.0,1.0,0.0
Artistic attitude,0.0,0.0,1.0,0.0
Dual-task postural paradigm,0.0,0.0,1.0,0.0
Engineering sciences,0.0,1.0,0.0,0.0
MAPT trial,0.0,0.0,1.0,0.0
bees,0.0,0.0,1.0,0.0
Disconnection hypothesis,0.0,0.0,1.0,0.0
Modeling neural networks,0.0,1.0,0.0,0.0
Fluid-attenuated inversion recovery (FLAIR),0.0,1.0,0.0,0.0
Prelinguistic,0.0,0.0,1.0,0.0
Gulf Arab countries,0.0,1.0,0.0,0.0
Age-related hearing impairment,0.0,0.0,1.0,0.0
response competition,1.0,0.0,0.0,0.0
LVAD,0.0,0.0,1.0,0.0
Visual crowding,0.0,0.0,1.0,0.0
user study,0.0,0.0,1.0,0.0
Orchestrated objective reduction,0.0,1.0,0.0,0.0
Hering illusion,0.0,0.0,1.0,0.0
military veterans,0.0,0.0,0.0,1.0
cardiac surgery,1.0,0.0,0.0,0.0
Pain beliefs,0.0,1.0,0.0,0.0
Other minds,0.0,0.0,1.0,0.0
capacity,0.0,0.0,1.0,0.0
Transient ischemic attack,0.0,1.0,0.0,0.0
CNS prophylaxis,0.0,1.0,0.0,0.0
Attentive state,0.0,0.0,1.0,0.0
Reading span test,0.0,0.0,1.0,0.0
Drug nave,0.0,0.0,1.0,0.0
Sleep physiology,0.0,0.0,1.0,0.0
Neuropsychological data,0.0,0.0,1.0,0.0
Intelligibility,0.0,1.0,0.0,0.0
Syntax comprehension,1.0,0.0,0.0,0.0
Exploratory data analysis,1.0,0.0,0.0,0.0
aetiology,0.0,0.0,0.0,1.0
Extracellular recording,0.0,1.0,0.0,0.0
Neuropsychological effects,0.0,1.0,0.0,0.0
salience,0.0,0.0,0.0,1.0
Affective response,0.0,0.0,1.0,0.0
Back space,0.0,1.0,0.0,0.0
Visual display terminal,0.0,1.0,0.0,0.0
saliency,0.0,0.0,1.0,0.0
C9ORF72 repeat expansion,0.0,1.0,0.0,0.0
psychological status,0.0,1.0,0.0,0.0
wild blueberry,0.0,0.0,1.0,0.0
Saccadic latencies,0.0,0.0,0.0,1.0
Prodromal Alzheimer's disease,0.0,0.0,0.0,1.0
Verbal skill,0.0,0.0,1.0,0.0
Nonsense mutation,0.0,1.0,0.0,0.0
Information processing flow,0.0,1.0,0.0,0.0
Skilled actions,1.0,0.0,0.0,0.0
Threat processing,0.0,0.0,1.0,0.0
Psychogenic movement disorder,0.0,0.0,1.0,0.0
Dexmedetomidine hydrochloride,0.0,0.0,1.0,0.0
Delay activity,0.0,0.0,1.0,0.0
Emotional facial expression,0.0,1.0,0.0,0.0
sports-related concussion,0.0,0.0,0.0,1.0
Executive cognitive function disorders,0.0,0.0,1.0,0.0
Nonsolid substances,0.0,1.0,0.0,0.0
Biological challenge,0.0,0.0,1.0,0.0
Frontal polar cortex,0.0,0.0,1.0,0.0
Perceptual animacy,1.0,0.0,0.0,0.0
Omega,0.0,1.0,0.0,0.0
Deception detection,0.0,0.0,1.0,0.0
Early Alzheimer's,0.0,0.0,1.0,0.0
dengineering,0.0,1.0,0.0,0.0
Distractor interference,0.0,0.0,1.0,0.0
Eye-tracking task,0.0,0.0,1.0,0.0
Interception,0.0,0.0,1.0,0.0
Affects,0.0,1.0,0.0,0.0
donkey,0.0,1.0,0.0,0.0
Pathological aging,0.0,0.0,0.0,1.0
Features,0.0,0.0,1.0,0.0
Human cueing,1.0,0.0,0.0,0.0
Reverse correlation,0.0,0.0,1.0,0.0
Pheromone,1.0,0.0,0.0,0.0
WAIS,0.0,0.0,1.0,0.0
Meta-iodobenzylguanidine,1.0,0.0,0.0,0.0
Premature,0.0,0.0,0.0,1.0
multimodal interaction,0.0,0.0,0.0,1.0
Expansion test,0.0,0.0,0.0,1.0
Syntactic processing,1.0,0.0,0.0,0.0
Sleeping,0.0,0.0,1.0,0.0
Support relation,0.0,1.0,0.0,0.0
Asian elephants,0.0,0.0,1.0,0.0
Letter-by-letter dyslexia,0.0,0.0,1.0,0.0
elderly people,0.0,1.0,0.0,0.0
Visual contrast,0.0,1.0,0.0,0.0
Decision aiding,0.0,0.0,1.0,0.0
Implicit associations,0.0,1.0,0.0,0.0
poststroke aphasia,0.0,1.0,0.0,0.0
Choice behavior,0.0,0.0,1.0,0.0
Meta-awareness,0.0,1.0,0.0,0.0
Relevance detection,1.0,0.0,0.0,0.0
Sequential affordances,0.0,0.0,1.0,0.0
Multiple brain oscillations,0.0,0.0,0.0,1.0
neurocognitive functioning,0.0,0.0,1.0,0.0
Negative BOLD response,0.0,1.0,0.0,0.0
TCF4,0.0,0.0,1.0,0.0
Response to intervention,0.0,0.0,1.0,0.0
Hole,1.0,0.0,0.0,0.0
chlorovirus ATCV-1,0.0,1.0,0.0,0.0
Steady-State Visual Evoked Potentials),0.0,1.0,0.0,0.0
Dementia with Levy's bodies,0.0,0.0,1.0,0.0
Cognitive marker,0.0,0.0,1.0,0.0
deviant sexual interest,0.0,0.0,1.0,0.0
Respiratory function tests,0.0,0.0,1.0,0.0
Learning performance,0.0,1.0,0.0,0.0
Social networks,0.0,0.0,1.0,0.0
Swarm intelligence,0.0,0.0,1.0,0.0
Composite resins,0.0,0.0,0.0,1.0
Nonspecific behavioral changes,0.0,0.0,1.0,0.0
Geovisual analytics,1.0,0.0,0.0,0.0
Dopamine dengineering receptors,0.0,1.0,0.0,0.0
"""Storage"" component,0.0,1.0,0.0,0.0
Kappa effect,0.0,1.0,0.0,0.0
Vomiting,1.0,0.0,0.0,0.0
expectations,0.0,0.0,0.0,1.0
Impulse control,0.0,0.0,1.0,0.0
Hyperthymestic syndrome,0.0,1.0,0.0,0.0
Herbal extract,1.0,0.0,0.0,0.0
fragile X syndrome,0.0,0.0,1.0,0.0
Serial and parallel processing,0.0,0.0,1.0,0.0
Vestibular physical therapy,0.0,0.0,1.0,0.0
suicidal behavior,0.0,1.0,0.0,0.0
Helmet,0.0,0.0,1.0,0.0
Cognitive penetration,0.0,0.0,1.0,0.0
Drebrin,0.0,0.0,1.0,0.0
Dynamic Field Theory,0.0,0.0,0.0,1.0
Avian attention,0.0,1.0,0.0,0.0
SMARC,0.0,1.0,0.0,0.0
Causal cues,1.0,0.0,0.0,0.0
Normative sample,0.0,0.0,1.0,0.0
Response mode,0.0,1.0,0.0,0.0
Odocoileus virginianus,0.0,0.0,1.0,0.0
Context positivity,0.0,0.0,1.0,0.0
VPMC,0.0,0.0,1.0,0.0
Primary visual cortex (V1),0.0,0.0,1.0,0.0
neuronal synchronization,0.0,0.0,0.0,1.0
Phase correlation,0.0,0.0,1.0,0.0
Emotion elicitation,0.0,0.0,0.0,1.0
Mexican american,0.0,0.0,1.0,0.0
Impoverished environment,1.0,0.0,0.0,0.0
Driving evaluation,1.0,0.0,0.0,0.0
Same/different,0.0,1.0,0.0,0.0
Logographic Kanji vs. syllabic Kana,0.0,0.0,0.0,1.0
Menopausal transition,0.0,0.0,1.0,0.0
Concurrent visual discrimination learning,0.0,0.0,1.0,0.0
media perceptual assessment,0.0,0.0,1.0,0.0
Cerebral blood volume,0.0,0.0,1.0,0.0
Visual and cognitive impairments,1.0,0.0,0.0,0.0
psychological refractory paradigm,0.0,1.0,0.0,0.0
Surgical menopause,0.0,0.0,1.0,0.0
Body scaling,1.0,0.0,0.0,0.0
Tunnel threshold zone,0.0,0.0,1.0,0.0
LCD display,1.0,0.0,0.0,0.0
Mental time-line,1.0,0.0,0.0,0.0
Marksmanship,0.0,1.0,0.0,0.0
Hypereosinophilic syndrome,1.0,0.0,0.0,0.0
asymmetry,0.0,0.0,1.0,0.0
Dynamic visual noise,0.0,1.0,0.0,0.0
Stroop and Garner interference,0.0,1.0,0.0,0.0
Multiple Sclerosis Neuropsychological Questionnaire,0.0,1.0,0.0,0.0
Sporadic Creutzfeldt Jakob disease,0.0,0.0,1.0,0.0
Gobies,0.0,0.0,1.0,0.0
Minineglect,0.0,0.0,1.0,0.0
Duration of PTSD,1.0,0.0,0.0,0.0
Spagnoli,0.0,1.0,0.0,0.0
Nonnumerical estimation,0.0,1.0,0.0,0.0
bottom-up selection,0.0,0.0,0.0,1.0
AMCC,1.0,0.0,0.0,0.0
Enriched environment (EE),0.0,1.0,0.0,0.0
Presence,0.0,0.0,0.0,1.0
Postconcussive,0.0,0.0,1.0,0.0
Inferolateral,0.0,0.0,1.0,0.0
Dual process model,0.0,0.0,1.0,0.0
Chronic renal failure,0.0,0.0,1.0,0.0
controlled cortical impact,0.0,1.0,0.0,0.0
Surface dysgraphia,1.0,0.0,0.0,0.0
electoral viability,0.0,0.0,1.0,0.0
Dynamic causal models,0.0,0.0,1.0,0.0
therapeutics,1.0,0.0,0.0,0.0
Developmental neuropsychology,0.0,1.0,0.0,0.0
Espagne,1.0,0.0,0.0,0.0
illness duration,1.0,0.0,0.0,0.0
Brake reaction time,0.0,1.0,0.0,0.0
Impaired memory,0.0,0.0,1.0,0.0
Consumer preference,1.0,0.0,0.0,0.0
Visuo-motor skills,0.0,0.0,1.0,0.0
Confidence-accuracy calibration,0.0,0.0,1.0,0.0
action planning,0.0,0.0,0.0,1.0
Visual aids,0.0,0.0,1.0,0.0
Cellular,0.0,0.0,0.0,0.0
Implicit vs. explicit tasks,0.0,1.0,0.0,0.0
Mental and psychomotor development,0.0,0.0,0.0,1.0
hospitalization,0.0,1.0,0.0,0.0
Mellitus,0.0,0.0,1.0,0.0
AX-CPT,0.0,0.0,1.0,0.0
Psychosocial development,0.0,0.0,1.0,0.0
Hylobatids,1.0,0.0,0.0,0.0
cerebral small vessel disease,0.0,0.0,1.0,0.0
Supranormal ERG,1.0,0.0,0.0,0.0
Sociocognitive development,1.0,0.0,0.0,0.0
Digit symbol subscale,0.0,1.0,0.0,0.0
Hashimoto's encephalopathy,0.0,0.0,1.0,0.0
Niemann Pick disease,0.0,0.0,1.0,0.0
Free-energy,0.0,0.0,0.0,1.0
bipolar I disorder,0.0,0.0,1.0,0.0
Lesion-symptom mapping,0.0,1.0,0.0,0.0
Video clustering,0.0,0.0,1.0,0.0
Longitudinal design,0.0,0.0,1.0,0.0
n-paraffins,0.0,0.0,1.0,0.0
Peduncular hallucinosis,0.0,0.0,1.0,0.0
active vision,0.0,0.0,0.0,1.0
mitochondrial disease,0.0,0.0,1.0,0.0
Amyloid?-protein,0.0,0.0,1.0,0.0
Image representation,0.0,0.0,1.0,0.0
Developmental fMRI,0.0,1.0,0.0,0.0
Robot,0.0,1.0,0.0,0.0
Current density reconstruction,0.0,1.0,0.0,0.0
Single shot,0.0,0.0,1.0,0.0
Children's alcohol use,0.0,1.0,0.0,0.0
Posner cueing,1.0,0.0,0.0,0.0
Neural prosthetics,1.0,0.0,0.0,0.0
Iconic memory,0.0,0.0,1.0,0.0
Medication effects,0.0,0.0,1.0,0.0
Difficulties identifying feelings,0.0,0.0,1.0,0.0
Need for cognition,0.0,1.0,0.0,0.0
Treatment of vocally disruptive behavior,0.0,0.0,1.0,0.0
Toxicology,0.0,0.0,1.0,0.0
Delusional parasitosis,0.0,0.0,1.0,0.0
Cortical modeling,0.0,1.0,0.0,0.0
Visual memory development,0.0,1.0,0.0,0.0
African population,1.0,0.0,0.0,0.0
Mapping method,0.0,1.0,0.0,0.0
DiGeorge's syndrome,1.0,0.0,0.0,0.0
aging psychiatry,0.0,0.0,0.0,1.0
Postural instability and gait disorders,0.0,0.0,1.0,0.0
Concepts and categories,1.0,0.0,0.0,0.0
fetal,0.0,0.0,1.0,0.0
Attention deficit-hyperactivity disorder,0.0,0.0,1.0,0.0
Social brain development,0.0,1.0,0.0,0.0
Meditation state,0.0,1.0,0.0,0.0
Sympathetic sprouting,0.0,0.0,1.0,0.0
Heroin addiction,0.0,1.0,0.0,0.0
Conflict negativity,0.0,0.0,1.0,0.0
Delusions of misidentification,0.0,0.0,1.0,0.0
Color encoding,0.0,0.0,1.0,0.0
Selective access,0.0,0.0,1.0,0.0
Central nervous system (CNS),0.0,1.0,0.0,0.0
Rat's hippocampus,0.0,0.0,1.0,0.0
Website aesthetics,1.0,0.0,0.0,0.0
Emotion recognition and identification,0.0,0.0,0.0,1.0
Vascularization,1.0,0.0,0.0,0.0
white matter/gray matter signal-intensity contrast,0.0,1.0,0.0,0.0
Systems theory,1.0,0.0,0.0,0.0
stimulus deviance,1.0,0.0,0.0,0.0
Triglycerides,0.0,1.0,0.0,0.0
Hyperbaric oxygen therapy,0.0,0.0,1.0,0.0
esthetic perception,0.0,1.0,0.0,0.0
value,0.0,0.0,0.0,1.0
vocabulary knowledge,0.0,0.0,1.0,0.0
Gender related familiarity,0.0,0.0,1.0,0.0
Phase locking value,0.0,0.0,0.0,1.0
Effect Size Signed Differential Mapping (ES-SDM),0.0,1.0,0.0,0.0
Instability,0.0,0.0,0.0,1.0
processing of threatening stimuli,0.0,1.0,0.0,0.0
inhibitory control,1.0,0.0,0.0,0.0
Premature birth,0.0,0.0,1.0,0.0
Internal-state,0.0,0.0,0.0,1.0
Treatment resistance,0.0,0.0,0.0,1.0
Communities,0.0,1.0,0.0,0.0
Sudden cardiac arrest,0.0,0.0,1.0,0.0
Rewards,0.0,0.0,1.0,0.0
enhanced perceptual functioning,0.0,1.0,0.0,0.0
auditory distraction,0.0,1.0,0.0,0.0
Task-set overlap,1.0,0.0,0.0,0.0
Adaptive automation,0.0,0.0,1.0,0.0
Occipital transtentorial approach,0.0,0.0,1.0,0.0
Symbol Digit Modalities Test,0.0,0.0,1.0,0.0
Student-athletes,0.0,0.0,1.0,0.0
Discrimination memory,0.0,0.0,1.0,0.0
5-HT1A receptors,0.0,0.0,1.0,0.0
Animate motion,0.0,0.0,1.0,0.0
Cognitive event-related potentials,0.0,1.0,0.0,0.0
Posttraumatic,0.0,0.0,1.0,0.0
Driving Assessment,0.0,1.0,0.0,0.0
Goal-neglect,0.0,1.0,0.0,0.0
Perceptual interpretation of bistable figures,0.0,0.0,0.0,1.0
neural model,0.0,0.0,1.0,0.0
Transgenic mouse model,0.0,0.0,1.0,0.0
Content congruency,0.0,0.0,1.0,0.0
cartographic assessment,0.0,1.0,0.0,0.0
Averted eye gaze,0.0,0.0,1.0,0.0
Far space,1.0,0.0,0.0,0.0
Orthographic transparency,0.0,0.0,1.0,0.0
pedigree,0.0,1.0,0.0,0.0
P300 event-related potentials,0.0,1.0,0.0,0.0
stair negotiation,0.0,1.0,0.0,0.0
Visual Analogue Scale,0.0,1.0,0.0,0.0
Falls in elderly,0.0,0.0,1.0,0.0
Eyewitness testimony,0.0,0.0,0.0,1.0
Perceived direction,0.0,1.0,0.0,0.0
Behavioral phenotyping,0.0,0.0,0.0,1.0
Level 1 visual perspective taking,1.0,0.0,0.0,0.0
medial temporal lobe,0.0,0.0,0.0,1.0
Muscle disease,1.0,0.0,0.0,0.0
Radio frequencies,0.0,0.0,1.0,0.0
Reorientation illusion,0.0,0.0,1.0,0.0
Analogic visual scale,0.0,1.0,0.0,0.0
Old-new discrimination,0.0,0.0,1.0,0.0
Proper names,0.0,1.0,0.0,0.0
Animacy perception,0.0,1.0,0.0,0.0
Children with cancer,0.0,0.0,1.0,0.0
Breathlessness,0.0,0.0,1.0,0.0
Respiratory chain disorder,0.0,0.0,1.0,0.0
Graspability,0.0,0.0,1.0,0.0
Parafoveal-on-foveal effect,0.0,1.0,0.0,0.0
Engrailed,0.0,0.0,1.0,0.0
Sex Differences in Brain Activation,0.0,0.0,1.0,0.0
Driving restriction,0.0,0.0,0.0,1.0
Cerebral vasoreactivity,0.0,0.0,1.0,0.0
Dehydroepiadrosterone (DHEA),1.0,0.0,0.0,0.0
cannabidiol,1.0,0.0,0.0,0.0
Control over memory,0.0,1.0,0.0,0.0
Sensory ratings,1.0,0.0,0.0,0.0
dorsal,0.0,1.0,0.0,0.0
Cumulative semantic effect,1.0,0.0,0.0,0.0
TMS-EEG,1.0,0.0,0.0,0.0
Multi-voxel pattern analysis,0.0,0.0,1.0,0.0
gravity,0.0,0.0,1.0,0.0
DRd-lifescience gene,1.0,0.0,0.0,0.0
COGNITION,1.0,0.0,0.0,0.0
Post-stroke hyperglycemia,0.0,1.0,0.0,0.0
European starling,0.0,1.0,0.0,0.0
fat droplet,0.0,0.0,1.0,0.0
AED,0.0,0.0,1.0,0.0
Relative mass,0.0,0.0,0.0,1.0
Saccadic peak velocity,0.0,0.0,1.0,0.0
Kennedy disease,0.0,0.0,1.0,0.0
Seed based functional correlation,0.0,0.0,1.0,0.0
Visuomotor transformations,0.0,0.0,1.0,0.0
Biological vision,0.0,1.0,0.0,0.0
Joint independent component analysis (jICA),1.0,0.0,0.0,0.0
Aided speech recognition in noise,0.0,1.0,0.0,0.0
Cerebral emboli,0.0,0.0,1.0,0.0
stimulus sampling theory,1.0,0.0,0.0,0.0
Object similarity,0.0,0.0,0.0,1.0
Retrograde tracers,0.0,0.0,1.0,0.0
Grating,1.0,0.0,0.0,0.0
Silhouette,0.0,1.0,0.0,0.0
Simultaneous chaining,0.0,0.0,1.0,0.0
Three-dimensional geological modeling,1.0,0.0,0.0,0.0
H1 agonist,0.0,1.0,0.0,0.0
Prisms,1.0,0.0,0.0,0.0
Histone deacetylase,0.0,0.0,0.0,1.0
Impulsive compulsive behaviour,0.0,0.0,1.0,0.0
Material perception,0.0,0.0,1.0,0.0
Action theory,0.0,0.0,1.0,0.0
old age psychiatry,0.0,0.0,0.0,1.0
red,0.0,0.0,0.0,1.0
Videogames,0.0,0.0,0.0,1.0
Sarcoidosis,0.0,1.0,0.0,0.0
Volitional,1.0,0.0,0.0,0.0
Belief bias,1.0,0.0,0.0,0.0
Bounce-stream,1.0,0.0,0.0,0.0
Unemployment,0.0,0.0,0.0,1.0
Visual control,0.0,0.0,1.0,0.0
LPN,0.0,0.0,1.0,0.0
structural magnetic resonance imaging,1.0,0.0,0.0,0.0
Fractal,0.0,0.0,0.0,1.0
Cognitive motion therapy,1.0,0.0,0.0,0.0
First-degree relative,1.0,0.0,0.0,0.0
Hippocampal memory,0.0,0.0,1.0,0.0
Pediatric cancer survivor,0.0,0.0,1.0,0.0
Affective uncertainty,0.0,0.0,1.0,0.0
Cogmed,0.0,1.0,0.0,0.0
Statistical power,1.0,0.0,0.0,0.0
Object-region binding,0.0,1.0,0.0,0.0
Flossing,0.0,1.0,0.0,0.0
A-not-B error,1.0,0.0,0.0,0.0
social exclusion,0.0,0.0,1.0,0.0
Lognormal,0.0,0.0,1.0,0.0
Medically unexplained symptoms,0.0,0.0,1.0,0.0
Egocentric coding,0.0,0.0,0.0,1.0
Imager ecognition,0.0,0.0,0.0,1.0
Institutionalization,0.0,0.0,1.0,0.0
Fear of Falling,0.0,0.0,1.0,0.0
Lewy body syndromes,0.0,1.0,0.0,0.0
Muscarinic M2 and M4 receptor,0.0,0.0,0.0,1.0
Activation,0.0,1.0,0.0,0.0
Left hemisphere,0.0,0.0,0.0,1.0
Anticholinergic,0.0,0.0,1.0,0.0
5-HT6,0.0,0.0,1.0,0.0
Magnitude of change,0.0,0.0,0.0,1.0
Mobile brain/body imaging,0.0,0.0,0.0,1.0
Multisensory 14 integration,0.0,0.0,0.0,1.0
Side effects of antiepileptic drugs,0.0,1.0,0.0,0.0
Paracingulate cortex,0.0,0.0,1.0,0.0
Reversible figures,0.0,0.0,1.0,0.0
selective vulnerability,0.0,1.0,0.0,0.0
Computerized training-tool brainStim,1.0,0.0,0.0,0.0
spatial ability,0.0,1.0,0.0,0.0
Blood-injury-injection fears,0.0,0.0,1.0,0.0
Naive optics,1.0,0.0,0.0,0.0
Object-centered suppression/inhibition,0.0,0.0,0.0,1.0
Pictorial Verbal Learning,0.0,0.0,1.0,0.0
Diurnal rhythm,1.0,0.0,0.0,0.0
Secondary visual pathway,0.0,0.0,1.0,0.0
preoperative anxiety,0.0,0.0,1.0,0.0
Involuntary processing,0.0,1.0,0.0,0.0
SMA,0.0,0.0,1.0,0.0
Friendship training,0.0,1.0,0.0,0.0
zeaxanthin,0.0,1.0,0.0,0.0
Crash risk,1.0,0.0,0.0,0.0
SMR,0.0,0.0,1.0,0.0
Mixed dementia,1.0,0.0,0.0,0.0
Systemic sclerosis,0.0,0.0,1.0,0.0
Group therapy,1.0,0.0,0.0,0.0
object tracking,1.0,0.0,0.0,0.0
Corticotectal,1.0,0.0,0.0,0.0
Bistability,0.0,0.0,1.0,0.0
Reinforcment learning,1.0,0.0,0.0,0.0
Arabic bilingual young adults,0.0,0.0,1.0,0.0
ragged red fiber,0.0,0.0,1.0,0.0
Formal language theory,0.0,1.0,0.0,0.0
distractibility,0.0,0.0,0.0,1.0
Cognitive biomarkers,0.0,1.0,0.0,0.0
Auditory behavioral task,1.0,0.0,0.0,0.0
Picture analysis,0.0,0.0,1.0,0.0
Interoceptive awareness,0.0,0.0,1.0,0.0
Wechsler Adult Intelligence Scale,0.0,0.0,1.0,0.0
Preview benefit,0.0,1.0,0.0,0.0
Arousal asymmetry,0.0,1.0,0.0,0.0
Deaf children,0.0,0.0,1.0,0.0
Involuntary memory,1.0,0.0,0.0,0.0
G2019S,0.0,1.0,0.0,0.0
Human cortex,0.0,0.0,0.0,1.0
Semantic mapping,0.0,1.0,0.0,0.0
Full remission,0.0,0.0,1.0,0.0
emergent phenomena,0.0,0.0,1.0,0.0
Avoidance learning,1.0,0.0,0.0,0.0
Chemokines,0.0,1.0,0.0,0.0
NASA-TLX,0.0,1.0,0.0,0.0
Business,0.0,1.0,0.0,0.0
Crataegus,0.0,0.0,1.0,0.0
Lyme encephalopathy,0.0,0.0,1.0,0.0
Functional somatic syndromes,0.0,0.0,1.0,0.0
neurophysiological correlates,0.0,1.0,0.0,0.0
Crossmaze,1.0,0.0,0.0,0.0
Therapeutical interventions,0.0,1.0,0.0,0.0
Problem drinkers,0.0,0.0,0.0,1.0
Electrophysiological data,0.0,0.0,1.0,0.0
Implicit perception,1.0,0.0,0.0,0.0
object permanence,0.0,0.0,1.0,0.0
Familiarity in recognition memory,0.0,0.0,1.0,0.0
Telemanipulation,0.0,0.0,0.0,1.0
touch screen,0.0,0.0,1.0,0.0
CRF1 receptor,0.0,0.0,1.0,0.0
real-life vision test,0.0,0.0,1.0,0.0
Benton Visual Retention Test,1.0,0.0,0.0,0.0
TEOAE,0.0,1.0,0.0,0.0
Brain-behavior correlations,0.0,0.0,1.0,0.0
Migrant women,0.0,1.0,0.0,0.0
Mental body rotation,0.0,0.0,1.0,0.0
Soot,0.0,0.0,1.0,0.0
Adaptability,1.0,0.0,0.0,0.0
Unitization,0.0,1.0,0.0,0.0
Multiple objects,1.0,0.0,0.0,0.0
allocentric strategies,1.0,0.0,0.0,0.0
rejection,0.0,0.0,1.0,0.0
Nave Bayes,0.0,1.0,0.0,0.0
Cognitive addition,0.0,0.0,1.0,0.0
Epileptiform,0.0,0.0,1.0,0.0
Rough set theory,1.0,0.0,0.0,0.0
semantic similarity,0.0,1.0,0.0,0.0
Visual arts,1.0,0.0,0.0,0.0
Action cognition,0.0,0.0,1.0,0.0
Replication,0.0,0.0,0.0,1.0
different Arabic TMT norms,0.0,0.0,1.0,0.0
Memory alignment effect,0.0,0.0,1.0,0.0
Stimulus evaluation,0.0,1.0,0.0,0.0
Sleep patterns,0.0,0.0,1.0,0.0
Contextualization,0.0,1.0,0.0,0.0
Retrieval mode,0.0,1.0,0.0,0.0
Dorsolateral prefrontal cortex (DLPFC),0.0,0.0,1.0,0.0
frontal-subcortical neuronal circuit,1.0,0.0,0.0,0.0
sedoanalgesia,0.0,0.0,1.0,0.0
neural hypothesis,0.0,1.0,0.0,0.0
Sequence-form,0.0,1.0,0.0,0.0
Implicit mental imagery,0.0,0.0,1.0,0.0
Impulse Control,1.0,0.0,0.0,0.0
Anterior choroidal artery,0.0,1.0,0.0,0.0
Tufail,0.0,1.0,0.0,0.0
isual cognition,0.0,0.0,1.0,0.0
English and Arabic TMT,0.0,0.0,1.0,0.0
Siamang,0.0,0.0,1.0,0.0
Sodium butyrate,0.0,0.0,0.0,1.0
Searching for identical pictures,0.0,1.0,0.0,0.0
temporal difference error prediction,0.0,1.0,0.0,0.0
catechol-O-methyltransferase,0.0,0.0,1.0,0.0
Evolved navigation theory,0.0,1.0,0.0,0.0
Cognitive ecology,0.0,0.0,1.0,0.0
Visual Discussion Technique,1.0,0.0,0.0,0.0
Pacemaker-counter clock,1.0,0.0,0.0,0.0
adiposity,0.0,1.0,0.0,0.0
autonomic dysfunction,0.0,0.0,0.0,1.0
Environmental sounds,0.0,0.0,0.0,1.0
Predictable switch,0.0,1.0,0.0,0.0
Familiarity effect,1.0,0.0,0.0,0.0
Reproducible,1.0,0.0,0.0,0.0
chemistry,0.0,1.0,0.0,0.0
landmark,1.0,0.0,0.0,0.0
APP23 transgenic mouse model,0.0,0.0,1.0,0.0
representational momentum,0.0,1.0,0.0,0.0
supervisory attentional system,0.0,0.0,1.0,0.0
Semantic impairments,0.0,1.0,0.0,0.0
Open-heart surgery,1.0,0.0,0.0,0.0
Facial motoneuron,0.0,1.0,0.0,0.0
Reliability Schizophrenia,0.0,1.0,0.0,0.0
Limited Commitment Mode control strategy,0.0,0.0,1.0,0.0
Chronometry,0.0,0.0,1.0,0.0
Gurwitsch,0.0,0.0,0.0,1.0
Bowel obsession,0.0,1.0,0.0,0.0
Attention deficit disorder with hyperactivity,0.0,0.0,1.0,0.0
copying,0.0,1.0,0.0,0.0
Psychological feeling,0.0,0.0,1.0,0.0
Missing stimulus,0.0,0.0,1.0,0.0
Sound spatialization,0.0,0.0,1.0,0.0
Dopaminergic neurons,1.0,0.0,0.0,0.0
Acoustic startle response,0.0,1.0,0.0,0.0
Craniofacial pain,0.0,0.0,1.0,0.0
Lewy body pathology,0.0,1.0,0.0,0.0
Behaving monkey,1.0,0.0,0.0,0.0
person construal,0.0,1.0,0.0,0.0
Rey-Osterreith Complex Figure,0.0,0.0,0.0,1.0
Ibuprofen,1.0,0.0,0.0,0.0
sexuality,1.0,0.0,0.0,0.0
Dyslexia subtypes,1.0,0.0,0.0,0.0
design concept,0.0,0.0,1.0,0.0
Smoking cues,1.0,0.0,0.0,0.0
Activity loss,0.0,0.0,1.0,0.0
Systematicity,0.0,0.0,1.0,0.0
Contrast gain,0.0,1.0,0.0,0.0
Engaged lifestyle,0.0,0.0,1.0,0.0
Electrical synapses,1.0,0.0,0.0,0.0
Meta - cognition,1.0,0.0,0.0,0.0
nonverbal intelligence,0.0,0.0,1.0,0.0
brain-machine interface,0.0,1.0,0.0,0.0
Erasure,0.0,0.0,1.0,0.0
Histone acetylation,0.0,0.0,1.0,0.0
Text chat,0.0,1.0,0.0,0.0
Noise/visual annoyance,0.0,0.0,0.0,1.0
Order memory,0.0,1.0,0.0,0.0
thrombolysis,0.0,0.0,1.0,0.0
dosage effect,1.0,0.0,0.0,0.0
Extremely preterm,0.0,0.0,0.0,1.0
Whole-exome sequencing,0.0,0.0,0.0,1.0
Filtering,0.0,1.0,0.0,0.0
Late positive complexes,0.0,0.0,1.0,0.0
General self-efficacy,0.0,0.0,1.0,0.0
DTNBP1,0.0,0.0,1.0,0.0
Neuropsychological Performance,0.0,0.0,1.0,0.0
Programming,0.0,0.0,1.0,0.0
Momentary assessment,0.0,0.0,1.0,0.0
Psychedelic,0.0,1.0,0.0,0.0
cerebellar degeneration,0.0,1.0,0.0,0.0
Looming and receding motion,0.0,0.0,1.0,0.0
Knowledge and Learning",0.0,0.0,0.0,0.0
Cognitive-motor interference,0.0,1.0,0.0,0.0
Right parietal lesion,0.0,0.0,1.0,0.0
Stabilometric platform,0.0,0.0,1.0,0.0
rapid serial visual processing,0.0,1.0,0.0,0.0
Motherese,0.0,0.0,1.0,0.0
Parkinson dementia,0.0,0.0,1.0,0.0
sensation seeking,1.0,0.0,0.0,0.0
Memory-delay task,0.0,0.0,1.0,0.0
Pain syndrome,0.0,0.0,1.0,0.0
Acoustic chamber,1.0,0.0,0.0,0.0
Opiate receptor,0.0,1.0,0.0,0.0
Functional Magnetic Resonance Imaging,1.0,0.0,0.0,0.0
Variance,0.0,0.0,1.0,0.0
Adjuvant hormonal therapy,0.0,0.0,1.0,0.0
Near-hand effect,0.0,0.0,1.0,0.0
fixation durations,0.0,0.0,1.0,0.0
Relational processing,0.0,0.0,1.0,0.0
gender-related differences,0.0,0.0,0.0,1.0
Illness representations,0.0,1.0,0.0,0.0
Signals,0.0,1.0,0.0,0.0
Orthographic learning,0.0,0.0,1.0,0.0
Statistical learning (SL),0.0,0.0,1.0,0.0
stimulus-object congruency,1.0,0.0,0.0,0.0
EEG alpha activity,0.0,1.0,0.0,0.0
Prenatal stroke,0.0,0.0,1.0,0.0
EEG phase jump (discontinuity),0.0,0.0,1.0,0.0
Multiple micronutrient supplementation,1.0,0.0,0.0,0.0
M4 muscarinic,0.0,0.0,1.0,0.0
Cognitive content specificity,0.0,0.0,1.0,0.0
Rhythmex,1.0,0.0,0.0,0.0
Affective photograph,0.0,0.0,1.0,0.0
neuromotor impairment,1.0,0.0,0.0,0.0
Visual inference,1.0,0.0,0.0,0.0
Dietary cognitive restraint,1.0,0.0,0.0,0.0
Motivated perception,0.0,0.0,1.0,0.0
Street crossing,0.0,1.0,0.0,0.0
small-for-gestational age,0.0,0.0,0.0,1.0
"ERPs,0.0,0.0,0.0,0.0
match-to-standards,0.0,0.0,1.0,0.0
Evaluative judgments,0.0,1.0,0.0,0.0
extracts of hops,0.0,0.0,1.0,0.0
Interhemispheric,1.0,0.0,0.0,0.0
Dwarf goats,0.0,1.0,0.0,0.0
Tetrahydrocannabinol,0.0,1.0,0.0,0.0
Rule retrieval,0.0,0.0,0.0,1.0
Floor projection maze,0.0,0.0,1.0,0.0
Computer aided manufacturing,0.0,0.0,1.0,0.0
Ambiguity intolerance,0.0,1.0,0.0,0.0
User interface,0.0,1.0,0.0,0.0
location matching,0.0,0.0,0.0,1.0
Anthropomorphism,0.0,0.0,0.0,1.0
Neuropsychological Function,1.0,0.0,0.0,0.0
anterograde interference,0.0,0.0,1.0,0.0
Vernier stimuli,0.0,0.0,0.0,1.0
Carer report,0.0,1.0,0.0,0.0
CSMdmedicine gene,1.0,0.0,0.0,0.0
pleasant,0.0,0.0,0.0,1.0
Agnosia for object orientation,0.0,1.0,0.0,0.0
Classical voice,0.0,0.0,1.0,0.0
EEG power,0.0,0.0,0.0,1.0
Electro-convulsive therapy,0.0,0.0,1.0,0.0
Inertia,0.0,0.0,1.0,0.0
Idealized Cognitive Models,0.0,0.0,1.0,0.0
Glutamic acid decarboxylase,0.0,1.0,0.0,0.0
Non-linear neural network analysis,0.0,0.0,1.0,0.0
Implicit sequence learning,0.0,0.0,1.0,0.0
Treadmill,0.0,0.0,1.0,0.0
Intralaminar thalamic nuclei,0.0,0.0,1.0,0.0
Anterior temporal face patch,0.0,0.0,1.0,0.0
Selective serotonin reuptake inhibitors (SSRIs),0.0,0.0,1.0,0.0
Lemur catta,0.0,0.0,1.0,0.0
Verbalizer,0.0,0.0,1.0,0.0
mass detection,0.0,0.0,1.0,0.0
N-Acetylaspartate (NAA),1.0,0.0,0.0,0.0
ventral stream,0.0,0.0,1.0,0.0
Pediatric hearing loss,0.0,1.0,0.0,0.0
Iteration,0.0,1.0,0.0,0.0
subjective experience,1.0,0.0,0.0,0.0
Global integration,0.0,0.0,1.0,0.0
Subdural electrodes,0.0,1.0,0.0,0.0
Symbolic mathematics,0.0,1.0,0.0,0.0
stereopsis,0.0,1.0,0.0,0.0
Neuronal activity,0.0,1.0,0.0,0.0
Handedness task,0.0,0.0,1.0,0.0
Perceptual fluency,0.0,0.0,1.0,0.0
Delayed retrieval,1.0,0.0,0.0,0.0
Geometric cues,0.0,0.0,0.0,1.0
pleasure,1.0,0.0,0.0,0.0
MHealth,0.0,0.0,1.0,0.0
Prospective activity,0.0,0.0,1.0,0.0
Biologically prepared,0.0,0.0,1.0,0.0
Apis mellifera,0.0,0.0,1.0,0.0
exemestane,0.0,0.0,1.0,0.0
Frontotemporal lobar dementia,0.0,0.0,0.0,0.0
reaction times,0.0,1.0,0.0,0.0
Cardiac arrest,1.0,0.0,0.0,0.0
phakic intraocular lens,0.0,0.0,0.0,1.0
temporal measure,0.0,0.0,1.0,0.0
Issue 88,0.0,0.0,1.0,0.0
Issue 84,0.0,0.0,1.0,0.0
Intermanual transfer,1.0,0.0,0.0,0.0
Non-verbal abilities,0.0,1.0,0.0,0.0
Scene memory,0.0,0.0,1.0,0.0
Transect,0.0,0.0,1.0,0.0
Kinesthetic perception,1.0,0.0,0.0,0.0
Post-lunch dip,0.0,1.0,0.0,0.0
Figurative discrimination tasks,0.0,1.0,0.0,0.0
Long term potentiation,0.0,1.0,0.0,0.0
Mother-child interaction,0.0,0.0,0.0,1.0
Training schedule,0.0,0.0,1.0,0.0
N2-P3,0.0,0.0,1.0,0.0
Color matching,0.0,0.0,1.0,0.0
Matrics,0.0,0.0,1.0,0.0
Lewy body variant,0.0,1.0,0.0,0.0
Assessment protocol,0.0,1.0,0.0,0.0
Cyprinus carpio,0.0,0.0,1.0,0.0
Triangle animations,0.0,0.0,1.0,0.0
IEEE 1599,1.0,0.0,0.0,0.0
Culture  Situation  Person interaction,0.0,1.0,0.0,0.0
extinction,0.0,1.0,0.0,0.0
Hand movement,0.0,0.0,1.0,0.0
Cataract extraction,0.0,0.0,1.0,0.0
Sarcasm,0.0,0.0,0.0,1.0
Object centered,0.0,0.0,1.0,0.0
Inverse solution,1.0,0.0,0.0,0.0
Human sensorimotor control,0.0,0.0,1.0,0.0
Alcohol use disorders,1.0,0.0,0.0,0.0
VMIQ-2,0.0,0.0,1.0,0.0
Scene understanding,0.0,0.0,1.0,0.0
Atresia,0.0,0.0,1.0,0.0
Heart rate analysis,0.0,1.0,0.0,0.0
Disengage,0.0,0.0,1.0,0.0
haploidentical transplantation,0.0,0.0,1.0,0.0
Coronary artery bypass graft,0.0,0.0,1.0,0.0
Attribute of information,0.0,1.0,0.0,0.0
motor preparation,0.0,0.0,1.0,0.0
Interpersonal communication,0.0,0.0,1.0,0.0
Family pictures,0.0,0.0,0.0,1.0
Verbal influences,1.0,0.0,0.0,0.0
Perceptual richness,0.0,1.0,0.0,0.0
Implicit visual learning,0.0,0.0,1.0,0.0
Selective updating,0.0,0.0,1.0,0.0
Delayed intentions,0.0,0.0,0.0,1.0
Moderately preterm children,1.0,0.0,0.0,0.0
Therapeutic relationships,0.0,1.0,0.0,0.0
Young adolescent,1.0,0.0,0.0,0.0
neurological,0.0,0.0,0.0,1.0
Control group,0.0,1.0,0.0,0.0
bottleneck,0.0,0.0,1.0,0.0
Episodic binding,0.0,0.0,1.0,0.0
Rapid ocular dominance plasticity requires cortical but not geniculate protein synthesis (2002) Neuron,0.0,0.0,1.0,0.0
Chinese character naming,1.0,0.0,0.0,0.0
Ceruloplasmin,0.0,0.0,1.0,0.0
Human mirror neuron system,0.0,1.0,0.0,0.0
Psychological test,1.0,0.0,0.0,0.0
Perception-action (P-A) modeling,0.0,0.0,1.0,0.0
Distal attribution,0.0,1.0,0.0,0.0
Successive matching,1.0,0.0,0.0,0.0
Venlafaxine extended release,0.0,1.0,0.0,0.0
BRAO,1.0,0.0,0.0,0.0
Interictal epileptiform abnormalities,1.0,0.0,0.0,0.0
Eye patch,0.0,0.0,0.0,1.0
Glioblastoma,0.0,0.0,0.0,1.0
lutein,0.0,1.0,0.0,0.0
Mathematical and technological education,0.0,0.0,1.0,0.0
CMRCC,0.0,1.0,0.0,0.0
Improvised gestural communication,0.0,0.0,0.0,1.0
Conscious and unconscious processing,0.0,0.0,1.0,0.0
BVRT,0.0,0.0,1.0,0.0
Phase resetting,1.0,0.0,0.0,0.0
Transfer effects,1.0,0.0,0.0,0.0
Relative size,0.0,1.0,0.0,0.0
McCracken-Aldrich technique,0.0,1.0,0.0,0.0
College students,0.0,0.0,0.0,1.0
Ketosis,0.0,0.0,1.0,0.0
Vasomotor,0.0,0.0,1.0,0.0
MIMIC,0.0,0.0,1.0,0.0
mild traumatic brain injury outcomes,1.0,0.0,0.0,0.0
KCTD7,0.0,0.0,1.0,0.0
Stimulus onset asynchrony (SOA),0.0,1.0,0.0,0.0
Memory awareness,0.0,0.0,1.0,0.0
Value of information,0.0,1.0,0.0,0.0
Target extraction,1.0,0.0,0.0,0.0
Hypomyelination,0.0,0.0,1.0,0.0
Homeostatic synaptic plasticity,1.0,0.0,0.0,0.0
Superposition principle,0.0,0.0,0.0,1.0
Version,0.0,0.0,1.0,0.0
intrauterine growth restriction,0.0,1.0,0.0,0.0
Automatic cognitive skills,0.0,0.0,1.0,0.0
Domain-specific,0.0,1.0,0.0,0.0
Conservative management,0.0,1.0,0.0,0.0
IUGR,0.0,1.0,0.0,0.0
Prelingual deafness,0.0,1.0,0.0,0.0
interpretive bias,1.0,0.0,0.0,0.0
Dimensions,0.0,1.0,0.0,0.0
Apolipoprotein A,0.0,1.0,0.0,0.0
metaphors,0.0,0.0,1.0,0.0
Work productivity,1.0,0.0,0.0,0.0
Acheulean,1.0,0.0,0.0,0.0
feature selection,0.0,1.0,0.0,0.0
visual abilityVisual ability,1.0,0.0,0.0,0.0
Endothelial dysfunction,1.0,0.0,0.0,0.0
People with mental handicap,0.0,0.0,1.0,0.0
Ethical sustainability,0.0,0.0,1.0,0.0
Visually guided performance,0.0,0.0,0.0,1.0
Early cognition,0.0,0.0,1.0,0.0
mood disorders-bipolar,0.0,0.0,1.0,0.0
benzodiazepine,0.0,1.0,0.0,0.0
Independent component analysis (ICA),1.0,0.0,0.0,0.0
Simultaneous comparison,0.0,0.0,1.0,0.0
Pathology,1.0,0.0,0.0,0.0
Sensory deficits,0.0,0.0,0.0,1.0
Fish oil,0.0,1.0,0.0,0.0
Implicit attitudes,0.0,0.0,0.0,1.0
EEG-based local brain activity (EEG-LBA-) feedback,0.0,1.0,0.0,0.0
Social behaviors,0.0,1.0,0.0,0.0
Anterior cingulated cortex (ACC),0.0,1.0,0.0,0.0
Predators,0.0,0.0,1.0,0.0
Manipulative semantic features,1.0,0.0,0.0,0.0
Noise tolerance,0.0,1.0,0.0,0.0
Hyper-mentalism,0.0,0.0,1.0,0.0
Noise reduction.,0.0,0.0,1.0,0.0
asthma,0.0,0.0,0.0,1.0
Case-control studies,0.0,1.0,0.0,0.0
Physical medicine,0.0,0.0,1.0,0.0
MEG/EEG,0.0,0.0,1.0,0.0
ACE-R,0.0,0.0,0.0,1.0
Phonological theory,0.0,1.0,0.0,0.0
early design,0.0,0.0,1.0,0.0
Neural decoding,0.0,0.0,0.0,1.0
Quality of sleep,0.0,0.0,1.0,0.0
Force adaptation,0.0,1.0,0.0,0.0
Oman,0.0,1.0,0.0,0.0
Perceptual filling-in,0.0,0.0,1.0,0.0
Placebo-controlled trial,0.0,1.0,0.0,0.0
Source modelling,0.0,0.0,1.0,0.0
Arrangement and description,0.0,1.0,0.0,0.0
Verbal-non verbal cognition,1.0,0.0,0.0,0.0
Technology and Work",0.0,0.0,0.0,0.0
Functional integration,1.0,0.0,0.0,0.0
Hierarchical letter,0.0,0.0,1.0,0.0
Transplant,0.0,0.0,1.0,0.0
Covariance analysis,1.0,0.0,0.0,0.0
High frequency stimulation,0.0,0.0,1.0,0.0
22q11.2 microduplication,0.0,0.0,0.0,1.0
Intermediate feeder,0.0,0.0,1.0,0.0
Racial and ethnic attitudes,0.0,0.0,1.0,0.0
Longitudinal assessment,1.0,0.0,0.0,0.0
memory encoding,0.0,1.0,0.0,0.0
Social context,0.0,0.0,0.0,1.0
SCOPA-autonomic,1.0,0.0,0.0,0.0
Preclinical dental training,0.0,1.0,0.0,0.0
CASL,0.0,0.0,1.0,0.0
Activation likelihood estimation,0.0,1.0,0.0,0.0
Non-cancer pain,0.0,1.0,0.0,0.0
NEPSY,0.0,1.0,0.0,0.0
Approximate and small number system,0.0,1.0,0.0,0.0
cancer,1.0,0.0,0.0,0.0
Stereotactic pallidotomy,0.0,0.0,0.0,1.0
Neglect rehabilitation,0.0,0.0,0.0,1.0
Epidemiologic methods,1.0,0.0,0.0,0.0
Atopy,0.0,1.0,0.0,0.0
Event-related spectral perturbation (ERSP),1.0,0.0,0.0,0.0
HF-rTMS,0.0,0.0,0.0,1.0
Pain stimulation,0.0,0.0,1.0,0.0
rugby,0.0,0.0,1.0,0.0
AR navigation,0.0,1.0,0.0,0.0
Essential fatty acids (EPA),0.0,0.0,1.0,0.0
orientation identification,0.0,0.0,1.0,0.0
Discordant identical twins,1.0,0.0,0.0,0.0
Redundant target effect,0.0,0.0,1.0,0.0
Prefrontal regions,0.0,0.0,1.0,0.0
Recollective experience,0.0,0.0,1.0,0.0
Pre-vocational rehabilitation,0.0,1.0,0.0,0.0
Number of CAG repeats,0.0,0.0,1.0,0.0
BNA,0.0,1.0,0.0,0.0
Autonomic dystonia,0.0,0.0,1.0,0.0
Retinal dystrophies,0.0,0.0,1.0,0.0
Developmental neuroimaging,0.0,0.0,1.0,0.0
Risk behavior,0.0,1.0,0.0,0.0
Spontaneous cognition,0.0,1.0,0.0,0.0
Spatial transformation,0.0,0.0,1.0,0.0
Atrioventricular reentry tachycardia,0.0,1.0,0.0,0.0
Modified mini-mental test,0.0,0.0,1.0,0.0
Smile,0.0,0.0,1.0,0.0
computerized neurocognitive testing,0.0,1.0,0.0,0.0
Non-linear digital filters,0.0,0.0,1.0,0.0
Word-length effect,0.0,1.0,0.0,0.0
Multifeature,0.0,0.0,0.0,1.0
obstructive,0.0,0.0,1.0,0.0
Perinatal 5-MT,0.0,1.0,0.0,0.0
Parkinsons disease,0.0,1.0,0.0,0.0
Hierarchical bayesian inference,0.0,0.0,1.0,0.0
Border-ownership,0.0,1.0,0.0,0.0
Design actions,1.0,0.0,0.0,0.0
Cognitive processess,0.0,1.0,0.0,0.0
Verbal Protocol,0.0,0.0,1.0,0.0
Visual-tracking performance,0.0,0.0,0.0,1.0
Coronary artery disease,0.0,0.0,1.0,0.0
Name,0.0,0.0,0.0,1.0
amantadine,0.0,0.0,1.0,0.0
Multimodal prominence,0.0,1.0,0.0,0.0
Gamma-band oscillations,0.0,0.0,1.0,0.0
Gaze control model,0.0,0.0,1.0,0.0
dual-task,0.0,0.0,1.0,0.0
Theories of mathematical cognition,0.0,0.0,0.0,1.0
Repetive transcranial magnetic stimulation,0.0,0.0,1.0,0.0
Verbal intelligence,0.0,0.0,0.0,1.0
Reminiscence bump,0.0,0.0,1.0,0.0
Problem-focused,0.0,0.0,1.0,0.0
Delayed choice,1.0,0.0,0.0,0.0
Brain shape,0.0,0.0,0.0,1.0
Muscarinic receptor agonists,0.0,0.0,1.0,0.0
central executive network,0.0,0.0,1.0,0.0
Diffusion tensor tractography,1.0,0.0,0.0,0.0
remember/know,0.0,0.0,1.0,0.0
Visual-constructive disorder,1.0,0.0,0.0,0.0
Body-model,0.0,1.0,0.0,0.0
Cerebral vasculature,1.0,0.0,0.0,0.0
AChE inhibitor,0.0,1.0,0.0,0.0
ISE,0.0,1.0,0.0,0.0
Neuropsychological norms,0.0,1.0,0.0,0.0
family history,0.0,0.0,1.0,0.0
Nursing home resident,0.0,0.0,1.0,0.0
Cycloparaffins,0.0,1.0,0.0,0.0
IST,0.0,1.0,0.0,0.0
Ventral,1.0,0.0,0.0,0.0
Redirective,0.0,1.0,0.0,0.0
Ape,0.0,0.0,0.0,1.0
time-on-task,0.0,0.0,1.0,0.0
change detection,0.0,1.0,0.0,0.0
Dysexecutive syndrome,0.0,1.0,0.0,0.0
Tumor,0.0,0.0,0.0,1.0
scattered ontologies,1.0,0.0,0.0,0.0
Antihistamine,0.0,1.0,0.0,0.0
Initial movement direction,0.0,1.0,0.0,0.0
Geospatial representation,0.0,1.0,0.0,0.0
compulsive checking,0.0,0.0,1.0,0.0
action parsing,0.0,0.0,1.0,0.0
Neuroleptic nave,0.0,0.0,1.0,0.0
Becker muscular dystrophy,1.0,0.0,0.0,0.0
Children with cochlear implants,0.0,1.0,0.0,0.0
Familiar face,0.0,1.0,0.0,0.0
Global efficiency,1.0,0.0,0.0,0.0
Subcortical infarction,0.0,1.0,0.0,0.0
MRI volumes,0.0,0.0,0.0,1.0
Vision and action,0.0,0.0,1.0,0.0
symbolic processing,0.0,0.0,0.0,1.0
"Behavioral assessment,0.0,0.0,0.0,0.0
Bisphenol-A,0.0,0.0,1.0,0.0
Event schemas,0.0,0.0,1.0,0.0
5-HT transporter gene,1.0,0.0,0.0,0.0
Atomoxetine,1.0,0.0,0.0,0.0
Visual event related potential,1.0,0.0,0.0,0.0
Cognitive task-set,0.0,0.0,1.0,0.0
Semantic Interference Test,0.0,0.0,0.0,1.0
Tail lamps,1.0,0.0,0.0,0.0
Dorsal visual cortical network,0.0,1.0,0.0,0.0
Remission of seizures,0.0,0.0,1.0,0.0
Co-infection,0.0,0.0,1.0,0.0
Cortico-basal ganglia loops,1.0,0.0,0.0,0.0
Work schedule tolerance,0.0,0.0,1.0,0.0
Infarction,1.0,0.0,0.0,0.0
Gait with obstacle,0.0,1.0,0.0,0.0
Longitudinal course,0.0,0.0,1.0,0.0
between-domain interference,1.0,0.0,0.0,0.0
Daidzein,0.0,0.0,1.0,0.0
Perceptual symbols,0.0,1.0,0.0,0.0
Next-generation sequencing,0.0,0.0,0.0,1.0
Transgenic mouse,0.0,0.0,1.0,0.0
elaborative encoding,0.0,0.0,1.0,0.0
Umbilical cord blood transplantation,0.0,0.0,1.0,0.0
Hybrid task,0.0,1.0,0.0,0.0
Simulation in normal readers,0.0,0.0,1.0,0.0
Motion capture,0.0,0.0,1.0,0.0
early/late selection,0.0,0.0,1.0,0.0
Neurodynamical model,0.0,1.0,0.0,0.0
Process approach,0.0,0.0,1.0,0.0
Child and adolescent health,0.0,0.0,0.0,1.0
Information flow,0.0,1.0,0.0,0.0
M170,0.0,1.0,0.0,0.0
Cooperative plasticity,0.0,0.0,0.0,1.0
Internal/external,1.0,0.0,0.0,0.0
Dutch,0.0,0.0,1.0,0.0
Childhood anxiety disorders,1.0,0.0,0.0,0.0
N-Back,1.0,0.0,0.0,0.0
Speech reception threshold,1.0,0.0,0.0,0.0
Reactivity of sensory zones,0.0,1.0,0.0,0.0
Reaction event,0.0,0.0,1.0,0.0
At risk mental state (ARMS),0.0,0.0,1.0,0.0
Neuroinformatics,0.0,0.0,0.0,1.0
Compensatory plasticity,0.0,0.0,1.0,0.0
Prodromal stage,1.0,0.0,0.0,0.0
curriculum,0.0,0.0,0.0,1.0
Granisetron,0.0,0.0,1.0,0.0
Neural,1.0,0.0,0.0,0.0
Processing orientation,0.0,0.0,1.0,0.0
Performance under pressure,1.0,0.0,0.0,0.0
Blood alcohol concentration,0.0,1.0,0.0,0.0
Analytical-Specific Visual Perception,1.0,0.0,0.0,0.0
Sequence behavior,0.0,1.0,0.0,0.0
Selective deficits,0.0,0.0,1.0,0.0
Integrative agnosia,1.0,0.0,0.0,0.0
brain plasticity,0.0,0.0,1.0,0.0
multi-tasking,0.0,1.0,0.0,0.0
Letter strings,0.0,0.0,1.0,0.0
Scopic regime,0.0,0.0,1.0,0.0
Neurodegenerative diseases,0.0,1.0,0.0,0.0
Area V4,0.0,0.0,0.0,1.0
Motion-sensitive neurons,0.0,1.0,0.0,0.0
Unit recording,0.0,0.0,0.0,1.0
NES2,0.0,1.0,0.0,0.0
CO 2,0.0,1.0,0.0,0.0
Magnetic resonance imaging-compatible interactive eyetracking,1.0,0.0,0.0,0.0
MRI-negative,1.0,0.0,0.0,0.0
Mothering,1.0,0.0,0.0,0.0
Functional change,0.0,0.0,0.0,1.0
Interpersonal relationships,0.0,0.0,0.0,1.0
Masterpiece,0.0,0.0,1.0,0.0
intrinsic activity,0.0,1.0,0.0,0.0
Image triage,0.0,1.0,0.0,0.0
Human-animal interaction,0.0,0.0,1.0,0.0
Pop-out effect,1.0,0.0,0.0,0.0
alpha rhythm,0.0,0.0,1.0,0.0
Head-up displays,0.0,1.0,0.0,0.0
Structural MRI,1.0,0.0,0.0,0.0
Responsiveness,0.0,0.0,1.0,0.0
Signal honesty,0.0,1.0,0.0,0.0
Learning disorder,1.0,0.0,0.0,0.0
Incidental learning,0.0,0.0,1.0,0.0
Coloured-hearing synesthesia,0.0,0.0,1.0,0.0
Attentional limited capacity,0.0,1.0,0.0,0.0
Hopfield attractor networks,0.0,0.0,1.0,0.0
Probability matching,0.0,0.0,1.0,0.0
automatic optimism,0.0,1.0,0.0,0.0
Cortical oscillation,0.0,0.0,1.0,0.0
self-efficacy,0.0,0.0,1.0,0.0
Taste perception,1.0,0.0,0.0,0.0
gestation,0.0,0.0,1.0,0.0
Assassination,0.0,1.0,0.0,0.0
Cognitive fluctuations,0.0,1.0,0.0,0.0
CB6F1  C3dengineeringF1,0.0,1.0,0.0,0.0
Brake lamps,1.0,0.0,0.0,0.0
Threaded cognition,0.0,0.0,1.0,0.0
Visual processing (Gv) ability,0.0,0.0,1.0,0.0
skin,1.0,0.0,0.0,0.0
Denial,0.0,0.0,1.0,0.0
Occipital lobe epilepsy,1.0,0.0,0.0,0.0
Preparatory attention,0.0,1.0,0.0,0.0
Alert behaving monkey,0.0,0.0,1.0,0.0
Allosteric modulator,0.0,0.0,1.0,0.0
pp. 359-372,0.0,1.0,0.0,0.0
Children's testimony,0.0,0.0,1.0,0.0
C145,0.0,0.0,1.0,0.0
Plasma total tau,1.0,0.0,0.0,0.0
Ordinal processing,0.0,0.0,1.0,0.0
diet,1.0,0.0,0.0,0.0
Prominence,0.0,0.0,1.0,0.0
amyloid imaging,1.0,0.0,0.0,0.0
Sensorimotor functioning,1.0,0.0,0.0,0.0
CNS side effects,0.0,0.0,1.0,0.0
Quantitative traits,1.0,0.0,0.0,0.0
Character structure,0.0,0.0,1.0,0.0
Trajectory planning,0.0,0.0,1.0,0.0
Cognitive aftereffects,0.0,0.0,1.0,0.0
Finger-number interactions,0.0,1.0,0.0,0.0
Survey,0.0,1.0,0.0,0.0
Exacerbation,0.0,0.0,1.0,0.0
Eye movement analysis,0.0,0.0,1.0,0.0
age-related memory impairment,0.0,0.0,0.0,1.0
Corticogeniculate,0.0,0.0,0.0,1.0
nicotinic,0.0,1.0,0.0,0.0
unaffected siblings,0.0,0.0,0.0,1.0
Lateral interactions,0.0,0.0,1.0,0.0
Flash visual evoked potentials,0.0,0.0,1.0,0.0
pediatric cancer,1.0,0.0,0.0,0.0
Workload capacity coefficient,0.0,0.0,1.0,0.0
prose recall,0.0,1.0,0.0,0.0
Attentional bottleneck,1.0,0.0,0.0,0.0
Playback,0.0,1.0,0.0,0.0
?2-adrenoceptors,1.0,0.0,0.0,0.0
Refractive surgical procedures,0.0,0.0,0.0,0.0
Childhood leukemia,1.0,0.0,0.0,0.0
Duration untreated psychosis,0.0,0.0,0.0,1.0
Multivalue,1.0,0.0,0.0,0.0
Frontal midline theta,1.0,0.0,0.0,0.0
Sweden,0.0,1.0,0.0,0.0
HDAC,0.0,0.0,1.0,0.0
Logogrpahic,0.0,0.0,1.0,0.0
Verbaliser,0.0,1.0,0.0,0.0
Ertapenem,0.0,0.0,1.0,0.0
TPA023,0.0,0.0,1.0,0.0
Social-skill,1.0,0.0,0.0,0.0
Effort discounting,0.0,0.0,1.0,0.0
FTDP-17,0.0,0.0,1.0,0.0
Dopamine agonist,0.0,0.0,1.0,0.0
Triadic interactions,0.0,0.0,1.0,0.0
computerized neuropsychological testing,0.0,0.0,0.0,1.0
Cognitive adaptability,1.0,0.0,0.0,0.0
Detection of change,0.0,1.0,0.0,0.0
visual regulation,0.0,1.0,0.0,0.0
Evolution of development,0.0,0.0,0.0,1.0
Neolamprologus pulcher,1.0,0.0,0.0,0.0
Event Related Potentials,0.0,0.0,1.0,0.0
Adenosine,1.0,0.0,0.0,0.0
Functional magnetic resonancce imaging,0.0,0.0,1.0,0.0
Chained sequential operations,1.0,0.0,0.0,0.0
GCaMP,0.0,1.0,0.0,0.0
Response latencies,0.0,1.0,0.0,0.0
Genetic imaging,1.0,0.0,0.0,0.0
human-computer interaction (HCI),0.0,0.0,1.0,0.0
postural balance,0.0,0.0,0.0,1.0
Local field potential,0.0,0.0,1.0,0.0
broader autism phenotype,0.0,0.0,1.0,0.0
Number facts,1.0,0.0,0.0,0.0
Congenital hypothyroidism,0.0,0.0,1.0,0.0
Lead poisoning,0.0,0.0,1.0,0.0
Central executive network,0.0,1.0,0.0,0.0
Cerebellar transcranial direct current stimulation,0.0,1.0,0.0,0.0
Phase-delay,0.0,1.0,0.0,0.0
Symptom validity testing,0.0,0.0,1.0,0.0
Aceruloplasminemia,0.0,0.0,1.0,0.0
Narcissism,0.0,0.0,1.0,0.0
Implicit/explicit memory,0.0,0.0,1.0,0.0
Test-Revised,0.0,0.0,1.0,0.0
shame,0.0,0.0,1.0,0.0
Serotonin transporter gene,0.0,1.0,0.0,0.0
Inflection,0.0,0.0,1.0,0.0
image viewing,0.0,0.0,1.0,0.0
Texture processing,0.0,0.0,1.0,0.0
Acquired alexia,0.0,0.0,1.0,0.0
Fronto-temporal connectivity,0.0,1.0,0.0,0.0
Adolescent-onset schizophrenia,0.0,0.0,1.0,0.0
Principal components analysis (PCA)",0.0,1.0,0.0,0.0
animal replacement technique,1.0,0.0,0.0,0.0
Valence evaluation,0.0,0.0,1.0,0.0
West's syndrome,1.0,0.0,0.0,0.0
Ontology,0.0,1.0,0.0,0.0
Motor hand region,0.0,0.0,1.0,0.0
Childhood obesity,0.0,1.0,0.0,0.0
Motion onset VEPs,1.0,0.0,0.0,0.0
NOP receptor,0.0,0.0,0.0,1.0
Motion-defined objects,0.0,0.0,1.0,0.0
The role of superior temporal sulcus in the control of irrelevant emotional face processing: atranscranial direct current stimulation study (2014) Neuropsychologia,0.0,1.0,0.0,0.0
Intrinsic reward,0.0,1.0,0.0,0.0
Opioid maintenance,0.0,0.0,1.0,0.0
Low contrast,0.0,0.0,1.0,0.0
Disorder in language development,0.0,0.0,1.0,0.0
Ankle dorsiflexor muscles,1.0,0.0,0.0,0.0
Elicitation,0.0,0.0,1.0,0.0
partial least square (PLS),0.0,1.0,0.0,0.0
Spatial data,0.0,1.0,0.0,0.0
Recall bias,0.0,1.0,0.0,0.0
Semantic transparency,0.0,1.0,0.0,0.0
Molecular hydrogen,0.0,0.0,1.0,0.0
Locomotive depot,1.0,0.0,0.0,0.0
Striate and extrastriate areas,0.0,0.0,0.0,1.0
Situation models,0.0,1.0,0.0,0.0
Patient reported outcomes,0.0,1.0,0.0,0.0
Hip fractures,1.0,0.0,0.0,0.0
Accessory stimuli,0.0,0.0,1.0,0.0
modeling,0.0,1.0,0.0,0.0
Nonverbal memory,0.0,1.0,0.0,0.0
Facial imitation,1.0,0.0,0.0,0.0
Population-based study,0.0,0.0,1.0,0.0
Idiothetic,0.0,0.0,1.0,0.0
Biology,0.0,0.0,1.0,0.0
Anti-ocularcentrism,0.0,0.0,1.0,0.0
Priority,1.0,0.0,0.0,0.0
Visual statistics,0.0,1.0,0.0,0.0
fertility,0.0,0.0,1.0,0.0
Latent fingerprinting,0.0,1.0,0.0,0.0
Alpha event-related desynchronization (ERD),0.0,0.0,1.0,0.0
Looking time,0.0,0.0,1.0,0.0
Unconscious processing,1.0,0.0,0.0,0.0
Nocturia,0.0,0.0,1.0,0.0
Mirror sign,0.0,1.0,0.0,0.0
Nonverbal fluency,0.0,1.0,0.0,0.0
Head injuries,0.0,0.0,1.0,0.0
Adverse drug reactions,1.0,0.0,0.0,0.0
Open science,1.0,0.0,0.0,0.0
Immunohistochemistry,0.0,1.0,0.0,0.0
Nondeclarative,0.0,0.0,1.0,0.0
Accelerometer,1.0,0.0,0.0,0.0
Body awareness,0.0,1.0,0.0,0.0
Head and neck,0.0,0.0,1.0,0.0
medical,0.0,0.0,1.0,0.0
Dykinesia,1.0,0.0,0.0,0.0
neurocognitive dimensions,0.0,1.0,0.0,0.0
Cognitive ethology,1.0,0.0,0.0,0.0
norepinephrine,0.0,1.0,0.0,0.0
Neonatal hypoxic-ischemic encephalopathy,0.0,0.0,1.0,0.0
sketch maps,0.0,0.0,1.0,0.0
Papio hamadryas Anubis,0.0,0.0,1.0,0.0
Time-frequency EEG,1.0,0.0,0.0,0.0
Price magnitude,0.0,0.0,1.0,0.0
visual selection,0.0,0.0,0.0,1.0
Autism spectrum disorders (ASDs),0.0,0.0,1.0,0.0
Information-processing,0.0,0.0,1.0,0.0
Statistical reliability,0.0,0.0,1.0,0.0
Macaques,0.0,0.0,1.0,0.0
Resting-state network,0.0,0.0,1.0,0.0
Visual-motor task,1.0,0.0,0.0,0.0
Object transfer,0.0,0.0,1.0,0.0
Center-of-pressure,0.0,1.0,0.0,0.0
behavioral variant frontotemporal dementia (bvFTD),1.0,0.0,0.0,0.0
Limbic encephalopathy,0.0,1.0,0.0,0.0
Sociality,0.0,1.0,0.0,0.0
resource-limited setting,0.0,0.0,0.0,1.0
Visuo-attentional test,0.0,0.0,1.0,0.0
Dipole,0.0,0.0,1.0,0.0
Semantic memory priming,1.0,0.0,0.0,0.0
Information space,0.0,1.0,0.0,0.0
Cognitive differences associated with bilingualism,0.0,1.0,0.0,0.0
Loquacity,0.0,0.0,0.0,1.0
Episodic ataxia,0.0,1.0,0.0,0.0
Conflict ratio,1.0,0.0,0.0,0.0
Direct administration,1.0,0.0,0.0,0.0
Lysosomal storage disorder,1.0,0.0,0.0,0.0
MOCA score,0.0,1.0,0.0,0.0
Morphological constraint,0.0,0.0,0.0,1.0
Gap junctions,1.0,0.0,0.0,0.0
Hyperbaric hyperoxia,0.0,1.0,0.0,0.0
Audio-visual synchrony,0.0,1.0,0.0,0.0
cognitive impairment no dementia,1.0,0.0,0.0,0.0
cerebrovascular autoregulatory dysfunction,1.0,0.0,0.0,0.0
Television viewing,0.0,0.0,0.0,1.0
Postcentral gyrus,0.0,1.0,0.0,0.0
Enhanced external counterpulsation,0.0,0.0,1.0,0.0
"Elderly,0.0,0.0,0.0,0.0
Range effect,0.0,0.0,0.0,1.0
Adverse outcomes,0.0,1.0,0.0,0.0
Physical work capacity,1.0,0.0,0.0,0.0
Heart rate variability (HRV),0.0,1.0,0.0,0.0
proprioceptive,0.0,1.0,0.0,0.0
Neonatal handling,0.0,1.0,0.0,0.0
Dementia prevention trials,0.0,1.0,0.0,0.0
Heterochrony,1.0,0.0,0.0,0.0
issue agreement,0.0,0.0,1.0,0.0
Sensory event-related potential,1.0,0.0,0.0,0.0
FCMTE3,0.0,0.0,1.0,0.0
Face-name pairs,0.0,0.0,0.0,1.0
Neuronal ceroid lipofuscinosis,0.0,0.0,1.0,0.0
Non-social cognitive tests,0.0,1.0,0.0,0.0
Action possibility judgments,0.0,0.0,0.0,1.0
Depression-linked effects,0.0,0.0,1.0,0.0
Clinical high risk,0.0,1.0,0.0,0.0
Tilt aftereffect,0.0,0.0,1.0,0.0
Additional disabilities,0.0,1.0,0.0,0.0
Elaboration,0.0,0.0,0.0,1.0
Stenosis,1.0,0.0,0.0,0.0
Healthy ageing,0.0,0.0,1.0,0.0
Threat recognition,1.0,0.0,0.0,0.0
Rat behavioral tasks,0.0,0.0,1.0,0.0
No-task resting,0.0,0.0,1.0,0.0
SPG11,0.0,0.0,0.0,1.0
gaze aversion,1.0,0.0,0.0,0.0
Chemical defense,0.0,1.0,0.0,0.0
Patterned string task,0.0,0.0,1.0,0.0
Catecholamines,0.0,1.0,0.0,0.0
Time-aspect mapping system,1.0,0.0,0.0,0.0
choline,0.0,1.0,0.0,0.0
Social crisis,0.0,0.0,1.0,0.0
[99mTc] TRODAT-1,1.0,0.0,0.0,0.0
Concept drift detection,0.0,1.0,0.0,0.0
Illustrations,0.0,1.0,0.0,0.0
Illness perceptions,0.0,1.0,0.0,0.0
Infectious hepatitis virus,0.0,1.0,0.0,0.0
Visual and spatial perception,1.0,0.0,0.0,0.0
Illusory pattern perception,0.0,1.0,0.0,0.0
Visual conceiving,0.0,1.0,0.0,0.0
Academic and behavioral assessment,0.0,1.0,0.0,0.0
spatial neglect,0.0,0.0,1.0,0.0
Short-delay recognition,1.0,0.0,0.0,0.0
Mislocalization of moving targets,0.0,1.0,0.0,0.0
Visual target detection,0.0,0.0,1.0,0.0
Pyramidal neuron,0.0,0.0,1.0,0.0
Bivariate dual change score modeling,0.0,0.0,1.0,0.0
Saccade target selection,0.0,1.0,0.0,0.0
Prefrontal-limbic circuitry,0.0,1.0,0.0,0.0
Voxel-based specific regional analysis system for Alzheimer's disease,0.0,1.0,0.0,0.0
intergroup processes,0.0,1.0,0.0,0.0
Hand action,1.0,0.0,0.0,0.0
Choline-early exposure delayed effects,0.0,1.0,0.0,0.0
brain perfusion,0.0,0.0,1.0,0.0
Grammatical aspect,0.0,0.0,1.0,0.0
Boundary extension,0.0,0.0,1.0,0.0
Human resources,0.0,0.0,1.0,0.0
Correction,0.0,0.0,1.0,0.0
Non-invasive brain stimulation,0.0,1.0,0.0,0.0
Pragmatic information,0.0,0.0,0.0,1.0
Regional specialization,1.0,0.0,0.0,0.0
School entry,0.0,1.0,0.0,0.0
Matching-to-Sample,1.0,0.0,0.0,0.0
Regulatory focus theory,0.0,1.0,0.0,0.0
Mathematical reasoning,0.0,0.0,1.0,0.0
Sense of self,0.0,0.0,1.0,0.0
Mouse-tracking,0.0,0.0,1.0,0.0
Genetic liability,0.0,0.0,1.0,0.0
structural magnetic resonance,1.0,0.0,0.0,0.0
drug-induced Parkinsonism,0.0,1.0,0.0,0.0
Syntax development,1.0,0.0,0.0,0.0
Intracranial electroencephalography,1.0,0.0,0.0,0.0
Negative,0.0,0.0,1.0,0.0
NATURE/NURTURE,1.0,0.0,0.0,0.0
Duchenne muscular dystrophy,0.0,1.0,0.0,0.0
early-onset dementia,1.0,0.0,0.0,0.0
Playback experiment,0.0,0.0,0.0,1.0
Protein kinase C ?,1.0,0.0,0.0,0.0
Hypothermic circulatory arrest,0.0,0.0,1.0,0.0
Neuronal circuits,0.0,0.0,1.0,0.0
Object Recognition,1.0,0.0,0.0,0.0
Juvenile offenders,0.0,1.0,0.0,0.0
Two-dimensional electrophoresis,0.0,0.0,1.0,0.0
Trait judgment,0.0,0.0,1.0,0.0
Conditionals,0.0,1.0,0.0,0.0
Neurocognitive impairments,0.0,0.0,1.0,0.0
Jerte valley cherry,0.0,0.0,1.0,0.0
Multiple myeloma,0.0,1.0,0.0,0.0
Vascular risk,0.0,1.0,0.0,0.0
KIBRA gene,0.0,0.0,1.0,0.0
Cognitive & perceptual development,0.0,1.0,0.0,0.0
Repeated Withdrawal,0.0,0.0,0.0,1.0
Contour length,1.0,0.0,0.0,0.0
Phosphatidylserine,0.0,0.0,1.0,0.0
Epistemic faculty of consciousness,0.0,0.0,1.0,0.0
Cardiopulmonary bypass surgery,0.0,1.0,0.0,0.0
Agreement morphology,0.0,1.0,0.0,0.0
Obsessive-compulsive personality traits,0.0,0.0,1.0,0.0
blur detection,0.0,0.0,1.0,0.0
lurasidone,0.0,1.0,0.0,0.0
Ametropia,0.0,0.0,0.0,1.0
Action observation-execution matching,0.0,0.0,1.0,0.0
Evoked magnetic fields,1.0,0.0,0.0,0.0
Prioritization,0.0,1.0,0.0,0.0
Content words,1.0,0.0,0.0,0.0
Anthraquinone,1.0,0.0,0.0,0.0
Trait marker,0.0,1.0,0.0,0.0
sense of effort,0.0,0.0,0.0,1.0
Feature-based inhibition,0.0,0.0,1.0,0.0
Mental economy,0.0,0.0,1.0,0.0
Posterior fossa tumors,1.0,0.0,0.0,0.0
Drifts,0.0,0.0,1.0,0.0
CGT,1.0,0.0,0.0,0.0
Perceptual averaging,0.0,0.0,0.0,1.0
Zhang,0.0,1.0,0.0,0.0
Mandarin Chinese,0.0,0.0,1.0,0.0
CogniCIS study,0.0,1.0,0.0,0.0
Spectral turbulence,1.0,0.0,0.0,0.0
fMRI study,0.0,0.0,1.0,0.0
Infant directed speech (IDS),1.0,0.0,0.0,0.0
construal level,1.0,0.0,0.0,0.0
Essence of chicken,0.0,0.0,1.0,0.0
narratology,0.0,1.0,0.0,0.0
Space and scene perception,0.0,0.0,1.0,0.0
Visuo-motor alteration,0.0,0.0,0.0,1.0
Motivation enhancement,0.0,1.0,0.0,0.0
Drawing impairments,1.0,0.0,0.0,0.0
Scleroderma,0.0,1.0,0.0,0.0
vegetative state,0.0,0.0,1.0,0.0
General health,0.0,0.0,1.0,0.0
pp. 278-294,0.0,0.0,1.0,0.0
ROC,0.0,0.0,1.0,0.0
mouse models,1.0,0.0,0.0,0.0
RON,1.0,0.0,0.0,0.0
Cognitive bistability,0.0,0.0,1.0,0.0
Task comparison,0.0,0.0,1.0,0.0
Coproprophyrinogen oxidase,0.0,1.0,0.0,0.0
Location backward masking,0.0,1.0,0.0,0.0
liking,1.0,0.0,0.0,0.0
Reprogramming,0.0,1.0,0.0,0.0
RELATIVISM,1.0,0.0,0.0,0.0
Printing textile design,1.0,0.0,0.0,0.0
Gerbil,0.0,1.0,0.0,0.0
Line orientation,0.0,0.0,1.0,0.0
Malformation,0.0,1.0,0.0,0.0
Motor speed and precision test,0.0,0.0,1.0,0.0
Geographical information system (GIS),0.0,1.0,0.0,0.0
Word fragment completion,0.0,1.0,0.0,0.0
Subtype selective GABAA receptor modulator,0.0,1.0,0.0,0.0
268,0.0,0.0,1.0,0.0
Attributes,0.0,0.0,0.0,1.0
Motivational stimuli,0.0,1.0,0.0,0.0
Ocular motility,0.0,0.0,1.0,0.0
Cognitive-emotional interactions,1.0,0.0,0.0,0.0
Continuum,1.0,0.0,0.0,0.0
Systematic search,0.0,1.0,0.0,0.0
Scene apprehension,1.0,0.0,0.0,0.0
Number-of-features effect,0.0,1.0,0.0,0.0
nondysphoric depression,0.0,0.0,1.0,0.0
late life depressive symptoms,0.0,1.0,0.0,0.0
pacemaker implantation,0.0,0.0,1.0,0.0
Ts1Cje,0.0,0.0,1.0,0.0
Hidden state,1.0,0.0,0.0,0.0
Subclinical psychosis,0.0,1.0,0.0,0.0
A?1-42,0.0,0.0,1.0,0.0
Image processing,0.0,1.0,0.0,0.0
Remember/Know procedure,1.0,0.0,0.0,0.0
Mediated interaction,0.0,1.0,0.0,0.0
Perospirone,0.0,0.0,1.0,0.0
Communicative development,0.0,1.0,0.0,0.0
Saturated fat,0.0,1.0,0.0,0.0
Virtual arm,0.0,0.0,0.0,1.0
sources of knowledge,0.0,0.0,1.0,0.0
Melissa officinalis,0.0,1.0,0.0,0.0
hydrocarbon solvents,0.0,0.0,1.0,0.0
Neuropsychological deficit,0.0,0.0,1.0,0.0
PPT,1.0,0.0,0.0,0.0
Dynamic visual scene,0.0,0.0,0.0,1.0
Sensory-motor assessment,0.0,0.0,1.0,0.0
PPA,0.0,1.0,0.0,0.0
PPC,1.0,0.0,0.0,0.0
autoantibodies,1.0,0.0,0.0,0.0
Neurotransmitter,0.0,1.0,0.0,0.0
Anti-epileptic drugs,0.0,0.0,0.0,1.0
visual ERPs (VERPs),0.0,0.0,1.0,0.0
Visual skills,0.0,0.0,1.0,0.0
Complex visual stimuli,1.0,0.0,0.0,0.0
Band power,0.0,0.0,1.0,0.0
Visual servoing,0.0,1.0,0.0,0.0
Therapeutic alliance,0.0,0.0,1.0,0.0
Topic maps,0.0,1.0,0.0,0.0
Underling mechanisms,0.0,0.0,0.0,1.0
Color Stroop Test format,0.0,0.0,1.0,0.0
Visualizations,0.0,0.0,1.0,0.0
Psychosis continuum,0.0,1.0,0.0,0.0
Brodmann area 44,0.0,0.0,0.0,1.0
Embodied perception,0.0,0.0,1.0,0.0
Horizontal,0.0,0.0,0.0,1.0
Dual-task cost,0.0,0.0,1.0,0.0
"""Hole-board"" task,0.0,0.0,1.0,0.0
Snacking,0.0,1.0,0.0,0.0
addition,0.0,0.0,1.0,0.0
Reflex epilepsy,0.0,0.0,1.0,0.0
Dementia patients,0.0,0.0,1.0,0.0
Stroop color-word interference task,1.0,0.0,0.0,0.0
Simulation capability,0.0,1.0,0.0,0.0
Neurobehavioral impairment,0.0,1.0,0.0,0.0
Dense-array EEG,0.0,1.0,0.0,0.0
Paired association,0.0,1.0,0.0,0.0
Generation processes,0.0,0.0,1.0,0.0
Brain-damage,0.0,1.0,0.0,0.0
Discrete Fourier transform,0.0,0.0,1.0,0.0
Bodily symptoms,0.0,0.0,1.0,0.0
Switching task,0.0,0.0,1.0,0.0
Dunbar's number,0.0,0.0,1.0,0.0
flickr,0.0,0.0,1.0,0.0
Optimality,0.0,1.0,0.0,0.0
Lexical conceptual processing,0.0,1.0,0.0,0.0
Social isolation,0.0,0.0,1.0,0.0
Cross-anchoring Hebbian learning,0.0,0.0,0.0,1.0
Belief in supernatural,0.0,1.0,0.0,0.0
Need for Cognition,0.0,0.0,1.0,0.0
Facial Affect,0.0,0.0,1.0,0.0
Driving safety,1.0,0.0,0.0,0.0
Cerebral cysts,0.0,1.0,0.0,0.0
surgical expertise,0.0,1.0,0.0,0.0
Urban park,1.0,0.0,0.0,0.0
Feature conjunction,1.0,0.0,0.0,0.0
Conflict detection,0.0,0.0,1.0,0.0
Remembering/knowing,1.0,0.0,0.0,0.0
Immediate recall,0.0,0.0,1.0,0.0
Orthopaedic conditions,0.0,0.0,1.0,0.0
Pseudoword superiority effect,0.0,0.0,1.0,0.0
Toxicity,0.0,1.0,0.0,0.0
Case-crossover,1.0,0.0,0.0,0.0
Math,0.0,0.0,1.0,0.0
Fragrance,0.0,0.0,1.0,0.0
Cervical vertebrae,0.0,0.0,0.0,1.0
clinical testing,0.0,0.0,1.0,0.0
Behavioural functions,0.0,0.0,1.0,0.0
mild TBI,0.0,0.0,1.0,0.0
Human-animal relationships,1.0,0.0,0.0,0.0
Convict cichlids,0.0,0.0,1.0,0.0
Shot transition,0.0,0.0,1.0,0.0
Incremental heart rate,0.0,0.0,1.0,0.0
Verbal/spatial processing,1.0,0.0,0.0,0.0
Acute trauma,0.0,0.0,1.0,0.0
Concept acquisition,0.0,1.0,0.0,0.0
Healing,1.0,0.0,0.0,0.0
Right temporal lobe,0.0,0.0,1.0,0.0
Perceived stress scale,0.0,0.0,1.0,0.0
Contingent aftereffects,0.0,0.0,0.0,1.0
Vitality forms,0.0,0.0,1.0,0.0
Abstract verb,0.0,0.0,0.0,1.0
middle school,0.0,0.0,0.0,1.0
nonlinear analysis,0.0,0.0,0.0,1.0
Parkinson's disease with dementia,0.0,0.0,0.0,1.0
Environmental navigation,0.0,1.0,0.0,0.0
dexmedetomidine,0.0,0.0,1.0,0.0
S-100B,1.0,0.0,0.0,0.0
Attention Deficit Hyperactivity Disorder (ADHD),0.0,0.0,1.0,0.0
Software agents,0.0,0.0,1.0,0.0
Judgment on safety of food contaminated by pesticide residue,0.0,1.0,0.0,0.0
Benton visual retention test,0.0,0.0,0.0,1.0
Action-perception coupling,0.0,1.0,0.0,0.0
Social Responsiveness Scale,0.0,0.0,1.0,0.0
the ""consciousness and the brain"" problem",0.0,0.0,1.0,0.0
Lesion patients,0.0,0.0,1.0,0.0
Early visual attention,0.0,0.0,0.0,1.0
Visual Categorical N-Back Task,0.0,1.0,0.0,0.0
Movement disorder,0.0,0.0,1.0,0.0
Aerobic sports,1.0,0.0,0.0,0.0
Age and gender differences,1.0,0.0,0.0,0.0
Spatial relationship,0.0,1.0,0.0,0.0
subliminal processing,0.0,0.0,1.0,0.0
PKB,0.0,1.0,0.0,0.0
TMT-A,0.0,1.0,0.0,0.0
PKU,0.0,0.0,1.0,0.0
Memory improvement,0.0,0.0,1.0,0.0
Fallow deer,0.0,1.0,0.0,0.0
Stimulus preceding negativity,1.0,0.0,0.0,0.0
Flavor,1.0,0.0,0.0,0.0
NoGo,0.0,1.0,0.0,0.0
joint attention,0.0,0.0,1.0,0.0
Frontal operculum,0.0,0.0,1.0,0.0
Case-control,0.0,0.0,1.0,0.0
End-to-end latency,0.0,1.0,0.0,0.0
treatment type,1.0,0.0,0.0,0.0
Klein bottle logic,1.0,0.0,0.0,0.0
Extrapersonal,0.0,0.0,1.0,0.0
Egocentric reference frame,0.0,1.0,0.0,0.0
Interactive behaviours,0.0,1.0,0.0,0.0
Eye-movement control,0.0,0.0,1.0,0.0
Lexical decision and naming,1.0,0.0,0.0,0.0
Motor asymmetry,0.0,1.0,0.0,0.0
Semantic representation,0.0,1.0,0.0,0.0
Categorical spatial representation,0.0,0.0,1.0,0.0
Prodromal phase,0.0,1.0,0.0,0.0
Cycling,0.0,1.0,0.0,0.0
follow-up study,0.0,0.0,1.0,0.0
Key words Alzheimer disease,0.0,0.0,0.0,1.0
Fear extinction,0.0,0.0,1.0,0.0
spelling,0.0,1.0,0.0,0.0
External remapping,0.0,0.0,0.0,1.0
queuing network,1.0,0.0,0.0,0.0
Plausibility violations,0.0,0.0,0.0,1.0
Interference reduction,0.0,0.0,1.0,0.0
COGNITIVE ACTIVITY,1.0,0.0,0.0,0.0
Ponzo illusion,0.0,1.0,0.0,0.0
Atypical,0.0,0.0,0.0,1.0
Infants physical reasoning,0.0,0.0,1.0,0.0
Medication compliance,0.0,1.0,0.0,0.0
Normalization,0.0,0.0,1.0,0.0
concept relationships,0.0,0.0,1.0,0.0
open space,0.0,0.0,0.0,1.0
Hippocampal-prefrontal circuitry,1.0,0.0,0.0,0.0
OFC,0.0,1.0,0.0,0.0
Loss of the insight,0.0,0.0,1.0,0.0
Number-space interactions,0.0,0.0,1.0,0.0
Collinear flankers,0.0,1.0,0.0,0.0
Disfigurement,0.0,1.0,0.0,0.0
Editorial,1.0,0.0,0.0,0.0
Desirable difficulites,0.0,0.0,1.0,0.0
Denmark,0.0,0.0,1.0,0.0
Gambling task,0.0,1.0,0.0,0.0
Binocular Depth Inversion Illusion (BDII),1.0,0.0,0.0,0.0
Computer aided diagnosis,1.0,0.0,0.0,0.0
Autonomic balance,0.0,0.0,1.0,0.0
Speed of encoding,1.0,0.0,0.0,0.0
Explicit knowledge,0.0,1.0,0.0,0.0
Eye (saccade),1.0,0.0,0.0,0.0
Postoperative pain,1.0,0.0,0.0,0.0
Hindi,0.0,1.0,0.0,0.0
beam-walking,0.0,1.0,0.0,0.0
One-target advantage,0.0,1.0,0.0,0.0
Wonder,0.0,0.0,0.0,1.0
Stigma,1.0,0.0,0.0,0.0
Retrospective think aloud,0.0,0.0,1.0,0.0
Reassuring thoughts,0.0,0.0,1.0,0.0
Judgement certainty,0.0,1.0,0.0,0.0
Home environment,0.0,1.0,0.0,0.0
Metacognitive sensitivity,0.0,0.0,1.0,0.0
Volumes,0.0,0.0,1.0,0.0
Greek,0.0,1.0,0.0,0.0
Crossmodal interactions,1.0,0.0,0.0,0.0
Appearance,1.0,0.0,0.0,0.0
E-Prime software,0.0,0.0,0.0,1.0
Meal size,0.0,1.0,0.0,0.0
Reward stakes,1.0,0.0,0.0,0.0
Teaching,0.0,0.0,0.0,1.0
Conversion hypothesis,0.0,0.0,1.0,0.0
Integration system,0.0,0.0,1.0,0.0
Joint performance,1.0,0.0,0.0,0.0
Dynamic assessment,0.0,1.0,0.0,0.0
Clade C,1.0,0.0,0.0,0.0
medical diagnosis,0.0,0.0,1.0,0.0
Enactive and extended cognition,0.0,0.0,1.0,0.0
Number module,0.0,0.0,1.0,0.0
SLC6A4,1.0,0.0,0.0,0.0
Combat,0.0,1.0,0.0,0.0
Patient-compliance,1.0,0.0,0.0,0.0
Spacing versus feature changes,1.0,0.0,0.0,0.0
preclinical atherosclerosis,1.0,0.0,0.0,0.0
Industrial lighting,0.0,0.0,1.0,0.0
Cognitive rest,0.0,0.0,1.0,0.0
Global fields,0.0,0.0,1.0,0.0
Top-down control of alpha-band activity,0.0,1.0,0.0,0.0
Slot model,0.0,0.0,0.0,1.0
Spatial hearing,1.0,0.0,0.0,0.0
Compound remote associates,1.0,0.0,0.0,0.0
Thought,1.0,0.0,0.0,0.0
Single-trial analyses,1.0,0.0,0.0,0.0
Symbolic meaning,0.0,0.0,1.0,0.0
Quasi-experimental research design,0.0,0.0,1.0,0.0
Bed rest,1.0,0.0,0.0,0.0
Constraint,0.0,0.0,1.0,0.0
Serum creatinine,0.0,0.0,1.0,0.0
Event-related desynchronization,0.0,0.0,1.0,0.0
Self-knowledge,0.0,1.0,0.0,0.0
Temporal violation,0.0,1.0,0.0,0.0
Object origins,0.0,0.0,1.0,0.0
Strange images,0.0,1.0,0.0,0.0
Ditches,0.0,0.0,1.0,0.0
noradrenalin,0.0,0.0,0.0,1.0
Venous infarction,1.0,0.0,0.0,0.0
Go/No-go,0.0,1.0,0.0,0.0
mood disorders,0.0,1.0,0.0,0.0
Amaurosis,0.0,1.0,0.0,0.0
Visual expertise,0.0,0.0,1.0,0.0
Psychoneuroticism,0.0,1.0,0.0,0.0
Opposites,0.0,0.0,0.0,1.0
Norms/normative studies,0.0,0.0,1.0,0.0
Concept-identification,1.0,0.0,0.0,0.0
Target interval,0.0,1.0,0.0,0.0
Affect misattribution,0.0,1.0,0.0,0.0
Fear bradycardia,0.0,1.0,0.0,0.0
baboons,0.0,1.0,0.0,0.0
Print exposure,0.0,1.0,0.0,0.0
Microcircuit,1.0,0.0,0.0,0.0
Moroccan cases,0.0,0.0,0.0,1.0
Subjective visual vertical test protocol,1.0,0.0,0.0,0.0
Occupational disease,0.0,1.0,0.0,0.0
Intelligence evaluation,0.0,0.0,1.0,0.0
Evoked gamma-band oscillatory activity,0.0,1.0,0.0,0.0
Probands,0.0,0.0,0.0,1.0
Perceptual coupling,1.0,0.0,0.0,0.0
Consumerism,0.0,0.0,1.0,0.0
Somato-sensory evoked potential,0.0,1.0,0.0,0.0
Disposition,0.0,0.0,0.0,1.0
CGG repeat,0.0,1.0,0.0,0.0
Ambulatory,0.0,0.0,1.0,0.0
Children's cognitive and behavioral functioning,1.0,0.0,0.0,0.0
Computer-assisted instruction (CAI),1.0,0.0,0.0,0.0
Hungtington's disease,0.0,1.0,0.0,0.0
Feedback representation,0.0,1.0,0.0,0.0
Hospital admission,0.0,0.0,1.0,0.0
Cognitive cerebellar pattern,0.0,0.0,1.0,0.0
Puerto Rican,0.0,0.0,1.0,0.0
Numerical magnitude processing,1.0,0.0,0.0,0.0
Visual symptoms,0.0,1.0,0.0,0.0
Arousal-sedation,0.0,0.0,0.0,1.0
Saccade-countermanding task,0.0,0.0,1.0,0.0
Psychopathological dimensions,0.0,0.0,1.0,0.0
Perceived reachability,1.0,0.0,0.0,0.0
7q22,0.0,0.0,1.0,0.0
Inspection Time,0.0,0.0,1.0,0.0
Gerstmann,0.0,0.0,1.0,0.0
Resting-state functional connectivity,0.0,0.0,1.0,0.0
Cognitive motor function,0.0,1.0,0.0,0.0
Preadolescents,0.0,0.0,1.0,0.0
Visuospatial analysis,1.0,0.0,0.0,0.0
Connectome,0.0,0.0,1.0,0.0
Functional underconnectivity,0.0,1.0,0.0,0.0
White matter density,0.0,0.0,1.0,0.0
Behavioral intentions,0.0,1.0,0.0,0.0
Mammillary body,0.0,0.0,1.0,0.0
Kudzu,0.0,0.0,0.0,1.0
feature binding,0.0,1.0,0.0,0.0
Symbol comprehension,0.0,0.0,1.0,0.0
Ceiling effects,0.0,1.0,0.0,0.0
NK3 antagonist,1.0,0.0,0.0,0.0
Stimulus,0.0,1.0,0.0,0.0
sham,0.0,0.0,0.0,1.0
Early phases of psychosis,0.0,0.0,1.0,0.0
Time-event structure,0.0,1.0,0.0,0.0
Metacognitive control,0.0,0.0,1.0,0.0
Traumatic memory retrieval,1.0,0.0,0.0,0.0
Disaster relief,1.0,0.0,0.0,0.0
Chemical warfare nerve agent therapy,0.0,1.0,0.0,0.0
neural engineering,0.0,0.0,1.0,0.0
Illusion of movement,0.0,0.0,0.0,1.0
Competing responses,0.0,1.0,0.0,0.0
Contextual effect,0.0,0.0,1.0,0.0
d-Cycloserine,0.0,1.0,0.0,0.0
Truth conditions,0.0,0.0,1.0,0.0
sense-making,0.0,0.0,0.0,1.0
First-order relatives,0.0,1.0,0.0,0.0
Paired-stimuli paradigm,0.0,0.0,1.0,0.0
PET scan,0.0,0.0,0.0,1.0
Hedonic detector,0.0,1.0,0.0,0.0
Colonoscopy,1.0,0.0,0.0,0.0
facial image stimuli,1.0,0.0,0.0,0.0
phenocopy syndrome,1.0,0.0,0.0,0.0
Prestimulus periods,1.0,0.0,0.0,0.0
Physical body,0.0,0.0,1.0,0.0
Avian visual model,0.0,1.0,0.0,0.0
Luminance adaptation,0.0,0.0,1.0,0.0
Separation anxiety disorder,1.0,0.0,0.0,0.0
sleep disorders,0.0,0.0,0.0,1.0
Situated learning,0.0,1.0,0.0,0.0
Tower of London task,0.0,0.0,0.0,1.0
histamine,0.0,1.0,0.0,0.0
Healthy control,0.0,0.0,1.0,0.0
In-depth body,1.0,0.0,0.0,0.0
mean diffusivity,0.0,1.0,0.0,0.0
Linear discriminant function analysis,0.0,0.0,1.0,0.0
Phonological assembly,0.0,1.0,0.0,0.0
TUDCA,1.0,0.0,0.0,0.0
Frontal cortical neurons,0.0,0.0,0.0,1.0
Body mass,1.0,0.0,0.0,0.0
Collision dynamics,0.0,0.0,0.0,1.0
Stroop-interference effect,1.0,0.0,0.0,0.0
Slavemaking ants,0.0,1.0,0.0,0.0
Neurophysiological correlates of quantum cognitive observables,0.0,0.0,1.0,0.0
Color sonification,0.0,0.0,1.0,0.0
scanning,1.0,0.0,0.0,0.0
N2p,1.0,0.0,0.0,0.0
Optical illusion,0.0,0.0,0.0,1.0
functional assessment,0.0,0.0,1.0,0.0
Anthropomorphic avatars,1.0,0.0,0.0,0.0
Microelectrode array,0.0,0.0,1.0,0.0
Language structure,0.0,0.0,1.0,0.0
Parent-child relationship,0.0,0.0,1.0,0.0
Median-nerve,0.0,0.0,1.0,0.0
Quantitative t1,0.0,1.0,0.0,0.0
Visible displacement,0.0,0.0,1.0,0.0
Traffic,0.0,1.0,0.0,0.0
Hyperlexia,0.0,1.0,0.0,0.0
Approach motivation,1.0,0.0,0.0,0.0
Normative values,0.0,1.0,0.0,0.0
Carr-Purcell PRESS,0.0,1.0,0.0,0.0
Bimodal stimulus,1.0,0.0,0.0,0.0
Intervention strategies,0.0,0.0,1.0,0.0
Part-based,0.0,0.0,1.0,0.0
Monosaccharide,0.0,0.0,1.0,0.0
Prestidigitation,0.0,0.0,1.0,0.0
Rolandic discharges,1.0,0.0,0.0,0.0
Cognitive design,0.0,0.0,1.0,0.0
Syntactic comprehension,1.0,0.0,0.0,0.0
PE training,0.0,1.0,0.0,0.0
Emotional facilitation effect,0.0,0.0,1.0,0.0
CANS (central auditory nervous system),0.0,1.0,0.0,0.0
Automatic numerical processing,0.0,1.0,0.0,0.0
In situ survey,0.0,1.0,0.0,0.0
pp. 470-473,0.0,1.0,0.0,0.0
Defence,0.0,1.0,0.0,0.0
Executive behaviour control,0.0,0.0,1.0,0.0
Archetype,0.0,1.0,0.0,0.0
Visually enabled reasoning,0.0,0.0,0.0,1.0
Chronic lyme disease,0.0,0.0,1.0,0.0
Digit Symbol Substitution Test,1.0,0.0,0.0,0.0
Phosphatases,0.0,0.0,1.0,0.0
negative number,0.0,1.0,0.0,0.0
Teller acuity cards,0.0,0.0,0.0,1.0
Race bias,1.0,0.0,0.0,0.0
Early cognitive development,0.0,1.0,0.0,0.0
Aptitude-treatment interaction effects,1.0,0.0,0.0,0.0
Brain neoplasms,1.0,0.0,0.0,0.0
Structure function,0.0,0.0,1.0,0.0
Constraint-induced aphasia therapy plus,0.0,1.0,0.0,0.0
Nature,0.0,0.0,1.0,0.0
Household air pollution,1.0,0.0,0.0,0.0
Arithmetic cognition,0.0,0.0,1.0,0.0
Neurobehavioral ability index,0.0,1.0,0.0,0.0
Store atmosphere,0.0,0.0,1.0,0.0
Reactivity,0.0,1.0,0.0,0.0
Speech in noise,1.0,0.0,0.0,0.0
Microstates,0.0,1.0,0.0,0.0
Temptation,0.0,0.0,1.0,0.0
Oportunidades,1.0,0.0,0.0,0.0
Scene content,0.0,1.0,0.0,0.0
Visuospatial imagery,0.0,1.0,0.0,0.0
Training duration,1.0,0.0,0.0,0.0
arterial spin-labeled fMRI,1.0,0.0,0.0,0.0
heroin,0.0,0.0,1.0,0.0
Cue exposure,0.0,0.0,0.0,1.0
positron emission tomography,0.0,0.0,1.0,0.0
Robotic surgery,0.0,1.0,0.0,0.0
Dose-response,0.0,0.0,1.0,0.0
Cross-modal neural interaction,0.0,0.0,1.0,0.0
human-machine interaction,0.0,0.0,0.0,1.0
Prosody and cognition,0.0,0.0,1.0,0.0
Symptom Validity Testing,1.0,0.0,0.0,0.0
Suicidality,0.0,1.0,0.0,0.0
Normal-Pressure Hydrocephalus,0.0,0.0,0.0,1.0
Flanker position,0.0,0.0,1.0,0.0
cGMP,0.0,0.0,0.0,1.0
Ice-hockey,0.0,1.0,0.0,0.0
Human higher functions,0.0,1.0,0.0,0.0
Human space perception,0.0,0.0,1.0,0.0
Case formulation,0.0,1.0,0.0,0.0
Supraliminal stimuli,0.0,0.0,1.0,0.0
Cue configuration,0.0,0.0,1.0,0.0
Verbal skills,0.0,1.0,0.0,0.0
Balance and Communication",0.0,0.0,0.0,0.0
low-grade glioma,0.0,0.0,1.0,0.0
Lexical concepts,0.0,1.0,0.0,0.0
mental state attribution,0.0,0.0,1.0,0.0
Genetic g,0.0,1.0,0.0,0.0
Water-maze,0.0,0.0,0.0,1.0
Speech recognition in noise,0.0,0.0,0.0,1.0
Auditory-motor mapping training (AMMT),0.0,0.0,1.0,0.0
Pure motor hemiparesis,0.0,0.0,1.0,0.0
assisted living,0.0,0.0,1.0,0.0
RhoGAP,0.0,0.0,1.0,0.0
Minor head trauma,1.0,0.0,0.0,0.0
Film,0.0,0.0,1.0,0.0
Titchener illusion,0.0,1.0,0.0,0.0
endothelin receptor antagonist,0.0,1.0,0.0,0.0
Transpositions,0.0,0.0,1.0,0.0
Reward rate,0.0,0.0,1.0,0.0
Complex network,1.0,0.0,0.0,0.0
Computerized test,0.0,0.0,1.0,0.0
Inhibition-of-return,0.0,0.0,1.0,0.0
Ocular surface area,0.0,0.0,1.0,0.0
Ring-tailed lemurs,0.0,0.0,1.0,0.0
Musical emotions,1.0,0.0,0.0,0.0
M-MAT,0.0,1.0,0.0,0.0
Organic psychosis,0.0,0.0,1.0,0.0
Fetal alcohol spectrum disorders (FASD),0.0,0.0,1.0,0.0
Gifted students,0.0,1.0,0.0,0.0
Hormonal influence,0.0,0.0,1.0,0.0
Attention bias modification,0.0,1.0,0.0,0.0
Open loop,0.0,0.0,1.0,0.0
modulatory connectivity,0.0,0.0,1.0,0.0
Zuckerman-Kuhlman Personality Questionnaire,0.0,1.0,0.0,0.0
visualization models,0.0,1.0,0.0,0.0
Binocular imbalance,0.0,1.0,0.0,0.0
Add-on,0.0,0.0,0.0,1.0
"Cognitive map,0.0,0.0,0.0,0.0
Oral,0.0,0.0,1.0,0.0
At risk,0.0,0.0,1.0,0.0
medication naive,0.0,0.0,1.0,0.0
Videophone,0.0,0.0,0.0,1.0
Chickens,0.0,1.0,0.0,0.0
Episodic trace hypothesis,0.0,0.0,1.0,0.0
Models of perceptual learning,0.0,0.0,0.0,0.0
Boosting,1.0,0.0,0.0,0.0
Single case,0.0,0.0,1.0,0.0
Child and adolescents,0.0,0.0,1.0,0.0
Iconic gestures,0.0,0.0,0.0,1.0
Creatine,1.0,0.0,0.0,0.0
Quantum spiking neural networks,0.0,0.0,0.0,1.0
Manual experience,0.0,0.0,1.0,0.0
Cervical cancer,0.0,1.0,0.0,0.0
Ipsilateral auditory stimuli,1.0,0.0,0.0,0.0
Visually-evoked field,0.0,1.0,0.0,0.0
Demographic variables,0.0,0.0,1.0,0.0
Cognition deficit,1.0,0.0,0.0,0.0
Driving performance and situation awareness,0.0,1.0,0.0,0.0
Object orientation,1.0,0.0,0.0,0.0
Motivational bias,1.0,0.0,0.0,0.0
d-lifescience receptor,0.0,0.0,1.0,0.0
Drug-utilisation,1.0,0.0,0.0,0.0
Driving capacity,0.0,0.0,0.0,1.0
HRQL,0.0,1.0,0.0,0.0
Impaired controls,1.0,0.0,0.0,0.0
Nagata,0.0,0.0,1.0,0.0
Testosterone enanthate,0.0,1.0,0.0,0.0
Climbing performance parameter,1.0,0.0,0.0,0.0
Art as experience,0.0,1.0,0.0,0.0
check-look,0.0,1.0,0.0,0.0
Visual-spatial working memory,0.0,0.0,1.0,0.0
HUI,0.0,0.0,1.0,0.0
Ventral lateral prefrontal cortex,0.0,0.0,0.0,1.0
Cerebellar astrocytoma,0.0,1.0,0.0,0.0
Mesmerism,0.0,0.0,1.0,0.0
Stroop Test,0.0,0.0,0.0,1.0
Recall error,0.0,1.0,0.0,0.0
Controlled environment,0.0,0.0,0.0,0.0
TSH,1.0,0.0,0.0,0.0
Flight safety,0.0,0.0,0.0,1.0
Tetracosactide,1.0,0.0,0.0,0.0
Human performance at sea,0.0,1.0,0.0,0.0
Even-related potentials,0.0,1.0,0.0,0.0
Top-down context,1.0,0.0,0.0,0.0
Quantity information,0.0,1.0,0.0,0.0
Parieto-occipital,0.0,1.0,0.0,0.0
Functional group,0.0,1.0,0.0,0.0
Fish swim bladder,0.0,0.0,0.0,1.0
RapidMiner,0.0,1.0,0.0,0.0
Developmental agent,0.0,1.0,0.0,0.0
Delayed recognition,1.0,0.0,0.0,0.0
Hippocampal system,0.0,0.0,1.0,0.0
Ambulation,1.0,0.0,0.0,0.0
Object number,0.0,0.0,1.0,0.0
Visuospatial mental imagery,0.0,1.0,0.0,0.0
biological motion,0.0,0.0,1.0,0.0
Set formation,1.0,0.0,0.0,0.0
Digital culture,0.0,0.0,1.0,0.0
Joint attention mechanism,0.0,1.0,0.0,0.0
Mediterranean diet,0.0,0.0,1.0,0.0
Immediate early-gene,1.0,0.0,0.0,0.0
Inverse effectiveness principle,0.0,0.0,1.0,0.0
Neurogliovascular unit,1.0,0.0,0.0,0.0
Latent class model,0.0,1.0,0.0,0.0
Non verbal learning disability,0.0,1.0,0.0,0.0
Reliability of animal communication,0.0,1.0,0.0,0.0
Kinesthesia,0.0,1.0,0.0,0.0
Time-space,0.0,1.0,0.0,0.0
Kinesthesis,0.0,1.0,0.0,0.0
A? degradation,0.0,1.0,0.0,0.0
5-HT 1A receptors,0.0,1.0,0.0,0.0
Action-perception matching,0.0,0.0,1.0,0.0
Central midline,1.0,0.0,0.0,0.0
uremia,0.0,1.0,0.0,0.0
Location-cueing paradigm,0.0,1.0,0.0,0.0
Associations across time,0.0,1.0,0.0,0.0
Mesenterico-left portal vein bypass,1.0,0.0,0.0,0.0
Symbol Digit Substitution Test,0.0,1.0,0.0,0.0
Spectral power,0.0,0.0,1.0,0.0
Mechanical paw withdrawal threshold,0.0,1.0,0.0,0.0
QASA,0.0,0.0,1.0,0.0
sleep deprivation,0.0,1.0,0.0,0.0
Context discrimination,0.0,1.0,0.0,0.0
pTau,0.0,1.0,0.0,0.0
Goal pursuit,0.0,1.0,0.0,0.0
Power EEG spectrum,0.0,1.0,0.0,0.0
ovulation,0.0,0.0,1.0,0.0
Lateralized behavior,1.0,0.0,0.0,0.0
Phospholipase C,1.0,0.0,0.0,0.0
Intrusive cognitions,1.0,0.0,0.0,0.0
Western scrub-jay,0.0,0.0,1.0,0.0
Eating behaviour,0.0,1.0,0.0,0.0
undergraduate,0.0,0.0,1.0,0.0
Dopamine circuits,0.0,0.0,1.0,0.0
Repeated items,0.0,1.0,0.0,0.0
Clinical protocol,1.0,0.0,0.0,0.0
Electrocortical stimulation mapping,0.0,0.0,1.0,0.0
Non-visual,0.0,0.0,1.0,0.0
oxcarbazepine,0.0,1.0,0.0,0.0
Menopausal age,0.0,0.0,1.0,0.0
Deep brain stimulation (DBS),1.0,0.0,0.0,0.0
limbic encephalitis,0.0,1.0,0.0,0.0
Diagnostic and operative techniques,0.0,1.0,0.0,0.0
Attention-based measurement,0.0,0.0,1.0,0.0
Donepezil chloride,0.0,0.0,1.0,0.0
Wind farm,0.0,0.0,0.0,1.0
Spacial perception,0.0,0.0,1.0,0.0
Internet search,0.0,0.0,1.0,0.0
18F-FDG PET,1.0,0.0,0.0,0.0
speed,1.0,0.0,0.0,0.0
EPT,0.0,0.0,0.0,1.0
Functional memory disorder,0.0,0.0,1.0,0.0
Pattern-reversal,0.0,1.0,0.0,0.0
deceit detection,0.0,0.0,1.0,0.0
Stimulus deviance,0.0,0.0,1.0,0.0
Possibility theory,0.0,0.0,1.0,0.0
Structural difference,1.0,0.0,0.0,0.0
Language abilities,0.0,0.0,1.0,0.0
Functional geriatrics screening,0.0,1.0,0.0,0.0
Cervical dystonia,1.0,0.0,0.0,0.0
Complex motor tasks,0.0,0.0,1.0,0.0
COMT genotype,0.0,1.0,0.0,0.0
Philadelphia Brief Assessment of Cognition,0.0,0.0,1.0,0.0
Embodied mind,0.0,1.0,0.0,0.0
Predictive Validity,0.0,1.0,0.0,0.0
bias,0.0,0.0,1.0,0.0
Diesel fuels,1.0,0.0,0.0,0.0
Anabolic agents,0.0,1.0,0.0,0.0
Older white women,1.0,0.0,0.0,0.0
Small numbers,1.0,0.0,0.0,0.0
In-vivo animation of event-related ?-oscillations,1.0,0.0,0.0,0.0
Forced exercise,0.0,1.0,0.0,0.0
Figure-ground perception,0.0,1.0,0.0,0.0
Equipercentile,0.0,0.0,1.0,0.0
Maternal health,1.0,0.0,0.0,0.0
psychiatric history,0.0,0.0,0.0,1.0
Disease progression score,1.0,0.0,0.0,0.0
Basal Ganglia,0.0,1.0,0.0,0.0
Racial and ethnic differences,1.0,0.0,0.0,0.0
rCBF,0.0,0.0,0.0,1.0
Emotion decoding,0.0,1.0,0.0,0.0
Cognitive information systems,0.0,0.0,1.0,0.0
Quasi-stable synchrony pattern,0.0,0.0,1.0,0.0
Goal perception,0.0,1.0,0.0,0.0
Aging society,0.0,0.0,1.0,0.0
social judgments,0.0,0.0,1.0,0.0
Songbird,1.0,0.0,0.0,0.0
Diagnostic Tool,0.0,0.0,0.0,1.0
Virtual reality.,0.0,1.0,0.0,0.0
Evoked gamma response,0.0,1.0,0.0,0.0
Interval-timing,0.0,0.0,0.0,1.0
Adaptive functioning,0.0,0.0,1.0,0.0
Birth disorders,0.0,0.0,1.0,0.0
Nitrite (NO<inf>2</inf>-),0.0,0.0,1.0,0.0
Dual change score model,0.0,0.0,1.0,0.0
Aftereffect,0.0,0.0,1.0,0.0
Shape School,0.0,0.0,1.0,0.0
Contextual cues,1.0,0.0,0.0,0.0
Somatic Signal Detection Task,0.0,0.0,1.0,0.0
Digit-symbol substitution task (DSST),0.0,0.0,0.0,1.0
Finger-counting,0.0,1.0,0.0,0.0
schizophrenia spectrum personality,0.0,0.0,1.0,0.0
Motor complications,1.0,0.0,0.0,0.0
Terminal air traffic control,0.0,1.0,0.0,0.0
Mental state,0.0,0.0,1.0,0.0
Kinship knowledge,0.0,0.0,1.0,0.0
MR tractography,0.0,0.0,1.0,0.0
Allen,1.0,0.0,0.0,0.0
Memory skills,0.0,1.0,0.0,0.0
Episodic encoding,0.0,0.0,1.0,0.0
center of pressure,0.0,0.0,0.0,1.0
Single process signal detection model,0.0,0.0,1.0,0.0
Tip of the tongue experience,0.0,0.0,1.0,0.0
Hypervigilance for pain,0.0,0.0,1.0,0.0
Munson,1.0,0.0,0.0,0.0
Subconscious,0.0,0.0,1.0,0.0
Axonal density,1.0,0.0,0.0,0.0
Sickle Cell,0.0,1.0,0.0,0.0
Chaining theory,0.0,0.0,1.0,0.0
Ravens matrices,0.0,1.0,0.0,0.0
Human laboratory study,0.0,0.0,1.0,0.0
Genotype-phenotype correlation,0.0,1.0,0.0,0.0
Normal cognitive variation,1.0,0.0,0.0,0.0
Structural morphometry,1.0,0.0,0.0,0.0
Mucopolysaccharidosis Type I,0.0,1.0,0.0,0.0
False memories,0.0,0.0,1.0,0.0
Functional independence measure,0.0,1.0,0.0,0.0
Chronic fatigue,1.0,0.0,0.0,0.0
Perception-to-action,0.0,0.0,1.0,0.0
Integrative neuroscience,0.0,0.0,0.0,1.0
breakfast,0.0,1.0,0.0,0.0
anger,0.0,1.0,0.0,0.0
Exogenous attention,0.0,0.0,1.0,0.0
Salt fortification,0.0,1.0,0.0,0.0
Visuospatial priming,0.0,0.0,1.0,0.0
Principle of inverse effectiveness,0.0,0.0,1.0,0.0
Bayesian surprise model,0.0,1.0,0.0,0.0
Wada procedure,0.0,1.0,0.0,0.0
Word associations,1.0,0.0,0.0,0.0
Neuron-specific enolase,1.0,0.0,0.0,0.0
Amplitude of low-frequency fluctuations,0.0,0.0,1.0,0.0
Infrared oculography,0.0,1.0,0.0,0.0
Social-cognitive component,0.0,0.0,0.0,1.0
Arithmetic operators,0.0,1.0,0.0,0.0
Binge Drinking,0.0,0.0,0.0,1.0
Posterior Cortical Atrophy,0.0,1.0,0.0,0.0
Major depressive episode,0.0,0.0,1.0,0.0
Spectral density,0.0,1.0,0.0,0.0
distributed representations,0.0,0.0,0.0,1.0
Alzheimers-disease,0.0,0.0,0.0,1.0
Numerical recognition,1.0,0.0,0.0,0.0
Subcortical cognitive impairment,1.0,0.0,0.0,0.0
Developmental psychology,0.0,1.0,0.0,0.0
Neuropsychological presentation,0.0,1.0,0.0,0.0
Alzheimer's disease dementia,0.0,1.0,0.0,0.0
social referencing,0.0,0.0,0.0,1.0
Journey,0.0,1.0,0.0,0.0
DISC1,0.0,1.0,0.0,0.0
Face in the crowd,1.0,0.0,0.0,0.0
Stakeholder,0.0,1.0,0.0,0.0
space,0.0,0.0,0.0,0.0
Inefficiency,0.0,0.0,1.0,0.0
Stimulus-response consistency,0.0,0.0,1.0,0.0
Sleep Disturbance Symptom Questionnaire,1.0,0.0,0.0,0.0
Implementation,0.0,0.0,1.0,0.0
urban environment,0.0,0.0,1.0,0.0
Irrelevant sound effect,0.0,1.0,0.0,0.0
Visual aura,0.0,1.0,0.0,0.0
cue-reactivity,0.0,1.0,0.0,0.0
Tryptophan hydroxylase-2,0.0,0.0,1.0,0.0
Perceptual motor processes,0.0,0.0,0.0,1.0
Compliance,0.0,0.0,0.0,1.0
Periodic complexes,0.0,0.0,1.0,0.0
Tandospirone,0.0,0.0,1.0,0.0
surgical skills training,0.0,1.0,0.0,0.0
Blind navigation,0.0,0.0,1.0,0.0
Perception-cognition of ambiguous figures,0.0,0.0,1.0,0.0
Oxy-Hb,0.0,0.0,1.0,0.0
Fragmented images,0.0,0.0,0.0,1.0
Autonomic physiology,0.0,1.0,0.0,0.0
Identification priming,0.0,0.0,1.0,0.0
Neuropeptide,0.0,0.0,1.0,0.0
Posttraumatic growth,0.0,0.0,1.0,0.0
Heparin,0.0,0.0,0.0,1.0
event-related potential,0.0,1.0,0.0,0.0
ADEM,0.0,0.0,1.0,0.0
Mathematical concepts,0.0,0.0,0.0,1.0
Central coherence theory,0.0,1.0,0.0,0.0
In vivo exposure,0.0,0.0,1.0,0.0
Hypometabolism,0.0,0.0,1.0,0.0
centenarians,0.0,1.0,0.0,0.0
Moving pictures,0.0,0.0,1.0,0.0
Semantic coding theory,0.0,0.0,1.0,0.0
Cardiovascular parameters,0.0,1.0,0.0,0.0
low birth weight,0.0,0.0,1.0,0.0
First onset psychosis,0.0,0.0,1.0,0.0
Unimanual action,0.0,0.0,0.0,1.0
Verbal though,1.0,0.0,0.0,0.0
middle frontal gyrus,0.0,0.0,1.0,0.0
Blind Opera,0.0,0.0,1.0,0.0
Misconception,0.0,0.0,0.0,1.0
Scene categorization,0.0,1.0,0.0,0.0
Rear-end collisions,1.0,0.0,0.0,0.0
tactical vehicle control,0.0,1.0,0.0,0.0
body language reading,0.0,0.0,1.0,0.0
Mathematical models of cognition,0.0,1.0,0.0,0.0
inference,1.0,0.0,0.0,0.0
Spatially distributed groups,0.0,0.0,1.0,0.0
Modality effects,0.0,1.0,0.0,0.0
Physiological aging,0.0,0.0,1.0,0.0
triad,0.0,0.0,1.0,0.0
Natural statistics,0.0,1.0,0.0,0.0
Functional composite,0.0,1.0,0.0,0.0
Ketanserin,0.0,0.0,0.0,1.0
tES,0.0,0.0,1.0,0.0
mRNA,0.0,1.0,0.0,0.0
Microcebus murinus,0.0,0.0,1.0,0.0
Fisher information,0.0,1.0,0.0,0.0
Minimum Current Estimate,1.0,0.0,0.0,0.0
PCL,0.0,0.0,1.0,0.0
PCN,0.0,0.0,1.0,0.0
Mousetracking,0.0,0.0,1.0,0.0
object files,1.0,0.0,0.0,0.0
Conners' continuous performance test II,0.0,0.0,1.0,0.0
Rapid serial visual presentation task,0.0,0.0,1.0,0.0
Five digits test,1.0,0.0,0.0,0.0
blast,1.0,0.0,0.0,0.0
Musician effect,0.0,0.0,0.0,1.0
Conditional motor learning,0.0,0.0,1.0,0.0
Cognition disorderst,0.0,0.0,1.0,0.0
neural oscillations,0.0,0.0,1.0,0.0
Tip of the nose experience,0.0,0.0,1.0,0.0
Response context,1.0,0.0,0.0,0.0
Illness perception,0.0,0.0,0.0,1.0
radioecologiia / Rossi?skaia akademiia nauk",0.0,0.0,0.0,0.0
Left fusiform gyrus,0.0,0.0,1.0,0.0
Generalized epilepsy,1.0,0.0,0.0,0.0
psychological refractory period (PRP),1.0,0.0,0.0,0.0
Human episodic memory,1.0,0.0,0.0,0.0
hormone therapy,0.0,0.0,1.0,0.0
Auditory stimulation,1.0,0.0,0.0,0.0
DHEA,0.0,0.0,0.0,1.0
Object property,0.0,0.0,1.0,0.0
Vestibular information,0.0,1.0,0.0,0.0
Patient Reported Outcomes Measurement Information System (PROMIS),0.0,0.0,1.0,0.0
Mapping behavior,0.0,0.0,1.0,0.0
Instructional design,0.0,0.0,1.0,0.0
Running,0.0,1.0,0.0,0.0
Three waves of cognitive science",0.0,1.0,0.0,0.0
derealization,0.0,0.0,1.0,0.0
Embodied cognition and affordances,1.0,0.0,0.0,0.0
word naming,0.0,0.0,1.0,0.0
Liver diseases,0.0,1.0,0.0,0.0
Anatomical,1.0,0.0,0.0,0.0
Developmental tuning,0.0,0.0,1.0,0.0
Extrastriate body area (EBA),0.0,1.0,0.0,0.0
Athematical model,0.0,0.0,1.0,0.0
Aromatherapy,0.0,0.0,1.0,0.0
Cerebral metabolic rate for oxygen,0.0,1.0,0.0,0.0
Face stimuli,0.0,1.0,0.0,0.0
Drumming,0.0,1.0,0.0,0.0
Consciousness and brain problem,1.0,0.0,0.0,0.0
Transsaccadic memory,0.0,0.0,1.0,0.0
Evidence-based design,0.0,0.0,1.0,0.0
Quality of health care,0.0,1.0,0.0,0.0
Non-visual representation,0.0,0.0,1.0,0.0
Piperine,0.0,0.0,1.0,0.0
Cue,0.0,1.0,0.0,0.0
Object-picture perception,0.0,0.0,1.0,0.0
Picture prime,0.0,0.0,1.0,0.0
Cortical midline structure,1.0,0.0,0.0,0.0
Alpha waves,0.0,0.0,1.0,0.0
Image,0.0,1.0,0.0,0.0
Margins of stability,0.0,0.0,1.0,0.0
hTau,0.0,1.0,0.0,0.0
Swine,1.0,0.0,0.0,0.0
Cognitive control network,0.0,0.0,0.0,1.0
Raised intracranial pressure,1.0,0.0,0.0,0.0
Finger-tap task,0.0,0.0,1.0,0.0
Route preview,1.0,0.0,0.0,0.0
flare,0.0,1.0,0.0,0.0
Visual processing near hands,0.0,0.0,1.0,0.0
Relationship,0.0,1.0,0.0,0.0
Visual resolution deficit,0.0,0.0,1.0,0.0
Concrete verbs,0.0,1.0,0.0,0.0
Heat maps,0.0,0.0,1.0,0.0
Cortical gyrification,1.0,0.0,0.0,0.0
NeuroTrax,0.0,1.0,0.0,0.0
Butyrylcholinesterase genetic polymorphism,1.0,0.0,0.0,0.0
Social Phobia,0.0,1.0,0.0,0.0
power spectra,0.0,0.0,1.0,0.0
astereognosis,0.0,0.0,1.0,0.0
Behavioral latency,1.0,0.0,0.0,0.0
Hartmann-Shack sensor,0.0,0.0,1.0,0.0
Blended expressions,1.0,0.0,0.0,0.0
Conceptual span,1.0,0.0,0.0,0.0
Hip fracture in elderly,1.0,0.0,0.0,0.0
Stop-signal paradigm,0.0,0.0,1.0,0.0
music and manipulation,1.0,0.0,0.0,0.0
Attention-related biases,0.0,1.0,0.0,0.0
Pets,0.0,1.0,0.0,0.0
Hydroxylated polychlorinated biphenyls,0.0,1.0,0.0,0.0
conflict processing,1.0,0.0,0.0,0.0
stereoscopic 3D,0.0,1.0,0.0,0.0
CANE,0.0,0.0,1.0,0.0
pediatric functional MRI,0.0,0.0,1.0,0.0
Poststroke seizures,1.0,0.0,0.0,0.0
progestin,1.0,0.0,0.0,0.0
Apolipoprotein ?4,0.0,0.0,1.0,0.0
Disease severity,0.0,0.0,0.0,1.0
betahistine,0.0,1.0,0.0,0.0
Internal fixators,0.0,0.0,0.0,1.0
Knowledge/ignorance,0.0,0.0,1.0,0.0
expressive writing skill,0.0,0.0,1.0,0.0
Task-relevance,0.0,0.0,0.0,1.0
agrammatism,0.0,1.0,0.0,0.0
voice,0.0,0.0,0.0,1.0
Personal protective eyewear,0.0,0.0,1.0,0.0
Targets segmentation,1.0,0.0,0.0,0.0
resting-state functional connectivity,0.0,0.0,1.0,0.0
3D shape and space perception,0.0,1.0,0.0,0.0
Principle-based reasoning,0.0,0.0,1.0,0.0
Computerized medical record systems,0.0,0.0,1.0,0.0
Semantics (N400),0.0,1.0,0.0,0.0
Long-term,0.0,0.0,1.0,0.0
Science education,0.0,0.0,0.0,1.0
Transcallosalre section,0.0,0.0,1.0,0.0
Vice,0.0,1.0,0.0,0.0
Second helpings,1.0,0.0,0.0,0.0
Groups,1.0,0.0,0.0,0.0
place-based education,0.0,0.0,1.0,0.0
environmental hazards,0.0,0.0,1.0,0.0
Mathematics learning,1.0,0.0,0.0,0.0
speed-accuracy tradeoff,0.0,0.0,1.0,0.0
New World monkeys,0.0,0.0,1.0,0.0
Psychology of emergency,0.0,0.0,1.0,0.0
High risk studies,0.0,1.0,0.0,0.0
Childhood stroke,0.0,1.0,0.0,0.0
Frontal executive,0.0,0.0,1.0,0.0
Prelimbic cortex,0.0,1.0,0.0,0.0
Saudi Arabia",0.0,0.0,0.0,0.0
antiepileptic drugs,0.0,0.0,1.0,0.0
At-risk,1.0,0.0,0.0,0.0
Laboratory-based approach,1.0,0.0,0.0,0.0
Ideomotor theory,0.0,1.0,0.0,0.0
Lateral hypothalamus,1.0,0.0,0.0,0.0
Visual simulation,0.0,0.0,0.0,1.0
Cerebral microbleeds,0.0,0.0,1.0,0.0
LCMV,1.0,0.0,0.0,0.0
Articulation,0.0,1.0,0.0,0.0
posthumanities,1.0,0.0,0.0,0.0
Principal components analysis (PCA),0.0,1.0,0.0,0.0
Mental maps,0.0,1.0,0.0,0.0
Motor experience,0.0,0.0,1.0,0.0
Computational model On-center off-surround,1.0,0.0,0.0,0.0
IHI,1.0,0.0,0.0,0.0
Naked mole rat,1.0,0.0,0.0,0.0
Adolescent rat,0.0,1.0,0.0,0.0
"Cerebral white matter,0.0,0.0,0.0,0.0
Questionnaires,0.0,0.0,1.0,0.0
1-60 Hz frequency band,0.0,0.0,1.0,0.0
adjuvant therapy,0.0,0.0,1.0,0.0
Behavioral anomalies,1.0,0.0,0.0,0.0
Partonomy,0.0,0.0,1.0,0.0
Psychopathic personality,0.0,0.0,1.0,0.0
Delta-9-tetrahydrocannabinol (THC),1.0,0.0,0.0,0.0
N-methyl-D-aspartate receptor antagonist,0.0,1.0,0.0,0.0
Spatial-temporal feature,1.0,0.0,0.0,0.0
Selection pressures,1.0,0.0,0.0,0.0
Conditional associative task,0.0,1.0,0.0,0.0
visualisation,0.0,0.0,1.0,0.0
Short-term exposure limits,0.0,0.0,1.0,0.0
Drug-dependency,0.0,0.0,1.0,0.0
Dynamic noise,1.0,0.0,0.0,0.0
OT-APST,0.0,1.0,0.0,0.0
Left-right discrimination,0.0,0.0,1.0,0.0
Analytic Hierarchy Process (AHP),0.0,0.0,1.0,0.0
migraine without aura,0.0,0.0,1.0,0.0
Fatty acids unsaturated,0.0,0.0,1.0,0.0
American tourists,1.0,0.0,0.0,0.0
Office noise,1.0,0.0,0.0,0.0
Cerebrospinal fluid (CSF),0.0,0.0,1.0,0.0
Heterosis,0.0,0.0,1.0,0.0
Distracter interference,0.0,0.0,1.0,0.0
Subclinical macroangiopathy,0.0,0.0,1.0,0.0
Immediate recognition,1.0,0.0,0.0,0.0
Autistic Disorder,1.0,0.0,0.0,0.0
preclinical dementia,0.0,0.0,1.0,0.0
Perceptual theories,0.0,0.0,1.0,0.0
Synapses,0.0,0.0,1.0,0.0
Cognate status,0.0,0.0,1.0,0.0
junior high,0.0,0.0,0.0,1.0
Strength training,0.0,0.0,1.0,0.0
5 alpha reductase,0.0,1.0,0.0,0.0
Intertrial phase coherence (ITC),0.0,1.0,0.0,0.0
Photographic assessment,0.0,0.0,1.0,0.0
MCI (mild cognitive impairment),0.0,0.0,1.0,0.0
Rubber Hand Illusion,0.0,1.0,0.0,0.0
Dimethylamine borane,0.0,0.0,1.0,0.0
Confusion effect,0.0,0.0,1.0,0.0
head-tracking,0.0,0.0,1.0,0.0
Neuropediatrics,0.0,0.0,1.0,0.0
Symbolic expression of emotion,0.0,0.0,0.0,1.0
psychological distance,1.0,0.0,0.0,0.0
List representation,0.0,1.0,0.0,0.0
Cambridge,0.0,0.0,1.0,0.0
Child neglect,0.0,0.0,0.0,1.0
Man-made,0.0,1.0,0.0,0.0
Baroreceptor,0.0,0.0,1.0,0.0
Virtual reality simulation,0.0,1.0,0.0,0.0
Attentional Network Test,0.0,0.0,1.0,0.0
Deictic gestures,0.0,0.0,0.0,1.0
Video abstraction,0.0,1.0,0.0,0.0
Action parsing,0.0,1.0,0.0,0.0
Wakefulness,0.0,1.0,0.0,0.0
Plasmapheresis,0.0,0.0,1.0,0.0
Longitudinal relationship,0.0,0.0,1.0,0.0
Perceptual templates,0.0,0.0,1.0,0.0
Insulin-like growth factor-1,0.0,1.0,0.0,0.0
Social hormones,0.0,0.0,1.0,0.0
Tg2576,1.0,0.0,0.0,0.0
Functional magnetic resonance,1.0,0.0,0.0,0.0
remission,0.0,1.0,0.0,0.0
Multisensory naming,1.0,0.0,0.0,0.0
Brief batteries,0.0,0.0,1.0,0.0
Shared representation,0.0,0.0,1.0,0.0
Amisulpride,0.0,0.0,1.0,0.0
Adolescent girls,0.0,1.0,0.0,0.0
Long-tailed macaques,0.0,1.0,0.0,0.0
GABA/Glutamate,1.0,0.0,0.0,0.0
Representation modes,0.0,0.0,1.0,0.0
Neural circuit,0.0,1.0,0.0,0.0
survival school,0.0,0.0,1.0,0.0
Brain modeling,0.0,0.0,1.0,0.0
Default resting state,1.0,0.0,0.0,0.0
Cultural object,0.0,0.0,1.0,0.0
FTDU-17,0.0,0.0,1.0,0.0
Temporal coordination,1.0,0.0,0.0,0.0
macaca mulatta,0.0,0.0,1.0,0.0
Brain theory,0.0,0.0,1.0,0.0
Area CM,1.0,0.0,0.0,0.0
Eye-height scaling,1.0,0.0,0.0,0.0
Tools representation,0.0,0.0,1.0,0.0
Cultural relativity,1.0,0.0,0.0,0.0
Object imagery,1.0,0.0,0.0,0.0
Vaccine,0.0,1.0,0.0,0.0
Reachable space,1.0,0.0,0.0,0.0
Memory activation,0.0,1.0,0.0,0.0
Human computer interaction,0.0,0.0,1.0,0.0
Prophylactic cranial irradiation,0.0,0.0,0.0,1.0
Apraxia of speech,0.0,0.0,1.0,0.0
Stereoscopic 3D,1.0,0.0,0.0,0.0
Frontal gyrus,0.0,0.0,1.0,0.0
DBA/2,0.0,1.0,0.0,0.0
Habit,0.0,1.0,0.0,0.0
Somato-autonomic reflexes,0.0,0.0,1.0,0.0
Action planning,1.0,0.0,0.0,0.0
Interference-by-process,0.0,0.0,1.0,0.0
Visuo-manual system,0.0,0.0,0.0,1.0
Eigen decomposition,0.0,1.0,0.0,0.0
Back-to-Center Paradigm,0.0,0.0,1.0,0.0
Right unilateral ECT,0.0,0.0,1.0,0.0
Cognitive skills,0.0,1.0,0.0,0.0
Inflected nouns,0.0,0.0,1.0,0.0
Care homes,0.0,0.0,1.0,0.0
functional activation,0.0,0.0,1.0,0.0
Legislation,0.0,0.0,1.0,0.0
Development and Education",0.0,0.0,0.0,0.0
Attention shaping,1.0,0.0,0.0,0.0
Visual sensation,0.0,0.0,1.0,0.0
Beta oscillations,0.0,0.0,1.0,0.0
Cultural objects,0.0,0.0,1.0,0.0
Premorbid IQ,0.0,0.0,1.0,0.0
Self-Referential processing,0.0,0.0,1.0,0.0
Cognitive processing load,0.0,0.0,0.0,1.0
Mu activity,1.0,0.0,0.0,0.0
Connectionist modelling,0.0,0.0,0.0,1.0
Captions,1.0,0.0,0.0,0.0
Serial Digit Learning Test,0.0,1.0,0.0,0.0
Invagination,0.0,0.0,1.0,0.0
Intracellular cytokines,1.0,0.0,0.0,0.0
Pain empathy,0.0,0.0,1.0,0.0
Proprioceptive perception,0.0,1.0,0.0,0.0
Abandonment,0.0,0.0,1.0,0.0
Group independent component analysis,0.0,0.0,0.0,1.0
SNP,0.0,0.0,1.0,0.0
SNR,0.0,1.0,0.0,0.0
Infant habilitation,0.0,0.0,0.0,1.0
Learning Abilities,1.0,0.0,0.0,0.0
"Behavioral molecular mapping,0.0,0.0,0.0,0.0
Multisensory experience,0.0,1.0,0.0,0.0
CT,0.0,0.0,0.0,1.0
Endogenous flexibility,0.0,0.0,1.0,0.0
Think-no-think,0.0,0.0,1.0,0.0
Schizotypal traits,0.0,1.0,0.0,0.0
Prolonging driving,0.0,0.0,0.0,1.0
Partial knowledge,0.0,0.0,1.0,0.0
ventral,0.0,1.0,0.0,0.0
Randomised double blind trial,0.0,1.0,0.0,0.0
User-computer interface,0.0,0.0,1.0,0.0
Delis-Kaplan Executive Function System (D-KEFS) sorting test,0.0,0.0,1.0,0.0
low vision,0.0,0.0,1.0,0.0
rural,0.0,0.0,1.0,0.0
Top-down and bottom-up processing,0.0,0.0,1.0,0.0
Phobia,0.0,0.0,1.0,0.0
Directed singing,0.0,1.0,0.0,0.0
Stimuli,0.0,1.0,0.0,0.0
Cognitive sequelae,0.0,0.0,1.0,0.0
Long-chain polyunsaturated fatty acids (LC-PUFA),0.0,0.0,1.0,0.0
Aqueductal stenosis,0.0,0.0,1.0,0.0
Uremia,1.0,0.0,0.0,0.0
Dynamic decision making,0.0,0.0,0.0,1.0
Local excitatory global inhibitory networks,0.0,0.0,1.0,0.0
Interpersonal resonance,0.0,1.0,0.0,0.0
Pointlight walkers,0.0,1.0,0.0,0.0
Cognitive skill retention,0.0,0.0,1.0,0.0
Early temporal alignment,0.0,1.0,0.0,0.0
Clinical,1.0,0.0,0.0,0.0
Combined mini-mental-cognitive capacity screening examination (CMC),1.0,0.0,0.0,0.0
reinforcement,0.0,0.0,1.0,0.0
Alcoholic Subjects,0.0,0.0,1.0,0.0
Rural planning,0.0,0.0,1.0,0.0
construction,0.0,1.0,0.0,0.0
Mathematical skills,1.0,0.0,0.0,0.0
Esthetic,0.0,0.0,1.0,0.0
housing,1.0,0.0,0.0,0.0
working memory capacity,0.0,1.0,0.0,0.0
hemi-spatial neglect,0.0,1.0,0.0,0.0
Arm/hand function,0.0,0.0,1.0,0.0
Symbolic space,1.0,0.0,0.0,0.0
Modularism,0.0,1.0,0.0,0.0
self-rated health,0.0,0.0,1.0,0.0
Perceptual integration,0.0,0.0,1.0,0.0
Imagery perspective,0.0,1.0,0.0,0.0
Amino acids,1.0,0.0,0.0,0.0
Obstacles avoidance,0.0,0.0,1.0,0.0
Atypical visual processing,0.0,0.0,1.0,0.0
Artificial brains,0.0,0.0,1.0,0.0
United Kingdom Disability Scale,0.0,0.0,0.0,1.0
Open-label extension,1.0,0.0,0.0,0.0
Age of ASL acquisition,0.0,0.0,1.0,0.0
Children TV Shows,0.0,0.0,1.0,0.0
Everyday cognitive battery,0.0,1.0,0.0,0.0
Neural bases,0.0,0.0,1.0,0.0
Physical reasoning in infancy,0.0,1.0,0.0,0.0
Cederlund,0.0,1.0,0.0,0.0
sleep apnoea,0.0,1.0,0.0,0.0
Healthy Subjects,0.0,1.0,0.0,0.0
Clinical practice guideline,0.0,0.0,1.0,0.0
KIBRA,1.0,0.0,0.0,0.0
driver safety,0.0,1.0,0.0,0.0
Vocal emotion,1.0,0.0,0.0,0.0
Orexin,0.0,1.0,0.0,0.0
Auditory recognition,1.0,0.0,0.0,0.0
Rating Scale,0.0,1.0,0.0,0.0
symbolic cognition,0.0,0.0,0.0,1.0
Multidisciplinarity,0.0,1.0,0.0,0.0
Physiotherapy,0.0,0.0,1.0,0.0
Exponential,1.0,0.0,0.0,0.0
Breakfast composition,0.0,0.0,1.0,0.0
Caesarean section,0.0,0.0,1.0,0.0
controlled rearing,0.0,1.0,0.0,0.0
Autonomous nervous system,0.0,1.0,0.0,0.0
Prehensile movement,0.0,0.0,1.0,0.0
Discrete quantity,0.0,1.0,0.0,0.0
topographical memory,0.0,0.0,1.0,0.0
P300 visual evoked potentials,0.0,0.0,1.0,0.0
diffusion tensor imaging (DTI),0.0,1.0,0.0,0.0
Model of the cortex,1.0,0.0,0.0,0.0
Audience design,0.0,0.0,1.0,0.0
Color-sensitive,0.0,1.0,0.0,0.0
Egocentric neglect,0.0,1.0,0.0,0.0
Single-process models,0.0,0.0,1.0,0.0
High-context images,0.0,0.0,1.0,0.0
Mu rhythm,1.0,0.0,0.0,0.0
goal orientation,0.0,1.0,0.0,0.0
Voluntary attention,0.0,1.0,0.0,0.0
Auditory memory,0.0,0.0,1.0,0.0
Geothermal,1.0,0.0,0.0,0.0
Mouse tracking,0.0,0.0,1.0,0.0
Normal birth weight,0.0,0.0,1.0,0.0
Numerical abilities,1.0,0.0,0.0,0.0
Subjective Visual Vertical,0.0,1.0,0.0,0.0
cognitive conflict,1.0,0.0,0.0,0.0
Drawing development,0.0,1.0,0.0,0.0
Output buffer,1.0,0.0,0.0,0.0
Angle discrimination,0.0,1.0,0.0,0.0
Pediatric population,0.0,0.0,1.0,0.0
Block-wise conflict adaptation effect,0.0,0.0,1.0,0.0
Pseudo-random generation,1.0,0.0,0.0,0.0
Test-validation,0.0,0.0,0.0,1.0
defensive behaviour,1.0,0.0,0.0,0.0
Three-dimensional geological structural model,1.0,0.0,0.0,0.0
Blood oxygen saturation,1.0,0.0,0.0,0.0
Post-injury time,0.0,0.0,1.0,0.0
Psychological change,0.0,0.0,1.0,0.0
Abreaction,0.0,1.0,0.0,0.0
Ambiguous anticipation,0.0,1.0,0.0,0.0
Ocular artifact,0.0,0.0,1.0,0.0
Crossmodel,0.0,0.0,0.0,1.0
embedded cognition,0.0,0.0,0.0,1.0
remotely operated vehicles,0.0,0.0,1.0,0.0
Symptom,0.0,0.0,0.0,1.0
Shifting,0.0,0.0,1.0,0.0
Concurrent recall,0.0,0.0,1.0,0.0
Object contour,0.0,0.0,1.0,0.0
Apolipoprotein ?4 allele,0.0,0.0,1.0,0.0
ataxia,0.0,0.0,1.0,0.0
Petri Nets,1.0,0.0,0.0,0.0
semantic interference,0.0,0.0,1.0,0.0
Pseudarthrosis,0.0,0.0,1.0,0.0
Needs assessment,0.0,0.0,1.0,0.0
drug,0.0,1.0,0.0,0.0
Radicals as signals,0.0,0.0,0.0,1.0
Bilateral gain,0.0,0.0,1.0,0.0
Native signers,1.0,0.0,0.0,0.0
Morphed figures,1.0,0.0,0.0,0.0
Sensory-motor controls,0.0,0.0,0.0,1.0
Interpersonal skills,0.0,0.0,1.0,0.0
Nonlocality,0.0,0.0,0.0,1.0
Akinesia,0.0,0.0,1.0,0.0
Observation space,0.0,0.0,1.0,0.0
High risk for schizophrenia,0.0,0.0,1.0,0.0
Intensity,0.0,0.0,0.0,1.0
Brain neoplasm,0.0,1.0,0.0,0.0
Visual system of children,0.0,0.0,1.0,0.0
Operation iraqi freedom,1.0,0.0,0.0,0.0
Positive and negative compatibility effects,0.0,0.0,1.0,0.0
Interactional differences,1.0,0.0,0.0,0.0
Perihandspace,0.0,0.0,1.0,0.0
Enabling,0.0,0.0,1.0,0.0
Manipulation knowledge,0.0,1.0,0.0,0.0
Audiovisual reaction time,1.0,0.0,0.0,0.0
Hierarchical figures,0.0,0.0,1.0,0.0
visuomotor priming,0.0,0.0,0.0,1.0
Motorcycle safety,0.0,0.0,1.0,0.0
Comorbidities,0.0,0.0,1.0,0.0
mood regulation,0.0,1.0,0.0,0.0
Eye-movement features,1.0,0.0,0.0,0.0
Specialist gene,0.0,0.0,1.0,0.0
DSM-V,0.0,1.0,0.0,0.0
Radiology,0.0,0.0,1.0,0.0
Medial-temporal lobe,0.0,0.0,1.0,0.0
3D videography,0.0,1.0,0.0,0.0
Squirrel monkeys,0.0,0.0,1.0,0.0
Object-color knowledge,0.0,1.0,0.0,0.0
Automatic postural response,0.0,0.0,1.0,0.0
Magnitude processing,0.0,1.0,0.0,0.0
Formicidae,0.0,1.0,0.0,0.0
Oscillatory networks,0.0,1.0,0.0,0.0
Spatiotemporal information,0.0,0.0,0.0,1.0
Unrestrained eaters,0.0,0.0,1.0,0.0
movement control,0.0,1.0,0.0,0.0
Obstacles,1.0,0.0,0.0,0.0
Methylation,0.0,1.0,0.0,0.0
Delayed verbal cued recall,0.0,0.0,1.0,0.0
Fear-circuit,0.0,1.0,0.0,0.0
Visuospatial interference,0.0,0.0,0.0,1.0
Perceptual load theory,0.0,0.0,1.0,0.0
Visual ontologies,0.0,1.0,0.0,0.0
filtering efficiency,0.0,0.0,1.0,0.0
Attentional deficits,0.0,0.0,1.0,0.0
Specific developmental disorders of speech and language,0.0,0.0,1.0,0.0
Tcf4,0.0,0.0,1.0,0.0
Visual saliency,0.0,0.0,1.0,0.0
Glasgow Outcome Scale-Extended,0.0,1.0,0.0,0.0
Classical,0.0,0.0,1.0,0.0
Brain hemodynamic response,0.0,0.0,0.0,1.0
Human-robot cooperation,0.0,0.0,1.0,0.0
Search orientation,0.0,0.0,1.0,0.0
Clinical follow-up,0.0,0.0,1.0,0.0
Visual change detection,0.0,0.0,1.0,0.0
Memory tasks,0.0,0.0,0.0,1.0
Choice updating,0.0,0.0,1.0,0.0
Prismatic adaptation,0.0,1.0,0.0,0.0
J.W.,0.0,1.0,0.0,0.0
Remedial neurofeedback training,0.0,1.0,0.0,0.0
Early symptoms,1.0,0.0,0.0,0.0
MRI visual rating,0.0,1.0,0.0,0.0
Subsyndromal depression,0.0,1.0,0.0,0.0
graph comprehension,0.0,1.0,0.0,0.0
Treatment effectiveness,0.0,1.0,0.0,0.0
interactions,0.0,1.0,0.0,0.0
response time,0.0,0.0,1.0,0.0
signal-to-clutter ratio (SCR),1.0,0.0,0.0,0.0
Williams-Beuren syndrome,0.0,0.0,1.0,0.0
Adaptive dual n-back training,1.0,0.0,0.0,0.0
Kana Pick-out Test,0.0,1.0,0.0,0.0
HUI3,0.0,0.0,1.0,0.0
Experimental semiotics,0.0,1.0,0.0,0.0
Subjective coercion,0.0,0.0,1.0,0.0
Computational vision,0.0,1.0,0.0,0.0
Dorsal and ventral neurons,0.0,1.0,0.0,0.0
prosopagnosia,0.0,0.0,1.0,0.0
Electromagnetic fields,0.0,0.0,1.0,0.0
Slowing by advance information,0.0,0.0,1.0,0.0
Deductive,0.0,0.0,1.0,0.0
Connectionist model,1.0,0.0,0.0,0.0
Perceptual bistability,0.0,0.0,1.0,0.0
Simultaneity judgment,0.0,0.0,0.0,1.0
Visual processing speed.,0.0,1.0,0.0,0.0
Social cue,0.0,0.0,1.0,0.0
Clinical features,0.0,0.0,1.0,0.0
Neural reserve,0.0,0.0,0.0,1.0
perceptual disorders,0.0,0.0,0.0,1.0
Community,0.0,1.0,0.0,0.0
V2 visual cortex,0.0,1.0,0.0,0.0
Sub-optimal effort,0.0,0.0,1.0,0.0
Reward reversal,0.0,0.0,1.0,0.0
Ambiguity resolution,0.0,0.0,1.0,0.0
Intentional behaviours,0.0,0.0,1.0,0.0
Bayesian brain,0.0,0.0,1.0,0.0
Blaut,0.0,0.0,1.0,0.0
Language and simulation theory,1.0,0.0,0.0,0.0
Neuropsychological tests/standards,0.0,0.0,1.0,0.0
Prenatal exposure delayed effects,0.0,0.0,0.0,1.0
Judgment of Line Orientation,0.0,1.0,0.0,0.0
Typically developing youth,0.0,1.0,0.0,0.0
Mental mapping,0.0,1.0,0.0,0.0
Rolipram,0.0,0.0,0.0,1.0
Numerical space,0.0,0.0,1.0,0.0
Cognitive/linguistic deficits,0.0,1.0,0.0,0.0
Predation,1.0,0.0,0.0,0.0
Dextrous hand function,1.0,0.0,0.0,0.0
Heart period,0.0,0.0,1.0,0.0
Elite athletes,0.0,0.0,1.0,0.0
Measles antibodies,0.0,0.0,1.0,0.0
Wernicke's encephalopathy,0.0,0.0,1.0,0.0
heart rate variability,0.0,1.0,0.0,0.0
Hippocalcin,0.0,1.0,0.0,0.0
Sensorimotor contingency,0.0,1.0,0.0,0.0
Central nervous system involvement,1.0,0.0,0.0,0.0
Washington State,0.0,0.0,1.0,0.0
Direct gaze,0.0,1.0,0.0,0.0
Abstract concept learning,0.0,0.0,1.0,0.0
Sholl,1.0,0.0,0.0,0.0
Face gender recognition,0.0,0.0,1.0,0.0
Contiguity,1.0,0.0,0.0,0.0
physiology,0.0,0.0,1.0,0.0
Social Cognitive Skills Test,0.0,0.0,1.0,0.0
Deaf education,0.0,0.0,1.0,0.0
Video training,0.0,0.0,1.0,0.0
Compomers,0.0,0.0,0.0,1.0
PWZ-029,0.0,0.0,1.0,0.0
Attention and executive tasks,1.0,0.0,0.0,0.0
bird,0.0,1.0,0.0,0.0
Psychometric validation,0.0,0.0,1.0,0.0
Spoken words,0.0,1.0,0.0,0.0
student understanding,0.0,1.0,0.0,0.0
Estrogen receptor polymorphisms,0.0,0.0,1.0,0.0
Raven's coloured progressive matrices,1.0,0.0,0.0,0.0
Preschool deaf children,0.0,0.0,1.0,0.0
Allocentric reference,1.0,0.0,0.0,0.0
Mirror apparatus,1.0,0.0,0.0,0.0
COLOUR OPPONENCY,1.0,0.0,0.0,0.0
forceps major,0.0,0.0,0.0,1.0
Pictorial Symbols,0.0,1.0,0.0,0.0
Visual input,0.0,1.0,0.0,0.0
Multidisciplinary team,0.0,1.0,0.0,0.0
Lateral competition,0.0,1.0,0.0,0.0
Goldstein,0.0,0.0,1.0,0.0
Humanoid robot,0.0,0.0,1.0,0.0
Linguistic function,0.0,0.0,0.0,1.0
Asperger disorder,0.0,0.0,0.0,1.0
Australian Imaging,0.0,0.0,0.0,0.0
research and practice : the journal of the Sarah Duffen Centre / University of Portsmouth",0.0,0.0,0.0,0.0
Explicit instruction,0.0,1.0,0.0,0.0
HIV Infections,0.0,0.0,0.0,1.0
Novel object discrimination (NOD) test,1.0,0.0,0.0,0.0
CPB,0.0,1.0,0.0,0.0
Late-positive potential,0.0,0.0,1.0,0.0
Chinese pseudo-character,0.0,0.0,1.0,0.0
Inference-making,1.0,0.0,0.0,0.0
Action effect,0.0,0.0,1.0,0.0
Neuro-behavioural manifestations,1.0,0.0,0.0,0.0
Spatial disorientation,0.0,0.0,0.0,1.0
rapid serial visual presentation,1.0,0.0,0.0,0.0
Tokenization,0.0,1.0,0.0,0.0
Forward models,0.0,0.0,1.0,0.0
Pre-menopause,1.0,0.0,0.0,0.0
Neural efficiency,0.0,1.0,0.0,0.0
Brain atlas,0.0,0.0,0.0,1.0
Hormone exposure,0.0,0.0,0.0,1.0
Parafoveal,0.0,0.0,1.0,0.0
Maximal oxygen consumption,0.0,0.0,1.0,0.0
Linear coding,0.0,0.0,1.0,0.0
People perception,0.0,0.0,1.0,0.0
Kernel learning,0.0,1.0,0.0,0.0
Functional specialization,1.0,0.0,0.0,0.0
Heroin maintenance treatment,0.0,1.0,0.0,0.0
Ironic processes,0.0,0.0,0.0,1.0
Infant behavior,0.0,0.0,1.0,0.0
Information-integration,0.0,1.0,0.0,0.0
simulator,0.0,0.0,1.0,0.0
Animal categorization,0.0,0.0,1.0,0.0
Full term,0.0,0.0,0.0,1.0
Duration of untreated psychosis (DUP),1.0,0.0,0.0,0.0
EEG classification,1.0,0.0,0.0,0.0
Lead exposure,0.0,0.0,1.0,0.0
First-time viewers,0.0,0.0,1.0,0.0
Aesthetic appreciation,0.0,0.0,1.0,0.0
Disengagement of attention,1.0,0.0,0.0,0.0
ACE,0.0,1.0,0.0,0.0
Psychoanalysis,0.0,0.0,1.0,0.0
distance effects,0.0,1.0,0.0,0.0
Neuritin,0.0,0.0,1.0,0.0
PTSDimaging genetics,1.0,0.0,0.0,0.0
Walhund scale,1.0,0.0,0.0,0.0
Cardiac activity,0.0,0.0,1.0,0.0
Spectral coherence,0.0,1.0,0.0,0.0
Steady-state visual-evoked potential (SSVEP),1.0,0.0,0.0,0.0
autopsy-confirmed,0.0,0.0,1.0,0.0
egr-1,0.0,1.0,0.0,0.0
Cognitive and motor impairments,0.0,0.0,1.0,0.0
Look,0.0,0.0,1.0,0.0
Information and Systems",0.0,0.0,0.0,0.0
Crossed fixation strabism,0.0,0.0,1.0,0.0
Acute lymphocytic leukemia,0.0,0.0,1.0,0.0
Interspecific visual kin recognition,0.0,0.0,1.0,0.0
disease burden,1.0,0.0,0.0,0.0
Schizophasia,0.0,1.0,0.0,0.0
Dopamine dengineering receptor,0.0,0.0,1.0,0.0
Social attribution,0.0,0.0,1.0,0.0
Visual stimuli,0.0,0.0,1.0,0.0
Kufs disease,0.0,0.0,1.0,0.0
Posturography and risk of recurrent falls in healthy non-institutionalized persons aged over 65 (2006) Gerontology,1.0,0.0,0.0,0.0
electroencephalogram,0.0,0.0,0.0,1.0
Goals/dispositions,1.0,0.0,0.0,0.0
beta-amyloid,0.0,0.0,1.0,0.0
Cognition intervention,0.0,0.0,1.0,0.0
Free-recall tests,0.0,0.0,1.0,0.0
Natural and artifact objects,0.0,0.0,0.0,1.0
Electrical neuroimaging,0.0,1.0,0.0,0.0
Myasthenia gravis,0.0,1.0,0.0,0.0
Error negativity,0.0,0.0,1.0,0.0
(re-)Cognition,0.0,0.0,1.0,0.0
Central coherence function,0.0,1.0,0.0,0.0
Drawing ability,0.0,0.0,1.0,0.0
processing of own face,1.0,0.0,0.0,0.0
"Obsession,0.0,0.0,0.0,0.0
Visual dyslexia,0.0,1.0,0.0,0.0
Novel object,0.0,0.0,0.0,1.0
Confounding factors,1.0,0.0,0.0,0.0
Rate,0.0,0.0,1.0,0.0
polyT polymorphism,0.0,0.0,1.0,0.0
"Early processing,0.0,0.0,0.0,0.0
Gamma EEG,0.0,1.0,0.0,0.0
Spreading depression,0.0,1.0,0.0,0.0
Coal mine safety information,0.0,1.0,0.0,0.0
Smell duration,0.0,0.0,0.0,1.0
Scene preferences,0.0,0.0,1.0,0.0
Endogenous Posner paradigm,0.0,0.0,0.0,1.0
Gaze direction recognition,1.0,0.0,0.0,0.0
Spatial communication,0.0,1.0,0.0,0.0
Fetal alcohol (fAS,0.0,0.0,0.0,0.0
challenge problems,0.0,0.0,1.0,0.0
Concern,0.0,0.0,0.0,1.0
Tactile temporal order judgment,0.0,0.0,1.0,0.0
Oral narrative,0.0,1.0,0.0,0.0
amyloid ?,0.0,0.0,1.0,0.0
Eastern Orthodoxy,1.0,0.0,0.0,0.0
Visual psychophysical experiment,0.0,1.0,0.0,0.0
Depression subtypes,0.0,0.0,1.0,0.0
Rapid progressive dementia,0.0,0.0,1.0,0.0
visual messages,1.0,0.0,0.0,0.0
falls prevention,0.0,0.0,1.0,0.0
Verbal representations,0.0,0.0,1.0,0.0
Automated driving aids,0.0,0.0,0.0,1.0
Different writing systems,0.0,0.0,1.0,0.0
Latent difference score model,0.0,0.0,1.0,0.0
Disorganization symptoms,0.0,1.0,0.0,0.0
Wilsons disease,0.0,0.0,0.0,1.0
Abstract sequence processing,0.0,0.0,1.0,0.0
Cardiovascular reactivity,0.0,1.0,0.0,0.0
Dopamine transporter scintigraphy,0.0,0.0,0.0,1.0
Reward-directed instrumental learning,0.0,1.0,0.0,0.0
Mesolimbic system,1.0,0.0,0.0,0.0
Visual mechanisms,0.0,0.0,1.0,0.0
Subject motion,0.0,0.0,1.0,0.0
avoidance,0.0,0.0,1.0,0.0
D 3 receptors,0.0,0.0,0.0,1.0
Neuropsychiatric symptoms,0.0,0.0,1.0,0.0
vitamins,1.0,0.0,0.0,0.0
General cognition,0.0,0.0,0.0,1.0
Acromegaly,0.0,0.0,1.0,0.0
s-Cones,0.0,1.0,0.0,0.0
Intention-reading-process,0.0,1.0,0.0,0.0
Road environment,0.0,0.0,0.0,1.0
trait judgments,0.0,1.0,0.0,0.0
Multi-modality aphasia therapy,0.0,1.0,0.0,0.0
Radial-arm water maze,0.0,1.0,0.0,0.0
neuronal representation,0.0,1.0,0.0,0.0
Equating,0.0,0.0,1.0,0.0
static magnetic fields (SMF),1.0,0.0,0.0,0.0
Delayed response task,1.0,0.0,0.0,0.0
judgements of learning,1.0,0.0,0.0,0.0
ActiveX,0.0,0.0,1.0,0.0
Sequence generation,0.0,0.0,0.0,1.0
Computer tasks,0.0,1.0,0.0,0.0
Parasympathetic,0.0,1.0,0.0,0.0
Parahippocampal,0.0,0.0,1.0,0.0
Speech reading,1.0,0.0,0.0,0.0
central executive,0.0,0.0,1.0,0.0
Parieto-frontal network,0.0,1.0,0.0,0.0
Online 5 december 2011,0.0,0.0,1.0,0.0
Strategic retrieval processing,0.0,0.0,1.0,0.0
Valence intensity,1.0,0.0,0.0,0.0
Choice reaction,0.0,1.0,0.0,0.0
Magnetoencephalography LPP,0.0,0.0,1.0,0.0
impact,0.0,0.0,1.0,0.0
TEMPS-A,0.0,0.0,1.0,0.0
Serotonin reuptake inhibitors,0.0,0.0,1.0,0.0
Synthetic aperture magnetometry,0.0,1.0,0.0,0.0
Psychological workload,0.0,0.0,1.0,0.0
Emotional cues,0.0,0.0,1.0,0.0
Maladaptation,0.0,0.0,1.0,0.0
Human posture,0.0,0.0,1.0,0.0
Taxonomy of cognition,0.0,0.0,1.0,0.0
P1 latency,0.0,0.0,1.0,0.0
Cholera toxin,0.0,0.0,1.0,0.0
Plate size,1.0,0.0,0.0,0.0
muscle contraction,0.0,1.0,0.0,0.0
Social change,0.0,0.0,1.0,0.0
Pre-supplementary motor area,0.0,0.0,1.0,0.0
Sea lion,0.0,0.0,1.0,0.0
"Semaphorin 5A,0.0,0.0,0.0,0.0
Multi-element processing,0.0,1.0,0.0,0.0
analogy,1.0,0.0,0.0,0.0
Great ape,0.0,0.0,1.0,0.0
Airsickness,0.0,0.0,1.0,0.0
Semantic violation,1.0,0.0,0.0,0.0
IMPACT,0.0,0.0,1.0,0.0
Diabetes technology,1.0,0.0,0.0,0.0
Arithmetic fact retrieval,0.0,0.0,1.0,0.0
Ambivalence,0.0,0.0,1.0,0.0
Language function,0.0,1.0,0.0,0.0
Chinese language,0.0,0.0,1.0,0.0
Rey-Osterrieth complex figure test,0.0,1.0,0.0,0.0
open-fire cooking,0.0,1.0,0.0,0.0
Automatic process,0.0,1.0,0.0,0.0
Visual aid,0.0,1.0,0.0,0.0
Almorexant,0.0,1.0,0.0,0.0
Psychological perspective,0.0,0.0,1.0,0.0
appreciation,1.0,0.0,0.0,0.0
student-generated representations,0.0,1.0,0.0,0.0
Physical training,0.0,0.0,1.0,0.0
Free recollection,0.0,0.0,0.0,1.0
Mobile 3D viewing,0.0,0.0,1.0,0.0
Thalamic stroke,0.0,0.0,1.0,0.0
Pictorial runes,1.0,0.0,0.0,0.0
Voltage clamp,0.0,1.0,0.0,0.0
functional reorganization,0.0,1.0,0.0,0.0
Self-rotation,0.0,1.0,0.0,0.0
Growth modeling,0.0,0.0,1.0,0.0
PPVT,0.0,0.0,1.0,0.0
Object-place binding,0.0,1.0,0.0,0.0
Glutamate release,0.0,1.0,0.0,0.0
Computer-assisted cognitive rehabilitation,0.0,1.0,0.0,0.0
Conditioned pain modulation (CPM),0.0,0.0,0.0,1.0
False-belief reasoning,0.0,1.0,0.0,0.0
Polysemy,0.0,1.0,0.0,0.0
Color diagnosticity,0.0,1.0,0.0,0.0
BMD,0.0,0.0,0.0,1.0
FMRI repetition suppression,1.0,0.0,0.0,0.0
Action tasks,0.0,0.0,1.0,0.0
Sounds,0.0,0.0,0.0,1.0
IPL,0.0,0.0,1.0,0.0
Child-directed speech,0.0,1.0,0.0,0.0
Light Sound Stimulation,0.0,0.0,1.0,0.0
Digit symbol coding,0.0,0.0,1.0,0.0
Visual metaphor,0.0,0.0,1.0,0.0
Return to work,0.0,0.0,1.0,0.0
Hierarchical stimulus,0.0,1.0,0.0,0.0
Intersensory processes,0.0,0.0,1.0,0.0
analog magnitudes,1.0,0.0,0.0,0.0
Cone system,1.0,0.0,0.0,0.0
Habit learning,0.0,0.0,1.0,0.0
Memory model,0.0,1.0,0.0,0.0
Audio/video interaction,0.0,0.0,0.0,1.0
Mild cognitive impairment subtypes,1.0,0.0,0.0,0.0
Treatment system,0.0,0.0,1.0,0.0
contralateral delay activity,0.0,0.0,1.0,0.0
Cognitive-linguistic,0.0,0.0,1.0,0.0
Health services accessibility,0.0,0.0,1.0,0.0
Dopamine transporter polymorphism,0.0,0.0,1.0,0.0
Endemic,0.0,1.0,0.0,0.0
proton radiation,0.0,0.0,1.0,0.0
facial and vocal emotion expressions,0.0,0.0,1.0,0.0
Penumbral zone,0.0,1.0,0.0,0.0
Log odds,0.0,0.0,1.0,0.0
Visual sysmptoms of dementia,0.0,0.0,1.0,0.0
physical attractiveness,0.0,0.0,1.0,0.0
Cervical laminoplasty,0.0,0.0,1.0,0.0
Protocol analysis,0.0,1.0,0.0,0.0
Foreign Accent Syndrome,0.0,0.0,1.0,0.0
STEP,0.0,0.0,1.0,0.0
STEM,0.0,0.0,1.0,0.0
Wound healing,0.0,0.0,0.0,1.0
Hypovigilance,0.0,1.0,0.0,0.0
Longitudinal trajectories,0.0,0.0,1.0,0.0
Oxybutynin,0.0,0.0,1.0,0.0
Digital collaboration,0.0,1.0,0.0,0.0
Ponerinae,0.0,0.0,1.0,0.0
Functional disorder,1.0,0.0,0.0,0.0
Long-term-care institutions,1.0,0.0,0.0,0.0
Magnetic sense,0.0,0.0,0.0,0.0
Intravenous drug use,1.0,0.0,0.0,0.0
Disorientation effect,0.0,0.0,0.0,1.0
Meaningless shapes,0.0,1.0,0.0,0.0
Periventricular hemorrhagic infarction,1.0,0.0,0.0,0.0
Anger superiority effect,0.0,0.0,1.0,0.0
Grey parrots,0.0,1.0,0.0,0.0
Shifting of attention,1.0,0.0,0.0,0.0
Descriptors: Multiple personality disorder,0.0,1.0,0.0,0.0
Unstable support surface,0.0,0.0,1.0,0.0
Partial seizures,0.0,0.0,1.0,0.0
Neurofibromatosis 1 - diagnosis,0.0,1.0,0.0,0.0
Reasoning by exclusion,0.0,0.0,0.0,1.0
Category learning. Categorization. Inference. Missing information,0.0,0.0,1.0,0.0
Reversed Stroop,1.0,0.0,0.0,0.0
Weight status,0.0,0.0,1.0,0.0
Tracing,0.0,0.0,0.0,1.0
Phase transitions,0.0,0.0,0.0,1.0
Patronage,0.0,0.0,1.0,0.0
Chromosome 19,1.0,0.0,0.0,0.0
Perception of size,1.0,0.0,0.0,0.0
problem representations,0.0,0.0,1.0,0.0
Wechsler Intelligence Scale for Children,1.0,0.0,0.0,0.0
incongruency,0.0,1.0,0.0,0.0
Cross-modality mapping,0.0,1.0,0.0,0.0
cerebrovascular disorders,0.0,0.0,0.0,1.0
electroconvulsive therapy,1.0,0.0,0.0,0.0
Local networks,0.0,1.0,0.0,0.0
NHANES,0.0,1.0,0.0,0.0
Taxonomic and thematic relations,0.0,0.0,0.0,1.0
Moving shapes,0.0,0.0,1.0,0.0
MWT-B,0.0,1.0,0.0,0.0
EDVA,0.0,1.0,0.0,0.0
Neural latency,0.0,0.0,1.0,0.0
PDS-95,0.0,0.0,1.0,0.0
rifampin,0.0,0.0,1.0,0.0
Re-appraisal,0.0,1.0,0.0,0.0
Cognitive opacity,0.0,0.0,1.0,0.0
gene-environment interaction,0.0,0.0,1.0,0.0
Semantic brain systems,1.0,0.0,0.0,0.0
wayfinding,0.0,0.0,0.0,1.0
Disobedience,0.0,0.0,1.0,0.0
SL65.1498,0.0,0.0,0.0,1.0
Vection,0.0,0.0,0.0,1.0
Stop signs,0.0,0.0,1.0,0.0
Rule application,0.0,0.0,0.0,1.0
Terrain displays,0.0,0.0,1.0,0.0
Human-Computer Interaction,1.0,0.0,0.0,0.0
Explanations,0.0,1.0,0.0,0.0
Absolute modularity,0.0,0.0,1.0,0.0
Institutionalisation,0.0,0.0,1.0,0.0
If-then rule learning,0.0,1.0,0.0,0.0
Self-other judgement,0.0,0.0,0.0,1.0
Subjective time,1.0,0.0,0.0,0.0
Bistable visual perception,0.0,1.0,0.0,0.0
Skill theory,0.0,1.0,0.0,0.0
Automatic attentional shifting,0.0,0.0,1.0,0.0
MR morphometry,1.0,0.0,0.0,0.0
false perception,0.0,1.0,0.0,0.0
oxidative damage,0.0,1.0,0.0,0.0
Close,0.0,1.0,0.0,0.0
Diagnostic effectiveness,0.0,0.0,0.0,1.0
HRQOL,0.0,0.0,1.0,0.0
Manipulable and non-manipulable objects,0.0,0.0,0.0,1.0
Speaker's gender,1.0,0.0,0.0,0.0
Design evaluation,0.0,0.0,1.0,0.0
Inhibition of Return,0.0,0.0,1.0,0.0
Intrinsic connectivity,0.0,1.0,0.0,0.0
Symbol mapping,0.0,0.0,1.0,0.0
Cognitive set shifting,0.0,0.0,1.0,0.0
Room acoustic simulation,1.0,0.0,0.0,0.0
medical education,0.0,1.0,0.0,0.0
Stimulus-driven attention,0.0,0.0,0.0,1.0
Inducing change blindness flicker paradigm,0.0,0.0,1.0,0.0
Configural encoding,0.0,0.0,1.0,0.0
Lateral pallium,1.0,0.0,0.0,0.0
Tuberous sclerosis,0.0,1.0,0.0,0.0
Adult congregate facilities,0.0,0.0,1.0,0.0
event segmentation,0.0,0.0,1.0,0.0
Outpatients,1.0,0.0,0.0,0.0
Radiation therapy,0.0,0.0,0.0,1.0
Concordance,0.0,1.0,0.0,0.0
Common cause account,0.0,0.0,1.0,0.0
4-Aminopyridine,0.0,0.0,1.0,0.0
Mixture modelling,0.0,0.0,1.0,0.0
multiple concussions,0.0,1.0,0.0,0.0
Methylxanthine,0.0,1.0,0.0,0.0
Auditory attention demanding task,0.0,0.0,1.0,0.0
Lexical integrity,0.0,1.0,0.0,0.0
nonselective processing,0.0,1.0,0.0,0.0
Positive versus negative cues,1.0,0.0,0.0,0.0
Target feature,1.0,0.0,0.0,0.0
Car following,0.0,0.0,0.0,1.0
Global rating scale,0.0,1.0,0.0,0.0
millennials,0.0,0.0,1.0,0.0
Gonadal steroid hormones,1.0,0.0,0.0,0.0
liberal acceptance,1.0,0.0,0.0,0.0
Child assessment,1.0,0.0,0.0,0.0
Cognitive effect,0.0,0.0,1.0,0.0
Neglect therapy,0.0,0.0,1.0,0.0
Interference effects,0.0,0.0,1.0,0.0
Synthetic faces,1.0,0.0,0.0,0.0
Ingestive behavior,0.0,0.0,1.0,0.0
City branding,0.0,0.0,1.0,0.0
SVD,0.0,0.0,1.0,0.0
Open field test,0.0,1.0,0.0,0.0
SVM,1.0,0.0,0.0,0.0
Yarbus,0.0,0.0,1.0,0.0
Temporal context memory,0.0,0.0,1.0,0.0
Face cues,0.0,0.0,1.0,0.0
Symptomatic congenital cytomegalovirus infection,0.0,0.0,1.0,0.0
Subjective cognition,0.0,0.0,1.0,0.0
Interferon beta-1b,0.0,0.0,0.0,1.0
Mullen,0.0,0.0,1.0,0.0
Primary auditory area,0.0,1.0,0.0,0.0
vascular dementia,0.0,1.0,0.0,0.0
Neurocognitive models of synaesthesia,1.0,0.0,0.0,0.0
Looking behavior,0.0,0.0,1.0,0.0
Creative problem solving,0.0,0.0,1.0,0.0
antihistamine,0.0,1.0,0.0,0.0
Structure mapping,0.0,1.0,0.0,0.0
Mindset,1.0,0.0,0.0,0.0
patient-relevant outcomes,0.0,1.0,0.0,0.0
Radial maze,0.0,0.0,1.0,0.0
Object substitution,0.0,1.0,0.0,0.0
Viewing time,0.0,0.0,1.0,0.0
Zonisamide,1.0,0.0,0.0,0.0
Caf/restaurant,0.0,0.0,1.0,0.0
Judgment and decision making,0.0,0.0,1.0,0.0
Sequential instruction,0.0,0.0,0.0,1.0
vigilance-avoidance,0.0,1.0,0.0,0.0
Size congruency,0.0,0.0,1.0,0.0
Coloration,0.0,0.0,1.0,0.0
Subjective symptoms,0.0,0.0,1.0,0.0
Performance matching,0.0,0.0,1.0,0.0
Cognitive impenetrability,0.0,1.0,0.0,0.0
migraine with aura,0.0,0.0,1.0,0.0
Non-word reading,0.0,0.0,1.0,0.0
Organ donation,0.0,0.0,1.0,0.0
Behavioural problems,0.0,0.0,1.0,0.0
Typical antipsychotics,0.0,1.0,0.0,0.0
Libet,1.0,0.0,0.0,0.0
ants,0.0,1.0,0.0,0.0
Cat V2,1.0,0.0,0.0,0.0
Kinematic specification of dynamics,0.0,0.0,0.0,1.0
Driving space,0.0,0.0,0.0,1.0
Obstacle,0.0,0.0,0.0,1.0
Reactance,1.0,0.0,0.0,0.0
deduction,0.0,0.0,1.0,0.0
WWW,0.0,0.0,1.0,0.0
prenatal learning,0.0,0.0,1.0,0.0
Experiental avoidance,0.0,0.0,1.0,0.0
Probiotics,0.0,0.0,1.0,0.0
medically impaired drivers,1.0,0.0,0.0,0.0
object identification,1.0,0.0,0.0,0.0
Learning by imitation,0.0,0.0,1.0,0.0
Motor speech disorders,0.0,1.0,0.0,0.0
Differential outcomes,0.0,1.0,0.0,0.0
Contour grouping,0.0,0.0,1.0,0.0
affecting,0.0,0.0,1.0,0.0
Sleep regulation,0.0,0.0,1.0,0.0
Simple Reaction Time Test,0.0,1.0,0.0,0.0
verbs,0.0,0.0,1.0,0.0
Behavior therapy,1.0,0.0,0.0,0.0
P100 ERP,1.0,0.0,0.0,0.0
Salience models,1.0,0.0,0.0,0.0
Prebiotics,0.0,0.0,1.0,0.0
man-machine systems,0.0,0.0,1.0,0.0
Dms48,0.0,1.0,0.0,0.0
Workforce and workload,0.0,0.0,1.0,0.0
Cognitive disorders polymorphism,0.0,1.0,0.0,0.0
atomoxetine,1.0,0.0,0.0,0.0
Distress,0.0,0.0,1.0,0.0
In-vivo MRI,0.0,0.0,1.0,0.0
Silhouette design,0.0,0.0,1.0,0.0
Earthquake,0.0,0.0,1.0,0.0
Visuospatial sketchpad,0.0,0.0,0.0,1.0
Spatial contexts,0.0,1.0,0.0,0.0
Hurricane Katrina,0.0,0.0,0.0,1.0
Reflection-impulsivity,0.0,0.0,1.0,0.0
Verb processing,0.0,1.0,0.0,0.0
Simultaneous fMRI and EEG,0.0,0.0,0.0,1.0
cohort studies,0.0,1.0,0.0,0.0
Portuguese,0.0,0.0,1.0,0.0
perceptual salience,0.0,1.0,0.0,0.0
Heterotopic,0.0,0.0,0.0,1.0
Visual brain,0.0,0.0,1.0,0.0
functional recovery,0.0,1.0,0.0,0.0
Reading time measures,0.0,0.0,1.0,0.0
Large-scale simulation,1.0,0.0,0.0,0.0
Sexual Dysfunction,0.0,0.0,1.0,0.0
Multidimensional space,1.0,0.0,0.0,0.0
Knowledge acquisition,0.0,1.0,0.0,0.0
Letters perception,0.0,0.0,1.0,0.0
search strategy,0.0,0.0,1.0,0.0
Lexical extension,0.0,1.0,0.0,0.0
Risk-taking,1.0,0.0,0.0,0.0
potentially driver-impairing medications,1.0,0.0,0.0,0.0
savant,0.0,0.0,1.0,0.0
Reelin,0.0,1.0,0.0,0.0
Inhibitory motor area,0.0,1.0,0.0,0.0
Vascular disorders,0.0,0.0,0.0,1.0
Synaptic proteins,1.0,0.0,0.0,0.0
Amenorrhea,0.0,0.0,1.0,0.0
Dual stream model,1.0,0.0,0.0,0.0
Canopy orientation,0.0,0.0,1.0,0.0
QLQ-C30,0.0,1.0,0.0,0.0
lacunar infarct,0.0,0.0,1.0,0.0
growth differentiation factor-15,0.0,0.0,1.0,0.0
Radial diffusivity,1.0,0.0,0.0,0.0
Spectral resolution,1.0,0.0,0.0,0.0
D-Cycloserine,0.0,0.0,1.0,0.0
support vector machines,0.0,1.0,0.0,0.0
Virchow-Robin spaces (VRS),1.0,0.0,0.0,0.0
Performance-based iadl,0.0,0.0,1.0,0.0
physical navigation,0.0,0.0,1.0,0.0
Obsessivecompulsive disorder,0.0,1.0,0.0,0.0
Selective gating,0.0,0.0,1.0,0.0
Free and cued reminding test (16 items),0.0,1.0,0.0,0.0
Visual sensitivity,0.0,0.0,1.0,0.0
Disadvantaged children,0.0,0.0,1.0,0.0
Attention-deficit disorder with hyperactivity,0.0,0.0,1.0,0.0
CATSYS,0.0,1.0,0.0,0.0
Bypass coronary surgery,0.0,0.0,1.0,0.0
VO<inf>2</inf> max,0.0,1.0,0.0,0.0
brain volumetry,0.0,0.0,1.0,0.0
midlife,0.0,0.0,0.0,1.0
Beetroot,0.0,0.0,1.0,0.0
Cognitive Function,1.0,0.0,0.0,0.0
Computer work,0.0,0.0,0.0,1.0
Uni-hemispheric sleep,1.0,0.0,0.0,0.0
BPVS-II,0.0,0.0,1.0,0.0
HIV dementia,0.0,0.0,1.0,0.0
postoperative cognitive impairment,1.0,0.0,0.0,0.0
Face aftereffects,0.0,0.0,0.0,1.0
Equivalent current dipole,0.0,1.0,0.0,0.0
Birth size,0.0,1.0,0.0,0.0
Power Generator,1.0,0.0,0.0,0.0
Community intervention,0.0,1.0,0.0,0.0
insomnia,1.0,0.0,0.0,0.0
Cockpit displays,0.0,0.0,0.0,1.0
SS-13BN,0.0,1.0,0.0,0.0
film databases,0.0,0.0,1.0,0.0
Wake up,0.0,1.0,0.0,0.0
High resolution,0.0,1.0,0.0,0.0
event-related desynchronization/event-related synchronization,0.0,0.0,0.0,1.0
attraction,0.0,0.0,1.0,0.0
Perceptual skills,1.0,0.0,0.0,0.0
Postural threat,1.0,0.0,0.0,0.0
Information volume,0.0,0.0,0.0,1.0
Safety behavior,1.0,0.0,0.0,0.0
quiet standing,0.0,0.0,0.0,1.0
High-resolution EEG,1.0,0.0,0.0,0.0
Mental load,0.0,1.0,0.0,0.0
Thalamostriatal,0.0,1.0,0.0,0.0
Executive process,0.0,1.0,0.0,0.0
Catching,0.0,1.0,0.0,0.0
Scene-object identification,1.0,0.0,0.0,0.0
Social evaluation,0.0,0.0,1.0,0.0
Term born,0.0,1.0,0.0,0.0
Mendelian randomization,0.0,1.0,0.0,0.0
communication disorders,0.0,0.0,0.0,1.0
Cognitive mechanisms,0.0,0.0,1.0,0.0
Medical comorbidity and cognitive impairment,0.0,1.0,0.0,0.0
AZdsocial science480,0.0,1.0,0.0,0.0
Single Source Hypothesis,0.0,1.0,0.0,0.0
Cd-lifescience level,0.0,0.0,1.0,0.0
Seasonal food distribution,0.0,0.0,1.0,0.0
Fragile visual short-term memory,0.0,0.0,1.0,0.0
structured models,0.0,1.0,0.0,0.0
nonverbal deception cues,0.0,0.0,1.0,0.0
Early intervention,1.0,0.0,0.0,0.0
Spine density,0.0,0.0,1.0,0.0
Desvenlafaxine,0.0,1.0,0.0,0.0
head cooling,0.0,0.0,1.0,0.0
Rhythmic movement coordination,1.0,0.0,0.0,0.0
duality,1.0,0.0,0.0,0.0
Emergent reading,0.0,1.0,0.0,0.0
mitochondrial myopathy,0.0,0.0,1.0,0.0
civilian casualties,1.0,0.0,0.0,0.0
Internal visual imagery,0.0,0.0,1.0,0.0
Epidemiological data,1.0,0.0,0.0,0.0
Multi-modal working memory,1.0,0.0,0.0,0.0
Perceptual discrimination,0.0,1.0,0.0,0.0
Neck muscle vibration,0.0,1.0,0.0,0.0
Protective clothing,1.0,0.0,0.0,0.0
Negative attributional style,0.0,1.0,0.0,0.0
Task relevancy,0.0,0.0,1.0,0.0
History of success and failure,0.0,1.0,0.0,0.0
Vagus nerve,0.0,0.0,1.0,0.0
Total Volatile Organic Compound (TVOC),1.0,0.0,0.0,0.0
Neuronal synchrony,0.0,1.0,0.0,0.0
Acute tolerance,0.0,0.0,1.0,0.0
facial judgments,0.0,0.0,1.0,0.0
Ictal fear,0.0,0.0,1.0,0.0
chromosome 13q deletion,0.0,0.0,1.0,0.0
Behavior-based connectivity analysis,0.0,0.0,1.0,0.0
Right anterior insula,0.0,0.0,1.0,0.0
BPSD,0.0,0.0,1.0,0.0
Research priority,0.0,1.0,0.0,0.0
Animal signals,0.0,0.0,1.0,0.0
radiation damage,1.0,0.0,0.0,0.0
Visuo-motor priming,0.0,0.0,0.0,1.0
imprinting,0.0,1.0,0.0,0.0
Competition and cooperation,0.0,0.0,0.0,1.0
cognition-based teaching,0.0,0.0,1.0,0.0
Cognitive control and automaticity,0.0,1.0,0.0,0.0
Time-out in basketball,0.0,1.0,0.0,0.0
Chronic treatment,0.0,1.0,0.0,0.0
Healthy humans,0.0,1.0,0.0,0.0
Pictureword interference task,0.0,1.0,0.0,0.0
Vestibular training,0.0,1.0,0.0,0.0
Post-Concussion Syndrome,0.0,1.0,0.0,0.0
Source location,0.0,1.0,0.0,0.0
String task,1.0,0.0,0.0,0.0
Temporal modulation,0.0,0.0,1.0,0.0
Hand use,0.0,0.0,1.0,0.0
concept definition,0.0,0.0,1.0,0.0
Premature/very-low-birth-weight children,1.0,0.0,0.0,0.0
Tau imaging,0.0,0.0,1.0,0.0
Vertical symmetry axis,1.0,0.0,0.0,0.0
Perceived need,0.0,0.0,1.0,0.0
Auditory comprehension,0.0,1.0,0.0,0.0
Preschool Age,1.0,0.0,0.0,0.0
Resemblance,0.0,1.0,0.0,0.0
Distaste,0.0,1.0,0.0,0.0
Gun focus,1.0,0.0,0.0,0.0
Chronic stroke,0.0,1.0,0.0,0.0
Congenital lesions,0.0,0.0,1.0,0.0
Local coherence,0.0,0.0,1.0,0.0
SVM-RFE,1.0,0.0,0.0,0.0
Experimental paradigm,1.0,0.0,0.0,0.0
ATR-N interpersonal-neurobiology,0.0,1.0,0.0,0.0
cognitive informatics,0.0,0.0,1.0,0.0
Color comparison,0.0,0.0,1.0,0.0
Conservative treatment,1.0,0.0,0.0,0.0
Prospective cohort study,0.0,0.0,1.0,0.0
EEG/ERPs,0.0,1.0,0.0,0.0
Driving aptitude,0.0,0.0,1.0,0.0
Get-up-and-go test,1.0,0.0,0.0,0.0
MARC effect,1.0,0.0,0.0,0.0
facial self-awareness,0.0,0.0,1.0,0.0
Nystagmus,0.0,0.0,1.0,0.0
Figural stimulation,0.0,0.0,1.0,0.0
Auditory ERP,0.0,0.0,1.0,0.0
Face learning,0.0,1.0,0.0,0.0
skill acquisition,0.0,0.0,0.0,1.0
Idiopathic NPH,0.0,1.0,0.0,0.0
Infant social cognition,0.0,0.0,1.0,0.0
Leads selection,0.0,1.0,0.0,0.0
Pan troglodytes verus,0.0,0.0,1.0,0.0
SLAG,0.0,0.0,1.0,0.0
hemisphere,0.0,0.0,1.0,0.0
Column,0.0,0.0,1.0,0.0
Approaches,0.0,0.0,1.0,0.0
Optic tectum,0.0,0.0,1.0,0.0
Neuroimaging studies,0.0,0.0,1.0,0.0
Gaze cuing,0.0,0.0,1.0,0.0
Synchrostate,1.0,0.0,0.0,0.0
Periorbital infantile hemangioma,0.0,1.0,0.0,0.0
Flanker compatibility effect,0.0,1.0,0.0,0.0
Clinical disorganization,1.0,0.0,0.0,0.0
Signal enhancement,0.0,1.0,0.0,0.0
Neurophysiological models,0.0,1.0,0.0,0.0
Visual Association Memory Test,0.0,1.0,0.0,0.0
multisensory processes,0.0,1.0,0.0,0.0
Frontal-lobe syndorome,1.0,0.0,0.0,0.0
Infants' attention to object parts,0.0,0.0,0.0,1.0
Perceived workload,0.0,0.0,0.0,1.0
Visual rhyming task,0.0,0.0,1.0,0.0
Misuse,1.0,0.0,0.0,0.0
Laterality judgment,0.0,0.0,1.0,0.0
Frontal-subcortical circuits,1.0,0.0,0.0,0.0
Nonmotor signs,0.0,0.0,0.0,1.0
Retrieval space,0.0,1.0,0.0,0.0
Visual knowledge,1.0,0.0,0.0,0.0
Semantic representations,0.0,1.0,0.0,0.0
Self-perspective,0.0,0.0,1.0,0.0
Vestibuloocular reflex suppression,0.0,1.0,0.0,0.0
Naming deficits,0.0,1.0,0.0,0.0
Aesthetic judgements,0.0,0.0,1.0,0.0
metagenomic sequencing,0.0,1.0,0.0,0.0
Magnitude estimation,0.0,0.0,0.0,1.0
High-density ERPs,0.0,0.0,0.0,1.0
abuse liability,0.0,0.0,1.0,0.0
New Zealand,1.0,0.0,0.0,0.0
Verbal processing,0.0,0.0,0.0,1.0
visual analogue scales,1.0,0.0,0.0,0.0
Mindblindness,0.0,1.0,0.0,0.0
Augmented reality (AR),1.0,0.0,0.0,0.0
Orthographic typicality,0.0,0.0,1.0,0.0
Post-concussion symptoms scale,0.0,0.0,1.0,0.0
adaptive behavior,0.0,0.0,1.0,0.0
Lexical boost,1.0,0.0,0.0,0.0
caregiver,1.0,0.0,0.0,0.0
Multivariate autoregressive models,0.0,1.0,0.0,0.0
Stages of operative rest,1.0,0.0,0.0,0.0
Scottish mental survey,0.0,1.0,0.0,0.0
Political attitudes,1.0,0.0,0.0,0.0
Parallel competition,0.0,0.0,1.0,0.0
Methyl mercury,0.0,1.0,0.0,0.0
Latency variation,0.0,0.0,0.0,1.0
Visual association areas,0.0,0.0,0.0,1.0
Withdrawal delirium,0.0,0.0,1.0,0.0
Dorsal tegmental nucleus,0.0,1.0,0.0,0.0
Novelty processing,0.0,0.0,1.0,0.0
Brain activations,0.0,1.0,0.0,0.0
Lateralized readiness potential (LRP),1.0,0.0,0.0,0.0
Noun-verb dissociation,0.0,1.0,0.0,0.0
White matter tracts,0.0,1.0,0.0,0.0
Canonical variates,1.0,0.0,0.0,0.0
Antiretroviral therapy,1.0,0.0,0.0,0.0
Egocentrism,0.0,0.0,1.0,0.0
Patient H.M,1.0,0.0,0.0,0.0
Vertebral fracture,1.0,0.0,0.0,0.0
Haptic interfaces,0.0,0.0,1.0,0.0
Cross-sectional studies,0.0,1.0,0.0,0.0
Contralateral hippocampus atrophy,0.0,0.0,1.0,0.0
American crow,1.0,0.0,0.0,0.0
Klinefelter syndrome,0.0,1.0,0.0,0.0
Driving while impaired,0.0,1.0,0.0,0.0
Functional neuroanatomy,0.0,1.0,0.0,0.0
Lewy pathology,0.0,0.0,1.0,0.0
Concrete,0.0,0.0,0.0,1.0
Peer knowledge modeling,0.0,0.0,1.0,0.0
diffusion model,0.0,0.0,1.0,0.0
hospitalized,1.0,0.0,0.0,0.0
Mothers,0.0,1.0,0.0,0.0
Modality-independent,0.0,0.0,1.0,0.0
Fronto-striatal networks,0.0,1.0,0.0,0.0
Femoral neck fracture,0.0,1.0,0.0,0.0
Theta wave,0.0,0.0,1.0,0.0
Navigational ability,0.0,0.0,0.0,1.0
Preference decision,0.0,0.0,0.0,1.0
communication aids,0.0,0.0,1.0,0.0
Numeric distance effect,0.0,1.0,0.0,0.0
Context-dependent reasoning,0.0,0.0,0.0,1.0
Unilateral,0.0,0.0,1.0,0.0
Complex figure,0.0,0.0,1.0,0.0
Affect processing,0.0,1.0,0.0,0.0
interpersonal influence and interpersonal adjustment,0.0,1.0,0.0,0.0
Space perception/physiology,0.0,0.0,1.0,0.0
Anti-correlated networks,0.0,0.0,1.0,0.0
: Austin Maze,0.0,0.0,1.0,0.0
Computerized analysis,0.0,0.0,1.0,0.0
score,0.0,0.0,1.0,0.0
Negative emotions,1.0,0.0,0.0,0.0
Homophonic,1.0,0.0,0.0,0.0
Smartphone applications,0.0,0.0,1.0,0.0
Children's spatial situation models,1.0,0.0,0.0,0.0
Posterior medial cortex (PMC),1.0,0.0,0.0,0.0
Pure sensory stroke,0.0,0.0,1.0,0.0
Multivariate data analysis,0.0,1.0,0.0,0.0
Error self-regulation,0.0,1.0,0.0,0.0
Inference-making processes,0.0,1.0,0.0,0.0
computational model,1.0,0.0,0.0,0.0
Ekman 60-Faces Test,1.0,0.0,0.0,0.0
Dissociative identity disorder,0.0,0.0,1.0,0.0
Discourse linking,0.0,0.0,1.0,0.0
Positive pictures,0.0,0.0,0.0,1.0
Chronic shoulder pain,0.0,0.0,1.0,0.0
Extramaze cues,0.0,0.0,1.0,0.0
Developmental disorder,0.0,0.0,1.0,0.0
self control,0.0,0.0,1.0,0.0
Automatic attitudes,0.0,1.0,0.0,0.0
Divided visual field paradigm,0.0,1.0,0.0,0.0
functional limitation,0.0,1.0,0.0,0.0
Dot-probe,0.0,0.0,1.0,0.0
Brodmann area 39,0.0,0.0,1.0,0.0
Cognitive-behavioral,1.0,0.0,0.0,0.0
Local visual processing,0.0,1.0,0.0,0.0
attachment style,0.0,1.0,0.0,0.0
Parasitosis,0.0,1.0,0.0,0.0
cognitive set and its stages,1.0,0.0,0.0,0.0
Inflammatory bowel,0.0,1.0,0.0,0.0
Categorization behavior,0.0,1.0,0.0,0.0
Direct perception,0.0,0.0,1.0,0.0
goal-directed behaviour,0.0,0.0,1.0,0.0
toddlers,1.0,0.0,0.0,0.0
Dumitru St?niloae,1.0,0.0,0.0,0.0
Blint syndrome,0.0,0.0,1.0,0.0
Animate-inanimate distinction,0.0,0.0,0.0,1.0
ACT-R architecture,0.0,1.0,0.0,0.0
Names,0.0,1.0,0.0,0.0
Real-time drawing,1.0,0.0,0.0,0.0
Subacute sclerosing panencephalitis,0.0,0.0,1.0,0.0
Psychodynamic assessment,0.0,1.0,0.0,0.0
Theta frequency band,0.0,0.0,1.0,0.0
inhibition of return,0.0,0.0,1.0,0.0
Verbal reasoning",0.0,0.0,1.0,0.0
community-dwelling older adults,0.0,0.0,1.0,0.0
Broca's region,1.0,0.0,0.0,0.0
Sensory abnormalities,1.0,0.0,0.0,0.0
cognitive screening tool,0.0,0.0,1.0,0.0
Cranial nerve,0.0,1.0,0.0,0.0
Cerebellar signs,0.0,1.0,0.0,0.0
Mirror self-recognition,0.0,1.0,0.0,0.0
cognitive complaints,0.0,0.0,1.0,0.0
Navon letter,0.0,1.0,0.0,0.0
Cross-cultural/minority,0.0,0.0,0.0,1.0
Methadone maintenance,1.0,0.0,0.0,0.0
Certain cues,0.0,0.0,0.0,1.0
Number notation,0.0,0.0,1.0,0.0
5-HT 6,0.0,0.0,1.0,0.0
Remember/know,0.0,0.0,1.0,0.0
Diesel pollutant,1.0,0.0,0.0,0.0
Emotional inhibition,0.0,0.0,0.0,1.0
Movement selection,0.0,1.0,0.0,0.0
IADL,0.0,0.0,1.0,0.0
Whole body choice reaction time chronoscopic reading 1 (WBCRT C1),0.0,0.0,1.0,0.0
Attributional styles,0.0,0.0,0.0,1.0
Illusory perceptions,0.0,0.0,1.0,0.0
Abstract art,0.0,1.0,0.0,0.0
Hormone replacement therapy,0.0,0.0,0.0,1.0
Saccharides,1.0,0.0,0.0,0.0
Axial motor symptoms,1.0,0.0,0.0,0.0
spotted hyaena,0.0,0.0,1.0,0.0
Immunomagnetic reduction,1.0,0.0,0.0,0.0
Human machine interaction,0.0,0.0,1.0,0.0
Vestibular neuritis,0.0,1.0,0.0,0.0
cardiovascular disease risk,1.0,0.0,0.0,0.0
fMRI BOLD,0.0,1.0,0.0,0.0
Alcohol Abuse,0.0,0.0,1.0,0.0
Embodied social cognition,0.0,0.0,1.0,0.0
Sinistral,1.0,0.0,0.0,0.0
Fossa cerebral tumor,0.0,0.0,1.0,0.0
Post-parietal cortex,0.0,0.0,1.0,0.0
rapid serial visual presentation time,0.0,0.0,1.0,0.0
Self report,0.0,0.0,1.0,0.0
Magnetic resonance perfusion weighted imaging,0.0,0.0,1.0,0.0
active processing,0.0,0.0,1.0,0.0
displacement,0.0,1.0,0.0,0.0
synucleinopathy,0.0,0.0,1.0,0.0
Race model inequality,0.0,0.0,1.0,0.0
Self-figure drawing,0.0,0.0,1.0,0.0
Pre-pulse inhibition,0.0,0.0,0.0,1.0
Lifetime course,0.0,0.0,1.0,0.0
Visual occlusion,0.0,0.0,0.0,1.0
Telencephalon,1.0,0.0,0.0,0.0
Neuronal migration,0.0,1.0,0.0,0.0
Complementary and alternative medicine (CAM),1.0,0.0,0.0,0.0
Tursiops,1.0,0.0,0.0,0.0
Cognitive-behavioural therapy,0.0,0.0,1.0,0.0
"Approximate arithmetic,0.0,0.0,0.0,0.0
marijuana dependence,0.0,0.0,1.0,0.0
Emotional status,0.0,1.0,0.0,0.0
Temporally asymmetric Hebbian learning,0.0,0.0,1.0,0.0
Validity indicators,0.0,0.0,1.0,0.0
Interdisciplinary networks,0.0,0.0,1.0,0.0
Center of Pressure,0.0,0.0,1.0,0.0
Particulate matter,0.0,0.0,1.0,0.0
perceptual quality,0.0,0.0,1.0,0.0
Frame rate,0.0,0.0,1.0,0.0
Experimentation,0.0,1.0,0.0,0.0
Healing environments,0.0,0.0,1.0,0.0
Environmental cues,1.0,0.0,0.0,0.0
Pre-attentional processing,0.0,0.0,1.0,0.0
hyper-self,0.0,0.0,1.0,0.0
Day care,0.0,0.0,1.0,0.0
Phosphene,0.0,0.0,1.0,0.0
Postnatal exposure,0.0,1.0,0.0,0.0
Classification (cognitive process),0.0,1.0,0.0,0.0
Naji al-Ali,0.0,0.0,1.0,0.0
Respiratory sinus arrhythmia (RSA),0.0,0.0,1.0,0.0
The fine-coarse semantic coding theory,0.0,0.0,1.0,0.0
Feature-based,0.0,0.0,0.0,1.0
picture-based retrieval task,1.0,0.0,0.0,0.0
Three-dimensional spatial cognition,0.0,1.0,0.0,0.0
DPN,1.0,0.0,0.0,0.0
UNIVERSALISM,1.0,0.0,0.0,0.0
Reality,0.0,0.0,1.0,0.0
category-adjustment model,0.0,0.0,0.0,1.0
Control law,1.0,0.0,0.0,0.0
Maternal epilepsy,0.0,0.0,1.0,0.0
Neurodevelopmental outcomes,0.0,0.0,1.0,0.0
Coordinate,0.0,0.0,1.0,0.0
Bifrontal approach,0.0,0.0,0.0,1.0
Neurocognitive Test,0.0,0.0,1.0,0.0
Functional connectivity fMRI,0.0,1.0,0.0,0.0
reconnection,0.0,0.0,1.0,0.0
Induced mood,0.0,1.0,0.0,0.0
Vulnerability indicator,1.0,0.0,0.0,0.0
Adjuvant treatment,0.0,0.0,0.0,1.0
Georgia gambling task,1.0,0.0,0.0,0.0
Ocular dominance,0.0,1.0,0.0,0.0
Functional food,0.0,1.0,0.0,0.0
elite coach,0.0,1.0,0.0,0.0
military,0.0,0.0,1.0,0.0
Ag(e)ing,1.0,0.0,0.0,0.0
hearing loss,1.0,0.0,0.0,0.0
Needle liver biopsy,0.0,1.0,0.0,0.0
visual rating,1.0,0.0,0.0,0.0
Contrafreeloading,0.0,1.0,0.0,0.0
Self-best-fit,1.0,0.0,0.0,0.0
foldable iris-fixated lens,0.0,0.0,0.0,1.0
interdependent,0.0,1.0,0.0,0.0
Spatial data mining,0.0,1.0,0.0,0.0
Mini-Emotional State Examination,0.0,0.0,1.0,0.0
feminist technoscience studies,1.0,0.0,0.0,0.0
Principal component analysis (PCA),0.0,0.0,1.0,0.0
Hockey,0.0,0.0,1.0,0.0
Scree,0.0,0.0,0.0,1.0
Infant cognition Michotte,1.0,0.0,0.0,0.0
Bender visual-motor Gestalt test,0.0,0.0,0.0,1.0
Human algorithms,1.0,0.0,0.0,0.0
age-related cognitive decline,0.0,1.0,0.0,0.0
Number series,0.0,0.0,0.0,1.0
Cocktail-party effect,0.0,1.0,0.0,0.0
CGMP,0.0,1.0,0.0,0.0
Resection,0.0,1.0,0.0,0.0
Mainz Severity Score Index (MSSI),0.0,1.0,0.0,0.0
Delayed sleep phase syndrome,0.0,0.0,1.0,0.0
object-substitution masking,0.0,0.0,0.0,1.0
patient-centered care,0.0,1.0,0.0,0.0
Per 2,0.0,0.0,1.0,0.0
Lifetime exposure,1.0,0.0,0.0,0.0
Chronic solvent-induced encephalopathy,0.0,1.0,0.0,0.0
Pairwise comparison,0.0,0.0,1.0,0.0
Sagittal synostosis,1.0,0.0,0.0,0.0
Time-sharing,0.0,1.0,0.0,0.0
Early vision,0.0,0.0,1.0,0.0
coupling,1.0,0.0,0.0,0.0
Signal to respond procedure,0.0,1.0,0.0,0.0
susceptibility-weighted imaging,0.0,1.0,0.0,0.0
Future,0.0,1.0,0.0,0.0
Maternal vitamin B12 status,0.0,1.0,0.0,0.0
motor processes,0.0,1.0,0.0,0.0
Substance consumption,1.0,0.0,0.0,0.0
Fabricated evidence,1.0,0.0,0.0,0.0
Heuristic perspective,0.0,1.0,0.0,0.0
Trauma symptoms,1.0,0.0,0.0,0.0
Fourier transformation,0.0,1.0,0.0,0.0
oxidative stress,1.0,0.0,0.0,0.0
FDG PET,1.0,0.0,0.0,0.0
Caregiver burden,0.0,1.0,0.0,0.0
visually evoked potential,0.0,0.0,1.0,0.0
Hospital incident reporting,0.0,0.0,1.0,0.0
Spatial information,0.0,0.0,1.0,0.0
Execution,1.0,0.0,0.0,0.0
Sensory-motor abilities,0.0,1.0,0.0,0.0
Choropleth maps,0.0,0.0,0.0,1.0
Multilingual,0.0,0.0,1.0,0.0
transfer,0.0,1.0,0.0,0.0
Exertion,0.0,0.0,1.0,0.0
Benign epileptiform spikes in children,0.0,0.0,1.0,0.0
Semantic access,1.0,0.0,0.0,0.0
Bereitshaftspotential,0.0,0.0,1.0,0.0
Genotype-phenotype correlations,0.0,0.0,1.0,0.0
Experience-dependent behavior,0.0,0.0,1.0,0.0
Test of Bell inequality for mental states,0.0,0.0,1.0,0.0
Health benefits,0.0,0.0,1.0,0.0
Conscious experience,0.0,0.0,1.0,0.0
attention resource theory,0.0,1.0,0.0,0.0
Realistic painting,0.0,1.0,0.0,0.0
dysbindin,0.0,0.0,1.0,0.0
event-related brain potential (ERP),0.0,1.0,0.0,0.0
Auditory oddball paradigm,0.0,0.0,0.0,1.0
Motor streams,0.0,1.0,0.0,0.0
Meningioma,0.0,0.0,0.0,1.0
Prospective studies,0.0,0.0,0.0,1.0
older adult drivers,1.0,0.0,0.0,0.0
Pretense comprehension,0.0,1.0,0.0,0.0
Digital signage,1.0,0.0,0.0,0.0
Antennal lobes,0.0,1.0,0.0,0.0
item and test information,0.0,0.0,1.0,0.0
Frontal EEG asymmetry,1.0,0.0,0.0,0.0
Mothers' estimates,0.0,0.0,1.0,0.0
case-control study,0.0,0.0,1.0,0.0
Noben,0.0,1.0,0.0,0.0
Computer-Aided Diagnosis,0.0,1.0,0.0,0.0
Spatial image,0.0,0.0,1.0,0.0
Dynamical causal modeling,1.0,0.0,0.0,0.0
Event integration,0.0,1.0,0.0,0.0
Secondary reinforcement,0.0,1.0,0.0,0.0
Psychophysiological measurements,1.0,0.0,0.0,0.0
Higher-level cognitive processing,0.0,0.0,0.0,1.0
Assistant referees,0.0,1.0,0.0,0.0
Compulsive behaviour,0.0,0.0,1.0,0.0
Species effect,0.0,1.0,0.0,0.0
Conformity,0.0,1.0,0.0,0.0
Subliminal stimulation,0.0,0.0,1.0,0.0
Right functional hemispherectomy,1.0,0.0,0.0,0.0
Familial hemiplegic migraine,0.0,1.0,0.0,0.0
Purdue,0.0,0.0,1.0,0.0
Paced auditory serial addition task,0.0,0.0,1.0,0.0
Medetomidine,0.0,1.0,0.0,0.0
Environmental contaminants,0.0,1.0,0.0,0.0
Arterial spin labelling,0.0,1.0,0.0,0.0
Levels of categorization,1.0,0.0,0.0,0.0
High gamma-band activity,0.0,1.0,0.0,0.0
Barrel cortex,1.0,0.0,0.0,0.0
Visual pictures,0.0,0.0,1.0,0.0
Chlorpyrifos,0.0,0.0,1.0,0.0
Mind/body problem,1.0,0.0,0.0,0.0
Ambiguous intention,0.0,0.0,1.0,0.0
coronary disease,1.0,0.0,0.0,0.0
interpretation bias,0.0,0.0,1.0,0.0
Extended endoscopic approach,0.0,0.0,1.0,0.0
Abstract stimulus relation-ships,0.0,1.0,0.0,0.0
IED,0.0,1.0,0.0,0.0
Task-based deactivation,1.0,0.0,0.0,0.0
Guilt,0.0,1.0,0.0,0.0
view matching,1.0,0.0,0.0,0.0
Subcortical coupling,0.0,0.0,1.0,0.0
Feature processing,0.0,0.0,0.0,1.0
genetic imaging,0.0,0.0,1.0,0.0
Intermittent,0.0,0.0,1.0,0.0
Arthroplasty,0.0,0.0,1.0,0.0
Locus of selection,0.0,0.0,0.0,1.0
Perception-action cycle,1.0,0.0,0.0,0.0
borderline personality disorder,0.0,0.0,1.0,0.0
Gamma and beta oscillations,0.0,0.0,0.0,1.0
Sternberg,1.0,0.0,0.0,0.0
False positives,0.0,0.0,1.0,0.0
Paraphrenia,1.0,0.0,0.0,0.0
Locomotor,0.0,0.0,1.0,0.0
Real world,1.0,0.0,0.0,0.0
Ongoing cognition,0.0,0.0,1.0,0.0
Steady-state visual evoked potential (SSVEP),0.0,1.0,0.0,0.0
Frontal variant,0.0,1.0,0.0,0.0
"Aging,0.0,0.0,0.0,0.0
LCC,0.0,1.0,0.0,0.0
Meta,1.0,0.0,0.0,0.0
Holocaust survivors,0.0,0.0,0.0,1.0
Inferior medial prefrontal cortex,0.0,0.0,1.0,0.0
Vector,0.0,0.0,1.0,0.0
body mass index.,0.0,0.0,0.0,1.0
Mid-cingulate cortex,0.0,0.0,1.0,0.0
isual cortex,1.0,0.0,0.0,0.0
Memory-guided pointing,0.0,0.0,1.0,0.0
Eccentric fixation,0.0,0.0,0.0,1.0
MTHFR polymorphism,0.0,0.0,1.0,0.0
instructional-design,0.0,0.0,1.0,0.0
Delayed-match-to-sample task,0.0,0.0,0.0,1.0
substance use disorders,0.0,1.0,0.0,0.0
Spatial recall,1.0,0.0,0.0,0.0
Visual detection task,0.0,1.0,0.0,0.0
ERN/Ne,0.0,0.0,1.0,0.0
Presbyphasia,0.0,1.0,0.0,0.0
Frontal executive function,0.0,0.0,1.0,0.0
Sleep apnoea,0.0,1.0,0.0,0.0
Lifestyle intervention,0.0,0.0,1.0,0.0
GPS,0.0,0.0,1.0,0.0
binocular disparity,0.0,0.0,1.0,0.0
Dementia caregiver,0.0,0.0,1.0,0.0
Body dissatisfaction,0.0,0.0,1.0,0.0
delayed-recall task,0.0,1.0,0.0,0.0
Perception system,0.0,0.0,1.0,0.0
peripheral and parafoveal vision,0.0,1.0,0.0,0.0
ZENK,0.0,1.0,0.0,0.0
Magnitude system,0.0,1.0,0.0,0.0
Neurocomputational models,0.0,1.0,0.0,0.0
Parietal-frontal network,0.0,0.0,1.0,0.0
sensory-motor model of semantic representations,0.0,0.0,1.0,0.0
Letter_encoding,0.0,0.0,0.0,1.0
Arm pointing,0.0,0.0,0.0,1.0
Dieters,0.0,1.0,0.0,0.0
fear,0.0,0.0,1.0,0.0
longevity,0.0,1.0,0.0,0.0
TOMM40,0.0,0.0,1.0,0.0
Image size,0.0,1.0,0.0,0.0
Immersive environment,1.0,0.0,0.0,0.0
Associative strength,0.0,1.0,0.0,0.0
Placebo effects,0.0,0.0,1.0,0.0
Event file,1.0,0.0,0.0,0.0
EEG-TMS combination,0.0,0.0,1.0,0.0
Plethodon shermani,0.0,1.0,0.0,0.0
Dyke-Davidoff-Masson syndrome,1.0,0.0,0.0,0.0
Cross-cultural differences,0.0,0.0,1.0,0.0
Hunter-gatherer,0.0,0.0,1.0,0.0
Rise-to-threshold model,0.0,0.0,0.0,1.0
Cognitive dysfunctions,0.0,0.0,1.0,0.0
Diffusion kurtosis imaging,1.0,0.0,0.0,0.0
Hyperimmunoglobulin E Syndrome,0.0,1.0,0.0,0.0
Prescription stimulant,1.0,0.0,0.0,0.0
Cooperative behavior tasks,0.0,1.0,0.0,0.0
Nonpharmacological intervention,1.0,0.0,0.0,0.0
Coordination disorder,0.0,1.0,0.0,0.0
Brain tumours,0.0,1.0,0.0,0.0
Pedaling,0.0,0.0,1.0,0.0
R.F.,0.0,1.0,0.0,0.0
Postoperative outcomes,0.0,1.0,0.0,0.0
Childhood brain tumors,0.0,1.0,0.0,0.0
Disengagement,0.0,1.0,0.0,0.0
anosognosia,0.0,1.0,0.0,0.0
experimental analogues of psychotic symptoms,0.0,0.0,1.0,0.0
Database,0.0,1.0,0.0,0.0
embodied transformation,0.0,0.0,1.0,0.0
Multivariate twin and family data analysis,0.0,0.0,1.0,0.0
Vicarious trial,1.0,0.0,0.0,0.0
Indexicality,0.0,1.0,0.0,0.0
Attitude measures,0.0,1.0,0.0,0.0
Stimulus-Response Compatability,0.0,0.0,0.0,1.0
embryonic cognition,0.0,0.0,1.0,0.0
Nociception,0.0,1.0,0.0,0.0
Opthalmoplegia,0.0,0.0,1.0,0.0
Nutrition assessment,0.0,1.0,0.0,0.0
Diving,0.0,0.0,1.0,0.0
Photorefraction,0.0,0.0,1.0,0.0
Statistical cognition,0.0,1.0,0.0,0.0
Partial least square,0.0,1.0,0.0,0.0
Standard Error of Measurement,0.0,0.0,1.0,0.0
Attention-deficit/ hyperactivity disorder,0.0,0.0,1.0,0.0
Tricyclic antidepressants,0.0,0.0,1.0,0.0
Threat detection,0.0,0.0,1.0,0.0
simulation of public speaking test,1.0,0.0,0.0,0.0
Cartoon,0.0,0.0,1.0,0.0
Cellular prion protein (PrPC),0.0,0.0,1.0,0.0
Response mechanism,0.0,0.0,1.0,0.0
Memory aids,0.0,1.0,0.0,0.0
Virtual Reality,0.0,0.0,0.0,1.0
Mirror box,0.0,1.0,0.0,0.0
Quality of care,0.0,0.0,1.0,0.0
Neurocognitive Tasks,0.0,0.0,1.0,0.0
Perceived affective qualities,0.0,0.0,1.0,0.0
Cognitive resource allocation,0.0,0.0,1.0,0.0
Antidepressant medications,0.0,1.0,0.0,0.0
Vienna Test System,0.0,0.0,1.0,0.0
Dystonia,1.0,0.0,0.0,0.0
Contrast effect,0.0,0.0,1.0,0.0
Clan corpus,0.0,0.0,1.0,0.0
Sound lateralization test,1.0,0.0,0.0,0.0
Kainic acid,0.0,0.0,0.0,1.0
Proportional analogy,0.0,0.0,1.0,0.0
Brain electrophysiology,0.0,0.0,1.0,0.0
vitamin D,0.0,1.0,0.0,0.0
Direct electrical stimulation,1.0,0.0,0.0,0.0
Metonymy,0.0,1.0,0.0,0.0
cognition enhancement,0.0,1.0,0.0,0.0
age stereotype,0.0,1.0,0.0,0.0
Selective inhibition,0.0,1.0,0.0,0.0
Antipsychotic treatment,0.0,0.0,1.0,0.0
Complex scene encoding,0.0,1.0,0.0,0.0
Image-guided surgery,0.0,1.0,0.0,0.0
Sysneuro,0.0,1.0,0.0,0.0
Affective psychoses,0.0,0.0,1.0,0.0
3D human factors,0.0,0.0,1.0,0.0
attentional networks,0.0,0.0,1.0,0.0
Lid removal,0.0,0.0,1.0,0.0
Japanese cedar pollinosis,1.0,0.0,0.0,0.0
Generality constraint,0.0,0.0,1.0,0.0
Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior (2009) Front. Neuroendocrinol.,0.0,0.0,1.0,0.0
2340,0.0,0.0,1.0,0.0
Visual reaction time,0.0,1.0,0.0,0.0
Schema,1.0,0.0,0.0,0.0
20 Hz rhythm,0.0,1.0,0.0,0.0
PSP,0.0,0.0,1.0,0.0
Visual co-orientation,0.0,0.0,1.0,0.0
information processing,0.0,0.0,1.0,0.0
Mix,0.0,0.0,1.0,0.0
Dizziness,1.0,0.0,0.0,0.0
naming test,0.0,1.0,0.0,0.0
opiates,1.0,0.0,0.0,0.0
Multimodal neuroimaging,0.0,0.0,0.0,1.0
nursing,0.0,1.0,0.0,0.0
Health services,0.0,1.0,0.0,0.0
Concurrent think aloud,0.0,0.0,1.0,0.0
Ventral attention network,0.0,0.0,1.0,0.0
Static posturography,0.0,0.0,1.0,0.0
Level of processing,0.0,1.0,0.0,0.0
Sketch-mapping technique,1.0,0.0,0.0,0.0
Instrumental conditioning,0.0,1.0,0.0,0.0
System WHERE,0.0,0.0,1.0,0.0
Reinforcement paradigm,0.0,1.0,0.0,0.0
Reflective/analytical thinking,0.0,0.0,1.0,0.0
Touch screen response,0.0,1.0,0.0,0.0
VlPFC,0.0,1.0,0.0,0.0
Functional magnetic resonance imaging-adaptation,0.0,0.0,1.0,0.0
Relational integration,0.0,0.0,1.0,0.0
Female mice,1.0,0.0,0.0,0.0
Shift-workers,0.0,0.0,0.0,1.0
Postural Deficiency Syndrome,0.0,0.0,0.0,1.0
Composer,0.0,0.0,1.0,0.0
High-jump photographs,0.0,1.0,0.0,0.0
Melodic contour,0.0,0.0,1.0,0.0
THOUGHTS,0.0,0.0,0.0,1.0
Anterior Cingulate Cortex,0.0,0.0,1.0,0.0
telephone testing,0.0,0.0,1.0,0.0
Group fMRI study,1.0,0.0,0.0,0.0
Clinical neuroimaging,0.0,0.0,1.0,0.0
Upright position,0.0,0.0,1.0,0.0
Spatial ability/cognition,1.0,0.0,0.0,0.0
Rapid automatised naming,0.0,1.0,0.0,0.0
Electro-encephalogram,0.0,0.0,1.0,0.0
Person-specific semantic knowledge,0.0,1.0,0.0,0.0
Facial EMG,0.0,1.0,0.0,0.0
health status,0.0,0.0,0.0,1.0
Competitive learning,0.0,1.0,0.0,0.0
Random-effects models,0.0,0.0,1.0,0.0
Wii Balance Board,0.0,1.0,0.0,0.0
View-based homing,0.0,0.0,1.0,0.0
spatial reference memory,0.0,0.0,1.0,0.0
Early negativity,0.0,0.0,1.0,0.0
Premorbid functioning,1.0,0.0,0.0,0.0
human vision,0.0,0.0,1.0,0.0
Hypertonic saline,0.0,0.0,1.0,0.0
amphetamine,0.0,0.0,1.0,0.0
Single domain amnesic mild cognitive impairment,0.0,0.0,1.0,0.0
bonding,0.0,1.0,0.0,0.0
Object-recognition memory,1.0,0.0,0.0,0.0
Anosognosia for hemiplegia,0.0,0.0,0.0,1.0
Auditory sensory memory,0.0,1.0,0.0,0.0
Face discrimination,1.0,0.0,0.0,0.0
lexical decision,1.0,0.0,0.0,0.0
Spatio-temporal processing,0.0,1.0,0.0,0.0
Philosophy of modeling,0.0,0.0,1.0,0.0
gesture imitation,0.0,0.0,1.0,0.0
Visual word perception,1.0,0.0,0.0,0.0
Monetary punishment,0.0,1.0,0.0,0.0
Performance status,1.0,0.0,0.0,0.0
?-opioid receptors,0.0,0.0,1.0,0.0
Delta waves,0.0,0.0,1.0,0.0
Mastication,0.0,1.0,0.0,0.0
Attention deficit/hyperactivity disorder (ADHD),0.0,0.0,1.0,0.0
Motion Planning,1.0,0.0,0.0,0.0
Microcog,0.0,0.0,1.0,0.0
Decentrism,1.0,0.0,0.0,0.0
Uncertain cues,0.0,0.0,0.0,1.0
Posterior STG,0.0,0.0,1.0,0.0
Sensation/Perception,1.0,0.0,0.0,0.0
A? Imaging,0.0,0.0,1.0,0.0
Spinal fusion,0.0,0.0,1.0,0.0
Emotional conflict,1.0,0.0,0.0,0.0
Cerebral asymmetry,0.0,0.0,0.0,1.0
Prejudice,0.0,0.0,1.0,0.0
Nectar,0.0,1.0,0.0,0.0
Object and substance,0.0,1.0,0.0,0.0
Molecular imaging,0.0,1.0,0.0,0.0
Acquired dyslexia,1.0,0.0,0.0,0.0
prurigo nodularis,1.0,0.0,0.0,0.0
Crashes,0.0,1.0,0.0,0.0
Recoding,0.0,0.0,1.0,0.0
Task battery,0.0,1.0,0.0,0.0
FMR1 gene,0.0,0.0,1.0,0.0
Aging-men,0.0,0.0,1.0,0.0
Pseudo-solution trap,0.0,1.0,0.0,0.0
cerebellar stroke,0.0,1.0,0.0,0.0
NAcc,0.0,0.0,0.0,1.0
Heaviness perception,0.0,0.0,0.0,1.0
Attention deficit,0.0,0.0,1.0,0.0
anti-endothelial cell antibodies,1.0,0.0,0.0,0.0
Language/Speech,0.0,1.0,0.0,0.0
Spatiotemporal,0.0,1.0,0.0,0.0
X-linked genetic disease,1.0,0.0,0.0,0.0
MicroCog,0.0,1.0,0.0,0.0
Performances,0.0,0.0,1.0,0.0
Acuity test,0.0,0.0,1.0,0.0
Cortical oscillations,1.0,0.0,0.0,0.0
Fitness relevance,0.0,0.0,1.0,0.0
T2 estimates,0.0,0.0,1.0,0.0
Natural menopause,0.0,0.0,0.0,1.0
Cancer treatment,0.0,0.0,1.0,0.0
Hebbian plasticity,0.0,0.0,0.0,1.0
Immediate postconcussion assessment and cognitive testing,0.0,0.0,1.0,0.0
Optotype,0.0,0.0,1.0,0.0
"Anxiety,0.0,0.0,0.0,0.0
Early Alzheimer's disease,0.0,0.0,1.0,0.0
nave physics,1.0,0.0,0.0,0.0
Performance level,0.0,1.0,0.0,0.0
Tuberculum sellae,0.0,1.0,0.0,0.0
Vestibular lesions,0.0,1.0,0.0,0.0
need for cognition,0.0,1.0,0.0,0.0
High-technology product,0.0,0.0,0.0,1.0
Platelet monoamine oxidase,1.0,0.0,0.0,0.0
Slow-cortical potentials (SCP),0.0,0.0,1.0,0.0
Memory for sequences of events,1.0,0.0,0.0,0.0
Representation translation,0.0,0.0,0.0,1.0
Exposure study,0.0,0.0,1.0,0.0
Visual sociology,0.0,0.0,0.0,1.0
Cortical midline structures,0.0,0.0,1.0,0.0
Aesthetic computing,0.0,1.0,0.0,0.0
Wholeness,0.0,1.0,0.0,0.0
Subitization,0.0,0.0,0.0,1.0
Spatiotemporal dynamics,0.0,0.0,1.0,0.0
Visual/kinesthetic effect,0.0,0.0,1.0,0.0
Dorsal and ventral cortical pathways and prefrontal cortex,1.0,0.0,0.0,0.0
Mirror focus,0.0,0.0,1.0,0.0
Sum of maximal deviation time,0.0,0.0,0.0,1.0
Inappropriate shocks,0.0,0.0,1.0,0.0
covert orienting,0.0,1.0,0.0,0.0
Behavioral domains analyses,0.0,0.0,1.0,0.0
motor evoked potentials,0.0,1.0,0.0,0.0
Geoinformation,1.0,0.0,0.0,0.0
Minimality,1.0,0.0,0.0,0.0
Joint space,0.0,0.0,1.0,0.0
Bells test,0.0,0.0,1.0,0.0
Perspective drawing,1.0,0.0,0.0,0.0
Visual cognitive functions,0.0,0.0,1.0,0.0
Infant and face recognition,0.0,1.0,0.0,0.0
Wolves,1.0,0.0,0.0,0.0
precision,0.0,0.0,1.0,0.0
Statistical parametric map,0.0,0.0,1.0,0.0
Spatial suppression,0.0,0.0,1.0,0.0
Properties,0.0,0.0,1.0,0.0
Jasad bhasma,0.0,1.0,0.0,0.0
Reminiscence therapy,1.0,0.0,0.0,0.0
Apples Test,0.0,0.0,0.0,1.0
Neuropsychological impairments,1.0,0.0,0.0,0.0
Dj vu,0.0,0.0,1.0,0.0
Response-related potentials (RRP),1.0,0.0,0.0,0.0
residual effect,1.0,0.0,0.0,0.0
Resource capture,0.0,1.0,0.0,0.0
Discriminative stimuli,1.0,0.0,0.0,0.0
3D advertising,0.0,0.0,1.0,0.0
Phenomenological overflow,0.0,0.0,1.0,0.0
High-functioning Pervasive Developmental Disorders,0.0,0.0,1.0,0.0
Self-organizing map,0.0,0.0,0.0,1.0
concussion testing,0.0,0.0,1.0,0.0
Paralysis,0.0,0.0,1.0,0.0
Hippocampal metabolites,1.0,0.0,0.0,0.0
Office ergonomics training,0.0,0.0,1.0,0.0
Cambridge Gambling Task,1.0,0.0,0.0,0.0
Environmental setting,1.0,0.0,0.0,0.0
Limited resources,0.0,1.0,0.0,0.0
Tone memory,0.0,1.0,0.0,0.0
Infection and Critical Care",0.0,0.0,0.0,0.0
Angles,0.0,1.0,0.0,0.0
Hannover principles,0.0,0.0,1.0,0.0
Reaching-grasping kinematics,1.0,0.0,0.0,0.0
Portal vein thrombosis,1.0,0.0,0.0,0.0
Progressive non-fluent aphasia,0.0,1.0,0.0,0.0
chacma baboons,0.0,0.0,1.0,0.0
Web-based neuropsychological assessment,1.0,0.0,0.0,0.0
Renewal effects,1.0,0.0,0.0,0.0
Collections,0.0,0.0,1.0,0.0
better decisions,0.0,0.0,1.0,0.0
autobiographical memory,0.0,1.0,0.0,0.0
Learning letters,0.0,1.0,0.0,0.0
Biosocial interaction,0.0,0.0,1.0,0.0
Risk awareness,0.0,0.0,1.0,0.0
Epsilon,1.0,0.0,0.0,0.0
Graph cut optimization,0.0,0.0,1.0,0.0
longitudinal change,0.0,0.0,1.0,0.0
High-energy dense,1.0,0.0,0.0,0.0
Perceptual inference,0.0,0.0,0.0,1.0
lateral connectivity,0.0,1.0,0.0,0.0
Attention focusing,0.0,1.0,0.0,0.0
Retrosplenial,1.0,0.0,0.0,0.0
informational constraint,0.0,1.0,0.0,0.0
Temporal rate change,0.0,0.0,1.0,0.0
Unimanual and bimanual pointing,0.0,0.0,0.0,1.0
TEAM,0.0,0.0,1.0,0.0
Frequency at maximum power,0.0,0.0,1.0,0.0
Cortical synchrony,0.0,0.0,1.0,0.0
Cut-off score,0.0,0.0,1.0,0.0
Focus gaze,0.0,1.0,0.0,0.0
EEG components,0.0,1.0,0.0,0.0
Retrospective memory,0.0,0.0,1.0,0.0
Physician treatment preferences,0.0,0.0,1.0,0.0
Group cognition,0.0,1.0,0.0,0.0
postoperative complications,0.0,1.0,0.0,0.0
Neuro-aesthetic,0.0,1.0,0.0,0.0
Spatial attention Individuation,1.0,0.0,0.0,0.0
Written AoA,0.0,1.0,0.0,0.0
Visual rhetoric,0.0,0.0,1.0,0.0
The right temporoparietal junction,0.0,1.0,0.0,0.0
Visuospatial span,0.0,0.0,1.0,0.0
semantic decision,0.0,0.0,1.0,0.0
Land use planning,0.0,1.0,0.0,0.0
Complex disabilities,0.0,1.0,0.0,0.0
replication study,1.0,0.0,0.0,0.0
Cerebral laterality,0.0,0.0,1.0,0.0
Probability-classification analysis,0.0,0.0,0.0,1.0
Subcortical disease,1.0,0.0,0.0,0.0
Disconfirmatory evidence integration,0.0,1.0,0.0,0.0
Geometric computing,0.0,1.0,0.0,0.0
Scatter-hoarding,0.0,1.0,0.0,0.0
Axes,0.0,0.0,1.0,0.0
Tool use pantomimes,0.0,0.0,1.0,0.0
Video lottery,0.0,0.0,1.0,0.0
Implicit and explicit processing,0.0,0.0,1.0,0.0
Presurgical mapping,1.0,0.0,0.0,0.0
Medaka,0.0,0.0,0.0,1.0
Object style,0.0,0.0,1.0,0.0
Procedural disorder,0.0,1.0,0.0,0.0
Simulated environment,0.0,0.0,0.0,1.0
paraneoplastic syndromes,0.0,0.0,1.0,0.0
ABCdmedicine,0.0,0.0,1.0,0.0
stimulus size,1.0,0.0,0.0,0.0
Trail Making,0.0,0.0,1.0,0.0
Neurocognitive outcome,1.0,0.0,0.0,0.0
Syntax (P600),0.0,1.0,0.0,0.0
Cognition and touch,0.0,1.0,0.0,0.0
Social interaction anxiety,0.0,1.0,0.0,0.0
Diffuse cerebral and cerebellar atrophy,0.0,1.0,0.0,0.0
Amyloid-beta deposition,1.0,0.0,0.0,0.0
multidisciplinary communication,0.0,1.0,0.0,0.0
Urban forest,1.0,0.0,0.0,0.0
Noradrenergic,0.0,0.0,1.0,0.0
Math development,1.0,0.0,0.0,0.0
Neuroleptics,0.0,0.0,1.0,0.0
Cohesion,0.0,0.0,0.0,1.0
Delayed-non-matching-to-sample task,0.0,0.0,1.0,0.0
Solvent neurotoxicity,0.0,1.0,0.0,0.0
Cultural transmission,0.0,0.0,1.0,0.0
whiplash injuries,0.0,0.0,0.0,1.0
choice tasks,0.0,0.0,1.0,0.0
polypharmacy,0.0,0.0,0.0,1.0
soccer,0.0,1.0,0.0,0.0
Repetition trial,0.0,0.0,1.0,0.0
Adult onset schizophrenia,0.0,0.0,1.0,0.0
Neuropsychiatric illness,0.0,0.0,1.0,0.0
Cognition disorders/epidemiology,0.0,0.0,0.0,1.0
Visual attention cues,1.0,0.0,0.0,0.0
Working memory subsystems,0.0,0.0,1.0,0.0
Bistable stimuli,0.0,1.0,0.0,0.0
Nonconvulsive status epilepticus (NCSE),0.0,0.0,1.0,0.0
Hand movements,0.0,0.0,1.0,0.0
Neuro-imagerie,0.0,1.0,0.0,0.0
image modeling,0.0,0.0,1.0,0.0
Cognitive event-related brain potentials,0.0,0.0,1.0,0.0
Wiki,0.0,0.0,0.0,1.0
neuro-ophthalmologic manifestations,0.0,1.0,0.0,0.0
Oral infections,0.0,0.0,1.0,0.0
Self-experience,0.0,1.0,0.0,0.0
Bayesian hypothesis testing,0.0,0.0,1.0,0.0
chunking,0.0,1.0,0.0,0.0
Insect learning,1.0,0.0,0.0,0.0
Shadow,0.0,1.0,0.0,0.0
Gaussian mixture modelling,1.0,0.0,0.0,0.0
Medial superior frontal cortex,1.0,0.0,0.0,0.0
phosphoglucomutase 3,0.0,1.0,0.0,0.0
risk judgments,0.0,1.0,0.0,0.0
HEP (heartbeat evoked potential),0.0,1.0,0.0,0.0
Thompson,0.0,1.0,0.0,0.0
Sensitive-motor cortex,1.0,0.0,0.0,0.0
body-specificity hypothesis,0.0,0.0,0.0,1.0
Computer-assisted learning,0.0,0.0,1.0,0.0
medial frontal region,0.0,0.0,0.0,1.0
Temporal multisensory binding,0.0,0.0,1.0,0.0
Closed loop stimulation,1.0,0.0,0.0,0.0
P-splines,0.0,1.0,0.0,0.0
Map Reading,0.0,1.0,0.0,0.0
Morocco,0.0,0.0,0.0,1.0
EEG analysis,0.0,1.0,0.0,0.0
Visual need,0.0,0.0,1.0,0.0
Situated and social learning,0.0,0.0,1.0,0.0
Functional asymmetry,0.0,0.0,1.0,0.0
Join attention,0.0,0.0,1.0,0.0
Stimulus properties,0.0,1.0,0.0,0.0
Process dissociation procedure,1.0,0.0,0.0,0.0
Theory of mind",0.0,0.0,0.0,1.0
Sociosexuality,0.0,1.0,0.0,0.0
V1 visual cortex,0.0,1.0,0.0,0.0
Malrotation,0.0,0.0,1.0,0.0
Metacontrast,0.0,0.0,1.0,0.0
Calorie,0.0,0.0,1.0,0.0
Hilbert transform,0.0,0.0,1.0,0.0
Error scores,0.0,0.0,1.0,0.0
Interferon alpha,0.0,0.0,1.0,0.0
Treatment adherence,0.0,0.0,0.0,1.0
Emotional interference,0.0,1.0,0.0,0.0
Postoperative assessment,1.0,0.0,0.0,0.0
Avoidance behavior,0.0,0.0,0.0,1.0
retinal vasculature,1.0,0.0,0.0,0.0
Minipig,0.0,1.0,0.0,0.0
Information and Communication",0.0,0.0,0.0,0.0
emotional faces,0.0,0.0,1.0,0.0
Word form,0.0,0.0,1.0,0.0
Evolution of reaching,0.0,0.0,1.0,0.0
Thinking aloud,0.0,0.0,1.0,0.0
Computerized cognitive training,1.0,0.0,0.0,0.0
Dual-Process Model,0.0,0.0,1.0,0.0
Warning signals,1.0,0.0,0.0,0.0
CVST,1.0,0.0,0.0,0.0
Neurophysiological model,0.0,0.0,0.0,1.0
BDS-II,0.0,0.0,1.0,0.0
Kind concepts,0.0,0.0,1.0,0.0
Rest,1.0,0.0,0.0,0.0
Spike index,0.0,0.0,1.0,0.0
nosology,0.0,1.0,0.0,0.0
Patterned-string task,1.0,0.0,0.0,0.0
Visuomotor skills,0.0,1.0,0.0,0.0
Egocentric/allocentric frames of reference,0.0,0.0,1.0,0.0
Primitive neuro-ectodermal tumour,0.0,0.0,1.0,0.0
Conformal radiotherapy,1.0,0.0,0.0,0.0
child molesters,0.0,0.0,1.0,0.0
Visual cortical maps,0.0,0.0,1.0,0.0
Memory-enhancement,1.0,0.0,0.0,0.0
Subjective reports,0.0,1.0,0.0,0.0
Time-course of negative priming,0.0,0.0,1.0,0.0
Neuropsychiatric disorder,0.0,1.0,0.0,0.0
Involuntary,0.0,0.0,1.0,0.0
Trial Making Test,0.0,1.0,0.0,0.0
Serum uric acid,0.0,0.0,1.0,0.0
Heterozygous reeler,1.0,0.0,0.0,0.0
Print knowledge,0.0,1.0,0.0,0.0
Task control,1.0,0.0,0.0,0.0
Mirror-gazing,0.0,0.0,1.0,0.0
P300 Dementia,0.0,1.0,0.0,0.0
Theta activity,0.0,0.0,1.0,0.0
DXA,1.0,0.0,0.0,0.0
Optic apraxia,0.0,1.0,0.0,0.0
Information-seeking behavior,0.0,0.0,1.0,0.0
Chromosomal substitution,0.0,1.0,0.0,0.0
Lego manipulative task,0.0,1.0,0.0,0.0
Dendritic growth,0.0,0.0,1.0,0.0
Perspective transformation,0.0,0.0,0.0,1.0
Birthweight,1.0,0.0,0.0,0.0
Visualization taxonomy,0.0,0.0,1.0,0.0
Psychotic-like experiences,0.0,0.0,1.0,0.0
Human-animal relations,0.0,1.0,0.0,0.0
Recovery from blindness,0.0,0.0,1.0,0.0
Protein kinases,0.0,0.0,1.0,0.0
Non-epileptic seizures,1.0,0.0,0.0,0.0
Intracerebral recordings,0.0,1.0,0.0,0.0
Jigsaw puzzle,1.0,0.0,0.0,0.0
Wavefront aberration,0.0,0.0,1.0,0.0
Near-IR spectroscopy,0.0,0.0,1.0,0.0
Bottom-up approach,0.0,0.0,1.0,0.0
Visual capacity,0.0,0.0,1.0,0.0
Hemisphere specialization,0.0,0.0,1.0,0.0
Cortical adaptability,0.0,1.0,0.0,0.0
Impaired cognitive performance in Parkinson's disease,0.0,1.0,0.0,0.0
DNS traffic,0.0,1.0,0.0,0.0
Psychotic disorder,1.0,0.0,0.0,0.0
Cognitive theory of depression,0.0,0.0,1.0,0.0
Doctored images,1.0,0.0,0.0,0.0
Holoprosencephaly,0.0,0.0,1.0,0.0
Sensory-motor model of semantic knowledge,0.0,0.0,1.0,0.0
Healthy individuals,0.0,0.0,1.0,0.0
Visuospatial sketch pad,0.0,0.0,1.0,0.0
brain circuitry,0.0,0.0,0.0,1.0
Single-suture craniosynostosis,0.0,1.0,0.0,0.0
Fuzzy trace theory,0.0,0.0,1.0,0.0
3D perception,1.0,0.0,0.0,0.0
Smart power wheelchair,0.0,1.0,0.0,0.0
22q11.2 deletion,1.0,0.0,0.0,0.0
COGNITIVE AGING,1.0,0.0,0.0,0.0
Alcohol problems,0.0,0.0,1.0,0.0
Cumulative,0.0,1.0,0.0,0.0
long-term potentiation (LTP),0.0,0.0,1.0,0.0
information processing speed,1.0,0.0,0.0,0.0
Glutamatergic neurotransmission system,1.0,0.0,0.0,0.0
Cephalopods,1.0,0.0,0.0,0.0
X-rays images,0.0,0.0,1.0,0.0
Spatial decisions,0.0,1.0,0.0,0.0
Silent picture-naming task,0.0,0.0,1.0,0.0
Object array,0.0,1.0,0.0,0.0
Pyramidal cell,0.0,1.0,0.0,0.0
Statistical probability.,1.0,0.0,0.0,0.0
Shopping center,1.0,0.0,0.0,0.0
Generic quality of life,0.0,0.0,0.0,0.0
Redundant signals effect (RSE),1.0,0.0,0.0,0.0
metabolomics,0.0,1.0,0.0,0.0
Conditioned emotional response,0.0,1.0,0.0,0.0
Physiological responding,0.0,0.0,1.0,0.0
Conceptual brain systems,0.0,0.0,1.0,0.0
Sound localization,0.0,1.0,0.0,0.0
Animal communication network,0.0,1.0,0.0,0.0
Dot Test,0.0,0.0,1.0,0.0
Hyperoxic air,1.0,0.0,0.0,0.0
Clinical tests,0.0,0.0,0.0,1.0
Absorption,0.0,0.0,1.0,0.0
Xhosa,1.0,0.0,0.0,0.0
Classification of disabilities,1.0,0.0,0.0,0.0
SLC6A3/DAT1,0.0,0.0,1.0,0.0
Metacognitive Assessment Scale,0.0,0.0,1.0,0.0
Innovativeness,0.0,0.0,1.0,0.0
Cognitive defusion,0.0,0.0,1.0,0.0
EEG/fMRI,0.0,1.0,0.0,0.0
Task performance,0.0,0.0,1.0,0.0
low-vision rehabilitation,0.0,0.0,1.0,0.0
community-dwelling older people,0.0,1.0,0.0,0.0
Individual-differences,0.0,0.0,1.0,0.0
Automatic association,0.0,1.0,0.0,0.0
Phonological disorder,1.0,0.0,0.0,0.0
Broaden-and-build,1.0,0.0,0.0,0.0
Digital technologies,0.0,0.0,1.0,0.0
PRNP gene,1.0,0.0,0.0,0.0
Eyeclosure,0.0,0.0,1.0,0.0
experiential knowledge,0.0,1.0,0.0,0.0
Left-hemisphere damage,1.0,0.0,0.0,0.0
Semantic error,0.0,0.0,1.0,0.0
exteroception,0.0,1.0,0.0,0.0
Religious sermons,0.0,0.0,0.0,1.0
Antiretroviral,0.0,1.0,0.0,0.0
cognitive outcome,0.0,0.0,0.0,1.0
Information transmission,0.0,0.0,1.0,0.0
Response Uncertainty,1.0,0.0,0.0,0.0
English tenses,1.0,0.0,0.0,0.0
"Cognitive function,0.0,0.0,0.0,0.0
XXY,0.0,1.0,0.0,0.0
Position coding,0.0,0.0,1.0,0.0
Cognitive memory,1.0,0.0,0.0,0.0
climbing perch,1.0,0.0,0.0,0.0
Associative models,0.0,0.0,1.0,0.0
Mental outcome,0.0,1.0,0.0,0.0
Therapeutic responsiveness,0.0,0.0,1.0,0.0
Immediate memory,1.0,0.0,0.0,0.0
BDNF polymorphism,0.0,0.0,1.0,0.0
WAGR syndrome,0.0,1.0,0.0,0.0
Action choice,0.0,1.0,0.0,0.0
Length perception,0.0,1.0,0.0,0.0
Clinical narratives categorization,0.0,1.0,0.0,0.0
Neuropsycology,0.0,0.0,0.0,1.0
Global/Local Processing,0.0,0.0,1.0,0.0
Passive Avoidance,0.0,0.0,1.0,0.0
naturalistic study,0.0,1.0,0.0,0.0
Adaptive control,0.0,0.0,0.0,1.0
Cross-modal adaptation,0.0,0.0,1.0,0.0
perceptual priming,1.0,0.0,0.0,0.0
Drug resistant,0.0,1.0,0.0,0.0
Body rotation,0.0,1.0,0.0,0.0
Embodiment theory,0.0,0.0,1.0,0.0
Fmr1,0.0,1.0,0.0,0.0
Fine motor programming,0.0,0.0,0.0,1.0
Peptide YY,1.0,0.0,0.0,0.0
pleasant emotions,0.0,0.0,1.0,0.0
Sense of community,0.0,0.0,1.0,0.0
Behavioral performance,0.0,0.0,0.0,1.0
cortisol,0.0,0.0,1.0,0.0
Design tools,1.0,0.0,0.0,0.0
Multiple-task environment,0.0,1.0,0.0,0.0
Metaknowledge,0.0,0.0,1.0,0.0
person-related semantics,0.0,1.0,0.0,0.0
Core beliefs,1.0,0.0,0.0,0.0
Adenosine receptor,0.0,1.0,0.0,0.0
Double cortex syndrome,0.0,1.0,0.0,0.0
Rate-adaptive pacing,1.0,0.0,0.0,0.0
Traffic-related air pollution,0.0,0.0,1.0,0.0
Sunscreen,0.0,1.0,0.0,0.0
Induced stress,0.0,1.0,0.0,0.0
Menu structure,0.0,0.0,1.0,0.0
Trait-mediated effects,0.0,1.0,0.0,0.0
Genomic imprinting,0.0,0.0,1.0,0.0
Cognitive brain,0.0,0.0,0.0,1.0
Head angle,0.0,0.0,1.0,0.0
Anterior P2,1.0,0.0,0.0,0.0
Neuropsycological investigation,0.0,0.0,1.0,0.0
Coding,0.0,0.0,1.0,0.0
Vertical addition of DEM,1.0,0.0,0.0,0.0
mutual information (MI),0.0,0.0,1.0,0.0
interruption masking,0.0,0.0,1.0,0.0
expectancy cost,0.0,1.0,0.0,0.0
Shared intentionality,0.0,0.0,1.0,0.0
?2A-adrenoceptor,1.0,0.0,0.0,0.0
Low dose of alcohol,0.0,0.0,1.0,0.0
AVNRT,1.0,0.0,0.0,0.0
Hallucinogens,0.0,0.0,1.0,0.0
External visual imagery,0.0,0.0,1.0,0.0
Language and action,1.0,0.0,0.0,0.0
Mime,1.0,0.0,0.0,0.0
Pitch height,0.0,0.0,0.0,1.0
Lemurs,0.0,1.0,0.0,0.0
Dysfunctional attitudes,0.0,0.0,1.0,0.0
Therapy skills,0.0,1.0,0.0,0.0
Vulnerability marker,0.0,0.0,0.0,1.0
Premature infant,0.0,0.0,1.0,0.0
High performance aircrafts pilots,0.0,0.0,1.0,0.0
differential diagnosis,1.0,0.0,0.0,0.0
Non-demented,0.0,1.0,0.0,0.0
Chronic kidney failure,0.0,0.0,1.0,0.0
Angiotensin II,0.0,0.0,0.0,1.0
Ayurveda,0.0,0.0,1.0,0.0
Angiotensin IV,1.0,0.0,0.0,0.0
Connection distance,0.0,1.0,0.0,0.0
Motor mirroring,0.0,0.0,1.0,0.0
Spondyloarthritis,0.0,0.0,1.0,0.0
Productive and inhibitory psychomotor responses,0.0,0.0,0.0,1.0
Action-specific representations,0.0,0.0,0.0,1.0
External noise method,0.0,0.0,1.0,0.0
Neurotensine,0.0,0.0,1.0,0.0
Female conduct disorder,0.0,0.0,1.0,0.0
Demonstration,0.0,1.0,0.0,0.0
IMT,0.0,0.0,1.0,0.0
Concussion symptoms,1.0,0.0,0.0,0.0
Audio-visual device,0.0,1.0,0.0,0.0
Visuo-manual pointing,0.0,1.0,0.0,0.0
grape seed,0.0,0.0,1.0,0.0
Paraphasias,0.0,0.0,0.0,1.0
Iron overload,0.0,0.0,1.0,0.0
Post-operative cognitive dysfunction (POCD),1.0,0.0,0.0,0.0
Interprofessional,0.0,1.0,0.0,0.0
UAHFEMF,0.0,0.0,1.0,0.0
executive skills,0.0,0.0,1.0,0.0
Battery,1.0,0.0,0.0,0.0
Attention levels,1.0,0.0,0.0,0.0
Evidence-based medicine,0.0,0.0,1.0,0.0
Propensity for synchronization,0.0,1.0,0.0,0.0
Motorways,0.0,1.0,0.0,0.0
Health evaluation,0.0,0.0,1.0,0.0
Abilities in reading/comprehension,0.0,0.0,0.0,1.0
Sleep complaints,0.0,1.0,0.0,0.0
Higher nervous activity,0.0,0.0,1.0,0.0
Choice reaction times,1.0,0.0,0.0,0.0
Observational cohort study,0.0,1.0,0.0,0.0
spider monkeys,0.0,1.0,0.0,0.0
Anti-pointing,0.0,1.0,0.0,0.0
brain development,0.0,1.0,0.0,0.0
Auditory event-related potential,1.0,0.0,0.0,0.0
Opera music,0.0,0.0,1.0,0.0
Nucleolar hypertrophy,0.0,0.0,1.0,0.0
posterior cingulate gyrus,1.0,0.0,0.0,0.0
Neurobehavioural Cognitive Status Exam (Cognistat),0.0,1.0,0.0,0.0
Cancer treatments,0.0,1.0,0.0,0.0
Mild Alzheimer disease,0.0,0.0,1.0,0.0
Stimulant abuse,1.0,0.0,0.0,0.0
*Learning,0.0,0.0,0.0,0.0
lure effects,1.0,0.0,0.0,0.0
Male brain,0.0,0.0,1.0,0.0
Web-based testing,1.0,0.0,0.0,0.0
Theta synchronization,1.0,0.0,0.0,0.0
Local-global paradigm,0.0,0.0,1.0,0.0
Dynamic action,1.0,0.0,0.0,0.0
visual recognition memory,0.0,0.0,0.0,1.0
Social and occupational functioning,1.0,0.0,0.0,0.0
Exercise rehabilitation,0.0,1.0,0.0,0.0
Autonomic disturbance,0.0,0.0,0.0,1.0
Confirmatory factor analysis (CFA),0.0,1.0,0.0,0.0
Outcome evaluation,0.0,0.0,1.0,0.0
Stimulus localization,1.0,0.0,0.0,0.0
Type II error,0.0,1.0,0.0,0.0
Paralympics Games,0.0,0.0,1.0,0.0
Open road,0.0,1.0,0.0,0.0
Distributional analyses,0.0,1.0,0.0,0.0
Disordered background,1.0,0.0,0.0,0.0
pictorial depth,0.0,1.0,0.0,0.0
Visuomotor resonance,0.0,0.0,1.0,0.0
Alpha-2 agonists,0.0,1.0,0.0,0.0
spatial frequencies,1.0,0.0,0.0,0.0
Onset time,0.0,0.0,1.0,0.0
dmPFC,0.0,0.0,1.0,0.0
Cue integration,0.0,0.0,1.0,0.0
Real-world functioning,0.0,0.0,1.0,0.0
learning styles,0.0,0.0,1.0,0.0
Menopause age,0.0,0.0,1.0,0.0
Vasospasm,0.0,0.0,1.0,0.0
Conditional Granger causality analysis,0.0,0.0,1.0,0.0
Approach avoidance,0.0,1.0,0.0,0.0
Affective responsiveness,1.0,0.0,0.0,0.0
social engagement,1.0,0.0,0.0,0.0
Physical Functioning,0.0,0.0,1.0,0.0
Media-mediated memory,0.0,0.0,0.0,1.0
Perceptual illusions,0.0,0.0,1.0,0.0
SCR,1.0,0.0,0.0,0.0
self-assessment,1.0,0.0,0.0,0.0
Numerical stroop,0.0,1.0,0.0,0.0
Italian sample,1.0,0.0,0.0,0.0
Behavioural symptoms,0.0,0.0,1.0,0.0
Laminar structure,0.0,0.0,1.0,0.0
Complexity analysis,1.0,0.0,0.0,0.0
physical functioning,0.0,1.0,0.0,0.0
computer-based learning,0.0,0.0,1.0,0.0
Multiple systems,1.0,0.0,0.0,0.0
Green exercise,0.0,0.0,1.0,0.0
Drug repositioning,0.0,0.0,0.0,1.0
BOLD effect,0.0,0.0,1.0,0.0
Corticoreticular pathway,0.0,1.0,0.0,0.0
Blood stream,0.0,0.0,1.0,0.0
Unipolar affective disorders,0.0,1.0,0.0,0.0
Upper space,1.0,0.0,0.0,0.0
Dynamic coding,1.0,0.0,0.0,0.0
tamoxifen,0.0,0.0,1.0,0.0
antipsychotics,0.0,1.0,0.0,0.0
MNS,0.0,1.0,0.0,0.0
Quiet standing,0.0,1.0,0.0,0.0
Information display,0.0,0.0,1.0,0.0
drug-nave schizophrenia,0.0,1.0,0.0,0.0
Feature based,0.0,0.0,1.0,0.0
neuro-psychoanalysis,0.0,0.0,0.0,1.0
Standardized regression-based change score norms,0.0,1.0,0.0,0.0
picture,0.0,0.0,1.0,0.0
arousal-valence plane,0.0,1.0,0.0,0.0
Video stimuli,0.0,0.0,1.0,0.0
HT1001,0.0,0.0,1.0,0.0
Spatial-sequences,1.0,0.0,0.0,0.0
Outcome measurement,1.0,0.0,0.0,0.0
temporal difference error,0.0,0.0,1.0,0.0
Nk1 receptor,0.0,1.0,0.0,0.0
Image culture,0.0,0.0,1.0,0.0
Visually-guided manual pointing,0.0,1.0,0.0,0.0
Canonical correlation analysis,0.0,0.0,1.0,0.0
Cohesiveness and continuity,0.0,1.0,0.0,0.0
Interaction of executive function and emotion,0.0,0.0,0.0,1.0
integrality,1.0,0.0,0.0,0.0
Enactive mind,0.0,1.0,0.0,0.0
Motion-onset,0.0,1.0,0.0,0.0
Bisphenol A-glycidyl methacrylate,0.0,0.0,0.0,1.0
Sperling experiment,0.0,1.0,0.0,0.0
Undergraduate education,1.0,0.0,0.0,0.0
evoked brain potentials,0.0,0.0,1.0,0.0
Episodic memory disorders,0.0,0.0,0.0,1.0
distance learning,0.0,1.0,0.0,0.0
Determiner competition,0.0,0.0,1.0,0.0
Inflammatory markers,0.0,0.0,1.0,0.0
asymptomatic carotid disease,0.0,1.0,0.0,0.0
ASDs,0.0,1.0,0.0,0.0
Driving Rehabilition,0.0,1.0,0.0,0.0
menopause,0.0,1.0,0.0,0.0
Coincidences,0.0,1.0,0.0,0.0
Hemiparkinsonism,0.0,1.0,0.0,0.0
Go/NoGo task (SART),0.0,1.0,0.0,0.0
Self-attentional biases,1.0,0.0,0.0,0.0
Looming cognitive style,1.0,0.0,0.0,0.0
Fixation depth,0.0,0.0,1.0,0.0
SCA,0.0,1.0,0.0,0.0
SCI,0.0,0.0,0.0,1.0
Thyroid function tests,0.0,0.0,1.0,0.0
Depths of processing,0.0,1.0,0.0,0.0
Approximate arithmetic,0.0,0.0,1.0,0.0
Mental magnitude,0.0,1.0,0.0,0.0
Graded Salience Hypothesis,0.0,0.0,1.0,0.0
Lysosomal disease,0.0,0.0,1.0,0.0
Herpes encephalitis,1.0,0.0,0.0,0.0
Visual signature,0.0,1.0,0.0,0.0
Clinico-anatomical correlation,1.0,0.0,0.0,0.0
avatar,0.0,0.0,1.0,0.0
neurocognitive development,0.0,1.0,0.0,0.0
Gap effect,0.0,1.0,0.0,0.0
Word subclasses,0.0,1.0,0.0,0.0
biological markers,0.0,1.0,0.0,0.0
Specific developmental language disorder,0.0,0.0,1.0,0.0
Computerized rehabilitation,0.0,0.0,1.0,0.0
Malformation of cortical development,0.0,0.0,1.0,0.0
Perceptual adaptation,0.0,1.0,0.0,0.0
Korean word,1.0,0.0,0.0,0.0
Clothing,0.0,0.0,1.0,0.0
Temozolamid,1.0,0.0,0.0,0.0
Estrogen therapy,0.0,0.0,1.0,0.0
test validity,0.0,0.0,0.0,1.0
Learning instructions,0.0,1.0,0.0,0.0
Perineuronal net,0.0,0.0,1.0,0.0
DRdsocial science,0.0,1.0,0.0,0.0
Compound-cue,1.0,0.0,0.0,0.0
TACS,0.0,1.0,0.0,0.0
Competition condition,0.0,0.0,0.0,1.0
Video interpretation,0.0,0.0,1.0,0.0
Roux-en-Y gastric bypass,0.0,0.0,0.0,1.0
Perceptual functions,1.0,0.0,0.0,0.0
pathology,0.0,0.0,0.0,1.0
Pain neurophysiology,0.0,0.0,1.0,0.0
Clomipramine,1.0,0.0,0.0,0.0
Neuropsychophysiology,0.0,0.0,1.0,0.0
Categories and Subject Descriptors (according to ACM CCS),0.0,1.0,0.0,0.0
Behavioural and psychological symptoms of dementia,0.0,0.0,1.0,0.0
Non-verbal learning disorder,0.0,0.0,1.0,0.0
Care facility,1.0,0.0,0.0,0.0
CP-115,1.0,0.0,0.0,0.0
Comparative neuroanatomy,1.0,0.0,0.0,0.0
Hypohydration,0.0,1.0,0.0,0.0
Prolongation,0.0,0.0,1.0,0.0
True belief,0.0,0.0,1.0,0.0
Intermittent presentation,0.0,1.0,0.0,0.0
Postmenopausal hormone treatment,0.0,0.0,0.0,1.0
Neurorobots,0.0,1.0,0.0,0.0
Slow wave,0.0,1.0,0.0,0.0
brain injury rehabilitation,0.0,0.0,1.0,0.0
Religious Orders Study,0.0,1.0,0.0,0.0
Sympathetic storm,1.0,0.0,0.0,0.0
Cross-modal masking,0.0,0.0,0.0,1.0
Mo.)",0.0,0.0,0.0,0.0
Pittsburgh compound B,0.0,0.0,0.0,1.0
Night shift work,1.0,0.0,0.0,0.0
Reading the eyes task,1.0,0.0,0.0,0.0
Direct reach,1.0,0.0,0.0,0.0
Structural equation modeling (SEM),0.0,1.0,0.0,0.0
Reconstructive and Aesthetic Surgery",0.0,0.0,0.0,0.0
Colavita effect,0.0,0.0,1.0,0.0
Subcortical processes,1.0,0.0,0.0,0.0
Trancutaneous electrical nerve stimulation (TENS),0.0,0.0,1.0,0.0
Resident Assessment Instrument Minimum Data Set (RAI-MDS),0.0,0.0,1.0,0.0
Attentional visual fields,0.0,0.0,1.0,0.0
Chronic Obstructive Pulmonary Disease,0.0,1.0,0.0,0.0
novelty-seeking,1.0,0.0,0.0,0.0
Instrumental mirror use,0.0,1.0,0.0,0.0
Dextral,1.0,0.0,0.0,0.0
Semantic match,0.0,1.0,0.0,0.0
Association model,0.0,1.0,0.0,0.0
Idiopathic trigeminal neuralgia,0.0,1.0,0.0,0.0
involuntary attention,1.0,0.0,0.0,0.0
Part C: Seminars in Medical Genetics",0.0,0.0,0.0,0.0
Decision fusion,0.0,1.0,0.0,0.0
Global geometry,0.0,1.0,0.0,0.0
Developing brain,1.0,0.0,0.0,0.0
Colour diagnosticity,0.0,0.0,0.0,1.0
Computational neurogenetic modeling,0.0,0.0,0.0,1.0
Opiate,0.0,1.0,0.0,0.0
Translational control,0.0,1.0,0.0,0.0
Nerve growth factor,0.0,0.0,1.0,0.0
Modified Rankin Scale,0.0,1.0,0.0,0.0
Hippocampectomy,0.0,0.0,1.0,0.0
Simultaneous and successive processing,0.0,0.0,1.0,0.0
Institutionalized,0.0,0.0,1.0,0.0
Texture recognition,0.0,1.0,0.0,0.0
Gray matter lesions,1.0,0.0,0.0,0.0
Engineering drawing,0.0,0.0,1.0,0.0
Yawning,0.0,0.0,0.0,1.0
Multivoxel pattern classification,0.0,1.0,0.0,0.0
Voices,0.0,0.0,1.0,0.0
Functional magnetic resonance scans,0.0,1.0,0.0,0.0
Elevated plus-maze,1.0,0.0,0.0,0.0
Special Education,0.0,0.0,1.0,0.0
Intradimensional/Extradimensional Set-Shift Task,1.0,0.0,0.0,0.0
Asperger's Disorder,1.0,0.0,0.0,0.0
Art education,0.0,1.0,0.0,0.0
Hormonal replacement therapy,1.0,0.0,0.0,0.0
Familial risk,0.0,1.0,0.0,0.0
EVO_ECOL,0.0,1.0,0.0,0.0
Spatial term apprehension,0.0,1.0,0.0,0.0
Cognitive perceptions,1.0,0.0,0.0,0.0
Optometry,0.0,0.0,0.0,0.0
neuropsychiatric test,0.0,0.0,0.0,1.0
Rhesus Macaque,0.0,1.0,0.0,0.0
Current source localization,0.0,0.0,1.0,0.0
Continuous magnitudes,0.0,1.0,0.0,0.0
Monte carlo algorithms,0.0,0.0,1.0,0.0
Spinal dysraphism/therapy,1.0,0.0,0.0,0.0
MSA-P,0.0,0.0,1.0,0.0
lesion studies,0.0,1.0,0.0,0.0
mind-wandering,0.0,1.0,0.0,0.0
polycystic ovary syndrome,0.0,1.0,0.0,0.0
Periventricular leukomalacia,1.0,0.0,0.0,0.0
Pattern integration,0.0,1.0,0.0,0.0
Desirable difficulties,0.0,0.0,1.0,0.0
Belief-bias,0.0,0.0,1.0,0.0
Memory short-term,0.0,1.0,0.0,0.0
Functional deficit zone,0.0,0.0,1.0,0.0
Response speed,0.0,1.0,0.0,0.0
Espaa,1.0,0.0,0.0,0.0
Movement recognition,0.0,0.0,0.0,1.0
Context-dependent learning,0.0,1.0,0.0,0.0
Multi-level mixed-effect biometric models,0.0,0.0,1.0,0.0
Unconscious knowledge,0.0,1.0,0.0,0.0
Minimum data set,1.0,0.0,0.0,0.0
Traits,0.0,0.0,1.0,0.0
Re-orientation negativity,0.0,1.0,0.0,0.0
States of Awareness,0.0,1.0,0.0,0.0
Cognitive abilities underlying reading,0.0,0.0,1.0,0.0
The science and technology foundation of guangdong province of china,0.0,0.0,1.0,0.0
High frequency EEC,0.0,1.0,0.0,0.0
Hip arthroplasty,0.0,0.0,1.0,0.0
Vertebrate brain evolution",0.0,0.0,1.0,0.0
Comprehensive driving evaluation,0.0,0.0,1.0,0.0
decision-making,1.0,0.0,0.0,0.0
Food preferences,0.0,0.0,0.0,1.0
affective cognition,0.0,0.0,1.0,0.0
intraindividual change,0.0,1.0,0.0,0.0
Periodontal disease,0.0,0.0,1.0,0.0
Primary prevention,0.0,1.0,0.0,0.0
User satisfaction,0.0,1.0,0.0,0.0
REM dream pictures,0.0,0.0,0.0,1.0
Psychometric g,0.0,1.0,0.0,0.0
Foreperiod,0.0,0.0,0.0,1.0
Distributed memory,0.0,0.0,1.0,0.0
Sighting dominance,0.0,0.0,1.0,0.0
Functional outcomes,0.0,0.0,1.0,0.0
Leftward bias,0.0,0.0,1.0,0.0
CHR,0.0,1.0,0.0,0.0
Deficits,0.0,0.0,1.0,0.0
CHD,0.0,1.0,0.0,0.0
CHC,0.0,0.0,0.0,1.0
Prospective memory interference effect,0.0,1.0,0.0,0.0
perceived duration,0.0,1.0,0.0,0.0
Mushiake,0.0,0.0,0.0,1.0
Emerging readers,1.0,0.0,0.0,0.0
Modification,0.0,1.0,0.0,0.0
Receiver operating characteristics,1.0,0.0,0.0,0.0
Arrogance,0.0,0.0,1.0,0.0
Possessions,0.0,1.0,0.0,0.0
Instantaneous frequency (IF),0.0,1.0,0.0,0.0
Very mild dementia,1.0,0.0,0.0,0.0
Isometric contraction,0.0,0.0,1.0,0.0
Endosome,0.0,0.0,1.0,0.0
Prey capture,0.0,1.0,0.0,0.0
Isolation rearing,0.0,1.0,0.0,0.0
Cerebral ischemia,0.0,0.0,1.0,0.0
Encyclopaedic knowledge,0.0,1.0,0.0,0.0
Poverty,0.0,1.0,0.0,0.0
Qualitative shape and colour,0.0,1.0,0.0,0.0
Three-dimensional space,0.0,1.0,0.0,0.0
Children and adolescents with autistic traits,0.0,1.0,0.0,0.0
"Central nervous system,0.0,0.0,0.0,0.0
Splinter skills,0.0,1.0,0.0,0.0
diabetic retinopathy,1.0,0.0,0.0,0.0
Crossover study,0.0,1.0,0.0,0.0
Affective relevance,0.0,0.0,1.0,0.0
Tactile information,0.0,1.0,0.0,0.0
Spatial working and reference memory,0.0,1.0,0.0,0.0
Neural binding,0.0,0.0,1.0,0.0
Cognition enhancement,0.0,0.0,1.0,0.0
Vladimir Lossky,1.0,0.0,0.0,0.0
methylxanthine,0.0,0.0,1.0,0.0
Recurrent brief depression,0.0,1.0,0.0,0.0
Vicarious learning,0.0,0.0,1.0,0.0
Threshold detection,0.0,0.0,1.0,0.0
Urban image,1.0,0.0,0.0,0.0
LRRK2 gene,0.0,1.0,0.0,0.0
Coriolis,0.0,0.0,0.0,1.0
Memory-formation principles,0.0,1.0,0.0,0.0
Visuo-spatial perception,1.0,0.0,0.0,0.0
Inpatients,1.0,0.0,0.0,0.0
Stage of cancer treatment,0.0,1.0,0.0,0.0
Group,0.0,0.0,1.0,0.0
Joint visual attention,0.0,0.0,1.0,0.0
Embodied technology,0.0,1.0,0.0,0.0
Gradual,0.0,1.0,0.0,0.0
True belief reasoning,0.0,0.0,1.0,0.0
Therapeutic hypothermia,0.0,0.0,1.0,0.0
Determinants,0.0,1.0,0.0,0.0
media theory,0.0,0.0,1.0,0.0
Psychological aesthetics,0.0,1.0,0.0,0.0
Preoperative sleep disruption,0.0,1.0,0.0,0.0
(C)APD [(central) auditory processing disorders],0.0,1.0,0.0,0.0
Perceptual Upright,0.0,1.0,0.0,0.0
Disease subtype,1.0,0.0,0.0,0.0
Delayed non-matched to positive,0.0,0.0,1.0,0.0
Neurological signs,0.0,0.0,1.0,0.0
Prelimbic,0.0,0.0,1.0,0.0
Phasic/tonic,1.0,0.0,0.0,0.0
Attention control condition,0.0,1.0,0.0,0.0
Reciprocal inhibition,0.0,0.0,1.0,0.0
visual dominance,0.0,0.0,1.0,0.0
Transactional model,0.0,0.0,1.0,0.0
Urine formaldehyde,1.0,0.0,0.0,0.0
High school athletes,0.0,1.0,0.0,0.0
anemia,0.0,1.0,0.0,0.0
Self attitude,0.0,0.0,1.0,0.0
artificial comparative psychology,0.0,1.0,0.0,0.0
Cognition and Adaptation,0.0,1.0,0.0,0.0
Time compression,0.0,1.0,0.0,0.0
Perspective calculation,1.0,0.0,0.0,0.0
Treatment-nave,0.0,0.0,1.0,0.0
city iconography,0.0,0.0,1.0,0.0
health literacy,0.0,0.0,1.0,0.0
Liver transplantation,1.0,0.0,0.0,0.0
Multimodalities,0.0,0.0,1.0,0.0
Interacting effector,1.0,0.0,0.0,0.0
Neurobehavioral development,0.0,1.0,0.0,0.0
Executive system,1.0,0.0,0.0,0.0
elaboration likelihood model,1.0,0.0,0.0,0.0
Neuronal networks,0.0,1.0,0.0,0.0
Written picture naming,0.0,0.0,1.0,0.0
Hypothalamus-pituitary-adrenal axis,0.0,0.0,0.0,1.0
Pre-saccadic attention,0.0,0.0,1.0,0.0
cognition theory,0.0,1.0,0.0,0.0
Cognitive masking task,0.0,1.0,0.0,0.0
Overgeneralization,0.0,0.0,1.0,0.0
Geniculocortical,0.0,0.0,0.0,1.0
emotion/worry,1.0,0.0,0.0,0.0
unimanual response,1.0,0.0,0.0,0.0
Lexical-semantic,0.0,0.0,1.0,0.0
Cognitive-psychomotor function,0.0,0.0,1.0,0.0
Adult readers,0.0,0.0,1.0,0.0
Perspective selection,1.0,0.0,0.0,0.0
Semantic congruency,0.0,1.0,0.0,0.0
GSK-742457,1.0,0.0,0.0,0.0
Music performance,0.0,1.0,0.0,0.0
Visual timing,0.0,0.0,1.0,0.0
Volatile anesthetics,0.0,0.0,1.0,0.0
Individuality,0.0,0.0,1.0,0.0
Study phase retrieval,1.0,0.0,0.0,0.0
Alcohol cues,0.0,0.0,1.0,0.0
Form-from-motion,0.0,0.0,1.0,0.0
Optimal paradigm,0.0,0.0,0.0,1.0
Animations,0.0,0.0,1.0,0.0
Attention fixation,0.0,0.0,1.0,0.0
Environmental information,0.0,1.0,0.0,0.0
Reading and bilingualism,0.0,0.0,1.0,0.0
Quantitative MRI,0.0,0.0,0.0,1.0
FASD,0.0,0.0,0.0,1.0
Gaze discrimination,0.0,0.0,0.0,1.0
Mosquitofish,0.0,0.0,0.0,1.0
Sad mood induction,0.0,0.0,1.0,0.0
Mitochondrial dysfunction,1.0,0.0,0.0,0.0
Compensatory mechanisms,0.0,0.0,1.0,0.0
Concept representation,0.0,0.0,1.0,0.0
amalgam-related complaints,0.0,1.0,0.0,0.0
Multiple monitor environments,0.0,0.0,1.0,0.0
Japan,0.0,1.0,0.0,0.0
Allometry,1.0,0.0,0.0,0.0
eye gaze,0.0,0.0,0.0,1.0
CPAP,0.0,0.0,0.0,1.0
Ankle dorsi-plantarflexion,0.0,1.0,0.0,0.0
Cross-disciplinary,0.0,1.0,0.0,0.0
Hepatocerebral degeneration,0.0,1.0,0.0,0.0
Action organization,0.0,1.0,0.0,0.0
OSN,0.0,1.0,0.0,0.0
Error analysis,1.0,0.0,0.0,0.0
Teleportation,0.0,0.0,1.0,0.0
OSP,0.0,0.0,1.0,0.0
Obsessive,0.0,1.0,0.0,0.0
visuospatial working memory,0.0,1.0,0.0,0.0
Feature-selective attention,0.0,0.0,1.0,0.0
Fixation durations,0.0,0.0,0.0,1.0
Carotenoid,1.0,0.0,0.0,0.0
Social contingency,0.0,1.0,0.0,0.0
Hypoxic-ischemic encephalopathy,1.0,0.0,0.0,0.0
Near transfer of learning,0.0,0.0,0.0,1.0
Chronic migraine,1.0,0.0,0.0,0.0
Whole-brain radiotherapy,0.0,0.0,0.0,1.0
Inflected,1.0,0.0,0.0,0.0
Consumer psychology,0.0,0.0,1.0,0.0
Brain-computer interfaces,0.0,1.0,0.0,0.0
Duration judgment,0.0,0.0,0.0,1.0
Inter-subject correlation,0.0,0.0,1.0,0.0
Sazetidine-A,0.0,0.0,1.0,0.0
"""Conventional"" metaphors,0.0,0.0,1.0,0.0
Cognitive throughput,0.0,0.0,1.0,0.0
Animated graphic,0.0,0.0,1.0,0.0
Leigh syndrome,0.0,1.0,0.0,0.0
Posterior parietal lobules,0.0,0.0,1.0,0.0
Eye movement-based memory effect,0.0,0.0,1.0,0.0
neural,1.0,0.0,0.0,0.0
Immediate post-concussion assessment and cognitive testing,0.0,1.0,0.0,0.0
MIBG cardiac scintigraphy,0.0,0.0,0.0,1.0
Social norms,0.0,0.0,1.0,0.0
Acquisition of natural numbers,0.0,0.0,0.0,1.0
Herpes simplex encephalitis,0.0,0.0,1.0,0.0
Virtual avatar,0.0,1.0,0.0,0.0
Cambridge University Press,1.0,0.0,0.0,0.0
Spanish speakers,0.0,1.0,0.0,0.0
Extradimensional,0.0,1.0,0.0,0.0
Contour decomposition,0.0,0.0,1.0,0.0
poster design,0.0,1.0,0.0,0.0
Fever,1.0,0.0,0.0,0.0
Featural and relational mapping,0.0,1.0,0.0,0.0
Pseudowords,0.0,0.0,1.0,0.0
Safety climate,1.0,0.0,0.0,0.0
Ball-bouncing,0.0,1.0,0.0,0.0
Nave theories,0.0,0.0,0.0,1.0
Menstrual phase,1.0,0.0,0.0,0.0
warning labels,0.0,0.0,1.0,0.0
dialysis disequilibrium,0.0,1.0,0.0,0.0
Executive skills,0.0,0.0,1.0,0.0
Engagement-Reflection computational model,0.0,1.0,0.0,0.0
M3 mAChR,0.0,0.0,1.0,0.0
Hopantenic acid,0.0,0.0,1.0,0.0
Impasse-induced self-rated stress,0.0,0.0,1.0,0.0
Early selection,0.0,0.0,1.0,0.0
Transsylvian selective amygdalohippocampectomy,0.0,0.0,1.0,0.0
Multi-infarct dementia,0.0,0.0,1.0,0.0
Functional visual loss,1.0,0.0,0.0,0.0
placebo,0.0,0.0,1.0,0.0
visual cultures,1.0,0.0,0.0,0.0
Learned discrimination,0.0,1.0,0.0,0.0
treatment response,0.0,0.0,0.0,1.0
Progressive supranuclear palsy (PSP),0.0,1.0,0.0,0.0
Movement ABC-2,0.0,1.0,0.0,0.0
Matching Familiar Figures task,0.0,1.0,0.0,0.0
Pro- and retroactive microcognition,0.0,0.0,1.0,0.0
Formidability,0.0,0.0,1.0,0.0
11C-PIB,0.0,0.0,1.0,0.0
biomeasures,0.0,1.0,0.0,0.0
self-medication,0.0,0.0,1.0,0.0
Human problem solving,0.0,0.0,1.0,0.0
Fibromyalgia syndrome,1.0,0.0,0.0,0.0
EGM,0.0,0.0,1.0,0.0
Musical tempo,0.0,0.0,1.0,0.0
Chlorogenic acid,0.0,0.0,0.0,1.0
A Quick Test for Cognitive Speed,0.0,1.0,0.0,0.0
iNOS,1.0,0.0,0.0,0.0
Juvenile idiopathic arthritis,0.0,0.0,1.0,0.0
Neuromotor performance,0.0,1.0,0.0,0.0
Culture differences,0.0,0.0,1.0,0.0
Anagram,0.0,1.0,0.0,0.0
Subcortical processing,1.0,0.0,0.0,0.0
Aesthetic evaluation,0.0,1.0,0.0,0.0
Spatial transposition,0.0,1.0,0.0,0.0
Jacob,0.0,1.0,0.0,0.0
knowledge,1.0,0.0,0.0,0.0
Cost-driving factors,0.0,0.0,1.0,0.0
APOC1,0.0,1.0,0.0,0.0
Phyto-oestrogens,0.0,1.0,0.0,0.0
Pattern shape,0.0,0.0,1.0,0.0
disease,0.0,0.0,1.0,0.0
Deafblind,0.0,0.0,0.0,1.0
uraemic toxins,0.0,1.0,0.0,0.0
decision by exclusion,0.0,0.0,1.0,0.0
Scenic beauty evaluation,1.0,0.0,0.0,0.0
Action-mirroring,0.0,0.0,1.0,0.0
Block design,0.0,0.0,1.0,0.0
contextual modulation,1.0,0.0,0.0,0.0
medroxyprogesterone acetate,0.0,1.0,0.0,0.0
Noun meaning,0.0,1.0,0.0,0.0
Brain oscillation,1.0,0.0,0.0,0.0
Postpartum,0.0,0.0,1.0,0.0
"Memory,0.0,0.0,0.0,0.0
Post-stroke cognitive impairment,1.0,0.0,0.0,0.0
Power wheelchair driving performance,0.0,0.0,1.0,0.0
Hypercholesterolemia,0.0,0.0,1.0,0.0
IQ-matched control group,0.0,1.0,0.0,0.0
Standardized road course,1.0,0.0,0.0,0.0
Extremely low birth weight infants,0.0,0.0,1.0,0.0
Coherent working models theory,1.0,0.0,0.0,0.0
Parkin mutation,0.0,0.0,1.0,0.0
Eye fixation related potential,0.0,0.0,1.0,0.0
Zinc supplementation,0.0,1.0,0.0,0.0
Cognitive dual-task,1.0,0.0,0.0,0.0
Rubber,0.0,0.0,0.0,1.0
Cumulative blood lead,1.0,0.0,0.0,0.0
Species recognition,0.0,0.0,1.0,0.0
Maple Syrup Urine Disease,1.0,0.0,0.0,0.0
Integrate-and-fire spiking neurons,0.0,0.0,1.0,0.0
Fingernail,0.0,1.0,0.0,0.0
Mental speed,0.0,0.0,0.0,1.0
Orientation specificity effect,0.0,0.0,1.0,0.0
Movement-related cortical potential,0.0,0.0,1.0,0.0
Spastic paraparesis,0.0,1.0,0.0,0.0
dorsal visual stream,0.0,1.0,0.0,0.0
Childhood abuse,1.0,0.0,0.0,0.0
China,0.0,1.0,0.0,0.0
Visuomotor deficit,0.0,0.0,0.0,1.0
autoimmunity,0.0,1.0,0.0,0.0
Interindividual differences,0.0,0.0,0.0,1.0
Comparator model,0.0,0.0,0.0,1.0
Laura source estimation,1.0,0.0,0.0,0.0
Dorsal attention network,0.0,0.0,1.0,0.0
Longitudinal data,0.0,0.0,1.0,0.0
TFLS,0.0,0.0,1.0,0.0
Group Decision Making,1.0,0.0,0.0,0.0
preschool,0.0,0.0,0.0,1.0
Global neuronal workspace,0.0,0.0,0.0,1.0
age-related cataract,0.0,0.0,1.0,0.0
Dandy-Walker continuum,0.0,0.0,0.0,1.0
Magic trick,0.0,1.0,0.0,0.0
Matching task,1.0,0.0,0.0,0.0
verbal descriptions,0.0,1.0,0.0,0.0
Cultural differences,0.0,0.0,1.0,0.0
Parenting and caregiving,1.0,0.0,0.0,0.0
Safety motivation,1.0,0.0,0.0,0.0
Working memory and hypertext,0.0,0.0,1.0,0.0
Musician bodily expression,0.0,1.0,0.0,0.0
Opioid antagonism,0.0,0.0,1.0,0.0
Retention interval,0.0,0.0,1.0,0.0
Gaboxadol,0.0,1.0,0.0,0.0
lexical organization,0.0,1.0,0.0,0.0
Overarching function,0.0,0.0,1.0,0.0
Non-neuropsychiatric SLE,0.0,1.0,0.0,0.0
speeded detection,0.0,0.0,1.0,0.0
Semantic diversity,0.0,1.0,0.0,0.0
Source estimation,0.0,0.0,1.0,0.0
Menire's disease patients,0.0,1.0,0.0,0.0
Lupus,0.0,0.0,1.0,0.0
profile,0.0,0.0,1.0,0.0
High density ERPs,0.0,0.0,0.0,1.0
Cadmium,0.0,1.0,0.0,0.0
Associative memory task,0.0,0.0,1.0,0.0
Binary categorization,0.0,0.0,1.0,0.0
Knockout mouse,0.0,1.0,0.0,0.0
EEG amplitude modulation (AM),0.0,0.0,1.0,0.0
Task-choice procedure,0.0,0.0,1.0,0.0
Disjunctions,0.0,1.0,0.0,0.0
Finger-digit mapping,0.0,0.0,1.0,0.0
Contextual constraints,0.0,0.0,1.0,0.0
Multiple linear regression,0.0,0.0,1.0,0.0
Memory clinic,1.0,0.0,0.0,0.0
Category selectivity,0.0,1.0,0.0,0.0
Overt naming,1.0,0.0,0.0,0.0
Neuronal responses,0.0,1.0,0.0,0.0
Driver,0.0,0.0,0.0,1.0
Cognitive protocol,0.0,1.0,0.0,0.0
Decision Making,0.0,1.0,0.0,0.0
sequential block tapping,1.0,0.0,0.0,0.0
Compensation strategy,0.0,0.0,1.0,0.0
Near infrared spectroscopy,0.0,0.0,0.0,1.0
Multimedia systems,0.0,1.0,0.0,0.0
Health information processing,0.0,1.0,0.0,0.0
Event-Related potential,0.0,1.0,0.0,0.0
Info-visualization,1.0,0.0,0.0,0.0
MCR (message-to-competition ratio),0.0,1.0,0.0,0.0
Anthropomorphizing,0.0,0.0,1.0,0.0
K-AD8,1.0,0.0,0.0,0.0
Communicative intent,0.0,1.0,0.0,0.0
Sibpair,1.0,0.0,0.0,0.0
Megapode,0.0,0.0,1.0,0.0
Response conflict adaptation,0.0,1.0,0.0,0.0
Word-stem completion,1.0,0.0,0.0,0.0
Geometrical gaze following,0.0,0.0,1.0,0.0
Semantic learning,0.0,1.0,0.0,0.0
Auditory feedback,0.0,1.0,0.0,0.0
Wahlund scale,0.0,0.0,1.0,0.0
cognitive cartography,0.0,0.0,1.0,0.0
Crossing road,0.0,0.0,1.0,0.0
Ventro-dorsal and dorso-dorsal stream",0.0,1.0,0.0,0.0
Translational medicine,0.0,1.0,0.0,0.0
PCEA,1.0,0.0,0.0,0.0
Quantitative skills,0.0,1.0,0.0,0.0
Visual Orienting,0.0,0.0,1.0,0.0
Non-inferiority,0.0,1.0,0.0,0.0
Egocentric-allocentric frame,0.0,0.0,1.0,0.0
Input degree,0.0,1.0,0.0,0.0
Galanthamine,0.0,0.0,1.0,0.0
Number space,0.0,1.0,0.0,0.0
mixed-effect model,0.0,0.0,1.0,0.0
Premotor theory,0.0,0.0,0.0,1.0
strenuous activity,0.0,0.0,1.0,0.0
Visual-motor processing,0.0,1.0,0.0,0.0
Attentive interfaces,0.0,0.0,0.0,1.0
Occasion-setting,0.0,1.0,0.0,0.0
Levels of description,0.0,1.0,0.0,0.0
Essential and toxic elements,1.0,0.0,0.0,0.0
conceptual metaphor,1.0,0.0,0.0,0.0
Simple visual matching tasks,0.0,0.0,1.0,0.0
Site of recording electrode,0.0,1.0,0.0,0.0
Motor-related biases,0.0,1.0,0.0,0.0
Fluid cognitive ability,1.0,0.0,0.0,0.0
Interference paradigm,0.0,1.0,0.0,0.0
Scaffolding,0.0,1.0,0.0,0.0
Noise-reduction algorithm,0.0,1.0,0.0,0.0
Scene Complexity,1.0,0.0,0.0,0.0
Trial and error,0.0,0.0,1.0,0.0
Gambling persistence,0.0,0.0,1.0,0.0
Timing of activation,0.0,1.0,0.0,0.0
Hidden figures,1.0,0.0,0.0,0.0
Sleep onset,0.0,1.0,0.0,0.0
Verbal comprehension index,1.0,0.0,0.0,0.0
Personal familiarity,0.0,1.0,0.0,0.0
Unilateral visual neglect,0.0,0.0,0.0,1.0
Mitochondrial disorder,0.0,0.0,1.0,0.0
maternal preference,0.0,0.0,1.0,0.0
Perception processes,1.0,0.0,0.0,0.0
NICU,0.0,0.0,1.0,0.0
Style-based recognition,0.0,0.0,1.0,0.0
Correlational,0.0,1.0,0.0,0.0
Energy intake,1.0,0.0,0.0,0.0
Anticipation of emotional stimuli,0.0,0.0,1.0,0.0
Attentional control setting,1.0,0.0,0.0,0.0
lanthony D-15.,0.0,0.0,1.0,0.0
Beijing,1.0,0.0,0.0,0.0
Preterm born adults,0.0,0.0,1.0,0.0
Idiopathic,1.0,0.0,0.0,0.0
alarm misperception,1.0,0.0,0.0,0.0
Attentional processing,0.0,1.0,0.0,0.0
Gyrus rectus,0.0,0.0,1.0,0.0
Block Design,0.0,0.0,0.0,1.0
Degenerative illness,0.0,1.0,0.0,0.0
Saccade-related potential,1.0,0.0,0.0,0.0
Interior design,0.0,0.0,1.0,0.0
FMRI/PET/MRI,0.0,0.0,1.0,0.0
Carotid artery thrombosis,0.0,1.0,0.0,0.0
Response Bias,1.0,0.0,0.0,0.0
Humans/monkeys,0.0,1.0,0.0,0.0
Studies on effectiveness,0.0,0.0,1.0,0.0
Phonological processing skills,1.0,0.0,0.0,0.0
Visual form agnosia,0.0,0.0,1.0,0.0
Orientation and mobility,0.0,1.0,0.0,0.0
Stimulus notation,0.0,0.0,1.0,0.0
VISION,0.0,0.0,0.0,1.0
Object substitution masking,0.0,0.0,1.0,0.0
single-item assessment,0.0,0.0,1.0,0.0
Modular,1.0,0.0,0.0,0.0
pp. 527-539,0.0,1.0,0.0,0.0
Glutamine,0.0,0.0,1.0,0.0
Hands-free cell phone,0.0,0.0,1.0,0.0
Conduction disturbance,1.0,0.0,0.0,0.0
Brain size,0.0,0.0,0.0,1.0
Cognitive theory,0.0,0.0,1.0,0.0
Human agency,0.0,1.0,0.0,0.0
Barkana,1.0,0.0,0.0,0.0
Aircraft cockpit,0.0,0.0,1.0,0.0
Truth,1.0,0.0,0.0,0.0
Advance-cue usage,0.0,1.0,0.0,0.0
approach-avoidance,0.0,1.0,0.0,0.0
information graphics,0.0,1.0,0.0,0.0
Encoding deficit,0.0,0.0,1.0,0.0
Comprehensive FMRI battery,1.0,0.0,0.0,0.0
minima rule,0.0,1.0,0.0,0.0
Exudative age-related macular degeneration,0.0,0.0,1.0,0.0
Surface-based,0.0,0.0,0.0,1.0
team work,0.0,1.0,0.0,0.0
Cognition-dementia,0.0,0.0,1.0,0.0
Basic study,0.0,0.0,1.0,0.0
Tactile-kinesthetics,1.0,0.0,0.0,0.0
Moving window,0.0,0.0,1.0,0.0
Frustration,0.0,0.0,1.0,0.0
muscle MIBI,0.0,0.0,1.0,0.0
test construction,1.0,0.0,0.0,0.0
Task dissociation,0.0,0.0,1.0,0.0
Qualitative representation,0.0,0.0,1.0,0.0
Fire emergency,0.0,0.0,1.0,0.0
Mediational analyses,0.0,0.0,1.0,0.0
Autobiographical belief,1.0,0.0,0.0,0.0
Von Kries transformation,0.0,0.0,1.0,0.0
DLMO,0.0,0.0,1.0,0.0
Subjective stress,0.0,0.0,0.0,1.0
Longitudinal research,0.0,0.0,1.0,0.0
Laughter,0.0,0.0,1.0,0.0
Minimal access,0.0,1.0,0.0,0.0
Remitted major depression,1.0,0.0,0.0,0.0
Efavirenz,0.0,0.0,1.0,0.0
Social intelligence hypothesis,0.0,0.0,1.0,0.0
Novel metaphors,0.0,0.0,1.0,0.0
NBAS,0.0,0.0,1.0,0.0
Children cerebral palsy,0.0,0.0,1.0,0.0
behavioral rating scale,0.0,1.0,0.0,0.0
Isochrony principle,0.0,1.0,0.0,0.0
Human machine interface evaluation,0.0,0.0,1.0,0.0
Proton magnetic resonance spectroscopy (1H-MRS),1.0,0.0,0.0,0.0
Prison,0.0,1.0,0.0,0.0
visual masking,1.0,0.0,0.0,0.0
Emotional arousal,0.0,1.0,0.0,0.0
hyper-IgE,0.0,1.0,0.0,0.0
Flexible battery,0.0,0.0,1.0,0.0
transformation rule,0.0,0.0,0.0,1.0
Spasmodic torticollis,1.0,0.0,0.0,0.0
Neural process,1.0,0.0,0.0,0.0
Visual-perspective,0.0,0.0,0.0,1.0
ATRT,0.0,0.0,1.0,0.0
CPRESS,0.0,1.0,0.0,0.0
physical and cognitive exercise program,1.0,0.0,0.0,0.0
preeclampsia,0.0,0.0,1.0,0.0
Colloid cyst,1.0,0.0,0.0,0.0
Monocyte,0.0,0.0,1.0,0.0
Processing,1.0,0.0,0.0,0.0
Post-concussive syndrome,0.0,1.0,0.0,0.0
Motor decline,1.0,0.0,0.0,0.0
mental space,0.0,0.0,1.0,0.0
Nonlesional epilepsy,1.0,0.0,0.0,0.0
Anticoagulation,0.0,0.0,1.0,0.0
complex partial seizures,1.0,0.0,0.0,0.0
Panoramic photographs,0.0,1.0,0.0,0.0
psychosocial functioning,0.0,0.0,1.0,0.0
Olfactory groove meningioma,0.0,0.0,0.0,1.0
Dot comparison,0.0,0.0,1.0,0.0
Synaptic,0.0,0.0,1.0,0.0
Object binding,1.0,0.0,0.0,0.0
V1b receptor,0.0,0.0,1.0,0.0
Cognitive organization,1.0,0.0,0.0,0.0
Action-related conceptual knowledge,0.0,0.0,1.0,0.0
Event related synchronization/ desynchronization,0.0,1.0,0.0,0.0
Cheating,0.0,0.0,1.0,0.0
Perceptron,0.0,1.0,0.0,0.0
Visuospatial error,0.0,0.0,1.0,0.0
Sample sizes,0.0,0.0,0.0,1.0
Visual categorisation,0.0,0.0,1.0,0.0
Preconscious processing,0.0,0.0,1.0,0.0
Human comfortability,0.0,1.0,0.0,0.0
Visual analog scale,0.0,0.0,1.0,0.0
Pain threshold,0.0,0.0,0.0,1.0
Crossmodal processing,0.0,0.0,1.0,0.0
AF-DX 384,0.0,0.0,0.0,1.0
Social engagement,0.0,0.0,0.0,1.0
Chebyshev inequality,1.0,0.0,0.0,0.0
SKILL Dark Acuity,0.0,0.0,1.0,0.0
Visual scene,0.0,0.0,1.0,0.0
Orientation discrimination,0.0,0.0,1.0,0.0
Business communication,0.0,0.0,1.0,0.0
Dual task training,0.0,0.0,1.0,0.0
Idiopathic normal pressure hydrocephalus,0.0,0.0,1.0,0.0
Domain-general,0.0,0.0,1.0,0.0
E-Z Reader,0.0,1.0,0.0,0.0
Implicit task,0.0,1.0,0.0,0.0
Syntactic complexity,1.0,0.0,0.0,0.0
Ukraine : 1994)",0.0,0.0,0.0,0.0
Psychomotor/performance physiology,0.0,0.0,1.0,0.0
Visual field dependenceindependence,0.0,1.0,0.0,0.0
Cochlear implantation,0.0,0.0,1.0,0.0
Power,0.0,0.0,1.0,0.0
TOT phenomenon,1.0,0.0,0.0,0.0
Children at-risk of reading problems,0.0,0.0,0.0,1.0
Computer screen,0.0,0.0,0.0,1.0
laterality recognition,0.0,1.0,0.0,0.0
Audio feedback,1.0,0.0,0.0,0.0
Metacognitive skills training,0.0,1.0,0.0,0.0
Memory binding,0.0,1.0,0.0,0.0
Social emotions,0.0,1.0,0.0,0.0
Succimer,0.0,0.0,1.0,0.0
Depression symptoms,0.0,0.0,1.0,0.0
Environmental,1.0,0.0,0.0,0.0
CogniFit,0.0,1.0,0.0,0.0
Oncology practice,0.0,0.0,1.0,0.0
Screen,0.0,0.0,1.0,0.0
Remote sensing,0.0,1.0,0.0,0.0
Bayesian model comparison,1.0,0.0,0.0,0.0
Utilization behaviour,0.0,0.0,1.0,0.0
Collective memory,0.0,1.0,0.0,0.0
Mineralocorticoid receptor,1.0,0.0,0.0,0.0
Organophosphate,0.0,0.0,1.0,0.0
Neoplasms,0.0,1.0,0.0,0.0
Psychomotor functions,0.0,1.0,0.0,0.0
Redundant information,0.0,0.0,1.0,0.0
Binaural,1.0,0.0,0.0,0.0
Aortic arch replacement,0.0,0.0,1.0,0.0
Intentional forgetting,0.0,1.0,0.0,0.0
Gelastic,0.0,0.0,1.0,0.0
Symbolic reach,1.0,0.0,0.0,0.0
Theta oscillations,0.0,1.0,0.0,0.0
herpes simplex virus,1.0,0.0,0.0,0.0
Intracellular injection,1.0,0.0,0.0,0.0
CAD viewer,0.0,0.0,1.0,0.0
analytic methods,0.0,0.0,1.0,0.0
Paramedian,0.0,0.0,1.0,0.0
color and rhythm therapy,0.0,0.0,0.0,1.0
PCNA,0.0,0.0,1.0,0.0
Cognitive impairment in SLE,0.0,1.0,0.0,0.0
Episodic specificity,0.0,0.0,1.0,0.0
Age estimation,0.0,0.0,1.0,0.0
Antipsychotic drugs,0.0,1.0,0.0,0.0
Hebb rule,0.0,0.0,1.0,0.0
Flanker interference,0.0,0.0,1.0,0.0
Recognition without identification,0.0,0.0,1.0,0.0
Verbal comprehension,1.0,0.0,0.0,0.0
driver's license testing,0.0,0.0,1.0,0.0
Body concept,1.0,0.0,0.0,0.0
Living-nonliving things,0.0,1.0,0.0,0.0
eastern gray squirrel,0.0,0.0,1.0,0.0
pp. 1284-1296,0.0,0.0,1.0,0.0
Motor responses,0.0,0.0,1.0,0.0
Near-work induced transient myopia,1.0,0.0,0.0,0.0
Mechanical causality,0.0,0.0,1.0,0.0
Motion adaptation,0.0,1.0,0.0,0.0
Internal representations,0.0,0.0,1.0,0.0
Positive reinforcement,1.0,0.0,0.0,0.0
face-name learning,1.0,0.0,0.0,0.0
Interpersonal multisensory stimulation,0.0,1.0,0.0,0.0
Chinese character recognition,0.0,0.0,1.0,0.0
Ventral temporal object processing stream,0.0,0.0,1.0,0.0
Autoimmune,0.0,1.0,0.0,0.0
Cognitive timing,1.0,0.0,0.0,0.0
Alcohol outcome expectancies,1.0,0.0,0.0,0.0
Facilitating,0.0,0.0,1.0,0.0
Visual surrogate,0.0,1.0,0.0,0.0
Bidirectional,0.0,0.0,1.0,0.0
Declarative,1.0,0.0,0.0,0.0
maps,1.0,0.0,0.0,0.0
total brain atrophy,0.0,0.0,1.0,0.0
SDT sensitivity,0.0,1.0,0.0,0.0
"Cognitive impairment,0.0,0.0,0.0,0.0
Cause,0.0,0.0,1.0,0.0
Educational games,1.0,0.0,0.0,0.0
Rescorla-Wagner theory,1.0,0.0,0.0,0.0
Non-conceptual content,0.0,0.0,1.0,0.0
Single-trial detection,0.0,1.0,0.0,0.0
Story comprehension,1.0,0.0,0.0,0.0
Romantic relationships,1.0,0.0,0.0,0.0
Neural integration,0.0,0.0,1.0,0.0
Posterior negative potential,0.0,0.0,1.0,0.0
Word prediction,0.0,0.0,1.0,0.0
van Dam,0.0,0.0,1.0,0.0
Self-priming,0.0,0.0,0.0,1.0
visual deficits,0.0,0.0,1.0,0.0
Cold pressor,0.0,0.0,1.0,0.0
Recurrent,0.0,1.0,0.0,0.0
Word blindness,0.0,1.0,0.0,0.0
Radiologically isolated syndrome,0.0,1.0,0.0,0.0
Modality effect,0.0,0.0,0.0,1.0
Early onset psychosis,0.0,0.0,1.0,0.0
Ideomotor compatibility,0.0,0.0,1.0,0.0
Hylobates,0.0,0.0,1.0,0.0
TAU aggregates,0.0,0.0,1.0,0.0
Cold Pressor,0.0,1.0,0.0,0.0
Image fusion,0.0,1.0,0.0,0.0
Visual stress,0.0,1.0,0.0,0.0
Fragile X syndrome (FXS),0.0,0.0,1.0,0.0
Cognitive and perceptual development,1.0,0.0,0.0,0.0
Hand (reach),1.0,0.0,0.0,0.0
Interhemispheric approach,0.0,1.0,0.0,0.0
False alarms and misses,0.0,0.0,1.0,0.0
malaria,0.0,0.0,0.0,1.0
Visuomotor function,0.0,1.0,0.0,0.0
The Rey-Osterrieth Complex Figure Test,0.0,0.0,1.0,0.0
Face orientation,1.0,0.0,0.0,0.0
Gated communities,0.0,1.0,0.0,0.0
Verbal rating scale (VRS),0.0,1.0,0.0,0.0
Rolandic rhythm,0.0,0.0,1.0,0.0
Alcohol mixed with caffeinated beverages,0.0,0.0,0.0,1.0
Laser evoked potential,0.0,1.0,0.0,0.0
Vocalisation,0.0,0.0,0.0,1.0
Naive theory,1.0,0.0,0.0,0.0
Eventrelated potentials,0.0,0.0,1.0,0.0
traumatic stress,0.0,1.0,0.0,0.0
Nonpharmacological therapy,0.0,0.0,0.0,1.0
Visual form perception,1.0,0.0,0.0,0.0
Mobile health,0.0,0.0,1.0,0.0
NOR-test,0.0,0.0,1.0,0.0
Vector inhibition,0.0,0.0,1.0,0.0
nutrient balance,0.0,0.0,1.0,0.0
TAU,0.0,0.0,1.0,0.0
Associative strategies,0.0,1.0,0.0,0.0
clock test,1.0,0.0,0.0,0.0
allergy,0.0,1.0,0.0,0.0
credit assignment,0.0,0.0,1.0,0.0
Math problem solving,0.0,0.0,1.0,0.0
Topographic brain mapping,1.0,0.0,0.0,0.0
Central pontine myelinolysis,0.0,1.0,0.0,0.0
Mapping error,0.0,1.0,0.0,0.0
Bottom-up fusion,1.0,0.0,0.0,0.0
Art therapy relational neurobiology,0.0,1.0,0.0,0.0
"Assessment,0.0,0.0,0.0,0.0
Nuclear hypertrophy,0.0,0.0,1.0,0.0
Cognitive changes after adjuvant therapy,1.0,0.0,0.0,0.0
Simulator sickness,0.0,0.0,0.0,1.0
Sjgren's syndrome,0.0,0.0,1.0,0.0
Daytime cognitive function,0.0,0.0,1.0,0.0
Conflict-monitoring,0.0,1.0,0.0,0.0
imagination,0.0,1.0,0.0,0.0
Viewer-rotation task,0.0,1.0,0.0,0.0
Image variance,1.0,0.0,0.0,0.0
SOPESS,0.0,1.0,0.0,0.0
Expanding learning schedules,0.0,0.0,1.0,0.0
Visual degradation,0.0,0.0,0.0,1.0
Working alliance,0.0,0.0,1.0,0.0
Anticipatory activation,0.0,1.0,0.0,0.0
Similarity assessment,0.0,1.0,0.0,0.0
exercise intensity,0.0,0.0,1.0,0.0
Visual disambiguation,0.0,1.0,0.0,0.0
onset delay,0.0,0.0,1.0,0.0
sirtuin,0.0,0.0,1.0,0.0
semantic numerical representation,0.0,1.0,0.0,0.0
Chromaesthesia,0.0,1.0,0.0,0.0
RRS,0.0,1.0,0.0,0.0
Memory suppression,0.0,0.0,1.0,0.0
Contrast detection,0.0,0.0,1.0,0.0
Middle-adulthood,0.0,0.0,1.0,0.0
Central / peripheral,0.0,1.0,0.0,0.0
Complex attention,0.0,0.0,1.0,0.0
conference posters,0.0,0.0,1.0,0.0
Medical ethics,0.0,0.0,0.0,1.0
Perception of causality,0.0,0.0,1.0,0.0
Representation of knowledge,0.0,0.0,1.0,0.0
Object indexing,0.0,1.0,0.0,0.0
Female vs. male faces,0.0,0.0,1.0,0.0
Intermediates,0.0,0.0,0.0,1.0
Psychosocial outcomes,0.0,0.0,1.0,0.0
Double opponent,0.0,1.0,0.0,0.0
Auditory reaction time,0.0,1.0,0.0,0.0
Lactate,1.0,0.0,0.0,0.0
Category-specific activation,0.0,1.0,0.0,0.0
Cross-age invariance,0.0,1.0,0.0,0.0
Spatial semantics,0.0,0.0,1.0,0.0
Hiragana characters,1.0,0.0,0.0,0.0
AI,1.0,0.0,0.0,0.0
Nidopallium caudolaterale,1.0,0.0,0.0,0.0
Meg,0.0,1.0,0.0,0.0
Differences in lateralization,0.0,0.0,1.0,0.0
Zoological exhibits,0.0,1.0,0.0,0.0
Fuzzy brain,1.0,0.0,0.0,0.0
Subclinical depressive mood,0.0,1.0,0.0,0.0
Passenger vehicle,1.0,0.0,0.0,0.0
NMDA glutaminergic,0.0,0.0,1.0,0.0
Myelin oligodendrocyte glycoprotein (MOG),0.0,0.0,1.0,0.0
Attractor dynamics,1.0,0.0,0.0,0.0
Hierarchical model,0.0,1.0,0.0,0.0
UFOV,0.0,0.0,0.0,1.0
Intensive care unit,0.0,0.0,1.0,0.0
Corticobasal,1.0,0.0,0.0,0.0
Perceptual reasoning,0.0,0.0,1.0,0.0
Confidence-accuracy relationship,0.0,0.0,1.0,0.0
White matter impairments,0.0,0.0,1.0,0.0
Fitness to drive vision,0.0,0.0,1.0,0.0
Rotation axis,0.0,0.0,1.0,0.0
Integrated visual and auditory continuous performance test (IVA-CPT),0.0,1.0,0.0,0.0
Visual visuospatial working memory,0.0,1.0,0.0,0.0
Two-digit Arabic number,0.0,1.0,0.0,0.0
Brain damaged patients,1.0,0.0,0.0,0.0
Local anaesthetics,1.0,0.0,0.0,0.0
Testicular cancer,1.0,0.0,0.0,0.0
Niikawa-Kuroki syndrome,0.0,0.0,0.0,1.0
Estrogen receptor modulators,1.0,0.0,0.0,0.0
Sensorimotor control,0.0,0.0,1.0,0.0
invariance,0.0,1.0,0.0,0.0
Preventive medicine,0.0,0.0,1.0,0.0
Implicit Cognition,0.0,0.0,1.0,0.0
Troms Eye Study,1.0,0.0,0.0,0.0
Multimedia rehabilitation,0.0,0.0,1.0,0.0
Antiphospholipid antibody syndrome,1.0,0.0,0.0,0.0
geriatric impairments,0.0,0.0,1.0,0.0
Bantams,0.0,1.0,0.0,0.0
Joint problem space,0.0,1.0,0.0,0.0
Factors,0.0,0.0,1.0,0.0
Brain-Computer Interface,1.0,0.0,0.0,0.0
oral reading,0.0,1.0,0.0,0.0
Field dependence-independence,0.0,0.0,1.0,0.0
Emotion maintenance,0.0,0.0,1.0,0.0
SCOPA-Sleep scale,1.0,0.0,0.0,0.0
Brainstem cholinergic nuclei,0.0,1.0,0.0,0.0
Health problems,0.0,1.0,0.0,0.0
hazard information processing,1.0,0.0,0.0,0.0
SRT (speech reception threshold),0.0,1.0,0.0,0.0
Cognitive agent-based computing,0.0,0.0,1.0,0.0
Neural network modelling,0.0,0.0,0.0,1.0
Normal adults,1.0,0.0,0.0,0.0
Optical,0.0,0.0,0.0,1.0
Assembly,0.0,1.0,0.0,0.0
Issue 63,1.0,0.0,0.0,0.0
State-dependent information processing,0.0,0.0,1.0,0.0
pancreatic resection,0.0,1.0,0.0,0.0
Non-verbal skills,1.0,0.0,0.0,0.0
nephrology,1.0,0.0,0.0,0.0
Pain-related fear,0.0,1.0,0.0,0.0
Delayed match-to-sample task,0.0,1.0,0.0,0.0
qualitative methods,0.0,0.0,1.0,0.0
visuospatial skills,1.0,0.0,0.0,0.0
Sign language poetry,1.0,0.0,0.0,0.0
Subgroups,0.0,1.0,0.0,0.0
Pannexin,1.0,0.0,0.0,0.0
film and city,0.0,0.0,1.0,0.0
Structurefunction relationship,0.0,0.0,1.0,0.0
Cognitive studies of technology,0.0,0.0,1.0,0.0
stigma,0.0,0.0,1.0,0.0
Agelaius phoeniceus,1.0,0.0,0.0,0.0
Computer supported collaborative learning (CSCL),1.0,0.0,0.0,0.0
Selegiline,0.0,0.0,1.0,0.0
Selection-for-perception,0.0,1.0,0.0,0.0
Family studies,0.0,0.0,1.0,0.0
Medical decision making,0.0,0.0,0.0,1.0
Cerebro-spinal fluid dynamics,0.0,0.0,1.0,0.0
Right,0.0,1.0,0.0,0.0
Public service announcement,0.0,0.0,0.0,1.0
Anodal tDCS,0.0,0.0,1.0,0.0
Dynamic systems,0.0,0.0,1.0,0.0
lipids,1.0,0.0,0.0,0.0
Early visual perception,0.0,1.0,0.0,0.0
Spatial and temporal context,0.0,1.0,0.0,0.0
Word generation task,0.0,0.0,1.0,0.0
Need for assistance,0.0,0.0,1.0,0.0
WM,1.0,0.0,0.0,0.0
Oxytocinase,1.0,0.0,0.0,0.0
Collaborative cognition,0.0,0.0,1.0,0.0
screening tool,0.0,0.0,0.0,1.0
Cognitive empathy,0.0,0.0,1.0,0.0
Dorsal and ventral visual systems,0.0,1.0,0.0,0.0
GMFCS,1.0,0.0,0.0,0.0
Affective states,0.0,0.0,1.0,0.0
Cognitive structures,1.0,0.0,0.0,0.0
picture categorization,0.0,0.0,1.0,0.0
Bsessive-compulsive disorder,0.0,1.0,0.0,0.0
beta,0.0,0.0,0.0,1.0
rehearsal,0.0,0.0,1.0,0.0
support surface,0.0,0.0,0.0,1.0
Timing of treatment,0.0,0.0,1.0,0.0
TIMM8A,0.0,0.0,0.0,1.0
pre-frontal cortex,0.0,0.0,1.0,0.0
Making measures accessible,0.0,1.0,0.0,0.0
Focused attention meditation (FAM),0.0,1.0,0.0,0.0
Mediation analysis,0.0,0.0,1.0,0.0
Object-location memory,0.0,1.0,0.0,0.0
Multi-Stimulus Box,0.0,1.0,0.0,0.0
object representation,0.0,1.0,0.0,0.0
mental simulation,0.0,1.0,0.0,0.0
Response shifting,0.0,0.0,1.0,0.0
Augmented objects,0.0,0.0,0.0,1.0
Cerebral autoregulation,1.0,0.0,0.0,0.0
Phase-encoded design,0.0,1.0,0.0,0.0
Abduction,0.0,0.0,1.0,0.0
Judgment accuracy,0.0,0.0,1.0,0.0
PVT,0.0,0.0,1.0,0.0
Population immigrating high altitude,0.0,0.0,0.0,1.0
cognitive task analysis,0.0,1.0,0.0,0.0
apathy,0.0,0.0,1.0,0.0
Reliable change indices,0.0,1.0,0.0,0.0
visual Wulst,0.0,0.0,1.0,0.0
Humanities,0.0,1.0,0.0,0.0
Time and motion studies,0.0,0.0,1.0,0.0
Jet pilots,0.0,0.0,1.0,0.0
Ontogeny,0.0,0.0,1.0,0.0
Anxiolytics,0.0,0.0,1.0,0.0
Own-ethnicity effect,0.0,0.0,1.0,0.0
Visual remapping of touch,0.0,1.0,0.0,0.0
Driving Performance,0.0,1.0,0.0,0.0
Adaptation effect,0.0,1.0,0.0,0.0
conditional random fields,0.0,1.0,0.0,0.0
Prenatal hormones,0.0,1.0,0.0,0.0
Evaluative bias,0.0,0.0,1.0,0.0
Work-centered support systems,0.0,0.0,1.0,0.0
Performance prediction,1.0,0.0,0.0,0.0
Kea,0.0,0.0,1.0,0.0
Object recognition task (ORT),1.0,0.0,0.0,0.0
Caregiver issues,1.0,0.0,0.0,0.0
Word fluency,0.0,1.0,0.0,0.0
Novel place recognition,1.0,0.0,0.0,0.0
Art and cognition,0.0,0.0,1.0,0.0
Psychomotor functioning,0.0,0.0,1.0,0.0
translational validity,1.0,0.0,0.0,0.0
Stream segregation,0.0,0.0,1.0,0.0
Magnetic resonance imaging brain scan,0.0,0.0,1.0,0.0
lexical retrieval of proper names,0.0,1.0,0.0,0.0
attentional deployment,1.0,0.0,0.0,0.0
Math learning difficulties,0.0,1.0,0.0,0.0
Mental demand,0.0,0.0,1.0,0.0
general cognitive factor,0.0,1.0,0.0,0.0
Cross-species,0.0,1.0,0.0,0.0
Perceptual invariances,0.0,1.0,0.0,0.0
laminar computing,0.0,1.0,0.0,0.0
Binge-eating,0.0,1.0,0.0,0.0
Digital imaging,1.0,0.0,0.0,0.0
Post-occupancy evaluation,0.0,1.0,0.0,0.0
Across-subject variability,0.0,1.0,0.0,0.0
Glycemic index,0.0,1.0,0.0,0.0
Regularity,0.0,1.0,0.0,0.0
Nonverbal vocalization,0.0,0.0,1.0,0.0
Sexual desire,0.0,0.0,0.0,1.0
Blind sailors,0.0,0.0,1.0,0.0
Driver's license test,0.0,1.0,0.0,0.0
"47,0.0,0.0,0.0,0.0
Event related coherence,1.0,0.0,0.0,0.0
Processing resources,0.0,0.0,1.0,0.0
Right visual field advantage,1.0,0.0,0.0,0.0
Saccade probability,0.0,0.0,1.0,0.0
Global motion processing,0.0,0.0,0.0,1.0
object-substance distinction,1.0,0.0,0.0,0.0
Stimulus generalization,1.0,0.0,0.0,0.0
Natural behavior,0.0,0.0,1.0,0.0
Count-mass,0.0,1.0,0.0,0.0
Written numbers,0.0,0.0,0.0,1.0
Cryptogenic focal epilepsy,0.0,0.0,1.0,0.0
background music,1.0,0.0,0.0,0.0
Encoding schemes,0.0,0.0,1.0,0.0
pulmonary rehabilitation,0.0,1.0,0.0,0.0
Endocrine therapy,0.0,0.0,1.0,0.0
object orientation,1.0,0.0,0.0,0.0
2D shape decomposition,0.0,1.0,0.0,0.0
Intellectual performance,1.0,0.0,0.0,0.0
Morris maze,0.0,0.0,1.0,0.0
Spatial categorisation,0.0,0.0,1.0,0.0
Exposure time,0.0,0.0,1.0,0.0
Event files,0.0,0.0,1.0,0.0
Li-Am,0.0,1.0,0.0,0.0
Visuo-spatial forms,0.0,1.0,0.0,0.0
image quality assessment,0.0,0.0,1.0,0.0
Rejection sensitivity,0.0,1.0,0.0,0.0
Masked_priming,0.0,0.0,0.0,1.0
Unfairness,0.0,0.0,1.0,0.0
DSI,0.0,0.0,1.0,0.0
Accenting,1.0,0.0,0.0,0.0
Temporopolar cortex,0.0,1.0,0.0,0.0
Learning strategy,0.0,1.0,0.0,0.0
Focal movement,0.0,0.0,1.0,0.0
Cross-sectional study,1.0,0.0,0.0,0.0
Chiapas,0.0,0.0,1.0,0.0
functional outcome,0.0,0.0,0.0,1.0
Nitrate (NO<inf>3</inf>-),0.0,0.0,1.0,0.0
School furniture,0.0,0.0,1.0,0.0
displays and controls,0.0,0.0,1.0,0.0
Group Based Perception,1.0,0.0,0.0,0.0
Response-bias distortion,0.0,1.0,0.0,0.0
Ischemia-reperfusion injury,0.0,0.0,0.0,1.0
Action-effect prediction,0.0,1.0,0.0,0.0
Responsive search score,0.0,0.0,1.0,0.0
Endovascular embolization,0.0,1.0,0.0,0.0
Road crossing,0.0,0.0,1.0,0.0
Response to treatment,0.0,0.0,0.0,1.0
Everyday memory,0.0,0.0,0.0,1.0
White matter integrity,0.0,1.0,0.0,0.0
Motor vehicle collisions,0.0,0.0,1.0,0.0
transient ischemic attack,0.0,0.0,1.0,0.0
PTSD (posttraumatic stress disorder),1.0,0.0,0.0,0.0
Urban tourism destination,1.0,0.0,0.0,0.0
"""Use"" and ""Grasp"" systems,0.0,1.0,0.0,0.0
visual adolescents,0.0,0.0,0.0,1.0
Pairing naming,0.0,1.0,0.0,0.0
Cross-domain cognition,0.0,1.0,0.0,0.0
CNQX,1.0,0.0,0.0,0.0
Winning,1.0,0.0,0.0,0.0
Judd illusion,0.0,0.0,0.0,1.0
Danaini,0.0,1.0,0.0,0.0
Bayley Scales of Infant and Toddler Development-Third Edition,0.0,0.0,0.0,1.0
Left inferior frontal gyrus,0.0,0.0,0.0,1.0
Flexible categorization,0.0,0.0,1.0,0.0
Hippocampal subregions,0.0,1.0,0.0,0.0
Mathematics instruction,1.0,0.0,0.0,0.0
vMMN,0.0,1.0,0.0,0.0
Multiple cognitive investigation,0.0,0.0,1.0,0.0
Right-left discrimination,0.0,0.0,1.0,0.0
Observational pain tools,0.0,1.0,0.0,0.0
Object saliency,0.0,0.0,1.0,0.0
Varicella-zoster virus (VZV),0.0,1.0,0.0,0.0
Emotional perception impairment,0.0,0.0,1.0,0.0
Lane change task,1.0,0.0,0.0,0.0
Tibet,0.0,0.0,1.0,0.0
Antiparkinsonian agents,1.0,0.0,0.0,0.0
Group attention,0.0,1.0,0.0,0.0
procedural learning,0.0,0.0,1.0,0.0
Primary taste cortex,0.0,1.0,0.0,0.0
Vuilleumier,0.0,0.0,1.0,0.0
Bounded optimality,1.0,0.0,0.0,0.0
Bilateral insula,1.0,0.0,0.0,0.0
wh- movement,1.0,0.0,0.0,0.0
Symbol identification,0.0,0.0,1.0,0.0
human factors,1.0,0.0,0.0,0.0
Late positive component (LPC),0.0,0.0,1.0,0.0
Medication nave,0.0,0.0,1.0,0.0
Emotional visual stimuli,0.0,1.0,0.0,0.0
Visual practices,0.0,1.0,0.0,0.0
Postictal,0.0,1.0,0.0,0.0
Pathological anxiety,0.0,1.0,0.0,0.0
Visuospatial representations,1.0,0.0,0.0,0.0
Autopoiesis,0.0,0.0,1.0,0.0
holistic processing,1.0,0.0,0.0,0.0
diagnostic markers,1.0,0.0,0.0,0.0
Agent-Based Model,1.0,0.0,0.0,0.0
Corticoreticulospinal tract,0.0,1.0,0.0,0.0
Petrol sniffing,0.0,0.0,0.0,1.0
Instrumental learning,0.0,0.0,1.0,0.0
Bottom-up saliency,0.0,0.0,1.0,0.0
Autonomous agents,1.0,0.0,0.0,0.0
Prenatal diagnosis,0.0,1.0,0.0,0.0
Language minority learners,0.0,0.0,1.0,0.0
Detrended fluctuation analysis,0.0,1.0,0.0,0.0
Alcohol Use Questionnaire (AUQ),0.0,0.0,0.0,1.0
Shape-from-shading,0.0,0.0,0.0,1.0
navigational strategies,1.0,0.0,0.0,0.0
Dorso-medial prefrontal cortex,0.0,0.0,0.0,1.0
Arm,0.0,0.0,0.0,1.0
Arc,1.0,0.0,0.0,0.0
Sequencing skill,0.0,1.0,0.0,0.0
HBO<inf>2</inf>,0.0,0.0,1.0,0.0
Visual-world eye-tracking,0.0,0.0,0.0,1.0
diffusion MRI,1.0,0.0,0.0,0.0
cognitive set,0.0,0.0,1.0,0.0
Eye tracker,0.0,0.0,0.0,1.0
Neuroendocrinology,0.0,0.0,1.0,0.0
STROOP task,0.0,1.0,0.0,0.0
Preterm infant,0.0,0.0,1.0,0.0
Hypobaric chamber training,0.0,0.0,1.0,0.0
Knowledge systems,0.0,0.0,1.0,0.0
ICH S9,0.0,1.0,0.0,0.0
Binocular vision,0.0,0.0,1.0,0.0
Brief nap,1.0,0.0,0.0,0.0
Perceptual consciousness,0.0,1.0,0.0,0.0
Diffusion-weighted MRI,0.0,0.0,1.0,0.0
Anterior third ventricle,0.0,0.0,0.0,1.0
Explicit categorization,0.0,1.0,0.0,0.0
Speed-accuracy tradeoff,0.0,0.0,1.0,0.0
perceptual style,0.0,1.0,0.0,0.0
Spatial alignment,0.0,1.0,0.0,0.0
Marmosets,0.0,1.0,0.0,0.0
punishment,0.0,0.0,1.0,0.0
Alignable differences,0.0,0.0,1.0,0.0
Congruence,1.0,0.0,0.0,0.0
Visuospatial working memory capacity,1.0,0.0,0.0,0.0
Accidents,0.0,0.0,1.0,0.0
Values,1.0,0.0,0.0,0.0
Visual and auditory perception,0.0,1.0,0.0,0.0
Medial temporal lobe memory system,1.0,0.0,0.0,0.0
Attention shift,0.0,0.0,0.0,1.0
V6,0.0,1.0,0.0,0.0
V5,0.0,1.0,0.0,0.0
Calculation efficiency,1.0,0.0,0.0,0.0
Unmodulated noise,0.0,0.0,0.0,1.0
Language and word processin,0.0,0.0,1.0,0.0
Autism spectrum,0.0,0.0,1.0,0.0
Diagnostic classification,0.0,0.0,1.0,0.0
critical discourse analysis,0.0,0.0,1.0,0.0
Blood oxygenation,0.0,0.0,1.0,0.0
Draft picks,0.0,0.0,1.0,0.0
Delayed Onset,0.0,0.0,1.0,0.0
driving performance,0.0,1.0,0.0,0.0
Double dose,0.0,0.0,1.0,0.0
Infants with severe developmental delay,0.0,1.0,0.0,0.0
Gestalt theory,0.0,0.0,1.0,0.0
Rhythmic irregularities,0.0,0.0,1.0,0.0
Epileptic,0.0,0.0,0.0,1.0
Back propagation,0.0,1.0,0.0,0.0
Exploratory behavior,0.0,0.0,0.0,1.0
M390R mutation,0.0,0.0,1.0,0.0
Smoothing pesudo-Wigner-Ville distribution (SPWVD),0.0,1.0,0.0,0.0
Ventral lateral PFC,0.0,0.0,1.0,0.0
Motor activity,0.0,1.0,0.0,0.0
Descending modulation,0.0,0.0,1.0,0.0
Achromatopsia,0.0,0.0,1.0,0.0
Riding experience,0.0,0.0,1.0,0.0
Clinico-pathological,0.0,1.0,0.0,0.0
nonamnestic mild cognitive impairment,1.0,0.0,0.0,0.0
Prefrontal cortex primate,0.0,1.0,0.0,0.0
Quetiapine immediate release,0.0,0.0,1.0,0.0
Symptom validity,0.0,0.0,0.0,1.0
Nonverbal LD,0.0,0.0,1.0,0.0
Tactile spatial resolution,0.0,0.0,1.0,0.0
EDSS,0.0,0.0,1.0,0.0
Quantification Theory Type I,0.0,0.0,1.0,0.0
Sensory bias,0.0,0.0,1.0,0.0
Motor affordances,0.0,0.0,0.0,1.0
Post-secondary education,0.0,1.0,0.0,0.0
Inter-areal synchrony,0.0,0.0,1.0,0.0
Left hemisphere activation,1.0,0.0,0.0,0.0
Sexual arousal,0.0,0.0,1.0,0.0
Physical aspect,0.0,0.0,1.0,0.0
Biological and environmental factors,0.0,0.0,1.0,0.0
Others,0.0,0.0,1.0,0.0
Interictal EEG discharges,0.0,0.0,1.0,0.0
sensory function,1.0,0.0,0.0,0.0
Face-responsive neurons,0.0,0.0,1.0,0.0
Perfusion,0.0,0.0,0.0,1.0
Gross motor skills,1.0,0.0,0.0,0.0
Thigmotaxis,0.0,0.0,1.0,0.0
observation,0.0,0.0,1.0,0.0
Content specificity,1.0,0.0,0.0,0.0
Verbal-instructions,0.0,1.0,0.0,0.0
Verbal and visual long term memory,0.0,0.0,1.0,0.0
Clinical practice,0.0,0.0,1.0,0.0
Follow-upstudy,0.0,1.0,0.0,0.0
Task-positive,0.0,0.0,1.0,0.0
Visual impairment through virtual simulation,0.0,1.0,0.0,0.0
Egyptian,0.0,0.0,1.0,0.0
E-CIAIS systems,0.0,0.0,1.0,0.0
Visuospatial level 1 perspective taking,0.0,0.0,0.0,1.0
Perceptual capacity,0.0,0.0,1.0,0.0
Appearance adjustment,0.0,0.0,0.0,1.0
ginger,0.0,0.0,1.0,0.0
Critical care,0.0,0.0,0.0,1.0
Cognitive system,0.0,1.0,0.0,0.0
Web-based research,0.0,0.0,1.0,0.0
Negative emotion networks,1.0,0.0,0.0,0.0
connectionism,0.0,0.0,0.0,1.0
Adult neuropsychology,1.0,0.0,0.0,0.0
External cues,1.0,0.0,0.0,0.0
Changes of mind,1.0,0.0,0.0,0.0
Information architecture,0.0,1.0,0.0,0.0
Subcortical route,0.0,1.0,0.0,0.0
Lesion mapping,0.0,0.0,1.0,0.0
cognitive models,0.0,0.0,1.0,0.0
Cognitive controls,0.0,0.0,0.0,1.0
Dimethyltryptamine,1.0,0.0,0.0,0.0
Feature learning,0.0,1.0,0.0,0.0
Lateralized N2,0.0,0.0,1.0,0.0
Grasping action,0.0,0.0,1.0,0.0
Preserved IQ,0.0,0.0,1.0,0.0
Pedestrian crossing signs,0.0,1.0,0.0,0.0
Gabor filter,0.0,0.0,1.0,0.0
Misinformation effects,0.0,0.0,1.0,0.0
Positive slow wave,0.0,0.0,1.0,0.0
Dyads,0.0,0.0,1.0,0.0
SST,1.0,0.0,0.0,0.0
Visual supports,0.0,1.0,0.0,0.0
Circuit,0.0,0.0,1.0,0.0
Impressions of foreseeability,1.0,0.0,0.0,0.0
Bi-stable perception,0.0,1.0,0.0,0.0
Functional network,0.0,0.0,1.0,0.0
Neuropsychologic,0.0,0.0,1.0,0.0
Cortical inhibition,0.0,0.0,1.0,0.0
Sustained selective attention,1.0,0.0,0.0,0.0
Lag-1 sparing,1.0,0.0,0.0,0.0
Retrospective semantic matching,0.0,0.0,1.0,0.0
Material-specific impairment,0.0,1.0,0.0,0.0
apolipoprotein,0.0,0.0,1.0,0.0
Training procedure,0.0,0.0,0.0,1.0
Letter position representation,0.0,0.0,1.0,0.0
Visual reaction times,0.0,0.0,1.0,0.0
Cotard syndrome,0.0,0.0,1.0,0.0
Hemifield paradigm,1.0,0.0,0.0,0.0
MEM 3454,0.0,0.0,1.0,0.0
Swarming behaviour,0.0,1.0,0.0,0.0
Sensory-motor area,0.0,1.0,0.0,0.0
Dental treatment,0.0,0.0,1.0,0.0
Rostral brainstem,1.0,0.0,0.0,0.0
Path,0.0,1.0,0.0,0.0
RELN,0.0,0.0,1.0,0.0
Saccade generation,0.0,0.0,1.0,0.0
Conditional probability,0.0,0.0,0.0,1.0
Balance disorder,0.0,1.0,0.0,0.0
Face blindness,0.0,0.0,1.0,0.0
Video ethnography,0.0,1.0,0.0,0.0
Visual mental representations,0.0,1.0,0.0,0.0
Educational game,0.0,0.0,1.0,0.0
Precision grasp,0.0,0.0,1.0,0.0
Dachshund,0.0,0.0,1.0,0.0
Lexical learning,0.0,1.0,0.0,0.0
Phase lag,0.0,0.0,0.0,1.0
Low birth weight infants,0.0,0.0,1.0,0.0
Logarithmic coding,0.0,0.0,1.0,0.0
Unified Parkinson's Disease Rating Scale,0.0,0.0,0.0,1.0
Second language processing,0.0,0.0,1.0,0.0
Perceptual/motor skills,0.0,0.0,1.0,0.0
Dissociative processing style,0.0,1.0,0.0,0.0
Amodal,0.0,0.0,1.0,0.0
Chromosomal abnormalities,1.0,0.0,0.0,0.0
Joint decision-making,1.0,0.0,0.0,0.0
Psychologie und Psychotherapie",0.0,0.0,0.0,0.0
Correlated variability,0.0,1.0,0.0,0.0
Late-life mood disorder,0.0,0.0,1.0,0.0
movies,0.0,1.0,0.0,0.0
emotional interference,0.0,0.0,1.0,0.0
Chronic exposition,0.0,1.0,0.0,0.0
Visual tilt,0.0,1.0,0.0,0.0
Refraction,0.0,1.0,0.0,0.0
age-related changes in brain structures,0.0,0.0,1.0,0.0
Phylogeny,0.0,1.0,0.0,0.0
N.J.)",0.0,0.0,0.0,0.0
Invalid cue,0.0,0.0,1.0,0.0
Teratology,0.0,1.0,0.0,0.0
War/peace,0.0,0.0,1.0,0.0
Pulmonary thromboendarterectomy,0.0,0.0,1.0,0.0
mobility,0.0,0.0,0.0,1.0
Diazepam,0.0,0.0,1.0,0.0
Intrinsic brain networks,0.0,0.0,1.0,0.0
Visual cognitive skills,0.0,1.0,0.0,0.0
Chronic Fatigue,0.0,1.0,0.0,0.0
Wordchains,0.0,0.0,1.0,0.0
polyphenol,0.0,1.0,0.0,0.0
Axon propagation speed,0.0,1.0,0.0,0.0
Visual categorization task,0.0,0.0,1.0,0.0
hMT/V5,1.0,0.0,0.0,0.0
mirror neurons,0.0,0.0,1.0,0.0
Sustained visual attention,0.0,0.0,1.0,0.0
Online laboratory,0.0,1.0,0.0,0.0
healthy elderly,0.0,1.0,0.0,0.0
general cognitive ability,0.0,1.0,0.0,0.0
Computer aided drafting (CAD),1.0,0.0,0.0,0.0
Visual preferences,0.0,0.0,1.0,0.0
Conjugated equine estrogens,0.0,0.0,1.0,0.0
Forward/backward span,0.0,0.0,0.0,1.0
Neural precursor groups,0.0,0.0,1.0,0.0
Paradigm of pointing,0.0,0.0,0.0,1.0
Line drawings,0.0,1.0,0.0,0.0
Analgesic,1.0,0.0,0.0,0.0
multivariate genetic analysis,0.0,1.0,0.0,0.0
Tympanic membrane temperature,0.0,0.0,0.0,1.0
neurological disorders,0.0,1.0,0.0,0.0
Public policy,0.0,1.0,0.0,0.0
Behavioural phenotypes,0.0,0.0,0.0,1.0
Summary statistics,0.0,0.0,1.0,0.0
gravity error,1.0,0.0,0.0,0.0
Inter Stimulus Interval,1.0,0.0,0.0,0.0
Three-stimulus oddball paradigm,0.0,0.0,1.0,0.0
E-commerce,0.0,0.0,1.0,0.0
figural realism,1.0,0.0,0.0,0.0
simultaneous stimulation,0.0,0.0,0.0,1.0
Transitive reasoning,0.0,0.0,1.0,0.0
ipods,0.0,1.0,0.0,0.0
multimodal,0.0,0.0,1.0,0.0
CA1 region,1.0,0.0,0.0,0.0
Signal detection analysis,0.0,0.0,1.0,0.0
Wavelet analysis,0.0,0.0,1.0,0.0
Alpha-beta,0.0,0.0,1.0,0.0
3D shapes,0.0,0.0,1.0,0.0
Pain Acute And Postoperative,1.0,0.0,0.0,0.0
Attention system,0.0,1.0,0.0,0.0
Functional cerebral asymmetry,0.0,1.0,0.0,0.0
Parietal damage,1.0,0.0,0.0,0.0
Diminished expression,1.0,0.0,0.0,0.0
Retrieval orientation,0.0,1.0,0.0,0.0
Biological clock,0.0,0.0,1.0,0.0
Peptide,1.0,0.0,0.0,0.0
Volumetric measurement,0.0,1.0,0.0,0.0
Rapid processing,0.0,1.0,0.0,0.0
Complex action,0.0,1.0,0.0,0.0
Phenomenal causality,0.0,1.0,0.0,0.0
Ambulatory long-term ECG,0.0,1.0,0.0,0.0
accumulator model,1.0,0.0,0.0,0.0
BBS1 gene,0.0,0.0,1.0,0.0
perception-action coupling,0.0,1.0,0.0,0.0
AZD6280,0.0,1.0,0.0,0.0
Conceptualization ability,0.0,1.0,0.0,0.0
Object-files,0.0,0.0,1.0,0.0
Mental,1.0,0.0,0.0,0.0
Archaeology,0.0,0.0,1.0,0.0
Temporal SNR,0.0,1.0,0.0,0.0
Perceptual grouping and organization,0.0,0.0,1.0,0.0
Whole brain radiotherapy,1.0,0.0,0.0,0.0
Context-effect,0.0,0.0,1.0,0.0
reaching,0.0,0.0,1.0,0.0
Perceptual motor coordination,0.0,0.0,1.0,0.0
Anterior shift,0.0,0.0,0.0,1.0
Prevalence trends,1.0,0.0,0.0,0.0
14-3-3,0.0,0.0,1.0,0.0
Sleeping hour,1.0,0.0,0.0,0.0
False sign reasoning,0.0,0.0,1.0,0.0
Neuro-development,0.0,1.0,0.0,0.0
Feedback signal,0.0,0.0,1.0,0.0
Avoid,0.0,1.0,0.0,0.0
Random generation task,0.0,1.0,0.0,0.0
Neural processing models,0.0,0.0,1.0,0.0
Positive mood,0.0,0.0,1.0,0.0
Information processing biases,0.0,1.0,0.0,0.0
Goal management,0.0,0.0,1.0,0.0
Dysfunctional cognition,1.0,0.0,0.0,0.0
Perceptual processes,0.0,0.0,1.0,0.0
Early action understanding,0.0,0.0,1.0,0.0
Subjective scales,1.0,0.0,0.0,0.0
Multimodal pain therapy,0.0,1.0,0.0,0.0
James Lind Alliance,0.0,1.0,0.0,0.0
Addison's disease,0.0,1.0,0.0,0.0
narcolepsy,0.0,1.0,0.0,0.0
Transposed-letter effect,0.0,1.0,0.0,0.0
Duality,0.0,0.0,0.0,1.0
TIN,0.0,0.0,0.0,1.0
Counterfactual thinking,0.0,1.0,0.0,0.0
Endoscopic neurosurgery,0.0,0.0,1.0,0.0
Attention cognitive model,1.0,0.0,0.0,0.0
Degraded stimuli,0.0,1.0,0.0,0.0
Naturalistic driving,0.0,0.0,1.0,0.0
P3b component,0.0,0.0,0.0,0.0
Gene homology,1.0,0.0,0.0,0.0
Synchronous,0.0,0.0,1.0,0.0
Phoneme awareness,0.0,0.0,1.0,0.0
neuropathy,0.0,0.0,1.0,0.0
Visual cliff,0.0,0.0,0.0,1.0
risk-taking behavior,0.0,1.0,0.0,0.0
Advanced driver assistance system,1.0,0.0,0.0,0.0
Aluminum,0.0,1.0,0.0,0.0
Common coding theory,0.0,1.0,0.0,0.0
Compatibility effects,0.0,1.0,0.0,0.0
Touchscreen chambers,0.0,1.0,0.0,0.0
clinical trials,0.0,0.0,1.0,0.0
Adult learning,0.0,0.0,0.0,1.0
Pesticides exposure,1.0,0.0,0.0,0.0
Indirect effect attributions,1.0,0.0,0.0,0.0
dopamine system,0.0,0.0,1.0,0.0
Ribavirin,0.0,0.0,1.0,0.0
Maculation,0.0,1.0,0.0,0.0
Barnes maze,0.0,0.0,1.0,0.0
Basic feature,0.0,0.0,1.0,0.0
Stair gait,0.0,0.0,1.0,0.0
Neurobehavioral performance,0.0,0.0,1.0,0.0
Myotonic dystrophy type 1 (DM 1),0.0,0.0,1.0,0.0
Reinforcement larning,0.0,0.0,1.0,0.0
Multivariate dynamical system model,0.0,1.0,0.0,0.0
Evoked-responses,0.0,0.0,0.0,1.0
First-person perspective,1.0,0.0,0.0,0.0
neurofibromatosis Type 1,0.0,0.0,1.0,0.0
Social categorization,0.0,0.0,1.0,0.0
dopamine dsocial science receptor,1.0,0.0,0.0,0.0
pedagogical considerations,0.0,0.0,0.0,1.0
Morphosyntactic,0.0,1.0,0.0,0.0
Binding problem,1.0,0.0,0.0,0.0
Amodal processing,0.0,0.0,1.0,0.0
Functional focus,0.0,1.0,0.0,0.0
Reversal learning set,0.0,0.0,1.0,0.0
Motor encoding,0.0,1.0,0.0,0.0
Minority health,0.0,0.0,1.0,0.0
Stereotypies,0.0,0.0,1.0,0.0
Concrete scale,1.0,0.0,0.0,0.0
donepezil,0.0,0.0,1.0,0.0
Post-novelty distraction,0.0,0.0,0.0,1.0
Voice discrimination,1.0,0.0,0.0,0.0
Perceptual representations,1.0,0.0,0.0,0.0
Rate control,0.0,0.0,0.0,1.0
Brain length,0.0,0.0,0.0,1.0
Off-pump surgery,0.0,1.0,0.0,0.0
Unpredictability,0.0,0.0,1.0,0.0
Endophenotype research,0.0,1.0,0.0,0.0
Level of detail,1.0,0.0,0.0,0.0
Midline thalamic nuclei,0.0,0.0,1.0,0.0
3D Web,0.0,0.0,0.0,1.0
Perceptual recognition,0.0,0.0,1.0,0.0
Open-field test,0.0,0.0,0.0,1.0
diagnostic validity,0.0,1.0,0.0,0.0
Simplex networks,0.0,0.0,0.0,1.0
Tactile textures,0.0,0.0,1.0,0.0
Cytokine theory,0.0,0.0,1.0,0.0
mortality,1.0,0.0,0.0,0.0
Normative,0.0,0.0,1.0,0.0
HCI,0.0,1.0,0.0,0.0
Communicative tasks,1.0,0.0,0.0,0.0
Lexical neighborhood,0.0,0.0,1.0,0.0
Genotyping,0.0,1.0,0.0,0.0
Psi,0.0,0.0,0.0,1.0
brain irradiation,0.0,1.0,0.0,0.0
audio-visual media,0.0,0.0,0.0,1.0
longitudinal assessment,0.0,0.0,1.0,0.0
Vestibular reflexes,0.0,0.0,1.0,0.0
Papio anubis,0.0,1.0,0.0,0.0
Mirror circuit,0.0,0.0,1.0,0.0
D.C.)",0.0,0.0,0.0,0.0
Encephalomalacia,0.0,0.0,1.0,0.0
Multimodally expressed humour,0.0,0.0,0.0,1.0
Prenatal steroids,0.0,0.0,1.0,0.0
Images and cognition,0.0,0.0,1.0,0.0
Extreme value distribution,0.0,0.0,1.0,0.0
Visual space,0.0,0.0,1.0,0.0
Quantum cognitive observables,0.0,0.0,1.0,0.0
Auditory-visual,0.0,1.0,0.0,0.0
Interview,0.0,0.0,1.0,0.0
High-voltage electrical trauma,0.0,1.0,0.0,0.0
Extremely Preterm Infants in Sweden Study,0.0,0.0,0.0,1.0
Symmetry perception,0.0,1.0,0.0,0.0
film and place,0.0,0.0,1.0,0.0
Macmillan,1.0,0.0,0.0,0.0
Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons (2008) Neuropsychopharmacology,1.0,0.0,0.0,0.0
Kernel methods,0.0,1.0,0.0,0.0
Associated movements,0.0,1.0,0.0,0.0
Gears,0.0,0.0,1.0,0.0
Wind power,0.0,0.0,1.0,0.0
Number connection test,1.0,0.0,0.0,0.0
[11C] Raclopride,0.0,0.0,1.0,0.0
twin study,0.0,0.0,1.0,0.0
Hallucinations in dementia,0.0,0.0,1.0,0.0
spatial representation,0.0,1.0,0.0,0.0
Response distribution,0.0,0.0,1.0,0.0
randomized,0.0,0.0,1.0,0.0
Emotional recognition,0.0,0.0,1.0,0.0
Functional weakness,1.0,0.0,0.0,0.0
Poor social functioning,1.0,0.0,0.0,0.0
Multi-scale dynamics,0.0,1.0,0.0,0.0
Map reading,0.0,0.0,1.0,0.0
Superior longitudinal fasciculus,0.0,1.0,0.0,0.0
Response delay,1.0,0.0,0.0,0.0
Hypopituitarism,0.0,0.0,1.0,0.0
drug interactions,1.0,0.0,0.0,0.0
Response learning,0.0,1.0,0.0,0.0
Metacognition (theory of mind),0.0,0.0,1.0,0.0
Brain dynamics,0.0,0.0,1.0,0.0
Brain cognition,1.0,0.0,0.0,0.0
Optical coherence tomography,0.0,1.0,0.0,0.0
Receiver psychology,0.0,0.0,1.0,0.0
Moral personality,0.0,0.0,1.0,0.0
Scenic beauty estimation,1.0,0.0,0.0,0.0
Motor activation,0.0,1.0,0.0,0.0
Tract-Based Spatial Statistics,0.0,0.0,0.0,1.0
fitness to drive,0.0,0.0,1.0,0.0
Multiscale entropy,0.0,0.0,0.0,1.0
Hierarchical models,0.0,1.0,0.0,0.0
Acquired vulnerability,1.0,0.0,0.0,0.0
Ketamine/midazolam combination,0.0,0.0,0.0,1.0
Verbal recognition memory,1.0,0.0,0.0,0.0
TDCPP,0.0,0.0,1.0,0.0
Bayesian models of cognition,0.0,1.0,0.0,0.0
Cortical dementia,1.0,0.0,0.0,0.0
Maintenance of wakefulness test,0.0,0.0,1.0,0.0
Aves: corvidae,0.0,0.0,1.0,0.0
Cushing's syndrome,1.0,0.0,0.0,0.0
Pattern and color,1.0,0.0,0.0,0.0
North American ginseng extract,0.0,0.0,1.0,0.0
Distracter suppression,1.0,0.0,0.0,0.0
Obstructive sleep apnoea,0.0,1.0,0.0,0.0
Posttraumatic stress,0.0,0.0,1.0,0.0
4-digit diagnostic code,1.0,0.0,0.0,0.0
Sinusoidal filters,0.0,1.0,0.0,0.0
Adolescent psychiatry,0.0,0.0,1.0,0.0
Modality effects: Error processing,0.0,0.0,1.0,0.0
Calretinin,1.0,0.0,0.0,0.0
Interpretative bias,0.0,0.0,1.0,0.0
Short-term memory capacity,0.0,0.0,1.0,0.0
Congenital nephrosis of the Finnish type,0.0,0.0,1.0,0.0
transparent orthography,0.0,1.0,0.0,0.0
Mller cell,1.0,0.0,0.0,0.0
Identification of variables,0.0,1.0,0.0,0.0
Conners',0.0,1.0,0.0,0.0
Usual gait speed,0.0,0.0,0.0,1.0
biofeedback technology,0.0,0.0,1.0,0.0
vOICe,0.0,0.0,1.0,0.0
Beagle,0.0,1.0,0.0,0.0
Cross modal interference,0.0,0.0,1.0,0.0
Steady-state visual evoked potential,0.0,0.0,1.0,0.0
Object words,1.0,0.0,0.0,0.0
Human procedural learning,0.0,1.0,0.0,0.0
slice electrophysiology,0.0,1.0,0.0,0.0
Social competence,0.0,1.0,0.0,0.0
NeuroAIDS,0.0,0.0,1.0,0.0
context-aware computing,0.0,0.0,1.0,0.0
Surface layout,0.0,0.0,1.0,0.0
Dissociative tendencies,0.0,0.0,0.0,1.0
Congruency tasks,0.0,0.0,1.0,0.0
Time trends,0.0,1.0,0.0,0.0
Neurosyphllis,0.0,1.0,0.0,0.0
Idiopathic generalized epilepsy,0.0,0.0,1.0,0.0
indirect immunofluorescence,1.0,0.0,0.0,0.0
Happy expression,0.0,0.0,1.0,0.0
Intracerebral EEG,0.0,0.0,0.0,1.0
Behavioral tasks,1.0,0.0,0.0,0.0
Assistance,0.0,0.0,1.0,0.0
Neuro-cognitive outcome,0.0,1.0,0.0,0.0
Piaget-like task,0.0,0.0,0.0,1.0
Repulsion,0.0,1.0,0.0,0.0
Rugby union,0.0,1.0,0.0,0.0
Corvus monedula,0.0,1.0,0.0,0.0
Visualizability,0.0,1.0,0.0,0.0
Implicit racial bias,0.0,1.0,0.0,0.0
Premotor RT,0.0,0.0,1.0,0.0
Thermal comfort,1.0,0.0,0.0,0.0
Modality bias,0.0,1.0,0.0,0.0
Baseline shift,1.0,0.0,0.0,0.0
N-acetyl aspartate,1.0,0.0,0.0,0.0
Intracellular recordings,0.0,1.0,0.0,0.0
Motion verbs,0.0,0.0,1.0,0.0
Dissociative amnesia,0.0,1.0,0.0,0.0
Embryo,0.0,0.0,1.0,0.0
Acquisition,0.0,0.0,0.0,1.0
Nsaids,0.0,1.0,0.0,0.0
Regulatory fit,0.0,1.0,0.0,0.0
ADHD children,1.0,0.0,0.0,0.0
prestimulus periods,0.0,0.0,1.0,0.0
low vision rehabilitation,0.0,0.0,1.0,0.0
Caucasian SLE women,0.0,1.0,0.0,0.0
emotional valence,0.0,0.0,0.0,1.0
Go/No-go Association Task,1.0,0.0,0.0,0.0
handball's goalkeeper,1.0,0.0,0.0,0.0
Contact points,0.0,1.0,0.0,0.0
Parent,0.0,1.0,0.0,0.0
Pain face,0.0,0.0,1.0,0.0
Social robots,0.0,1.0,0.0,0.0
Data-driven processing,0.0,0.0,0.0,1.0
meal pattern,0.0,0.0,0.0,1.0
Moss Attention Rating Scale,0.0,0.0,1.0,0.0
Prospective cohort,0.0,1.0,0.0,0.0
Cercopithecine,0.0,0.0,1.0,0.0
line of sight,0.0,0.0,1.0,0.0
Perseverations,0.0,1.0,0.0,0.0
postmenopausal,0.0,0.0,1.0,0.0
Light environment,0.0,0.0,1.0,0.0
Posteroventral pallidotomy,0.0,1.0,0.0,0.0
ampakine,0.0,0.0,1.0,0.0
accessibility,0.0,0.0,1.0,0.0
Model psychosis,1.0,0.0,0.0,0.0
Overconfidence,0.0,1.0,0.0,0.0
Early-onset bipolar disorder,0.0,0.0,1.0,0.0
Fine-motor,0.0,1.0,0.0,0.0
Immediate retrieval,1.0,0.0,0.0,0.0
Wechlser Adult Intelligence Scale-R,0.0,0.0,1.0,0.0
Fentanyl,0.0,1.0,0.0,0.0
Lexical competition,1.0,0.0,0.0,0.0
posterior cingulate,0.0,1.0,0.0,0.0
Parkinson's Disease (PD),1.0,0.0,0.0,0.0
Visual spatial working memory task,0.0,1.0,0.0,0.0
Dementia with Lewy bodies (DLB),0.0,0.0,1.0,0.0
Biopsychosocial,1.0,0.0,0.0,0.0
Image quality,0.0,0.0,1.0,0.0
Goffin cockatoo,0.0,0.0,1.0,0.0
Paracingulate,0.0,1.0,0.0,0.0
Prolonged effect,0.0,1.0,0.0,0.0
Quadratic phase coupling (QPC),0.0,1.0,0.0,0.0
Dual-system model,0.0,0.0,0.0,1.0
Orienting of attention,1.0,0.0,0.0,0.0
Taylor,0.0,1.0,0.0,0.0
Generalized social anxiety,0.0,0.0,0.0,1.0
Anterior inferotemporal cortex,1.0,0.0,0.0,0.0
Association strength,0.0,0.0,1.0,0.0
Economics,0.0,1.0,0.0,0.0
Testosterone replacement,0.0,0.0,1.0,0.0
Perceptual pleasure,0.0,0.0,1.0,0.0
Ketogenic diet,1.0,0.0,0.0,0.0
Venlafaxine,0.0,0.0,0.0,1.0
Justice sensitivity,0.0,0.0,1.0,0.0
AMF,0.0,0.0,1.0,0.0
AMD,0.0,0.0,1.0,0.0
Free testosterone,0.0,1.0,0.0,0.0
Relapsing remitting multiple sclerosis,1.0,0.0,0.0,0.0
self-motion,0.0,0.0,1.0,0.0
Topographic analysis,0.0,1.0,0.0,0.0
Pattern,0.0,1.0,0.0,0.0
Cognition of the elderly,0.0,0.0,1.0,0.0
Gesture N450,0.0,1.0,0.0,0.0
Multiple personality,0.0,0.0,1.0,0.0
Cognitive tutoring systems,1.0,0.0,0.0,0.0
Nutritional stress,0.0,0.0,1.0,0.0
State dependency,1.0,0.0,0.0,0.0
P3 NoGo,0.0,0.0,1.0,0.0
Global synchrony,1.0,0.0,0.0,0.0
Visual fixation instability,0.0,1.0,0.0,0.0
ponds,1.0,0.0,0.0,0.0
Social anxiety disorder/social phobia,0.0,0.0,1.0,0.0
Postdramatic theatre,1.0,0.0,0.0,0.0
Reach-to-grasp action,0.0,1.0,0.0,0.0
PIB,0.0,1.0,0.0,0.0
Low-level sensory signals,0.0,1.0,0.0,0.0
Gradient acoustic noise,0.0,0.0,1.0,0.0
brain imaging,0.0,1.0,0.0,0.0
Visual search task,0.0,1.0,0.0,0.0
emotional response,1.0,0.0,0.0,0.0
Movies,1.0,0.0,0.0,0.0
Image registration,0.0,0.0,0.0,1.0
prescription medications,0.0,0.0,0.0,1.0
Macrocolumns,0.0,0.0,1.0,0.0
Effective field of view,0.0,0.0,1.0,0.0
Kanizsa figure,0.0,1.0,0.0,0.0
Viral load,0.0,1.0,0.0,0.0
Repetitive transcranial magnetic stimulation (rTMS),0.0,1.0,0.0,0.0
DHCA,0.0,1.0,0.0,0.0
Familiar size,0.0,1.0,0.0,0.0
Cronbach's ?,0.0,1.0,0.0,0.0
Switch,1.0,0.0,0.0,0.0
Functional MRS,0.0,1.0,0.0,0.0
Raven's progressive matrices,0.0,0.0,1.0,0.0
Attentional set-shifting,1.0,0.0,0.0,0.0
Implicit measure,0.0,1.0,0.0,0.0
Adipsia,0.0,0.0,1.0,0.0
Beta 2 synchronization,0.0,0.0,1.0,0.0
Categorical boundary,0.0,0.0,1.0,0.0
Reading skills,0.0,0.0,1.0,0.0
Visual letter monitoring score,0.0,0.0,0.0,1.0
Cutaneous pain,0.0,1.0,0.0,0.0
Chatroom,0.0,0.0,1.0,0.0
Viewpoint deviation effect,1.0,0.0,0.0,0.0
Learned associations,1.0,0.0,0.0,0.0
Whole-report,0.0,1.0,0.0,0.0
Speechin noise,1.0,0.0,0.0,0.0
Neighborhood,1.0,0.0,0.0,0.0
Mu,0.0,1.0,0.0,0.0
DTI-based fiber tractography,0.0,0.0,1.0,0.0
Emotional distraction,0.0,1.0,0.0,0.0
Target uncertainty,0.0,1.0,0.0,0.0
Redundant,0.0,0.0,1.0,0.0
Retrospective time,1.0,0.0,0.0,0.0
Hierarchical processing,0.0,1.0,0.0,0.0
Information discovery,0.0,0.0,1.0,0.0
APOE & 4,1.0,0.0,0.0,0.0
color vision,0.0,1.0,0.0,0.0
EQ-5D,0.0,0.0,1.0,0.0
pictures,0.0,0.0,0.0,1.0
Agrammatic comprehension,0.0,1.0,0.0,0.0
Antioxidant enzyme,0.0,0.0,1.0,0.0
Encephalomyopathy,0.0,0.0,1.0,0.0
mediators,0.0,1.0,0.0,0.0
France,0.0,0.0,1.0,0.0
GRIA4,0.0,0.0,1.0,0.0
GRIA2,0.0,0.0,1.0,0.0
Ego disturbances,0.0,0.0,1.0,0.0
Cerebral hypoperfusion,0.0,1.0,0.0,0.0
Motor velocity,0.0,0.0,1.0,0.0
ERK1/2,0.0,0.0,1.0,0.0
Image-based rendering,1.0,0.0,0.0,0.0
Understanding pictures,0.0,1.0,0.0,0.0
Counselor,0.0,0.0,1.0,0.0
Autistic-like traits,1.0,0.0,0.0,0.0
Second-to-fourth digit ratio,0.0,0.0,1.0,0.0
Modular granular vision architecture,0.0,0.0,1.0,0.0
Abstract sentences,0.0,0.0,1.0,0.0
Incentive motivation,0.0,0.0,1.0,0.0
Preattentive processing,0.0,1.0,0.0,0.0
Individualised treatment,0.0,1.0,0.0,0.0
Fascia iliaca,0.0,0.0,0.0,1.0
Vocal expression,0.0,0.0,1.0,0.0
IEG Arc expression,0.0,1.0,0.0,0.0
Tacts,0.0,1.0,0.0,0.0
Probabilistic Classification Learning,1.0,0.0,0.0,0.0
visual exploration,0.0,1.0,0.0,0.0
Neuropsychology in Dravet syndrome,0.0,0.0,1.0,0.0
Cholinergic synapsis,0.0,0.0,1.0,0.0
Policosanol,0.0,1.0,0.0,0.0
Lack of habituation,0.0,0.0,1.0,0.0
Switching costs,0.0,0.0,0.0,1.0
Paired reading,0.0,0.0,1.0,0.0
opsoclonus-myoclonus syndrome,0.0,0.0,1.0,0.0
Second language reading,0.0,0.0,1.0,0.0
unintentional prediction,0.0,1.0,0.0,0.0
Stress tolerance,0.0,0.0,1.0,0.0
Neurocatalysis,0.0,0.0,1.0,0.0
exogenous attention,1.0,0.0,0.0,0.0
Infant vision,0.0,0.0,1.0,0.0
Self-consistency,0.0,0.0,1.0,0.0
Diffusion-model,0.0,1.0,0.0,0.0
Affective ratings,0.0,0.0,0.0,1.0
5-HT6 receptor,0.0,0.0,1.0,0.0
visual and spatial processes,0.0,0.0,1.0,0.0
Mirror image,0.0,0.0,1.0,0.0
Stimulus presentation,0.0,1.0,0.0,0.0
Classification image technique,0.0,0.0,1.0,0.0
Visual sampling,0.0,0.0,1.0,0.0
useful field of view,0.0,1.0,0.0,0.0
Strategy change,0.0,1.0,0.0,0.0
""Pure"" learning disabilities,1.0,0.0,0.0,0.0
Convex hull calculation,0.0,0.0,1.0,0.0
Inferior frontal junction,0.0,0.0,0.0,1.0
Volitional orientation,0.0,0.0,1.0,0.0
Neuropsychological symptoms,0.0,1.0,0.0,0.0
Posterior lobe of the cerebellum,0.0,0.0,0.0,1.0
Communication difficulties,0.0,1.0,0.0,0.0
Neuronal resistance,0.0,0.0,1.0,0.0
Youngsters,0.0,0.0,1.0,0.0
Depression vulnerability,0.0,1.0,0.0,0.0
Domain-sensitivity,0.0,0.0,1.0,0.0
Neural components,0.0,0.0,1.0,0.0
Type I error,0.0,1.0,0.0,0.0
Simulation Research Design,0.0,0.0,0.0,1.0
Serotonin transporter-linked polymorphic region (5-HTTLPR),0.0,1.0,0.0,0.0
Sturnus vulgaris,0.0,0.0,1.0,0.0
executive dysfunction,1.0,0.0,0.0,0.0
Artifactual categories,0.0,1.0,0.0,0.0
Lesional frontal lobe epilepsy,0.0,0.0,1.0,0.0
Prion mutation,1.0,0.0,0.0,0.0
Mooney faces,0.0,1.0,0.0,0.0
REM dreams,0.0,0.0,1.0,0.0
Memory functioning,0.0,0.0,1.0,0.0
Arousal regulation,0.0,0.0,1.0,0.0
women's health,0.0,1.0,0.0,0.0
Quail,0.0,0.0,1.0,0.0
Brain lateralisation,0.0,0.0,1.0,0.0
b-amyloid,1.0,0.0,0.0,0.0
Critical discourse analysis,0.0,0.0,1.0,0.0
Gender and number,0.0,0.0,0.0,1.0
Fearful,0.0,1.0,0.0,0.0
systems,0.0,0.0,1.0,0.0
Scientific reasoning,0.0,0.0,1.0,0.0
blood oxygen level dependent (BOLD),0.0,1.0,0.0,0.0
Habitat stability,0.0,0.0,1.0,0.0
Caudal luring,0.0,0.0,1.0,0.0
Body parts coding,0.0,0.0,1.0,0.0
Exploratory movements,0.0,1.0,0.0,0.0
Low-level visual perception,0.0,1.0,0.0,0.0
stimulus-hand congruency,1.0,0.0,0.0,0.0
Eye fixations,1.0,0.0,0.0,0.0
Frontostriatal cognition,1.0,0.0,0.0,0.0
Alzheimers disease,0.0,0.0,1.0,0.0
Heart-brain synchronization,0.0,1.0,0.0,0.0
Knowledge work,0.0,1.0,0.0,0.0
Arterial territory,0.0,1.0,0.0,0.0
Legal blindness,0.0,1.0,0.0,0.0
Hurst parameter,0.0,0.0,1.0,0.0
Phosphatidylcholine,0.0,0.0,1.0,0.0
non-human primate,0.0,1.0,0.0,0.0
Shift of attention,0.0,1.0,0.0,0.0
Low-contrast acuity,0.0,0.0,1.0,0.0
Correspondence problem,0.0,1.0,0.0,0.0
Graded representation,0.0,1.0,0.0,0.0
Haemodynamic response functions,0.0,0.0,1.0,0.0
Physiological regulation,0.0,0.0,1.0,0.0
Interface / the Royal Society",0.0,0.0,0.0,0.0
Stimulus-onset asynchrony (SOA),0.0,1.0,0.0,0.0
Frontal-subcortical,0.0,0.0,1.0,0.0
SA,0.0,0.0,1.0,0.0
Verticality,1.0,0.0,0.0,0.0
MDMA (3,0.0,0.0,0.0,0.0
Nuclear tumour grading,0.0,1.0,0.0,0.0
Rolandic spikes,1.0,0.0,0.0,0.0
Depressive symptomatology,0.0,0.0,1.0,0.0
Smoker,0.0,1.0,0.0,0.0
Sp,0.0,0.0,1.0,0.0
Attention.,0.0,0.0,1.0,0.0
Human milk fortification,0.0,1.0,0.0,0.0
RL/RI-16 items,0.0,0.0,1.0,0.0
Visual vigilance,0.0,1.0,0.0,0.0
Corrugator activity,0.0,0.0,1.0,0.0
Ratio preferences,0.0,0.0,1.0,0.0
Transcranial alternating current stimulation,1.0,0.0,0.0,0.0
Outcomes of high-risk infants,0.0,0.0,1.0,0.0
Facial emotion identification,1.0,0.0,0.0,0.0
Audiovisual interactions,1.0,0.0,0.0,0.0
MRI volumetry,1.0,0.0,0.0,0.0
Accelerated forgetting,0.0,0.0,1.0,0.0
Geomatics,0.0,1.0,0.0,0.0
ape-human comparisons,0.0,1.0,0.0,0.0
Employment duration,1.0,0.0,0.0,0.0
Ordinal rule,0.0,0.0,1.0,0.0
Language grounding,0.0,0.0,1.0,0.0
Region-of-interest analysis,0.0,1.0,0.0,0.0
Gyrus cinguli,1.0,0.0,0.0,0.0
resting-state fMRI,0.0,1.0,0.0,0.0
80 years and over,0.0,0.0,1.0,0.0
Patient,0.0,1.0,0.0,0.0
Bradykinesia,0.0,0.0,1.0,0.0
BVMT-R,0.0,0.0,1.0,0.0
Impressions of necessity,1.0,0.0,0.0,0.0
Supplement",0.0,0.0,0.0,0.0
Associative symmetry,1.0,0.0,0.0,0.0
Ordinal numerical knowledge,1.0,0.0,0.0,0.0
Room-tilt illusion,0.0,0.0,0.0,1.0
Semi-institutions,0.0,0.0,1.0,0.0
Action knowledge,1.0,0.0,0.0,0.0
Steroid,1.0,0.0,0.0,0.0
Temporal attention,0.0,1.0,0.0,0.0
Environmental hazard,1.0,0.0,0.0,0.0
Memory complaint,0.0,0.0,1.0,0.0
Inter-subject registration,0.0,0.0,1.0,0.0
Perceptual content,0.0,0.0,1.0,0.0
Inversion superiority,0.0,0.0,1.0,0.0
qualitative research,0.0,1.0,0.0,0.0
Action verb,0.0,0.0,0.0,1.0
Cognitive conjunction,1.0,0.0,0.0,0.0
Eloquent circuits,0.0,1.0,0.0,0.0
mitochondria,0.0,0.0,1.0,0.0
Magnocellular processing,0.0,1.0,0.0,0.0
Working memory maintenance,0.0,1.0,0.0,0.0
Mental state decoding,0.0,1.0,0.0,0.0
Temazepam,1.0,0.0,0.0,0.0
Benign partial epilepsy,0.0,0.0,1.0,0.0
Leukaemia,0.0,1.0,0.0,0.0
Lingual,0.0,1.0,0.0,0.0
Attractive alternatives,1.0,0.0,0.0,0.0
Reversible sentences,0.0,1.0,0.0,0.0
Incongruous cues,0.0,0.0,1.0,0.0
power of potentials,1.0,0.0,0.0,0.0
Slow oscillation,1.0,0.0,0.0,0.0
Neurocognitive binding,1.0,0.0,0.0,0.0
Auditory stroop,0.0,1.0,0.0,0.0
Tupu-cognition,0.0,0.0,1.0,0.0
Space familiarity,0.0,1.0,0.0,0.0
Vision function,0.0,0.0,1.0,0.0
Psychosis in Parkinson,0.0,1.0,0.0,0.0
Alcohol sensitivity,1.0,0.0,0.0,0.0
Limb apraxia,0.0,1.0,0.0,0.0
Naive theory of vision,1.0,0.0,0.0,0.0
Problem Solving/Decision Making,0.0,0.0,1.0,0.0
Decentering,0.0,1.0,0.0,0.0
BCI illiteracy,1.0,0.0,0.0,0.0
response category width,1.0,0.0,0.0,0.0
Methyl anthranilate,1.0,0.0,0.0,0.0
novel apparatus,0.0,0.0,1.0,0.0
Spatial grouping,0.0,0.0,0.0,1.0
operant conditioning,0.0,0.0,0.0,1.0
Dopamine dmedicine receptor,0.0,1.0,0.0,0.0
biomedical engineering,0.0,0.0,1.0,0.0
Hoehn & Yahr stage,0.0,0.0,1.0,0.0
conditioned emotional response,0.0,0.0,1.0,0.0
Virtual space,1.0,0.0,0.0,0.0
Artificial vision,0.0,1.0,0.0,0.0
Competitive relationship,0.0,0.0,1.0,0.0
Photovoice,1.0,0.0,0.0,0.0
Digit-color synesthesia,0.0,0.0,1.0,0.0
Minerals,0.0,0.0,1.0,0.0
Time-frequency,1.0,0.0,0.0,0.0
Hydroxyzine,0.0,0.0,1.0,0.0
Atrial fibrillation,0.0,0.0,0.0,1.0
Ice hockey,0.0,1.0,0.0,0.0
ACTH,1.0,0.0,0.0,0.0
Within-subjects,0.0,0.0,1.0,0.0
Emotion-mirroring,0.0,0.0,1.0,0.0
Inverse efficiency,0.0,0.0,1.0,0.0
dynamic cues,0.0,1.0,0.0,0.0
ToT-phenomenons,0.0,1.0,0.0,0.0
location negative priming,1.0,0.0,0.0,0.0
Valproic acid,0.0,1.0,0.0,0.0
Inter-stimulus interval,0.0,1.0,0.0,0.0
Melia,0.0,0.0,0.0,1.0
Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab (2012) Arch Neurol,1.0,0.0,0.0,0.0
Direction aftereffect,0.0,1.0,0.0,0.0
Filling-in,0.0,1.0,0.0,0.0
Multiplication,1.0,0.0,0.0,0.0
Developmental Dyscalculia,0.0,1.0,0.0,0.0
brain connectivity,0.0,0.0,1.0,0.0
Top-down facilitation,1.0,0.0,0.0,0.0
Eidetic imagery,1.0,0.0,0.0,0.0
Older patients,1.0,0.0,0.0,0.0
Social activity,0.0,0.0,1.0,0.0
Voice quality,0.0,0.0,1.0,0.0
Cultural psychology,0.0,0.0,1.0,0.0
Gases,0.0,0.0,1.0,0.0
age of acquisition,0.0,0.0,1.0,0.0
Primary hyperparathyroidism,0.0,1.0,0.0,0.0
Neuroendocrine systems,0.0,1.0,0.0,0.0
Visual grasp reflex,0.0,0.0,1.0,0.0
Adult Parkinson,0.0,0.0,1.0,0.0
Genetic diagnosis,0.0,0.0,1.0,0.0
Attractive images,0.0,1.0,0.0,0.0
Multi-sensory stimulation (MSS),0.0,0.0,1.0,0.0
radial maze,0.0,1.0,0.0,0.0
Fagan Test of Infant Intelligence,1.0,0.0,0.0,0.0
Neural coding,1.0,0.0,0.0,0.0
monounsaturated fat intake,0.0,0.0,1.0,0.0
Neuropsychological Evaluation,1.0,0.0,0.0,0.0
Childhood cancer,0.0,0.0,1.0,0.0
In-vehicle technology,0.0,1.0,0.0,0.0
Higher vestibular functions,0.0,0.0,0.0,1.0
metric,1.0,0.0,0.0,0.0
Left fronto-parietal areas,0.0,0.0,1.0,0.0
PowerPoint,0.0,0.0,0.0,1.0
Selective stop signal task,0.0,1.0,0.0,0.0
Late-life depression,0.0,0.0,1.0,0.0
Speech processing,1.0,0.0,0.0,0.0
Steroids,0.0,1.0,0.0,0.0
G-protein-coupled receptor 30,0.0,0.0,1.0,0.0
effet de familiarit,0.0,1.0,0.0,0.0
P50 suppression,0.0,0.0,1.0,0.0
C957T polymorphism,1.0,0.0,0.0,0.0
Visual dominance,0.0,0.0,1.0,0.0
Cerebellar Cognitive Affective Syndrome,0.0,1.0,0.0,0.0
Directed attention,0.0,0.0,1.0,0.0
sequence learning,0.0,1.0,0.0,0.0
long-term potentiation,0.0,0.0,1.0,0.0
Antisocial behavior,0.0,0.0,1.0,0.0
Maze leasing,1.0,0.0,0.0,0.0
Walking ability,0.0,0.0,0.0,1.0
Nucleus reuniens,0.0,1.0,0.0,0.0
vasospasm,0.0,1.0,0.0,0.0
sparseness,0.0,0.0,1.0,0.0
Malaysia,0.0,0.0,1.0,0.0
Post-treatment lyme disease syndrome,0.0,0.0,1.0,0.0
R/1,0.0,0.0,1.0,0.0
Unit-decade compatibility,0.0,0.0,0.0,1.0
Symphalangus,0.0,0.0,1.0,0.0
Unpleasant stimuli,0.0,1.0,0.0,0.0
Executive control function,0.0,0.0,1.0,0.0
MDS-UPDRS,0.0,0.0,0.0,1.0
Org 25935,0.0,1.0,0.0,0.0
Caregiver interaction,0.0,0.0,1.0,0.0
Cluster analyses,0.0,0.0,0.0,1.0
Fourier-Independent Component Analysis,0.0,1.0,0.0,0.0
Performance slowing,1.0,0.0,0.0,0.0
EMF,0.0,0.0,1.0,0.0
Spatial relation,0.0,0.0,1.0,0.0
Behavioural conflict resolution,1.0,0.0,0.0,0.0
H3 receptor,0.0,0.0,1.0,0.0
Intellectual,1.0,0.0,0.0,0.0
Brain organization,0.0,1.0,0.0,0.0
Brodmann area 6,1.0,0.0,0.0,0.0
Ganglion cells,0.0,0.0,1.0,0.0
Beta Gamma,0.0,0.0,1.0,0.0
Maternal interaction style,0.0,0.0,1.0,0.0
Lunate sulcus,0.0,0.0,0.0,1.0
Point cluster,0.0,1.0,0.0,0.0
Awake,0.0,0.0,1.0,0.0
Quantum neuroscience,0.0,0.0,1.0,0.0
Letter-speech sound pairs,0.0,0.0,1.0,0.0
Visual-evoked response,0.0,0.0,0.0,1.0
Woman,1.0,0.0,0.0,0.0
Risk factors delirium,1.0,0.0,0.0,0.0
Acute exposure,0.0,1.0,0.0,0.0
Associativity,1.0,0.0,0.0,0.0
Self-reported memory,0.0,0.0,1.0,0.0
Web,0.0,0.0,1.0,0.0
Enactive perception,0.0,1.0,0.0,0.0
Refrontal cortex,1.0,0.0,0.0,0.0
Phnotype,0.0,1.0,0.0,0.0
postconcussive syndrome,1.0,0.0,0.0,0.0
Representativeness,0.0,0.0,1.0,0.0
IN-SPIRE,0.0,1.0,0.0,0.0
Clioquinol,0.0,0.0,1.0,0.0
Cognitive penetrability,0.0,0.0,0.0,1.0
Sciuridae,0.0,1.0,0.0,0.0
Posterior atrophy,0.0,1.0,0.0,0.0
rank order cells,0.0,1.0,0.0,0.0
Serotonin antagonists,0.0,0.0,0.0,1.0
Expert system,0.0,1.0,0.0,0.0
Behavioral disturbances,0.0,1.0,0.0,0.0
Nonspatial cognition,0.0,0.0,1.0,0.0
Priming of pop out,0.0,1.0,0.0,0.0
Diachronic thinking,0.0,0.0,1.0,0.0
Medical errors,0.0,0.0,1.0,0.0
Neurocognitive endophenotype,0.0,1.0,0.0,0.0
Semantic dissonance,0.0,0.0,1.0,0.0
Spinocerebellar ataxia type 3,1.0,0.0,0.0,0.0
Implicit approach,0.0,0.0,1.0,0.0
Perceptual-cognitive skill,1.0,0.0,0.0,0.0
Grooming,0.0,0.0,1.0,0.0
child abuse,0.0,0.0,1.0,0.0
Response,0.0,1.0,0.0,0.0
Point light display,0.0,0.0,1.0,0.0
Antihypertensive drugs,0.0,1.0,0.0,0.0
Mid-life risk factors,0.0,0.0,1.0,0.0
Semi-parametric models,1.0,0.0,0.0,0.0
Cognitive processing of currency,0.0,0.0,0.0,1.0
Driving experience,0.0,0.0,0.0,1.0
Suicide,0.0,0.0,1.0,0.0
Perspective changes,0.0,0.0,1.0,0.0
clinical subtypes,0.0,0.0,1.0,0.0
Rotational displacement,0.0,1.0,0.0,0.0
Modularity of perception,0.0,0.0,0.0,1.0
Snake fear,0.0,0.0,1.0,0.0
Emotional neural networks,0.0,1.0,0.0,0.0
Background subtraction,0.0,1.0,0.0,0.0
Nighttime,1.0,0.0,0.0,0.0
Orientation agnosia,1.0,0.0,0.0,0.0
Shift work sleep disorder,1.0,0.0,0.0,0.0
Bayesian model averaging,1.0,0.0,0.0,0.0
Sternberg-Wagner Self-assessment inventory,1.0,0.0,0.0,0.0
naming,0.0,1.0,0.0,0.0
Mental Rotation,0.0,0.0,1.0,0.0
Oxygen administration,0.0,0.0,1.0,0.0
Transfer of training,0.0,0.0,0.0,1.0
Hierarchical level,0.0,0.0,1.0,0.0
Gamma-band activity (GBA),0.0,0.0,1.0,0.0
Audio-visual correspondences,0.0,0.0,1.0,0.0
Theory of embodied cognition,0.0,0.0,1.0,0.0
Perturbation,0.0,0.0,1.0,0.0
Color-word-Stroop task,1.0,0.0,0.0,0.0
Visual-spatial tasks,1.0,0.0,0.0,0.0
Prolonged physiological activity,0.0,0.0,1.0,0.0
Conceptual change,0.0,0.0,0.0,1.0
Apolipoprotein E genotype,0.0,0.0,1.0,0.0
Tumour location,0.0,0.0,0.0,1.0
inversion,0.0,0.0,1.0,0.0
Borderline IQ,0.0,0.0,1.0,0.0
premorbid intelligence,0.0,0.0,1.0,0.0
Principle component analysis,0.0,1.0,0.0,0.0
Resource-sharing,0.0,0.0,0.0,1.0
Food caching,0.0,1.0,0.0,0.0
A?42,0.0,0.0,0.0,1.0
RD,0.0,0.0,1.0,0.0
Trajectories,0.0,0.0,1.0,0.0
Auditory agnosia,0.0,0.0,1.0,0.0
Use,1.0,0.0,0.0,0.0
Biochemistry,0.0,1.0,0.0,0.0
Community-dwelling elderly,0.0,0.0,1.0,0.0
perception and action,0.0,0.0,1.0,0.0
SCN1A,0.0,0.0,0.0,1.0
Cross-media retrieval,0.0,0.0,1.0,0.0
Vertex positive potential,0.0,1.0,0.0,0.0
Radix,0.0,0.0,1.0,0.0
road testing,0.0,0.0,0.0,1.0
Receptor binding,0.0,0.0,1.0,0.0
Food-specific satiety,1.0,0.0,0.0,0.0
birdsong,0.0,0.0,0.0,1.0
Visual judgment,0.0,1.0,0.0,0.0
Burden,1.0,0.0,0.0,0.0
Rebel,0.0,1.0,0.0,0.0
Subjective cognitive decline,0.0,1.0,0.0,0.0
Orientation identification,0.0,0.0,1.0,0.0
Spreading activation,0.0,0.0,1.0,0.0
Frontal lobe dementia,1.0,0.0,0.0,0.0
ERD,0.0,0.0,1.0,0.0
Usability engineering,1.0,0.0,0.0,0.0
ERS,0.0,0.0,1.0,0.0
fear of pain,0.0,0.0,0.0,1.0
Centrifuge,0.0,0.0,1.0,0.0
first-episode schizophrenia,0.0,1.0,0.0,0.0
Connectionist learning systems,0.0,0.0,0.0,1.0
Neural network model,0.0,0.0,1.0,0.0
Sense of control,0.0,1.0,0.0,0.0
Time-frequency decomposition,1.0,0.0,0.0,0.0
Human faculty of language,0.0,0.0,0.0,1.0
Neurotrophic factors,0.0,0.0,1.0,0.0
Amygdala laterality,1.0,0.0,0.0,0.0
Frontoparietal,0.0,0.0,0.0,1.0
cognitive cost,0.0,0.0,1.0,0.0
Mass screening,0.0,0.0,1.0,0.0
Sitting position,0.0,0.0,1.0,0.0
Gratton effect,0.0,1.0,0.0,0.0
Cognitive structure,0.0,0.0,1.0,0.0
Parent-child relation,0.0,0.0,1.0,0.0
Surface-based methods,0.0,0.0,1.0,0.0
Gut hormones,0.0,1.0,0.0,0.0
CVI,0.0,1.0,0.0,0.0
Global and local perception,0.0,0.0,1.0,0.0
English,0.0,0.0,1.0,0.0
Extraventricular neurocytoma,0.0,0.0,1.0,0.0
B complex,1.0,0.0,0.0,0.0
Possible and impossible figures,0.0,0.0,0.0,1.0
Hypothetical scenarios,0.0,0.0,1.0,0.0
Social deficit,0.0,0.0,1.0,0.0
cognitive behavioural therapy,0.0,1.0,0.0,0.0
Solifenacin,0.0,0.0,1.0,0.0
Approach avoidance task,0.0,0.0,1.0,0.0
High-density electrical neuroimaging,0.0,0.0,0.0,1.0
Causal models,1.0,0.0,0.0,0.0
grounded cognition,0.0,1.0,0.0,0.0
Functional hemisphere dominance,0.0,1.0,0.0,0.0
Glocalization,0.0,0.0,1.0,0.0
cholinergic pathway,0.0,0.0,1.0,0.0
long-term facility,0.0,0.0,0.0,1.0
Dementia in Parkinson's disease,0.0,0.0,1.0,0.0
Parietal dysfunction,1.0,0.0,0.0,0.0
varenicline,0.0,1.0,0.0,0.0
correlation analysis,1.0,0.0,0.0,0.0
synapses,0.0,1.0,0.0,0.0
Nonturner,0.0,1.0,0.0,0.0
Containment,0.0,0.0,1.0,0.0
Papez circuit,0.0,1.0,0.0,0.0
Internal forward models,0.0,1.0,0.0,0.0
Chicken,0.0,0.0,0.0,1.0
Authenticity,0.0,1.0,0.0,0.0
Displays,0.0,0.0,1.0,0.0
Everyday cognition,0.0,1.0,0.0,0.0
Audio Visual Stimulation,0.0,0.0,1.0,0.0
Response stereotypy,0.0,0.0,1.0,0.0
Visual disruption,1.0,0.0,0.0,0.0
GESTALT,1.0,0.0,0.0,0.0
Small-group learning,0.0,1.0,0.0,0.0
Single rising doses,0.0,1.0,0.0,0.0
Port Pirie Cohort study,0.0,0.0,1.0,0.0
Neoplasm metastasis,0.0,0.0,0.0,1.0
professional competence,0.0,0.0,1.0,0.0
Visually-guided action,0.0,0.0,1.0,0.0
Adaptive Control of Thought-Rational,0.0,1.0,0.0,0.0
Neuronal network,0.0,0.0,1.0,0.0
Social adaptation,0.0,1.0,0.0,0.0
Latent process,1.0,0.0,0.0,0.0
Fluorodeoxyglucose,0.0,1.0,0.0,0.0
ERRC,0.0,0.0,1.0,0.0
Food texture,0.0,1.0,0.0,0.0
Intracranial ECoG recording,0.0,1.0,0.0,0.0
MP3,0.0,1.0,0.0,0.0
Environmental intervention,0.0,1.0,0.0,0.0
NOS1 gene,0.0,1.0,0.0,0.0
Spike detection,0.0,0.0,1.0,0.0
Blast,0.0,0.0,0.0,1.0
Ankylosing spondylitis,0.0,1.0,0.0,0.0
Hyperbaric oxygen,0.0,0.0,1.0,0.0
Composite face effect,1.0,0.0,0.0,0.0
Anti-reach,0.0,0.0,1.0,0.0
RNA-binding proteins,0.0,0.0,1.0,0.0
Central attention,1.0,0.0,0.0,0.0
Radner reading acuity test,0.0,1.0,0.0,0.0
Inter-modal oddball task,1.0,0.0,0.0,0.0
Hydrocarbon solvents,0.0,1.0,0.0,0.0
shooting cognition,1.0,0.0,0.0,0.0
Unfamiliar objects,0.0,0.0,0.0,1.0
Hypoxia following cardiac arrest,0.0,1.0,0.0,0.0
(FFA) the fusiform face area,0.0,0.0,1.0,0.0
default network,0.0,0.0,1.0,0.0
Picture perception,0.0,1.0,0.0,0.0
Gyrus,0.0,0.0,1.0,0.0
Visual asymmetry,0.0,1.0,0.0,0.0
Case marking,0.0,0.0,1.0,0.0
visual P1,1.0,0.0,0.0,0.0
Effector,0.0,0.0,1.0,0.0
Fast-acting compression,0.0,0.0,0.0,1.0
Interindividual variability,0.0,0.0,0.0,1.0
immune deficiency,0.0,1.0,0.0,0.0
Photographic appraisal,0.0,0.0,1.0,0.0
School children,0.0,0.0,0.0,1.0
Qualitative analysis,0.0,0.0,1.0,0.0
Self recognition,0.0,1.0,0.0,0.0
Quantum probability,0.0,0.0,1.0,0.0
Visuo-limbic circuit,0.0,0.0,1.0,0.0
volumetric,0.0,1.0,0.0,0.0
Numerals,1.0,0.0,0.0,0.0
neurocutaneous syndrome,0.0,0.0,1.0,0.0
Cambodia,0.0,0.0,1.0,0.0
Molecular diagnosis,0.0,0.0,0.0,1.0
IDH mutation,0.0,0.0,1.0,0.0
High-altitude migrants,0.0,0.0,1.0,0.0
graphic design tools,0.0,0.0,1.0,0.0
S-Ketamine,1.0,0.0,0.0,0.0
Learning outcomes,0.0,0.0,1.0,0.0
Spontaneous ongoing activity,0.0,1.0,0.0,0.0
Sensorimotor stroke,0.0,0.0,1.0,0.0
Visuoperceptive,0.0,0.0,0.0,1.0
Probability assessment,0.0,1.0,0.0,0.0
Body inversion effect,0.0,0.0,0.0,1.0
Visual signaling,0.0,1.0,0.0,0.0
Color temperature,0.0,0.0,1.0,0.0
Classroom,0.0,0.0,1.0,0.0
Lower extremity function,0.0,0.0,1.0,0.0
Electronic gaming machine,0.0,0.0,1.0,0.0
Sleep inertia,0.0,0.0,1.0,0.0
CVA,0.0,0.0,0.0,1.0
FMR1,0.0,0.0,1.0,0.0
Convention,1.0,0.0,0.0,0.0
emotional expressivity,1.0,0.0,0.0,0.0
Animal perception,0.0,1.0,0.0,0.0
Depersonalization debate,0.0,1.0,0.0,0.0
Serial testing,0.0,1.0,0.0,0.0
human visual perception,0.0,0.0,1.0,0.0
cross-talk,0.0,1.0,0.0,0.0
belief flexibility,0.0,1.0,0.0,0.0
Visual isolation,0.0,0.0,1.0,0.0
Space fog,0.0,0.0,1.0,0.0
transposition of great vessels,0.0,0.0,0.0,1.0
Elections,0.0,0.0,1.0,0.0
Infant sibling,0.0,0.0,1.0,0.0
Emotion-recognition deficits,0.0,0.0,1.0,0.0
Level-set method,0.0,0.0,1.0,0.0
Stimulus diversity,0.0,1.0,0.0,0.0
Nonverbal cognitive ability,0.0,1.0,0.0,0.0
Immediate serial recall,0.0,1.0,0.0,0.0
Dual-regression,0.0,0.0,1.0,0.0
Escape drinking,0.0,1.0,0.0,0.0
Cognition verbs,1.0,0.0,0.0,0.0
Permanent night work,1.0,0.0,0.0,0.0
restoration,0.0,0.0,1.0,0.0
Variable directional error,1.0,0.0,0.0,0.0
Collinearity,0.0,0.0,1.0,0.0
Thin slice perception,1.0,0.0,0.0,0.0
Alphabetic knowledge,0.0,0.0,1.0,0.0
Aging Street-crossing,0.0,0.0,1.0,0.0
Cognitive preferences,1.0,0.0,0.0,0.0
Deaf people,1.0,0.0,0.0,0.0
Renal disease,1.0,0.0,0.0,0.0
Modality-specific attention,0.0,0.0,1.0,0.0
cooperation,0.0,0.0,1.0,0.0
Computer-assisted instruction,0.0,0.0,1.0,0.0
three-axis maze,1.0,0.0,0.0,0.0
Shift-work sleep disorder,1.0,0.0,0.0,0.0
Chronic lower back pain,0.0,0.0,1.0,0.0
Developmental disregard,0.0,0.0,1.0,0.0
Empirical validation,0.0,0.0,0.0,1.0
Visual spatial learning,0.0,1.0,0.0,0.0
Theory of world,1.0,0.0,0.0,0.0
(minimal) traumatic brain injury (mTBI),0.0,1.0,0.0,0.0
TBI Index,0.0,0.0,1.0,0.0
Neocortical cell density,1.0,0.0,0.0,0.0
Urban population,0.0,1.0,0.0,0.0
Agent,0.0,1.0,0.0,0.0
Visual disability,0.0,0.0,1.0,0.0
Postcards,0.0,0.0,0.0,1.0
Real-time,0.0,1.0,0.0,0.0
Components of attention,0.0,1.0,0.0,0.0
Photography,0.0,0.0,1.0,0.0
Intertemporal choice,0.0,0.0,1.0,0.0
Ventral Stream,1.0,0.0,0.0,0.0
Form recognition performance,0.0,1.0,0.0,0.0
Bodily threat,0.0,0.0,1.0,0.0
Orientation alignment,0.0,0.0,1.0,0.0
Event-related potentials linguistic relativity,0.0,0.0,1.0,0.0
Blast-related brain injury,0.0,0.0,1.0,0.0
Self-propulsion,0.0,1.0,0.0,0.0
Numbing,0.0,1.0,0.0,0.0
Familiar faces,0.0,1.0,0.0,0.0
Temporal lobes,0.0,0.0,1.0,0.0
Donor human milk,0.0,1.0,0.0,0.0
Pharmacoresistant epilepsy,0.0,1.0,0.0,0.0
Visual object cognition,0.0,1.0,0.0,0.0
Real-world scene viewing,0.0,0.0,1.0,0.0
5-HT7 receptor,1.0,0.0,0.0,0.0
Violin playing,0.0,0.0,1.0,0.0
Psycho-physiological interaction,0.0,0.0,1.0,0.0
Clockwise and counterclockwise rotations,0.0,0.0,1.0,0.0
Information layout,0.0,0.0,1.0,0.0
Behavioral tests,0.0,0.0,0.0,1.0
Qualitative scoring,0.0,0.0,1.0,0.0
Visual platform water maze,0.0,1.0,0.0,0.0
Simultaneous visual discrimination,0.0,0.0,1.0,0.0
Computer-aided innovation,0.0,1.0,0.0,0.0
Rapid Visual Information Processing,1.0,0.0,0.0,0.0
Patient preferences,0.0,0.0,1.0,0.0
Cardiac autonomic dysfunction,1.0,0.0,0.0,0.0
Object-animal categorization,0.0,0.0,1.0,0.0
Pro-active interference,0.0,0.0,1.0,0.0
parental smoking,1.0,0.0,0.0,0.0
Fronto-striatal,0.0,1.0,0.0,0.0
Endogenous control,0.0,0.0,0.0,1.0
Spatial distance,0.0,0.0,1.0,0.0
Eye-hand span,0.0,0.0,1.0,0.0
Virtual reality (VR),0.0,0.0,1.0,0.0
Attentional probe,0.0,0.0,1.0,0.0
Nonverbal cues,0.0,0.0,1.0,0.0
Tactile display,0.0,0.0,0.0,1.0
mobility disability,0.0,0.0,1.0,0.0
transferability,0.0,0.0,1.0,0.0
Embedding,0.0,0.0,1.0,0.0
Interference effect,0.0,0.0,0.0,1.0
Emotional bias,0.0,0.0,1.0,0.0
Scalar implicature,0.0,0.0,1.0,0.0
Pediatric-onset multiple sclerosis,0.0,1.0,0.0,0.0
First impression,1.0,0.0,0.0,0.0
"Concussion,0.0,0.0,0.0,0.0
Nonlinear layout,0.0,0.0,1.0,0.0
neuropsychological injury,1.0,0.0,0.0,0.0
Hippocampus dysfunction,1.0,0.0,0.0,0.0
cartography,0.0,1.0,0.0,0.0
Spontaneous perspective taking,0.0,0.0,1.0,0.0
Illusory conjunctions,0.0,1.0,0.0,0.0
Cognitive deterioration,0.0,0.0,1.0,0.0
Endogenous orienting,0.0,0.0,0.0,1.0
Middle age,0.0,1.0,0.0,0.0
Mental entanglement,1.0,0.0,0.0,0.0
Early bilingualism,1.0,0.0,0.0,0.0
Vulvodynia,1.0,0.0,0.0,0.0
Theory of computation,0.0,1.0,0.0,0.0
DHEAS,0.0,0.0,1.0,0.0
Visuo-spatial perspective taking,0.0,0.0,0.0,1.0
Absolute time,0.0,0.0,1.0,0.0
Organist,0.0,0.0,1.0,0.0
Craniectomy,0.0,0.0,1.0,0.0
Mental effort,0.0,0.0,1.0,0.0
NAP (davunetide),0.0,0.0,1.0,0.0
naturalistic decision making,0.0,0.0,1.0,0.0
Population based.,0.0,0.0,1.0,0.0
Construal level theory,0.0,0.0,1.0,0.0
reactive inhibition,0.0,1.0,0.0,0.0
Probabilistic independent component analysis,0.0,0.0,1.0,0.0
Number knowledge,0.0,1.0,0.0,0.0
Non-invasive brain stimulation (NIBS),0.0,0.0,1.0,0.0
Voltage sensitive dyes,1.0,0.0,0.0,0.0
Enhanced perceptual processing,0.0,0.0,1.0,0.0
22q11.2 Deletion syndrome,0.0,0.0,1.0,0.0
Form and shape perception,0.0,1.0,0.0,0.0
Embodied simulation,0.0,0.0,0.0,1.0
computer simulation,1.0,0.0,0.0,0.0
Perception-Action coupling,0.0,0.0,1.0,0.0
Mind Machines,0.0,0.0,1.0,0.0
Interpretive community,0.0,0.0,1.0,0.0
Response inhibition training,1.0,0.0,0.0,0.0
medical treatment,0.0,0.0,1.0,0.0
DESIRE,0.0,1.0,0.0,0.0
Environmental preference,0.0,1.0,0.0,0.0
WRAP,0.0,1.0,0.0,0.0
House pictures,1.0,0.0,0.0,0.0
perception & psychophysics",0.0,0.0,0.0,0.0
5-I-A-85380-SPECT,0.0,0.0,1.0,0.0
Divisive normalization,0.0,1.0,0.0,0.0
Intravenous sedation,0.0,0.0,1.0,0.0
Parallel,0.0,0.0,0.0,1.0
Leukomalacia,0.0,0.0,0.0,0.0
Form processing,0.0,0.0,1.0,0.0
Engage,0.0,0.0,1.0,0.0
Gaze behaviour,0.0,1.0,0.0,0.0
Flirtatiousness,0.0,0.0,1.0,0.0
scale cognition,1.0,0.0,0.0,0.0
Commonality in factor structure,0.0,1.0,0.0,0.0
FmRI compatibility,0.0,0.0,0.0,1.0
Workingmemory,0.0,0.0,0.0,1.0
Theta-synchronization,0.0,0.0,1.0,0.0
Data-driven analysis,1.0,0.0,0.0,0.0
Nervous system,0.0,0.0,1.0,0.0
Diagrammatic representation,0.0,1.0,0.0,0.0
Out of body,0.0,0.0,1.0,0.0
Screening mental status,0.0,1.0,0.0,0.0
Text-to-sketch,1.0,0.0,0.0,0.0
human electroencephalogram,0.0,1.0,0.0,0.0
Retrospective processing,0.0,1.0,0.0,0.0
Fearful emotion,1.0,0.0,0.0,0.0
kinematic characteristics,0.0,1.0,0.0,0.0
Dynamism,0.0,0.0,1.0,0.0
Nonspatial,0.0,1.0,0.0,0.0
FALFF,0.0,0.0,1.0,0.0
Troponin,1.0,0.0,0.0,0.0
object alternation task,0.0,0.0,0.0,1.0
driving behaviors,0.0,0.0,1.0,0.0
Clinical cases,0.0,1.0,0.0,0.0
Chloral hydrate,0.0,0.0,1.0,0.0
Alpha and theta potentials,0.0,0.0,1.0,0.0
Gross motor development,0.0,0.0,1.0,0.0
organophosphorus compounds,0.0,0.0,0.0,1.0
Cattell-Horn-Carroll (CHC) theory,0.0,1.0,0.0,0.0
Model testing and validation,0.0,1.0,0.0,0.0
Merleau-Ponty,0.0,1.0,0.0,0.0
Deafference,0.0,1.0,0.0,0.0
Abstinent,0.0,1.0,0.0,0.0
BSITD-III,0.0,0.0,0.0,1.0
Lesion overlap,0.0,1.0,0.0,0.0
Chronic burnout,0.0,1.0,0.0,0.0
Utility measurement,0.0,0.0,1.0,0.0
Subspace learning,0.0,1.0,0.0,0.0
Innate fear-related responses,0.0,0.0,1.0,0.0
task complexity,0.0,1.0,0.0,0.0
human-computer interaction,0.0,1.0,0.0,0.0
entropy,1.0,0.0,0.0,0.0
FMRI at 7T,0.0,0.0,1.0,0.0
Behavior ratings,1.0,0.0,0.0,0.0
magnetic,1.0,0.0,0.0,0.0
Fetal growth retardation/epidemiology,0.0,0.0,0.0,1.0
Cortical prosthesis,0.0,0.0,1.0,0.0
Attention and hyperactivity disorder,0.0,0.0,1.0,0.0
theta rhythm,0.0,0.0,1.0,0.0
Complete network,0.0,0.0,1.0,0.0
tagged images,0.0,0.0,1.0,0.0
Early-stage,0.0,0.0,1.0,0.0
Peers,1.0,0.0,0.0,0.0
Homo sapiens,0.0,1.0,0.0,0.0
illusion,0.0,0.0,1.0,0.0
Spatial mapping,0.0,1.0,0.0,0.0
Biopsy,0.0,0.0,1.0,0.0
Overeating,0.0,1.0,0.0,0.0
Mirror fallacy,0.0,1.0,0.0,0.0
Seed based correlation analysis,0.0,1.0,0.0,0.0
tactile-visual-auditory stimulation,0.0,0.0,0.0,1.0
Visual Mismatch Negativity,1.0,0.0,0.0,0.0
App23 transgenic mouse model,1.0,0.0,0.0,0.0
Lymphocyte,0.0,1.0,0.0,0.0
Scaphocephaly,1.0,0.0,0.0,0.0
Questionnaire development,1.0,0.0,0.0,0.0
Three-dimensional renderings,1.0,0.0,0.0,0.0
Deformation-based morphometry,0.0,0.0,1.0,0.0
Bohm,0.0,1.0,0.0,0.0
User-centred design,1.0,0.0,0.0,0.0
Cardiomyopathy,0.0,0.0,1.0,0.0
Memory loss,0.0,0.0,1.0,0.0
N220,0.0,0.0,1.0,0.0
pre-SMA,0.0,1.0,0.0,0.0
family day-care,0.0,1.0,0.0,0.0
Ideal observer,0.0,0.0,1.0,0.0
Tyrosine hydroxylase,0.0,0.0,1.0,0.0
Multimodal stimuli,0.0,0.0,0.0,1.0
Posterior midline region,0.0,1.0,0.0,0.0
Multi-sensory impairment,0.0,0.0,0.0,1.0
Human interactive behaviour,0.0,0.0,0.0,1.0
Fragile X-associated tremor/ataxia syndrome (FXTAS),0.0,1.0,0.0,0.0
Motor Go/NoGo task,0.0,1.0,0.0,0.0
longitudinal latent variable model,0.0,1.0,0.0,0.0
Kanji,0.0,0.0,0.0,1.0
Neuropsychology.,0.0,0.0,1.0,0.0
Speaking,0.0,0.0,1.0,0.0
G-1,0.0,0.0,1.0,0.0
Mental development,0.0,0.0,1.0,0.0
Glutamatergic synapsis,0.0,0.0,1.0,0.0
Pain in elderly,1.0,0.0,0.0,0.0
Infant formula,0.0,0.0,0.0,1.0
Conditioned learning,1.0,0.0,0.0,0.0
Inverse problem,0.0,0.0,1.0,0.0
fMRI connectivity,0.0,0.0,1.0,0.0
Texture segregation,0.0,0.0,0.0,1.0
Theatrical event,1.0,0.0,0.0,0.0
Subtle Cognitive Impairment Test,0.0,0.0,0.0,1.0
Cross-frequency interactions,0.0,0.0,1.0,0.0
thematic relations,1.0,0.0,0.0,0.0
Analogies,0.0,0.0,1.0,0.0
caudate,0.0,0.0,1.0,0.0
Self-talk,0.0,0.0,0.0,1.0
Symbol digit modalities test,0.0,1.0,0.0,0.0
Microarray neuropsychology,0.0,0.0,1.0,0.0
Artists,0.0,0.0,1.0,0.0
Microstimulation,0.0,0.0,1.0,0.0
Global attention,0.0,1.0,0.0,0.0
Wisconsin Card Sorting Test-64,0.0,0.0,1.0,0.0
identity,1.0,0.0,0.0,0.0
caudate nucleus,0.0,0.0,1.0,0.0
tandospirone,0.0,1.0,0.0,0.0
conception risk,0.0,0.0,1.0,0.0
Spike sorting,0.0,0.0,1.0,0.0
pp. 125-136,0.0,1.0,0.0,0.0
Dietary behavior,0.0,1.0,0.0,0.0
Vision-centrality,0.0,0.0,1.0,0.0
Cognitive rhetoric,0.0,1.0,0.0,0.0
Small worldness,0.0,1.0,0.0,0.0
Lesser apes,0.0,1.0,0.0,0.0
Cardiac surgery,0.0,0.0,0.0,1.0
Theory of biology,1.0,0.0,0.0,0.0
Meta-stable dynamics,0.0,0.0,0.0,1.0
Biliary atresia,0.0,0.0,1.0,0.0
Repetition attenuation,0.0,0.0,0.0,1.0
head growth,0.0,1.0,0.0,0.0
pain perception and modulation,0.0,1.0,0.0,0.0
Vermis,0.0,1.0,0.0,0.0
Implicit/explicit,0.0,1.0,0.0,0.0
Tau-coupling analysis,0.0,1.0,0.0,0.0
Splitting,0.0,1.0,0.0,0.0
Transfer entropy,1.0,0.0,0.0,0.0
identit,1.0,0.0,0.0,0.0
B complex vitamins,0.0,1.0,0.0,0.0
cognitive and behavioral disabilities,0.0,0.0,1.0,0.0
statistical learning,0.0,1.0,0.0,0.0
Voluntary selection,0.0,1.0,0.0,0.0
Pressure,0.0,0.0,1.0,0.0
T1DM,0.0,1.0,0.0,0.0
Shetland ponies,0.0,0.0,1.0,0.0
peripheral vision,1.0,0.0,0.0,0.0
Kinaesthetic imagery,1.0,0.0,0.0,0.0
Information gating,0.0,0.0,1.0,0.0
Concealed information test (CIT),0.0,0.0,1.0,0.0
Bidirectionality,0.0,0.0,1.0,0.0
diver safety,1.0,0.0,0.0,0.0
Attentional demands,1.0,0.0,0.0,0.0
Self-reported cognitive change,0.0,0.0,0.0,1.0
Line motion illusion,1.0,0.0,0.0,0.0
Remote collaboration,0.0,1.0,0.0,0.0
ImPACT test,0.0,0.0,0.0,1.0
Joint model,0.0,1.0,0.0,0.0
Brain mri,0.0,0.0,0.0,1.0
Fact retrieval,1.0,0.0,0.0,0.0
White matter lesion (WML),0.0,1.0,0.0,0.0
Implicit Memory,0.0,0.0,1.0,0.0
Diffusion imaging,0.0,0.0,0.0,1.0
Sensorimotor network,0.0,0.0,1.0,0.0
PE,0.0,0.0,1.0,0.0
APOE promoter and AD,0.0,0.0,1.0,0.0
Superoxide,0.0,1.0,0.0,0.0
Stimulus-response compatibility effect,0.0,0.0,1.0,0.0
Ideation,0.0,0.0,1.0,0.0
Matching bias,0.0,0.0,1.0,0.0
Canonical neuron,0.0,0.0,1.0,0.0
guessing,0.0,0.0,1.0,0.0
Computerized battery,0.0,0.0,1.0,0.0
multiagent systems,0.0,0.0,1.0,0.0
Attentional awakening,1.0,0.0,0.0,0.0
Testosterone and cognition,1.0,0.0,0.0,0.0
Event-related Potentials,0.0,0.0,1.0,0.0
bronchopulmonary dysplasia,1.0,0.0,0.0,0.0
Neurobehavioural signs and symptoms,0.0,0.0,1.0,0.0
Eye-head coordination,0.0,0.0,1.0,0.0
DLPC,0.0,1.0,0.0,0.0
Intrapersonal factor,0.0,0.0,1.0,0.0
Hallucinogen,0.0,1.0,0.0,0.0
Isoflavones,0.0,0.0,1.0,0.0
The Mller-Lyer illusion,1.0,0.0,0.0,0.0
Spatial knowledge,0.0,0.0,1.0,0.0
Legisign,0.0,0.0,1.0,0.0
Crosstalk,0.0,0.0,0.0,1.0
SLE,0.0,1.0,0.0,0.0
Individual-based model,0.0,0.0,1.0,0.0
SLI,0.0,0.0,1.0,0.0
Midline lipoma,0.0,0.0,1.0,0.0
Reaction-time tasks,0.0,0.0,1.0,0.0
Interactions among sources of knowledge,0.0,0.0,1.0,0.0
Analogue trauma,1.0,0.0,0.0,0.0
Cognitive dys function,0.0,1.0,0.0,0.0
Clinical manifestation,0.0,1.0,0.0,0.0
Typical absence seizure,0.0,0.0,1.0,0.0
Education - methods,0.0,0.0,1.0,0.0
Aggressive behaviour,1.0,0.0,0.0,0.0
Dynamic links,0.0,0.0,1.0,0.0
generalized measure of association (GMA),0.0,0.0,1.0,0.0
Markers,0.0,0.0,1.0,0.0
Clinical course,0.0,0.0,0.0,1.0
cardiac rehabilitation,0.0,0.0,1.0,0.0
Degree effect,0.0,1.0,0.0,0.0
Allostasis,0.0,0.0,1.0,0.0
Man-made objects,0.0,1.0,0.0,0.0
AIDS dementia complex,0.0,1.0,0.0,0.0
Endogenous analgesia,0.0,0.0,0.0,1.0
Rule violation,0.0,1.0,0.0,0.0
Object-based,0.0,0.0,0.0,1.0
Fronto-parietal,0.0,0.0,1.0,0.0
Functionalmagnetic resonance imaging,0.0,0.0,0.0,1.0
Tonsillitis,0.0,1.0,0.0,0.0
Lateral eye movements,0.0,0.0,1.0,0.0
Iran,0.0,0.0,1.0,0.0
Salvia,0.0,0.0,1.0,0.0
Incidence rate,0.0,0.0,1.0,0.0
intermediate phenotype,1.0,0.0,0.0,0.0
Taekwondo,0.0,1.0,0.0,0.0
Postmenopausal androgen therapy,1.0,0.0,0.0,0.0
Subclinical disease,0.0,1.0,0.0,0.0
Visual mapping,0.0,1.0,0.0,0.0
Percepti phenomenology,0.0,0.0,1.0,0.0
White matter changes,0.0,0.0,1.0,0.0
Ridge wavelet analysis,0.0,0.0,1.0,0.0
QoL,0.0,0.0,1.0,0.0
Passing,0.0,0.0,1.0,0.0
Prosthetic vision,0.0,0.0,1.0,0.0
Mitochondrial cytochrome oxidase-rich areas,0.0,0.0,0.0,1.0
Individual difference,0.0,1.0,0.0,0.0
Memory fidelity,0.0,1.0,0.0,0.0
Autism in children,0.0,0.0,1.0,0.0
Spatio-temporal functional neuroimaging,0.0,1.0,0.0,0.0
Degeneration,0.0,0.0,1.0,0.0
cast shadows,0.0,1.0,0.0,0.0
[11C]PIB,0.0,1.0,0.0,0.0
Motor features,0.0,0.0,1.0,0.0
Mental navigation,1.0,0.0,0.0,0.0
Allothetic,0.0,0.0,1.0,0.0
Expertnovice paradigm,1.0,0.0,0.0,0.0
circadian misalignment,0.0,0.0,1.0,0.0
factor structure,1.0,0.0,0.0,0.0
Size discrimination,0.0,0.0,1.0,0.0
Head movement,0.0,0.0,1.0,0.0
Semantic variant,0.0,0.0,1.0,0.0
Categorical visuocognitive ERPs,0.0,0.0,0.0,1.0
Cornell Scale for Depression in Dementia (CSDD),0.0,0.0,1.0,0.0
ADL/IADL disability,0.0,0.0,1.0,0.0
Tactile object recognition,0.0,0.0,1.0,0.0
Globus pallidus pars interna,1.0,0.0,0.0,0.0
Visuoperceptual functions,0.0,0.0,0.0,1.0
Embodied memory,0.0,1.0,0.0,0.0
Event related field,0.0,0.0,0.0,1.0
insight,0.0,0.0,1.0,0.0
Zhu-Yin,0.0,0.0,0.0,1.0
Cognitive rhythms,0.0,0.0,0.0,1.0
Clinical competence,1.0,0.0,0.0,0.0
Tickertape synesthesia,1.0,0.0,0.0,0.0
Shape recognition,1.0,0.0,0.0,0.0
Ono,0.0,0.0,0.0,1.0
Psychomotor development of offspring,0.0,0.0,1.0,0.0
disconnection syndrome,0.0,0.0,0.0,1.0
Forward solution,0.0,0.0,0.0,1.0
Levodopa (l-dopa),0.0,0.0,0.0,1.0
speeded categorization,0.0,0.0,1.0,0.0
BOLD signal,0.0,1.0,0.0,0.0
Visual object agnosia,0.0,0.0,1.0,0.0
Pupillary diameter,1.0,0.0,0.0,0.0
Transliteration,0.0,1.0,0.0,0.0
Anterior insular cortex,0.0,1.0,0.0,0.0
Puerarin,0.0,0.0,0.0,1.0
Rule difficulty,0.0,0.0,0.0,1.0
Learning with images,0.0,1.0,0.0,0.0
Social statistical information,0.0,1.0,0.0,0.0
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor,0.0,0.0,1.0,0.0
Approximate quantification,0.0,0.0,0.0,1.0
Regression towards the mean,0.0,0.0,1.0,0.0
Merge,0.0,1.0,0.0,0.0
Gaze-tracking,0.0,0.0,1.0,0.0
Cingulotomy,0.0,0.0,1.0,0.0
Directional hypokinesia,0.0,0.0,1.0,0.0
Right temporoparietal junction,0.0,1.0,0.0,0.0
performance-based measures,0.0,0.0,1.0,0.0
Systems biology,0.0,1.0,0.0,0.0
Symbolic and non-symbolic inputs,0.0,1.0,0.0,0.0
Presupplementary motor area,0.0,0.0,1.0,0.0
sexual abuse,0.0,0.0,1.0,0.0
Visuo-motor processing,1.0,0.0,0.0,0.0
Point-to-origin,0.0,1.0,0.0,0.0
psychosis continuum,0.0,0.0,1.0,0.0
?4?2 nicotinic receptors,1.0,0.0,0.0,0.0
Lateral geniculate nucleus,1.0,0.0,0.0,0.0
Accessory information,0.0,1.0,0.0,0.0
Visual stream,0.0,0.0,1.0,0.0
Brain morphometry,0.0,0.0,1.0,0.0
Symptom response,1.0,0.0,0.0,0.0
Conscious intentions,1.0,0.0,0.0,0.0
UPSA-B,0.0,0.0,1.0,0.0
multimedia,1.0,0.0,0.0,0.0
Self-questioning,1.0,0.0,0.0,0.0
child psychiatry,0.0,0.0,1.0,0.0
Immediate Post-concussion Assessment and Cognitive Testing,0.0,0.0,1.0,0.0
Transformation,0.0,0.0,1.0,0.0
video,0.0,0.0,1.0,0.0
Patient-reported outcomes (PROs),1.0,0.0,0.0,0.0
Binocular visual field loss,1.0,0.0,0.0,0.0
Gilles de la Tourette,0.0,0.0,1.0,0.0
Optimal control,0.0,1.0,0.0,0.0
minerals,1.0,0.0,0.0,0.0
Current testosterone levels,0.0,0.0,1.0,0.0
Oscillatory dynamics,1.0,0.0,0.0,0.0
Identification latency,0.0,0.0,1.0,0.0
Multi-modal,0.0,0.0,1.0,0.0
Multiletter features,1.0,0.0,0.0,0.0
Learning skills,0.0,1.0,0.0,0.0
cognitive treatment,1.0,0.0,0.0,0.0
Driving skills,0.0,0.0,1.0,0.0
Cornelia de Lange syndrome,1.0,0.0,0.0,0.0
Japanese quail,0.0,1.0,0.0,0.0
Glossophaga,0.0,0.0,0.0,1.0
Flashbulb memory,0.0,1.0,0.0,0.0
Breakfast glycaemic index,0.0,0.0,0.0,1.0
Geometric properties,0.0,0.0,1.0,0.0
Deafferented patient,0.0,1.0,0.0,0.0
Functional measurement,0.0,0.0,1.0,0.0
Curved trajectories,0.0,1.0,0.0,0.0
Prime awareness,0.0,0.0,0.0,1.0
non-opioid analgesics,0.0,0.0,1.0,0.0
histamine iontophoresis,0.0,1.0,0.0,0.0
neurosurgery,0.0,0.0,0.0,0.0
Brain operations,0.0,1.0,0.0,0.0
influence,0.0,0.0,0.0,1.0
Inter-individual difference,1.0,0.0,0.0,0.0
Thin slices,0.0,1.0,0.0,0.0
Familial prosopagnosia,1.0,0.0,0.0,0.0
Circadian effects,0.0,0.0,0.0,1.0
Aura,0.0,1.0,0.0,0.0
Emmetropization,0.0,0.0,1.0,0.0
Perceptive difficulties,0.0,0.0,1.0,0.0
Erectile Dysfunction,0.0,0.0,1.0,0.0
Human color vision,1.0,0.0,0.0,0.0
Single opponent,0.0,1.0,0.0,0.0
Emotion suppression,0.0,1.0,0.0,0.0
HFA,0.0,0.0,1.0,0.0
Eye-movement classification,0.0,1.0,0.0,0.0
Taxonomic organization,0.0,1.0,0.0,0.0
Health Utilities Index Mark 2/3,0.0,0.0,1.0,0.0
peripheral nervous system neoplasms - etiology,0.0,1.0,0.0,0.0
List linking,0.0,0.0,1.0,0.0
Reliability of results,0.0,1.0,0.0,0.0
Histological findings,0.0,0.0,1.0,0.0
Anticipatory emotions,0.0,1.0,0.0,0.0
Conversion disorder,0.0,0.0,1.0,0.0
Parietal-occipital area,0.0,1.0,0.0,0.0
Spatial priming effect,1.0,0.0,0.0,0.0
Facilitated learning,1.0,0.0,0.0,0.0
Mathematical modeling,1.0,0.0,0.0,0.0
randomized controlled trial,1.0,0.0,0.0,0.0
Familiar,0.0,0.0,1.0,0.0
Educational measurement,1.0,0.0,0.0,0.0
Human information processing,0.0,0.0,1.0,0.0
Affective Go/No-go,1.0,0.0,0.0,0.0
Oxytocin receptor,0.0,0.0,1.0,0.0
WMHs,0.0,0.0,1.0,0.0
PET amyloid imaging,1.0,0.0,0.0,0.0
Social profiles,0.0,0.0,1.0,0.0
numerical continuum,0.0,1.0,0.0,0.0
Cerebral tumour,0.0,1.0,0.0,0.0
English language teachers,0.0,0.0,1.0,0.0
emergency,0.0,1.0,0.0,0.0
On,0.0,1.0,0.0,0.0
Simple view of reading,0.0,0.0,1.0,0.0
Prosocial intervention,0.0,1.0,0.0,0.0
transfer of training,0.0,0.0,1.0,0.0
Apnea,0.0,0.0,0.0,1.0
Olfactory stimulation,0.0,0.0,1.0,0.0
Breast cancer survivors,0.0,0.0,1.0,0.0
Natural cues,0.0,0.0,0.0,1.0
Cardiac defense,0.0,1.0,0.0,0.0
Implementation intentions.,0.0,1.0,0.0,0.0
Attention coordination,0.0,1.0,0.0,0.0
Sense of agency (SoA),0.0,0.0,1.0,0.0
Noncomposite,0.0,0.0,1.0,0.0
cultural products,0.0,0.0,1.0,0.0
psychological reasoning,0.0,1.0,0.0,0.0
Immunoreactivity,0.0,0.0,1.0,0.0
Scene construction,0.0,0.0,1.0,0.0
human errors,0.0,0.0,1.0,0.0
Broaden-and-build theory,0.0,1.0,0.0,0.0
Magnetization transfer ratio imaging,0.0,1.0,0.0,0.0
Artificial consciousness,0.0,0.0,0.0,1.0
Training loads,0.0,0.0,1.0,0.0
Implantable cardioverter- defibrillator,0.0,0.0,1.0,0.0
FA maps,0.0,0.0,1.0,0.0
Individual trade-off,1.0,0.0,0.0,0.0
Intertrial variability,1.0,0.0,0.0,0.0
Expressway,1.0,0.0,0.0,0.0
music performance,1.0,0.0,0.0,0.0
Visual continuity,1.0,0.0,0.0,0.0
temporal fusion,0.0,0.0,0.0,1.0
word frequency,1.0,0.0,0.0,0.0
Visual cognitive capacity,0.0,0.0,1.0,0.0
biophilia,0.0,0.0,1.0,0.0
Display design,0.0,1.0,0.0,0.0
MENOPAUSAL HORMONE THERAPY,1.0,0.0,0.0,0.0
Subjective reality,0.0,1.0,0.0,0.0
Spatial skill,1.0,0.0,0.0,0.0
Ont.)",0.0,0.0,0.0,0.0
Nutraceutical,0.0,1.0,0.0,0.0
Base rates,0.0,0.0,1.0,0.0
semantic knowledge,0.0,1.0,0.0,0.0
Hemispheric dominance,1.0,0.0,0.0,0.0
Technical limitations,0.0,0.0,1.0,0.0
Infants' experiences,0.0,1.0,0.0,0.0
Cognitive stress,1.0,0.0,0.0,0.0
adaptation,0.0,0.0,1.0,0.0
Object-based mental transformations,0.0,0.0,1.0,0.0
Pantocalcin,0.0,0.0,1.0,0.0
Scholastic achievement,0.0,1.0,0.0,0.0
SwLORETA,0.0,1.0,0.0,0.0
Nonconscious,1.0,0.0,0.0,0.0
Speech-reading,1.0,0.0,0.0,0.0
Heroin dependence,0.0,0.0,1.0,0.0
Regret,0.0,0.0,1.0,0.0
single subject,0.0,1.0,0.0,0.0
Antipsychotic medications,0.0,0.0,1.0,0.0
Geological time,0.0,0.0,1.0,0.0
Savant,0.0,1.0,0.0,0.0
Visual support,0.0,0.0,1.0,0.0
Flat-panel detector,0.0,0.0,1.0,0.0
Anaesthetics,0.0,1.0,0.0,0.0
Clinically isolated syndromes,0.0,1.0,0.0,0.0
"Anaesthetics gases,0.0,0.0,0.0,0.0
metacontrast,0.0,0.0,1.0,0.0
assistant system,1.0,0.0,0.0,0.0
Left-turns,0.0,0.0,1.0,0.0
Atypical lacunar syndrome,0.0,0.0,1.0,0.0
PSOM,0.0,1.0,0.0,0.0
Functional hemispheric differences,0.0,1.0,0.0,0.0
Rubinstein-Taybi syndrome,1.0,0.0,0.0,0.0
Orientation deficit,0.0,1.0,0.0,0.0
Clinicopath-ological features,0.0,0.0,1.0,0.0
Intimate relationships,0.0,0.0,1.0,0.0
Delayed cerebral ischemia,1.0,0.0,0.0,0.0
schema reliance,0.0,1.0,0.0,0.0
Object identity,1.0,0.0,0.0,0.0
transcallosal,0.0,0.0,0.0,1.0
Orthodontic treatment,0.0,0.0,1.0,0.0
refractory error,0.0,1.0,0.0,0.0
Brain activation change,1.0,0.0,0.0,0.0
Cognitive evoked potentials (P300),0.0,0.0,0.0,1.0
Senior citizens,1.0,0.0,0.0,0.0
Neuropolitics,0.0,0.0,1.0,0.0
Disconnection syndromes,1.0,0.0,0.0,0.0
Cephalic index,1.0,0.0,0.0,0.0
Preoccupation,0.0,0.0,1.0,0.0
Recognition-familiarity,0.0,0.0,1.0,0.0
United Kingdom,1.0,0.0,0.0,0.0
Blind people,1.0,0.0,0.0,0.0
Telephone assesment,0.0,0.0,0.0,1.0
Bacterial meningitis,0.0,0.0,1.0,0.0
minimal phrases,1.0,0.0,0.0,0.0
Wistar rats,1.0,0.0,0.0,0.0
Gap acceptance,0.0,0.0,1.0,0.0
contingency learning,0.0,1.0,0.0,0.0
Verbal dysfunction,0.0,0.0,1.0,0.0
Tactile object localization,0.0,0.0,1.0,0.0
Balance reactions,0.0,0.0,1.0,0.0
Ghrelin,1.0,0.0,0.0,0.0
Tactile spatial attention,0.0,1.0,0.0,0.0
imageability,0.0,0.0,1.0,0.0
human vision perceptual dissimilarity measure (VPDM),1.0,0.0,0.0,0.0
Stress and Coping",0.0,0.0,0.0,0.0
Generalized versus specific deficit,1.0,0.0,0.0,0.0
route directions,0.0,0.0,1.0,0.0
SISCOM (subtraction ictal SPECT co-registered to MRI),1.0,0.0,0.0,0.0
Lexical acquisition,0.0,0.0,1.0,0.0
Memory errors,0.0,0.0,1.0,0.0
Community-based participatory research,1.0,0.0,0.0,0.0
Cerebrospinal fluid shunt,0.0,0.0,1.0,0.0
VOLT,0.0,0.0,1.0,0.0
Gap junction,1.0,0.0,0.0,0.0
Deduction,0.0,0.0,1.0,0.0
Word_recognition,0.0,0.0,0.0,1.0
Mood induction procedure,0.0,0.0,1.0,0.0
Separability,0.0,0.0,1.0,0.0
Confidence-accuracy relation,0.0,0.0,1.0,0.0
Cerebrovascular risk factor,0.0,0.0,1.0,0.0
Repeated picture naming,0.0,0.0,1.0,0.0
Static balance,0.0,0.0,1.0,0.0
Neuroimmunology,0.0,0.0,1.0,0.0
Numbers and space,0.0,0.0,0.0,1.0
Jordanian Architects,0.0,1.0,0.0,0.0
post-constructionism,1.0,0.0,0.0,0.0
Polychlorinated dibenzofurans,0.0,1.0,0.0,0.0
V4 color center,0.0,0.0,1.0,0.0
Jamais vu,0.0,0.0,1.0,0.0
Growth factors,0.0,0.0,1.0,0.0
conditioned place preference,1.0,0.0,0.0,0.0
Conceptual spaces,0.0,0.0,1.0,0.0
11p Deletion,0.0,1.0,0.0,0.0
Dopamine antagonists,0.0,1.0,0.0,0.0
Computational neurosciences,1.0,0.0,0.0,0.0
object exploration,0.0,1.0,0.0,0.0
universality,1.0,0.0,0.0,0.0
Natural viewing behavior,0.0,0.0,1.0,0.0
Cognition disorder,0.0,0.0,0.0,1.0
Task-set,0.0,0.0,1.0,0.0
Cognitive Functions,0.0,0.0,1.0,0.0
analytic-nonanalytic processing,0.0,0.0,1.0,0.0
Pre-orthographic,0.0,1.0,0.0,0.0
Reference frame transformation,0.0,1.0,0.0,0.0
Renal replacement therapy,0.0,1.0,0.0,0.0
visual cues,0.0,0.0,1.0,0.0
Changes in physical functioning,0.0,0.0,1.0,0.0
Stroop paradigm,0.0,1.0,0.0,0.0
Hypogonadotropic hypogonadism,0.0,0.0,1.0,0.0
Scale invariant feature transform,0.0,0.0,1.0,0.0
myo-inositol,0.0,1.0,0.0,0.0
modifiable characteristics,0.0,0.0,1.0,0.0
bioinformatics,0.0,0.0,1.0,0.0
Resting states,0.0,0.0,1.0,0.0
Dyskinesias,0.0,0.0,0.0,1.0
Compatibility,0.0,0.0,1.0,0.0
Terminal cancer patients,0.0,0.0,1.0,0.0
Prime duration,0.0,1.0,0.0,0.0
Triflusal,1.0,0.0,0.0,0.0
Capnic status,0.0,0.0,1.0,0.0
Emotional expressivity,1.0,0.0,0.0,0.0
Gaze apraxia,0.0,1.0,0.0,0.0
Dual process,0.0,0.0,1.0,0.0
Geometric shapes,1.0,0.0,0.0,0.0
Delayed-matching-to-sample,0.0,1.0,0.0,0.0
psychiatric adverse effects,1.0,0.0,0.0,0.0
Traffic-awareness campaign,0.0,1.0,0.0,0.0
Early cognitive decline,0.0,0.0,0.0,1.0
length of stay,0.0,1.0,0.0,0.0
Events-interface,0.0,0.0,1.0,0.0
(f)MRI,0.0,0.0,1.0,0.0
Object based,0.0,0.0,1.0,0.0
Crash,0.0,0.0,1.0,0.0
study skills,0.0,0.0,1.0,0.0
Knowledge states,1.0,0.0,0.0,0.0
Cocaine use,1.0,0.0,0.0,0.0
Penalty,0.0,1.0,0.0,0.0
Interference model,0.0,0.0,0.0,1.0
Heat acclimation,1.0,0.0,0.0,0.0
Offspring cognitive function,0.0,1.0,0.0,0.0
Embedded Figures Task (EFT),0.0,0.0,1.0,0.0
attentional orienting,1.0,0.0,0.0,0.0
Circadian timing system,0.0,0.0,1.0,0.0
melancholia,0.0,0.0,0.0,1.0
prospective time estimation,0.0,1.0,0.0,0.0
Onset capture,1.0,0.0,0.0,0.0
college students,0.0,1.0,0.0,0.0
Sensory-specific satiety,0.0,1.0,0.0,0.0
Animal communication,0.0,0.0,1.0,0.0
length estimation,0.0,0.0,1.0,0.0
superior colliculus,1.0,0.0,0.0,0.0
displays,1.0,0.0,0.0,0.0
Biased competition model of attention,0.0,0.0,1.0,0.0
intelligibility,1.0,0.0,0.0,0.0
Moderate intellectual,0.0,1.0,0.0,0.0
signal detection task,0.0,1.0,0.0,0.0
Object files,0.0,0.0,0.0,1.0
Hierarchical objects,1.0,0.0,0.0,0.0
Examinations,0.0,0.0,1.0,0.0
Superior verbal ability,1.0,0.0,0.0,0.0
brain oscillations,0.0,0.0,0.0,1.0
General linear modeling,0.0,0.0,1.0,0.0
Information systems,0.0,0.0,0.0,1.0
Kinds of art,0.0,1.0,0.0,0.0
Smoking craving,0.0,0.0,1.0,0.0
Appearance self-esteem,0.0,0.0,1.0,0.0
physical fitness,1.0,0.0,0.0,0.0
Photon beam radiation,1.0,0.0,0.0,0.0
cognitive aspects,1.0,0.0,0.0,0.0
Evoked response potentials,0.0,0.0,1.0,0.0
Emotional-cognitive interaction,1.0,0.0,0.0,0.0
Interhemispheric transfer time (IHTT),0.0,0.0,1.0,0.0
Home-dwelling,0.0,0.0,1.0,0.0
?7 Nicotinic acetylcholine receptor agonists,0.0,1.0,0.0,0.0
Cocial cognition,1.0,0.0,0.0,0.0
Bayley Scales of Infant Development,1.0,0.0,0.0,0.0
Hypomania,1.0,0.0,0.0,0.0
Captive welfare,0.0,1.0,0.0,0.0
Video game,0.0,0.0,1.0,0.0
Magnocellular basal nucleus,1.0,0.0,0.0,0.0
Communication disorders,0.0,0.0,0.0,1.0
Shape and contour,0.0,0.0,1.0,0.0
Surface transportation systems,0.0,1.0,0.0,0.0
Closure Flexibility Test,0.0,1.0,0.0,0.0
cortical deactivation,1.0,0.0,0.0,0.0
Road test,0.0,0.0,1.0,0.0
introspection,0.0,0.0,1.0,0.0
Odor recognition memory,1.0,0.0,0.0,0.0
Omentum,1.0,0.0,0.0,0.0
MEPs,0.0,0.0,1.0,0.0
Inferencing,0.0,1.0,0.0,0.0
Hard question,0.0,0.0,1.0,0.0
Broad band phase,1.0,0.0,0.0,0.0
Proactive,1.0,0.0,0.0,0.0
Time scales,1.0,0.0,0.0,0.0
affordances,0.0,1.0,0.0,0.0
Numerical operations,1.0,0.0,0.0,0.0
Visual field loss,0.0,1.0,0.0,0.0
temporal variation,0.0,1.0,0.0,0.0
Job's Syndrome,0.0,1.0,0.0,0.0
Spelling development,1.0,0.0,0.0,0.0
Non-verbal discrimination,0.0,0.0,0.0,1.0
X-linked intellectual and developmental disability,0.0,0.0,1.0,0.0
ND,0.0,1.0,0.0,0.0
Alcohol-related neurodevelopmental disorder (ARND),0.0,0.0,1.0,0.0
NO,0.0,1.0,0.0,0.0
PKC/ERK/CREB/BDNF,0.0,0.0,1.0,0.0
Numerical representations,1.0,0.0,0.0,0.0
secondary curriculum,0.0,0.0,1.0,0.0
Positivity,0.0,0.0,1.0,0.0
Olfactory identification,0.0,0.0,0.0,1.0
Visual field dependence,0.0,0.0,1.0,0.0
Speech-gesture mismatches,0.0,0.0,1.0,0.0
Numerosity-tuned neurons,0.0,0.0,0.0,1.0
Neural gain,0.0,1.0,0.0,0.0
Mediodorsal nucleus of thalamus,0.0,1.0,0.0,0.0
Schizophrenia risk alleles,1.0,0.0,0.0,0.0
Task performance and analysis,0.0,0.0,1.0,0.0
Global or local coding,0.0,0.0,0.0,1.0
Integrate-and-fire network,0.0,0.0,1.0,0.0
Preclinical signs,1.0,0.0,0.0,0.0
Quadratic effect,0.0,0.0,1.0,0.0
temporoparietal junction,0.0,0.0,1.0,0.0
Immunomodulation,0.0,0.0,1.0,0.0
diving,1.0,0.0,0.0,0.0
Socio-emotional processing,0.0,1.0,0.0,0.0
Bimanual learning,0.0,1.0,0.0,0.0
Spectral frequency,0.0,0.0,1.0,0.0
Dose ranging,0.0,1.0,0.0,0.0
rivastigmine,0.0,1.0,0.0,0.0
Psychoeducational group therapy,0.0,0.0,0.0,1.0
Genetic loading,0.0,1.0,0.0,0.0
reverse causality,0.0,0.0,1.0,0.0
preference,0.0,0.0,1.0,0.0
traffic,0.0,0.0,1.0,0.0
Pediatric neuropsychology,0.0,0.0,0.0,1.0
Fixation duration,0.0,1.0,0.0,0.0
Pleasantness,0.0,0.0,0.0,1.0
Steroid responsive encephalopathy with autoimmune thyroiditis (SREAT),0.0,0.0,1.0,0.0
Psychiatric history,0.0,1.0,0.0,0.0
Galaxies,0.0,1.0,0.0,0.0
Old/new effects,0.0,0.0,1.0,0.0
Foreknowledge,0.0,0.0,1.0,0.0
NAA,0.0,0.0,1.0,0.0
Corvids,0.0,0.0,1.0,0.0
hypoxia,0.0,0.0,1.0,0.0
tracking,1.0,0.0,0.0,0.0
IRM,0.0,0.0,0.0,1.0
PCNN,0.0,1.0,0.0,0.0
Event-related-potential,0.0,1.0,0.0,0.0
Familiar names,0.0,0.0,1.0,0.0
3D interaction,0.0,0.0,1.0,0.0
Blood,0.0,0.0,1.0,0.0
Flexibility of meaning,0.0,0.0,1.0,0.0
Speech disorders,0.0,0.0,1.0,0.0
Postnatal development,1.0,0.0,0.0,0.0
Confirmatory Factorial Analysis,0.0,0.0,1.0,0.0
Chlorpromazine,1.0,0.0,0.0,0.0
Anticholinergics,1.0,0.0,0.0,0.0
technology,0.0,0.0,1.0,0.0
Metals,0.0,1.0,0.0,0.0
Top-down regulation,0.0,0.0,1.0,0.0
New language learning,0.0,0.0,0.0,1.0
Head motion analysis,0.0,0.0,1.0,0.0
Perceived naturalness,0.0,0.0,1.0,0.0
Biology education,0.0,0.0,1.0,0.0
Music theater voice,0.0,0.0,1.0,0.0
Serotonin receptors,0.0,0.0,1.0,0.0
Safety errors,0.0,0.0,1.0,0.0
Tractor-trailer,1.0,0.0,0.0,0.0
Event-related-potentials,0.0,0.0,1.0,0.0
Leuprolide,0.0,0.0,1.0,0.0
Cholecalciferol,0.0,0.0,1.0,0.0
accelerometer,1.0,0.0,0.0,0.0
epistemology,0.0,0.0,1.0,0.0
Trail making task,0.0,1.0,0.0,0.0
Brain TRODAT-SPECT,0.0,0.0,1.0,0.0
Action goal,0.0,0.0,0.0,1.0
brain cognitive dissimilarity measure (BCDM),1.0,0.0,0.0,0.0
Wechsler adult intelligence scale,0.0,0.0,1.0,0.0
Dual-pathway,1.0,0.0,0.0,0.0
11-beta-hydroxysteroid dehydrogenase type 2,1.0,0.0,0.0,0.0
Social problem solving Facial expression recognition,0.0,1.0,0.0,0.0
Mestizo,0.0,0.0,1.0,0.0
"Internal capsule,0.0,0.0,0.0,0.0
VLSM,0.0,0.0,0.0,1.0
Placement,1.0,0.0,0.0,0.0
Hip,0.0,0.0,0.0,1.0
Modality switch,0.0,0.0,1.0,0.0
Jumping spider,0.0,0.0,0.0,1.0
Incentive habit,0.0,1.0,0.0,0.0
Cognitive experiments,0.0,1.0,0.0,0.0
N270-P300,0.0,1.0,0.0,0.0
Functional semantic features,1.0,0.0,0.0,0.0
Spontaneous preference,0.0,0.0,1.0,0.0
unmanned ground vehicles,0.0,0.0,1.0,0.0
P/8,0.0,0.0,1.0,0.0
response ordering,0.0,1.0,0.0,0.0
Survey knowledge,0.0,1.0,0.0,0.0
Leadership,0.0,0.0,1.0,0.0
Attentional adjustment,1.0,0.0,0.0,0.0
Ska,0.0,0.0,0.0,1.0
Congenital hydrocephalus,0.0,0.0,1.0,0.0
Ethiopia,0.0,0.0,0.0,1.0
TACO1,0.0,1.0,0.0,0.0
Congenital blindness,0.0,0.0,1.0,0.0
Event-related EEG responses,1.0,0.0,0.0,0.0
Context-embedded,0.0,1.0,0.0,0.0
Visual MMN,1.0,0.0,0.0,0.0
Indirect names,0.0,1.0,0.0,0.0
Frugivore,0.0,0.0,1.0,0.0
Hybrid systems,1.0,0.0,0.0,0.0
Navigator,1.0,0.0,0.0,0.0
Group bias,0.0,0.0,1.0,0.0
Nonverbal IQ,1.0,0.0,0.0,0.0
Gender effects,0.0,0.0,0.0,1.0
Non-visual and motor imagery,1.0,0.0,0.0,0.0
normal cognitive aging,0.0,1.0,0.0,0.0
Linearization,0.0,0.0,1.0,0.0
Gaze contact,0.0,0.0,0.0,1.0
trait and state markers,0.0,1.0,0.0,0.0
interstimulus interval,0.0,0.0,1.0,0.0
Percutaneous transluminal angioplasty,0.0,1.0,0.0,0.0
Matlab,0.0,0.0,1.0,0.0
Volleyball players,1.0,0.0,0.0,0.0
Infarct,0.0,1.0,0.0,0.0
Cognitive correlates of hyperopia,0.0,0.0,1.0,0.0
Neurpsycologic alterations,0.0,0.0,0.0,1.0
Response-time theories,0.0,1.0,0.0,0.0
Early treatment,0.0,0.0,1.0,0.0
Dynamic superiority effect,0.0,0.0,1.0,0.0
Anabas testudineus,1.0,0.0,0.0,0.0
Home cage testing,1.0,0.0,0.0,0.0
Pattern recognition/visual,0.0,0.0,1.0,0.0
Das-Naglieri Cognitive Assessment System (DN-CAS),0.0,0.0,1.0,0.0
Simulation of neglect,1.0,0.0,0.0,0.0
Psittacines,0.0,0.0,1.0,0.0
Total anomalous pulmonary venous connection,0.0,0.0,1.0,0.0
Emotional ontogenesis,0.0,0.0,1.0,0.0
Middle distance runs,0.0,0.0,1.0,0.0
Functional-imaging,1.0,0.0,0.0,0.0
South Africa,0.0,1.0,0.0,0.0
Attentional shroud,0.0,0.0,0.0,1.0
nondeclarative memory,0.0,1.0,0.0,0.0
Child cognition,0.0,0.0,1.0,0.0
Continuity violations,0.0,1.0,0.0,0.0
incentives,1.0,0.0,0.0,0.0
visuo-spatial attention,0.0,1.0,0.0,0.0
Pongo pygmaeus,0.0,0.0,1.0,0.0
Agitation of the elderly,0.0,0.0,1.0,0.0
disorders of consciousness,0.0,0.0,1.0,0.0
Social performance anxiety,0.0,1.0,0.0,0.0
Physiological systems,1.0,0.0,0.0,0.0
Caloric preload,0.0,0.0,1.0,0.0
dental amalgam,0.0,1.0,0.0,0.0
Stimulus discrimination,0.0,1.0,0.0,0.0
Imagery use,0.0,0.0,1.0,0.0
Facial motion,0.0,1.0,0.0,0.0
Change characterization,0.0,0.0,0.0,1.0
Network science,0.0,1.0,0.0,0.0
Experiment,0.0,0.0,1.0,0.0
Infant numerical abilities,0.0,0.0,0.0,1.0
Abstract words,0.0,1.0,0.0,0.0
Attention-defcit/hyperactivity disorder,1.0,0.0,0.0,0.0
Ordinal judgment,1.0,0.0,0.0,0.0
Movement observation-execution,0.0,0.0,1.0,0.0
Abuse liability,0.0,0.0,1.0,0.0
Hiding,0.0,0.0,1.0,0.0
Overt visual attention,0.0,0.0,0.0,1.0
Choice decision,1.0,0.0,0.0,0.0
Neural re-use,1.0,0.0,0.0,0.0
LIP,0.0,1.0,0.0,0.0
The divided visual field paradigm,0.0,0.0,1.0,0.0
Conventional antipsychotics,0.0,1.0,0.0,0.0
Stereotypy,0.0,0.0,1.0,0.0
autobiographical hallucinations,0.0,1.0,0.0,0.0
Reference frame coordinates,0.0,1.0,0.0,0.0
Adderall,0.0,0.0,0.0,1.0
Wiesel,0.0,0.0,0.0,1.0
STM,1.0,0.0,0.0,0.0
Female suit,0.0,0.0,1.0,0.0
Head stabilisation,0.0,0.0,1.0,0.0
STG,1.0,0.0,0.0,0.0
OMEGA-3 FATTY ACIDS,1.0,0.0,0.0,0.0
neighborhood frequency,1.0,0.0,0.0,0.0
Unfamiliar visual objects,0.0,0.0,1.0,0.0
Word familiarity,0.0,0.0,1.0,0.0
Behavioral Dyscontrol Scale-II,0.0,0.0,1.0,0.0
biased familiarity,0.0,1.0,0.0,0.0
performance deficit,0.0,0.0,1.0,0.0
aripiprazole,0.0,0.0,0.0,1.0
Body semantics,0.0,0.0,1.0,0.0
opioids,0.0,0.0,0.0,1.0
Mediating mechanisms,1.0,0.0,0.0,0.0
Dipole source localization,1.0,0.0,0.0,0.0
Doubles,0.0,0.0,1.0,0.0
Reduced activity,0.0,0.0,0.0,1.0
inspection time (IT),0.0,1.0,0.0,0.0
Category-specific effects,0.0,1.0,0.0,0.0
Approach-avoidance motivation,0.0,0.0,1.0,0.0
object manipulation,0.0,1.0,0.0,0.0
Growth hormone deficiency (GHD),0.0,0.0,1.0,0.0
statistical parametric mapping,0.0,0.0,1.0,0.0
System WHAT,0.0,0.0,1.0,0.0
neuropsychological function,1.0,0.0,0.0,0.0
Body movements,1.0,0.0,0.0,0.0
Task speed,0.0,0.0,1.0,0.0
Performance decrement,0.0,0.0,0.0,1.0
Face-name memory encoding,0.0,0.0,1.0,0.0
Mobile eye tracking,1.0,0.0,0.0,0.0
Husserl,1.0,0.0,0.0,0.0
Decoding emotional expressions,0.0,0.0,1.0,0.0
Controlled retrieval,0.0,1.0,0.0,0.0
object matching,0.0,0.0,0.0,1.0
CD-1 mice,0.0,0.0,0.0,1.0
Location-based inhibition,0.0,0.0,1.0,0.0
Drawing from memory,0.0,0.0,1.0,0.0
Jun kinases,1.0,0.0,0.0,0.0
Self-management,1.0,0.0,0.0,0.0
Chronicity,0.0,0.0,1.0,0.0
Associative value,0.0,0.0,1.0,0.0
Copernicus,0.0,0.0,0.0,1.0
essential tremor,0.0,0.0,1.0,0.0
S-R binding,0.0,0.0,1.0,0.0
dose-response relationship,1.0,0.0,0.0,0.0
Non-verbal learning disabilities,1.0,0.0,0.0,0.0
Multicultural,0.0,1.0,0.0,0.0
Visual media,0.0,0.0,1.0,0.0
Tourism,0.0,0.0,0.0,1.0
Normal cognition,1.0,0.0,0.0,0.0
State-anxiety,0.0,0.0,1.0,0.0
Nightmares,0.0,0.0,1.0,0.0
Six degree of freedom,0.0,0.0,1.0,0.0
Environmental distraction,0.0,0.0,1.0,0.0
phoneme awareness,0.0,0.0,1.0,0.0
"?2-m,0.0,0.0,0.0,0.0
Forced hospitalization,0.0,1.0,0.0,0.0
Posterror slowing,1.0,0.0,0.0,0.0
motion in depth,0.0,0.0,1.0,0.0
Natural image statistics,0.0,0.0,1.0,0.0
Emotional chimeric faces,1.0,0.0,0.0,0.0
Hummingbird,0.0,0.0,1.0,0.0
neurological basis of cognition,1.0,0.0,0.0,0.0
Imitation inhibition,1.0,0.0,0.0,0.0
Preceptorship,1.0,0.0,0.0,0.0
Visual artwork,1.0,0.0,0.0,0.0
Reading mind in the eyes,1.0,0.0,0.0,0.0
Calibration,0.0,1.0,0.0,0.0
Synaptic function,1.0,0.0,0.0,0.0
Health utility,1.0,0.0,0.0,0.0
cognitive conspicuity,0.0,1.0,0.0,0.0
Cerebrovascular,0.0,0.0,1.0,0.0
Entorhinal and hippocampal atrophy,0.0,0.0,1.0,0.0
Extremely preterm birth,0.0,1.0,0.0,0.0
Nonvisual effects of light,0.0,0.0,1.0,0.0
Procedural versus declarative,0.0,0.0,0.0,1.0
Initial rapid orienting,0.0,0.0,1.0,0.0
Self-directed behavior,0.0,0.0,1.0,0.0
altitude,0.0,0.0,1.0,0.0
Semantic landmarks,1.0,0.0,0.0,0.0
facial age estimation,0.0,1.0,0.0,0.0
Spatial EEG patterns,0.0,0.0,0.0,1.0
activity theory,0.0,0.0,1.0,0.0
assessment strategies,1.0,0.0,0.0,0.0
mGlu7 receptors,1.0,0.0,0.0,0.0
Dorsal stream processing,0.0,1.0,0.0,0.0
Subjective perspective,1.0,0.0,0.0,0.0
Statin,0.0,0.0,1.0,0.0
Patient preference,1.0,0.0,0.0,0.0
Functional organization,0.0,1.0,0.0,0.0
Aricept,1.0,0.0,0.0,0.0
Antidementia agent,0.0,0.0,0.0,1.0
EEG (electroencephalogram),1.0,0.0,0.0,0.0
Focal radiotherapy,0.0,1.0,0.0,0.0
Word stem completion,0.0,1.0,0.0,0.0
Home literacy experiences,0.0,1.0,0.0,0.0
Hardness,0.0,0.0,1.0,0.0
moral cognition,0.0,0.0,1.0,0.0
treadmill,0.0,1.0,0.0,0.0
Facebook,0.0,0.0,1.0,0.0
primary visual cortex,0.0,1.0,0.0,0.0
Perception and understanding of intentions and actions,0.0,0.0,1.0,0.0
Humanization,0.0,0.0,1.0,0.0
CHRNA4 rs1044396,0.0,1.0,0.0,0.0
medical decision making,0.0,0.0,1.0,0.0
Fetal alcohol (FAS,0.0,0.0,0.0,0.0
Cell assemblies,1.0,0.0,0.0,0.0
Sternberg task,0.0,0.0,0.0,1.0
Auditory P300,0.0,0.0,0.0,1.0
Low-birth-weight infants,0.0,1.0,0.0,0.0
Scene Perception,1.0,0.0,0.0,0.0
Biophilia,1.0,0.0,0.0,0.0
PET neuroimaging,0.0,1.0,0.0,0.0
Product expression,0.0,0.0,1.0,0.0
In vivo,0.0,0.0,0.0,1.0
Sensory conflict,1.0,0.0,0.0,0.0
Face-to-face,0.0,1.0,0.0,0.0
Adult-onset,0.0,0.0,1.0,0.0
Fatigue-transfer effect,0.0,0.0,0.0,1.0
Coloured hearing,0.0,1.0,0.0,0.0
Tiredness,0.0,1.0,0.0,0.0
academic,0.0,0.0,1.0,0.0
Autonomous centenarians,0.0,1.0,0.0,0.0
EBA,0.0,0.0,0.0,1.0
Rebus,0.0,1.0,0.0,0.0
Assessment of cognitive disorders/dementia,0.0,1.0,0.0,0.0
Proust phenomenon,1.0,0.0,0.0,0.0
Neurotoxins,0.0,0.0,0.0,1.0
Shape and color,0.0,0.0,1.0,0.0
multisensory enhancement,0.0,0.0,1.0,0.0
Premedication,0.0,1.0,0.0,0.0
Hearing screenings,0.0,0.0,0.0,1.0
Task modulation,0.0,1.0,0.0,0.0
Imaging biomarkers,0.0,0.0,1.0,0.0
GABA receptor,0.0,0.0,1.0,0.0
Imaging genetics,0.0,1.0,0.0,0.0
First episode MDD,1.0,0.0,0.0,0.0
Consensus,0.0,1.0,0.0,0.0
Brain ageing,0.0,0.0,0.0,1.0
2LIP,0.0,0.0,0.0,1.0
Cognitive screening measures,0.0,1.0,0.0,0.0
B-SIT,0.0,1.0,0.0,0.0
Xp11.23p11.3 duplication,0.0,0.0,1.0,0.0
Sitting,0.0,0.0,0.0,1.0
Parallel forms,0.0,0.0,1.0,0.0
response complexity,0.0,0.0,1.0,0.0
Intraventricular meningioma,0.0,0.0,1.0,0.0
Nasal continuous positive airway pressure,0.0,0.0,1.0,0.0
Hierarchical object processing,0.0,1.0,0.0,0.0
8B Auditory,0.0,1.0,0.0,0.0
Top-down influences,1.0,0.0,0.0,0.0
Rhesus monkeys,0.0,0.0,1.0,0.0
Battery for functional magnetic resonance imaging (FMRI),1.0,0.0,0.0,0.0
functional near-infrared spectroscopy,0.0,0.0,1.0,0.0
nature,0.0,0.0,1.0,0.0
Allosterics,1.0,0.0,0.0,0.0
Natural kinds,0.0,0.0,1.0,0.0
Ibertsson,0.0,1.0,0.0,0.0
Endophenocognitype,0.0,1.0,0.0,0.0
Upright standing,0.0,0.0,1.0,0.0
Scan path,0.0,0.0,1.0,0.0
etic,0.0,0.0,1.0,0.0
N-Methyl-d-aspartate receptor,1.0,0.0,0.0,0.0
Visual habituation paradigm,0.0,0.0,1.0,0.0
Movement representations,0.0,0.0,1.0,0.0
Dilept (GZR-123),0.0,0.0,1.0,0.0
Conversif disorders,1.0,0.0,0.0,0.0
$Apolipoprotein E$Cognitive performance$Executive processes$Antagonistic pleiotropy$Metaanalysis,0.0,1.0,0.0,0.0
Concussion Vital Signs,0.0,1.0,0.0,0.0
Ecology,0.0,0.0,1.0,0.0
Speaker variability,0.0,0.0,0.0,1.0
Intermediate-level form vision,1.0,0.0,0.0,0.0
spontaneous monitoring,0.0,0.0,0.0,1.0
Single prolonged stress,0.0,0.0,1.0,0.0
Motor primitives,0.0,1.0,0.0,0.0
Mining brain dynamics,0.0,1.0,0.0,0.0
Phonemic fluency,1.0,0.0,0.0,0.0
Extracellular matrix,0.0,0.0,1.0,0.0
Reflexive consciousness,1.0,0.0,0.0,0.0
Threat of shock,0.0,0.0,0.0,1.0
MiniMental Parkinson,0.0,1.0,0.0,0.0
Moving object detection,0.0,1.0,0.0,0.0
All-or-none,1.0,0.0,0.0,0.0
Landscape management,1.0,0.0,0.0,0.0
Homing pigeon,0.0,0.0,1.0,0.0
Adolescent onset schizophrenia,0.0,0.0,1.0,0.0
Treatment effects,0.0,1.0,0.0,0.0
Elemental processing,0.0,0.0,1.0,0.0
Respiratory sinus arrhythmia,0.0,0.0,1.0,0.0
periodontitis,1.0,0.0,0.0,0.0
Discrimination Reversal,0.0,0.0,0.0,1.0
visual illusion,0.0,0.0,1.0,0.0
Thalamocortical connections,0.0,0.0,0.0,1.0
Sociodemographic variables,0.0,0.0,1.0,0.0
Symbol interdependency,0.0,1.0,0.0,0.0
Familial Alzheimer's disease,0.0,1.0,0.0,0.0
activation trends,0.0,0.0,1.0,0.0
Lexical categorization,1.0,0.0,0.0,0.0
lexical space,0.0,1.0,0.0,0.0
Surface-based attention,0.0,1.0,0.0,0.0
Target processing,1.0,0.0,0.0,0.0
Critical flicker frequency,0.0,0.0,1.0,0.0
Sleep stage shifts,0.0,0.0,1.0,0.0
Dose-equivalence relationship,0.0,0.0,1.0,0.0
Virtual fixtures,0.0,1.0,0.0,0.0
QLQ-C15-PAL,0.0,0.0,1.0,0.0
Model species,0.0,0.0,1.0,0.0
Cambridge Automated Neuropsychological Test Battery,0.0,0.0,0.0,1.0
Cognitive affective syndrome,0.0,0.0,1.0,0.0
Neuroleptic medication,0.0,1.0,0.0,0.0
Luria,0.0,0.0,0.0,1.0
Cardinality,0.0,1.0,0.0,0.0
Interlocking pentagons drawing,0.0,0.0,0.0,1.0
Nonsymbolic magnitudes,0.0,1.0,0.0,0.0
Hepatitis C,0.0,0.0,1.0,0.0
Word-referent,1.0,0.0,0.0,0.0
Cerebral small vessel disease,0.0,0.0,1.0,0.0
Letter-by-letter reading,0.0,0.0,1.0,0.0
Mental Processing Speed,0.0,0.0,1.0,0.0
Health cognitions,0.0,1.0,0.0,0.0
Mooney,1.0,0.0,0.0,0.0
Interhemispheric cooperation,1.0,0.0,0.0,0.0
Ultradian rhythm,0.0,0.0,1.0,0.0
Nonsymbolic fractions,0.0,0.0,1.0,0.0
Adrenocortical activity,0.0,0.0,1.0,0.0
Self-rated driving,0.0,0.0,1.0,0.0
Health services for the aged,0.0,0.0,1.0,0.0
Experiential blindness,0.0,1.0,0.0,0.0
Surgical outcome,0.0,1.0,0.0,0.0
Cognitive impairment index,0.0,0.0,1.0,0.0
Reduced folate carrier,0.0,0.0,1.0,0.0
alpha-amino adipic acid semialdehyde,1.0,0.0,0.0,0.0
Symbolic image,0.0,0.0,0.0,1.0
VU0467154,0.0,0.0,1.0,0.0
Vision tests,0.0,1.0,0.0,0.0
Evoked visual potentials,0.0,0.0,1.0,0.0
amyotrophic lateral sclerosis,0.0,0.0,1.0,0.0
Neurological disease,1.0,0.0,0.0,0.0
Object-position recognition,0.0,0.0,1.0,0.0
Copy,0.0,0.0,1.0,0.0
Argentina)",0.0,0.0,0.0,0.0
Insulin resistance,0.0,0.0,1.0,0.0
Blast-related injury,0.0,1.0,0.0,0.0
comparative study,0.0,1.0,0.0,0.0
Functional mapping,0.0,0.0,1.0,0.0
folate,0.0,1.0,0.0,0.0
Sexual maturation,1.0,0.0,0.0,0.0
Language deficit,0.0,0.0,1.0,0.0
neuromotor speech disorders,1.0,0.0,0.0,0.0
"Aged,0.0,0.0,0.0,0.0
Blood oxygenation level-dependent response,0.0,1.0,0.0,0.0
Verbal code,0.0,1.0,0.0,0.0
spatial recall biases,0.0,0.0,1.0,0.0
Type I and II deletions,0.0,1.0,0.0,0.0
Color scale,0.0,0.0,1.0,0.0
CFS,0.0,0.0,1.0,0.0
Texture density,1.0,0.0,0.0,0.0
Functional response,0.0,1.0,0.0,0.0
Biased-competition,0.0,1.0,0.0,0.0
Mller-Lyer deception,0.0,0.0,0.0,1.0
L2,0.0,1.0,0.0,0.0
Mid-level vision,1.0,0.0,0.0,0.0
inert gas narcosis,1.0,0.0,0.0,0.0
cadence,0.0,1.0,0.0,0.0
Stochasticity,1.0,0.0,0.0,0.0
Sensory-gating,0.0,0.0,0.0,1.0
Attentional set shifting,0.0,0.0,1.0,0.0
Autotopagnosia,1.0,0.0,0.0,0.0
Expert along training,0.0,1.0,0.0,0.0
Robotic soccer,0.0,0.0,0.0,1.0
Chiari malformation etiology,1.0,0.0,0.0,0.0
Pomaglumetad methionil,0.0,0.0,1.0,0.0
Objective Threshold/Strategic Model,0.0,0.0,1.0,0.0
Behavioral strategy,1.0,0.0,0.0,0.0
Agent-based modeling,0.0,0.0,1.0,0.0
affective images,0.0,1.0,0.0,0.0
bipolar II disorder,0.0,0.0,1.0,0.0
Spatial audition,1.0,0.0,0.0,0.0
Map generalization,0.0,0.0,1.0,0.0
Perimenopause,1.0,0.0,0.0,0.0
Visual completion,0.0,1.0,0.0,0.0
Long-acting antichilinergics (LAMA),0.0,1.0,0.0,0.0
Young females,1.0,0.0,0.0,0.0
facial emotion,0.0,1.0,0.0,0.0
Rural area,0.0,0.0,1.0,0.0
egocentric bias,0.0,0.0,1.0,0.0
Psychomotricity,0.0,0.0,1.0,0.0
Multimedia learning,1.0,0.0,0.0,0.0
Social threat,0.0,0.0,0.0,1.0
White noise,0.0,0.0,0.0,1.0
Chicago Electrical NeuroImaging Analytics (CENA),0.0,0.0,0.0,1.0
topography,0.0,0.0,0.0,1.0
Nogo-anteriorisation (NGA),1.0,0.0,0.0,0.0
Fractal dimension,0.0,0.0,1.0,0.0
Motor sequence,0.0,1.0,0.0,0.0
Oscillopsia,0.0,1.0,0.0,0.0
Landmark use,0.0,0.0,1.0,0.0
distributed attention,0.0,1.0,0.0,0.0
Degenerative dementia,0.0,0.0,1.0,0.0
Extrahepatic manifestations,0.0,0.0,0.0,0.0
Positron emission tomography (PET),0.0,1.0,0.0,0.0
Cognitive-control,0.0,0.0,0.0,1.0
Audiovisual crossmodal integration,0.0,0.0,1.0,0.0
Neurological impairment,0.0,0.0,1.0,0.0
Cross-modal conversion,0.0,0.0,1.0,0.0
errors,1.0,0.0,0.0,0.0
emergency shelter,0.0,0.0,1.0,0.0
feasibility,0.0,0.0,1.0,0.0
Hypoglycaemia awareness,1.0,0.0,0.0,0.0
Multi-digit number processing,0.0,1.0,0.0,0.0
Internal attention,1.0,0.0,0.0,0.0
Visual-event coding,0.0,0.0,1.0,0.0
Minority groups,1.0,0.0,0.0,0.0
Prepsychosis,1.0,0.0,0.0,0.0
Visual motion processing,0.0,1.0,0.0,0.0
driving ability,0.0,1.0,0.0,0.0
Cognition in sports,0.0,1.0,0.0,0.0
Memory and attention impairment,1.0,0.0,0.0,0.0
pretuning,0.0,0.0,1.0,0.0
Rs16965628,1.0,0.0,0.0,0.0
Western,0.0,1.0,0.0,0.0
Numerical serial positions,0.0,0.0,1.0,0.0
Cognitive stability,0.0,1.0,0.0,0.0
semi-supervised learning,0.0,1.0,0.0,0.0
and individual variability (1984) Vision Res,1.0,0.0,0.0,0.0
factorial invariance,1.0,0.0,0.0,0.0
Monoamine,1.0,0.0,0.0,0.0
Experimental neuroethics,0.0,1.0,0.0,0.0
